Supplemental Rebate Utilization Report

Transcription

Utilization Report
2/18/2005
Listing by PDL Category and Drug
This listing is a reference guide only and may be subject to change.
* Market Share is based on scripts per PDL category.
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
5HT#?OTHER ANTIEMETICS
00006355259
PRIMAXIN IV INJ 500MG
4
$2,801.96
80.00%
0
$0.00
0.00%
00006358275
PRIMAXIN IM INJ 500MG
1
$856.56
20.00%
0
$0.00
0.00%
1
$36.02
0.04%
0
$0.00
0.00%
ACE AND THIAZIDE COMBO'S
00006014058
PRINZIDE
00071022023
ACCURETIC
TAB 20/12.5
17
$632.88
0.66%
0
$0.00
0.00%
00071022223
ACCURETIC
TAB 10/12.5
5
$139.99
0.19%
2
$71.00
0.08%
00071022323
ACCURETIC
TAB 20/25MG
3
$133.91
0.12%
0
$0.00
0.00%
00083005730
LOTENSIN HCT TAB 5-6.25MG
1
$31.33
0.04%
0
$0.00
0.00%
00083007230
LOTENSIN HCT TAB 10-12.5
30
$898.08
1.16%
3
$91.89
0.11%
00083007430
LOTENSIN HCT TAB 20-12.5
51
$1,511.51
1.98%
0
$0.00
0.00%
00083007530
LOTENSIN HCT TAB 20-25MG
23
$635.45
0.89%
0
$0.00
0.00%
00087149201
MONOPRIL HCT TAB 10/12.5
9
$355.17
0.35%
8
$229.11
0.30%
00087149301
MONOPRIL HCT TAB 20/12.5
3
$106.05
0.12%
0
$0.00
0.00%
00091371201
UNIRETIC
TAB 7.5/12.5
30
$906.80
1.16%
34
$1,180.92
1.28%
00091372001
UNIRETIC
TAB 15-12.5
36
$1,064.16
1.40%
66
$2,164.46
2.48%
00091372501
UNIRETIC
TAB 15/25MG
98
$2,933.45
3.80%
76
$2,351.56
2.86%
00093017601
CAPTOPR/HCTZ TAB 25-15MG
2
$24.50
0.08%
0
$0.00
0.00%
00093017701
1
$7.45
0.04%
0
$0.00
0.00%
Copyright GHS Data Management, 2005
TAB 20-12.5
Page 1 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
- Category Continued -
00093103501
LISINOP-HCTZ TAB 10-12.5
14
$196.80
0.54%
11
$118.55
0.41%
00093103601
29
$512.27
1.13%
13
$173.05
0.49%
00093103701
LISINOP-HCTZ TAB 20-25MG
31
$454.15
1.20%
19
$253.75
0.71%
00093104401
ENALAPR/HCTZ TAB 5-12.5MG
0
$0.00
0.00%
2
$19.10
0.08%
00093105201
ENALAPR/HCTZ TAB 10-25MG
10
$166.60
0.39%
20
$287.00
0.75%
00143126301
0
$0.00
0.00%
27
$296.45
1.01%
00143126401
4
$88.70
0.16%
8
$86.00
0.30%
00172503260
39
$631.23
1.51%
288
$3,497.01
10.82%
00172503270
1
$28.45
0.04%
3
$32.25
0.11%
00172503360
73
$955.72
2.83%
213
$2,267.46
8.00%
00172503370
16
$235.54
0.62%
2
$19.49
0.08%
00172503460
66
$1,069.41
2.56%
225
$2,824.69
8.46%
00172503470
37
$604.41
1.44%
52
$642.75
1.95%
00172536260
BENAZEP/HCTZ TAB 20-12.5
0
$0.00
0.00%
3
$19.77
0.11%
00185015101
1
$9.55
0.04%
0
$0.00
0.00%
00185015201
214
$3,698.92
8.31%
23
$298.55
0.86%
00185017201
3
$65.85
0.12%
0
$0.00
0.00%
00185017301
233
$4,092.52
9.05%
27
$332.45
1.01%
00185710001
140
$1,881.69
5.43%
15
$213.75
0.56%
00228270611
3
$39.25
0.12%
0
$0.00
0.00%
00228270703
0
$0.00
0.00%
1
$9.85
0.04%
00228270711
2
$53.30
0.08%
0
$0.00
0.00%
00228270811
5
$87.05
0.19%
6
$79.50
0.23%
00310014110
ZESTORETIC TAB 10/12.5
1
$15.28
0.04%
3
$105.02
0.11%
00310014210
ZESTORETIC TAB 20-12.5
2
$76.40
0.08%
3
$128.26
0.11%
00310014510
ZESTORETIC TAB 20-25MG
2
$77.28
0.08%
3
$114.81
0.11%
00378008101
12
$91.90
0.47%
9
$85.17
0.34%
Page 2 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
00378008601
00378071201
00378072301
00378101201
$
Market Share*
00378008301
# of Scripts
$21.50
0.08%
$14.90
0.08%
0
$0.00
0.00%
21
$183.45
0.82%
3
$29.55
0.11%
30
$299.00
1.13%
96
$1,286.93
3.73%
67
$943.77
2.52%
235
$3,314.45
9.12%
238
$2,653.83
8.94%
00378201201
345
00378202501
337
$6,041.79
13.39%
327
$4,759.60
12.29%
$6,126.07
13.08%
322
$4,680.69
12.10%
00378474501
0
$0.00
0.00%
1
$4.50
0.04%
00378477501
BENAZEP/HCTZ TAB 20-25MG
0
$0.00
0.00%
2
$67.06
0.08%
00591086001
00591086005
23
$479.15
0.89%
67
$669.67
2.52%
0
$0.00
0.00%
2
$18.50
0.08%
00591086101
28
$760.95
1.09%
57
$734.95
2.14%
00591086105
0
$0.00
0.00%
7
$86.26
0.26%
00591086201
27
$610.35
1.05%
79
$930.80
2.97%
00591086205
0
$0.00
0.00%
9
$87.60
0.34%
00781117601
30
$536.61
1.16%
45
$575.75
1.69%
00781117801
25
$402.65
0.97%
34
$482.84
1.28%
00781184801
33
$438.63
1.28%
31
$325.18
1.16%
49884068701
5
$92.95
0.19%
4
$105.70
0.15%
51672404501
23
$223.13
0.89%
25
$235.49
0.94%
51672404601
45
$612.24
1.75%
55
$675.61
2.07%
52152024030
QUINARETIC TAB 20/25
0
$0.00
0.00%
1
$5.10
0.04%
59772516005
3
$36.75
0.12%
6
$56.40
0.23%
59772516105
0
$0.00
0.00%
6
$44.70
0.23%
59772516205
7
$119.35
0.27%
5
$85.25
0.19%
59772516305
5
$114.25
0.19%
4
$39.40
0.15%
62037075701
0
$0.00
0.00%
3
$50.96
0.11%
2
2
Page 3 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
63304053601
14
$219.60
0.54%
15
$143.23
0.56%
63304053701
13
$237.35
0.50%
22
$217.50
0.83%
63304053801
9
$129.12
0.35%
27
$362.05
1.01%
64455014601
VASERETIC
2
$74.34
0.08%
0
$0.00
0.00%
TAB 10-25MG
ACE INHIBITORS
00006001954
PRINIVIL
TAB 5MG
6
$258.90
0.02%
3
$167.88
0.01%
00006001958
PRINIVIL
TAB 5MG
2
$58.10
0.01%
0
$0.00
0.00%
00006010654
PRINIVIL
TAB 10MG
2
$34.70
0.01%
0
$0.00
0.00%
00006010658
PRINIVIL
TAB 10MG
1
$29.97
0.00%
0
$0.00
0.00%
00006010682
PRINIVIL
TAB 10MG
1
$32.20
0.00%
0
$0.00
0.00%
00006020754
PRINIVIL
TAB 20MG
3
$111.68
0.01%
3
$100.86
0.01%
00006020758
PRINIVIL
TAB 20MG
5
$191.32
0.01%
2
$62.62
0.01%
00006023758
PRINIVIL
TAB 40MG
7
$370.68
0.02%
3
$148.05
0.01%
00006071382
VASOTEC
0
$0.00
0.00%
4
$113.23
0.01%
00032110101
ACEON
TAB 2MG
3
$56.03
0.01%
0
$0.00
0.00%
00032110201
ACEON
TAB 4MG
10
$344.89
0.03%
0
$0.00
0.00%
00032110301
ACEON
TAB 8MG
9
$618.02
0.03%
1
$7.22
0.00%
00048580601
MAVIK
TAB 2MG
6
$112.10
0.02%
0
$0.00
0.00%
00048580701
MAVIK
TAB 4MG
4
$119.62
0.01%
1
$35.12
0.00%
00071052723
ACCUPRIL
TAB 5MG
37
$1,093.55
0.11%
10
$239.99
0.03%
00071053023
ACCUPRIL
TAB 10MG
116
$3,371.67
0.33%
34
$1,004.22
0.09%
00071053223
ACCUPRIL
TAB 20MG
136
$4,026.94
0.39%
56
$2,211.38
0.16%
00071053523
ACCUPRIL
TAB 40MG
195
$6,815.76
0.56%
46
$1,662.61
0.13%
00074227813
MAVIK
TAB 1MG
13
$320.91
0.04%
1
$31.40
0.00%
00074227913
MAVIK
TAB 2MG
27
$675.19
0.08%
6
$161.92
0.02%
00074228011
MAVIK
TAB 4MG
1
$52.27
0.00%
0
$0.00
0.00%
TAB 10MG
Page 4 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
MAVIK
00083005930
LOTENSIN
00083006330
LOTENSIN
00083006390
$
Market Share*
ACE INHIBITORS
00074228013
# of Scripts
TAB 4MG
28
$803.33
0.08%
5
$222.17
0.01%
TAB 5MG
53
$1,325.61
0.15%
10
$173.43
0.03%
TAB 10MG
159
$4,714.50
0.46%
17
$562.09
0.05%
LOTENSIN
TAB 10MG
7
$201.65
0.02%
0
$0.00
0.00%
00083007930
LOTENSIN
TAB 20MG
265
$8,088.67
0.76%
44
$1,534.41
0.12%
00083007990
LOTENSIN
TAB 20MG
8
$226.72
0.02%
0
$0.00
0.00%
00083009430
LOTENSIN
TAB 40MG
155
$5,266.19
0.45%
11
$434.21
0.03%
00083009490
LOTENSIN
TAB 40MG
4
$158.29
0.01%
0
$0.00
0.00%
00087015846
MONOPRIL
TAB 10MG
166
$5,475.86
0.48%
62
$2,184.56
0.17%
00087060942
MONOPRIL
TAB 20MG
132
$5,000.24
0.38%
60
$2,502.67
0.17%
00087120213
MONOPRIL
TAB 40MG
91
$3,268.20
0.26%
62
$2,562.83
0.17%
00091370701
UNIVASC
TAB 7.5MG
305
$8,968.07
0.88%
200
$7,071.68
0.56%
00091370709
UNIVASC
TAB 7.5MG
3
$85.64
0.01%
22
$781.44
0.06%
00091371501
UNIVASC
TAB 15MG
335
$11,574.79
0.96%
291
$11,928.35
0.81%
00091371509
UNIVASC
TAB 15MG
9
$418.27
0.03%
6
$213.12
0.02%
00093001701
MOEXIPRIL
TAB 7.5MG
30
$621.73
0.09%
18
$196.68
0.05%
00093002601
ENALAPRIL
TAB 2.5MG
39
$512.08
0.11%
70
$904.94
0.19%
00093002701
ENALAPRIL
TAB 5MG
119
$976.36
0.34%
144
$1,684.48
0.40%
00093002710
ENALAPRIL
TAB 5MG
2
$24.50
0.01%
0
$0.00
0.00%
00093002801
ENALAPRIL
TAB 10MG
168
$1,615.59
0.48%
210
$2,385.11
0.58%
00093002901
ENALAPRIL
TAB 20MG
198
$2,644.21
0.57%
242
$4,480.66
0.67%
00093002910
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
1
$20.15
0.00%
00093009101
CAPTOPRIL
TAB 12.5MG
77
$224.09
0.22%
3
$7.76
0.01%
00093009201
CAPTOPRIL
TAB 25MG
85
$343.52
0.24%
3
$11.67
0.01%
00093009701
CAPTOPRIL
TAB 50MG
65
$467.11
0.19%
0
$0.00
0.00%
00093009801
CAPTOPRIL
TAB 100MG
13
$142.95
0.04%
3
$19.74
0.01%
00093111101
LISINOPRIL TAB 2.5MG
11
$58.65
0.03%
27
$134.75
0.07%
Page 5 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00093111201
LISINOPRIL TAB 5MG
7
$35.35
0.02%
60
$372.78
0.17%
00093111210
LISINOPRIL TAB 5MG
142
$851.41
0.41%
177
$1,025.60
0.49%
00093111301
LISINOPRIL TAB 10MG
42
$330.30
0.12%
32
$258.85
0.09%
00093111310
LISINOPRIL TAB 10MG
441
$3,270.95
1.27%
391
$2,851.47
1.09%
00093111401
LISINOPRIL TAB 20MG
76
$688.78
0.22%
29
$289.65
0.08%
00093111410
LISINOPRIL TAB 20MG
390
$3,914.65
1.12%
209
$2,090.26
0.58%
00093111501
LISINOPRIL TAB 40MG
149
$1,968.98
0.43%
148
$1,922.41
0.41%
00093111505
LISINOPRIL TAB 40MG
0
$0.00
0.00%
2
$23.40
0.01%
00093512401
BENAZEPRIL TAB 5MG
0
$0.00
0.00%
5
$99.74
0.01%
00093512501
BENAZEPRIL TAB 10MG
0
$0.00
0.00%
4
$47.65
0.01%
00093512601
BENAZEPRIL TAB 20MG
0
$0.00
0.00%
9
$132.13
0.02%
00093512701
BENAZEPRIL TAB 40MG
0
$0.00
0.00%
6
$114.31
0.02%
00093515001
MOEXIPRIL
TAB 15MG
27
$610.45
0.08%
10
$81.58
0.03%
00093515701
LISINOPRIL TAB 30MG
13
$216.25
0.04%
29
$368.15
0.08%
00093722298
FOSINOPRIL TAB 10MG
2
$21.52
0.01%
22
$630.41
0.06%
00093722398
FOSINOPRIL TAB 20MG
0
$0.00
0.00%
9
$187.27
0.02%
00093722410
FOSINOPRIL TAB 40MG
0
$0.00
0.00%
2
$91.70
0.01%
00093722498
FOSINOPRIL TAB 40MG
0
$0.00
0.00%
12
$257.30
0.03%
00093813201
CAPTOPRIL
TAB 12.5MG
3
$13.89
0.01%
74
$212.29
0.21%
00093813301
CAPTOPRIL
TAB 25MG
22
$88.27
0.06%
86
$364.00
0.24%
00093813401
CAPTOPRIL
TAB 50MG
8
$86.02
0.02%
56
$404.74
0.16%
00093813501
CAPTOPRIL
TAB 100MG
1
$20.15
0.00%
9
$86.21
0.02%
00143117101
CAPTOPRIL
TAB 12.5MG
45
$149.62
0.13%
42
$124.88
0.12%
00143117110
CAPTOPRIL
TAB 12.5MG
37
$126.90
0.11%
25
$83.64
0.07%
00143117201
CAPTOPRIL
TAB 25MG
28
$151.16
0.08%
52
$230.48
0.14%
00143117210
CAPTOPRIL
TAB 25MG
50
$216.40
0.14%
86
$384.19
0.24%
00143117301
CAPTOPRIL
TAB 50MG
22
$164.12
0.06%
18
$109.19
0.05%
Page 6 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00143117310
CAPTOPRIL
TAB 50MG
18
$129.16
0.05%
65
$398.15
0.18%
00143117401
CAPTOPRIL
TAB 100MG
8
$100.95
0.02%
13
$173.93
0.04%
00143126601
LISINOPRIL TAB 5MG
0
$0.00
0.00%
18
$103.07
0.05%
00143126701
LISINOPRIL TAB 10MG
14
$103.40
0.04%
35
$244.17
0.10%
00143126710
LISINOPRIL TAB 10MG
0
$0.00
0.00%
1
$3.65
0.00%
00143126801
LISINOPRIL TAB 20MG
9
$82.65
0.03%
39
$414.35
0.11%
00143126810
LISINOPRIL TAB 20MG
0
$0.00
0.00%
16
$157.20
0.04%
00143127001
LISINOPRIL TAB 40MG
15
$193.65
0.04%
44
$535.34
0.12%
00172375760
184
$1,058.62
0.53%
208
$1,388.81
0.58%
00172375770
172
$1,148.89
0.50%
221
$1,464.90
0.61%
00172375810
LISINOPRIL TAB 5MG
6
$52.40
0.02%
0
$0.00
0.00%
00172375860
LISINOPRIL TAB 5MG
442
$2,751.63
1.27%
557
$3,789.71
1.55%
00172375870
LISINOPRIL TAB 5MG
586
$4,134.76
1.69%
466
$3,273.93
1.29%
00172375960
LISINOPRIL TAB 10MG
537
$3,863.10
1.55%
113
$705.58
0.31%
00172375970
LISINOPRIL TAB 10MG
798
$6,084.53
2.30%
1,324
$10,398.67
3.68%
00172376060
LISINOPRIL TAB 20MG
366
$3,711.08
1.05%
493
$5,178.22
1.37%
00172376070
LISINOPRIL TAB 20MG
599
$6,210.79
1.72%
603
$6,411.79
1.67%
00172376110
LISINOPRIL TAB 40MG
7
$77.35
0.02%
0
$0.00
0.00%
00172376160
LISINOPRIL TAB 40MG
179
$2,286.69
0.52%
188
$2,468.53
0.52%
00172376170
LISINOPRIL TAB 40MG
219
$2,819.12
0.63%
272
$3,214.61
0.76%
00172376260
LISINOPRIL TAB 30MG
24
$270.48
0.07%
45
$456.12
0.12%
00172376270
LISINOPRIL TAB 30MG
15
$192.37
0.04%
28
$431.10
0.08%
00172419560
ENALAPRIL
TAB 2.5MG
58
$595.93
0.17%
148
$1,918.74
0.41%
00172419580
ENALAPRIL
TAB 2.5MG
7
$54.10
0.02%
25
$327.48
0.07%
00172419660
ENALAPRIL
TAB 5MG
27
$228.04
0.08%
442
$3,842.23
1.23%
00172419680
ENALAPRIL
TAB 5MG
198
$1,782.73
0.57%
139
$1,164.00
0.39%
00172419760
ENALAPRIL
TAB 10MG
53
$546.65
0.15%
504
$4,550.11
1.40%
Page 7 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00172419780
ENALAPRIL
TAB 10MG
00172419785
ENALAPRIL
TAB 10MG
00172419860
ENALAPRIL
TAB 20MG
00172419864
ENALAPRIL
TAB 20MG
00172419880
ENALAPRIL
$1,188.00
0.38%
$809.46
0.23%
4
$37.40
0.01%
61
$839.13
0.18%
0
$0.00
0.00%
476
$7,236.30
1.32%
5
$88.25
0.01%
0
$0.00
0.00%
TAB 20MG
31
$444.71
0.09%
29
$393.27
0.08%
00172535060
BENAZEPRIL TAB 5MG
0
$0.00
0.00%
00172535160
BENAZEPRIL TAB 10MG
0
$0.00
0.00%
4
$48.59
0.01%
14
$106.40
0.04%
00172535260
BENAZEPRIL TAB 20MG
0
$0.00
0.00%
15
$114.35
0.04%
00172535360
BENAZEPRIL TAB 40MG
0
$0.00
0.00%
1
$8.05
0.00%
00185002501
59
00185002510
0
$337.80
0.17%
33
$158.39
0.09%
$0.00
0.00%
76
$485.94
0.21%
00185004209
FOSINOPRIL TAB 20MG
0
$0.00
0.00%
1
$3.85
0.00%
00185004801
BENAZEPRIL TAB 40MG
0
$0.00
0.00%
3
$23.13
0.01%
00185005301
BENAZEPRIL TAB 10MG
00185010101
LISINOPRIL TAB 10MG
0
$0.00
0.00%
2
$15.80
0.01%
373
$2,667.04
1.07%
157
$1,136.02
0.44%
00185010110
LISINOPRIL TAB 10MG
0
$0.00
0.00%
246
$1,734.44
0.68%
00185010201
LISINOPRIL TAB 20MG
0
$0.00
0.00%
5
$49.25
0.01%
00185010210
LISINOPRIL TAB 20MG
00185010233
LISINOPRIL TAB 20MG
0
$0.00
0.00%
99
$369.18
0.27%
23
$227.05
0.07%
42
$473.20
0.12%
00185010301
LISINOPRIL TAB 30MG
0
$0.00
0.00%
2
$20.90
0.01%
00185010401
LISINOPRIL TAB 40MG
0
$0.00
0.00%
5
$52.25
0.01%
00185010410
LISINOPRIL TAB 40MG
0
$0.00
0.00%
63
$696.39
0.17%
00185012701
ENALAPRIL
TAB 5MG
7
$63.35
0.02%
17
$138.85
0.05%
00185014701
ENALAPRIL
TAB 10MG
10
$93.50
0.03%
13
$113.20
0.04%
00185021401
ENALAPRIL
TAB 20MG
3
$35.25
0.01%
2
$18.50
0.01%
00185021410
ENALAPRIL
TAB 20MG
2
$102.50
0.01%
0
$0.00
0.00%
00185021450
ENALAPRIL
TAB 20MG
27
$367.35
0.08%
5
$71.45
0.01%
133
82
Page 8 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00185540001
LISINOPRIL TAB 5MG
117
00185540010
LISINOPRIL TAB 5MG
00310013010
ZESTRIL
TAB 5MG
00310013034
ZESTRIL
00310013110
$659.07
0.34%
85
$445.00
0.24%
0
$0.00
0.00%
178
$1,126.11
0.49%
4
$115.69
0.01%
0
$0.00
0.00%
TAB 5MG
1
$30.48
0.00%
0
$0.00
0.00%
ZESTRIL
TAB 10MG
2
$63.54
0.01%
0
$0.00
0.00%
00310013210
ZESTRIL
TAB 20MG
18
$781.13
0.05%
8
$335.35
0.02%
00310013310
ZESTRIL
TAB 30MG
1
$47.71
0.00%
0
$0.00
0.00%
00310013410
ZESTRIL
TAB 40MG
6
$343.90
0.02%
3
$146.31
0.01%
00310013510
ZESTRIL
TAB 2.5MG
1
$20.82
0.00%
0
$0.00
0.00%
00364269801
ENALAPRIL
TAB 2.5MG
26
$262.25
0.07%
0
$0.00
0.00%
00364270101
ENALAPRIL
TAB 5MG
2
$24.50
0.01%
0
$0.00
0.00%
00364272701
ENALAPRIL
TAB 10MG
2
$19.70
0.01%
0
$0.00
0.00%
00364273401
ENALAPRIL
TAB 20MG
2
$35.30
0.01%
0
$0.00
0.00%
00378044301
BENAZEPRIL TAB 10MG
0
$0.00
0.00%
19
$150.39
0.05%
00378044401
BENAZEPRIL TAB 20MG
0
$0.00
0.00%
11
$118.25
0.03%
00378044701
BENAZEPRIL TAB 40MG
0
$0.00
0.00%
9
$134.95
0.02%
00378105101
ENALAPRIL
TAB 2.5MG
59
$816.97
0.17%
51
$763.43
0.14%
00378105201
ENALAPRIL
TAB 5MG
121
$1,132.95
0.35%
105
$1,117.71
0.29%
00378105210
ENALAPRIL
TAB 5MG
12
$86.10
0.03%
0
$0.00
0.00%
00378105301
ENALAPRIL
TAB 10MG
195
$1,733.25
0.56%
144
$1,237.55
0.40%
00378105401
ENALAPRIL
TAB 20MG
128
$2,124.71
0.37%
98
$1,516.28
0.27%
00378105405
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
2
$21.00
0.01%
00378207201
395
$2,149.36
1.14%
326
$1,957.99
0.91%
00378207301
LISINOPRIL TAB 5MG
1,310
$7,910.69
3.77%
1,152
$7,327.03
3.20%
00378207310
LISINOPRIL TAB 5MG
163
$980.32
0.47%
81
$469.32
0.22%
00378207401
LISINOPRIL TAB 10MG
2,554
$17,835.35
7.35%
2,362
$17,655.69
6.56%
00378207410
LISINOPRIL TAB 10MG
635
$4,397.96
1.83%
75
$506.70
0.21%
Page 9 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00378207501
LISINOPRIL TAB 20MG
00378207510
LISINOPRIL TAB 20MG
00378207601
LISINOPRIL TAB 40MG
00378207701
LISINOPRIL TAB 30MG
00378300701
CAPTOPRIL
00378300710
00378301201
$21,118.37
6.19%
$23,209.83
5.90%
365
$3,640.20
1.05%
1,384
$18,547.53
3.98%
49
$528.25
0.14%
1,341
$18,745.72
3.72%
129
$1,713.01
0.37%
77
$1,127.77
0.21%
TAB 12.5MG
48
$207.59
0.14%
43
$145.29
0.12%
CAPTOPRIL
TAB 12.5MG
116
CAPTOPRIL
TAB 25MG
103
$568.60
0.33%
95
$446.23
0.26%
$448.10
0.30%
79
$374.72
0.22%
00378301210
CAPTOPRIL
TAB 25MG
81
$460.44
0.23%
75
$400.63
0.21%
00378301701
CAPTOPRIL
TAB 50MG
72
$543.07
0.21%
49
$279.10
0.14%
00378301710
00378302201
CAPTOPRIL
TAB 50MG
35
$290.97
0.10%
37
$241.31
0.10%
CAPTOPRIL
TAB 100MG
8
$120.05
0.02%
6
$75.43
0.02%
00591040501
189
$963.31
0.54%
230
$1,153.65
0.64%
00591040601
LISINOPRIL TAB 5MG
828
$4,763.92
2.38%
915
$5,309.04
2.54%
00591040610
LISINOPRIL TAB 5MG
0
$0.00
0.00%
58
$430.00
0.16%
00591040701
LISINOPRIL TAB 10MG
1,849
$12,929.80
5.32%
1,925
$13,272.93
5.35%
00591040710
LISINOPRIL TAB 10MG
0
$0.00
0.00%
166
$1,384.60
0.46%
00591040801
LISINOPRIL TAB 20MG
1,616
$15,411.46
4.65%
1,814
$17,961.51
5.04%
00591040810
LISINOPRIL TAB 20MG
0
$0.00
0.00%
122
$1,417.14
0.34%
00591040901
LISINOPRIL TAB 40MG
933
$12,136.11
2.69%
1,096
$13,665.35
3.04%
00591040905
LISINOPRIL TAB 40MG
0
$0.00
0.00%
9
$94.05
0.02%
00591066801
ENALAPRIL
TAB 2.5MG
68
$858.59
0.20%
42
$462.94
0.12%
00591066805
ENALAPRIL
TAB 2.5MG
11
$155.85
0.03%
14
$201.90
0.04%
00591066901
ENALAPRIL
TAB 5MG
128
$1,054.68
0.37%
59
$427.80
0.16%
00591066905
ENALAPRIL
TAB 5MG
4
$30.69
0.01%
0
$0.00
0.00%
00591067001
ENALAPRIL
TAB 10MG
119
$1,088.15
0.34%
72
$735.65
0.20%
00591067005
ENALAPRIL
TAB 10MG
5
$30.05
0.01%
0
$0.00
0.00%
00591067101
ENALAPRIL
TAB 20MG
75
$1,167.88
0.22%
31
$457.05
0.09%
2,150
2,124
Page 10 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00591088501
LISINOPRIL TAB 30MG
00615452153
CAPTOPRIL
TAB 50MG
00781122901
ENALAPRIL
TAB 2.5MG
00781122910
ENALAPRIL
TAB 2.5MG
00781123101
ENALAPRIL
TAB 5MG
00781123110
ENALAPRIL
TAB 5MG
00781123201
ENALAPRIL
TAB 10MG
00781123210
ENALAPRIL
TAB 10MG
00781123301
ENALAPRIL
TAB 20MG
00781123310
ENALAPRIL
TAB 20MG
00781166501
LISINOPRIL TAB 5MG
00781166601
LISINOPRIL TAB 10MG
00781166701
$1,283.26
0.27%
$1,619.49
0.38%
0
$0.00
0.00%
146
$2,015.10
0.42%
1
$2.02
0.00%
28
$337.70
0.08%
6
$69.10
0.02%
5
$49.25
0.01%
461
$3,762.33
1.33%
19
$189.14
0.05%
10
$118.60
0.03%
474
$4,476.05
1.36%
0
$0.00
0.00%
17
$144.45
0.05%
19
$162.85
0.05%
0
$0.00
0.00%
469
$6,916.29
1.35%
9
$175.65
0.02%
12
$130.30
0.03%
184
$1,118.82
0.53%
4
$81.50
0.01%
179
$1,076.00
0.50%
445
$3,081.51
1.28%
490
$3,378.90
1.36%
LISINOPRIL TAB 20MG
320
$3,144.89
0.92%
418
$4,141.79
1.16%
00781166801
LISINOPRIL TAB 40MG
212
00781166901
58
$2,834.28
0.61%
265
$3,335.74
0.74%
$278.60
0.17%
51
$260.21
0.14%
00781167301
LISINOPRIL TAB 30MG
22
$272.76
0.06%
26
$322.20
0.07%
00781189201
BENAZEPRIL TAB 10MG
0
$0.00
0.00%
1
$7.45
0.00%
00781508392
FOSINOPRIL TAB 10MG
1
$15.00
0.00%
9
$140.51
0.02%
00781508492
FOSINOPRIL TAB 20MG
1
$34.40
0.00%
12
$328.50
0.03%
00781508592
FOSINOPRIL TAB 40MG
0
$0.00
0.00%
7
$234.75
0.02%
00904504680
CAPTOPRIL
TAB 25MG
4
$7.96
0.01%
0
$0.00
0.00%
00904550260
ENALAPRIL
TAB 5MG
0
$0.00
0.00%
9
$68.10
0.02%
00904550280
ENALAPRIL
TAB 5MG
6
$50.70
0.02%
7
$45.85
0.02%
00904550480
ENALAPRIL
TAB 20MG
4
$62.20
0.01%
0
$0.00
0.00%
00904560960
ENALAPRIL
TAB 2.5MG
0
$0.00
0.00%
2
$53.70
0.01%
00904561060
ENALAPRIL
TAB 10MG
0
$0.00
0.00%
3
$126.09
0.01%
00904561080
ENALAPRIL
TAB 10MG
0
$0.00
0.00%
10
$484.57
0.03%
94
137
Page 11 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
00904561160
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
14
$460.24
0.04%
00904561180
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
4
$200.55
0.01%
49884055801
LISINOPRIL TAB 10MG
1
$5.95
0.00%
0
$0.00
0.00%
49884059101
ENALAPRIL
TAB 2.5MG
35
$470.53
0.10%
38
$548.46
0.11%
49884059110
ENALAPRIL
TAB 2.5MG
10
$152.00
0.03%
21
$295.00
0.06%
49884059201
ENALAPRIL
TAB 5MG
69
$623.26
0.20%
55
$472.81
0.15%
49884059210
ENALAPRIL
TAB 5MG
141
$1,271.36
0.41%
129
$1,140.00
0.36%
49884059301
ENALAPRIL
TAB 10MG
54
$492.84
0.16%
54
$539.40
0.15%
49884059310
ENALAPRIL
TAB 10MG
244
$2,127.85
0.70%
197
$1,962.55
0.55%
49884059401
ENALAPRIL
TAB 20MG
147
$2,091.51
0.42%
143
$2,299.07
0.40%
49884059410
ENALAPRIL
TAB 20MG
170
$2,068.75
0.49%
150
$2,203.44
0.42%
49884061901
CAPTOPRIL
TAB 12.5MG
2
$8.25
0.01%
0
$0.00
0.00%
49884061910
CAPTOPRIL
TAB 12.5MG
9
$27.97
0.03%
7
$36.89
0.02%
49884062001
CAPTOPRIL
TAB 25MG
14
$68.42
0.04%
4
$20.02
0.01%
49884062010
CAPTOPRIL
TAB 25MG
11
$56.75
0.03%
0
$0.00
0.00%
49884062101
CAPTOPRIL
TAB 50MG
1
$12.37
0.00%
0
$0.00
0.00%
49884062110
CAPTOPRIL
TAB 50MG
11
$77.13
0.03%
0
$0.00
0.00%
49884062201
CAPTOPRIL
TAB 100MG
1
$19.89
0.00%
0
$0.00
0.00%
51079095120
ENALAPRIL
TAB 5MG
1
$6.96
0.00%
15
$69.06
0.04%
51079095220
ENALAPRIL
TAB 10MG
13
$77.75
0.04%
31
$145.65
0.09%
51079095320
ENALAPRIL
TAB 20MG
3
$19.01
0.01%
0
$0.00
0.00%
51672403701
ENALAPRIL
TAB 2.5MG
5
$47.65
0.01%
25
$309.80
0.07%
51672403801
ENALAPRIL
TAB 5MG
34
$244.96
0.10%
92
$755.67
0.26%
51672403901
ENALAPRIL
TAB 10MG
26
$211.90
0.07%
72
$618.53
0.20%
51672404001
ENALAPRIL
TAB 20MG
72
$1,138.02
0.21%
74
$977.19
0.21%
52544068901
CAPTOPRIL
TAB 25MG
1
$3.13
0.00%
1
$4.30
0.00%
55370014507
CAPTOPRIL
TAB 100MG
2
$23.62
0.01%
0
$0.00
0.00%
Page 12 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
55370016409
CAPTOPRIL
TAB 12.5MG
3
$17.34
0.01%
1
$1.17
0.00%
55370092307
ENALAPRIL
TAB 5MG
2
$18.10
0.01%
0
$0.00
0.00%
55370092309
ENALAPRIL
TAB 5MG
1
$6.55
0.00%
0
$0.00
0.00%
55370092509
ENALAPRIL
TAB 20MG
0
$0.00
0.00%
2
$23.50
0.01%
58177034104
BENAZEPRIL TAB 5MG
0
$0.00
0.00%
2
$69.70
0.01%
58177034204
BENAZEPRIL TAB 10MG
0
$0.00
0.00%
1
$7.45
0.00%
58177034304
BENAZEPRIL TAB 20MG
0
$0.00
0.00%
7
$64.15
0.02%
58177034404
BENAZEPRIL TAB 40MG
0
$0.00
0.00%
8
$126.20
0.02%
59772704501
CAPTOPRIL
TAB 12.5MG
66
$220.89
0.19%
26
$101.10
0.07%
59772704503
CAPTOPRIL
TAB 12.5MG
44
$173.94
0.13%
35
$151.15
0.10%
59772704505
CAPTOPRIL
TAB 12.5MG
2
$9.94
0.01%
1
$4.97
0.00%
59772704601
CAPTOPRIL
TAB 25MG
92
$392.28
0.26%
63
$310.51
0.17%
59772704603
CAPTOPRIL
TAB 25MG
70
$347.31
0.20%
40
$178.59
0.11%
59772704701
CAPTOPRIL
TAB 50MG
64
$463.45
0.18%
55
$331.95
0.15%
59772704703
CAPTOPRIL
TAB 50MG
12
$95.66
0.03%
5
$31.68
0.01%
59772704801
CAPTOPRIL
TAB 100MG
16
$178.11
0.05%
7
$173.44
0.02%
60505018400
1
$4.45
0.00%
112
$590.36
0.31%
60505018500
LISINOPRIL TAB 5MG
7
$45.35
0.02%
94
$628.28
0.26%
60505018501
LISINOPRIL TAB 5MG
0
$0.00
0.00%
134
$866.26
0.37%
60505018600
LISINOPRIL TAB 10MG
0
$0.00
0.00%
154
$1,076.18
0.43%
60505018601
LISINOPRIL TAB 10MG
0
$0.00
0.00%
315
$2,226.72
0.87%
60505018700
LISINOPRIL TAB 20MG
210
$2,111.47
0.60%
170
$1,693.36
0.47%
60505018701
LISINOPRIL TAB 20MG
138
$1,317.55
0.40%
672
$6,898.67
1.87%
60505018800
LISINOPRIL TAB 30MG
9
$146.95
0.03%
76
$932.88
0.21%
60505018900
LISINOPRIL TAB 40MG
95
$1,153.94
0.27%
182
$2,347.71
0.51%
61570011001
ALTACE
CAP 1.25MG
1
$29.90
0.00%
0
$0.00
0.00%
61570011101
ALTACE
CAP 2.5MG
217
$7,054.31
0.62%
132
$4,403.85
0.37%
Page 13 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
61570011201
ALTACE
CAP 5MG
260
$9,358.94
0.75%
122
$4,428.29
0.34%
61570012001
ALTACE
CAP 10MG
238
$12,771.82
0.69%
151
$8,078.82
0.42%
62037051601
BENAZEPRIL TAB 5MG
0
$0.00
0.00%
4
$91.66
0.01%
62037051701
BENAZEPRIL TAB 10MG
0
$0.00
0.00%
27
$206.69
0.07%
62037051801
BENAZEPRIL TAB 20MG
0
$0.00
0.00%
32
$255.93
0.09%
62037051901
BENAZEPRIL TAB 40MG
0
$0.00
0.00%
11
$214.13
0.03%
63304052201
ENALAPRIL
TAB 2.5MG
4
$39.40
0.01%
0
$0.00
0.00%
63304052310
ENALAPRIL
TAB 5MG
3
$53.85
0.01%
0
$0.00
0.00%
63304052401
ENALAPRIL
TAB 10MG
6
$65.10
0.02%
0
$0.00
0.00%
63304052410
ENALAPRIL
TAB 10MG
1
$6.85
0.00%
0
$0.00
0.00%
63304052501
ENALAPRIL
TAB 20MG
1
$17.65
0.00%
0
$0.00
0.00%
63304052510
ENALAPRIL
TAB 20MG
2
$68.90
0.01%
0
$0.00
0.00%
63304053101
16
$91.25
0.05%
35
$213.93
0.10%
63304053201
LISINOPRIL TAB 5MG
10
$50.32
0.03%
37
$205.47
0.10%
63304053210
LISINOPRIL TAB 5MG
120
$772.08
0.35%
101
$597.15
0.28%
63304053301
LISINOPRIL TAB 10MG
28
$179.80
0.08%
45
$332.51
0.12%
63304053310
LISINOPRIL TAB 10MG
50
$345.50
0.14%
159
$1,079.79
0.44%
63304053401
LISINOPRIL TAB 20MG
35
$271.55
0.10%
33
$323.51
0.09%
63304053410
LISINOPRIL TAB 20MG
10
$140.75
0.03%
100
$957.15
0.28%
63304053501
LISINOPRIL TAB 40MG
49
$608.80
0.14%
173
$2,055.27
0.48%
63304053510
LISINOPRIL TAB 40MG
30
$414.26
0.09%
112
$1,239.18
0.31%
63304073790
BENAZEPRIL TAB 10MG
0
$0.00
0.00%
4
$26.02
0.01%
63304073890
BENAZEPRIL TAB 20MG
0
$0.00
0.00%
10
$81.70
0.03%
63304073990
BENAZEPRIL TAB 40MG
0
$0.00
0.00%
4
$37.90
0.01%
63304077690
FOSINOPRIL TAB 20MG
0
$0.00
0.00%
4
$87.55
0.01%
63304083401
ENALAPRIL
TAB 2.5MG
2
$22.20
0.01%
67
$796.36
0.19%
63304083410
ENALAPRIL
TAB 2.5MG
5
$58.40
0.01%
2
$19.70
0.01%
Page 14 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
63304083501
ENALAPRIL
TAB 5MG
11
$83.45
0.03%
63304083510
ENALAPRIL
TAB 5MG
75
$615.85
0.22%
63304083601
ENALAPRIL
TAB 10MG
14
$137.90
0.04%
63304083610
ENALAPRIL
TAB 10MG
56
$563.45
0.16%
63304083701
ENALAPRIL
TAB 20MG
7
$64.75
63304083710
ENALAPRIL
TAB 20MG
49
64455014090
VASOTEC
TAB 2.5MG
8
64455014190
VASOTEC
TAB 5MG
64455014210
VASOTEC
64455014290
64455014390
64679092602
ENALAPRIL
66685030100
$318.69
0.10%
30
$292.70
0.08%
331
$3,001.15
0.92%
60
$543.30
0.17%
0.02%
44
$754.08
0.12%
$925.97
0.14%
58
$1,098.64
0.16%
$390.66
0.02%
8
$339.55
0.02%
6
$379.02
0.02%
7
$273.03
0.02%
TAB 10MG
0
$0.00
0.00%
1
$9.35
0.00%
VASOTEC
TAB 10MG
11
$475.75
0.03%
3
$148.10
0.01%
VASOTEC
TAB 20MG
8
$424.41
0.02%
3
$274.56
0.01%
TAB 20MG
0
$0.00
0.00%
1
$28.30
0.00%
ENALAPRIL
TAB 2.5MG
119
$1,162.86
0.34%
47
$602.86
0.13%
66685030102
ENALAPRIL
TAB 2.5MG
43
$467.73
0.12%
43
$532.55
0.12%
66685030200
ENALAPRIL
TAB 5MG
312
$2,673.00
0.90%
351
$3,229.33
0.97%
66685030202
ENALAPRIL
TAB 5MG
106
$913.45
0.31%
98
$791.74
0.27%
66685030300
ENALAPRIL
TAB 10MG
317
$2,774.32
0.91%
31
$261.89
0.09%
66685030302
ENALAPRIL
TAB 10MG
135
$958.63
0.39%
181
$1,606.05
0.50%
66685030400
ENALAPRIL
TAB 20MG
378
$5,549.53
1.09%
378
$5,814.01
1.05%
66685030402
ENALAPRIL
TAB 20MG
84
$1,252.29
0.24%
106
$1,531.30
0.29%
66685070101
120
$661.19
0.35%
104
$581.51
0.29%
66685070102
0
$0.00
0.00%
10
$62.70
0.03%
66685070201
LISINOPRIL TAB 5MG
179
$1,059.20
0.52%
134
$816.26
0.37%
66685070202
LISINOPRIL TAB 5MG
12
$74.02
0.03%
167
$965.85
0.46%
66685070301
LISINOPRIL TAB 10MG
249
$1,694.86
0.72%
265
$1,911.63
0.74%
66685070302
LISINOPRIL TAB 10MG
15
$130.77
0.04%
367
$2,520.51
1.02%
66685070401
LISINOPRIL TAB 20MG
226
$2,165.47
0.65%
190
$1,804.23
0.53%
35
Page 15 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ACE INHIBITORS
66685070402
LISINOPRIL TAB 20MG
66685070501
LISINOPRIL TAB 30MG
66685070601
LISINOPRIL TAB 40MG
66685070603
LISINOPRIL TAB 40MG
13
$139.80
0.04%
26
$356.30
0.07%
237
$3,050.94
0.68%
10
$167.40
0.03%
347
$3,420.78
0.96%
43
$457.97
0.12%
223
$2,708.00
0.62%
57
$663.73
0.16%
ACE INHIBITORS AND CA CHANNEL BLOCKERS
00074328713
TARKA
TAB 2-180 CR
2
$119.44
0.54%
0
$0.00
0.00%
00074328913
TARKA
TAB 2-240 CR
2
$111.22
0.54%
3
$41.55
2.80%
00074329013
TARKA
TAB 4-240 CR
8
$441.91
2.16%
0
$0.00
0.00%
00078036405
LOTREL
CAP 10-20MG
46
$2,648.59
12.40%
34
$1,878.51
31.78%
00083225530
LOTREL
CAP 2.5-10MG
17
$784.70
4.58%
0
$0.00
0.00%
00083226030
LOTREL
CAP 5-10MG
103
$6,040.41
27.76%
32
$1,186.34
29.91%
00083226530
LOTREL
CAP 5-20MG
186
$10,771.61
50.13%
37
$2,171.00
34.58%
00186000131
LEXXEL
TAB 5-5MG
5
$261.23
1.35%
0
$0.00
0.00%
00186000168
LEXXEL
TAB 5-5MG
2
$169.30
0.54%
1
$12.19
0.93%
ALCOHOL DETERRENTS
50111033101
DISULFIRAM TAB 250MG
65473070601
ANTABUSE
TAB 250MG
5
$118.40
4.42%
1
$38.91
0.64%
108
$3,905.28
95.58%
155
$5,317.12
99.36%
17
$13,738.03
100.00%
13
$10,165.18
100.00%
ALS DRUG
00075770060
RILUTEK
TAB 50MG
ALTERNATIVE MEDICINES
00182404826
GLUCOSAMINE CAP 500MG
8
$91.81
8.16%
11
$183.83
11.58%
00536641208
MELATONIN TAB 3MG
2
$63.02
2.04%
6
$91.65
6.32%
00677165206
GLUCOS/CHOND CAP 500-400
6
$439.85
6.12%
5
$301.46
5.26%
Page 16 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ALTERNATIVE MEDICINES
00677165267
00904501546
00904548152
24
$1,249.62
24.49%
23
$950.40
24.21%
COENZYME Q10 CAP 30MG
6
$786.28
6.12%
6
$730.25
6.32%
2
$158.20
2.04%
3
$55.54
3.16%
00904559489
GLUC/CHONDR TAB 750-600M
2
$32.06
2.04%
3
$51.48
3.16%
24385038141
GLUC/CHONDR TAB 750-600M
3
$55.90
3.06%
1
$14.82
1.05%
37205026771
GLUCOS/CHOND TAB 500/400
0
$0.00
0.00%
1
$12.54
1.05%
49348032644
COENZYME Q10 CAP 50MG
5
$167.67
5.10%
2
$114.50
2.11%
51991003106
0
$0.00
0.00%
3
$59.90
3.16%
51991011006
CO ENZYME Q- CAP 50MG
0
$0.00
0.00%
2
$60.14
2.11%
52297089771
HM GINKGO TAB 120MG
2
$11.44
2.04%
0
$0.00
0.00%
54022205501
COENZYME Q10 TAB 25MG
3
$617.46
3.06%
5
$639.08
5.26%
54022208001
27
$2,737.78
27.55%
13
$555.16
13.68%
54022208101
0
$0.00
0.00%
3
$15.00
3.16%
54022209001
CO-ENZYME
2
$126.76
2.04%
3
$186.00
3.16%
54022800201
6
$436.42
6.12%
5
$315.89
5.26%
WAF Q10/E
ALZHEIMER - Cholinomimetics
00078032306
EXELON
CAP 1.5MG
4
$543.60
0.11%
0
$0.00
0.00%
00078032344
EXELON
CAP 1.5MG
91
$11,406.02
2.51%
36
$4,827.57
0.75%
00078032406
EXELON
CAP 3MG
0
$0.00
0.00%
6
$888.93
0.13%
00078032444
EXELON
CAP 3MG
89
$10,716.69
2.46%
87
$11,383.36
1.81%
00078032544
EXELON
CAP 4.5MG
45
$5,689.68
1.24%
50
$6,014.22
1.04%
00078032644
EXELON
CAP 6MG
98
$11,617.42
2.71%
45
$5,376.59
0.94%
00078033931
EXELON
SOL 2MG/ML
5
$1,267.47
0.14%
4
$852.06
0.08%
00456320014
NAMENDA
TAB 5-10MG
0
$0.00
0.00%
19
$1,742.39
0.40%
00456320560
NAMENDA
TAB 5MG
0
$0.00
0.00%
177
$13,458.49
3.69%
00456321060
NAMENDA
TAB 10MG
0
$0.00
0.00%
427
$44,753.06
8.91%
Page 17 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ALZHEIMER - Cholinomimetics
50458039060
REMINYL
TAB 4MG
146
$18,542.38
4.03%
111
$11,922.13
2.32%
50458039160
REMINYL
TAB 8MG
126
$15,560.04
3.48%
147
$17,572.79
3.07%
50458039260
REMINYL
TAB 12MG
45
$4,935.61
1.24%
56
$6,638.38
1.17%
50458039910
REMINYL
SOL 4MG/ML
0
$0.00
0.00%
9
$1,199.28
0.19%
59630019012
COGNEX
CAP 10MG
1
$307.89
0.03%
0
$0.00
0.00%
62856024530
ARICEPT
TAB 5MG
757
$91,456.43
20.92%
539
$63,403.50
11.24%
62856024590
ARICEPT
TAB 5MG
305
$36,993.67
8.43%
511
$58,134.32
10.66%
62856024630
ARICEPT
TAB 10MG
1,129
$138,350.82
31.20%
1,338
$166,837.29
27.91%
62856024641
ARICEPT
TAB 10MG
3
$23.23
0.08%
5
$386.79
0.10%
62856024690
ARICEPT
TAB 10MG
775
$94,398.54
21.41%
1,227
$146,484.45
25.59%
$379.30
1.39%
1
$73.21
0.63%
AMINO GLYCOSIDES
00003272510
TOBRAMYCIN INJ 40MG/ML
2
00074120703
GENTAMICIN INJ 40MG/ML
1
$8.23
0.69%
1
$11.33
0.63%
00074357801
2
$549.36
1.39%
3
$626.18
1.90%
00093117701
NEOMYCIN
73
$4,800.20
50.69%
72
$3,522.76
45.57%
00641039525
0
$0.00
0.00%
1
$8.79
0.63%
00703941601
0
$0.00
0.00%
2
$135.12
1.27%
39822033005
NEO-FRADIN SOL 125/5ML
0
$0.00
0.00%
2
$39.59
1.27%
53905006501
TOBI
55
$108,528.45
38.19%
60
$101,693.24
37.97%
57664017508
PAROMOMYCIN CAP 250MG
1
$96.21
0.69%
0
$0.00
0.00%
63323001002
4
$146.72
2.78%
13
$165.90
8.23%
63323001020
0
$0.00
0.00%
3
$18.60
1.90%
63430006501
TOBI
6
$7,341.14
4.17%
0
$0.00
0.00%
1
$175.65
0.02%
0
$0.00
0.00%
TAB 500MG
NEB 300/5ML
NEB 300/5ML
ANALGESICS - MISC.
00034050580
TRILISATE
TAB 750MG
Page 18 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
00045012215
TYLENOL INF DRO 80/0.8ML
0
$0.00
0.00%
1
00045012304
TYLENOL CHLD SUS 160/5ML
2
$10.64
0.04%
00045012410
TYLENOL
2
$17.22
0.04%
00045018716
TYLENOL CHLD ELX 160/5ML
1
$10.98
00045044909
TYLENOL
TAB 500MG
1
00045045270
TYLENOL
TAB 325MG
00045046865
TYLENOL
TAB 500MG
00045049660
TYLENOL
00045049960
$10.73
0.02%
0
$0.00
0.00%
2
$15.06
0.03%
0.02%
0
$0.00
0.00%
$8.61
0.02%
1
$15.78
0.02%
3
$27.51
0.05%
0
$0.00
0.00%
0
$0.00
0.00%
5
$57.37
0.08%
TAB 325MG
1
$9.57
0.02%
1
$4.83
0.02%
TYLENOL
TAB 500MG
1
$10.83
0.02%
0
$0.00
0.00%
00045083810
TYLENOL
TAB ARTHRITI
0
$0.00
0.00%
2
$21.86
0.03%
00045083850
TYLENOL
TAB ARTHRITI
12
$112.17
0.22%
18
$169.26
0.28%
00054301050
ACETAMIN
ELX 160/5ML
0
$0.00
0.00%
2
$7.70
0.03%
00054801425
ACETAMIN
TAB 325MG
0
$0.00
0.00%
1
$15.79
0.02%
00078008405
FIORICET
TAB
13
$806.81
0.24%
5
$291.80
0.08%
00078008408
FIORICET
TAB
1
$25.81
0.02%
0
$0.00
0.00%
00078010305
FIORINAL
CAP
2
$58.96
0.04%
0
$0.00
0.00%
00093075501
DIFLUNISAL TAB 500MG
20
$1,371.22
0.36%
30
$2,361.83
0.47%
00093075505
3
$144.85
0.05%
3
$48.15
0.05%
00093075506
220
$11,966.07
3.98%
225
$12,142.52
3.55%
00093085401
BUT/APAP/CAF TAB
11
$143.82
0.20%
21
$372.85
0.33%
00113013026
APAP
1
$2.63
0.02%
0
$0.00
0.00%
00113025968
ASPIRIN
TAB 81MG EC
1
$1.38
0.02%
1
$0.19
0.02%
00113040378
ACETAMIN
TAB 325MG
4
$16.23
0.07%
1
$3.02
0.02%
00113041678
ASPIRIN
TAB 325MG EC
0
$0.00
0.00%
3
$4.14
0.05%
00113042978
ASPIRIN
TAB 325MG EC
3
$11.80
0.05%
3
$12.56
0.05%
00113048462
ACETAMIN
TAB 500MG
1
$4.60
0.02%
0
$0.00
0.00%
00113048490
ACETAMIN
TAB 500MG
1
$3.33
0.02%
0
$0.00
0.00%
TAB 500MG
SUS CHILD
Page 19 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ASPIRIN
00143111501
00143178501
$
Market Share*
ANALGESICS - MISC.
00113053576
# of Scripts
TAB 81MG EC
7
$35.81
0.13%
BUT/APAP/CAF TAB
15
$1,134.33
0.27%
BUT/ASA/CAFF TAB
376
$7,496.09
6.80%
00143178510
BUT/ASA/CAFF TAB
38
$642.27
0.69%
00143178701
BUT/APAP/CAF TAB
121
$1,172.15
00143178705
BUT/APAP/CAF TAB
15
00182014101
GENEBS
TAB 325MG
22
00182014110
GENEBS
TAB 325MG
00182044401
ASPIRIN
00182044410
00182044801
$21.63
0.05%
21
$792.38
0.33%
287
$3,914.37
4.53%
34
$325.84
0.54%
2.19%
118
$1,371.29
1.86%
$227.75
0.27%
28
$369.45
0.44%
$101.19
0.40%
46
$214.06
0.73%
19
$41.93
0.34%
3
$12.57
0.05%
TAB 325MG
7
$8.40
0.13%
24
$75.22
0.38%
ASPIRIN
TAB 325MG
0
$0.00
0.00%
12
$17.71
0.19%
ASPIRIN
TAB 325MG EC
8
$8.67
0.14%
26
$74.83
0.41%
00182044810
ASPIRIN
TAB 325MG EC
3
$3.54
0.05%
0
$0.00
0.00%
00182044889
ASPIRIN
TAB 325MG EC
1
$3.68
0.02%
0
$0.00
0.00%
00182100010
ACETAMIN
TAB 325MG
22
$68.03
0.40%
9
$28.91
0.14%
00182100019
ACETAMIN
TAB 325MG
3
$13.39
0.05%
0
$0.00
0.00%
00182106105
ASPIRIN
TAB 81MG EC
99
$281.33
1.79%
212
$720.91
3.35%
00182106107
ASPIRIN
TAB 81MG EC
79
$209.41
1.43%
99
$263.02
1.56%
00182109511
ACETAMIN
SUP 650MG
7
$40.35
0.13%
4
$27.34
0.06%
00182142095
CHILD ASA CHW 81MG
101
$245.58
1.83%
160
$596.58
2.53%
00182145301
GENEBS
TAB 500MG
23
$136.85
0.42%
24
$127.96
0.38%
00182145310
GENEBS
TAB 500MG
8
$11.82
0.14%
31
$167.80
0.49%
00182145701
GENAPAP
2
$8.61
0.04%
0
$0.00
0.00%
00182147337
ACETAMIN
ELX 160/5ML
2
$10.42
0.04%
1
$5.21
0.02%
00182147340
ACETAMIN
ELX 160/5ML
2
$7.79
0.04%
4
$28.22
0.06%
00182166211
ACETAMIN
SUP 120MG
3
$21.13
0.05%
2
$13.87
0.03%
00182183201
GENEBS
16
$89.53
0.29%
6
$34.22
0.09%
00182190901
BUFFERED ASA TAB 325MG
0
$0.00
0.00%
7
$24.74
0.11%
TAB 500MG
TAB 500MG
3
Page 20 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
00182215401
GENAPAP
TAB 500MG
27
$192.51
0.49%
38
$250.25
0.60%
00182700111
ACETAMIN
00182821789
ASPIRIN EC TAB 81MG
SUP 325MG
3
$31.56
0.05%
1
$14.88
0.02%
1
$4.49
0.02%
1
$5.49
0.02%
00182844789
ACETAMIN
4
$21.82
0.07%
6
$82.76
0.09%
00228202310
BUT/ASA/CAFF TAB
19
$322.12
0.34%
100
$1,309.52
1.58%
00258365701
BUT/APAP/CAF TAB
7
$239.57
0.13%
5
$100.20
0.08%
00364067702
BUTALBITAL TAB CPD
0
$0.00
0.00%
1
$1.69
0.02%
00406097001
BUT/APAP/CAF TAB
13
$207.45
0.24%
25
$177.18
0.39%
00406097005
BUT/APAP/CAF TAB
62
$533.17
1.12%
176
$1,944.60
2.78%
00456067801
ESGIC-PLUS TAB
3
$901.62
0.05%
3
$916.02
0.05%
00456067901
ESGIC-PLUS CAP
1
$38.18
0.02%
1
$31.91
0.02%
00472120006
FEVERALL INF SUP 80MG
1
$11.72
0.02%
1
$23.79
0.02%
00472120106
FEVERALL
SUP 120MG
2
$27.62
0.04%
3
$48.22
0.05%
00472120206
FEVERALL
SUP 325MG
0
$0.00
0.00%
1
$9.62
0.02%
00472120350
FEVERALL
SUP 650MG
0
$0.00
0.00%
1
$6.72
0.02%
00472141016
APAP
ELX 160/5ML
0
$0.00
0.00%
11
$83.85
0.17%
00472141799
APAP
DRO 80/0.8ML
6
$35.76
0.11%
6
$35.76
0.09%
00527155201
BUT/ASA/CAFF CAP
262
$8,504.88
4.74%
291
$9,900.34
4.60%
00536012285
ACETAMIN
7
$100.41
0.13%
5
$61.80
0.08%
00536012372
CHILD PN/FEV DRO 80/0.8ML
0
$0.00
0.00%
1
$19.79
0.02%
00536308610
ASPIRIN
TAB 81MG EC
6
$33.47
0.11%
15
$54.27
0.24%
00536308641
ASPIRIN
TAB 81MG EC
4
$17.16
0.07%
28
$92.80
0.44%
00536321801
ACETAMIN
TAB 500MG
0
$0.00
0.00%
9
$55.25
0.14%
00536322201
ACETAMIN
TAB 325MG
7
$39.01
0.13%
7
$28.58
0.11%
00536322210
ACETAMIN
TAB 325MG
2
$11.22
0.04%
0
$0.00
0.00%
00536323101
ACETAMIN
TAB 500MG
23
$156.59
0.42%
19
$121.73
0.30%
00536323110
ACETAMIN
TAB 500MG
9
$64.85
0.16%
0
$0.00
0.00%
TAB 325MG
ELX 160/5ML
Page 21 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
00536323307
ACETAMIN
00536329736
ASPIRIN
00536330501
ASPIRIN
00536331301
CHW 80MG
1
$10.21
0.02%
0
$0.00
0.00%
CHW 81MG
20
$59.41
0.36%
52
$212.76
0.82%
TAB 325MG
2
$7.02
0.04%
3
$10.53
0.05%
ASPIRIN EC TAB 325MG
19
$48.68
0.34%
46
$103.32
0.73%
00536331310
17
$16.52
0.31%
0
$0.00
0.00%
00536331810
2
$2.36
0.04%
2
$3.88
0.03%
00574000211
ASPIRIN
1
$1.18
0.02%
0
$0.00
0.00%
00574000701
ACETAMIN
2
$4.28
0.04%
1
$0.07
0.02%
00591048501
BUT/APAP/CAF TAB
1
$6.85
0.02%
15
$176.10
0.24%
00591321901
BUT/ASA/CAFF CAP
0
$0.00
0.00%
10
$418.69
0.16%
00591341601
BUT/APAP/CAF TAB
0
$0.00
0.00%
16
$232.65
0.25%
00603002436
ASPIRIN CHLD CHW 81MG
3
$11.08
0.05%
6
$16.92
0.09%
00603002522
ASA LOW DOSE TAB 81MG EC
38
$144.90
0.69%
89
$198.91
1.41%
00603003121
ASPIRIN
TAB 325MG
7
$12.71
0.13%
21
$24.53
0.33%
00603016621
ASPIRIN
TAB 325MG EC
1
$1.94
0.02%
1
$1.94
0.02%
00603016721
EC ASPIRIN TAB 325MG
7
$8.47
0.13%
20
$43.44
0.32%
00603026321
Q-PAP
8
$51.46
0.14%
7
$46.93
0.11%
00603026821
Q-PAP EX STR TAB 500MG
10
$63.24
0.18%
12
$76.75
0.19%
00603083958
Q-PAP
ELX 160/5ML
0
$0.00
0.00%
2
$13.56
0.03%
00603083994
Q-PAP
ELX 160/5ML
0
$0.00
0.00%
5
$27.50
0.08%
00603254021
BUTAL/APAP TAB 50-325
56
$1,416.01
1.01%
65
$1,521.59
1.03%
00603254421
BUT/APAP/CAF TAB
0
$0.00
0.00%
681
$13,207.75
10.76%
00603254428
BUT/APAP/CAF TAB
0
$0.00
0.00%
2
$26.18
0.03%
00603254521
BUT/APAP/CAF TAB
0
$0.00
0.00%
1
$14.59
0.02%
00603254621
BUT/APAP/CAF CAP
2
$20.00
0.04%
4
$62.04
0.06%
00603254721
BUT/APAP/CAF TAB
609
$5,774.68
11.01%
151
$1,540.70
2.39%
00603254728
BUT/APAP/CAF TAB
4
$83.90
0.07%
0
$0.00
0.00%
TAB 325MG EC
TAB 325MG
TAB 325MG
Page 22 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
00603254821
BUTALBITAL TAB CPD
2
$38.93
0.04%
0
$0.00
0.00%
00603255021
BUTALBITAL CAP CPD
2
$27.07
0.04%
2
$51.30
0.03%
00603255121
BUT/APAP/CAF TAB
3
$73.78
0.05%
0
$0.00
0.00%
00603575421
SALSALATE
TAB 500MG
6
$97.08
0.11%
2
$51.68
0.03%
00603575521
SALSALATE
TAB 750MG
54
$1,697.18
0.98%
4
$146.56
0.06%
00603575528
SALSALATE
TAB 750MG
0
$0.00
0.00%
4
$193.08
0.06%
00642016610
REPAN-CF
TAB 650-50MG
1
$65.25
0.02%
0
$0.00
0.00%
00642713210
QUALA-CET
TAB
3
$48.31
0.05%
0
$0.00
0.00%
00677000101
ACETAMIN
TAB 325MG
2
$20.76
0.04%
0
$0.00
0.00%
00677067801
ACETAMIN
CAP 500MG
7
$55.27
0.13%
9
$53.69
0.14%
00677067810
ACETAMIN
CAP 500MG
1
$1.64
0.02%
0
$0.00
0.00%
00677070012
ACETAMIN
SUP 120MG
2
$27.43
0.04%
0
$0.00
0.00%
00677077101
ASPIRIN
TAB 325MG EC
5
$11.02
0.09%
8
$22.65
0.13%
00677077110
ASPIRIN
TAB 325MG EC
47
$157.22
0.85%
44
$156.11
0.69%
00677082701
FORTABS
3
$58.95
0.05%
1
$10.55
0.02%
00677101612
ACETAMIN
SUP 650MG
0
$0.00
0.00%
1
$10.05
0.02%
00677102401
SALSALATE
TAB 500MG
2
$44.58
0.04%
3
$65.55
0.05%
00677102501
SALSALATE
TAB 750MG
3
$91.05
0.05%
4
$126.72
0.06%
00677134701
ASPIRIN
TAB 975MG EC
5
$36.83
0.09%
3
$28.83
0.05%
00677143901
BUT/ASA/CAFF CAP
87
$2,631.50
1.57%
9
$291.39
0.14%
00677173801
BUT/APAP/CAF TAB
1
$31.47
0.02%
0
$0.00
0.00%
00677174801
BUT/APAP/CAF TAB
3
$32.55
0.05%
0
$0.00
0.00%
00677178101
ACETAMIN
TAB 325MG
23
$129.71
0.42%
16
$98.27
0.25%
00677178110
ACETAMIN
TAB 325MG
19
$58.27
0.34%
38
$144.78
0.60%
00677178201
ACETAMIN
TAB 500MG
1
$4.99
0.02%
2
$12.47
0.03%
00677178401
ACETAMIN
TAB 500MG
13
$55.56
0.24%
21
$113.57
0.33%
00677178410
ACETAMIN
TAB 500MG
1
$5.34
0.02%
10
$36.38
0.16%
TAB
Page 23 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
00677183933
ACETAMIN
LIQ 160/5ML
00677185510
ASPIRIN
TAB 81MG EC
00713011812
ACEPHEN
SUP 120MG
00713016412
ACEPHEN
00713016501
$46.60
0.16%
1
$4.49
0.02%
14
$22.71
0.25%
30
$42.91
0.47%
14
$124.29
0.25%
4
$38.68
0.06%
SUP 325MG
4
$31.71
0.07%
4
$31.72
0.06%
ACEPHEN
SUP 650MG
1
$9.63
0.02%
0
$0.00
0.00%
00713016512
ACEPHEN
SUP 650MG
1
$7.79
0.02%
2
$10.15
0.03%
00761003324
0
$0.00
0.00%
1
$1.09
0.02%
00781129410
ACETAMIN
62
$269.54
1.12%
57
$236.02
0.90%
00781160310
ASPIRIN
TAB 325MG EC
1
$1.18
0.02%
0
$0.00
0.00%
00904197446
MAPAP
CHW 80MG
4
$17.76
0.07%
3
$15.93
0.05%
00904198260
MAPAP
TAB 325MG
0
$0.00
0.00%
1
$4.62
0.02%
00904198280
MAPAP
TAB 325MG
17
$115.49
0.31%
15
$90.63
0.24%
00904198340
MAPAP
TAB 500MG
4
$25.34
0.07%
7
$29.78
0.11%
00904198359
MAPAP
TAB 500MG
4
$10.57
0.07%
13
$79.17
0.21%
00904198380
MAPAP
TAB 500MG
0
$0.00
0.00%
1
$6.47
0.02%
00904198516
MAPAP
ELX 160/5ML
2
$5.96
0.04%
3
$14.02
0.05%
00904198760
MAPAP
CAP 500MG
2
$7.78
0.04%
1
$3.82
0.02%
00904198880
MAPAP
TAB 500MG
19
$86.60
0.34%
13
$61.72
0.21%
00904200960
ASPIRIN
TAB 325MG
11
$36.11
0.20%
9
$21.59
0.14%
00904201360
ASPIRIN
TAB 325MG EC
2
$8.12
0.04%
11
$17.65
0.17%
00904201372
ASPIRIN
TAB 325MG EC
2
$5.98
0.04%
2
$5.51
0.03%
00904201380
ASPIRIN
TAB 325MG EC
1
$1.18
0.02%
23
$37.65
0.36%
00904328040
BUT/APAP/CAF TAB
35
$401.13
0.63%
28
$299.30
0.44%
00904328060
BUT/APAP/CAF TAB
4
$23.97
0.07%
15
$146.55
0.24%
00904389260
BUTALBITAL TAB CPD
2
$25.66
0.04%
0
$0.00
0.00%
00904389280
BUTALBITAL TAB CPD
5
$38.93
0.09%
0
$0.00
0.00%
00904393460
BUTALBITAL CAP CPD
2
$41.34
0.04%
0
$0.00
0.00%
TAB 325MG
9
Page 24 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
00904404073
ASPIRIN
CHW 81MG
00904525530
INF MAPAP
00904525646
MAPAP
CHW 80MG
00904769212
MAPAP
SUP 120MG
00904770418
ASPIR-LOW
TAB 81MG EC
00904770470
ASPIR-LOW
TAB 81MG EC
00904770480
ASPIR-LOW
TAB 81MG EC
10135012301
ACETAMIN
TAB 325MG
10135012310
ACETAMIN
TAB 325MG
10135012601
ASPIRIN
10135012603
ASPIRIN
10135012610
ASPIRIN
10135015201
ACETAMIN
10135015210
10135015213
10135017310
2
$10.48
0.04%
4
$16.79
0.06%
2
$13.22
0.04%
0
$0.00
0.00%
5
$26.55
0.09%
0
$0.00
0.00%
0
$0.00
0.00%
1
$8.05
0.02%
6
$34.48
0.11%
8
$25.04
0.13%
1
$2.85
0.02%
2
$4.59
0.03%
32
$99.59
0.58%
41
$125.12
0.65%
0
$0.00
0.00%
1
$1.58
0.02%
6
$25.72
0.11%
0
$0.00
0.00%
TAB 325MG EC
0
$0.00
0.00%
3
$3.51
0.05%
TAB 325MG EC
0
$0.00
0.00%
1
$1.94
0.02%
TAB 325MG EC
0
$0.00
0.00%
2
$3.10
0.03%
TAB 500MG
1
$4.65
0.02%
1
$1.09
0.02%
ACETAMIN
TAB 500MG
3
$12.54
0.05%
17
$57.61
0.27%
ACETAMIN
TAB 500MG
0
$0.00
0.00%
1
$5.96
0.02%
ASPIRIN
TAB 81MG EC
14
$44.59
0.25%
32
$112.98
0.51%
10135017362
ASPIRIN
TAB 81MG EC
9
$33.95
0.16%
5
$21.13
0.08%
10135017369
ASPIRIN
TAB 81MG EC
0
$0.00
0.00%
2
$2.12
0.03%
11822300240
RA ASPIRIN TAB 325MG EC
1
$1.18
0.02%
4
$6.93
0.06%
11822316050
RA ACETAMIN CHW 80MG
0
$0.00
0.00%
1
$2.49
0.02%
11822317520
RA ASPIRIN CHW 81MG
2
$3.30
0.04%
5
$10.99
0.08%
11822330410
RA ARTHRITIS TAB RELIEF
3
$24.14
0.05%
0
$0.00
0.00%
11822361530
RA CHILD ASP CHW 81MG
0
$0.00
0.00%
3
$7.45
0.05%
11822361570
MIGRAINE REL TAB
0
$0.00
0.00%
1
$4.68
0.02%
11845090701
ACETAMIN
1
$6.42
0.02%
0
$0.00
0.00%
11845099316
ASA LOW STR TAB 81MG EC
1
$1.29
0.02%
0
$0.00
0.00%
12843010117
BAYER ASA
1
$1.01
0.02%
0
$0.00
0.00%
DRO 80/0.8ML
TAB 500MG
TAB 325MG
Page 25 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
12843010238
BAYER ASA
TAB 325MG
12843010349
THERAP BAYER TAB 325MG EC
12843010605
BAYER LOW
12843013105
$0.00
0.00%
2
$4.63
0.03%
2
$5.72
7
$34.96
0.04%
7
$12.56
0.11%
0.13%
17
$44.20
0.27%
BAYER CHILD CHW ASA 81MG
4
$14.58
0.07%
9
$31.19
0.14%
12843013231
BAYER CHILD CHW ASA 81MG
0
$0.00
0.00%
2
$5.89
0.03%
17236035010
ACETAMIN
17236038201
ASPIRIN
TAB 325MG EC
3
$6.66
0.05%
1
$4.12
0.02%
0
$0.00
0.00%
7
$12.82
0.11%
17236038210
ASPIRIN
TAB 325MG EC
3
$3.85
0.05%
10
$16.77
0.16%
17236060701
APAP
4
$14.06
0.07%
1
$2.39
0.02%
17236070510
ASPIRIN
17236070566
ASPIRIN
TAB 81MG EC
22
$41.47
0.40%
30
$82.06
0.47%
TAB 81MG EC
4
$11.95
0.07%
4
$10.32
0.06%
17714001301
ACETAMIN
TAB 500MG
0
$0.00
0.00%
1
$2.79
0.02%
24385041687
ASPIRIN
0
$0.00
0.00%
1
$1.38
0.02%
37205000805
ACETAMIN
37205002071
PAIN RELIEVE TAB 500MG
4
$77.76
0.07%
5
$40.36
0.08%
3
$16.96
0.05%
0
$0.00
0.00%
37205002078
11
$104.19
0.20%
20
$172.51
0.32%
37205002090
8
$32.39
0.14%
16
$78.56
0.25%
37205002571
7
$55.02
0.13%
0
$0.00
0.00%
37205002578
1
$6.11
0.02%
3
$17.37
0.05%
37205003178
45
$311.53
0.81%
27
$139.00
0.43%
37205003572
19
$141.75
0.34%
12
$70.52
0.19%
37205003578
43
$309.73
0.78%
68
$528.38
1.07%
37205004565
PAIN RELIEVE CHW 80MG
0
$0.00
0.00%
1
$5.96
0.02%
37205005565
PAIN RELIEVE CHW 80MG
3
$23.10
0.05%
0
$0.00
0.00%
37205014578
ASPIRIN
TAB 325MG
6
$20.07
0.11%
18
$53.17
0.28%
37205014587
ASPIRIN
TAB 325MG
19
$63.78
0.34%
28
$83.40
0.44%
37205015078
BUFFERED ASA TAB 325MG
4
$21.28
0.07%
3
$16.29
0.05%
TAB 81MG EC
TAB 325MG
TAB 500MG
TAB 325MG
DRO 100MG/ML
0
Page 26 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
37205018778
2
37205028062
MIGRAINE
37205031905
INF PAIN REL DRO 80/0.8ML
37205036968
ASPIRIN
CHW 81MG
37205042978
ASPIRIN
37205042990
ASPIRIN
37205046768
CHILD ASA CHW 81MG
37205050526
$17.82
0.04%
5
$32.71
0.08%
0
$0.00
0.00%
2
$27.00
0.03%
1
$16.23
0.02%
1
$6.57
0.02%
0
$0.00
0.00%
4
$9.72
0.06%
TAB 325MG EC
11
$24.85
0.20%
18
$43.19
0.28%
TAB 325MG EC
21
$48.41
0.38%
14
$45.56
0.22%
18
$54.12
0.33%
50
$192.85
0.79%
CHILD PAIN LIQ RELIEVER
3
$19.82
0.05%
0
$0.00
0.00%
37205050826
CHILD PAIN SUS 160/5ML
3
$21.56
0.05%
1
$4.21
0.02%
37205051076
ASA LO-DOSE TAB 81MG EC
31
$104.07
0.56%
87
$362.69
1.37%
37205051087
ASA LO-DOSE TAB 81MG EC
2
$2.98
0.04%
23
$63.82
0.36%
37205051172
ASPIRIN
TAB 500MG EC
6
$25.86
0.11%
0
$0.00
0.00%
37205051826
PAIN RELIEV SUS 160/5ML
0
$0.00
0.00%
2
$8.30
0.03%
37205070378
HEADACHE FOR TAB ADDED ST
37205070868
CHILD ASA CHW 81MG
41100000375
ST JOSEPH
41163040378
TAB FORMULA
1
$4.99
0.02%
3
$15.75
0.05%
19
$95.79
0.34%
14
$48.90
0.22%
0
$0.00
0.00%
1
$2.27
0.02%
0
$0.00
0.00%
1
$8.19
0.02%
45802073030
ACETAMIN
SUP 650MG
3
$25.37
0.05%
1
$20.73
0.02%
45802073032
ACETAMIN
SUP 650MG
1
$7.72
0.02%
0
$0.00
0.00%
45802073033
ACETAMIN
SUP 650MG
0
$0.00
0.00%
1
$45.73
0.02%
45802073230
ACETAMIN
SUP 120MG
5
$29.66
0.09%
6
$66.96
0.09%
45802073232
ACETAMIN
SUP 120MG
0
$0.00
0.00%
1
$5.47
0.02%
46672005310
BUT/APAP/CAF TAB
209
$1,873.26
3.78%
198
$1,792.56
3.13%
46672005350
BUT/APAP/CAF TAB
93
$1,044.10
1.68%
86
$1,059.40
1.36%
49260050319
ASPIRIN
0
$0.00
0.00%
1
$0.78
0.02%
49348000110
SM ASPIRIN TAB 325MG
0
$0.00
0.00%
2
$2.74
0.03%
49348000910
NON-ASPIRIN TAB 325MG
12
$104.62
0.22%
8
$60.94
0.13%
CHW 75MG ADU
TAB 81MG
Page 27 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
49348002310
0
49348002312
49348003410
SM ASPIRIN TAB 325MG EC
49348028423
$0.00
0.00%
1
$8.64
0.02%
0
$0.00
0.00%
8
$19.53
0.14%
1
$7.51
0.02%
9
$24.77
0.14%
0
$0.00
0.00%
1
$0.92
0.02%
49348028609
3
$25.87
0.05%
3
$15.03
0.05%
49348028610
49348075653
18
$123.69
0.33%
0
$0.00
0.00%
7
$33.70
0.13%
35
$90.16
0.55%
49348079204
SM NON-ASA TAB JR 160MG
0
$0.00
0.00%
6
$42.24
0.09%
49348088834
V-R NON-ASA SUS CHILDREN
2
$13.98
0.04%
0
$0.00
0.00%
49614012278
MEDI-TABS
5
$35.95
0.09%
3
$23.07
0.05%
49614042378
ARTHRIT PAIN TAB
0
$0.00
0.00%
1
$7.45
0.02%
49614053576
ADLT ASA LOW TAB 81MG EC
3
$11.97
0.05%
5
$19.95
0.08%
49692090120
ECOTRIN
TAB 325MG EC
6
$8.41
0.11%
4
$11.64
0.06%
49692090236
ECOTRIN
TAB 81MG EC
2
$4.56
0.04%
5
$3.00
0.08%
49692090377
ECOTRIN
TAB 325MG EC
0
$0.00
0.00%
5
$5.56
0.08%
49692090875
ECOTRIN
TAB 325MG EC
0
$0.00
0.00%
1
$5.04
0.02%
49692091236
ECOTRIN
TAB 81MG EC
1
$4.90
0.02%
16
$33.52
0.25%
49884065701
ZORPRIN
TAB 800MG CR
1
$23.91
0.02%
0
$0.00
0.00%
50111039001
SALSALATE
TAB 500MG
89
$1,427.43
1.61%
94
$1,452.51
1.48%
50111039002
SALSALATE
TAB 500MG
10
$123.69
0.18%
29
$414.15
0.46%
50111039101
SALSALATE
TAB 750MG
81
$1,425.34
1.47%
68
$1,271.45
1.07%
50111039102
SALSALATE
TAB 750MG
26
$532.38
0.47%
16
$325.73
0.25%
50111052801
CHO MAG TRIS TAB 500MG
48
$2,172.53
0.87%
29
$1,272.48
0.46%
50111052901
56
$2,698.18
1.01%
53
$2,910.83
0.84%
50111053001
9
$670.26
0.16%
11
$734.06
0.17%
50428132704
0
$0.00
0.00%
2
$13.18
0.03%
50428140897
CVS ASPIRIN TAB 325MG EC
0
$0.00
0.00%
1
$1.69
0.02%
TAB 500MG
Page 28 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
50428193588
ARTHRTS PAIN TAB 650MG
1
50428207688
NON-ASPIRIN SUS CHILD
50428230268
CVS ASPIRIN TAB EC 81MG
50428301424
ACETAMIN
50428371914
$6.99
0.02%
0
$0.00
0.00%
5
$11.66
0.09%
$14.87
0.05%
1
$4.49
0.02%
12
$22.28
0.19%
0
$0.00
0.00%
2
$9.60
0.03%
1
$5.29
0.02%
1
$5.29
0.02%
50428547802
ASPIRIN CHIL CHW 81MG
1
50428606384
1
$0.49
0.02%
3
$2.27
0.05%
$2.29
0.02%
0
$0.00
0.00%
50428738104
0
$0.00
0.00%
2
$3.38
0.03%
50428862623
CVS NON-ASA DRO
1
$6.49
0.02%
0
$0.00
0.00%
50428923789
0
$0.00
0.00%
3
$7.47
0.05%
50580010124
TYLENOL JR CHW 160MG
1
$7.07
0.02%
3
$31.88
0.05%
50580010324
TYLENOL JR CHW 160MG
1
$18.68
0.02%
0
$0.00
0.00%
50580011108
TYLENOL
9
$69.95
0.16%
8
$84.37
0.13%
50580011210
TYLENOL ARTH TAB 650MG
9
$97.63
0.16%
34
$369.81
0.54%
50580011212
0
$0.00
0.00%
2
$21.16
0.03%
50580011215
1
$13.16
0.02%
0
$0.00
0.00%
50580011224
0
$0.00
0.00%
1
$4.63
0.02%
50580011225
1
$17.19
0.02%
2
$22.54
0.03%
50580011250
3
$32.05
0.05%
10
$75.29
0.16%
50580012201
1
$9.60
0.02%
0
$0.00
0.00%
50580012215
8
$63.26
0.14%
4
$41.12
0.06%
50580012304
6
$49.22
0.11%
6
$57.05
0.09%
50580012342
1
$8.26
0.02%
2
$16.38
0.03%
50580012410
TYLENOL
TAB 500MG
9
$62.72
0.16%
5
$22.30
0.08%
50580012415
TYLENOL
TAB 500MG
0
$0.00
0.00%
4
$27.57
0.06%
50580012450
TYLENOL
TAB 500MG
0
$0.00
0.00%
1
$3.14
0.02%
50580012610
ST JOSEPH AS TAB 81MG
2
$0.48
0.04%
2
$0.48
0.03%
TAB 325MG
LIQ 167/5ML
3
Page 29 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
50580012618
9
$9.70
0.16%
7
50580012636
5
$16.38
0.09%
50580014315
0
$0.00
0.00%
50580017308
ST JOSEPH AS CHW 81MG
1
$5.70
50580017336
ST JOSEPH AS CHW 81MG
1
50580018615
TYLENOL
DRO INFANTS
50580018630
TYLENOL
DRO INFANTS
50580029604
$10.58
0.11%
3
$3.50
0.05%
2
$14.39
0.03%
0.02%
0
$0.00
0.00%
$4.77
0.02%
3
$6.70
0.05%
6
$40.62
0.11%
6
$47.26
0.09%
1
$9.60
0.02%
1
$8.91
0.02%
3
$24.93
0.05%
2
$16.38
0.03%
50580029705
TYLENOL 8 HR TAB 650MG
0
$0.00
0.00%
2
$21.39
0.03%
50580029710
TYLENOL 8 HR TAB 650MG
1
$12.03
0.02%
0
$0.00
0.00%
50580040704
5
$37.30
0.09%
2
$22.87
0.03%
50580044900
TYLENOL
TAB 500MG
1
$6.59
0.02%
0
$0.00
0.00%
50580044905
TYLENOL
TAB 500MG
0
$0.00
0.00%
1
$10.38
0.02%
50580044909
TYLENOL
TAB 500MG
3
$18.57
0.05%
8
$75.27
0.13%
50580044923
TYLENOL
TAB 500MG
0
$0.00
0.00%
4
$23.12
0.06%
50580044930
TYLENOL
TAB 500MG
1
$10.47
0.02%
0
$0.00
0.00%
50580044980
TYLENOL
TAB 500MG
1
$2.33
0.02%
1
$15.60
0.02%
50580046850
TYLENOL
TAB 500MG
0
$0.00
0.00%
1
$3.69
0.02%
50580046870
TYLENOL
TAB 500MG
0
$0.00
0.00%
2
$16.05
0.03%
50580049304
0
$0.00
0.00%
1
$8.19
0.02%
50580049660
TYLENOL
TAB 325MG
16
$130.61
0.29%
13
$122.35
0.21%
50580049932
TYLENOL
TAB 500MG
1
$4.07
0.02%
1
$4.07
0.02%
50580049960
TYLENOL
TAB 500MG
7
$69.43
0.13%
10
$101.21
0.16%
50580049968
TYLENOL
TAB 500MG
2
$19.04
0.04%
1
$12.08
0.02%
50580049970
TYLENOL
TAB 500MG
2
$22.70
0.04%
6
$55.62
0.09%
50580050008
TYLENOL
LIQ 167MG/5
17
$130.18
0.31%
3
$23.91
0.05%
50844022216
ASPIRIN
3
$10.38
0.05%
0
$0.00
0.00%
TAB 81MG
Page 30 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
50844022712
ASPIRIN
TAB 325MG EC
50844032512
ACETAMIN
51079000220
ACETAMIN
51079000240
3
$3.94
0.05%
1
$2.98
0.02%
TAB 500MG
0
$0.00
0.00%
1
$3.84
0.02%
TAB 325MG
0
$0.00
0.00%
1
$7.47
0.02%
ACETAMIN
TAB 325MG
1
$2.47
0.02%
4
$7.77
0.06%
51079000260
ACETAMIN
TAB 325MG
10
$40.84
0.18%
5
$16.30
0.08%
51079000540
ASPIRIN
1
$1.01
0.02%
0
$0.00
0.00%
51111048878
ACETAMIN
TAB 325MG
6
$23.46
0.11%
14
$54.74
0.22%
51111048893
ACETAMIN
TAB 325MG
30
$93.79
0.54%
67
$221.84
1.06%
51111048978
ACETAMIN
TAB 500MG
1
$0.86
0.02%
1
$1.70
0.02%
51111048993
ACETAMIN
TAB 500MG
2
$5.19
0.04%
1
$1.64
0.02%
51672250108
ELIXSURE
GEL F/P CHRY
1
$7.57
0.02%
0
$0.00
0.00%
52152008402
2
$127.18
0.04%
1
$43.93
0.02%
52152008502
4
$208.10
0.07%
2
$99.12
0.03%
52544048501
BUT/APAP/CAF TAB
53
$461.40
0.96%
0
$0.00
0.00%
52544048505
BUT/APAP/CAF TAB
18
$248.80
0.33%
4
$80.40
0.06%
52569085110
APAP
TAB 325MG
0
$0.00
0.00%
1
$4.75
0.02%
52569085410
APAP
TAB 500MG
0
$0.00
0.00%
1
$10.01
0.02%
52735070370
FP ASPIRIN TAB 325MG EC
0
$0.00
0.00%
2
$2.36
0.03%
52735070901
ACETAMIN
0
$0.00
0.00%
1
$5.61
0.02%
52735074614
ASPIRIN LS TAB 81MG
18
$50.90
0.33%
21
$70.65
0.33%
52735075405
ACETAMIN JR CHW 160MG FR
2
$10.90
0.04%
0
$0.00
0.00%
52735075941
NON-ASA PAIN SUS 160/5ML
7
$111.32
0.13%
7
$121.87
0.11%
52735076025
NON-ASA INF DRO 80/0.8ML
1
$6.24
0.02%
0
$0.00
0.00%
52735078008
CHILD APAP CHW 80MG
0
$0.00
0.00%
1
$5.22
0.02%
53265013210
SALSALATE
TAB 500MG
0
$0.00
0.00%
9
$247.57
0.14%
53265013250
SALSALATE
TAB 500MG
0
$0.00
0.00%
5
$113.61
0.08%
53265013310
SALSALATE
TAB 750MG
0
$0.00
0.00%
40
$1,343.06
0.63%
TAB 325MG
TAB 325MG
Page 31 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
53265023510
BUT/APAP/CAF TAB
96
$4,130.98
1.74%
70
$2,483.36
1.11%
53265023610
BUT/APAP/CAF TAB
485
$4,876.94
8.77%
215
$2,510.92
3.40%
53265023650
BUT/APAP/CAF TAB
198
$2,125.12
3.58%
197
$1,906.60
3.11%
53489046601
SALSALATE
2
$52.19
0.04%
0
$0.00
0.00%
53807012916
NON-ASPIRIN ELX 160/5ML
0
$0.00
0.00%
2
$12.36
0.03%
53807013101
NON-ASPIRIN SOL EX STR
0
$0.00
0.00%
1
$2.20
0.02%
54499022601
ASPIRIN
3
$12.04
0.05%
0
$0.00
0.00%
54499022894
1
$2.98
0.02%
1
$0.48
0.02%
54738054813
ACETAMIN
TAB 325MG
0
$0.00
0.00%
1
$2.35
0.02%
55505010914
HALFPRIN
TAB 81MG EC
0
$0.00
0.00%
14
$39.20
0.22%
55966008903
ASA LOW STR TAB 81MG EC
0
$0.00
0.00%
1
$3.81
0.02%
57664010308
SALSALATE
TAB 500MG
9
$243.65
0.16%
5
$147.88
0.08%
57664010508
SALSALATE
TAB 750MG
45
$1,076.84
0.81%
39
$965.52
0.62%
57664010513
SALSALATE
TAB 750MG
4
$73.66
0.07%
0
$0.00
0.00%
57664021908
3
$111.06
0.05%
2
$82.08
0.03%
57664022008
7
$374.03
0.13%
0
$0.00
0.00%
57896002201
ACETAMIN
TAB 500MG
0
$0.00
0.00%
2
$6.06
0.03%
57896010010
ACETAMIN
TAB 325MG
0
$0.00
0.00%
1
$1.21
0.02%
57896020010
ACETAMIN
TAB 500MG
16
$46.92
0.29%
43
$134.75
0.68%
57896022101
ACETAMIN
TAB 500MG
3
$4.58
0.05%
2
$2.87
0.03%
57896022110
ACETAMIN
TAB 500MG
2
$6.03
0.04%
0
$0.00
0.00%
57896090101
ASPIRIN
TAB 325MG
2
$1.58
0.04%
1
$1.04
0.02%
57896090110
ASPIRIN
TAB 325MG
1
$1.74
0.02%
0
$0.00
0.00%
57896091136
ASPIRIN
CHW 81MG
1
$1.17
0.02%
0
$0.00
0.00%
57896092101
ASPIRIN
TAB 325MG EC
30
$106.72
0.54%
22
$77.64
0.35%
57896092110
ASPIRIN
TAB 325MG EC
23
$51.01
0.42%
38
$90.63
0.60%
58659311004
ASPIRIN
TAB 81MG EC
2
$2.58
0.04%
0
$0.00
0.00%
TAB 750MG
TAB 325MG EC
Page 32 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANALGESICS - MISC.
59390000113
INFANTAIRE DRO 80/0.8ML
3
$9.21
0.05%
0
59606003020
PAIN RELIEF TAB 325MG
3
$13.07
0.05%
59630017010
ZEBUTAL
1
$30.69
0.02%
60242011501
EC ASPIRIN TAB 325MG EC
1
$1.94
60258009008
CHO MAG TRIS LIQ 500/5ML
10
60951076960
62107002726
ASPIR-81
62107005101
TACTINAL
64248009110
EQUAGESIC
64899051244
HCA CHILD
65234005010
65234005610
CAP
$0.00
0.00%
0
$0.00
0.00%
1
$39.79
0.02%
0.02%
0
$0.00
0.00%
$411.50
0.18%
20
$833.00
0.32%
2
$55.05
0.04%
2
$51.24
0.03%
TAB 81MG EC
17
$35.15
0.31%
21
$66.68
0.33%
TAB 500MG
9
$46.36
0.16%
8
$43.47
0.13%
TAB 200-325
1
$62.49
0.02%
0
$0.00
0.00%
SUS NON-ASA
0
$0.00
0.00%
1
$7.12
0.02%
PHRENILIN TAB 325-50MG
5
$41.49
0.09%
0
$0.00
0.00%
PHRENILIN FO CAP 650-50MG
7
$143.36
0.13%
0
$0.00
0.00%
66375010101
ACETAMIN
TAB 500MG
0
$0.00
0.00%
1
$5.11
0.02%
66553000701
ACETAMIN
TAB 325MG
0
$0.00
0.00%
3
$28.44
0.05%
68115003530
ASPIRIN EC TAB 81MG
0
$0.00
0.00%
1
$4.93
0.02%
ANAPHYLAXIS THERAPY
49502050001
EPIPEN
INJ 0.3MG
277
$17,754.41
61.28%
268
$15,317.64
63.51%
49502050002
EPIPEN
INJ 0.3MG
75
$6,319.96
16.59%
68
$5,610.44
16.11%
49502050101
EPIPEN-JR
INJ 0.15MG
61
$4,265.84
13.50%
43
$2,803.39
10.19%
49502050102
EPIPEN-JR
INJ 0.15MG
39
$3,322.71
8.63%
43
$3,886.00
10.19%
1
$65.48
0.24%
0
$0.00
0.00%
2.64%
3
$155.77
0.59%
ANDROGENS / ANABOLICS
00009001401
HALOTESTIN TAB 2MG
00009034702
DEPO-TESTOST INJ 100MG/ML
11
$540.83
00009041701
37
$1,023.86
8.89%
67
$2,335.42
13.24%
00009041702
43
$3,929.48
10.34%
52
$4,814.15
10.28%
Page 33 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANDROGENS / ANABOLICS
00024030506
DANOCRINE
CAP 200MG
00024225304
WINSTROL
00051842530
ANDROGEL
GEL 1%(25MG)
00051845030
ANDROGEL
GEL 1%(50MG)
00115703701
METHITEST
TAB 10MG
00187090101
TESTRED
00187090201
ANDROID
00555063302
$360.22
0.24%
$0.00
0.00%
2
$32.76
0.48%
14
$2,034.65
3.37%
0
$0.00
0.00%
10
$2,790.92
1.98%
66
$12,186.10
15.87%
76
$14,718.99
15.02%
4
$358.73
0.96%
0
$0.00
0.00%
CAP 10MG
15
CAP 10MG
14
$1,142.85
3.61%
25
$2,092.32
4.94%
$2,159.06
3.37%
35
$6,326.12
6.92%
DANAZOL
CAP 50MG
5
$217.86
1.20%
2
$225.68
0.40%
00555063402
DANAZOL
CAP 100MG
3
$377.71
0.72%
3
$602.89
0.59%
00555063502
00555063509
DANAZOL
CAP 200MG
12
$1,475.16
2.88%
3
$350.55
0.59%
DANAZOL
CAP 200MG
5
$579.97
1.20%
0
$0.00
0.00%
00574046025
TESTOSTERONE POW
1
$40.75
0.24%
0
$0.00
0.00%
00574046105
TESTOST PROP POW
2
$25.94
0.48%
3
$23.31
0.59%
00591322126
TESTOST ENAN INJ 200MG/ML
0
$0.00
0.00%
8
$600.81
1.58%
00591322379
TESTOST CYP INJ 200MG/ML
0
$0.00
0.00%
20
$1,747.09
3.95%
00832008600
ANDROXY
8
$887.39
1.92%
5
$667.60
0.99%
17314283603
TESTODERM
DIS 6MG/24HR
11
$1,278.19
2.64%
0
$0.00
0.00%
17314460803
TESTODERM
DIS 4MG/24HR
12
$1,393.48
2.88%
0
$0.00
0.00%
17314460903
TESTODERM
DIS 6MG/24HR
6
$691.74
1.44%
0
$0.00
0.00%
52544046960
ANDRODERM
DIS 2.5MG/24
15
$1,624.86
3.61%
24
$2,128.48
4.74%
52544047030
ANDRODERM
DIS 5MG/24HR
54
$8,442.35
12.98%
118
$20,594.08
23.32%
54396011060
OXANDRIN
TAB 10MG
3
$2,059.75
0.72%
6
$5,300.67
1.19%
54396011111
OXANDRIN
TAB 2.5MG
53
$15,948.94
12.74%
34
$9,611.10
6.72%
54396032840
DELATESTRYL INJ 200MG/ML
18
$1,489.52
4.33%
12
$864.18
2.37%
5
$219.17
0.07%
6
$278.28
0.09%
TAB 2MG
TAB 10MG
1
0
ANGIOTENSIN RECEPTOR BLOCKER
00006095128
COZAAR
TAB 25MG
Page 34 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00006095154
COZAAR
TAB 25MG
265
$11,367.34
3.84%
329
$14,756.30
5.13%
00006095158
COZAAR
TAB 25MG
256
$10,214.99
3.71%
178
$8,211.16
2.77%
00006095228
COZAAR
TAB 50MG
2
$69.29
0.03%
9
$402.95
0.14%
00006095231
COZAAR
TAB 50MG
132
$5,674.16
1.91%
127
$5,720.47
1.98%
00006095254
COZAAR
TAB 50MG
663
$28,399.57
9.62%
1,192
$52,498.16
18.57%
00006095258
COZAAR
TAB 50MG
1,087
$46,048.43
15.77%
505
$25,401.22
7.87%
00006095282
COZAAR
TAB 50MG
3
$128.70
0.04%
1
$45.13
0.02%
00006096028
COZAAR
TAB 100MG
54
$3,230.31
0.78%
26
$1,582.20
0.41%
00006096031
COZAAR
TAB 100MG
331
$19,424.25
4.80%
480
$29,117.99
7.48%
00006096054
COZAAR
TAB 100MG
63
$3,732.86
0.91%
808
$48,976.68
12.59%
00006096058
COZAAR
TAB 100MG
893
$51,183.13
12.96%
372
$27,702.83
5.80%
00051504401
TEVETEN
TAB 400MG
11
$283.66
0.16%
0
$0.00
0.00%
00051504601
TEVETEN
TAB 600MG
29
$1,025.72
0.42%
0
$0.00
0.00%
00078035805
DIOVAN
TAB 80MG
539
$22,781.18
7.82%
47
$1,278.95
0.73%
00078035806
DIOVAN
TAB 80MG
1
$85.05
0.01%
0
$0.00
0.00%
00078035834
DIOVAN
TAB 80MG
0
$0.00
0.00%
81
$2,556.93
1.26%
00078035905
DIOVAN
TAB 160MG
442
$20,256.34
6.41%
42
$1,524.55
0.65%
00078035934
DIOVAN
TAB 160MG
0
$0.00
0.00%
87
$3,727.69
1.36%
00078036005
DIOVAN
TAB 320MG
78
$4,114.59
1.13%
12
$768.10
0.19%
00078036034
DIOVAN
TAB 320MG
0
$0.00
0.00%
27
$1,293.77
0.42%
00078037606
DIOVAN
TAB 40MG
1
$37.16
0.01%
1
$5.94
0.02%
00078037615
DIOVAN
TAB 40MG
11
$399.01
0.16%
9
$158.46
0.14%
00083400001
DIOVAN
CAP 80MG
3
$111.96
0.04%
0
$0.00
0.00%
00083400101
DIOVAN
CAP 160MG
1
$40.44
0.01%
0
$0.00
0.00%
00087277131
AVAPRO
TAB 75MG
1
$42.09
0.01%
0
$0.00
0.00%
00087277132
AVAPRO
TAB 75MG
9
$376.73
0.13%
2
$31.22
0.03%
00087277215
AVAPRO
TAB 150MG
2
$88.52
0.03%
0
$0.00
0.00%
Page 35 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00087277231
AVAPRO
TAB 150MG
33
$1,154.38
0.48%
20
$718.54
0.31%
00087277232
AVAPRO
TAB 150MG
105
$4,005.57
1.52%
42
$1,627.34
0.65%
00087277331
AVAPRO
TAB 300MG
17
$876.73
0.25%
0
$0.00
0.00%
00087277332
AVAPRO
TAB 300MG
52
$2,425.12
0.75%
5
$221.25
0.08%
00186000431
ATACAND
TAB 4MG
9
$243.96
0.13%
0
$0.00
0.00%
00186000831
ATACAND
TAB 8MG
30
$1,152.21
0.44%
16
$526.59
0.25%
00186001628
ATACAND
TAB 16MG
0
$0.00
0.00%
2
$47.64
0.03%
00186001631
ATACAND
TAB 16MG
107
$3,726.47
1.55%
20
$549.02
0.31%
00186001654
ATACAND
TAB 16MG
5
$246.04
0.07%
10
$128.98
0.16%
00186003228
ATACAND
TAB 32MG
0
$0.00
0.00%
1
$62.00
0.02%
00186003231
ATACAND
TAB 32MG
102
$5,322.03
1.48%
30
$1,541.80
0.47%
00186003254
ATACAND
TAB 32MG
14
$712.64
0.20%
6
$295.06
0.09%
00597003928
MICARDIS
TAB 20MG
25
$1,040.24
0.36%
51
$2,317.08
0.79%
00597004028
MICARDIS
TAB 40MG
181
$7,489.94
2.63%
182
$7,975.13
2.84%
00597004037
MICARDIS
TAB 40MG
0
$0.00
0.00%
3
$93.13
0.05%
00597004128
MICARDIS
TAB 80MG
148
$6,775.27
2.15%
192
$9,128.56
2.99%
00597004137
MICARDIS
TAB 80MG
0
$0.00
0.00%
5
$332.79
0.08%
64455013001
TEVETEN
TAB 400MG
41
$1,239.03
0.59%
72
$3,260.90
1.12%
64455013101
TEVETEN
TAB 600MG
163
$6,109.93
2.36%
185
$7,259.22
2.88%
65597010130
BENICAR
TAB 5MG
19
$832.40
0.28%
32
$1,583.38
0.50%
65597010310
BENICAR
TAB 20MG
54
$2,382.82
0.78%
49
$2,162.21
0.76%
65597010330
BENICAR
TAB 20MG
417
$15,503.41
6.05%
491
$20,598.70
7.65%
65597010390
BENICAR
TAB 20MG
117
$4,401.58
1.70%
155
$7,224.14
2.42%
65597010410
BENICAR
TAB 40MG
14
$491.56
0.20%
4
$174.24
0.06%
65597010430
BENICAR
TAB 40MG
291
$10,852.21
4.22%
359
$16,341.14
5.59%
65597010490
BENICAR
TAB 40MG
67
$2,556.54
0.97%
145
$6,305.75
2.26%
Page 36 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANORECTAL - MISC.
00091069010
PROCTOFOAM AER -HC 1%
00091069520
CORTIFOAM
00091464024
PROCTOCREAM CRE HC 2.5%
00093916871
HYDROCORT
00472051112
72
$3,336.06
15.79%
23
$1,041.71
4.72%
2
$235.78
0.44%
2
$165.76
0.41%
1
$32.95
0.22%
1
$12.65
0.21%
9
$1,180.59
1.97%
3
$341.92
0.62%
HEMORRHOIDAL SUP -HC 25MG
2
$38.46
0.44%
1
$20.42
0.21%
00472051124
7
$92.75
1.54%
1
$7.08
0.21%
00482480014
ANAMANTLE HC CRE
1
$58.60
0.22%
0
$0.00
0.00%
00496077804
ANALPRAM-HC CRE 1%
16
$625.82
3.51%
34
$1,437.80
6.98%
00496080004
ANALPRAM-HC CRE 2.5%
31
$1,225.78
6.80%
55
$2,377.19
11.29%
00496082430
ELA-MAX 5
7
$335.43
1.54%
0
$0.00
0.00%
00496088315
LMX 5
0
$0.00
0.00%
1
$50.97
0.21%
00574202001
COLOCORT
ENE 100MG
0
$0.00
0.00%
1
$273.85
0.21%
00574202007
COLOCORT
ENE 100MG
5
$807.40
1.10%
3
$451.70
0.62%
00603812711
0
$0.00
0.00%
1
$7.61
0.21%
00603812718
0
$0.00
0.00%
4
$22.67
0.82%
00603813611
PROCTOSERT H SUP 30 MG
6
$477.45
1.32%
0
$0.00
0.00%
00603813618
PROCTOSERT H SUP 30 MG
0
$0.00
0.00%
1
$25.67
0.21%
58634002501
PROCTOSOL HC CRE 2.5%
0
$0.00
0.00%
1
$12.44
0.21%
61570031311
ANUSOL-HC
CRE 2.5%
7
$245.91
1.54%
2
$71.78
0.41%
63304040601
PROCTO-KIT CRE 2.5%
9
$278.01
1.97%
3
$25.28
0.62%
63304040701
PROCTOSOL HC CRE 2.5%
38
$935.12
8.33%
12
$115.08
2.46%
64980030130
PROCTOZONE CRE -HC 2.5%
243
$4,868.04
53.29%
338
$3,715.30
69.40%
AER 90MG
ENE 100MG
CRE 5%
CRE 5%
ANTHELMINTICS
00006003220
STROMECTOL TAB 3MG
61
$1,936.82
20.96%
8
$485.61
5.48%
00006013910
STROMECTOL TAB 6MG
2
$73.61
0.69%
0
$0.00
0.00%
00007550040
ALBENZA
12
$186.91
4.12%
5
$61.82
3.42%
TAB 200MG
Page 37 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTHELMINTICS
00026252106
BILTRICIDE TAB 600MG
00093910729
MEBENDAZOLE CHW 100MG
50580007012
VERMOX
CHW 100MG
2
$32.76
0.69%
2
$77.51
1.37%
213
$1,817.70
73.20%
131
$1,333.35
89.73%
1
$13.64
0.34%
0
$0.00
0.00%
ANTI INFECTIVE COMBO'S - MISC.
00004011701
BACTRIM DS TAB 800-160
0
$0.00
0.00%
3
$14.16
0.06%
00074715613
EES/SULFISOX SUS 200-600
5
$102.24
0.09%
0
$0.00
0.00%
00074715643
8
$142.33
0.14%
2
$35.14
0.04%
00074715653
8
$198.20
0.14%
6
$149.58
0.11%
00093008801
SMZ-TMP
TAB 400-80MG
258
$1,629.69
4.59%
182
$1,230.01
3.45%
00093008805
SMZ-TMP
TAB 400-80MG
105
$625.71
1.87%
133
$756.00
2.52%
00093008901
SMZ/TMP DS TAB 800-160
681
$2,593.19
12.10%
641
$2,453.70
12.14%
00093008905
2,668
$10,834.27
47.41%
2,507
$9,966.01
47.48%
00093056216
SMZ-TMP PED SUS 200-40/5
00173066518
MEPRON
00364206990
00472128416
SULFATRIM
00472128516
00472128533
1
$19.14
0.02%
1
$7.62
0.02%
32
$17,980.18
0.57%
33
$27,891.53
0.63%
1
$3.47
0.02%
0
$0.00
0.00%
SUS 200-40/5
10
$158.45
0.18%
21
$525.53
0.40%
SULFATRIM
SUS 200-40/5
194
$2,667.60
3.45%
168
$2,247.91
3.18%
SULFATRIM
SUS 200-40/5
2
$20.80
0.04%
0
$0.00
0.00%
00555044521
20
$425.24
0.36%
10
$186.44
0.19%
00555044522
6
$141.54
0.11%
6
$124.98
0.11%
00555044523
13
$327.06
0.23%
4
$75.73
0.08%
00591554601
SMZ-TMP
0
$0.00
0.00%
4
$23.37
0.08%
00591554705
3
$11.90
0.05%
0
$0.00
0.00%
00603168758
SMZ-TMP PED SUS 200-40/5
2
$22.49
0.04%
0
$0.00
0.00%
00677078301
SMZ-TMP
TAB 400-80MG
0
$0.00
0.00%
1
$7.33
0.02%
00677078305
SMZ-TMP
TAB 400-80MG
0
$0.00
0.00%
5
$35.32
0.09%
SUS
TAB 400-80MG
Page 38 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTI INFECTIVE COMBO'S - MISC.
00677078401
21
$79.78
0.37%
12
$53.15
0.23%
00677078405
10
$39.70
0.18%
85
$381.35
1.61%
00904247504
0
$0.00
0.00%
1
$13.74
0.02%
00904272540
62
$255.77
1.10%
0
$0.00
0.00%
00904272560
8
$34.66
0.14%
0
$0.00
0.00%
00904272561
6
$15.12
0.11%
0
$0.00
0.00%
50383082316
SMZ-TMP
SUS 200-40/5
392
$5,072.22
6.97%
325
$4,027.66
6.16%
50383082416
SMZ-TMP
SUS 200-40/5
212
$2,688.96
3.77%
256
$3,237.93
4.85%
53489014501
SMZ-TMP
TAB 400-80MG
33
$225.54
0.59%
35
$191.17
0.66%
53489014505
SMZ-TMP
TAB 400-80MG
7
$49.98
0.12%
5
$36.65
0.09%
53489014601
270
$1,104.06
4.80%
262
$1,031.65
4.96%
53489014605
502
$2,014.88
8.92%
496
$2,083.60
9.39%
61570005201
SEPTRA
TAB 400-80MG
3
$49.35
0.05%
0
$0.00
0.00%
61570005301
SEPTRA DS
TAB 800-160
20
$642.83
0.36%
2
$55.35
0.04%
61570005305
SEPTRA DS
TAB 800-160
60
$1,175.65
1.07%
73
$1,336.14
1.38%
64248011710
BACTRIM DS TAB 800-160
4
$112.16
0.07%
0
$0.00
0.00%
67546021221
ALINIA
0
$0.00
0.00%
1
$58.18
0.02%
8
$358.21
0.23%
11
$667.85
0.37%
SUS 100MG/5M
ANTI-PARKINSONIAN DRUGS
00056051168
LODOSYN
00056052168
SINEMET CR TAB 50/200
11
$1,667.92
0.31%
5
$793.94
0.17%
00056060168
SINEMET CR TAB 25/100
8
$1,431.23
0.23%
5
$882.44
0.17%
00056065068
SINEMET
TAB 25/100
7
$627.27
0.20%
9
$882.19
0.31%
00056065468
SINEMET
TAB 25/250
0
$0.00
0.00%
2
$370.72
0.07%
00078001705
PARLODEL
TAB 2.5MG
2
$164.60
0.06%
3
$261.57
0.10%
00078001715
PARLODEL
TAB 2.5MG
2
$328.40
0.06%
3
$522.00
0.10%
00078010205
PARLODEL
CAP 5MG
11
$2,333.22
0.31%
6
$1,854.66
0.20%
TAB 25MG
Page 39 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
PARLODEL
00078040705
00078040805
CAP 5MG
$
Market Share*
00078010215
# of Scripts
6
$1,856.72
0.17%
STALEVO 50 TAB
0
$0.00
0.00%
STALEVO 100 TAB
0
$0.00
0.00%
00078040905
STALEVO 150 TAB
4
$691.02
0.11%
00093029201
CARB/LEVO TAB 10-100MG
64
$1,771.20
1.81%
00093029205
3
$46.27
0.08%
00093029301
237
$8,169.45
6.71%
00093029305
142
$5,027.75
4.02%
00093029310
15
$606.95
00093029401
49
00093029405
10
00115391101
CARB/LEVO ER TAB 50-200MG
00115392201
CARB/LEVO ER TAB 25/100
00121064616
AMANTADINE SYP 50MG/5ML
00228253810
00228253850
$1,261.65
0.10%
3
$534.69
0.10%
20
$3,953.90
0.68%
8
$1,390.72
0.27%
104
$2,516.95
3.54%
6
$118.13
0.20%
266
$11,185.10
9.07%
185
$6,525.87
6.31%
0.42%
11
$445.85
0.37%
$2,120.87
1.39%
47
$2,154.44
1.60%
$380.00
0.28%
6
$209.10
0.20%
0
$0.00
0.00%
9
$561.90
0.31%
0
$0.00
0.00%
2
$77.74
0.07%
29
$212.28
0.82%
9
$100.31
0.31%
87
$2,213.29
2.46%
76
$1,629.80
2.59%
58
$1,746.64
1.64%
51
$1,516.52
1.74%
00228253910
30
$610.22
0.85%
106
$3,309.85
3.61%
00228253950
140
$4,937.31
3.96%
60
$1,812.59
2.04%
00228253996
467
$17,527.28
13.22%
459
$18,595.28
15.64%
00228254010
16
$704.45
0.45%
17
$545.40
0.58%
00228254050
11
$325.87
0.31%
29
$1,394.42
0.99%
00228254096
71
$2,949.07
2.01%
20
$703.91
0.68%
00378008801
CARB/LEVO ER TAB 25/100
185
$11,257.44
5.24%
187
$10,265.79
6.37%
00378009401
340
$34,659.05
9.62%
319
$28,571.80
10.87%
00378201191
SELEGILINE TAB 5MG
8
$325.46
0.23%
10
$359.14
0.34%
00378204293
BROMOCRIPTIN TAB 2.5MG
0
$0.00
0.00%
2
$310.43
0.07%
00378225291
SELEGILINE CAP 5MG
30
$2,598.17
0.85%
19
$1,250.95
0.65%
3
Page 40 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00677112801
AMANTADINE CAP 100MG
00781181701
00781181731
00781204801
$
Market Share*
00472083316
# of Scripts
$102.62
0.11%
11
$276.26
0.37%
0
$0.00
0.00%
30
$3,946.28
0.85%
1
$5.97
0.03%
3
$412.55
0.10%
4
$127.64
0.11%
48
$3,858.45
1.64%
288
$6,094.78
8.15%
174
$3,437.13
5.93%
00781204805
00832011100
AMANTADINE TAB 100MG
2
$69.98
0.06%
0
$0.00
0.00%
3
$34.29
0.08%
0
$0.00
0.00%
00832101500
538
$9,376.88
15.23%
232
$4,643.51
7.91%
00832101550
6
$51.72
0.17%
0
$0.00
0.00%
00904343061
0
$0.00
0.00%
1
$27.35
0.03%
00904771861
0
$0.00
0.00%
1
$20.84
0.03%
49884061002
SELEGILINE TAB 5MG
6
$228.60
0.17%
5
$191.75
0.17%
50383080716
17
$148.49
0.48%
5
$78.09
0.17%
51079048120
79
$397.80
2.24%
0
$0.00
0.00%
51079075620
10
$341.23
0.28%
7
$97.85
0.24%
52544013660
SELEGILINE TAB 5MG
2
$78.70
0.06%
0
$0.00
0.00%
52544013760
SELEGILINE CAP 5MG
1
$20.27
0.03%
0
$0.00
0.00%
58177038304
0
$0.00
0.00%
3
$185.55
0.10%
59075071110
MYOBLOC
INJ 5000/ML
0
$0.00
0.00%
1
$30.00
0.03%
59075071210
MYOBLOC
INJ 5000/ML
1
$30.00
0.03%
0
$0.00
0.00%
60432009316
14
$347.09
0.40%
6
$116.73
0.20%
60505005501
SELEGILINE CAP 5MG
5
$317.10
0.14%
4
$205.78
0.14%
60505013101
CARB/LEVO SR TAB 25/100
0
$0.00
0.00%
3
$155.37
0.10%
60505343803
SELEGILINE TAB 5MG
12
$459.70
0.34%
14
$558.90
0.48%
60951060368
67
$2,368.60
1.90%
31
$520.00
1.06%
60951060568
133
$4,901.32
3.76%
38
$2,001.72
1.30%
60951060585
129
$4,890.32
3.65%
182
$7,145.22
6.20%
4
Page 41 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
60951060768
14
$455.10
0.40%
13
$466.73
0.44%
60951060785
5
$301.15
0.14%
12
$393.75
0.41%
60951062060
SELEGILINE TAB 5MG
4
$214.45
0.11%
3
$31.65
0.10%
60951065616
23
$187.25
0.65%
0
$0.00
0.00%
62269021124
46
$696.83
1.30%
9
$223.98
0.31%
66685590500
29
$4,149.91
0.82%
29
$3,454.95
0.99%
66685590503
10
$1,968.93
0.28%
20
$1,627.04
0.68%
ANTI-PSORIATICS
00004021357
SORIATANE
CAP 10MG
1
$235.62
0.18%
0
$0.00
0.00%
00004028857
SORIATANE
CAP 10MG
5
$2,128.74
0.90%
5
$2,444.96
0.87%
00004028957
SORIATANE
CAP 25MG
27
$10,133.34
4.87%
37
$15,296.93
6.46%
00023004203
TAZORAC
GEL 0.1%
18
$1,401.24
3.25%
8
$562.68
1.40%
00023004210
TAZORAC
GEL 0.1%
1
$248.04
0.18%
3
$831.78
0.52%
00023833503
TAZORAC
GEL 0.05%
5
$365.75
0.90%
7
$504.47
1.22%
00023833510
TAZORAC
GEL 0.05%
0
$0.00
0.00%
4
$1,017.66
0.70%
00023915515
TAZORAC
CRE 0.05%
1
$73.14
0.18%
3
$166.48
0.52%
00023915530
TAZORAC
CRE 0.05%
17
$1,242.70
3.07%
18
$1,355.33
3.14%
00023915560
TAZORAC
CRE 0.05%
7
$993.08
1.26%
4
$632.76
0.70%
00023915630
TAZORAC
CRE 0.1%
25
$1,896.51
4.51%
24
$2,597.88
4.19%
00023915660
TAZORAC
CRE 0.1%
4
$596.67
0.72%
16
$2,640.25
2.79%
00072026003
DOVONEX
CRE 0.005%
1
$88.72
0.18%
0
$0.00
0.00%
00072026006
DOVONEX
CRE 0.005%
137
$17,363.23
24.73%
134
$16,215.04
23.39%
00072026012
DOVONEX
CRE 0.005%
32
$7,090.81
5.78%
22
$5,207.94
3.84%
00072116006
DOVONEX
SOL 0.005%
51
$4,981.64
9.21%
56
$5,606.85
9.77%
00072254003
DOVONEX
OIN 0.005%
1
$88.72
0.18%
30
$2,603.10
5.24%
00072254006
DOVONEX
OIN 0.005%
133
$16,589.60
24.01%
114
$13,765.94
19.90%
Page 42 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTI-PSORIATICS
00072254012
DOVONEX
OIN 0.005%
00187065042
50242005804
63032009125
SORIATANE
64980031250
ANTHRALIN
65880041550
PSORIATEC
75
$19,520.19
13.54%
79
OXSORALEN-UL CAP 10MG
9
$2,288.73
1.62%
RAPTIVA
0
$0.00
0.00%
CAP 25MG
0
$0.00
CRE 1%
1
KIT 125MG
ANTIANGINALS--Isosorbide
CRE 1%
$21,707.23
13.79%
2
$597.43
0.35%
3
$2,451.72
0.52%
0.00%
1
$407.14
0.17%
$52.09
0.18%
2
$106.68
0.35%
3
$196.33
0.54%
1
$69.31
0.17%
2
$19.20
0.07%
2
$43.42
0.07%
Di-nitrate
00008419201
ISORDIL
TAB 40MG
00091092001
DILATRATE SR CAP 40MG
1
$14.66
0.03%
0
$0.00
0.00%
00143176501
ISOSORB DIN SUB 2.5MG
0
$0.00
0.00%
2
$5.28
0.07%
00143176701
ISOSORB DIN SUB 5MG
1
$4.81
0.03%
0
$0.00
0.00%
00143176901
ISOSORB DIN TAB 5MG
13
$31.10
0.42%
20
$54.90
0.68%
00143176910
ISOSORB DIN TAB 5MG
25
$84.21
0.82%
23
$95.20
0.79%
00143177101
ISOSORB DIN TAB 10MG
16
$45.74
0.52%
23
$84.22
0.79%
00143177110
156
$537.20
5.10%
119
$497.40
4.07%
00143177201
9
$35.51
0.29%
22
$79.81
0.75%
00143177210
202
$816.50
6.60%
188
$735.58
6.43%
00182268701
ISOSORB MONO TAB 60MG ER
26
$195.25
0.85%
2
$11.90
0.07%
00228271111
31
$240.14
1.01%
4
$22.97
0.14%
00228271150
279
$2,204.34
9.12%
310
$2,370.41
10.61%
00258354910
ISOSORB DIN TAB 40MG CR
0
$0.00
0.00%
3
$72.33
0.10%
00258361301
ISOSORB DIN TAB 40MG ER
295
$11,006.08
9.64%
243
$9,062.82
8.31%
00677068910
8
$34.52
0.26%
0
$0.00
0.00%
00781155601
15
$47.11
0.49%
26
$101.08
0.89%
00781155610
11
$47.79
0.36%
15
$69.24
0.51%
00781163501
ISOSORB DIN TAB 5MG
4
$11.60
0.13%
2
$10.10
0.07%
Page 43 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
ANTIANGINALS--Isosorbide
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
Di-nitrate
00781169501
29
$100.68
0.95%
20
$79.25
0.68%
00781169510
22
$69.89
0.72%
15
$69.93
0.51%
00904215060
ISOSORB DIN TAB 5MG
1
$4.90
0.03%
0
$0.00
0.00%
00904215180
0
$0.00
0.00%
2
$4.44
0.07%
49884000901
39
$197.30
1.27%
31
$278.91
1.06%
49884000910
23
$180.05
0.75%
18
$191.00
0.62%
49884002001
ISOSORB DIN TAB 5MG
7
$17.90
0.23%
9
$20.95
0.31%
49884002010
ISOSORB DIN TAB 5MG
0
$0.00
0.00%
5
$23.50
0.17%
49884002101
11
$33.01
0.36%
0
$0.00
0.00%
49884002110
31
$80.94
1.01%
9
$32.47
0.31%
49884002201
4
$20.66
0.13%
2
$4.34
0.07%
49884002210
34
$126.92
1.11%
22
$89.67
0.75%
58177023804
477
$3,507.28
15.59%
306
$2,426.65
10.47%
59930154901
1,046
$7,613.34
34.18%
1,053
$7,551.14
36.02%
62175011937
242
$1,818.04
7.91%
427
$3,051.83
14.61%
ANTIARRHYTHMICS
00008418804
CORDARONE
TAB 200MG
13
$1,262.80
1.23%
7
$803.67
0.79%
00025273231
NORPACE
CAP 100MG CR
10
$874.19
0.95%
7
$584.77
0.79%
00025274231
NORPACE
CAP 150MG CR
9
$756.39
0.85%
28
$3,157.19
3.16%
00025274234
NORPACE
CAP 150MG CR
0
$0.00
0.00%
1
$160.82
0.11%
00025275231
NORPACE
CAP 100MG
1
$13.50
0.09%
12
$886.10
1.35%
00025276231
NORPACE
CAP 150MG
1
$32.52
0.09%
11
$908.29
1.24%
00031664963
QUINIDEX EXT TAB 300MG CR
2
$181.21
0.19%
0
$0.00
0.00%
00044502202
RYTHMOL
6
$1,306.86
0.57%
0
$0.00
0.00%
00054261625
MEXILETINE CAP 150MG
5
$418.38
0.47%
0
$0.00
0.00%
00069580060
TIKOSYN
0
$0.00
0.00%
1
$111.05
0.11%
TAB 150MG
CAP 125MCG
Page 44 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIARRHYTHMICS
00069581060
TIKOSYN
CAP 250MCG
00069582060
TIKOSYN
CAP 500MCG
00074162814
RYTHMOL
TAB 150MG
00074173212
RYTHMOL
TAB 225MG
00074173214
RYTHMOL
00089030510
00089030710
$0.00
0.00%
$523.76
0.56%
4
$275.76
0.38%
29
$5,100.60
2.74%
4
$340.86
0.45%
31
$7,780.34
3.49%
0
$0.00
0.00%
3
$453.27
0.34%
TAB 225MG
8
$1,658.63
0.76%
15
$3,300.22
1.69%
TAMBOCOR
TAB 50MG
27
TAMBOCOR
TAB 100MG
65
$3,518.15
2.55%
20
$2,859.75
2.25%
$10,501.82
6.14%
65
$10,421.06
7.33%
00089031410
TAMBOCOR
TAB 150MG
9
$2,129.42
0.85%
3
$817.20
0.34%
00093873901
7
$571.95
0.66%
11
$777.32
1.24%
00093874001
00093911401
7
$420.45
0.66%
6
$322.10
0.68%
PROCAINAMIDE TAB 750MG ER
0
$0.00
0.00%
3
$397.47
0.34%
00093911701
PROCAINAMIDE TAB 1000 ER
2
$186.12
0.19%
6
$494.49
0.68%
00093913306
AMIODARONE TAB 200MG
88
$1,579.07
8.32%
42
$552.17
4.74%
00093913352
8
$229.40
0.76%
12
$365.15
1.35%
00093917501
QUINIDINE SU TAB 300MG ER
1
$16.13
0.09%
3
$174.98
0.34%
00093917552
QUINIDINE SU TAB 300MG ER
3
$64.47
0.28%
0
$0.00
0.00%
00093918801
PROCAINAMIDE TAB 500MG CR
0
$0.00
0.00%
2
$168.74
0.23%
00172234560
PROCAINAMIDE CAP 250MG
2
$103.70
0.19%
1
$51.85
0.11%
00172234760
PROCAINAMIDE CAP 500MG
4
$337.41
0.38%
3
$301.05
0.34%
00185014405
69
$1,538.49
6.52%
67
$1,561.03
7.55%
00185014460
205
$5,042.50
19.38%
178
$4,039.86
20.07%
00245014760
PACERONE
16
$376.50
1.51%
0
$0.00
0.00%
00364060405
QUINIDINE GL TAB 324MG ER
1
$24.49
0.09%
4
$128.60
0.45%
00364073901
DISOPYRAMIDE CAP 100MG
3
$143.70
0.28%
0
$0.00
0.00%
00378850501
FLECAINIDE TAB 50MG
5
$138.15
0.47%
0
$0.00
0.00%
00378851001
FLECAINIDE TAB 100MG
5
$274.57
0.47%
3
$80.08
0.34%
00378851501
0
$0.00
0.00%
1
$146.91
0.11%
TAB 200MG
0
5
Page 45 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIARRHYTHMICS
00555091704
0
$0.00
0.00%
9
$200.95
1.01%
00555091709
6
$147.90
0.57%
30
$917.05
3.38%
00591058201
PROPAFENONE TAB 150MG
3
$306.42
0.28%
1
$169.09
0.11%
00591543801
QUINIDINE SU TAB 200MG
10
$274.21
0.95%
8
$159.51
0.90%
00591545401
QUINIDINE SU TAB 300MG
3
$103.50
0.28%
5
$127.82
0.56%
00591553801
QUINIDINE GL TAB 324MG SA
6
$142.84
0.57%
3
$91.05
0.34%
00591553825
QUINIDINE GL TAB 324MG SA
0
$0.00
0.00%
4
$175.40
0.45%
00591556001
15
$755.40
1.42%
0
$0.00
0.00%
00591556101
23
$2,110.49
2.17%
3
$144.70
0.34%
00677067501
QUINIDINE GL TAB 324MG CR
3
$83.55
0.28%
2
$109.70
0.23%
00677067503
15
$422.65
1.42%
3
$3.00
0.34%
00677067505
7
$128.05
0.66%
4
$4.00
0.45%
00781120305
89
$1,663.59
8.41%
102
$2,055.46
11.50%
00781120360
64
$925.47
6.05%
35
$1,055.67
3.95%
00781120392
0
$0.00
0.00%
1
$32.65
0.11%
49884045802
40
$879.50
3.78%
10
$244.20
1.13%
49884045805
7
$126.04
0.66%
8
$125.52
0.90%
49884069501
3
$92.75
0.28%
0
$0.00
0.00%
49884069601
1
$197.02
0.09%
0
$0.00
0.00%
51672402504
54
$1,490.70
5.10%
67
$1,497.90
7.55%
53489014101
34
$1,761.61
3.21%
24
$1,143.90
2.71%
53489014103
2
$143.20
0.19%
2
$144.88
0.23%
53489014105
4
$172.69
0.38%
3
$131.55
0.34%
53489055101
1
$128.93
0.09%
0
$0.00
0.00%
58177000204
DISOPYRAMIDE CAP 150MG ER
35
$1,897.41
3.31%
4
$53.40
0.45%
58177033104
2
$155.07
0.19%
1
$26.79
0.11%
58177033204
1
$147.49
0.09%
0
$0.00
0.00%
Page 46 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIARRHYTHMICS
61570006960
PROCANBID
TAB 500MG CR
8
$831.93
0.76%
0
$0.00
0.00%
61570007101
PROCANBID
TAB 1000 MG
4
$748.82
0.38%
0
$0.00
0.00%
61570007160
PROCANBID
TAB 1000 MG
1
$90.57
0.09%
0
$0.00
0.00%
61570007170
PROCANBID
TAB 1000 MG
2
$197.68
0.19%
3
$309.75
0.34%
4
$379.25
100.00%
0
$0.00
0.00%
ANTIASTHMATIC - 5-Lipoxygenase Inhibitors
00074803622
ZYFLO
TAB 600MG
ANTIASTHMATIC - ADRENERGIC COMBOS
00173069500
ADVAIR DISKU MIS 100/50
2,894
$301,758.85
18.14%
3,267
$361,240.62
18.63%
00173069502
2
$316.14
0.01%
0
$0.00
0.00%
00173069600
4,248
$564,373.27
26.63%
4,798
$684,020.69
27.36%
00173069602
0
$0.00
0.00%
2
$395.92
0.01%
00173069700
2,176
$399,357.98
13.64%
2,521
$497,792.70
14.38%
00173069702
2
$538.76
0.01%
1
$289.28
0.01%
00597001314
COMBIVENT
6,199
$352,202.34
38.86%
6,760
$460,788.46
38.55%
49502067230
DUONEB
SOL
297
$27,176.29
1.86%
120
$5,326.28
0.68%
49502067260
DUONEB
SOL
136
$17,800.86
0.85%
68
$3,881.27
0.39%
22
$123,684.50
100.00%
20
$127,386.32
100.00%
AER
ANTIASTHMATIC - ALPHA-PROTEINASE INHIBITOR
00026060135
PROLASTIN
INJ 1000MG
ANTIASTHMATIC - ANTI-CHOLINERGICS
00054840211
IPRATROPIUM SOL INHAL
36
$1,206.86
0.94%
8
$179.06
0.20%
00172640744
403
$14,853.63
10.48%
381
$12,457.16
9.33%
00172640749
48
$1,823.62
1.25%
58
$2,852.10
1.42%
00472075123
518
$11,776.85
13.47%
37
$937.41
0.91%
Page 47 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIASTHMATIC - ANTI-CHOLINERGICS
00472075130
3
$45.53
0.08%
7
$118.48
0.17%
00472075160
74
$3,169.59
1.92%
38
$1,460.84
0.93%
00472075323
0
$0.00
0.00%
28
$844.22
0.69%
00472075330
0
$0.00
0.00%
7
$224.92
0.17%
00472075360
3
$152.93
0.08%
42
$1,883.44
1.03%
00487980101
0
$0.00
0.00%
1
$17.60
0.02%
00487980125
0
$0.00
0.00%
1
$14.99
0.02%
00487980130
12
$562.48
0.31%
9
$405.40
0.22%
00487980160
11
$397.96
0.29%
11
$381.63
0.27%
00597007506
SPIRIVA
CAP HANDIHLR
0
$0.00
0.00%
1
$28.47
0.02%
00597007537
SPIRIVA
CAP HANDIHLR
0
$0.00
0.00%
235
$22,653.78
5.75%
00597008062
ATROVENT
SOL INHAL
0
$0.00
0.00%
1
$42.30
0.02%
00597008214
ATROVENT INH AER 18MCG/AC
1,479
$85,789.72
38.46%
1,439
$94,423.27
35.24%
49502068503
904
$21,185.16
23.50%
171
$3,509.30
4.19%
49502068524
0
$0.00
0.00%
1,195
$26,205.90
29.26%
49502068529
0
$0.00
0.00%
4
$148.40
0.10%
49502068533
4
$75.47
0.10%
2
$75.46
0.05%
49502068560
157
$6,927.45
4.08%
31
$1,356.32
0.76%
49502068561
0
$0.00
0.00%
45
$1,555.90
1.10%
60505080601
15
$432.37
0.39%
22
$470.31
0.54%
65271000125
33
$1,273.56
0.86%
17
$651.09
0.42%
65271000160
16
$573.81
0.42%
0
$0.00
0.00%
66794000225
117
$4,406.72
3.04%
167
$6,824.77
4.09%
66794000230
0
$0.00
0.00%
1
$43.60
0.02%
66794000260
13
$963.70
0.34%
125
$7,873.71
3.06%
ANTIASTHMATIC - ANTIINFLAMMATORY AGENTS
Page 48 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIASTHMATIC - ANTIINFLAMMATORY AGENTS
00054816721
CROMOLYN SOD NEB 20MG/2ML
9
$241.35
4.33%
10
00054816723
1
$60.95
0.48%
00172640659
3
$89.25
1.44%
00585067501
INTAL INH
AER 800MCG
105
$8,395.31
00585067502
INTAL INH
AER 800MCG
43
00585068502
TILADE
49502068902
49502068912
49502068961
$211.30
4.13%
1
$41.75
0.41%
5
$199.15
2.07%
50.48%
49
$3,670.87
20.25%
$2,672.56
20.67%
41
$2,947.45
16.94%
6
$340.35
2.88%
10
$562.46
4.13%
16
$479.95
7.69%
8
$230.80
3.31%
20
$591.40
9.62%
20
$566.20
8.26%
0
$0.00
0.00%
6
$300.35
2.48%
50242004062
XOLAIR
5
$14,138.40
2.40%
40
$64,574.62
16.53%
60793001108
INTAL INH
AER 800MCG
0
$0.00
0.00%
8
$460.57
3.31%
60793001114
INTAL INH
AER 800MCG
0
$0.00
0.00%
37
$3,241.05
15.29%
60793012001
TILADE
0
$0.00
0.00%
7
$457.75
2.89%
13
$271.06
0.04%
2
$22.72
0.01%
3
$48.52
0.01%
0
$0.00
0.00%
AER 1.75/ACT
SOL 150MG
AER 1.75/ACT
ANTIASTHMATIC - BETA - ADRENERGICS
00028007201
BRETHINE
TAB 2.5MG
00028010501
BRETHINE
TAB 5MG
00054806311
ALBUTEROL
NEB 0.083%
6
$70.20
0.02%
0
$0.00
0.00%
00083016702
FORADIL
CAP AEROLIZE
4
$461.88
0.01%
0
$0.00
0.00%
00083016774
FORADIL
CAP AEROLIZE
235
$17,993.99
0.69%
24
$1,772.06
0.08%
00085061402
PROVENTIL
AER 90MCG
27
$1,456.11
0.08%
8
$738.80
0.03%
00085113201
PROVENTIL
264
$11,473.42
0.77%
47
$1,840.01
0.15%
00085140101
FORADIL
CAP AEROLIZE
222
$16,667.11
0.65%
415
$35,681.23
1.30%
00085140201
FORADIL
CAP AEROLIZE
0
$0.00
0.00%
10
$1,182.42
0.03%
00089081521
MAXAIR AUTOH AER 200MCG
393
$27,844.17
1.15%
311
$24,024.65
0.97%
00093066116
ALBUTEROL
308
$3,760.20
0.90%
142
$1,678.09
0.44%
00115261101
TERBUTALINE TAB 2.5MG
51
$1,371.26
0.15%
30
$852.36
0.09%
AER HFA
SYP 2MG/5ML
Page 49 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
TERBUTALINE TAB 5MG
00172439018
ALBUTEROL
00172640544
ALBUTEROL
00172640549
ALBUTEROL
00173032188
VENTOLIN
00173046400
SEREVENT
00173052000
SEREVENT DIS AER 50MCG
00173052100
SEREVENT DIS AER 50MCG
00173068200
VENTOLIN HFA AER
00182601465
ALBUTEROL
00378025501
ALBUTEROL
00378025505
$
Market Share*
00115262201
# of Scripts
52
$1,820.29
0.15%
52
$2,004.15
0.16%
AER 90MCG
2,539
$28,731.77
7.42%
2,190
$24,453.59
6.85%
NEB 0.083%
1,141
$16,234.42
3.34%
382
$5,485.72
1.19%
NEB 0.083%
67
$1,289.95
0.20%
125
$1,972.95
0.39%
AER 90MCG
10
$485.58
0.03%
0
$0.00
0.00%
AER 21MCG/AC
41
$3,259.76
0.12%
0
$0.00
0.00%
1
$109.54
0.00%
0
$0.00
0.00%
2,610
$211,590.52
7.63%
1,898
$172,957.55
5.94%
10
$348.40
0.03%
5
$158.44
0.02%
NEB 0.5%
7
$108.35
0.02%
0
$0.00
0.00%
TAB 2MG
28
$561.62
0.08%
27
$558.19
0.08%
ALBUTEROL
TAB 2MG
17
$408.81
0.05%
4
$93.85
0.01%
00378057201
ALBUTEROL
TAB 4MG
67
$839.92
0.20%
60
$632.87
0.19%
00378057205
ALBUTEROL
TAB 4MG
16
$161.86
0.05%
6
$61.13
0.02%
00451039850
VOLMAX
TAB 4MG ER
60
$2,976.88
0.18%
0
$0.00
0.00%
00451039950
VOLMAX
TAB 8 MG
16
$2,048.74
0.05%
0
$0.00
0.00%
00472082516
ALBUTEROL
SYP 2MG/5ML
82
$1,251.12
0.24%
49
$699.98
0.15%
00472083123
ALBUTEROL
NEB 0.083%
11
$326.85
0.03%
9
$195.69
0.03%
00472083160
ALBUTEROL
NEB 0.083%
26
$604.90
0.08%
9
$106.98
0.03%
00487950103
ALBUTEROL
NEB 0.083%
0
$0.00
0.00%
13
$211.43
0.04%
00487950125
ALBUTEROL
NEB 0.083%
15
$326.25
0.04%
35
$364.70
0.11%
00487950160
ALBUTEROL
NEB 0.083%
76
$1,546.32
0.22%
122
$2,314.16
0.38%
00597007017
ALUPENT INH AER 0.65/ACT
22
$772.31
0.06%
10
$314.90
0.03%
00603142258
METAPROTEREN SYP 10MG/5ML
1
$7.68
0.00%
0
$0.00
0.00%
00677135901
ALBUTEROL
TAB 2MG
4
$70.18
0.01%
8
$160.38
0.03%
00677136001
ALBUTEROL
TAB 4MG
12
$138.93
0.04%
3
$31.16
0.01%
00904765855
ALBUTEROL
NEB 0.5%
2
$15.90
0.01%
7
$69.05
0.02%
Page 50 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ALBUTEROL
AER 90MCG
24208034720
ALBUTEROL
NEB 0.5%
49502010501
ALBUTEROL
NEB 0.5%
49502033317
ALBUTEROL
AER 90MCG
49502067603
METAPROTEREN NEB 0.6%
49502067803
METAPROTEREN NEB 0.4%
49502069203
ACCUNEB
NEB 0.63MG/3
49502069303
ACCUNEB
NEB 1.25MG/3
49502069703
ALBUTEROL
49502069724
49502069729
$
Market Share*
17270072101
# of Scripts
$0.00
0.00%
2,738
$30,184.56
8.56%
29
$361.41
0.08%
40
$705.67
0.13%
382
$3,128.90
1.12%
1
$7.72
0.00%
48
$574.77
0.14%
0
$0.00
0.00%
2
$31.14
0.01%
0
$0.00
0.00%
1
$13.16
0.00%
0
$0.00
0.00%
21
$1,031.75
0.06%
10
$389.92
0.03%
30
$1,836.89
0.09%
18
$665.98
0.06%
NEB 0.083%
1,634
$20,290.24
4.78%
211
$2,448.46
0.66%
ALBUTEROL
NEB 0.083%
0
$0.00
0.00%
940
$11,553.62
2.94%
ALBUTEROL
NEB 0.083%
0
$0.00
0.00%
26
$359.29
0.08%
49502069733
ALBUTEROL
NEB 0.083%
33
$334.56
0.10%
6
$99.02
0.02%
49502069760
ALBUTEROL
NEB 0.083%
584
$10,099.46
1.71%
208
$3,131.62
0.65%
49502069761
ALBUTEROL
NEB 0.083%
0
$0.00
0.00%
475
$7,233.45
1.49%
49884025901
METAPROTEREN TAB 20MG
2
$80.12
0.01%
3
$81.78
0.01%
50111080131
ALBUTEROL
AER 90MCG
604
$6,980.71
1.77%
111
$1,173.58
0.35%
50111080132
ALBUTEROL
AER 90MCG RF
1
$10.00
0.00%
0
$0.00
0.00%
50383074016
ALBUTEROL
SYP 2MG/5ML
278
$3,759.48
0.81%
253
$3,300.10
0.79%
50383074120
ALBUTEROL
NEB 0.5%
218
$2,168.49
0.64%
716
$5,591.79
2.24%
52555059417
ALBUTEROL
AER 90MCG
11
$113.48
0.03%
2
$20.86
0.01%
53489017601
ALBUTEROL
TAB 2MG
28
$552.24
0.08%
19
$374.19
0.06%
53489017605
ALBUTEROL
TAB 2MG
3
$50.82
0.01%
3
$53.32
0.01%
53489017701
ALBUTEROL
TAB 4MG
49
$584.43
0.14%
45
$502.65
0.14%
59930150006
ALBUTEROL
NEB 0.083%
63
$967.50
0.18%
0
$0.00
0.00%
59930150008
ALBUTEROL
NEB 0.083%
121
$1,747.97
0.35%
0
$0.00
0.00%
59930151504
ALBUTEROL
NEB 0.5%
93
$958.61
0.27%
69
$493.63
0.22%
59930151701
ALBUTEROL
NEB 0.083%
1,758
$23,273.21
5.14%
1,776
$24,008.32
5.56%
0
Page 51 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
59930151702
ALBUTEROL
NEB 0.083%
89
$1,750.62
0.26%
73
$1,638.71
0.23%
59930156001
ALBUTEROL
AER 90MCG
14,167
$157,653.46
41.42%
15,288
$174,556.28
47.82%
59930156002
ALBUTEROL
AER 90MCG RF
9
$99.24
0.03%
0
$0.00
0.00%
59930164702
ALBUTEROL
NEB 0.5%
225
$1,920.69
0.66%
172
$1,678.19
0.54%
62037079444
ALBUTEROL
AER 90MCG
4,333
$47,980.06
12.67%
1,210
$13,389.76
3.78%
63402051124
XOPENEX
NEB 0.31MG
21
$2,498.45
0.06%
12
$473.35
0.04%
63402051224
XOPENEX
NEB 0.63MG
268
$22,012.49
0.78%
94
$5,850.50
0.29%
63402051324
XOPENEX
NEB 1.25/3ML
162
$19,399.53
0.47%
119
$13,109.77
0.37%
65473075401
VOSPIRE ER TAB 4MG
13
$531.47
0.04%
26
$1,443.94
0.08%
65473075801
VOSPIRE ER TAB 8MG
3
$328.21
0.01%
5
$576.20
0.02%
66794000125
ALBUTEROL
NEB 0.083%
458
$6,695.97
1.34%
1,232
$17,388.09
3.85%
66794000130
ALBUTEROL
NEB 0.083%
2
$30.50
0.01%
12
$151.24
0.04%
66794000160
ALBUTEROL
NEB 0.083%
1
$12.95
0.00%
53
$2,481.90
0.17%
0.00%
2
$2,730.10
3.39%
ANTIASTHMATIC - HYDRO-LYTIC ENZYMES
50242010039
PULMOZYME
SOL 1MG/ML
0
$0.00
50242010040
PULMOZYME
SOL 1MG/ML
95
$84,226.86
100.00%
57
$63,119.12
96.61%
ANTIASTHMATIC - NASAL MISC.
00009770901
NASALCROM
AER 5.2/ACT
82
$904.46
16.33%
65
$730.76
17.71%
00009770902
NASALCROM
AER 5.2/ACT
43
$620.01
8.57%
49
$677.53
13.35%
00024131501
NASAL
3
$9.16
0.60%
0
$0.00
0.00%
00024131630
NASAL MOIST SPR 0.65%
1
$1.89
0.20%
0
$0.00
0.00%
00029152611
BACTROBAN
37
$2,092.31
7.37%
41
$2,918.99
11.17%
00037024110
ASTELIN NASA SPR 137MCG
50
$2,533.32
9.96%
7
$344.36
1.91%
00037024130
ASTELIN NASA SPR 137MCG
0
$0.00
0.00%
19
$1,131.87
5.18%
00054004544
IPRATROPIUM SPR 0.03%
36
$1,549.71
7.17%
10
$305.60
2.72%
SPR 0.65%
OIN NASAL 2%
Page 52 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00054004641
35
00113031213
SALINE NASAL SPR 0.65%
00182613577
NASAL
00225038080
AYR
00225055050
BABY AYR
00256015201
00472007513
$1,221.30
6.97%
4
$112.60
1.09%
1
$3.99
0.20%
7
$20.01
1.39%
1
$2.36
0.27%
9
$39.17
2.45%
16
$77.07
3.19%
17
$76.80
4.63%
1
$3.86
0.20%
0
$0.00
0.00%
OCEAN NASAL SPR 0.65%
CROMOLYN SOD AER 5.2/ACT
1
$4.32
0.20%
1
$1.96
0.27%
0
$0.00
0.00%
1
$7.35
0.27%
00536250676
SALINE MIST SPR 0.65%
1
$3.83
0.20%
2
$6.70
0.54%
00597008130
ATROVENT NAS SOL 0.03%
35
$1,814.19
6.97%
20
$981.01
5.45%
00597008676
ATROVENT NAS SOL 0.06%
22
$854.83
4.38%
10
$456.90
2.72%
00904386575
DEEP SEA
33
$129.51
6.57%
41
$211.97
11.17%
24208039830
6
$280.01
1.20%
2
$95.82
0.54%
24208039915
5
$197.80
1.00%
3
$126.41
0.82%
37205093013
23
$92.72
4.58%
31
$147.61
8.45%
37205093021
4
$17.67
0.80%
6
$24.93
1.63%
41250031213
1
$5.89
0.20%
1
$4.94
0.27%
45802031758
4
$12.30
0.80%
0
$0.00
0.00%
45802035758
22
$142.36
4.38%
9
$48.54
2.45%
49158020744
SEA MIST
5
$7.75
1.00%
0
$0.00
0.00%
49348035625
NASAL SALINE SPR 0.65%
1
$0.70
0.20%
4
$11.60
1.09%
49502078530
4
$114.69
0.80%
0
$0.00
0.00%
49502078615
9
$282.24
1.79%
0
$0.00
0.00%
50383057745
0
$0.00
0.00%
1
$3.40
0.27%
50428006205
1
$4.99
0.20%
0
$0.00
0.00%
50428891465
SALINE NOSE SPR 0.65%
0
$0.00
0.00%
5
$10.75
1.36%
50486002701
NASAL MOIST SPR 0.65%
3
$14.10
0.60%
3
$11.54
0.82%
52735042528
NASAL SALINE SPR 0.65%
1
$4.00
0.20%
1
$2.15
0.27%
SPR 0.65%
SPR 0.65%
SPR 0.65%
SPR 0.65%
SPR 0.65%
Page 53 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
57782039726
CROMOLYN SOD AER 5.2/ACT
0
59390003526
ALTAMIST
60505082601
60505082701
64899054487
$0.00
0.00%
1
$11.32
0.27%
0
$0.00
0.00%
2
$11.48
0.54%
3
$101.19
0.60%
0
$0.00
0.00%
5
$182.09
1.00%
1
$39.45
0.27%
1
$3.49
0.20%
0
$0.00
0.00%
14
$705.71
0.16%
1
$54.22
0.01%
567
$32,010.76
6.29%
113
$5,102.74
1.19%
2,074
$130,762.17
23.00%
2,770
$188,886.58
29.19%
1
$50.51
0.01%
0
$0.00
0.00%
181
$10,905.07
2.01%
44
$2,652.73
0.46%
5,555
$331,300.23
61.61%
6,423
$408,561.20
67.67%
SPR 0.65%
ANTIASTHMATIC - NASAL STEROIDS
00075150543
NASACORT
AER 55MCG/AC
00075150616
NASACORT AQ AER 55MCG/AC
00085119701
NASONEX
00173033602
BECONASE NA AER INHALER
00173038879
BECONASE AQ SPR 0.042%
00173045301
FLONASE
00186107006
RHINOCORT
SUS AQUA
1
$79.78
0.01%
0
$0.00
0.00%
00186107008
RHINOCORT
SUS AQUA
594
$33,994.03
6.59%
125
$5,496.61
1.32%
24208034425
FLUNISOLIDE SPR 0.025%
20
$776.40
0.22%
13
$396.57
0.14%
59310003725
NASAREL
9
$393.49
0.10%
2
$78.92
0.02%
1,230
$83,645.74
14.83%
935
$80,105.98
12.58%
1
$35.23
0.01%
0
$0.00
0.00%
SPR 50MCG/AC
SPR 0.05%
SPR 29/0.025
ANTIASTHMATIC - STEROID INHALANTS
00075006037
AZMACORT
00173031298
BECLOVENT RF AER 42MCG
00173049100
FLOVENT
AER 44MCG/AC
1,241
$64,402.70
14.96%
1,226
$71,240.64
16.50%
00173049400
FLOVENT
AER 110MCG/A
2,477
$175,768.14
29.87%
2,267
$178,455.07
30.51%
00173049500
FLOVENT
AER 220MCG/A
1,414
$162,626.87
17.05%
1,293
$166,411.35
17.40%
00173049700
FLOVENT
AER 44MCG/AC
1
$79.44
0.01%
0
$0.00
0.00%
00173050400
FLOVENT ROTA AER 250MCG
9
$837.34
0.11%
1
$83.15
0.01%
00173050900
32
$1,729.24
0.39%
16
$910.80
0.22%
AER 100MCG
Page 54 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00186091542
PULMICORT
00186198804
PULMICORT
00186198904
$
Market Share*
ANTIASTHMATIC - STEROID INHALANTS
00173051100
# of Scripts
36
$1,412.61
0.43%
18
$656.17
0.24%
INH 200MCG
452
$55,990.85
5.45%
271
$32,611.27
3.65%
SUS 0.25MG/2
348
$53,368.77
4.20%
362
$56,588.81
4.87%
PULMICORT
SUS 0.5MG/2
490
$72,767.10
5.91%
538
$78,414.05
7.24%
00456067099
AEROBID-M
AER 250MCG
33
$2,671.55
0.40%
10
$1,476.28
0.13%
00456067299
AEROBID
389
$30,462.12
4.69%
279
$22,872.77
3.76%
59310017540
QVAR
AER 40MCG
64
$3,460.54
0.77%
91
$4,740.54
1.22%
59310017780
QVAR
AER 80MCG
76
$4,499.89
0.92%
123
$8,180.83
1.66%
AER 250MCG
ANTIASTHMATIC - XANTHINES
00034700470
UNIPHYL
TAB 400MG CR
2
$49.44
0.11%
8
$210.37
0.55%
00034700480
UNIPHYL
TAB 400MG CR
103
$3,335.18
5.72%
73
$2,686.08
5.03%
00034700680
UNIPHYL
TAB 600MG CR
178
$7,537.52
9.88%
99
$4,694.15
6.82%
00089034410
THEOLAIR
1
$7.49
0.06%
0
$0.00
0.00%
00143102501
AMINOPHYLLIN TAB 200MG
3
$15.81
0.17%
2
$17.30
0.14%
00182140089
THEOPHYLLINE TAB 300MG TD
1
$17.05
0.06%
0
$0.00
0.00%
00258358101
THEOPHYLLINE TAB 300MG ER
124
$2,636.57
6.88%
5
$98.55
0.34%
00258358105
34
$528.45
1.89%
18
$285.85
1.24%
00258358110
90
$1,778.67
4.99%
45
$1,033.55
3.10%
00258358301
62
$885.19
3.44%
9
$133.33
0.62%
00258358305
18
$223.54
1.00%
3
$54.39
0.21%
00258358310
32
$434.41
1.78%
22
$333.77
1.52%
00258358401
4
$31.80
0.22%
1
$7.95
0.07%
00258361401
1
$14.37
0.06%
0
$0.00
0.00%
00258362501
THEOPHYLLINE CAP 300MG ER
52
$2,010.05
2.89%
33
$1,388.83
2.27%
00258363401
49
$1,593.70
2.72%
28
$938.83
1.93%
00258363801
3
$109.21
0.17%
6
$144.02
0.41%
TAB 250MG
Page 55 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00456064416
ELIXOPHYLLIN ELX 80/15ML
0
00456432000
THEOCHRON
TAB 200MG CR
00456432001
THEOCHRON
TAB 200MG CR
00456432002
THEOCHRON
00456433000
$0.00
0.00%
2
$168.28
0.14%
0
$0.00
0.00%
5
$74.41
0.34%
4
$51.60
0.22%
0
$0.00
0.00%
TAB 200MG CR
0
$0.00
0.00%
1
$12.99
0.07%
THEOCHRON
TAB 300MG CR
1
$33.25
0.06%
1
$24.99
0.07%
00456433001
THEOCHRON
TAB 300MG CR
3
$51.15
0.17%
0
$0.00
0.00%
00591790401
0
$0.00
0.00%
1
$4.19
0.07%
00603594421
THEOPHYLLINE TAB 100MG CR
2
$12.35
0.11%
2
$18.40
0.14%
00603594521
5
$79.23
0.28%
0
$0.00
0.00%
00603594532
5
$52.45
0.28%
0
$0.00
0.00%
00603594621
17
$331.50
0.94%
21
$330.73
1.45%
00603594628
0
$0.00
0.00%
3
$58.65
0.21%
00603594632
6
$125.50
0.33%
0
$0.00
0.00%
00603595121
4
$149.60
0.22%
3
$130.47
0.21%
00677000701
1
$4.75
0.06%
3
$13.08
0.21%
00677081701
3
$26.85
0.17%
1
$25.15
0.07%
00677081705
8
$214.30
0.44%
2
$18.17
0.14%
00677084601
7
$70.75
0.39%
6
$55.32
0.41%
00904161060
6
$69.84
0.33%
0
$0.00
0.00%
00904161140
1
$58.70
0.06%
0
$0.00
0.00%
00904161160
0
$0.00
0.00%
2
$35.62
0.14%
00904161180
0
$0.00
0.00%
2
$25.98
0.14%
00904161280
5
$152.59
0.28%
8
$162.60
0.55%
17236032405
0
$0.00
0.00%
2
$15.75
0.14%
50111045901
286
$5,594.56
15.87%
361
$7,217.50
24.86%
50111045902
59
$1,484.84
3.27%
36
$815.92
2.48%
50111045903
98
$1,805.20
5.44%
96
$1,955.12
6.61%
Page 56 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
50111048201
252
$3,465.10
13.98%
231
$3,305.05
15.91%
50111048202
55
$669.10
3.05%
32
$440.02
2.20%
50111048203
71
$888.26
3.94%
49
$589.14
3.37%
50111048301
29
$248.02
1.61%
34
$340.23
2.34%
50111048302
29
$492.51
1.61%
26
$453.81
1.79%
50111051801
36
$1,131.85
2.00%
28
$831.55
1.93%
50474010001
THEO-24
CAP 100MG CR
3
$75.64
0.17%
3
$74.28
0.21%
50474020001
THEO-24
CAP 200MG CR
10
$258.10
0.55%
1
$5.73
0.07%
50474030001
THEO-24
CAP 300MG CR
15
$569.65
0.83%
4
$206.62
0.28%
50474040001
THEO-24
CAP 400MG ER
20
$545.97
1.11%
3
$94.86
0.21%
53265038010
0
$0.00
0.00%
79
$2,517.40
5.44%
53265038050
0
$0.00
0.00%
7
$290.65
0.48%
53265038210
0
$0.00
0.00%
34
$1,605.36
2.34%
61570002001
QUIBRON-T
3
$91.41
0.17%
0
$0.00
0.00%
61570002201
QUIBRON
CAP 150-90
1
$72.39
0.06%
3
$212.25
0.21%
67781025101
UNIPHYL
TAB 400MG CR
0
$0.00
0.00%
2
$60.27
0.14%
67781025201
UNIPHYL
TAB 600MG CR
0
$0.00
0.00%
6
$353.90
0.41%
TAB 300MG
ANTIASTHMATIC -LEUKOTRIENE RECEPTOR ANTAGONISTS
00006011728
SINGULAIR
TAB 10MG
27
$1,782.80
0.27%
19
$1,637.81
0.19%
00006011731
SINGULAIR
TAB 10MG
3,475
$279,602.93
35.32%
3,458
$280,978.25
33.96%
00006011754
SINGULAIR
TAB 10MG
2,474
$195,651.67
25.14%
2,907
$250,015.54
28.54%
00006027528
SINGULAIR
CHW 5MG
14
$1,362.45
0.14%
8
$707.07
0.08%
00006027531
SINGULAIR
CHW 5MG
1,947
$151,110.12
19.79%
1,954
$147,076.96
19.19%
00006027554
SINGULAIR
CHW 5MG
351
$26,395.61
3.57%
342
$27,033.98
3.36%
00006071128
SINGULAIR
CHW 4MG
3
$255.12
0.03%
2
$173.98
0.02%
00006071131
SINGULAIR
CHW 4MG
911
$72,781.74
9.26%
1,042
$84,539.38
10.23%
Page 57 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIASTHMATIC -LEUKOTRIENE RECEPTOR ANTAGONISTS
00006071154
SINGULAIR
CHW 4MG
215
$15,688.43
2.19%
206
$15,404.26
2.02%
00006384130
SINGULAIR
GRA 4MG
56
$4,323.24
0.57%
120
$9,443.33
1.18%
00310040160
ACCOLATE
TAB 10MG
12
$808.64
0.12%
5
$162.46
0.05%
00310040239
ACCOLATE
TAB 20MG
0
$0.00
0.00%
3
$214.83
0.03%
00310040260
ACCOLATE
TAB 20MG
354
$21,969.67
3.60%
118
$7,008.88
1.16%
ANTIBIOTICS - MISC.
00002312542
VANCOCIN HCL CAP 125MG
17
$3,935.37
0.71%
37
$8,559.23
1.49%
00002312642
VANCOCIN HCL CAP 250MG
38
$19,408.53
1.59%
52
$25,323.70
2.10%
00002317030
LORABID
2
$230.51
0.08%
0
$0.00
0.00%
00002732101
VANCOCIN HCL INJ 1GM
5
$82.10
0.21%
0
$0.00
0.00%
00004100328
GANTRIS PED SUS 500/5ML
53
$912.07
2.22%
42
$780.16
1.70%
00009056601
TROBICIN
INJ 2GM
0
$0.00
0.00%
1
$58.29
0.04%
00025182150
FLAGYL
TAB 500MG
1
$54.02
0.04%
0
$0.00
0.00%
00025194234
FLAGYL
CAP 375MG
0
$0.00
0.00%
1
$29.74
0.04%
00025194250
FLAGYL
CAP 375MG
13
$785.26
0.54%
1
$53.63
0.04%
00025196130
FLAGYL ER
22
$1,825.84
0.92%
0
$0.00
0.00%
00074433201
VANCOMYCIN INJ 500MG
2
$100.65
0.08%
0
$0.00
0.00%
00074650901
VANCOMYCIN INJ 5GM
1
$39.24
0.04%
8
$736.70
0.32%
00074653301
12
$465.25
0.50%
17
$615.11
0.69%
00074653401
7
$52.50
0.29%
0
$0.00
0.00%
00074653501
9
$2,059.01
0.38%
0
$0.00
0.00%
00074781124
METRON/NACL INJ 500MG
2
$7.44
0.08%
2
$7.42
0.08%
00088222507
KETEK PAK
0
$0.00
0.00%
13
$551.90
0.52%
00088222541
KETEK
0
$0.00
0.00%
9
$370.38
0.36%
00093085101
METRONIDAZOL TAB 250MG
75
$267.46
3.14%
74
$264.30
2.99%
00093085105
5
$15.32
0.21%
3
$9.39
0.12%
CAP 200MG
TAB 750MG
TAB 400MG
TAB 400MG
Page 58 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIBIOTICS - MISC.
00093085152
17
$66.08
0.71%
9
$31.41
0.36%
00093085205
122
$453.37
5.10%
119
$472.50
4.80%
00093085253
229
$851.50
9.58%
206
$720.52
8.32%
00093215801
TRIMETHOPRIM TAB 100MG
21
$148.86
0.88%
24
$183.74
0.97%
00093215901
1
$5.58
0.04%
0
$0.00
0.00%
00172221860
SULFISOXAZOL TAB 0.5GM
7
$97.92
0.29%
3
$35.31
0.12%
00172297160
1
$10.11
0.04%
14
$56.85
0.57%
00172300760
6
$20.30
0.25%
24
$98.70
0.97%
00185075701
SULFADIAZINE TAB 500MG
3
$906.18
0.13%
3
$761.35
0.12%
00338355148
VANCOCIN/DEX INJ 500MG
00338355248
VANCOCIN HCL INJ
00364059501
3
$54.90
0.13%
0
$0.00
0.00%
86
$22,050.14
3.60%
40
$12,114.30
1.61%
1
$6.50
0.04%
0
$0.00
0.00%
00364059504
0
$0.00
0.00%
5
$17.78
0.20%
00364059590
14
$48.26
0.59%
0
$0.00
0.00%
00364064901
1
$10.35
0.04%
3
$32.55
0.12%
00364068750
0
$0.00
0.00%
25
$154.95
1.01%
00574020001
BACITRACIN INJ 50000UNT
1
$244.45
0.04%
0
$0.00
0.00%
00591554001
66
$220.98
2.76%
41
$127.23
1.66%
00591554025
46
$216.59
1.92%
74
$269.53
2.99%
00591555250
438
$1,698.61
18.32%
450
$1,672.47
18.17%
00591557101
136
$2,896.23
5.69%
125
$2,468.92
5.05%
00677069001
2
$20.58
0.08%
0
$0.00
0.00%
00677069003
1
$1.53
0.04%
0
$0.00
0.00%
00677081601
16
$65.10
0.67%
11
$39.55
0.44%
39822061501
COLISTIMETH INJ 150MG
4
$5,562.48
0.17%
5
$3,128.42
0.20%
50111033301
106
$366.43
4.43%
148
$500.79
5.97%
50111033302
6
$23.77
0.25%
9
$46.74
0.36%
Page 59 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIBIOTICS - MISC.
50111033306
3
$7.51
0.13%
6
$21.17
0.24%
50111033401
648
$2,244.49
27.10%
677
$2,242.92
27.33%
50111033402
25
$78.45
1.05%
7
$20.45
0.28%
51479004115
AZACTAM
INJ 1GM
0
$0.00
0.00%
1
$119.07
0.04%
51479004215
AZACTAM
INJ 2GM
0
$0.00
0.00%
1
$662.45
0.04%
53265035203
13
$799.83
0.54%
6
$365.72
0.24%
53265035305
METRONIDAZOL CAP 375MG
0
$0.00
0.00%
2
$51.68
0.08%
53265037410
0
$0.00
0.00%
5
$26.89
0.20%
53265037470
0
$0.00
0.00%
1
$5.60
0.04%
53265037510
0
$0.00
0.00%
4
$33.18
0.16%
53265037550
0
$0.00
0.00%
50
$273.70
2.02%
53265037560
0
$0.00
0.00%
2
$19.49
0.08%
53489013601
63
$232.40
2.63%
75
$258.01
3.03%
54092043016
FUROXONE
59439047802
PRIMSOL
61570005701
PROLOPRIM
61570013610
LIQ 50/15ML
1
$17.22
0.04%
0
$0.00
0.00%
SOL 50MG/5ML
4
$150.17
0.17%
0
$0.00
0.00%
TAB 100MG
1
$29.88
0.04%
1
$31.72
0.04%
LORABID
SUS 200/5ML
11
$758.39
0.46%
11
$723.58
0.44%
61570017001
LORABID
CAP 200MG
4
$560.33
0.17%
2
$80.00
0.08%
61570017101
LORABID
CAP 400MG
1
$111.84
0.04%
2
$110.14
0.08%
61570041451
COLY-MYCIN-M INJ 150MG
1
$897.99
0.04%
0
$0.00
0.00%
63323022110
1
$25.21
0.04%
2
$64.55
0.08%
63323029561
VANCOMYCIN INJ 5GM
5
$327.80
0.21%
14
$970.04
0.57%
63323087715
NEBUPENT
12
$409.46
0.50%
10
$274.36
0.40%
INH 300MG
ANTICOAGULANTS
00009026802
HEPARIN SOD INJ 1000U/ML
2
$56.82
0.02%
0
$0.00
0.00%
00013240691
FRAGMIN
2
$151.42
0.02%
1
$26.20
0.01%
INJ 2500/0.2
Page 60 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
00013242601
FRAGMIN
INJ 7500/0.3
1
$2,065.36
0.01%
1
$1,052.48
0.01%
00013242691
FRAGMIN
INJ 5000/0.2
56
$27,249.25
0.44%
37
$12,205.57
0.28%
00013243606
FRAGMIN
INJ 10000/ML
29
$14,067.67
0.23%
3
$6,390.03
0.02%
00013519001
FRAGMIN
INJ 10000/ML
3
$2,233.98
0.02%
0
$0.00
0.00%
00056016870
COUMADIN
TAB 4MG
31
$928.21
0.24%
19
$467.25
0.14%
00056016875
COUMADIN
TAB 4MG
33
$419.57
0.26%
0
$0.00
0.00%
00056016890
COUMADIN
TAB 4MG
4
$98.36
0.03%
0
$0.00
0.00%
00056016970
COUMADIN
TAB 1MG
93
$3,351.94
0.73%
48
$2,034.22
0.36%
00056016975
COUMADIN
TAB 1MG
60
$472.25
0.47%
7
$30.91
0.05%
00056016990
COUMADIN
TAB 1MG
2
$10.62
0.02%
2
$166.68
0.02%
00056017070
COUMADIN
TAB 2MG
63
$1,923.75
0.50%
44
$1,275.06
0.33%
00056017075
COUMADIN
TAB 2MG
33
$385.30
0.26%
0
$0.00
0.00%
00056017090
COUMADIN
TAB 2MG
6
$68.90
0.05%
0
$0.00
0.00%
00056017270
COUMADIN
TAB 5MG
145
$5,021.04
1.14%
95
$3,499.35
0.72%
00056017275
COUMADIN
TAB 5MG
45
$492.96
0.36%
0
$0.00
0.00%
00056017290
COUMADIN
TAB 5MG
19
$848.67
0.15%
12
$687.65
0.09%
00056017370
COUMADIN
TAB 7.5MG
12
$349.88
0.09%
6
$135.78
0.05%
00056017375
COUMADIN
TAB 7.5MG
9
$128.00
0.07%
0
$0.00
0.00%
00056017470
COUMADIN
TAB 10MG
18
$630.44
0.14%
11
$341.15
0.08%
00056017670
COUMADIN
TAB 2.5MG
53
$1,788.43
0.42%
27
$976.60
0.20%
00056017675
COUMADIN
TAB 2.5MG
44
$638.22
0.35%
0
$0.00
0.00%
00056017690
COUMADIN
TAB 2.5MG
4
$82.29
0.03%
1
$1.00
0.01%
00056018870
COUMADIN
TAB 3MG
36
$897.35
0.28%
24
$452.08
0.18%
00056018875
COUMADIN
TAB 3MG
46
$656.97
0.36%
0
$0.00
0.00%
00056018970
COUMADIN
TAB 6MG
7
$189.83
0.06%
9
$256.80
0.07%
00056018975
COUMADIN
TAB 6MG
10
$139.53
0.08%
0
$0.00
0.00%
00074115170
HEPARIN LOCK INJ 10UNT/ML
4
$53.22
0.03%
0
$0.00
0.00%
Page 61 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
00074115178
00074115212
HEPARIN LOCK INJ 100/ML
00074115270
00074115278
00074128035
$4.78
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
3
$53.55
0.02%
17
$394.79
0.13%
2
$9.20
0.02%
1
$14.33
0.01%
1
$7.03
0.01%
0
$0.00
0.00%
2
$112.60
0.02%
00074128135
3
$14.49
0.02%
2
$35.40
0.02%
00074131614
HEPARIN SOD INJ 10000/ML
2
$79.81
0.02%
0
$0.00
0.00%
00074131632
0
$0.00
0.00%
3
$104.56
0.02%
00074140231
6
$255.22
0.05%
0
$0.00
0.00%
00075062040
LOVENOX
INJ 40/0.4ML
79
$20,228.67
0.62%
69
$14,416.35
0.52%
00075062160
LOVENOX
INJ 60/0.6ML
38
$19,339.20
0.30%
62
$25,273.61
0.47%
00075062280
LOVENOX
INJ 80/0.8ML
40
$23,047.62
0.32%
63
$28,978.30
0.48%
00075062300
LOVENOX
INJ 100/1ML
63
$70,267.62
0.50%
55
$49,217.14
0.42%
00075062403
LOVENOX
INJ 30/0.3ML
1
$19.31
0.01%
0
$0.00
0.00%
00075062430
LOVENOX
INJ 30/0.3ML
39
$8,725.29
0.31%
38
$7,430.84
0.29%
00075062603
LOVENOX
INJ 300/3ML
3
$532.98
0.02%
15
$5,139.48
0.11%
00075291201
LOVENOX
INJ 120/0.8
17
$21,753.10
0.13%
30
$28,312.89
0.23%
00075291501
LOVENOX
INJ 150/1ML
8
$12,377.84
0.06%
27
$32,910.91
0.20%
00555083102
WARFARIN
TAB 1MG
818
$11,855.95
6.45%
790
$9,602.31
5.96%
00555083105
WARFARIN
TAB 1MG
496
$5,056.26
3.91%
504
$3,733.94
3.80%
00555083202
WARFARIN
TAB 2.5MG
662
$6,811.23
5.22%
644
$5,232.51
4.86%
00555083205
WARFARIN
TAB 2.5MG
355
$3,390.28
2.80%
496
$4,077.54
3.74%
00555083302
WARFARIN
TAB 5MG
1,317
$18,474.02
10.39%
1,002
$12,548.52
7.56%
00555083305
WARFARIN
TAB 5MG
740
$8,229.55
5.84%
897
$9,089.34
6.77%
00555083402
WARFARIN
TAB 7.5MG
268
$3,155.87
2.11%
277
$1,859.63
2.09%
00555083502
WARFARIN
TAB 10MG
150
$2,476.65
1.18%
180
$1,513.48
1.36%
00555086902
WARFARIN
TAB 2MG
740
$8,815.25
5.84%
725
$7,091.91
5.47%
1
Page 62 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
00555086905
WARFARIN
TAB 2MG
396
$3,923.48
3.12%
404
$3,878.81
3.05%
00555087402
WARFARIN
TAB 4MG
596
$5,575.85
4.70%
453
$3,972.18
3.42%
00555087405
WARFARIN
TAB 4MG
226
$2,002.67
1.78%
392
$3,319.28
2.96%
00555092502
WARFARIN SOD TAB 3MG
1,106
$10,356.76
8.73%
1,324
$10,844.24
9.99%
00555092602
WARFARIN SOD TAB 6MG
264
$3,302.22
2.08%
294
$2,496.07
2.22%
00641038725
HEP-LOCK
2
$33.20
0.02%
0
$0.00
0.00%
00641040025
27
$366.17
0.21%
39
$966.37
0.29%
00641041025
2
$92.27
0.02%
3
$79.09
0.02%
00641243641
HEP-LOCK
INJ 100/ML
0
$0.00
0.00%
3
$14.25
0.02%
00641243841
HEP-LOCK
INJ 10UNT/ML
1
$3.95
0.01%
0
$0.00
0.00%
00641243845
HEP-LOCK
INJ 10UNT/ML
1
$21.02
0.01%
3
$41.75
0.02%
00641244045
1
$12.81
0.01%
1
$34.07
0.01%
00641244241
HEP-LOCK
INJ 10UNT/ML
6
$51.60
0.05%
1
$5.08
0.01%
00641244341
HEP-LOCK
INJ 100/ML
22
$158.48
0.17%
2
$10.08
0.02%
00641246045
1
$7.19
0.01%
0
$0.00
0.00%
00641247045
1
$120.21
0.01%
1
$41.54
0.01%
00781035207
WARFARIN
TAB 1MG
65
$1,226.14
0.51%
1
$12.65
0.01%
00781036307
WARFARIN
TAB 2MG
86
$1,662.05
0.68%
5
$108.96
0.04%
00781036407
WARFARIN
TAB 2.5MG
65
$1,090.85
0.51%
0
$0.00
0.00%
00781036607
WARFARIN
TAB 3MG
32
$443.71
0.25%
1
$1.00
0.01%
00781036907
WARFARIN
TAB 4MG
60
$756.04
0.47%
23
$250.34
0.17%
00781037707
WARFARIN
TAB 5MG
131
$2,427.46
1.03%
2
$24.00
0.02%
00781038107
WARFARIN
TAB 6MG
1
$17.49
0.01%
0
$0.00
0.00%
00781038607
WARFARIN
TAB 7.5MG
18
$346.80
0.14%
5
$61.25
0.04%
00781038707
WARFARIN
TAB 10MG
24
$438.00
0.19%
0
$0.00
0.00%
00832121100
JANTOVEN
TAB 1MG
0
$0.00
0.00%
171
$3,502.81
1.29%
00832121101
JANTOVEN
TAB 1MG
0
$0.00
0.00%
3
$196.05
0.02%
INJ 100/ML
Page 63 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
00832121200
JANTOVEN
TAB 2MG
0
$0.00
0.00%
153
$2,859.44
1.15%
00832121300
JANTOVEN
TAB 2.5MG
0
$0.00
0.00%
69
$1,281.79
0.52%
00832121400
JANTOVEN
TAB 3MG
0
$0.00
0.00%
54
$843.34
0.41%
00832121500
JANTOVEN
TAB 4MG
0
$0.00
0.00%
66
$1,030.22
0.50%
00832121600
JANTOVEN
TAB 5MG
0
$0.00
0.00%
347
$6,225.67
2.62%
00832121700
JANTOVEN
TAB 6MG
0
$0.00
0.00%
18
$259.70
0.14%
00832121800
JANTOVEN
TAB 7.5MG
0
$0.00
0.00%
12
$190.00
0.09%
00832121900
JANTOVEN
TAB 10MG
0
$0.00
0.00%
25
$410.95
0.19%
00832121901
JANTOVEN
TAB 10MG
0
$0.00
0.00%
2
$36.70
0.02%
08290036005
47
$4,087.89
0.37%
0
$0.00
0.00%
08290038005
0
$0.00
0.00%
10
$44.35
0.08%
08290039003
2
$11.30
0.02%
0
$0.00
0.00%
08290039005
325
$18,115.95
2.56%
5
$16.58
0.04%
51672402701
WARFARIN
TAB 1MG
380
$7,045.78
3.00%
364
$7,560.95
2.75%
51672402703
WARFARIN
TAB 1MG
5
$55.75
0.04%
24
$295.96
0.18%
51672402801
WARFARIN
TAB 2MG
375
$5,650.26
2.96%
389
$6,921.76
2.94%
51672402803
WARFARIN
TAB 2MG
0
$0.00
0.00%
15
$222.70
0.11%
51672402901
WARFARIN
TAB 2.5MG
137
$2,445.94
1.08%
195
$3,637.06
1.47%
51672402903
WARFARIN
TAB 2.5MG
8
$124.60
0.06%
7
$78.30
0.05%
51672403001
WARFARIN
TAB 3MG
236
$2,600.67
1.86%
155
$2,474.21
1.17%
51672403003
WARFARIN
TAB 3MG
1
$10.75
0.01%
1
$10.75
0.01%
51672403101
WARFARIN
TAB 4MG
222
$2,426.10
1.75%
275
$3,395.28
2.08%
51672403103
WARFARIN
TAB 4MG
0
$0.00
0.00%
3
$32.25
0.02%
51672403201
WARFARIN
TAB 5MG
675
$11,618.49
5.33%
911
$15,631.72
6.87%
51672403203
WARFARIN
TAB 5MG
72
$1,075.42
0.57%
123
$1,868.97
0.93%
51672403301
WARFARIN
TAB 6MG
18
$301.44
0.14%
19
$409.53
0.14%
51672403401
WARFARIN
TAB 7.5MG
35
$549.60
0.28%
49
$710.54
0.37%
Page 64 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICOAGULANTS
51672403501
WARFARIN
TAB 10MG
53303001101
ORAL WOUND SOL RINSE
59772035207
WARFARIN
TAB 1MG
59772036307
WARFARIN
59772036907
$536.50
0.16%
66
$1,051.90
0.50%
0
$0.00
0.00%
2
$93.70
0.02%
4
$96.40
0.03%
0
$0.00
0.00%
TAB 2MG
7
$161.05
0.06%
0
$0.00
0.00%
WARFARIN
TAB 4MG
1
$10.75
0.01%
0
$0.00
0.00%
59772037707
WARFARIN
TAB 5MG
10
$134.85
0.08%
0
$0.00
0.00%
62584099477
WARFARIN
TAB 5MG
0
$0.00
0.00%
2
$21.50
0.02%
63323026201
29
$838.93
0.23%
44
$1,219.19
0.33%
63323054001
0
$0.00
0.00%
1
$3.66
0.01%
63323054201
11
$421.59
0.09%
2
$239.10
0.02%
63323054207
0
$0.00
0.00%
1
$30.21
0.01%
63323054505
6
$77.65
0.05%
2
$18.59
0.02%
63323091501
2
$228.49
0.02%
0
$0.00
0.00%
64054100301
HEP SOD/NACL INJ 100/ML
0
$0.00
0.00%
23
$1,573.24
0.17%
64054100302
HEP SOD/NACL INJ 100/ML
1
$10.00
0.01%
225
$12,564.75
1.70%
64054300302
HEPARIN COMB KIT 10UNT/ML
0
$0.00
0.00%
7
$837.25
0.05%
64054300502
HEPARIN COMB KIT 10UNT/ML
0
$0.00
0.00%
14
$720.91
0.11%
64253022223
21
$505.40
0.17%
11
$228.86
0.08%
64253022233
21
$300.58
0.17%
14
$418.02
0.11%
64253022235
7
$243.30
0.06%
4
$327.46
0.03%
64253033333
53
$2,240.21
0.42%
55
$739.55
0.42%
64253033335
75
$2,685.68
0.59%
85
$1,159.68
0.64%
66203230001
ARIXTRA
SOL 2.5/0.5
1
$1.00
0.01%
0
$0.00
0.00%
66203230002
ARIXTRA
SOL 2.5/0.5
0
$0.00
0.00%
2
$1,983.45
0.02%
67211034208
INNOHEP
INJ 20000/ML
0
$0.00
0.00%
24
$12,802.28
0.18%
67211034253
INNOHEP
INJ 20000/ML
0
$0.00
0.00%
11
$2,981.40
0.08%
20
Page 65 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICONVULSANTS
00004005801
KLONOPIN
TAB 1MG
36
$3,279.13
0.05%
30
$2,275.17
0.05%
00004006801
KLONOPIN
TAB 0.5MG
26
$1,416.26
0.04%
25
$2,141.53
0.04%
00004009801
KLONOPIN
TAB 2MG
22
$994.52
0.03%
11
$809.98
0.02%
00004028122
KLONOPIN WAF TAB 0.5MG
1
$55.66
0.00%
1
$10.64
0.00%
00037043001
FELBATOL
TAB 400MG
51
$14,688.88
0.08%
50
$14,909.60
0.08%
00037043101
FELBATOL
TAB 600MG
149
$40,364.04
0.22%
154
$44,784.55
0.25%
00037044267
FELBATOL
SUS 600/5ML
23
$9,589.95
0.03%
15
$8,027.38
0.02%
00045063965
TOPAMAX
TAB 25MG
1,994
$255,387.73
3.00%
1,275
$169,338.39
2.07%
00045064065
TOPAMAX
TAB 50MG
0
$0.00
0.00%
105
$15,093.83
0.17%
00045064165
TOPAMAX
TAB 100MG
2,321
$477,955.29
3.50%
1,822
$420,020.88
2.96%
00045064265
TOPAMAX
TAB 200MG
753
$170,296.49
1.13%
670
$169,276.11
1.09%
00045064565
TOPAMAX
CAP 25MG
45
$12,135.87
0.07%
31
$10,595.91
0.05%
00045064765
TOPAMAX
CAP 15MG
60
$5,745.22
0.09%
25
$3,158.76
0.04%
00071000724
DILANTIN
CHW 50MG
722
$15,848.59
1.09%
641
$13,567.21
1.04%
00071000740
DILANTIN
CHW 50MG
1
$8.38
0.00%
3
$59.80
0.00%
00071023724
ZARONTIN
58
$5,594.09
0.09%
37
$4,001.28
0.06%
00071036224
DILANTIN
CAP 100MG
1,229
$37,022.63
1.85%
992
$29,555.80
1.61%
00071036232
DILANTIN
CAP 100MG
729
$20,590.68
1.10%
611
$17,607.87
0.99%
00071036240
DILANTIN
CAP 100MG
16
$477.14
0.02%
28
$779.94
0.05%
00071036524
DILANTIN
CAP 30MG
322
$5,643.18
0.48%
282
$4,638.28
0.46%
00071040124
NEURONTIN
TAB 800MG
0
$0.00
0.00%
1,399
$355,383.24
2.27%
00071041624
NEURONTIN
TAB 600MG
3,119
$459,940.92
4.70%
216
$32,508.02
0.35%
00071042624
NEURONTIN
TAB 800MG
1,810
$379,431.71
2.73%
103
$22,312.74
0.17%
00071051324
NEURONTIN
TAB 600MG
0
$0.00
0.00%
2,321
$408,252.16
3.76%
00071052524
CELONTIN
CAP 300MG
6
$218.29
0.01%
8
$387.40
0.01%
00071053724
CELONTIN
CAP 150MG
9
$401.21
0.01%
0
$0.00
0.00%
00071080324
NEURONTIN
1,766
$80,998.17
2.66%
1,146
$52,810.39
1.86%
CAP 250MG
CAP 100MG
Page 66 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICONVULSANTS
00071080340
NEURONTIN
CAP 100MG
0
$0.00
0.00%
1
$33.49
0.00%
00071080524
NEURONTIN
CAP 300MG
4,166
$349,381.56
6.27%
2,470
$219,322.93
4.01%
00071080540
NEURONTIN
CAP 300MG
2
$83.56
0.00%
1
$5.97
0.00%
00071080624
NEURONTIN
CAP 400MG
1,555
$220,918.74
2.34%
977
$136,313.29
1.58%
00071201223
NEURONTIN
SOL 250/5ML
39
$4,230.76
0.06%
60
$4,519.77
0.10%
00071221420
DILANTIN-125 SUS 125/5ML
110
$4,904.06
0.17%
48
$2,415.92
0.08%
00071241823
ZARONTIN
SOL 250/5ML
21
$1,111.86
0.03%
20
$875.00
0.03%
00071400705
CEREBYX
INJ 50MG/ML
3
$946.60
0.00%
1
$116.80
0.00%
00074568113
DEPAKENE
CAP 250MG
4
$1,020.82
0.01%
4
$697.22
0.01%
00074568216
DEPAKENE
SYP 250/5ML
16
$6,179.45
0.02%
11
$3,698.37
0.02%
00074611411
DEPAKOTE SPR CAP 125 MG
3
$206.40
0.00%
0
$0.00
0.00%
00074611413
DEPAKOTE SPR CAP 125 MG
1,007
$87,631.67
1.52%
1,022
$100,924.22
1.66%
00074621213
DEPAKOTE
TAB 125MG DR
597
$23,412.99
0.90%
488
$22,842.75
0.79%
00074621411
DEPAKOTE
TAB 250MG DR
1
$7.55
0.00%
1
$5.72
0.00%
00074621413
DEPAKOTE
TAB 250MG DR
2,038
$174,791.97
3.07%
1,627
$159,348.86
2.64%
00074621453
DEPAKOTE
TAB 250MG DR
1,089
$93,882.43
1.64%
951
$90,389.00
1.54%
00074621513
DEPAKOTE
TAB 500MG DR
2,558
$388,230.17
3.85%
2,078
$354,374.66
3.37%
00074621553
DEPAKOTE
TAB 500MG DR
964
$150,975.76
1.45%
838
$147,167.38
1.36%
00078033605
TRILEPTAL
TAB 150MG
411
$25,594.34
0.62%
300
$21,489.97
0.49%
00078033606
TRILEPTAL
TAB 150MG
5
$301.18
0.01%
2
$323.19
0.00%
00078033705
TRILEPTAL
TAB 300MG
1,074
$139,026.91
1.62%
852
$108,318.60
1.38%
00078033706
TRILEPTAL
TAB 300MG
3
$379.56
0.00%
7
$613.79
0.01%
00078033805
TRILEPTAL
TAB 600MG
677
$132,752.91
1.02%
623
$142,309.99
1.01%
00078033806
TRILEPTAL
TAB 600MG
6
$1,207.00
0.01%
0
$0.00
0.00%
00078035752
TRILEPTAL
SUS 300MG/5M
46
$5,445.68
0.07%
107
$9,937.17
0.17%
00083001976
TEGRETOL
SUS 100/5ML
102
$7,542.85
0.15%
73
$5,996.49
0.12%
00083002730
TEGRETOL
TAB 200MG
236
$14,763.64
0.36%
190
$13,078.95
0.31%
Page 67 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICONVULSANTS
00083002740
TEGRETOL
TAB 200MG
95
$6,910.81
0.14%
66
$5,223.55
0.11%
00083005230
TEGRETOL
CHW 100MG
99
$4,506.31
0.15%
83
$4,333.75
0.13%
00083005232
TEGRETOL
CHW 100MG
2
$36.86
0.00%
0
$0.00
0.00%
00083006030
TEGRETOL XR TAB 400MG
427
$31,491.60
0.64%
445
$34,292.97
0.72%
00083006130
269
$6,896.09
0.41%
279
$6,768.10
0.45%
00083006230
555
$28,161.89
0.84%
608
$31,824.49
0.99%
00083006232
0
$0.00
0.00%
1
$14.04
0.00%
00093009001
EPITOL
128
$1,756.61
0.19%
178
$2,375.15
0.29%
00093010901
CARBAMAZEPIN TAB 200MG
792
$9,777.84
1.19%
846
$9,830.25
1.37%
00093010910
124
$1,615.62
0.19%
66
$948.45
0.11%
00093077801
CARBAMAZEPIN CHW 100MG
697
$14,677.97
1.05%
523
$8,826.40
0.85%
00093083201
CLONAZEPAM TAB 0.5MG
3,595
$21,235.89
5.41%
3,582
$21,704.55
5.81%
00093083205
1,167
$7,235.62
1.76%
69
$403.85
0.11%
00093083210
345
$2,195.88
0.52%
308
$1,764.39
0.50%
00093083301
CLONAZEPAM TAB 1MG
4,410
$32,337.08
6.64%
4,562
$33,172.79
7.40%
00093083305
CLONAZEPAM TAB 1MG
1,095
$7,920.24
1.65%
113
$777.87
0.18%
00093083310
CLONAZEPAM TAB 1MG
468
$3,313.80
0.70%
425
$2,860.76
0.69%
00093083401
CLONAZEPAM TAB 2MG
1,163
$10,313.44
1.75%
1,098
$9,390.56
1.78%
00093083405
CLONAZEPAM TAB 2MG
62
$419.06
0.09%
7
$34.37
0.01%
00093103801
GABAPENTIN CAP 100MG
0
$0.00
0.00%
23
$701.64
0.04%
00093103901
0
$0.00
0.00%
66
$4,293.87
0.11%
00093104001
0
$0.00
0.00%
27
$4,401.48
0.04%
00093963316
VALPROIC ACD SYP 250/5ML
57
$2,172.60
0.09%
62
$1,888.20
0.10%
00093966016
ETHOSUXIMIDE SOL 250/5ML
0
$0.00
0.00%
4
$149.84
0.01%
00121067016
ETHOSUXIMIDE SOL 250/5ML
5
$281.13
0.01%
8
$267.34
0.01%
00121067516
59
$3,006.07
0.09%
75
$3,149.00
0.12%
00172205760
PHENY SOD
7
$263.71
0.01%
9
$232.52
0.01%
TAB 200MG
CAP PROMPT
Page 68 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICONVULSANTS
00172444160
GABAPENTIN TAB 300MG
00172444260
GABAPENTIN TAB 400MG
00173052600
LAMICTAL
CHW 5MG
00173052700
LAMICTAL
CHW 25MG
00173063302
LAMICTAL
00173064255
00173064360
$0.00
0.00%
$440.14
0.01%
0
$0.00
0.00%
50
$10,124.80
0.08%
1
$125.20
0.00%
32
$9,913.40
0.05%
132
$38,657.30
0.20%
145
$56,743.96
0.24%
TAB 25MG
1,075
$224,946.25
1.62%
1,462
$299,379.21
2.37%
LAMICTAL
TAB 100MG
1,176
LAMICTAL
TAB 150MG
404
$171,546.30
1.77%
1,751
$274,755.01
2.84%
$70,516.16
0.61%
513
$93,499.52
0.83%
00173064460
LAMICTAL
TAB 200MG
832
$153,973.60
1.25%
1,008
$195,496.87
1.64%
00182175401
VALPROIC ACD CAP 250MG
84
$4,039.09
0.13%
11
$492.63
0.02%
00185006301
35
$249.65
0.05%
33
$188.39
0.05%
00185006305
10
$50.75
0.02%
14
$93.22
0.02%
00185006310
26
$179.42
0.04%
6
$14.86
0.01%
00185006401
CLONAZEPAM TAB 1MG
81
$451.75
0.12%
93
$576.68
0.15%
00185006405
CLONAZEPAM TAB 1MG
77
$600.42
0.12%
49
$381.26
0.08%
00185006410
CLONAZEPAM TAB 1MG
11
$80.50
0.02%
15
$100.73
0.02%
00185006501
CLONAZEPAM TAB 2MG
6
$46.10
0.01%
7
$34.75
0.01%
00185006505
CLONAZEPAM TAB 2MG
4
$32.20
0.01%
0
$0.00
0.00%
00185006510
CLONAZEPAM TAB 2MG
31
$348.75
0.05%
1
$14.15
0.00%
00228214310
1
$6.85
0.00%
2
$10.70
0.00%
00228214350
31
$360.85
0.05%
0
$0.00
0.00%
00228214396
373
$5,032.72
0.56%
334
$4,613.12
0.54%
00228266511
0
$0.00
0.00%
22
$531.48
0.04%
00228266611
0
$0.00
0.00%
43
$2,508.55
0.07%
00228266711
0
$0.00
0.00%
20
$1,895.64
0.03%
00228300311
146
$908.82
0.22%
118
$749.96
0.19%
00228300350
933
$6,011.43
1.40%
1,087
$7,200.45
1.76%
00228300411
CLONAZEPAM TAB 1MG
118
$965.14
0.18%
42
$342.38
0.07%
0
5
Page 69 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICONVULSANTS
00228300450
CLONAZEPAM TAB 1MG
1,016
$7,715.80
1.53%
681
$5,047.37
1.10%
00228300511
CLONAZEPAM TAB 2MG
139
$1,321.87
0.21%
152
$1,538.98
0.25%
00228300550
CLONAZEPAM TAB 2MG
129
$1,155.80
0.19%
125
$1,245.25
0.20%
00258358701
2
$2.46
0.00%
279
$3,273.59
0.45%
00258358710
32
$350.20
0.05%
36
$447.60
0.06%
00364036601
PRIMIDONE
0
$0.00
0.00%
3
$175.50
0.00%
00378156001
PHENYTOIN EX CAP 100MG
1,446
$42,523.68
2.18%
1,254
$35,485.34
2.03%
00378156010
PHENYTOIN EX CAP 100MG
1,115
$28,189.53
1.68%
1,160
$31,618.23
1.88%
00378191001
13
$56.43
0.02%
20
$132.26
0.03%
00378191010
390
$2,505.53
0.59%
222
$1,414.98
0.36%
00378191201
CLONAZEPAM TAB 1MG
18
$157.48
0.03%
17
$148.25
0.03%
00378191210
CLONAZEPAM TAB 1MG
337
$2,006.24
0.51%
233
$1,813.39
0.38%
00378191401
CLONAZEPAM TAB 2MG
39
$227.04
0.06%
41
$317.53
0.07%
00378191405
CLONAZEPAM TAB 2MG
00472006708
PHENYTOIN SUS 125/5ML
00472021016
00527123101
PRIMIDONE
TAB 250MG
00527123110
PRIMIDONE
TAB 250MG
00527130101
PRIMIDONE
TAB 50MG
00591074601
00591074605
00591074701
TAB 250MG
0
$0.00
0.00%
15
$159.97
0.02%
302
$10,751.35
0.45%
395
$13,866.48
0.64%
0
$0.00
0.00%
2
$42.34
0.00%
124
$6,120.90
0.19%
66
$3,788.20
0.11%
3
$157.49
0.00%
4
$266.40
0.01%
51
$1,663.64
0.08%
47
$1,451.66
0.08%
120
$679.70
0.18%
128
$796.32
0.21%
2
$7.80
0.00%
0
$0.00
0.00%
CLONAZEPAM TAB 1MG
44
$304.64
0.07%
32
$295.29
0.05%
00591074705
CLONAZEPAM TAB 1MG
12
$80.32
0.02%
0
$0.00
0.00%
00591074801
CLONAZEPAM TAB 2MG
44
$413.00
0.07%
18
$175.53
0.03%
00591074805
CLONAZEPAM TAB 2MG
13
$91.57
0.02%
0
$0.00
0.00%
00591401201
26
$1,161.79
0.04%
23
$1,109.60
0.04%
00591532101
PRIMIDONE
54
$2,543.03
0.08%
32
$1,252.49
0.05%
TAB 250MG
Page 70 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
PRIMIDONE
00603184058
00603536921
$
Market Share*
ANTICONVULSANTS
00591532110
# of Scripts
TAB 250MG
14
$583.67
0.02%
0
$0.00
0.00%
5
$158.89
PRIMIDONE
TAB 50MG
9
$253.66
0.01%
6
$166.81
0.01%
0.01%
11
$552.59
0.02%
00603537021
PRIMIDONE
TAB 250MG
9
$453.15
0.01%
0
$0.00
0.00%
00603633421
1
$9.55
0.00%
0
$0.00
0.00%
00641049325
00641255545
PHENYTOIN INJ 50MG/ML
1
$30.83
0.00%
2
$26.93
0.00%
PHENYTOIN INJ 50MG/ML
0
$0.00
0.00%
1
$11.32
0.00%
00677035401
PRIMIDONE
1
$58.50
0.00%
0
$0.00
0.00%
00677107901
14
$1,052.48
0.02%
8
$331.30
0.01%
00832100700
26
$677.26
0.04%
11
$321.35
0.02%
00832100800
40
$2,664.72
0.06%
101
$4,765.40
0.16%
00904056080
PRIMIDONE
1
$7.50
0.00%
0
$0.00
0.00%
00904210316
1
$19.98
0.00%
0
$0.00
0.00%
00904385460
9
$135.89
0.01%
0
$0.00
0.00%
00904385560
10
$92.50
0.02%
3
$24.55
0.00%
00904385580
1
$12.85
0.00%
0
$0.00
0.00%
00904534240
7
$55.25
0.01%
0
$0.00
0.00%
00904534260
28
$168.30
0.04%
2
$11.30
0.00%
00904534280
139
$785.40
0.21%
199
$1,274.43
0.32%
00904534340
CLONAZEPAM TAB 1MG
54
$461.59
0.08%
0
$0.00
0.00%
00904534360
CLONAZEPAM TAB 1MG
4
$35.40
0.01%
0
$0.00
0.00%
00904534380
CLONAZEPAM TAB 1MG
66
$482.31
0.10%
0
$0.00
0.00%
00904534440
CLONAZEPAM TAB 2MG
13
$132.35
0.02%
17
$179.55
0.03%
00904555940
PRIMIDONE
5
$179.80
0.01%
3
$40.85
0.00%
50111085201
74
$3,187.74
0.11%
42
$1,879.00
0.07%
50111090101
ETHOSUXIMIDE CAP 250MG
39
$2,298.28
0.06%
36
$2,308.44
0.06%
50383079216
4
$182.80
0.01%
13
$439.54
0.02%
TAB 250MG
TAB 250MG
TAB 50MG
Page 71 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICONVULSANTS
50474000148
KEPPRA
SOL 100MG/ML
50474059140
KEPPRA
TAB 250MG
50474059240
KEPPRA
TAB 500MG
50474059340
KEPPRA
TAB 750MG
51079088120
51672400501
51672400502
$2,089.56
0.03%
$6,794.68
0.15%
114
$15,053.86
0.17%
661
$134,272.05
1.00%
88
$12,669.89
0.14%
746
$156,288.62
1.21%
118
$23,924.55
0.18%
139
$33,322.82
0.23%
5
$17.87
0.01%
0
$0.00
0.00%
499
291
$6,188.05
0.75%
198
$2,281.20
0.32%
$3,488.95
0.44%
308
$3,708.13
0.50%
51672400503
411
$5,196.62
0.62%
500
$6,176.33
0.81%
51672404101
123
$2,011.80
0.19%
177
$3,323.81
0.29%
51672404102
115
$2,155.82
0.17%
173
$2,772.59
0.28%
51672404709
CARBAMAZEPIN SUS 100/5ML
165
$6,323.28
0.25%
89
$3,632.35
0.14%
51672406901
0
$0.00
0.00%
5
$236.86
0.01%
52544074601
1
$10.15
0.00%
0
$0.00
0.00%
54092017112
CARBATROL
CAP 100MG
0
$0.00
0.00%
40
$2,943.10
0.06%
54092017212
CARBATROL
CAP 200MG
533
$42,225.15
0.80%
613
$53,328.36
0.99%
54092017312
CARBATROL
CAP 300MG
421
$28,738.50
0.63%
413
$29,306.67
0.67%
57664027308
12
$98.60
0.02%
17
$119.45
0.03%
57664027313
82
$496.07
0.12%
226
$1,384.74
0.37%
57664027318
418
$2,627.30
0.63%
813
$5,116.67
1.32%
57664027408
CLONAZEPAM TAB 1MG
23
$179.00
0.03%
61
$471.45
0.10%
57664027413
CLONAZEPAM TAB 1MG
477
$3,491.13
0.72%
679
$4,586.35
1.10%
57664027418
CLONAZEPAM TAB 1MG
80
$574.15
0.12%
687
$5,361.19
1.11%
57664027508
CLONAZEPAM TAB 2MG
32
$269.42
0.05%
36
$334.58
0.06%
57664027513
CLONAZEPAM TAB 2MG
14
$96.84
0.02%
101
$763.64
0.16%
57664027518
CLONAZEPAM TAB 2MG
85
$910.91
0.13%
116
$1,030.66
0.19%
57664034213
0
$0.00
0.00%
1
$20.15
0.00%
57664034288
9
$172.76
0.01%
24
$261.79
0.04%
19
94
Page 72 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICONVULSANTS
58521017212
CARBATROL
CAP 200MG
127
$6,155.54
0.19%
40
$2,718.21
0.06%
58521017312
CARBATROL
CAP 300MG
87
$5,236.71
0.13%
19
$996.00
0.03%
59075065020
DIASTAT PED MIS 2.5M GEL
1
$187.53
0.00%
1
$42.89
0.00%
59075065120
DIASTAT PED MIS 5MG GEL
9
$2,813.16
0.01%
9
$1,303.35
0.01%
59075065220
DIASTAT UNIV MIS 10MG GEL
27
$5,558.08
0.04%
11
$3,299.20
0.02%
59075065420
DIASTAT
59075068010
ZONEGRAN
CAP 100MG
59075068110
ZONEGRAN
59075068210
ZONEGRAN
59075069010
59075069050
MIS 15MG GEL
3
$562.59
0.00%
1
$363.24
0.00%
442
$79,324.96
0.67%
466
$80,954.83
0.76%
CAP 25MG
0
$0.00
0.00%
38
$1,153.56
0.06%
CAP 50MG
0
$0.00
0.00%
37
$2,089.56
0.06%
MYSOLINE
TAB 50MG
36
$1,377.36
0.05%
24
$739.49
0.04%
MYSOLINE
TAB 50MG
4
$286.53
0.01%
0
$0.00
0.00%
59075069110
MYSOLINE
TAB 250MG
73
$8,455.11
0.11%
23
$1,990.17
0.04%
59075069111
MYSOLINE
TAB 250MG
2
$214.19
0.00%
3
$362.58
0.00%
59762502601
0
$0.00
0.00%
55
$2,301.37
0.09%
59762502701
0
$0.00
0.00%
153
$10,788.32
0.25%
59762502801
0
$0.00
0.00%
74
$8,899.20
0.12%
60432012916
CARBAMAZEPIN SUS 100/5ML
8
$202.31
0.01%
33
$1,268.84
0.05%
60432013108
267
$9,846.80
0.40%
75
$2,633.82
0.12%
60432062116
440
$16,019.19
0.66%
350
$14,243.54
0.57%
60505006601
0
$0.00
0.00%
78
$454.92
0.13%
60505006603
0
$0.00
0.00%
790
$4,819.87
1.28%
60505006701
CLONAZEPAM TAB 1MG
0
$0.00
0.00%
31
$182.49
0.05%
60505006703
CLONAZEPAM TAB 1MG
0
$0.00
0.00%
1,288
$9,558.85
2.09%
60505006801
CLONAZEPAM TAB 2MG
0
$0.00
0.00%
167
$1,607.87
0.27%
60505018300
65
$706.00
0.10%
84
$937.81
0.14%
62037095205
51
$376.75
0.08%
12
$82.48
0.02%
62037095301
CLONAZEPAM TAB 1MG
5
$28.55
0.01%
0
$0.00
0.00%
Page 73 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTICONVULSANTS
62037095305
CLONAZEPAM TAB 1MG
13
$122.25
0.02%
1
$11.45
0.00%
62037095405
CLONAZEPAM TAB 2MG
20
$164.08
0.03%
15
$130.23
0.02%
62269035424
CLONAZEPAM TAB 1MG
3
$18.75
0.00%
0
$0.00
0.00%
62794067001
PHENYTEK
CAP 200MG
17
$444.26
0.03%
19
$553.55
0.03%
62794067093
PHENYTEK
CAP 200MG
25
$587.05
0.04%
12
$442.45
0.02%
62794075001
PHENYTEK
CAP 300MG
12
$318.25
0.02%
23
$893.04
0.04%
62794075093
PHENYTEK
CAP 300MG
10
$343.58
0.02%
15
$470.56
0.02%
63459040201
GABITRIL
TAB 2MG
46
$4,523.94
0.07%
31
$3,473.75
0.05%
63459040401
GABITRIL
TAB 4MG
159
$17,030.83
0.24%
134
$17,682.03
0.22%
63459041201
GABITRIL
TAB 12MG
30
$2,515.65
0.05%
20
$1,530.88
0.03%
63459041601
GABITRIL
TAB 16MG
32
$3,437.75
0.05%
17
$2,049.50
0.03%
63739026301
3
$31.65
0.00%
0
$0.00
0.00%
63739026401
CLONAZEPAM TAB 1MG
3
$18.15
0.00%
6
$39.00
0.01%
66490065020
DIASTAT PED MIS 2.5M GEL
5
$253.41
0.01%
2
$391.80
0.00%
66490065120
DIASTAT PED MIS 5MG GEL
23
$4,851.09
0.03%
34
$14,655.15
0.06%
66490065220
DIASTAT UNIV MIS 10MG GEL
30
$8,686.26
0.05%
58
$16,270.56
0.09%
66490065420
DIASTAT
11
$4,202.33
0.02%
10
$2,916.75
0.02%
66490065520
DIASTAT ADUL MIS 20MG GEL
7
$2,366.62
0.01%
9
$2,145.70
0.01%
66490069010
MYSOLINE
TAB 50MG
99
$4,535.40
0.15%
198
$8,761.93
0.32%
66490069050
MYSOLINE
TAB 50MG
5
$420.74
0.01%
0
$0.00
0.00%
66490069110
MYSOLINE
TAB 250MG
183
$21,945.89
0.28%
274
$36,349.51
0.44%
66490069111
MYSOLINE
TAB 250MG
12
$1,472.17
0.02%
23
$2,363.93
0.04%
66490069181
MYSOLINE
TAB 250MG
1
$182.96
0.00%
0
$0.00
0.00%
21
$1,395.64
32.81%
23
$1,395.29
44.23%
21
$1,003.93
32.81%
0
$0.00
0.00%
MIS 15MG GEL
ANTIDEPRESSANTS - MAO INHIBITORS
00007447120
PARNATE
00071027024
NARDIL
TAB 10MG
TAB 15MG
Page 74 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
NARDIL
TAB 15MG
$
Market Share*
ANTIDEPRESSANTS - MAO INHIBITORS
00071035024
# of Scripts
22
$1,022.18
34.38%
29
$1,342.77
55.77%
46
$3,793.76
0.03%
22
$2,039.11
0.02%
ANTIDEPRESSANTS - SELECTED SSRI's
00002300475
PROZAC WEEKL CAP 90MG
00002321045
SARAFEM
CAP 10MG
4
$288.65
0.00%
0
$0.00
0.00%
00002322045
SARAFEM
CAP 20MG
21
$1,463.39
0.02%
3
$68.48
0.00%
00002323560
CYMBALTA
CAP 20MG
0
$0.00
0.00%
78
$4,280.76
0.06%
00002323730
CYMBALTA
CAP 60MG
0
$0.00
0.00%
437
$33,533.15
0.33%
00002323733
CYMBALTA
CAP 60MG
0
$0.00
0.00%
3
$122.61
0.00%
00002324030
CYMBALTA
CAP 30MG
0
$0.00
0.00%
240
$14,018.27
0.18%
00002324033
CYMBALTA
CAP 30MG
0
$0.00
0.00%
7
$300.92
0.01%
00002400602
PROZAC
TAB 10MG
2
$130.15
0.00%
0
$0.00
0.00%
00002400630
PROZAC
TAB 10MG
10
$817.67
0.01%
7
$639.13
0.01%
00008070101
EFFEXOR
TAB 25MG
99
$7,457.66
0.07%
39
$2,813.32
0.03%
00008070102
EFFEXOR
TAB 25MG
0
$0.00
0.00%
3
$208.53
0.00%
00008070301
EFFEXOR
TAB 50MG
58
$5,459.36
0.04%
25
$1,665.97
0.02%
00008070302
EFFEXOR
TAB 50MG
1
$97.81
0.00%
2
$191.16
0.00%
00008070401
EFFEXOR
TAB 75MG
456
$41,033.57
0.34%
263
$23,038.38
0.20%
00008070402
EFFEXOR
TAB 75MG
2
$165.85
0.00%
0
$0.00
0.00%
00008070501
EFFEXOR
TAB 100MG
85
$7,051.00
0.06%
45
$3,878.98
0.03%
00008078101
EFFEXOR
TAB 37.5MG
280
$20,747.49
0.21%
144
$9,437.07
0.11%
00008083301
EFFEXOR XR CAP 75MG
4,950
$415,586.99
3.71%
3,542
$285,416.42
2.68%
00008083303
EFFEXOR XR CAP 75MG
63
$5,283.99
0.05%
41
$3,273.39
0.03%
00008083601
EFFEXOR XR CAP 150MG
6,988
$757,265.51
5.24%
5,716
$650,576.01
4.32%
00008083603
EFFEXOR XR CAP 150MG
2
$185.34
0.00%
2
$190.94
0.00%
00008083701
EFFEXOR XR CAP 37.5MG
1,181
$84,726.13
0.89%
727
$51,237.77
0.55%
00008083703
EFFEXOR XR CAP 37.5MG
2
$153.60
0.00%
3
$178.33
0.00%
Page 75 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00029320613
PAXIL CR
TAB 12.5MG
1,552
$109,873.58
1.16%
1,452
$105,614.02
1.10%
00029320713
PAXIL CR
TAB 25MG
3,412
$304,886.87
2.56%
3,762
$363,772.56
2.84%
00029320813
PAXIL CR
TAB 37.5MG
835
$70,995.51
0.63%
1,114
$96,727.23
0.84%
00029321013
PAXIL
TAB 10MG
1,610
$114,473.17
1.21%
14
$656.95
0.01%
00029321113
PAXIL
TAB 20MG
403
$30,652.48
0.30%
4
$525.04
0.00%
00029321120
PAXIL
TAB 20MG
3,889
$292,327.18
2.92%
28
$1,803.35
0.02%
00029321213
PAXIL
TAB 30MG
1,721
$157,542.52
1.29%
13
$1,265.39
0.01%
00029321313
PAXIL
TAB 40MG
2,598
$225,895.03
1.95%
26
$1,368.98
0.02%
00029321548
PAXIL
SUS 10MG/5ML
127
$13,619.63
0.10%
66
$5,749.29
0.05%
00049490041
ZOLOFT
TAB 50MG
6
$199.64
0.00%
12
$201.42
0.01%
00049490066
ZOLOFT
TAB 50MG
4,434
$262,982.58
3.33%
2,268
$79,840.70
1.71%
00049490073
ZOLOFT
TAB 50MG
2,356
$134,923.92
1.77%
1,425
$49,757.31
1.08%
00049491041
ZOLOFT
TAB 100MG
45
$3,624.08
0.03%
119
$8,218.79
0.09%
00049491066
ZOLOFT
TAB 100MG
11,191
$845,322.64
8.40%
13,867
$1,030,117.60
10.49%
00049491073
ZOLOFT
TAB 100MG
4,467
$312,440.00
3.35%
5,981
$402,759.86
4.52%
00049494023
ZOLOFT
CON 20MG/ML
112
$7,457.95
0.08%
119
$6,838.70
0.09%
00049496050
ZOLOFT
TAB 25MG
1,410
$83,253.60
1.06%
366
$11,784.22
0.28%
00052010530
REMERON
23
$1,346.12
0.02%
0
$0.00
0.00%
00052010630
REMERON SLTB TAB 15MG
90
$4,488.18
0.07%
14
$488.39
0.01%
00052010693
5
$176.38
0.00%
2
$90.11
0.00%
00052010730
REMERON
12
$926.21
0.01%
1
$85.62
0.00%
00052010830
79
$4,394.36
0.06%
8
$430.78
0.01%
00052010893
00052010930
REMERON
00052011030
TAB 15MG
TAB 30MG
1
$73.91
0.00%
0
$0.00
0.00%
25
$1,938.85
0.02%
5
$357.05
0.00%
27
$1,771.47
0.02%
6
$367.12
0.00%
00054467221
NEFAZODONE TAB 100MG
14
$685.04
0.01%
6
$107.70
0.00%
00054467321
14
$1,259.65
0.01%
7
$254.45
0.01%
TAB 45MG
Page 76 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00054467613
MIRTAZAPINE TAB 15MG
00054467713
00054467813
00054867625
00087003147
SERZONE
TAB 50MG
00087003231
SERZONE
TAB 100MG
00087003331
SERZONE
TAB 200MG
00087003931
SERZONE
00087004131
00087077541
$
Market Share*
00054467421
# of Scripts
6
$511.13
0.00%
6
$210.60
0.00%
0
$0.00
0.00%
264
$3,718.82
0.20%
15
$368.93
0.01%
151
$2,707.15
0.11%
1
$75.26
0.00%
24
$431.36
0.02%
0
$0.00
0.00%
1
$15.25
0.00%
56
$3,390.90
0.04%
0
$0.00
0.00%
168
$17,199.14
0.13%
16
$1,203.79
0.01%
178
$16,296.55
0.13%
12
$1,404.83
0.01%
TAB 150MG
143
$14,926.12
0.11%
13
$865.17
0.01%
SERZONE
TAB 250MG
24
$1,965.19
0.02%
0
$0.00
0.00%
DESYREL
TAB 50MG
1
$62.18
0.00%
2
$116.66
0.00%
00087077641
DESYREL
TAB 100MG
3
$310.98
0.00%
3
$303.87
0.00%
00087077843
DESYREL
TAB 150MG
15
$1,557.45
0.01%
9
$1,048.15
0.01%
00087079641
DESYREL
TAB 300MG
4
$619.39
0.00%
1
$152.80
0.00%
00093028001
BUPROPION
TAB 75MG
365
$7,865.29
0.27%
286
$4,675.27
0.22%
00093029001
BUPROPION
TAB 100MG
295
$7,987.39
0.22%
195
$4,364.46
0.15%
00093063701
TRAZODONE
TAB 50MG
2,736
$9,062.63
2.05%
2,822
$9,690.62
2.13%
00093063710
TRAZODONE
TAB 50MG
00093063801
TRAZODONE
TAB 100MG
00093102406
38
$130.00
0.03%
4
$21.50
0.00%
1,646
$8,302.72
1.23%
2,086
$10,932.16
1.58%
121
$11,254.27
0.09%
64
$1,801.75
0.05%
00093102506
117
$9,864.42
0.09%
90
$3,247.36
0.07%
00093102606
16
$1,128.22
0.01%
10
$282.10
0.01%
00093104201
FLUOXETINE CAP 10MG
109
$816.20
0.08%
156
$1,276.80
0.12%
00093104301
FLUOXETINE CAP 20MG
68
$822.41
0.05%
57
$746.29
0.04%
00093550101
BUDEPRION
TAB 100MG SR
0
$0.00
0.00%
159
$9,564.38
0.12%
00093550201
BUDEPRION
TAB 150MG SR
0
$0.00
0.00%
1,309
$109,423.03
0.99%
00093610812
FLUOXETINE SOL 20MG/5ML
83
$2,188.09
0.06%
71
$1,578.75
0.05%
Page 77 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00093711306
96
$8,973.80
0.07%
72
$2,207.11
0.05%
00093717801
NEFAZODONE TAB 50MG
18
$1,106.95
0.01%
22
$392.50
0.02%
00093718856
FLUOXETINE TAB 10MG
74
$495.33
0.06%
74
$566.45
0.06%
00093719856
FLUOXETINE CAP 40MG
50
$525.81
0.04%
46
$70.28
0.03%
00093720656
670
$12,300.37
0.50%
799
$12,514.53
0.60%
00093720756
633
$13,984.89
0.47%
535
$10,266.17
0.40%
00093720856
120
$8,422.83
0.09%
122
$2,179.72
0.09%
00121072104
66
$1,083.70
0.05%
48
$800.98
0.04%
00172433249
0
$0.00
0.00%
19
$483.06
0.01%
00172433260
49
$3,258.79
0.04%
71
$1,709.55
0.05%
00172433310
2
$105.64
0.00%
0
$0.00
0.00%
00172433349
0
$0.00
0.00%
17
$545.38
0.01%
00172433360
41
$3,562.74
0.03%
63
$2,137.40
0.05%
00172433410
4
$307.29
0.00%
14
$346.80
0.01%
00172433449
0
$0.00
0.00%
26
$731.85
0.02%
00172433460
32
$2,828.38
0.02%
44
$1,067.25
0.03%
00172433470
0
$0.00
0.00%
1
$40.45
0.00%
00172433510
0
$0.00
0.00%
2
$30.50
0.00%
00172433549
0
$0.00
0.00%
2
$59.30
0.00%
00172433560
10
$532.20
0.01%
11
$223.83
0.01%
00172434360
NEFAZODONE TAB 50MG
27
$1,494.35
0.02%
15
$353.15
0.01%
00172435660
FLUOXETINE CAP 20MG
213
$2,265.28
0.16%
119
$1,374.51
0.09%
00172435670
FLUOXETINE CAP 20MG
258
$2,700.84
0.19%
237
$2,739.41
0.18%
00172435680
FLUOXETINE CAP 20MG
150
$1,608.64
0.11%
224
$2,732.21
0.17%
00172436360
FLUOXETINE CAP 10MG
119
$960.75
0.09%
98
$668.27
0.07%
00172436370
FLUOXETINE CAP 10MG
2
$16.30
0.00%
18
$108.80
0.01%
00172436380
FLUOXETINE CAP 10MG
26
$171.55
0.02%
30
$241.58
0.02%
Page 78 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
FLUVOXAMINE TAB 25MG
00172439160
00172439260
00172451060
$
Market Share*
00172438960
# of Scripts
33
$542.74
0.02%
52
$726.03
0.04%
88
$1,976.90
0.07%
107
$1,819.74
0.08%
161
$6,160.55
0.12%
191
$6,032.13
0.14%
FLUOXETINE TAB 10MG
13
$116.11
0.01%
20
$165.02
0.02%
00172451070
FLUOXETINE TAB 10MG
4
$33.52
0.00%
7
$52.29
0.01%
00172451080
FLUOXETINE TAB 10MG
6
$75.20
0.00%
0
$0.00
0.00%
00172567546
0
$0.00
0.00%
4
$61.00
0.00%
00173013555
WELLBUTRIN TAB 150MG SR
8,860
$832,085.34
6.65%
40
$1,671.99
0.03%
00173017755
WELLBUTRIN TAB 75MG
10
$1,198.53
0.01%
3
$193.82
0.00%
00173017855
WELLBUTRIN TAB 100MG
5
$353.72
0.00%
4
$297.64
0.00%
00173072200
1,240
$195,009.23
0.93%
62
$3,172.41
0.05%
00173073001
WELLBUTRIN TAB XL 150MG
517
$42,438.11
0.39%
3,547
$315,160.95
2.68%
00173073101
WELLBUTRIN TAB XL 300MG
924
$85,633.79
0.69%
5,157
$524,474.70
3.90%
00173094755
2,441
$209,601.34
1.83%
15
$621.40
0.01%
00185001701
34
$973.20
0.03%
49
$854.88
0.04%
00185002010
6
$107.70
0.00%
0
$0.00
0.00%
00185002030
23
$428.23
0.02%
50
$690.46
0.04%
00185002701
182
$3,884.22
0.14%
110
$1,683.12
0.08%
00185002705
0
$0.00
0.00%
3
$54.35
0.00%
00185008160
0
$0.00
0.00%
1
$40.25
0.00%
00185008510
FLUOXETINE CAP 20MG
16
$158.60
0.01%
0
$0.00
0.00%
00185015701
312
$12,118.57
0.23%
275
$8,910.29
0.21%
00185015705
3
$56.85
0.00%
0
$0.00
0.00%
00185021210
75
$1,921.42
0.06%
93
$1,771.31
0.07%
00185021230
3
$76.95
0.00%
4
$68.30
0.00%
00185022230
12
$868.68
0.01%
6
$112.70
0.00%
00185037301
CITALOPRAM TAB 40MG
0
$0.00
0.00%
2
$15.00
0.00%
Page 79 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00185041060
BUPROPION
TAB 100MG ER
0
$0.00
0.00%
335
$18,778.34
0.25%
00185041501
BUPROPION
TAB 150MG ER
0
$0.00
0.00%
19
$1,895.61
0.01%
00185041505
BUPROPION
TAB 150MG ER
0
$0.00
0.00%
15
$1,431.01
0.01%
00185041560
BUPROPION
TAB 150MG ER
0
$0.00
0.00%
127
$10,976.33
0.10%
00228243910
TRAZODONE
TAB 50MG
3
$10.20
0.00%
1
$3.40
0.00%
00228243950
TRAZODONE
TAB 50MG
23
$93.01
0.02%
37
$146.88
0.03%
00228244110
TRAZODONE
TAB 100MG
1
$3.25
0.00%
0
$0.00
0.00%
00228265511
0
$0.00
0.00%
2
$37.90
0.00%
00228265611
5
$77.25
0.00%
0
$0.00
0.00%
00228270211
FLUOXETINE CAP 10MG
55
$395.16
0.04%
0
$0.00
0.00%
00228270311
FLUOXETINE CAP 20MG
40
$552.97
0.03%
2
$17.12
0.00%
00228275511
CITALOPRAM TAB 10MG
0
$0.00
0.00%
3
$156.44
0.00%
00228275611
CITALOPRAM TAB 20MG
0
$0.00
0.00%
5
$94.24
0.00%
00228275711
CITALOPRAM TAB 40MG
0
$0.00
0.00%
6
$175.28
0.00%
00258369501
CITALOPRAM TAB 10MG
0
$0.00
0.00%
1
$10.00
0.00%
00258369601
CITALOPRAM TAB 20MG
0
$0.00
0.00%
18
$355.89
0.01%
00258369701
CITALOPRAM TAB 40MG
0
$0.00
0.00%
11
$367.45
0.01%
00364210901
TRAZODONE
TAB 50MG
13
$48.45
0.01%
1
$6.05
0.00%
00364210902
TRAZODONE
TAB 50MG
9
$27.77
0.01%
1
$4.70
0.00%
00364211001
TRAZODONE
TAB 100MG
57
$302.35
0.04%
20
$142.62
0.02%
00364211002
TRAZODONE
TAB 100MG
11
$56.45
0.01%
0
$0.00
0.00%
00378006001
MAPROTILINE TAB 25MG
1
$13.03
0.00%
0
$0.00
0.00%
00378008701
4
$109.06
0.00%
1
$39.53
0.00%
00378009201
3
$45.12
0.00%
2
$20.00
0.00%
00378040701
12
$259.10
0.01%
16
$239.51
0.01%
00378041201
105
$2,374.41
0.08%
71
$1,026.00
0.05%
00378041401
214
$8,489.35
0.16%
242
$8,017.79
0.18%
Page 80 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00378043301
BUPROPION
TAB 75MG
94
$1,920.24
0.07%
140
$2,191.80
0.11%
00378043501
BUPROPION
TAB 100MG
46
$1,192.75
0.03%
84
$2,119.90
0.06%
00378205291
3
$234.78
0.00%
1
$12.25
0.00%
00378205391
1
$79.68
0.00%
0
$0.00
0.00%
00378205491
1
$86.65
0.00%
0
$0.00
0.00%
00378351593
900
$15,633.68
0.68%
1,064
$14,876.90
0.80%
00378353093
841
$18,339.95
0.63%
974
$18,265.37
0.74%
00378354593
348
$24,836.89
0.26%
385
$6,868.50
0.29%
00378421001
FLUOXETINE CAP 10MG
0
$0.00
0.00%
2
$11.30
0.00%
00378422001
FLUOXETINE CAP 20MG
72
$829.65
0.05%
60
$652.33
0.05%
00406066101
FLUOXETINE CAP 10MG
54
$386.35
0.04%
81
$591.00
0.06%
00406066301
FLUOXETINE CAP 20MG
258
$2,636.81
0.19%
408
$4,630.12
0.31%
00406066303
FLUOXETINE CAP 20MG
3
$27.15
0.00%
0
$0.00
0.00%
00406066305
FLUOXETINE CAP 20MG
140
$1,394.81
0.11%
301
$3,648.54
0.23%
00406066701
46
$756.40
0.03%
39
$544.85
0.03%
00430043514
SARAFEM
CAP 10MG
0
$0.00
0.00%
3
$64.47
0.00%
00430043614
SARAFEM
CAP 20MG
0
$0.00
0.00%
3
$55.02
0.00%
00456200501
LEXAPRO
TAB 5MG
0
$0.00
0.00%
8
$210.12
0.01%
00456201001
LEXAPRO
TAB 10MG
7,173
$451,739.87
5.38%
6,707
$408,462.94
5.07%
00456201063
LEXAPRO
TAB 10MG
2
$104.32
0.00%
0
$0.00
0.00%
00456202001
LEXAPRO
TAB 20MG
3,885
$257,941.16
2.91%
9,487
$578,767.14
7.17%
00456202063
LEXAPRO
TAB 20MG
8
$528.22
0.01%
10
$527.87
0.01%
00456210108
LEXAPRO
17
$1,639.41
0.01%
24
$2,342.61
0.02%
00456401001
CELEXA
TAB 10MG
1,145
$79,112.74
0.86%
151
$5,999.78
0.11%
00456402001
CELEXA
TAB 20MG
5,468
$367,443.39
4.10%
1,684
$62,407.34
1.27%
00456402063
CELEXA
TAB 20MG
6
$320.57
0.00%
1
$36.12
0.00%
00456404001
CELEXA
TAB 40MG
4,281
$323,909.51
3.21%
6,453
$407,142.85
4.88%
SOL 5MG/5ML
Page 81 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
CELEXA
TAB 40MG
00456413008
CELEXA
SOL 10MG/5ML
00555024171
00555024271
00555048902
TRAZODONE
TAB 50MG
00555048904
TRAZODONE
TAB 50MG
00555049002
TRAZODONE
TAB 100MG
00555049004
TRAZODONE
TAB 100MG
00555073202
TRAZODONE
TAB 150MG
00555073204
TRAZODONE
TAB 150MG
00555073302
TRAZODONE
TAB 300MG
00555087602
FLUOXETINE CAP 10MG
00555087702
FLUOXETINE CAP 20MG
00555096702
00555096802
$
Market Share*
00456404063
# of Scripts
2
$90.79
0.00%
1
$73.60
0.00%
71
$5,390.78
0.05%
55
$3,752.59
0.04%
0
$0.00
0.00%
18
$250.85
0.01%
0
$0.00
0.00%
20
$378.20
0.02%
188
$631.80
0.14%
164
$534.48
0.12%
28
$88.99
0.02%
29
$110.58
0.02%
203
$1,029.23
0.15%
191
$985.83
0.14%
2
$6.50
0.00%
0
$0.00
0.00%
581
$7,809.87
0.44%
458
$6,749.67
0.35%
1
$17.65
0.00%
0
$0.00
0.00%
13
$1,414.44
0.01%
3
$670.47
0.00%
309
$2,308.65
0.23%
5
$30.75
0.00%
3,638
$40,661.65
2.73%
1,917
$24,340.54
1.45%
8
$206.35
0.01%
5
$47.50
0.00%
25
$689.28
0.02%
24
$459.64
0.02%
00555096902
34
$1,218.44
0.03%
49
$1,722.96
0.04%
00591076460
0
$0.00
0.00%
3
$139.35
0.00%
00591076760
0
$0.00
0.00%
2
$59.30
0.00%
00591082701
FLUOXETINE CAP 20MG
191
$2,129.20
0.14%
0
$0.00
0.00%
00591082710
FLUOXETINE CAP 20MG
23
$237.73
0.02%
0
$0.00
0.00%
00591082730
FLUOXETINE CAP 20MG
29
$224.34
0.02%
0
$0.00
0.00%
00591083925
BUPROPION
TAB 150MG SR
0
$0.00
0.00%
962
$83,608.88
0.73%
00591083960
BUPROPION
TAB 150MG SR
0
$0.00
0.00%
3,028
$276,175.96
2.29%
00591085860
BUPROPION
TAB 100MG SR
0
$0.00
0.00%
1,308
$77,581.28
0.99%
00591111730
795
$13,799.36
0.60%
357
$5,206.99
0.27%
00591111830
421
$9,236.20
0.32%
250
$4,404.47
0.19%
00591111930
180
$12,008.23
0.14%
141
$2,478.59
0.11%
Page 82 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00591230001
TRAZODONE
TAB 150MG
1
$5.31
0.00%
8
$93.82
0.01%
00591559901
TRAZODONE
TAB 100MG
584
$3,231.81
0.44%
657
$3,463.69
0.50%
00591559910
TRAZODONE
TAB 100MG
294
$1,553.74
0.22%
300
$1,686.17
0.23%
00591560001
TRAZODONE
TAB 50MG
673
$2,356.46
0.50%
612
$2,117.40
0.46%
00591560010
TRAZODONE
TAB 50MG
622
$2,370.95
0.47%
1,182
$4,852.75
0.89%
00677113301
TRAZODONE
TAB 50MG
17
$67.05
0.01%
3
$14.15
0.00%
00677113305
TRAZODONE
TAB 50MG
43
$167.46
0.03%
25
$108.50
0.02%
00677113401
TRAZODONE
TAB 100MG
134
$687.58
0.10%
18
$103.24
0.01%
00677113405
TRAZODONE
TAB 100MG
63
$337.71
0.05%
21
$116.61
0.02%
00677130201
TRAZODONE
TAB 150MG
34
$343.81
0.03%
30
$398.08
0.02%
00677130205
TRAZODONE
TAB 150MG
1
$17.65
0.00%
0
$0.00
0.00%
00777310402
PROZAC
CAP 10MG
24
$1,912.46
0.02%
22
$2,037.85
0.02%
00777310502
PROZAC
CAP 20MG
198
$35,772.60
0.15%
88
$17,570.79
0.07%
00777310530
PROZAC
CAP 20MG
51
$10,307.94
0.04%
23
$5,335.77
0.02%
00777310730
PROZAC
CAP 40MG
66
$14,206.69
0.05%
25
$8,510.74
0.02%
00777512058
PROZAC
SOL 20MG/5ML
17
$1,369.44
0.01%
1
$24.63
0.00%
00781105301
BUPROPION
TAB 75MG
152
$2,938.47
0.11%
146
$2,235.45
0.11%
00781105310
BUPROPION
TAB 75MG
4
$35.90
0.00%
0
$0.00
0.00%
00781106401
BUPROPION
TAB 100MG
116
$2,916.75
0.09%
112
$2,549.94
0.08%
00781106410
BUPROPION
TAB 100MG
3
$92.85
0.00%
0
$0.00
0.00%
00781180701
TRAZODONE
TAB 50MG
12
$42.75
0.01%
0
$0.00
0.00%
00781180710
TRAZODONE
TAB 50MG
2
$12.50
0.00%
0
$0.00
0.00%
00781180801
TRAZODONE
TAB 100MG
10
$44.70
0.01%
0
$0.00
0.00%
00781282201
FLUOXETINE CAP 20MG
3,081
$34,592.91
2.31%
3,006
$33,883.51
2.27%
00781282301
FLUOXETINE CAP 10MG
576
$4,043.31
0.43%
633
$4,660.20
0.48%
00781282401
FLUOXETINE CAP 40MG
76
$1,055.41
0.06%
27
$114.18
0.02%
00781504001
5
$111.25
0.00%
0
$0.00
0.00%
Page 83 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00781504010
3
$66.75
0.00%
00781504101
28
$1,047.37
0.02%
00781504201
54
$2,099.20
0.04%
00904521940
TRAZODONE
TAB 50MG
89
$320.49
0.07%
00904521980
TRAZODONE
TAB 50MG
51
$190.11
00904522040
TRAZODONE
TAB 100MG
128
00904522060
TRAZODONE
TAB 100MG
2
17236080810
FLUOXETINE CAP 20MG
49884069937
49884073201
49884073210
$0.00
0.00%
4
$64.36
0.00%
16
$542.05
0.01%
14
$62.39
0.01%
0.04%
27
$101.92
0.02%
$646.35
0.10%
8
$43.00
0.01%
$11.50
0.00%
0
$0.00
0.00%
16
$199.60
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
42
$921.71
0.03%
FLUOXETINE CAP 10MG
141
$1,129.18
0.11%
155
$1,213.06
0.12%
FLUOXETINE CAP 10MG
84
$574.34
0.06%
98
$820.01
0.07%
49884073301
FLUOXETINE CAP 20MG
281
$2,907.85
0.21%
222
$2,297.67
0.17%
49884073310
FLUOXETINE CAP 20MG
522
$6,117.94
0.39%
562
$6,607.90
0.42%
49884073401
FLUOXETINE TAB 10MG
295
$2,046.74
0.22%
360
$2,752.37
0.27%
49884073410
FLUOXETINE TAB 10MG
138
$1,077.04
0.10%
176
$1,383.64
0.13%
49884073411
FLUOXETINE TAB 10MG
150
$1,124.73
0.11%
158
$1,221.58
0.12%
49884073501
FLUOXETINE TAB 20MG
194
$2,312.34
0.15%
277
$2,725.30
0.21%
49884073510
FLUOXETINE TAB 20MG
420
$5,572.22
0.32%
350
$3,744.60
0.26%
49884073511
FLUOXETINE TAB 20MG
38
$421.07
0.03%
35
$315.95
0.03%
49884074301
FLUOXETINE CAP 40MG
21
$178.05
0.02%
15
$131.89
0.01%
49884074311
FLUOXETINE CAP 40MG
101
$1,072.16
0.08%
21
$33.56
0.02%
49884075101
FLUOXETINE CAP 20MG
26
$622.34
0.02%
31
$375.76
0.02%
49884075110
FLUOXETINE CAP 20MG
156
$5,432.82
0.12%
60
$874.58
0.05%
49884087311
1
$75.25
0.00%
1
$17.95
0.00%
49884087605
PAROXETINE TAB 10MG
0
$0.00
0.00%
111
$3,764.79
0.08%
49884087611
PAROXETINE TAB 10MG
57
$2,723.26
0.04%
506
$19,721.98
0.38%
49884087701
PAROXETINE TAB 20MG
86
$4,451.53
0.06%
1,177
$39,815.38
0.89%
0
Page 84 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
49884087705
PAROXETINE TAB 20MG
0
$0.00
0.00%
155
$4,544.88
0.12%
49884087711
PAROXETINE TAB 20MG
17
$1,074.31
0.01%
78
$2,630.37
0.06%
49884087805
PAROXETINE TAB 30MG
0
$0.00
0.00%
59
$2,450.62
0.04%
49884087811
PAROXETINE TAB 30MG
50
$3,310.33
0.04%
500
$25,351.34
0.38%
49884087905
PAROXETINE TAB 40MG
0
$0.00
0.00%
65
$2,014.61
0.05%
49884087911
PAROXETINE TAB 40MG
78
$4,671.27
0.06%
693
$33,730.28
0.52%
49884091802
1
$82.69
0.00%
0
$0.00
0.00%
50111043301
TRAZODONE
TAB 50MG
1,450
$4,824.71
1.09%
1,461
$4,852.32
1.10%
50111043302
TRAZODONE
TAB 50MG
337
$1,100.21
0.25%
229
$744.80
0.17%
50111043303
TRAZODONE
TAB 50MG
2,336
$9,321.93
1.75%
2,359
$9,245.72
1.78%
50111043401
TRAZODONE
TAB 100MG
1,041
$5,390.74
0.78%
1,286
$6,867.73
0.97%
50111043402
TRAZODONE
TAB 100MG
455
$2,325.04
0.34%
523
$2,751.18
0.40%
50111043403
TRAZODONE
TAB 100MG
337
$1,944.88
0.25%
389
$2,080.35
0.29%
50111044101
TRAZODONE
TAB 150MG
288
$3,289.61
0.22%
736
$8,762.31
0.56%
50111044102
TRAZODONE
TAB 150MG
224
$2,384.55
0.17%
222
$2,664.81
0.17%
50111064701
FLUOXETINE CAP 10MG
5
$33.20
0.00%
418
$3,186.37
0.32%
50111064702
FLUOXETINE CAP 10MG
45
$306.12
0.03%
28
$283.49
0.02%
50111064703
FLUOXETINE CAP 10MG
0
$0.00
0.00%
11
$77.85
0.01%
50111064801
FLUOXETINE CAP 20MG
113
$1,315.16
0.08%
1,798
$20,814.12
1.36%
50111064802
FLUOXETINE CAP 20MG
36
$305.07
0.03%
3
$53.85
0.00%
50111064803
FLUOXETINE CAP 20MG
291
$3,206.31
0.22%
340
$3,972.41
0.26%
50111064844
FLUOXETINE CAP 20MG
109
$1,274.95
0.08%
188
$2,009.23
0.14%
51079042720
TRAZODONE
TAB 50MG
4
$14.99
0.00%
13
$47.42
0.01%
51079097120
FLUOXETINE CAP 20MG
12
$91.12
0.01%
26
$136.12
0.02%
52152022630
144
$2,644.49
0.11%
139
$1,802.73
0.11%
52152022730
87
$1,905.38
0.07%
110
$1,966.19
0.08%
52152022830
128
$8,843.41
0.10%
114
$1,932.46
0.09%
Page 85 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
TRAZODONE
TAB 50MG
53489051005
TRAZODONE
TAB 50MG
53489051010
TRAZODONE
TAB 50MG
53489051101
TRAZODONE
TAB 100MG
53489051105
TRAZODONE
53489051110
53489051701
$
Market Share*
53489051001
# of Scripts
$77.00
0.02%
8
$26.18
0.01%
6
$17.25
93
$371.91
0.00%
6
$13.69
0.00%
0.07%
13
$47.66
0.01%
23
$111.47
0.02%
8
$38.10
0.01%
TAB 100MG
44
$191.27
0.03%
38
$179.02
0.03%
TRAZODONE
TRAZODONE
TAB 100MG
116
$526.32
0.09%
31
$159.57
0.02%
TAB 150MG
22
$269.88
0.02%
488
$5,914.28
0.37%
53489051705
TRAZODONE
TAB 150MG
46
$670.54
0.03%
33
$500.25
0.02%
55111034201
CITALOPRAM TAB 10MG
0
$0.00
0.00%
2
$26.78
0.00%
55111034301
CITALOPRAM TAB 20MG
0
$0.00
0.00%
4
$35.00
0.00%
55111034401
CITALOPRAM TAB 40MG
0
$0.00
0.00%
3
$37.50
0.00%
57664049983
0
$0.00
0.00%
25
$401.25
0.02%
57664050083
0
$0.00
0.00%
34
$646.70
0.03%
57664050183
0
$0.00
0.00%
29
$531.21
0.02%
59772317101
TRAZODONE
TAB 150MG
788
$9,556.53
0.59%
112
$1,453.96
0.08%
59772317102
TRAZODONE
TAB 150MG
47
$581.79
0.04%
68
$840.89
0.05%
60432016204
0
$0.00
0.00%
15
$170.65
0.01%
60505008301
PAROXETINE TAB 20MG
1,275
$84,960.10
0.96%
2,213
$77,936.01
1.67%
60505008302
PAROXETINE TAB 20MG
0
$0.00
0.00%
350
$12,284.08
0.26%
60505008304
PAROXETINE TAB 20MG
44
$2,662.94
0.03%
97
$2,936.73
0.07%
60505008401
PAROXETINE TAB 30MG
544
$47,396.77
0.41%
1,195
$61,172.51
0.90%
60505008404
PAROXETINE TAB 30MG
0
$0.00
0.00%
1
$46.85
0.00%
60505009701
PAROXETINE TAB 10MG
418
$25,234.01
0.31%
894
$35,133.73
0.68%
60505009704
PAROXETINE TAB 10MG
0
$0.00
0.00%
1
$23.60
0.00%
60505010101
PAROXETINE TAB 40MG
957
$69,819.96
0.72%
1,963
$100,865.02
1.48%
60505010104
PAROXETINE TAB 40MG
0
$0.00
0.00%
22
$1,095.70
0.02%
60505016401
5
$125.15
0.00%
6
$119.05
0.00%
26
Page 86 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
60505016501
49
$1,167.60
0.04%
48
$802.20
0.04%
60505016601
90
$3,345.35
0.07%
139
$4,538.31
0.11%
60505035201
30
$850.75
0.02%
96
$1,745.50
0.07%
62037053801
FLUOXETINE CAP 10MG
53
$317.34
0.04%
21
$160.43
0.02%
62037053805
FLUOXETINE CAP 10MG
1
$1.97
0.00%
2
$7.56
0.00%
62037053810
FLUOXETINE CAP 10MG
45
$321.70
0.03%
34
$281.10
0.03%
62037053901
FLUOXETINE CAP 20MG
3
$33.90
0.00%
0
$0.00
0.00%
62037053905
FLUOXETINE CAP 20MG
3
$55.05
0.00%
1
$14.75
0.00%
62037053910
FLUOXETINE CAP 20MG
403
$4,584.68
0.30%
198
$2,470.12
0.15%
62037075310
0
$0.00
0.00%
10
$127.08
0.01%
62037075330
0
$0.00
0.00%
23
$276.59
0.02%
62037075410
0
$0.00
0.00%
10
$213.80
0.01%
62037075430
0
$0.00
0.00%
48
$750.04
0.04%
62037075530
0
$0.00
0.00%
11
$176.23
0.01%
62037084530
PAROXETINE TAB 10MG
0
$0.00
0.00%
36
$1,273.10
0.03%
62037084601
PAROXETINE TAB 20MG
0
$0.00
0.00%
120
$4,260.04
0.09%
62037084730
PAROXETINE TAB 30MG
0
$0.00
0.00%
32
$1,794.70
0.02%
62037084830
PAROXETINE TAB 40MG
0
$0.00
0.00%
81
$3,793.65
0.06%
66993070930
0
$0.00
0.00%
1
$37.24
0.00%
66993071130
0
$0.00
0.00%
1
$73.18
0.00%
ANTIDEPRESSANTS - TRI-CYCLICS
00002081902
AVENTYL
CAP 25MG
1
$11.79
0.01%
0
$0.00
0.00%
00006002668
VIVACTIL
TAB 5MG
0
$0.00
0.00%
1
$5.16
0.01%
00008413201
SURMONTIL
CAP 25MG
1
$67.86
0.01%
2
$94.00
0.01%
00008413301
SURMONTIL
CAP 50MG
0
$0.00
0.00%
3
$224.25
0.02%
00008415801
SURMONTIL
CAP 100MG
2
$107.94
0.01%
0
$0.00
0.00%
Page 87 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00028004501
TOFRANIL-PM CAP 125MG
1
$208.84
0.01%
0
$0.00
0.00%
00028013601
TOFRANIL
TAB 50MG
1
$178.36
0.01%
0
$0.00
0.00%
00028014001
TOFRANIL
TAB 25MG
1
$126.28
0.01%
0
$0.00
0.00%
00049536066
SINEQUAN
CAP 50MG
3
$321.19
0.02%
3
$334.97
0.02%
00049538066
SINEQUAN
CAP 100MG
1
$77.09
0.01%
0
$0.00
0.00%
00068002001
NORPRAMIN
TAB 100MG
0
$0.00
0.00%
1
$50.31
0.01%
00078001633
PAMELOR
SOL 10MG/5ML
9
$2,368.42
0.06%
6
$2,398.14
0.04%
00078007905
PAMELOR
CAP 75MG
2
$415.32
0.01%
0
$0.00
0.00%
00078031805
ANAFRANIL
1
$1.00
0.01%
0
$0.00
0.00%
00093081001
NORTRIPTYLIN CAP 10MG
132
$690.39
0.84%
217
$1,093.41
1.44%
00093081005
13
$88.33
0.08%
9
$65.85
0.06%
00093081101
180
$1,427.85
1.14%
271
$2,030.24
1.79%
00093081105
12
$98.52
0.08%
11
$52.77
0.07%
00093081201
196
$1,814.43
1.24%
245
$2,453.75
1.62%
00093081205
8
$99.47
0.05%
0
$0.00
0.00%
00093081301
93
$946.31
0.59%
107
$1,096.36
0.71%
00093095601
CLOMIPRAMINE CAP 25MG
3
$23.13
0.02%
12
$99.44
0.08%
00093095801
0
$0.00
0.00%
21
$672.19
0.14%
00093096001
3
$80.10
0.02%
2
$28.40
0.01%
00093961212
DOXEPIN HCL CON 10MG/ML
2
$8.58
0.01%
1
$4.29
0.01%
00121067816
NORTRIPTYLIN SOL 10MG/5ML
14
$383.57
0.09%
19
$811.05
0.13%
00185001901
DESIPRAMINE TAB 25MG
12
$138.14
0.08%
3
$47.89
0.02%
00185002901
4
$45.92
0.03%
4
$69.21
0.03%
00185072101
7
$242.80
0.04%
4
$64.40
0.03%
00185072201
1
$4.74
0.01%
3
$52.05
0.02%
00185073601
8
$254.20
0.05%
1
$18.85
0.01%
00185076053
1
$26.65
0.01%
3
$87.45
0.02%
CAP 75MG
Page 88 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00310004010
ELAVIL
TAB 10MG
1
$51.10
0.01%
0
00310004110
ELAVIL
TAB 50MG
1
$77.71
0.01%
00310004210
ELAVIL
TAB 75MG
0
$0.00
0.00%
00364211301
DOXEPIN HCL CAP 10MG
5
$23.95
00364211701
1
00364243401
AMOXAPINE
TAB 100MG
00364250801
00364250805
$0.00
0.00%
0
$0.00
0.00%
2
$15.84
0.01%
0.03%
0
$0.00
0.00%
$14.65
0.01%
0
$0.00
0.00%
1
$61.15
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
1
$3.25
0.01%
4
$36.80
0.03%
2
$21.10
0.01%
00364250901
26
$171.78
0.17%
15
$124.83
0.10%
00364251001
9
$115.63
0.06%
6
$64.10
0.04%
00364251005
1
$7.83
0.01%
0
$0.00
0.00%
00364251101
14
$126.94
0.09%
2
$17.42
0.01%
00378104901
82
$587.86
0.52%
72
$544.54
0.48%
00378104910
22
$152.03
0.14%
12
$72.42
0.08%
00378141001
68
$388.80
0.43%
47
$212.30
0.31%
00378232501
104
$752.53
0.66%
50
$461.54
0.33%
00378261001
AMITRIPTYLIN TAB 10MG
128
$401.23
0.81%
120
$377.24
0.79%
00378261010
194
$626.43
1.23%
204
$676.08
1.35%
00378262501
297
$1,309.91
1.89%
339
$1,803.02
2.24%
00378262510
278
$1,272.72
1.77%
302
$1,297.71
2.00%
00378265001
199
$571.43
1.26%
234
$646.48
1.55%
00378265010
229
$667.20
1.45%
252
$771.19
1.67%
00378267501
100
$405.61
0.64%
90
$416.65
0.60%
00378268501
252
$1,832.71
1.60%
238
$1,941.40
1.58%
00378269501
61
$552.02
0.39%
84
$843.15
0.56%
00378302501
27
$463.24
0.17%
16
$273.05
0.11%
00378305001
50
$1,082.97
0.32%
46
$1,548.25
0.30%
Page 89 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00378312501
00378312510
$
Market Share*
00378307501
# of Scripts
3
$42.60
0.02%
3
$96.15
0.02%
178
$1,327.67
1.13%
145
$1,336.07
0.96%
26
$224.05
0.17%
13
$121.55
0.09%
00378325001
90
$1,008.18
0.57%
55
$638.83
0.36%
00378417501
44
$489.12
0.28%
35
$406.97
0.23%
00378425001
221
$1,278.89
1.40%
208
$1,226.10
1.38%
00378425010
43
$215.04
0.27%
36
$195.52
0.24%
00378537501
75
$873.28
0.48%
68
$783.95
0.45%
00378537510
3
$28.53
0.02%
5
$57.36
0.03%
00378641001
137
$1,743.60
0.87%
118
$1,681.36
0.78%
00378641010
10
$140.72
0.06%
25
$262.65
0.17%
00406990601
ANAFRANIL
3
$260.52
0.02%
3
$292.38
0.02%
00406991001
PAMELOR
CAP 10MG
3
$503.85
0.02%
5
$762.74
0.03%
00406991101
PAMELOR
CAP 25MG
1
$111.98
0.01%
0
$0.00
0.00%
00406991201
PAMELOR
CAP 50MG
4
$2,100.25
0.03%
6
$3,994.77
0.04%
00406992101
TOFRANIL
TAB 25MG
0
$0.00
0.00%
3
$97.50
0.02%
00406992301
1
$20.00
0.01%
0
$0.00
0.00%
00406992303
1
$201.02
0.01%
0
$0.00
0.00%
00406992403
1
$150.98
0.01%
0
$0.00
0.00%
00406992603
4
$408.10
0.03%
0
$0.00
0.00%
00591037901
AMOXAPINE
3
$58.20
0.02%
0
$0.00
0.00%
00591054501
3
$56.55
0.02%
1
$18.85
0.01%
00591059601
3
$90.15
0.02%
3
$90.15
0.02%
00591080801
22
$225.30
0.14%
12
$198.94
0.08%
00591080805
6
$47.70
0.04%
0
$0.00
0.00%
00591080901
32
$770.00
0.20%
15
$376.55
0.10%
00591562901
28
$187.31
0.18%
10
$101.99
0.07%
CAP 25MG
TAB 25MG
Page 90 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00591563001
33
$294.99
0.21%
25
$222.81
0.17%
00591563010
33
$271.69
0.21%
34
$277.38
0.23%
00591563101
15
$78.95
0.10%
7
$44.95
0.05%
00591563110
14
$72.51
0.09%
7
$24.07
0.05%
00591563201
10
$91.40
0.06%
8
$76.08
0.05%
00591563301
7
$92.45
0.04%
7
$110.65
0.05%
00591571301
AMOXAPINE
TAB 25MG
1
$16.90
0.01%
0
$0.00
0.00%
00591571401
AMOXAPINE
TAB 50MG
15
$385.01
0.10%
13
$357.89
0.09%
00591571501
AMOXAPINE
TAB 100MG
6
$535.50
0.04%
9
$653.70
0.06%
00591578601
158
$842.20
1.00%
148
$760.79
0.98%
00591578605
68
$447.16
0.43%
75
$485.67
0.50%
00591578701
177
$1,297.85
1.12%
221
$1,591.12
1.46%
00591578705
63
$529.91
0.40%
63
$563.34
0.42%
00591578710
45
$320.76
0.29%
29
$208.30
0.19%
00591578801
318
$3,015.94
2.02%
323
$3,125.51
2.14%
00591578805
49
$463.83
0.31%
43
$419.49
0.28%
00591578901
128
$1,224.88
0.81%
108
$1,037.97
0.71%
00603221221
601
$1,957.97
3.82%
556
$1,732.04
3.68%
00603221232
534
$1,674.26
3.39%
556
$1,797.77
3.68%
00603221321
40
$172.96
0.25%
62
$274.82
0.41%
00603221332
2,316
$10,292.35
14.71%
2,259
$10,168.89
14.95%
00603221421
110
$317.58
0.70%
198
$551.80
1.31%
00603221432
1,585
$4,464.36
10.07%
1,435
$3,906.43
9.50%
00603221521
447
$1,893.24
2.84%
387
$1,643.65
2.56%
00603221621
743
$5,549.82
4.72%
870
$6,319.05
5.76%
00603221721
261
$2,564.91
1.66%
274
$2,550.66
1.81%
00603404432
IMIPRAM HCL TAB 25MG
7
$86.45
0.04%
0
$0.00
0.00%
Page 91 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00677042101
0
$0.00
0.00%
00677042107
2
$24.52
0.01%
00677042201
5
$83.43
0.03%
00677047510
16
$76.85
0.10%
00677047601
3
$14.31
00677047610
14
00677047701
2
00677047710
00677047801
$45.63
0.03%
3
$50.16
0.02%
18
$347.02
0.12%
11
$46.44
0.07%
0.02%
3
$14.31
0.02%
$60.12
0.09%
15
$52.09
0.10%
$6.06
0.01%
0
$0.00
0.00%
23
$94.14
0.15%
32
$120.94
0.21%
15
$65.69
0.10%
11
$49.16
0.07%
00677056801
20
$165.72
0.13%
7
$46.90
0.05%
00677064501
25
$274.21
0.16%
4
$39.66
0.03%
00781148601
63
$211.52
0.40%
39
$129.38
0.26%
00781148610
199
$759.98
1.26%
147
$592.37
0.97%
00781148701
24
$141.56
0.15%
9
$26.11
0.06%
00781148710
352
$1,629.73
2.24%
231
$1,110.77
1.53%
00781148801
74
$193.45
0.47%
57
$138.87
0.38%
00781148810
131
$445.74
0.83%
102
$381.55
0.68%
00781148901
77
$376.61
0.49%
65
$333.54
0.43%
00781149001
119
$904.58
0.76%
111
$738.71
0.73%
00781149101
23
$190.21
0.15%
24
$195.50
0.16%
00781176201
71
$662.11
0.45%
59
$589.63
0.39%
00781176401
102
$2,235.24
0.65%
130
$2,532.09
0.86%
00781176410
82
$1,557.09
0.52%
103
$2,110.39
0.68%
00781176413
0
$0.00
0.00%
5
$156.81
0.03%
00781176601
112
$2,591.97
0.71%
247
$6,461.17
1.64%
00781176610
99
$2,356.97
0.63%
72
$1,711.98
0.48%
00781176613
0
$0.00
0.00%
2
$44.90
0.01%
4
Page 92 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00781197101
39
$879.88
0.25%
20
$291.52
0.13%
00781197201
84
$753.66
0.53%
58
$1,147.81
0.38%
00781197210
0
$0.00
0.00%
2
$24.84
0.01%
00781197213
6
$37.65
0.04%
0
$0.00
0.00%
00781197301
88
$2,229.75
0.56%
70
$2,118.72
0.46%
00781197310
1
$15.05
0.01%
0
$0.00
0.00%
00781197401
23
$637.26
0.15%
17
$427.05
0.11%
00781197501
60
$1,608.00
0.38%
50
$1,432.26
0.33%
00781197650
13
$388.10
0.08%
23
$873.05
0.15%
00781202701
42
$860.34
0.27%
25
$255.75
0.17%
00781203701
43
$1,049.48
0.27%
52
$1,375.23
0.34%
00781204701
17
$299.33
0.11%
8
$150.30
0.05%
00781263001
0
$0.00
0.00%
2
$21.10
0.01%
00781263101
4
$16.96
0.03%
0
$0.00
0.00%
00904020060
0
$0.00
0.00%
4
$24.10
0.03%
00904020160
0
$0.00
0.00%
2
$14.54
0.01%
00904020180
43
$186.61
0.27%
4
$15.16
0.03%
00904020360
1
$3.07
0.01%
0
$0.00
0.00%
49884005401
66
$797.75
0.42%
60
$709.50
0.40%
49884005501
164
$3,538.09
1.04%
168
$3,143.60
1.11%
49884005510
130
$2,637.73
0.83%
54
$907.26
0.36%
49884005601
312
$8,199.96
1.98%
219
$5,252.27
1.45%
49884005610
42
$1,106.56
0.27%
31
$765.87
0.21%
49884021701
71
$382.42
0.45%
42
$273.14
0.28%
49884021710
3
$26.61
0.02%
0
$0.00
0.00%
49884021801
125
$1,346.69
0.79%
127
$1,026.71
0.84%
49884021810
1
$26.05
0.01%
3
$37.55
0.02%
Page 93 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
49884021901
140
49884022001
49884022101
49884022201
$757.52
0.89%
132
$630.18
0.87%
29
$348.28
0.18%
93
$1,350.76
0.59%
34
$375.83
0.23%
89
$1,205.69
0.59%
64
$966.25
0.41%
53
$661.67
0.35%
49884022203
10
$136.14
0.06%
25
$349.64
0.17%
49884022205
50111036603
3
$20.65
0.02%
0
$0.00
0.00%
1
$1.78
0.01%
0
$0.00
0.00%
50111036803
7
$20.35
0.04%
0
$0.00
0.00%
50111037001
1
$7.81
0.01%
0
$0.00
0.00%
51672401101
83
$1,506.11
0.53%
72
$1,090.84
0.48%
51672401201
150
$4,567.59
0.95%
142
$3,496.20
0.94%
51672401301
33
$983.04
0.21%
40
$942.87
0.26%
52544059401
6
$59.31
0.04%
6
$69.37
0.04%
52544059501
17
$530.87
0.11%
17
$536.99
0.11%
52544059601
3
$90.15
0.02%
0
$0.00
0.00%
53489010401
5
$18.41
0.03%
7
$25.27
0.05%
53489010410
13
$34.65
0.08%
3
$12.84
0.02%
53489010501
0
$0.00
0.00%
11
$47.31
0.07%
53489010510
119
$477.16
0.76%
90
$406.67
0.60%
53489010601
42
$147.28
0.27%
10
$32.32
0.07%
53489010610
51
$138.49
0.32%
34
$102.18
0.23%
53489010701
11
$34.38
0.07%
6
$23.42
0.04%
53489010705
0
$0.00
0.00%
1
$3.07
0.01%
53489010801
22
$191.77
0.14%
21
$195.60
0.14%
53489010901
17
$192.51
0.11%
16
$171.57
0.11%
53489033001
24
$247.91
0.15%
9
$84.50
0.06%
53489033010
4
$10.81
0.03%
3
$3.00
0.02%
Page 94 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
53489033110
53489033201
53489033210
60432065104
$
Market Share*
53489033101
# of Scripts
23
$372.58
0.15%
51
$1,096.64
0.34%
9
$162.56
0.06%
78
$1,559.01
0.50%
12
$271.08
0.08%
61
$1,471.20
0.40%
10
$210.96
0.06%
6
$158.80
0.04%
DOXEPIN HCL CON 10MG/ML
0
$0.00
0.00%
3
$13.80
0.02%
63304020201
NORTRIPTYLIN SOL 10MG/5ML
65473070101
VIVACTIL
TAB 5MG
3
$39.94
0.02%
2
$97.17
0.01%
2
$100.36
0.01%
0
$0.00
0.00%
65473070201
VIVACTIL
TAB 10MG
10
$465.86
0.06%
12
$1,090.23
0.08%
65473071801
SURMONTIL
CAP 25MG
6
$251.85
0.04%
2
$192.19
0.01%
65473071901
65473072001
SURMONTIL
CAP 50MG
13
$824.88
0.08%
12
$938.84
0.08%
SURMONTIL
CAP 100MG
18
$1,715.34
0.11%
4
$614.94
0.03%
ANTIEMETIC - 5-HT3 RECEPTOR ANTAGONISTS/ SUBSTANCE P NEUROKININ
00004023709
KYTRIL
SOL 2MG/10ML
1
$248.95
0.14%
0
$0.00
0.00%
00004024126
KYTRIL
TAB 1MG
15
$13,597.25
2.04%
15
$19,509.95
2.19%
00004024133
KYTRIL
TAB 1MG
16
$6,991.20
2.17%
14
$10,353.31
2.05%
00006046105
EMEND
CAP 80MG
0
$0.00
0.00%
18
$3,649.74
2.63%
00006046130
EMEND
CAP 80MG
0
$0.00
0.00%
1
$167.71
0.15%
00006386203
EMEND
CAP 80-125MG
7
$1,426.26
0.95%
18
$4,931.50
2.63%
00029415105
KYTRIL
TAB 1MG
2
$738.39
0.27%
0
$0.00
0.00%
00051002121
MARINOL
CAP 2.5MG
82
$20,742.31
11.14%
90
$25,257.12
13.16%
00051002211
MARINOL
CAP 5MG
78
$56,855.64
10.60%
57
$47,444.92
8.33%
00051002321
MARINOL
CAP 10MG
13
$13,427.31
1.77%
27
$36,098.76
3.95%
00088120305
ANZEMET
TAB 100MG
3
$1,859.76
0.41%
0
$0.00
0.00%
00173044200
ZOFRAN
INJ 2MG/ML
11
$4,037.77
1.49%
37
$14,771.23
5.41%
00173044202
ZOFRAN
INJ 2MG/ML
22
$975.09
2.99%
30
$2,648.90
4.39%
00173044600
ZOFRAN
TAB 4MG
160
$60,453.30
21.74%
106
$50,119.07
15.50%
Page 95 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIEMETIC - 5-HT3 RECEPTOR ANTAGONISTS/ SUBSTANCE P NEUROKININ
00173044604
ZOFRAN
TAB 4MG
16
$4,973.01
2.17%
18
$5,029.91
2.63%
00173044700
ZOFRAN
TAB 8MG
206
$165,333.16
27.99%
171
$176,784.71
25.00%
00173044702
ZOFRAN
TAB 8MG
0
$0.00
0.00%
1
$1,410.19
0.15%
00173044704
ZOFRAN
TAB 8MG
17
$12,680.66
2.31%
12
$13,420.66
1.75%
00173048900
ZOFRAN
SOL 4MG/5ML
16
$2,429.01
2.17%
21
$8,323.68
3.07%
00173056900
ZOFRAN ODT TAB 4MG
25
$8,295.50
3.40%
24
$6,803.18
3.51%
00173057000
ZOFRAN ODT TAB 8MG
34
$12,792.77
4.62%
15
$9,310.22
2.19%
00173057004
ZOFRAN ODT TAB 8MG
12
$4,043.52
1.63%
9
$2,857.49
1.32%
118
$1,086.52
1.91%
26
$178.68
0.43%
ANTIEMETIC - ANTICHOLINERGIC / DOPAMINERGIC
00008001901
PHENERGAN
TAB 12.5MG
00008002702
PHENERGAN
TAB 25MG
2
$27.40
0.03%
3
$40.20
0.05%
00008006301
PHENERGAN
INJ 25MG/ML
1
$70.76
0.02%
1
$8.62
0.02%
00008021201
PHENERGAN
SUP 25MG
283
$16,153.23
4.57%
285
$17,403.89
4.67%
00008022901
PHENERGAN
SUP 50MG
8
$587.98
0.13%
2
$115.90
0.03%
00008049801
PHENERGAN
SUP 12.5MG
105
$4,156.14
1.70%
58
$2,410.71
0.95%
00009364804
DRAMAMINE
TAB 25MG
0
$0.00
0.00%
1
$3.69
0.02%
00054474825
TORECAN
1
$41.21
0.02%
0
$0.00
0.00%
00067434504
TRANSDERM-SC DIS 1.5MG
176
$5,224.90
2.84%
141
$4,134.81
2.31%
00067434624
5
$244.68
0.08%
1
$29.86
0.02%
00074231231
PROMETHAZINE INJ 25MG/ML
0
$0.00
0.00%
1
$28.00
0.02%
00182709911
PROMETHAZINE SUP 12.5MG
0
$0.00
0.00%
1
$43.19
0.02%
00364022201
PROMETHAZINE TAB 25MG
3
$8.74
0.05%
0
$0.00
0.00%
00364022202
2
$2.68
0.03%
0
$0.00
0.00%
00472009612
PROMETHAZINE SUP 25MG
44
$2,154.56
0.71%
66
$3,369.32
1.08%
00472150404
PROMETHAZINE SYP 6.25/5ML
2
$14.37
0.03%
0
$0.00
0.00%
00536398501
MECLIZINE
1
$2.27
0.02%
2
$7.04
0.03%
TAB 10MG
TAB 12.5MG
Page 96 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00574723412
PHENADOZ
SUP 25MG
00574723612
PHENADOZ
SUP 12.5MG
00591080301
MECLIZINE
00591080310
MECLIZINE
00591530701
00591530710
$
Market Share*
00574083625
# of Scripts
6
$278.51
0.10%
9
$745.33
0.15%
24
$1,092.36
0.39%
18
$904.50
0.29%
2
$115.11
0.03%
20
$689.52
0.33%
TAB 25MG
1
$3.00
0.02%
6
$26.82
0.10%
TAB 25MG
0
$0.00
0.00%
172
$672.96
2.82%
1,185
$17,530.74
19.15%
1,033
$15,513.94
16.93%
424
$6,546.81
6.85%
200
$3,468.84
3.28%
00591531901
4
$51.00
0.06%
5
$64.26
0.08%
00641092825
3
$123.69
0.05%
5
$172.92
0.08%
00641092925
2
$330.24
0.03%
2
$528.70
0.03%
00641094935
2
$134.62
0.03%
3
$205.68
0.05%
00641149535
74
$1,717.35
1.20%
66
$1,896.01
1.08%
00641149635
2
$11.92
0.03%
5
$205.70
0.08%
00713013212
PROMETHEGAN SUP 50MG
6
$466.09
0.10%
2
$57.14
0.03%
00713052612
PROMETHEGAN SUP 25MG
195
$7,615.08
3.15%
58
$1,618.45
0.95%
00713053612
PROMETHEGAN SUP 12.5MG
31
$667.80
0.50%
23
$536.01
0.38%
00781134501
MECLIZINE
TAB 12.5MG
5
$13.24
0.08%
0
$0.00
0.00%
00781134510
MECLIZINE
TAB 12.5MG
2
$10.34
0.03%
3
$24.12
0.05%
00781137501
MECLIZINE
TAB 25MG
8
$62.00
0.13%
6
$23.22
0.10%
00781137510
MECLIZINE
TAB 25MG
4
$24.90
0.06%
0
$0.00
0.00%
00781154201
MECLIZINE
TAB 12.5MG
148
$763.41
2.39%
131
$619.06
2.15%
00781154210
MECLIZINE
TAB 12.5MG
18
$98.77
0.29%
0
$0.00
0.00%
00781154401
MECLIZINE
TAB 25MG
410
$2,073.67
6.62%
398
$1,501.51
6.52%
00781154410
MECLIZINE
TAB 25MG
2
$9.58
0.03%
1
$9.45
0.02%
00781183001
684
$10,081.62
11.05%
559
$8,017.91
9.16%
00781183010
146
$2,953.13
2.36%
26
$606.07
0.43%
00781183201
4
$30.60
0.06%
0
$0.00
0.00%
Page 97 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00904129012
1
$45.40
0.02%
0
$0.00
0.00%
10019055302
0
$0.00
0.00%
71
$3,647.09
1.16%
10267269104
MECLIZINE
0
$0.00
0.00%
6
$44.23
0.10%
45802075830
8
$174.68
0.13%
54
$1,596.61
0.88%
45802075930
24
$1,428.79
0.39%
261
$13,667.13
4.28%
49884003401
MECLIZINE
TAB 12.5MG
104
$528.19
1.68%
90
$406.62
1.47%
49884003410
MECLIZINE
TAB 12.5MG
305
$1,590.75
4.93%
322
$1,695.38
5.28%
49884003501
MECLIZINE
TAB 25MG
205
$1,082.80
3.31%
214
$1,069.24
3.51%
49884003510
MECLIZINE
TAB 25MG
948
$5,310.80
15.32%
730
$3,375.38
11.96%
52152011702
MECLIZINE
CHW 25MG
7
$27.11
0.11%
0
$0.00
0.00%
52152018502
TRIMETHOBENZ CAP 300MG
2
$36.97
0.03%
5
$181.64
0.08%
52544080310
MECLIZINE
0
$0.00
0.00%
1
$1.15
0.02%
53265040610
0
$0.00
0.00%
537
$7,928.93
8.80%
53265040611
0
$0.00
0.00%
281
$4,592.31
4.61%
53265040710
0
$0.00
0.00%
2
$45.00
0.03%
53265076212
89
$2,539.85
1.44%
28
$714.68
0.46%
53265076312
239
$11,007.78
3.86%
63
$2,610.84
1.03%
53265076412
4
$194.57
0.06%
6
$549.77
0.10%
53489037601
TRIMETHOBENZ CAP 300MG
1
$27.32
0.02%
2
$36.98
0.03%
59911587101
PROMETHAZINE TAB 12.5MG
1
$6.57
0.02%
0
$0.00
0.00%
60432060804
25
$210.68
0.40%
16
$186.96
0.26%
60432060816
69
$478.60
1.11%
70
$592.97
1.15%
61570007901
TIGAN
CAP 300MG
6
$195.18
0.10%
1
$20.00
0.02%
61570018701
TIGAN
CAP 250MG
1
$23.63
0.02%
0
$0.00
0.00%
61570050310
TIGAN
SUP 100MG
3
$116.52
0.05%
0
$0.00
0.00%
61570050410
TIGAN
SUP 200MG
3
$78.03
0.05%
0
$0.00
0.00%
61570054002
TIGAN
INJ 100MG/ML
1
$24.79
0.02%
2
$40.95
0.03%
TAB 25MG
TAB 25MG
Page 98 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
TIGAN
INJ 100MG/ML
$
Market Share*
61570054120
# of Scripts
0
$0.00
0.00%
1
$51.73
0.02%
4
$3,382.10
0.08%
4
$6,206.37
0.08%
ANTIFUNGALS - ASSORTED
00049318030
VFEND
TAB 200MG
00049341030
DIFLUCAN
TAB 50MG
13
$360.39
0.26%
0
$0.00
0.00%
00049342030
DIFLUCAN
TAB 100MG
498
$44,122.83
10.13%
18
$851.04
0.37%
00049343030
DIFLUCAN
TAB 200MG
224
$26,298.25
4.56%
10
$298.05
0.21%
00049343526
DIFLUCAN/
INJ NACL 200
2
$1,864.04
0.04%
0
$0.00
0.00%
00049343626
DIFLUCAN/
INJ NACL 400
5
$1,783.48
0.10%
0
$0.00
0.00%
00049344019
DIFLUCAN
SUS 10MG/ML
90
$3,584.87
1.83%
9
$314.10
0.19%
00049345019
DIFLUCAN
SUS 40MG/ML
39
$5,459.07
0.79%
9
$1,051.27
0.19%
00049350079
DIFLUCAN
TAB 150MG
3,578
$70,193.28
72.81%
26
$800.69
0.54%
00054000285
FLUCONAZOLE SUS 10MG/ML
0
$0.00
0.00%
4
$177.64
0.08%
00054000385
0
$0.00
0.00%
14
$1,278.37
0.29%
00054428813
FLUCONAZOLE TAB 100MG
0
$0.00
0.00%
2
$19.20
0.04%
00054828906
0
$0.00
0.00%
13
$64.15
0.27%
00062020604
GRIFULVIN V SUS 125/5ML
30
$2,679.70
0.61%
23
$2,252.50
0.48%
00062021460
GRIFULVIN V TAB MICR 500
41
$2,544.25
0.83%
53
$3,299.16
1.10%
00078017905
LAMISIL
TAB 250MG
7
$1,591.58
0.14%
19
$4,341.44
0.39%
00078017915
LAMISIL
TAB 250MG
144
$33,604.23
2.93%
147
$31,335.90
3.04%
00085049603
FULVICIN U/F TAB MICR 500
0
$0.00
0.00%
1
$42.25
0.02%
00093023756
0
$0.00
0.00%
5
$46.42
0.10%
00093090001
KETOCONAZOLE TAB 200MG
76
$724.05
1.55%
90
$688.70
1.86%
00093098301
NYSTATIN
10
$480.41
0.20%
11
$644.45
0.23%
00093720356
0
$0.00
0.00%
165
$2,590.39
3.41%
00093720422
0
$0.00
0.00%
1,370
$5,838.49
28.34%
00093720556
0
$0.00
0.00%
97
$2,076.72
2.01%
TAB 500000
Page 99 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00172541060
0
$0.00
0.00%
00172541146
0
$0.00
0.00%
00172541160
0
$0.00
0.00%
00172541211
0
$0.00
0.00%
00172541360
0
$0.00
00378026101
2
00378251693
0
00555077201
00574040405
NYSTATIN
00574040415
NYSTATIN
00677170001
00677170007
$17.16
0.02%
2
$24.20
0.04%
52
$730.19
1.08%
109
$784.51
2.25%
0.00%
7
$145.95
0.14%
$16.80
0.04%
8
$127.95
0.17%
$0.00
0.00%
1
$14.60
0.02%
0
$0.00
0.00%
1
$27.10
0.02%
POW
3
$86.38
0.06%
4
$116.86
0.08%
POW
0
$0.00
0.00%
1
$71.44
0.02%
4
$28.25
0.08%
5
$60.15
0.10%
0
$0.00
0.00%
1
$15.95
0.02%
00781192106
0
$0.00
0.00%
200
$739.64
4.14%
00781192931
0
$0.00
0.00%
36
$722.71
0.74%
00781193131
0
$0.00
0.00%
13
$236.05
0.27%
00884076304
GRIS-PEG
TAB 125MG
2
$76.34
0.04%
2
$132.72
0.04%
00884077304
GRIS-PEG
TAB 250MG
16
$815.43
0.33%
26
$2,204.87
0.54%
00884077350
GRIS-PEG
TAB 250MG
3
$120.94
0.06%
0
$0.00
0.00%
17314940002
MYCELEX
TRO 10MG
3
$208.47
0.06%
1
$113.72
0.02%
49884093911
0
$0.00
0.00%
1
$15.85
0.02%
49884094099
0
$0.00
0.00%
18
$69.60
0.37%
50111062101
4
$23.00
0.08%
5
$30.15
0.10%
50458029001
SPORANOX
CAP 100MG
0
$0.00
0.00%
1
$230.35
0.02%
50458029004
SPORANOX
CAP 100MG
39
$10,928.90
0.79%
19
$3,686.85
0.39%
50458029028
SPORANOX
CAP PULSEPAK
7
$1,564.72
0.14%
6
$1,481.22
0.12%
50458029515
SPORANOX
SOL 10MG/ML
8
$772.56
0.16%
3
$298.15
0.06%
51672402601
25
$161.50
0.51%
16
$155.65
0.33%
1
Page 100 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
51672402606
12
$93.05
0.24%
5
51672406506
0
$0.00
0.00%
51672406607
0
$0.00
0.00%
53489040001
NYSTATIN
2
$131.78
53489055401
2
53489055407
55111014571
55370055807
$46.35
0.10%
1
$4.60
0.02%
1
$26.75
0.02%
0.04%
4
$953.41
0.08%
$31.20
0.04%
13
$110.90
0.27%
17
$173.80
0.35%
22
$172.90
0.46%
0
$0.00
0.00%
22
$83.97
0.46%
2
$6.20
0.04%
0
$0.00
0.00%
59762501501
0
$0.00
0.00%
1
$10.54
0.02%
59762501601
0
$0.00
0.00%
197
$3,461.99
4.08%
59762501701
0
$0.00
0.00%
1,053
$4,340.02
21.78%
59762501801
0
$0.00
0.00%
46
$876.78
0.95%
59762502901
0
$0.00
0.00%
42
$1,651.07
0.87%
59762503001
0
$0.00
0.00%
6
$698.88
0.12%
60505009200
2
$14.30
0.04%
2
$11.35
0.04%
60505012103
0
$0.00
0.00%
3
$8.10
0.06%
63304080330
0
$0.00
0.00%
1
$34.78
0.02%
63304080401
0
$0.00
0.00%
8
$95.25
0.17%
63304080430
0
$0.00
0.00%
51
$1,263.17
1.06%
63304080512
0
$0.00
0.00%
669
$2,997.93
13.84%
63304080601
0
$0.00
0.00%
5
$57.47
0.10%
63304080630
0
$0.00
0.00%
22
$401.17
0.46%
63304097505
0
$0.00
0.00%
16
$707.31
0.33%
63304097605
0
$0.00
0.00%
12
$977.84
0.25%
67253050010
0
$0.00
0.00%
3
$28.65
0.06%
TAB 500000
ANTIHEMOPHILIC AGENTS
Page 101 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
HUMATE-P
INJ 1000UNIT
00053813001
HELIXATE FS SOL 250UNIT
00053813002
00053813004
$
Market Share*
ANTIHEMOPHILIC AGENTS
00053762010
# of Scripts
1
$3,197.25
0.70%
0
$0.00
0.00%
1
$2,368.74
0.70%
3
$16,925.14
2.10%
2
$9,425.33
3.08%
2
$18,062.54
3.08%
6
$55,231.23
4.20%
6
$169,977.44
9.23%
00169706001
NOVOSEVEN INJ 1200MCG
4
$55,994.67
2.80%
14
$151,727.20
21.54%
00169706101
NOVOSEVEN INJ 2400MCG
00944293801
RECOMBINATE INJ 220-400
25
$145,325.03
17.48%
6
$270,682.50
9.23%
2
$10,799.86
1.40%
2
$2,957.60
3.08%
00944293802
5
$28,085.15
3.50%
1
$4,226.35
1.54%
00944293803
49
$689,331.93
34.27%
10
$572,770.77
15.38%
00944294001
ADVATE
KIT 250UNIT
5
$33,472.95
3.50%
0
$0.00
0.00%
58394000101
BENEFIX
INJ 1000UNIT
37
$262,071.01
25.87%
18
$368,509.00
27.69%
58394000201
BENEFIX
INJ 500UNIT
5
$9,426.67
3.50%
4
$6,511.44
6.15%
ANTIHISTAMINES - NON-SEDATING
00043011530
TAVIST ND
TAB 10MG
0
$0.00
0.00%
32
$465.03
0.20%
00067606310
TAVIST ND
TAB 10MG
0
$0.00
0.00%
2
$29.04
0.01%
00067606330
TAVIST ND
TAB 10MG
875
$16,344.26
5.77%
582
$8,990.03
3.72%
00069144003
ZYRTEC
CHW 5MG
0
$0.00
0.00%
30
$929.31
0.19%
00069145003
ZYRTEC
CHW 10MG
0
$0.00
0.00%
52
$2,200.66
0.33%
00069550066
ZYRTEC
TAB 5MG
115
$6,679.54
0.76%
89
$4,640.46
0.57%
00069551066
ZYRTEC
TAB 10MG
1,711
$83,188.99
11.27%
1,645
$78,010.66
10.53%
00069553047
ZYRTEC
SYP 5MG/5ML
685
$22,364.40
4.51%
630
$19,627.50
4.03%
00069553093
ZYRTEC
SYP 5MG/5ML
397
$13,799.53
2.62%
443
$16,487.54
2.83%
00085045803
CLARITIN
TAB 10MG
57
$4,456.37
0.38%
1
$11.83
0.01%
00085045805
CLARITIN
TAB 10MG
5
$433.10
0.03%
0
$0.00
0.00%
00085045806
CLARITIN
TAB 10MG
8
$729.78
0.05%
0
$0.00
0.00%
00085112802
CLARITIN
TAB REDITAB
36
$2,100.19
0.24%
0
$0.00
0.00%
Page 102 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
CLARITIN
00085126401
CLARINEX
00085126402
CLARINEX
00085126403
SYP 10/10ML
$
Market Share*
00085122301
# of Scripts
42
$2,354.33
0.28%
0
$0.00
0.00%
TAB 5MG
1,062
$62,282.23
7.00%
988
$60,750.80
6.32%
TAB 5MG
4
$258.78
0.03%
0
$0.00
0.00%
CLARINEX
TAB 5MG
3
$192.18
0.02%
0
$0.00
0.00%
00085126404
CLARINEX
TAB 5MG
3
$199.68
0.02%
13
$761.17
0.08%
00085128001
CLARINEX
TAB REDITABS
5
$328.63
0.03%
1
$76.40
0.01%
00088110247
ALLEGRA
CAP 60MG
1
$62.63
0.01%
0
$0.00
0.00%
00088110647
ALLEGRA
TAB 30MG
77
$2,825.08
0.51%
50
$1,642.93
0.32%
00088110747
ALLEGRA
TAB 60MG
403
$24,118.48
2.66%
320
$19,291.32
2.05%
00088110749
ALLEGRA
TAB 60MG
1
$52.43
0.01%
0
$0.00
0.00%
00088110755
ALLEGRA
TAB 60MG
31
$1,617.36
0.20%
30
$1,440.34
0.19%
00088110947
ALLEGRA
TAB 180MG
693
$39,082.08
4.57%
648
$35,036.66
4.15%
00113027565
LORATADINE TAB 10MG
0
$0.00
0.00%
2
$7.90
0.01%
00573262006
ALAVERT
TAB NON-DROW
0
$0.00
0.00%
11
$185.87
0.07%
00573262012
ALAVERT
TAB NON-DROW
1
$38.15
0.01%
30
$468.14
0.19%
00573262024
ALAVERT
TAB NON-DROW
3
$62.83
0.02%
34
$516.48
0.22%
00573262048
ALAVERT
TAB NON-DROW
7,142
$127,626.36
47.06%
6,682
$110,160.47
42.76%
00573264515
ALAVERT
TAB 10MG
0
$0.00
0.00%
93
$1,836.25
0.60%
00573264530
ALAVERT
TAB 10MG
1,016
$17,874.89
6.69%
1,495
$22,005.40
9.57%
00781507701
LORATADINE TAB 10MG
0
$0.00
0.00%
537
$7,906.08
3.44%
11523715701
CLARITIN
TAB REDITABS
0
$0.00
0.00%
2
$77.98
0.01%
11523716001
CLARITIN
TAB 10MG
0
$0.00
0.00%
3
$90.58
0.02%
11523716002
CLARITIN
TAB 10MG
1
$29.95
0.01%
0
$0.00
0.00%
11523716003
CLARITIN
TAB 10MG
278
$6,716.60
1.83%
317
$7,894.17
2.03%
11523716005
CLARITIN
TAB 10MG
0
$0.00
0.00%
2
$37.58
0.01%
11523716301
CLARITIN
SYP 5MG/5ML
520
$7,310.45
3.43%
415
$5,705.23
2.66%
11822033150
LORATADINE TAB 10MG
0
$0.00
0.00%
2
$18.12
0.01%
Page 103 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
11822312780
LORATADINE TAB 10MG
0
$0.00
0.00%
1
$12.48
0.01%
11822315230
LORATADINE TAB 10MG
0
$0.00
0.00%
1
$19.99
0.01%
11822320150
LORATADINE TAB 10MG
0
$0.00
0.00%
2
$27.98
0.01%
11822331520
LORATADINE TAB 10MG
0
$0.00
0.00%
1
$13.99
0.01%
37205034652
LORATADINE TAB 10MG
0
$0.00
0.00%
18
$180.10
0.12%
37205034660
LORATADINE TAB 10MG
0
$0.00
0.00%
44
$560.79
0.28%
37205034665
LORATADINE TAB 10MG
0
$0.00
0.00%
266
$2,360.74
1.70%
37205034672
LORATADINE TAB 10MG
0
$0.00
0.00%
71
$616.39
0.45%
37205038153
ALLERGY RELF TAB QUICK DL
0
$0.00
0.00%
14
$208.28
0.09%
37205038752
ALLERGY RELF TAB REDI-TAB
0
$0.00
0.00%
18
$256.10
0.12%
49348054244
LORATADINE TAB 10MG
1
$13.78
0.01%
0
$0.00
0.00%
50428232642
LORATADINE TAB 10MG
0
$0.00
0.00%
3
$32.08
0.02%
50428258877
ALLERGY RELF TAB 10MG
0
$0.00
0.00%
4
$39.66
0.03%
51079013220
LORATADINE TAB 10MG
0
$0.00
0.00%
3
$47.85
0.02%
1
$27.01
100.00%
0
$0.00
0.00%
ANTIHYPERTENSIVE COMBOS
62794000101
CLORPRES
TAB 0.1-15MG
ANTIHYPERTENSIVES - CENTRAL
00005318023
CLONIDINE
TAB 0.1MG
2
$16.60
0.02%
0
$0.00
0.00%
00005318034
CLONIDINE
TAB 0.1MG
20
$143.90
0.21%
0
$0.00
0.00%
00005318123
CLONIDINE
TAB 0.2MG
17
$142.69
0.18%
0
$0.00
0.00%
00005318134
CLONIDINE
TAB 0.2MG
10
$74.00
0.10%
0
$0.00
0.00%
00005318223
CLONIDINE
TAB 0.3MG
2
$21.14
0.02%
0
$0.00
0.00%
00031890163
TENEX
TAB 1MG
12
$1,332.69
0.13%
0
$0.00
0.00%
00031890363
TENEX
TAB 2MG
2
$506.58
0.02%
0
$0.00
0.00%
00172293160
METHYLDOPA TAB 250MG
82
$1,624.70
0.86%
59
$1,092.53
0.60%
Page 104 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00172293180
5
$58.32
0.05%
2
$57.51
0.02%
00172293260
23
$637.43
0.24%
25
$915.97
0.25%
00172293270
9
$156.90
0.09%
7
$225.23
0.07%
00172406760
PRAZOSIN HCL CAP 1MG
53
$393.40
0.55%
43
$368.00
0.44%
00172406860
16
$340.11
0.17%
48
$867.10
0.49%
00172406880
2
$82.30
0.02%
0
$0.00
0.00%
00172406960
16
$451.82
0.17%
12
$338.70
0.12%
00172422660
GUANABENZ
3
$52.22
0.03%
0
$0.00
0.00%
00182055489
HYDRALAZINE TAB 25MG
2
$21.92
0.02%
0
$0.00
0.00%
00185003201
RESERPINE
TAB 0.1MG
18
$157.78
0.19%
16
$141.25
0.16%
00185013401
RESERPINE
TAB 0.25MG
21
$431.46
0.22%
17
$398.71
0.17%
00185013410
RESERPINE
TAB 0.25MG
0
$0.00
0.00%
2
$19.00
0.02%
00228212710
CLONIDINE
TAB 0.1MG
516
$3,188.08
5.38%
689
$4,160.87
7.01%
00228212750
CLONIDINE
TAB 0.1MG
1,887
$12,085.92
19.69%
2,047
$12,863.40
20.84%
00228212810
CLONIDINE
TAB 0.2MG
171
$1,429.35
1.78%
156
$1,368.28
1.59%
00228212850
CLONIDINE
TAB 0.2MG
385
$3,540.82
4.02%
414
$3,535.06
4.22%
00228212910
CLONIDINE
TAB 0.3MG
155
$1,353.03
1.62%
187
$1,620.15
1.90%
00364217201
MINOXIDIL
TAB 2.5MG
0
$0.00
0.00%
2
$15.50
0.02%
00364217301
MINOXIDIL
TAB 10MG
3
$25.95
0.03%
3
$54.35
0.03%
00378015201
CLONIDINE
TAB 0.1MG
1,408
$9,085.57
14.69%
1,278
$8,199.61
13.01%
00378015210
CLONIDINE
TAB 0.1MG
1,685
$10,994.76
17.58%
1,679
$10,657.93
17.09%
00378018601
CLONIDINE
TAB 0.2MG
448
$4,041.46
4.67%
454
$4,274.78
4.62%
00378018610
CLONIDINE
TAB 0.2MG
105
$862.95
1.10%
140
$1,119.83
1.43%
00378019901
CLONIDINE
TAB 0.3MG
132
$1,196.85
1.38%
138
$1,291.38
1.41%
00378042101
38
$1,220.48
0.40%
29
$818.52
0.30%
00378042105
0
$0.00
0.00%
1
$36.50
0.01%
00378061101
38
$729.75
0.40%
47
$725.19
0.48%
TAB 4MG
Page 105 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00378110101
00378116001
GUANFACINE TAB 1MG
00378119001
GUANFACINE TAB 2MG
00378230201
$
Market Share*
00378061110
# of Scripts
$221.57
0.09%
$42.87
0.02%
38
$269.33
0.40%
351
$4,177.12
3.66%
34
$233.11
0.35%
623
$6,831.31
6.34%
48
$975.90
0.50%
46
$923.45
0.47%
45
$603.90
0.47%
23
$352.53
0.23%
00378320501
9
00378320525
5
$227.01
0.09%
13
$381.35
0.13%
$75.65
0.05%
1
$21.25
0.01%
00591044401
GUANFACINE TAB 1MG
358
$3,817.98
3.74%
167
$1,896.58
1.70%
00591045301
GUANFACINE TAB 2MG
31
$639.10
0.32%
22
$482.03
0.22%
00591564201
MINOXIDIL
00591564205
MINOXIDIL
TAB 2.5MG
8
$253.56
0.08%
10
$290.60
0.10%
TAB 2.5MG
4
$122.42
0.04%
0
$0.00
0.00%
00591564301
MINOXIDIL
TAB 10MG
11
$179.47
0.11%
2
$65.64
0.02%
00597000601
CATAPRES
TAB 0.1MG
17
$1,069.21
0.18%
9
$445.41
0.09%
00597000701
CATAPRES
TAB 0.2MG
0
$0.00
0.00%
3
$124.86
0.03%
00597001101
CATAPRES
TAB 0.3MG
1
$50.37
0.01%
1
$51.37
0.01%
00597003112
CATAPRES-TTS DIS 0.1/24HR
262
$12,447.18
2.73%
217
$10,706.14
2.21%
00597003212
178
$15,341.58
1.86%
209
$18,429.96
2.13%
00597003334
224
$27,284.55
2.34%
221
$27,983.96
2.25%
00603377421
GUANFACINE TAB 1MG
1
$12.95
0.01%
0
$0.00
0.00%
00603383121
2
$2.00
0.02%
0
$0.00
0.00%
00904557960
GUANFACINE TAB 1MG
29
$319.55
0.30%
11
$104.05
0.11%
49884002701
5
$35.30
0.05%
3
$14.70
0.03%
49884002710
3
$22.38
0.03%
0
$0.00
0.00%
49884002801
7
$50.68
0.07%
0
$0.00
0.00%
49884002901
13
$94.78
0.14%
25
$124.99
0.25%
49884012101
5
$48.73
0.05%
1
$8.94
0.01%
49884025601
MINOXIDIL
35
$844.63
0.37%
21
$464.85
0.21%
TAB 2.5MG
9
2
Page 106 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
MINOXIDIL
49884057201
49884057301
50111032701
TAB 10MG
$
Market Share*
49884025701
# of Scripts
13
$411.05
0.14%
13
$491.13
0.13%
GUANFACINE TAB 1MG
19
$179.86
0.20%
23
$198.38
0.23%
GUANFACINE TAB 2MG
2
$36.85
0.02%
0
$0.00
0.00%
102
$665.85
1.06%
92
$549.50
0.94%
50111032703
55
$354.14
0.57%
104
$584.08
1.06%
50111032801
115
$860.87
1.20%
108
$799.30
1.10%
50111032803
49
$367.08
0.51%
51
$377.46
0.52%
50111039701
31
$337.33
0.32%
37
$372.44
0.38%
50111039801
77
$469.52
0.80%
69
$442.15
0.70%
50111039803
64
$421.29
0.67%
64
$388.05
0.65%
51079063220
0
$0.00
0.00%
1
$23.75
0.01%
52152011802
GUANFACINE TAB 1MG
30
$366.60
0.31%
46
$526.71
0.47%
52152011902
GUANFACINE TAB 2MG
4
$168.40
0.04%
5
$132.25
0.05%
52544044401
GUANFACINE TAB 1MG
20
$133.20
0.21%
14
$97.48
0.14%
53489038601
MINOXIDIL
TAB 2.5MG
5
$100.85
0.05%
18
$369.70
0.18%
53489038701
MINOXIDIL
TAB 10MG
12
$467.18
0.13%
12
$363.70
0.12%
67286890101
TENEX
TAB 1MG
0
$0.00
0.00%
4
$405.67
0.04%
67286890301
TENEX
TAB 2MG
0
$0.00
0.00%
2
$575.63
0.02%
$401.05
10.00%
0
$0.00
0.00%
ANTILEPROTIC
59572010511
THALOMID
CAP 50MG
1
59572010592
THALOMID
CAP 50MG
1
$797.77
10.00%
0
$0.00
0.00%
59572010593
THALOMID
CAP 50MG
3
$1,762.82
30.00%
3
$2,559.57
20.00%
59572021015
THALOMID
CAP 100MG
1
$2,005.33
10.00%
0
$0.00
0.00%
59572021095
THALOMID
CAP 100MG
4
$2,607.60
40.00%
7
$16,505.37
46.67%
59572022016
THALOMID
CAP 200MG
0
$0.00
0.00%
3
$8,908.51
20.00%
59572022096
THALOMID
CAP 200MG
0
$0.00
0.00%
2
$6,745.62
13.33%
Page 107 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIMALARIAL AGENTS
00004017202
LARIAM
00024156210
PLAQUENIL
00093977401
TAB 250MG
3
$271.21
0.09%
0
$0.00
0.00%
38
$3,177.87
1.18%
20
$1,842.90
0.62%
HYDROXYCHLOR TAB 200MG
10
$245.55
0.31%
13
$413.05
0.40%
00093977405
12
$337.04
0.37%
0
$0.00
0.00%
00143212522
CHLOROQUINE TAB 500MG
5
$265.43
0.15%
9
$322.77
0.28%
00172300160
QUININE SULF TAB 260MG
175
$4,600.53
5.41%
194
$4,924.34
6.04%
00172300170
54
$990.46
1.67%
18
$491.01
0.56%
00172417160
QUININE SULF CAP 200MG
47
$985.23
1.45%
74
$1,443.92
2.30%
00172417260
50
$1,465.62
1.55%
31
$682.70
0.96%
00172417280
3
$32.40
0.09%
4
$82.93
0.12%
00173020155
DARAPRIM
10
$294.38
0.31%
13
$274.87
0.40%
00173067501
MALARONE
TAB 250-100
7
$1,575.16
0.22%
9
$1,609.51
0.28%
00173067502
MALARONE
TAB 250-100
2
$297.50
0.06%
1
$645.95
0.03%
00173067601
MALARONE
TAB 62.5/25
0
$0.00
0.00%
2
$92.44
0.06%
00378037301
162
$4,188.96
5.01%
201
$5,670.58
6.25%
00591069801
136
$3,505.53
4.21%
158
$4,654.56
4.92%
00591069805
54
$1,155.78
1.67%
61
$1,676.78
1.90%
00591071501
109
$2,853.17
3.37%
149
$4,288.66
4.64%
00591071505
73
$1,930.46
2.26%
97
$2,376.72
3.02%
00591071510
9
$356.85
0.28%
12
$365.28
0.37%
00591071601
225
$5,706.57
6.96%
241
$5,991.17
7.50%
00591071610
54
$1,543.77
1.67%
14
$477.40
0.44%
00603561821
131
$2,427.77
4.05%
155
$3,578.13
4.82%
00603561828
22
$509.70
0.68%
11
$465.76
0.34%
00603561832
6
$169.06
0.19%
52
$1,639.42
1.62%
00603562121
QUININE SULF CAP 5GR
8
$259.99
0.25%
0
$0.00
0.00%
TAB 200MG
TAB 25MG
Page 108 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
00603562228
00603562232
00677164701
00677164705
00677164707
00677164710
00781140701
00781140705
00781507686
00904056460
$
Market Share*
ANTIMALARIAL AGENTS
00603562221
# of Scripts
$8,374.22
11.81%
611
$14,566.83
19.01%
3
$112.05
0.09%
11
$208.64
0.34%
37
$1,036.82
1.14%
23
$604.20
0.72%
10
$331.05
0.31%
50
$1,482.87
1.56%
10
$200.00
0.31%
33
$863.19
1.03%
2
$89.30
0.06%
1
$22.75
0.03%
13
$494.87
0.40%
3
$136.45
0.09%
485
$12,023.77
15.00%
365
$10,990.71
11.36%
1
$21.25
0.03%
4
$109.10
0.12%
MEFLOQUINE TAB 250MG
7
$672.57
0.22%
8
$712.76
0.25%
20
$486.94
0.62%
10
$275.49
0.31%
00904539880
0
$0.00
0.00%
2
$9.85
0.06%
00904564860
3
$18.47
0.09%
19
$454.47
0.59%
10267023101
6
$72.32
0.19%
1
$20.00
0.03%
10267023104
17
$249.86
0.53%
1
$44.65
0.03%
10267023105
0
$0.00
0.00%
3
$92.65
0.09%
52544069801
5
$146.20
0.15%
3
$82.45
0.09%
52544071501
2
$50.54
0.06%
0
$0.00
0.00%
52544071505
2
$43.16
0.06%
5
$190.33
0.16%
52544071601
20
$489.82
0.62%
2
$50.50
0.06%
52544071610
9
$107.20
0.28%
8
$96.40
0.25%
53489022101
149
$2,925.55
4.61%
83
$1,831.89
2.58%
53489022105
37
$682.17
1.14%
30
$683.49
0.93%
53489022110
110
$2,554.00
3.40%
55
$1,105.50
1.71%
53489046207
0
$0.00
0.00%
10
$211.30
0.31%
62584074000
8
$131.26
0.25%
5
$134.77
0.16%
64125012001
228
$6,230.72
7.05%
148
$4,123.62
4.60%
382
Page 109 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIMALARIAL AGENTS
64125012010
81
$2,520.79
2.50%
47
$1,452.99
1.46%
64125012101
152
$4,206.84
4.70%
84
$2,810.02
2.61%
64125012105
30
$725.71
0.93%
50
$1,299.55
1.56%
2
$183.07
1.63%
8
$2,652.54
4.73%
2
$160.01
1.63%
0
$0.00
0.00%
ANTIMYCOBACTERIALS / ANTITUBERCULOSIS
00013530117
MYCOBUTIN
CAP 150MG
00068050861
RIFADIN
00143126101
ISONIAZID TAB 300MG
3
$18.06
2.44%
1
$5.49
0.59%
00143126110
ISONIAZID TAB 300MG
0
$0.00
0.00%
1
$3.44
0.59%
00185079901
RIFAMPIN
CAP 300MG
19
$1,010.24
15.45%
21
$1,305.93
12.43%
00185079905
RIFAMPIN
CAP 300MG
1
$31.63
0.81%
0
$0.00
0.00%
00185079930
RIFAMPIN
CAP 300MG
22
$1,258.07
17.89%
24
$1,440.78
14.20%
00185079960
RIFAMPIN
CAP 300MG
8
$733.24
6.50%
6
$604.70
3.55%
00185080101
RIFAMPIN
CAP 150MG
2
$39.41
1.63%
3
$153.37
1.78%
00185080130
RIFAMPIN
CAP 150MG
0
$0.00
0.00%
3
$104.38
1.78%
00185435001
ISONIAZID TAB 300MG
7
$33.94
5.69%
26
$129.33
15.38%
00555007102
ISONIAZID TAB 300MG
22
$96.29
17.89%
36
$134.88
21.30%
00555092302
ETHAMBUTOL TAB 400MG
10
$963.60
8.13%
14
$2,308.17
8.28%
00781201801
RIMACTANE
2
$33.60
1.63%
0
$0.00
0.00%
00781207701
RIFAMPIN
CAP 300MG
1
$26.90
0.81%
0
$0.00
0.00%
00781207731
RIFAMPIN
CAP 300MG
9
$383.22
7.32%
19
$1,468.85
11.24%
17236018230
ISONIAZID TAB 300MG
4
$23.55
3.25%
1
$10.87
0.59%
46287000901
ISONIAZID SYP 50MG/5ML
0
$0.00
0.00%
1
$32.50
0.59%
51479004701
MYAMBUTOL
TAB 400MG
4
$852.27
3.25%
2
$463.34
1.18%
61748001101
1
$22.48
0.81%
0
$0.00
0.00%
61748001201
PYRAZINAMIDE TAB 500MG
0
$0.00
0.00%
1
$87.48
0.59%
61748001206
PYRAZINAMIDE TAB 500MG
0
$0.00
0.00%
1
$30.02
0.59%
CAP 300MG
CAP 300MG
Page 110 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIMYCOBACTERIALS / ANTITUBERCULOSIS
61748001401
3
$343.32
2.44%
0
61748001801
RIFAMPIN
CAP 300MG
1
$64.87
0.81%
61748001830
RIFAMPIN
CAP 300MG
0
$0.00
0.00%
$0.00
0.00%
0
$0.00
0.00%
1
$39.25
0.59%
ANTIPSYCHOTICS - ATYPICALS
00002411204
ZYPREXA
TAB 2.5MG
225
$28,309.07
0.54%
254
$35,188.03
0.55%
00002411233
ZYPREXA
TAB 2.5MG
6
$862.60
0.01%
2
$309.76
0.00%
00002411260
ZYPREXA
TAB 2.5MG
1,373
$174,919.86
3.28%
1,247
$175,669.58
2.68%
00002411504
ZYPREXA
TAB 5MG
213
$33,305.09
0.51%
238
$37,530.48
0.51%
00002411533
ZYPREXA
TAB 5MG
0
$0.00
0.00%
2
$279.67
0.00%
00002411560
ZYPREXA
TAB 5MG
1,970
$325,546.58
4.71%
1,924
$328,034.72
4.13%
00002411633
ZYPREXA
TAB 7.5MG
4
$438.05
0.01%
37
$8,026.78
0.08%
00002411660
ZYPREXA
TAB 7.5MG
489
$99,974.55
1.17%
450
$97,588.60
0.97%
00002411704
ZYPREXA
TAB 10MG
198
$45,955.08
0.47%
146
$39,455.02
0.31%
00002411733
ZYPREXA
TAB 10MG
2
$546.60
0.00%
0
$0.00
0.00%
00002411760
ZYPREXA
TAB 10MG
1,896
$484,986.22
4.53%
1,732
$456,876.34
3.72%
00002441533
ZYPREXA
TAB 15MG
1
$378.18
0.00%
14
$4,865.05
0.03%
00002441560
ZYPREXA
TAB 15MG
1,042
$449,688.46
2.49%
931
$435,769.78
2.00%
00002442033
ZYPREXA
TAB 20MG
17
$7,674.98
0.04%
18
$9,739.51
0.04%
00002442060
ZYPREXA
TAB 20MG
1,532
$824,042.38
3.66%
1,509
$850,110.48
3.24%
00002445301
ZYPREXA ZYDI TAB 5MG
2
$300.97
0.00%
1
$431.75
0.00%
00002445385
94
$16,843.32
0.22%
158
$35,612.94
0.34%
00002445401
1
$285.49
0.00%
1
$218.09
0.00%
00002445485
63
$20,227.67
0.15%
78
$30,780.14
0.17%
00002445501
2
$1,638.48
0.00%
2
$890.64
0.00%
00002445585
22
$8,911.43
0.05%
24
$11,103.67
0.05%
00002445601
2
$1,067.62
0.00%
2
$1,164.50
0.00%
Page 111 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00049392083
GEODON
00049396041
GEODON
00049396060
$
Market Share*
00002445685
# of Scripts
26
$14,169.91
0.06%
36
$24,481.49
0.08%
INJ 20MG
1
$2,287.10
0.00%
CAP 20MG
0
$0.00
0.00%
0
$0.00
0.00%
1
$142.18
0.00%
GEODON
CAP 20MG
386
$78,106.84
0.92%
524
$94,484.51
1.13%
00049397041
GEODON
CAP 40MG
6
$950.96
0.01%
29
$4,629.66
0.06%
00049397060
GEODON
CAP 40MG
00049398041
GEODON
CAP 60MG
458
$88,111.56
1.09%
571
$109,050.80
1.23%
0
$0.00
0.00%
1
$136.65
0.00%
00049398060
GEODON
CAP 60MG
281
$60,125.64
0.67%
445
$98,527.52
0.96%
00049399041
GEODON
CAP 80MG
6
$1,148.58
0.01%
6
$1,086.77
0.01%
00049399060
GEODON
CAP 80MG
443
$93,604.00
1.06%
718
$158,336.94
1.54%
00310027110
SEROQUEL
TAB 100MG
3,677
$531,081.94
8.78%
4,397
$600,193.70
9.44%
00310027139
SEROQUEL
TAB 100MG
8
$945.27
0.02%
9
$949.72
0.02%
00310027210
SEROQUEL
TAB 200MG
2,472
$713,013.16
5.91%
2,955
$821,434.80
6.35%
00310027239
SEROQUEL
TAB 200MG
27
$7,463.90
0.06%
5
$3,138.90
0.01%
00310027439
SEROQUEL
TAB 300MG
70
$18,664.11
0.17%
82
$27,201.92
0.18%
00310027460
SEROQUEL
TAB 300MG
1,197
$306,507.27
2.86%
1,578
$454,334.63
3.39%
00310027510
SEROQUEL
TAB 25MG
4,882
$519,847.81
11.66%
5,935
$666,438.63
12.75%
00310027534
SEROQUEL
TAB 25MG
1
$90.13
0.00%
38
$5,543.36
0.08%
00310027539
SEROQUEL
TAB 25MG
20
$2,295.92
0.05%
4
$328.44
0.01%
50458030001
RISPERDAL
TAB 1MG
13
$719.87
0.03%
396
$36,829.81
0.85%
50458030006
RISPERDAL
TAB 1MG
3,802
$358,455.21
9.08%
3,723
$345,535.80
8.00%
50458030050
RISPERDAL
TAB 1MG
1,010
$88,581.95
2.41%
698
$59,851.23
1.50%
50458030104
RISPERDAL
TAB 0.25MG
820
$65,529.12
1.96%
716
$57,086.59
1.54%
50458030150
RISPERDAL
TAB 0.25MG
258
$19,809.91
0.62%
345
$24,047.36
0.74%
50458030201
RISPERDAL
TAB 0.5MG
0
$0.00
0.00%
3
$71.73
0.01%
50458030206
RISPERDAL
TAB 0.5MG
2,535
$216,710.01
6.06%
2,060
$171,763.03
4.42%
50458030250
RISPERDAL
TAB 0.5MG
753
$60,190.25
1.80%
865
$73,443.45
1.86%
Page 112 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
RISPERDAL
SOL 1MG/ML
50458030611
RISPERDAL
50458030711
RISPERDAL
50458030811
$
Market Share*
50458030503
# of Scripts
843
$135,584.66
2.01%
664
$99,809.32
1.43%
INJ 25MG/2ML
1
$32.07
0.00%
176
$65,010.16
0.38%
INJ 37.5MG/2
0
$0.00
0.00%
94
$50,544.99
0.20%
RISPERDAL
INJ 50MG/2ML
0
$0.00
0.00%
129
$89,200.86
0.28%
50458031528
RISPERDAL
TAB M-TAB 1M
24
$4,333.39
0.06%
36
$5,872.96
0.08%
50458031530
RISPERDAL
TAB M-TAB 1M
8
$863.50
0.02%
44
$7,655.10
0.09%
50458032001
RISPERDAL
TAB 2MG
2
$291.22
0.00%
8
$1,221.04
0.02%
50458032006
RISPERDAL
TAB 2MG
2,934
$420,916.53
7.01%
2,850
$411,920.41
6.12%
50458032050
RISPERDAL
TAB 2MG
489
$70,687.14
1.17%
430
$61,928.73
0.92%
50458032528
RISPERDAL
TAB M-TAB 2M
15
$3,866.03
0.04%
57
$17,078.49
0.12%
50458033001
RISPERDAL
TAB 3MG
0
$0.00
0.00%
9
$1,637.58
0.02%
50458033006
RISPERDAL
TAB 3MG
1,727
$432,200.54
4.13%
1,654
$405,509.70
3.55%
50458033050
RISPERDAL
TAB 3MG
259
$60,449.28
0.62%
271
$65,624.17
0.58%
50458035001
RISPERDAL
TAB 4MG
0
$0.00
0.00%
17
$10,486.29
0.04%
50458035006
RISPERDAL
TAB 4MG
1,801
$495,995.34
4.30%
1,837
$499,598.43
3.95%
50458039528
RISPERDAL
TAB M-TAB0.5
37
$3,824.03
0.09%
57
$6,378.03
0.12%
50458039530
RISPERDAL
TAB M-TAB0.5
7
$879.14
0.02%
21
$2,813.04
0.05%
59148000713
ABILIFY
TAB 5MG
36
$8,347.38
0.09%
451
$97,943.37
0.97%
59148000735
ABILIFY
TAB 5MG
1
$146.57
0.00%
19
$4,802.01
0.04%
59148000813
ABILIFY
TAB 10MG
408
$98,839.30
0.97%
893
$211,017.06
1.92%
59148000835
ABILIFY
TAB 10MG
2
$859.30
0.00%
2
$456.83
0.00%
59148000913
ABILIFY
TAB 15MG
537
$149,169.74
1.28%
928
$239,657.63
1.99%
59148000935
ABILIFY
TAB 15MG
3
$859.29
0.01%
2
$587.12
0.00%
59148001013
ABILIFY
TAB 20MG
147
$58,990.96
0.35%
456
$173,504.52
0.98%
59148001035
ABILIFY
TAB 20MG
0
$0.00
0.00%
3
$1,255.53
0.01%
59148001113
ABILIFY
TAB 30MG
268
$94,330.18
0.64%
544
$219,125.93
1.17%
59148001135
ABILIFY
TAB 30MG
1
$405.92
0.00%
0
$0.00
0.00%
Page 113 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIPSYCHOTICS - SPECIAL ATYPICALS
00078012605
CLOZARIL
TAB 25MG
216
$11,214.82
3.97%
176
$9,562.77
3.51%
00078012606
CLOZARIL
TAB 25MG
9
$264.78
0.17%
2
$48.60
0.04%
00078012705
CLOZARIL
TAB 100MG
410
$72,628.36
7.53%
298
$51,823.00
5.94%
00078012706
CLOZARIL
TAB 100MG
21
$2,079.25
0.39%
17
$2,621.64
0.34%
00172430360
CLOZAPINE
TAB 12.5
11
$63.55
0.20%
3
$12.12
0.06%
00172435910
CLOZAPINE
TAB 25MG
8
$109.28
0.15%
6
$175.90
0.12%
00172435960
CLOZAPINE
TAB 25MG
881
$18,705.21
16.18%
749
$16,796.45
14.92%
00172435970
CLOZAPINE
TAB 25MG
285
$6,445.06
5.23%
345
$7,383.36
6.87%
00172436010
CLOZAPINE
TAB 100MG
19
$872.95
0.35%
32
$1,371.20
0.64%
00172436060
CLOZAPINE
TAB 100MG
1,905
$108,878.88
34.98%
1,386
$77,865.40
27.62%
00172436070
CLOZAPINE
TAB 100MG
526
$27,751.05
9.66%
626
$32,525.15
12.47%
00378082501
CLOZAPINE
TAB 25MG
354
$8,563.67
6.50%
393
$8,089.59
7.83%
00378086001
CLOZAPINE
TAB 100MG
267
$14,356.25
4.90%
309
$17,760.55
6.16%
00378086005
CLOZAPINE
TAB 100MG
534
$37,251.20
9.81%
538
$36,388.40
10.72%
57664034713
CLOZAPINE
TAB 100MG
0
$0.00
0.00%
138
$8,262.80
2.75%
68322000201
FAZACLO
0
$0.00
0.00%
1
$86.53
0.02%
10
$1,012.13
0.13%
2
$219.96
0.03%
TAB 100MG
ANTIPSYCHOTICS - TYPICAL
00003056915
PROLIXIN-DEC INJ 25MG/ML
00003082030
PROLIXIN
ELX 2.5/5ML
1
$119.52
0.01%
0
$0.00
0.00%
00003087750
PROLIXIN
TAB 5MG
8
$674.89
0.10%
6
$1,292.63
0.08%
00003095650
PROLIXIN
TAB 10MG
2
$471.10
0.03%
0
$0.00
0.00%
00007335216
COMPAZINE
INJ 5MG/ML
1
$8.36
0.01%
0
$0.00
0.00%
00007336003
COMPAZINE
SUP 2.5MG
1
$25.16
0.01%
0
$0.00
0.00%
00007336103
COMPAZINE
SUP 5MG
5
$178.95
0.06%
0
$0.00
0.00%
00007507620
THORAZINE
TAB 50MG
1
$48.03
0.01%
0
$0.00
0.00%
Page 114 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00045025301
HALDOL DECAN INJ 50MG/ML
6
$114.86
0.08%
0
$0.00
0.00%
00045025303
1
$116.22
0.01%
0
$0.00
0.00%
00045025346
5
$965.85
0.06%
0
$0.00
0.00%
00045025414
7
$1,212.95
0.09%
1
$146.86
0.01%
00045025446
14
$4,943.82
0.18%
1
$368.37
0.01%
00045025501
HALDOL
INJ 5MG/ML
35
$1,863.60
0.44%
16
$681.29
0.21%
00045025549
HALDOL
INJ 5MG/ML
0
$0.00
0.00%
2
$107.83
0.03%
00049574066
NAVANE
CAP 10MG
6
$459.75
0.08%
3
$355.71
0.04%
00049577066
NAVANE
CAP 20MG
9
$972.09
0.11%
9
$1,013.36
0.12%
00054314450
CHLORPROMAZ CON 30MG/ML
1
$5.17
0.01%
0
$0.00
0.00%
00054314658
2
$21.54
0.03%
1
$4.61
0.01%
00078000405
MELLARIL
1
$41.76
0.01%
0
$0.00
0.00%
00093960412
HALOPERIDOL CON 2MG/ML
51
$1,737.10
0.64%
42
$1,572.29
0.56%
00093960423
11
$124.60
0.14%
13
$76.10
0.17%
00093963012
FLUPHENAZINE CON 5MG/ML
2
$452.90
0.03%
0
$0.00
0.00%
00093964301
PROCHLORPER TAB 5MG
7
$92.81
0.09%
3
$30.45
0.04%
00093965201
PROCHLORPER TAB 10MG
45
$1,908.28
0.56%
39
$1,348.24
0.52%
00108490620
STELAZINE
1
$51.99
0.01%
0
$0.00
0.00%
00121058104
4
$234.00
0.05%
3
$135.45
0.04%
00121065304
FLUPHENAZINE CON 5MG/ML
3
$391.08
0.04%
10
$1,099.00
0.13%
00121067304
PERPHENAZINE CON 16MG/5ML
0
$0.00
0.00%
2
$109.04
0.03%
00172366760
PERPHENAZINE TAB 2MG
2
$18.50
0.03%
1
$9.25
0.01%
00172366860
3
$95.64
0.04%
9
$292.89
0.12%
00172366960
3
$158.29
0.04%
0
$0.00
0.00%
00172367060
1
$41.61
0.01%
0
$0.00
0.00%
00172369060
PROCHLORPER TAB 5MG
18
$156.65
0.23%
10
$92.34
0.13%
00172369160
13
$116.86
0.16%
17
$202.05
0.23%
TAB 50MG
TAB 5MG
Page 115 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
00182709611
PROCHLORPER SUP 25MG
00364216801
THIOTHIXENE CAP 5MG
00364216802
$
Market Share*
00182605971
# of Scripts
2
$22.35
0.03%
0
$0.00
0.00%
44
$1,454.90
0.55%
4
$70.58
0.05%
1
$5.05
0.01%
0
$0.00
0.00%
THIOTHIXENE CAP 5MG
1
$11.75
0.01%
0
$0.00
0.00%
00364216901
THIOTHIXENE CAP 10MG
0
$0.00
0.00%
1
$27.74
0.01%
00364216902
1
$39.94
0.01%
0
$0.00
0.00%
00378021401
HALOPERIDOL TAB 2MG
207
$2,955.05
2.60%
178
$2,429.68
2.36%
00378021410
HALOPERIDOL TAB 2MG
106
$1,437.09
1.33%
91
$1,148.40
1.21%
00378025701
HALOPERIDOL TAB 1MG
100
$417.64
1.25%
100
$521.90
1.32%
00378025710
HALOPERIDOL TAB 1MG
163
$762.46
2.04%
136
$733.57
1.80%
00378032701
HALOPERIDOL TAB 5MG
250
$3,532.37
3.14%
231
$3,142.87
3.06%
00378032710
HALOPERIDOL TAB 5MG
117
$1,796.68
1.47%
165
$2,109.20
2.19%
00378035101
HALOPERIDOL TAB 0.5MG
81
$339.76
1.02%
74
$308.51
0.98%
00378035110
246
$1,039.80
3.09%
254
$1,082.57
3.36%
00378061201
THIORIDAZINE TAB 10MG
68
$1,385.64
0.85%
27
$632.23
0.36%
00378061210
17
$601.73
0.21%
19
$638.52
0.25%
00378061401
69
$1,130.95
0.87%
48
$904.05
0.64%
00378061410
27
$392.69
0.34%
15
$266.67
0.20%
00378061601
84
$2,052.16
1.05%
63
$1,779.10
0.83%
00378061610
3
$79.98
0.04%
3
$60.83
0.04%
00378061801
91
$2,123.12
1.14%
85
$1,857.34
1.13%
00378100101
THIOTHIXENE CAP 1MG
11
$205.24
0.14%
24
$392.27
0.32%
00378200201
THIOTHIXENE CAP 2MG
21
$381.31
0.26%
26
$428.57
0.34%
00378200210
THIOTHIXENE CAP 2MG
0
$0.00
0.00%
1
$7.10
0.01%
00378240101
TRIFLUOPERAZ TAB 1MG
8
$100.94
0.10%
6
$129.39
0.08%
00378240201
60
$954.43
0.75%
53
$1,006.52
0.70%
00378240501
62
$1,635.20
0.78%
83
$1,970.23
1.10%
Page 116 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00378241001
44
$1,569.60
0.55%
37
$1,324.37
0.49%
00378300501
THIOTHIXENE CAP 5MG
67
$602.95
0.84%
57
$565.90
0.75%
00378300510
THIOTHIXENE CAP 5MG
1
$5.05
0.01%
0
$0.00
0.00%
00378501001
63
$1,953.02
0.79%
59
$1,290.83
0.78%
00378510501
PROCHLORPER TAB 5MG
27
$295.98
0.34%
29
$388.96
0.38%
00378511001
74
$1,249.70
0.93%
47
$980.32
0.62%
00378600401
FLUPHENAZINE TAB 1MG
27
$481.52
0.34%
23
$339.93
0.30%
00378600405
5
$153.12
0.06%
9
$183.57
0.12%
00378600901
FLUPHENAZINE TAB 2.5MG
15
$347.63
0.19%
21
$280.23
0.28%
00378600905
3
$50.84
0.04%
2
$24.74
0.03%
00378607401
67
$1,471.71
0.84%
63
$1,480.25
0.83%
00378607405
33
$654.84
0.41%
41
$714.40
0.54%
00378609701
64
$2,203.95
0.80%
56
$1,936.68
0.74%
00378609705
22
$759.56
0.28%
23
$849.86
0.30%
00378705001
LOXAPINE
0
$0.00
0.00%
1
$90.85
0.01%
00472074298
8
$135.55
0.10%
1
$20.28
0.01%
00555052102
PROCHLORPER TAB 5MG
8
$96.41
0.10%
9
$141.03
0.12%
00555052202
56
$1,190.01
0.70%
67
$1,400.56
0.89%
00574722612
COMPRO
SUP 25MG
53
$2,441.37
0.66%
45
$1,524.33
0.60%
00591036901
LOXAPINE
CAP 5MG
3
$80.31
0.04%
4
$184.84
0.05%
00591037001
LOXAPINE
CAP 10MG
38
$2,387.58
0.48%
36
$1,952.90
0.48%
00591037101
LOXAPINE
CAP 25MG
41
$4,101.92
0.51%
51
$5,843.11
0.68%
00591037201
LOXAPINE
CAP 50MG
25
$2,537.14
0.31%
38
$4,462.80
0.50%
00597002001
SERENTIL
TAB 10MG
7
$233.97
0.09%
0
$0.00
0.00%
00597002101
SERENTIL
TAB 25MG
52
$4,840.52
0.65%
0
$0.00
0.00%
00597002301
SERENTIL
TAB 100MG
28
$3,256.78
0.35%
0
$0.00
0.00%
00597002504
SERENTIL
CON 25MG/ML
3
$210.84
0.04%
0
$0.00
0.00%
CAP 50MG
Page 117 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
CHLORPROMAZ TAB 50MG
00603509021
00603509121
00603509221
$
Market Share*
00603281021
# of Scripts
$8.87
0.03%
$0.00
0.00%
34
$793.37
0.43%
73
$2,031.29
0.92%
41
$902.73
0.54%
112
$2,581.91
1.48%
113
$5,660.32
1.42%
120
$6,154.41
1.59%
00603509228
7
$416.10
0.09%
0
$0.00
0.00%
00603509321
31
00641049125
PROCHLORPER INJ 5MG/ML
1
$1,274.80
0.39%
48
$1,937.40
0.64%
$19.99
0.01%
6
$402.78
0.08%
00641139735
CHLORPROMAZ INJ 25MG/ML
2
$79.36
0.03%
0
$0.00
0.00%
00641139835
CHLORPROMAZ INJ 25MG/ML
4
$2,126.96
0.05%
3
$135.13
0.04%
00677082301
9
$233.78
0.11%
2
$19.50
0.03%
00677082401
0
$0.00
0.00%
2
$18.66
0.03%
00677083201
0
$0.00
0.00%
7
$144.85
0.09%
00677083206
2
$61.60
0.03%
0
$0.00
0.00%
00703500301
FLUPHENAZ DE INJ 25MG/ML
166
$3,934.51
2.08%
149
$4,623.57
1.97%
00703701103
HALOPER DEC INJ 50MG/ML
4
$113.64
0.05%
1
$15.88
0.01%
00703701301
14
$838.12
0.18%
13
$865.43
0.17%
00703702103
1
$103.57
0.01%
5
$583.05
0.07%
00703702301
56
$7,130.78
0.70%
50
$6,313.80
0.66%
00703717104
PROCHLORPER INJ 5MG/ML
0
$0.00
0.00%
1
$5.49
0.01%
00713013512
95
$3,713.56
1.19%
90
$3,343.83
1.19%
00781103001
2
$20.50
0.03%
0
$0.00
0.00%
00781103201
57
$939.55
0.72%
38
$684.94
0.50%
00781103210
5
$95.95
0.06%
0
$0.00
0.00%
00781103401
96
$2,239.24
1.20%
91
$2,307.53
1.21%
00781103410
11
$190.45
0.14%
0
$0.00
0.00%
00781103601
54
$2,244.95
0.68%
52
$1,987.04
0.69%
00781103610
7
$275.00
0.09%
0
$0.00
0.00%
2
0
Page 118 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00781104601
43
$854.25
0.54%
39
$753.48
0.52%
00781104701
145
$3,115.23
1.82%
67
$1,631.67
0.89%
00781104713
3
$95.64
0.04%
3
$74.95
0.04%
00781104801
62
$3,114.00
0.78%
46
$2,905.32
0.61%
00781104810
0
$0.00
0.00%
3
$159.93
0.04%
00781104901
33
$1,522.43
0.41%
17
$1,034.56
0.23%
00781139101
38
$183.45
0.48%
50
$215.65
0.66%
00781139110
2
$8.07
0.03%
0
$0.00
0.00%
00781139113
0
$0.00
0.00%
1
$1.59
0.01%
00781139201
HALOPERIDOL TAB 1MG
42
$213.48
0.53%
44
$244.16
0.58%
00781139210
HALOPERIDOL TAB 1MG
11
$50.25
0.14%
26
$136.71
0.34%
00781139301
HALOPERIDOL TAB 2MG
68
$886.78
0.85%
71
$918.98
0.94%
00781139310
HALOPERIDOL TAB 2MG
10
$131.25
0.13%
6
$71.85
0.08%
00781139601
HALOPERIDOL TAB 5MG
127
$2,342.81
1.59%
147
$2,386.08
1.95%
00781139610
HALOPERIDOL TAB 5MG
0
$0.00
0.00%
2
$35.25
0.03%
00781139701
HALOPERIDOL TAB 10MG
231
$14,039.75
2.90%
233
$14,722.16
3.09%
00781139710
4
$123.83
0.05%
0
$0.00
0.00%
00781139801
8
$2,201.96
0.10%
6
$1,005.81
0.08%
00781143601
56
$1,169.83
0.70%
46
$897.84
0.61%
00781143650
3
$153.24
0.04%
0
$0.00
0.00%
00781143701
41
$708.81
0.51%
36
$827.40
0.48%
00781143801
159
$3,343.15
1.99%
129
$2,757.38
1.71%
00781143805
1
$35.26
0.01%
4
$94.55
0.05%
00781143901
217
$3,882.86
2.72%
177
$3,373.48
2.34%
00781143905
8
$259.02
0.10%
2
$39.95
0.03%
00781160401
54
$2,156.60
0.68%
28
$709.55
0.37%
00781160410
6
$125.53
0.08%
4
$71.48
0.05%
Page 119 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00781161401
9
$192.92
0.11%
25
$456.07
0.33%
00781162401
49
$673.57
0.61%
44
$571.87
0.58%
00781162410
33
$503.66
0.41%
24
$420.83
0.32%
00781163401
62
$1,619.95
0.78%
69
$1,823.45
0.91%
00781163410
23
$742.61
0.29%
20
$660.61
0.26%
00781164401
47
$1,171.11
0.59%
53
$1,240.42
0.70%
00781166401
23
$1,181.69
0.29%
18
$873.42
0.24%
00781167401
6
$199.50
0.08%
4
$92.30
0.05%
00781171501
16
$293.36
0.20%
19
$205.25
0.25%
00781171601
61
$697.55
0.77%
77
$1,033.29
1.02%
00781171610
11
$99.02
0.14%
2
$9.88
0.03%
00781171701
64
$1,295.36
0.80%
26
$461.82
0.34%
00781171710
56
$942.53
0.70%
47
$755.03
0.62%
00781171801
83
$1,399.17
1.04%
91
$1,457.37
1.21%
00781171810
7
$188.95
0.09%
4
$59.90
0.05%
00781171813
2
$60.70
0.03%
0
$0.00
0.00%
00781171901
14
$219.70
0.18%
8
$85.30
0.11%
00781222601
THIOTHIXENE CAP 1MG
41
$578.08
0.51%
21
$319.89
0.28%
00781222701
THIOTHIXENE CAP 2MG
61
$621.88
0.77%
40
$370.59
0.53%
00781222710
THIOTHIXENE CAP 2MG
4
$25.15
0.05%
2
$14.20
0.03%
00781222801
THIOTHIXENE CAP 5MG
131
$1,214.74
1.64%
124
$1,085.34
1.64%
00781222810
THIOTHIXENE CAP 5MG
15
$142.51
0.19%
6
$34.70
0.08%
00781222901
111
$3,065.62
1.39%
94
$2,826.35
1.25%
00781502001
PROCHLORPER TAB 5MG
120
$1,277.11
1.51%
143
$1,919.16
1.89%
00781502101
384
$7,420.66
4.82%
441
$8,923.50
5.84%
00832030000
16
$218.01
0.20%
30
$518.41
0.40%
00832030100
128
$1,532.54
1.61%
162
$1,814.28
2.15%
Page 120 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00832030110
3
$44.44
0.04%
0
$0.00
0.00%
00832030200
117
$2,747.00
1.47%
197
$4,109.40
2.61%
00832030210
22
$666.48
0.28%
25
$631.32
0.33%
00832030300
269
$3,313.96
3.37%
284
$3,414.74
3.76%
00832030310
25
$381.60
0.31%
0
$0.00
0.00%
00832030400
42
$1,280.20
0.53%
38
$1,126.42
0.50%
00904205361
0
$0.00
0.00%
4
$24.82
0.05%
49884006101
5
$44.07
0.06%
6
$91.94
0.08%
49884006201
11
$295.78
0.14%
12
$363.24
0.16%
49884006401
12
$400.26
0.15%
21
$660.16
0.28%
49884006405
3
$142.72
0.04%
3
$124.78
0.04%
49884007601
6
$207.21
0.08%
13
$261.64
0.17%
49884007605
8
$277.25
0.10%
0
$0.00
0.00%
51079013020
1
$17.76
0.01%
0
$0.00
0.00%
51079048520
0
$0.00
0.00%
1
$8.81
0.01%
51079051920
1
$5.62
0.01%
0
$0.00
0.00%
51079054220
2
$8.24
0.03%
0
$0.00
0.00%
51079058720
THIOTHIXENE CAP 2MG
3
$25.68
0.04%
1
$8.93
0.01%
51079090020
LOXAPINE
1
$18.25
0.01%
0
$0.00
0.00%
51285052102
PROCHLORPER TAB 5MG
3
$27.35
0.04%
0
$0.00
0.00%
51285052202
8
$172.23
0.10%
2
$32.40
0.03%
51991019601
PROCHLORPER TAB 5MG
2
$17.55
0.03%
11
$127.85
0.15%
51991019701
14
$237.80
0.18%
48
$1,074.00
0.64%
52544036901
LOXAPINE
CAP 5MG
0
$0.00
0.00%
1
$35.25
0.01%
52544037001
LOXAPINE
CAP 10MG
6
$228.10
0.08%
4
$422.67
0.05%
52544037101
LOXAPINE
CAP 25MG
8
$387.11
0.10%
3
$409.62
0.04%
52544037201
LOXAPINE
CAP 50MG
6
$501.60
0.08%
1
$90.85
0.01%
CAP 5MG
Page 121 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
LOXITANE
CAP 10MG
53265024312
PROCHLORPER SUP 2.5MG
53265024412
PROCHLORPER SUP 5MG
53265024512
$
Market Share*
52544049501
# of Scripts
$514.86
0.04%
3
$582.84
0.04%
1
$5.30
0.01%
8
$179.56
0.10%
3
$41.80
0.04%
6
$147.36
0.08%
101
$2,944.06
1.27%
97
$3,285.36
1.28%
53489014801
4
$83.53
0.05%
19
$408.86
0.25%
53489014810
53489014901
0
$0.00
0.00%
5
$285.63
0.07%
39
$770.29
0.49%
41
$644.35
0.54%
53489014910
16
$288.10
0.20%
24
$380.93
0.32%
53489015001
31
$1,113.82
0.39%
34
$1,035.88
0.45%
53489015010
53489050001
9
$190.47
0.11%
3
$79.98
0.04%
26
$694.17
0.33%
23
$1,022.80
0.30%
55390014710
HALOPER LAC INJ 5MG/ML
5
$94.45
0.06%
6
$191.73
0.08%
55390041205
2
$132.20
0.03%
1
$68.60
0.01%
55390041301
0
$0.00
0.00%
7
$352.75
0.09%
55390041305
9
$1,199.65
0.11%
3
$396.55
0.04%
55390046505
65
$1,830.00
0.82%
35
$1,000.75
0.46%
59746011306
PROCHLORPER TAB 5MG
0
$0.00
0.00%
2
$29.00
0.03%
59746011506
6
$96.98
0.08%
116
$2,400.72
1.54%
60505066402
11
$272.85
0.14%
11
$256.10
0.15%
60505070201
5
$678.08
0.06%
11
$1,354.15
0.15%
60505070301
33
$7,649.06
0.41%
34
$7,153.74
0.45%
62269027624
7
$176.83
0.09%
0
$0.00
0.00%
62269027824
17
$271.92
0.21%
12
$98.90
0.16%
63323027205
8
$556.91
0.10%
11
$685.00
0.15%
63323028110
FLUPHENAZINE INJ 2.5MG/ML
0
$0.00
0.00%
1
$58.71
0.01%
63323046901
1
$24.34
0.01%
10
$346.51
0.13%
63323046905
1
$118.30
0.01%
3
$359.90
0.04%
3
Page 122 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
63323047105
63323047401
HALOPER LAC INJ 5MG/ML
63481007270
MOBAN
TAB 5MG
63481007370
MOBAN
63481007470
63481007670
66993080502
66993081002
$
Market Share*
63323047101
# of Scripts
14
$1,235.28
0.18%
4
$1,085.04
0.05%
27
$838.22
0.34%
13
$770.80
0.16%
TAB 10MG
19
$3,055.92
MOBAN
TAB 25MG
9
MOBAN
TAB 50MG
6
PROCHLORPER TAB 5MG
4
$788.59
0.05%
2
$434.86
0.03%
38
$1,122.92
0.50%
9
$760.45
0.12%
0.24%
17
$3,030.13
0.23%
$2,219.22
0.11%
10
$2,134.18
0.13%
$457.65
0.08%
6
$556.49
0.08%
16
$138.70
0.20%
28
$444.46
0.37%
128
$2,629.62
1.61%
32
$615.96
0.42%
ANTIRETROVIRALS
00003196401
ZERIT
CAP 15MG
2
$560.18
0.08%
0
$0.00
0.00%
00003196501
ZERIT
CAP 20MG
12
$2,650.17
0.48%
6
$2,077.65
0.24%
00003196601
ZERIT
CAP 30MG
20
$6,181.81
0.80%
10
$3,073.98
0.40%
00003196701
ZERIT
CAP 40MG
152
$45,230.06
6.06%
90
$27,845.58
3.63%
00003196801
ZERIT
SOL 1MG/ML
6
$1,985.64
0.24%
3
$1,253.13
0.12%
00003362312
REYATAZ
CAP 100MG
2
$727.06
0.08%
0
$0.00
0.00%
00003362412
REYATAZ
CAP 150MG
33
$21,617.15
1.32%
66
$46,428.29
2.66%
00003363112
REYATAZ
CAP 200MG
20
$13,019.48
0.80%
27
$20,525.60
1.09%
00004022101
HIVID
2
$447.12
0.08%
1
$218.44
0.04%
00004024515
INVIRASE
10
$5,099.61
0.40%
4
$1,668.22
0.16%
00004024648
FORTOVASE
16
$5,202.87
0.64%
10
$3,099.88
0.40%
00004038039
FUZEON
21
$38,011.24
0.84%
21
$38,921.94
0.85%
00006057143
CRIXIVAN
CAP 200MG
1
$478.66
0.04%
3
$730.50
0.12%
00006057354
CRIXIVAN
CAP 400MG
8
$3,727.84
0.32%
8
$3,065.17
0.32%
00006057362
CRIXIVAN
CAP 400MG
30
$14,208.20
1.20%
21
$9,977.79
0.85%
00006057465
CRIXIVAN
CAP 333MG
3
$1,760.76
0.12%
3
$1,798.14
0.12%
TAB 0.75MG
CAP 200MG
CAP 200MG
KIT
Page 123 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIRETROVIRALS
00056047330
SUSTIVA
CAP 100MG
2
$141.02
0.08%
00056047492
SUSTIVA
CAP 200MG
105
$39,105.76
00056051030
SUSTIVA
TAB 600MG
180
$71,157.29
00074194063
NORVIR
SOL 80MG/ML
5
00074395646
KALETRA
SOL
00074395977
KALETRA
CAP
00074663322
NORVIR
00087663341
VIDEX
00087665201
VIDEX BUFFER CHW 100MG
00087666515
VIDEX BUFFER CHW 200MG
00087667217
VIDEX EC
CAP 200MG
00087667317
VIDEX EC
CAP 250MG
00087667417
VIDEX EC
CAP 400MG
00173010855
RETROVIR
CAP 100MG
00173011318
RETROVIR
SYP 10MG/ML
00173047001
EPIVIR
TAB 150MG
00173047100
EPIVIR
SOL 10MG/ML
00173050100
RETROVIR
TAB 300MG
00173059500
COMBIVIR
TAB
00173066100
ZIAGEN
00173066101
ZIAGEN
00173066200
CAP 100MG
SOL 4GM
3
$1,311.43
0.12%
4.19%
57
$22,346.18
2.30%
7.18%
230
$95,393.94
9.29%
$1,935.24
0.20%
6
$13,791.99
0.24%
6
$3,687.28
0.24%
3
$2,887.04
0.12%
223
$136,784.49
8.89%
164
$94,441.35
6.62%
52
$14,054.52
2.07%
105
$57,947.96
4.24%
3
$717.02
0.12%
0
$0.00
0.00%
4
$785.26
0.16%
0
$0.00
0.00%
1
$248.36
0.04%
0
$0.00
0.00%
19
$3,922.86
0.76%
20
$3,219.04
0.81%
40
$7,136.10
1.59%
27
$4,896.72
1.09%
89
$22,312.09
3.55%
47
$13,061.98
1.90%
16
$3,645.69
0.64%
11
$2,126.65
0.44%
1
$29.04
0.04%
0
$0.00
0.00%
283
$73,674.37
11.28%
244
$64,725.94
9.85%
4
$599.96
0.16%
2
$307.30
0.08%
10
$3,060.47
0.40%
20
$5,655.11
0.81%
241
$141,555.65
9.61%
228
$139,007.24
9.20%
TAB 300MG
9
$3,332.89
0.36%
6
$1,163.81
0.24%
TAB 300MG
141
$50,471.86
5.62%
128
$46,764.48
5.17%
EPIVIR HBV TAB 100MG
26
$4,221.26
1.04%
12
$2,201.32
0.48%
00173067200
AGENERASE
21
$7,281.54
0.84%
12
$4,878.07
0.48%
00173069100
TRIZIVIR
52
$46,312.48
2.07%
55
$54,375.25
2.22%
00173071400
EPIVIR
31
$8,227.85
1.24%
78
$21,284.97
3.15%
00173072100
LEXIVA
0
$0.00
0.00%
44
$29,660.66
1.78%
00173074200
EPZICOM
0
$0.00
0.00%
1
$661.33
0.04%
CAP 150MG
TAB
TAB 300MG
TAB 700MG
TAB
Page 124 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTIRETROVIRALS
00597004601
VIRAMUNE
TAB 200MG
20
$6,518.07
0.80%
7
$2,467.94
0.28%
00597004660
VIRAMUNE
TAB 200MG
121
$41,626.05
4.82%
149
$51,116.64
6.02%
00597004724
VIRAMUNE
SUS 50MG/5ML
1
$79.68
0.04%
0
$0.00
0.00%
61958040101
VIREAD
334
$125,510.22
13.32%
404
$165,491.10
16.31%
61958060101
EMTRIVA
5
$1,321.55
0.20%
57
$14,956.02
2.30%
61958070101
TRUVADA
TAB
63010001030
VIRACEPT
TAB 250MG
63010002118
TAB 300MG
CAP 200MG
0
$0.00
0.00%
3
$837.78
0.12%
106
$64,903.85
4.23%
60
$36,225.81
2.42%
RESCRIPTOR TAB 200MG
2
$1,095.08
0.08%
2
$539.50
0.08%
63010002770
VIRACEPT
0
$0.00
0.00%
13
$8,354.63
0.52%
63304063628
GANCICLOVIR CAP 250MG
0
$0.00
0.00%
1
$369.88
0.04%
63304063728
GANCICLOVIR CAP 500MG
17
$21,657.52
0.68%
5
$4,694.25
0.20%
TAB 625MG
ANTISPASMODICS
00009454102
DETROL
TAB 1MG
35
$1,995.46
1.83%
6
$115.47
0.33%
00009454103
DETROL
TAB 1MG
4
$161.60
0.21%
4
$392.48
0.22%
00009454401
DETROL
TAB 2MG
1
$97.63
0.05%
0
$0.00
0.00%
00009454402
DETROL
TAB 2MG
109
$6,706.14
5.69%
64
$3,287.87
3.48%
00009454403
DETROL
TAB 2MG
26
$1,140.30
1.36%
11
$473.42
0.60%
00115181101
FLAVOXATE
3
$155.31
0.16%
20
$1,608.54
1.09%
00182128901
OXYBUTYNIN TAB 5MG
19
$192.30
0.99%
0
$0.00
0.00%
00182128989
OXYBUTYNIN TAB 5MG
4
$28.80
0.21%
0
$0.00
0.00%
00364034901
BETHANECHOL TAB 10MG
0
$0.00
0.00%
3
$58.20
0.16%
00364041001
1
$49.55
0.05%
0
$0.00
0.00%
00591077901
OXYBUTYNIN TAB 5MG
99
$1,005.23
5.16%
105
$1,183.94
5.72%
00591077905
OXYBUTYNIN TAB 5MG
90
$671.74
4.69%
89
$722.54
4.84%
00603149058
OXYBUTYNIN SYP 5MG/5ML
13
$353.83
0.68%
10
$277.80
0.54%
00603497521
OXYBUTYNIN TAB 5MG
38
$387.00
1.98%
462
$4,554.95
25.15%
TAB 100MG
Page 125 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTISPASMODICS
00603497528
OXYBUTYNIN TAB 5MG
8
$82.90
0.42%
21
$197.90
1.14%
00603497532
OXYBUTYNIN TAB 5MG
16
$169.60
0.83%
25
$204.20
1.36%
00677175901
OXYBUTYNIN TAB 5MG
2
$18.60
0.10%
0
$0.00
0.00%
00677175905
OXYBUTYNIN TAB 5MG
6
$43.60
0.31%
2
$16.10
0.11%
00832003800
OXYBUTYNIN TAB 5MG
0
$0.00
0.00%
1
$10.55
0.05%
00832003810
OXYBUTYNIN TAB 5MG
6
$38.80
0.31%
4
$81.50
0.22%
00904282180
OXYBUTYNIN TAB 5MG
0
$0.00
0.00%
3
$42.45
0.16%
17314920001
DITROPAN
TAB 5MG
1
$54.54
0.05%
3
$143.95
0.16%
17314920104
DITROPAN
SYP 5MG/5ML
2
$88.69
0.10%
3
$43.99
0.16%
17314922001
URISPAS
61
$6,556.05
3.18%
27
$3,061.86
1.47%
38779038406
OXYBUTININ POW CHLORIDE
1
$18.69
0.05%
0
$0.00
0.00%
50111032401
0
$0.00
0.00%
2
$53.40
0.11%
50111032501
0
$0.00
0.00%
39
$1,853.23
2.12%
50111032601
0
$0.00
0.00%
1
$10.48
0.05%
50111045601
OXYBUTYNIN TAB 5MG
663
$6,639.13
34.59%
266
$2,940.33
14.48%
50111045602
OXYBUTYNIN TAB 5MG
145
$1,358.57
7.56%
114
$969.17
6.21%
50111045603
OXYBUTYNIN TAB 5MG
473
$4,784.43
24.67%
443
$4,732.17
24.12%
51991013501
HYOSPAZ
TAB 0.15MG
2
$10.94
0.10%
0
$0.00
0.00%
52544077901
OXYBUTYNIN TAB 5MG
14
$126.00
0.73%
8
$64.40
0.44%
52544077905
OXYBUTYNIN TAB 5MG
1
$33.25
0.05%
0
$0.00
0.00%
60258007116
2
$28.70
0.10%
0
$0.00
0.00%
60432009216
31
$846.07
1.62%
42
$976.17
2.29%
60505600809
39
$1,200.80
2.03%
28
$915.18
1.52%
63304099401
1
$70.71
0.05%
2
$47.23
0.11%
63304099501
0
$0.00
0.00%
11
$1,647.81
0.60%
65473098004
SANCTURA
0
$0.00
0.00%
18
$931.75
0.98%
66993040202
HYOSCYAMINE TAB 0.15MG
1
$9.29
0.05%
0
$0.00
0.00%
TAB 100MG
TAB 20MG
Page 126 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANTISPASMODICS - LONG ACTING
00009519001
DETROL LA
CAP 2MG
448
$35,684.82
8.18%
436
$36,130.95
7.67%
00009519002
DETROL LA
CAP 2MG
328
$25,083.18
5.99%
350
$28,107.17
6.16%
00009519004
DETROL LA
CAP 2MG
1
$27.21
0.02%
0
$0.00
0.00%
00009519101
DETROL LA
CAP 4MG
2,727
$226,942.43
49.81%
2,939
$270,922.88
51.72%
00009519102
DETROL LA
CAP 4MG
1,037
$85,859.82
18.94%
1,154
$100,070.10
20.31%
00009519103
DETROL LA
CAP 4MG
7
$575.69
0.13%
45
$3,128.29
0.79%
00009519104
DETROL LA
CAP 4MG
2
$158.41
0.04%
9
$767.25
0.16%
17314850001
DITROPAN XL TAB 5MG
235
$16,608.71
4.29%
94
$5,352.06
1.65%
17314850101
DITROPAN XL TAB 10MG
424
$35,511.26
7.74%
312
$24,850.51
5.49%
17314850201
DITROPAN XL TAB 15MG
220
$19,980.76
4.02%
193
$17,610.58
3.40%
52544092008
OXYTROL
46
$3,182.81
0.84%
150
$13,990.13
2.64%
DIS 3.9MG/24
ANTITHYROID THERAPIES
00005460923
PROPYLTHIOUR TAB 50MG
1
$2.39
0.22%
0
$0.00
0.00%
00143148001
50
$943.67
11.06%
44
$812.36
9.21%
00143148010
25
$152.02
5.53%
23
$153.23
4.81%
00185020501
METHIMAZOLE TAB 5MG
40
$508.25
8.85%
65
$822.00
13.60%
00185020510
METHIMAZOLE TAB 5MG
1
$23.35
0.22%
0
$0.00
0.00%
00185021001
METHIMAZOLE TAB 10MG
47
$1,104.95
10.40%
88
$2,642.18
18.41%
00228234810
111
$2,048.28
24.56%
90
$1,934.00
18.83%
00689108401
METHIMAZOLE TAB 5MG
0
$0.00
0.00%
2
$16.70
0.42%
49884064001
METHIMAZOLE TAB 5MG
112
$1,430.45
24.78%
96
$1,139.50
20.08%
49884064074
METHIMAZOLE TAB 5MG
4
$17.40
0.88%
6
$95.85
1.26%
49884064101
48
$1,138.10
10.62%
61
$1,352.75
12.76%
49884064174
8
$201.70
1.77%
3
$46.05
0.63%
52604109401
TAPAZOLE
1
$14.77
0.22%
0
$0.00
0.00%
TAB 5MG
Page 127 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
TAPAZOLE
$
Market Share*
ANTITHYROID THERAPIES
52604109501
# of Scripts
TAB 10MG
4
$128.64
0.88%
0
$0.00
0.00%
$899.08
0.03%
4
$115.40
0.01%
ANXIOLYTICS - BENZODIAZEPINES
00008006402
ATIVAN
TAB 1MG
11
00008006502
ATIVAN
TAB 2MG
2
$94.36
0.01%
0
$0.00
0.00%
00008008102
ATIVAN
TAB 0.5MG
9
$389.97
0.02%
9
$463.10
0.02%
00008058104
ATIVAN
INJ 2MG/ML
1
$77.85
0.00%
0
$0.00
0.00%
00008058115
ATIVAN
INJ 2MG/ML
10
$261.46
0.03%
0
$0.00
0.00%
00009002901
XANAX
TAB 0.25MG
8
$676.72
0.02%
5
$413.35
0.01%
00009005501
XANAX
TAB 0.5MG
8
$841.41
0.02%
10
$860.79
0.03%
00009005503
XANAX
TAB 0.5MG
4
$475.34
0.01%
2
$273.50
0.01%
00009009001
XANAX
TAB 1MG
9
$1,984.29
0.02%
8
$1,485.13
0.02%
00009009401
XANAX
TAB 2MG
2
$159.48
0.01%
3
$233.79
0.01%
00054318544
DIAZEPAM
CON 5MG/ML
3
$81.21
0.01%
9
$238.77
0.02%
00054318863
DIAZEPAM
SOL 1MG/ML
34
$758.63
0.09%
47
$1,804.54
0.13%
00054353244
LORAZEPAM
109
$5,272.68
0.30%
88
$4,112.80
0.24%
00054820716
DIAZEPAM
SOL 1MG/ML
1
$1.90
0.00%
0
$0.00
0.00%
00074127302
DIAZEPAM
INJ 5MG/ML
14
$110.07
0.04%
0
$0.00
0.00%
00074127332
DIAZEPAM
INJ 5MG/ML
14
$469.27
0.04%
32
$253.45
0.09%
00074198501
LORAZEPAM
INJ 2MG/ML
4
$81.37
0.01%
2
$32.80
0.01%
00074198510
LORAZEPAM
INJ 2MG/ML
7
$222.95
0.02%
7
$791.23
0.02%
00074198530
LORAZEPAM
INJ 2MG/ML
0
$0.00
0.00%
3
$62.45
0.01%
00074198531
LORAZEPAM
INJ 2MG/ML
12
$177.11
0.03%
11
$244.41
0.03%
00074269913
TRANXENE-SD TAB 11.25MG
8
$2,227.10
0.02%
0
$0.00
0.00%
00074299713
4
$1,430.72
0.01%
0
$0.00
0.00%
00074321302
DIAZEPAM
2
$9.59
0.01%
7
$36.30
0.02%
00074438913
TRANXENE T TAB 3.75MG
4
$489.36
0.01%
0
$0.00
0.00%
CON 2MG/ML
INJ 5MG/ML
Page 128 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
LORAZEPAM
00074677802
LORAZEPAM
00172392560
DIAZEPAM
TAB 2MG
00172392570
DIAZEPAM
00172392660
$
Market Share*
00074677801
# of Scripts
INJ 2MG/ML
1
$5.94
0.00%
0
$0.00
0.00%
INJ 2MG/ML
87
$1,629.35
0.24%
45
$641.46
0.12%
7
$22.42
0.02%
10
$25.04
0.03%
TAB 2MG
343
$1,269.49
0.93%
501
$1,956.35
1.38%
DIAZEPAM
TAB 5MG
39
$311.94
0.11%
89
$446.35
0.24%
00172392670
DIAZEPAM
TAB 5MG
1,980
$9,947.61
5.37%
1,818
$9,004.69
5.00%
00172392680
DIAZEPAM
TAB 5MG
56
$267.33
0.15%
9
$23.28
0.02%
00172392760
DIAZEPAM
TAB 10MG
73
$754.86
0.20%
93
$550.85
0.26%
00172392770
DIAZEPAM
TAB 10MG
1,039
$10,537.36
2.82%
1,084
$6,872.96
2.98%
00172392780
DIAZEPAM
TAB 10MG
10
$127.80
0.03%
0
$0.00
0.00%
00172480460
OXAZEPAM
CAP 10MG
35
$476.61
0.09%
67
$1,451.45
0.18%
00172480470
OXAZEPAM
CAP 10MG
12
$142.45
0.03%
12
$150.08
0.03%
00172480560
OXAZEPAM
CAP 15MG
15
$472.55
0.04%
82
$2,573.74
0.23%
00172480570
OXAZEPAM
CAP 15MG
5
$234.35
0.01%
19
$748.03
0.05%
00172480660
OXAZEPAM
CAP 30MG
33
$756.14
0.09%
48
$1,063.25
0.13%
00228202710
ALPRAZOLAM TAB 0.25MG
6
$30.57
0.02%
3
$8.05
0.01%
00228202750
86
$360.78
0.23%
27
$102.68
0.07%
00228202796
499
$2,242.11
1.35%
446
$2,039.08
1.23%
00228202910
10
$54.78
0.03%
11
$43.48
0.03%
00228202950
120
$572.86
0.33%
53
$211.44
0.15%
00228202996
366
$1,860.55
0.99%
348
$1,816.39
0.96%
00228203110
ALPRAZOLAM TAB 1MG
38
$230.48
0.10%
26
$152.02
0.07%
00228203150
ALPRAZOLAM TAB 1MG
177
$1,021.57
0.48%
168
$925.52
0.46%
00228203196
ALPRAZOLAM TAB 1MG
311
$1,857.35
0.84%
144
$870.13
0.40%
00228203910
ALPRAZOLAM TAB 2MG
17
$210.52
0.05%
128
$1,197.60
0.35%
00228203950
ALPRAZOLAM TAB 2MG
16
$180.53
0.04%
11
$94.08
0.03%
00228205110
DIAZEPAM
9
$49.24
0.02%
0
$0.00
0.00%
TAB 2MG
Page 129 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
DIAZEPAM
TAB 2MG
00228205210
DIAZEPAM
TAB 5MG
00228205250
DIAZEPAM
TAB 5MG
00228205310
DIAZEPAM
TAB 10MG
00228205350
DIAZEPAM
TAB 10MG
00228205710
LORAZEPAM
00228205750
LORAZEPAM
00228205950
$
Market Share*
00228205150
# of Scripts
$776.95
0.39%
$42.98
0.04%
9
$51.15
0.02%
198
$1,218.98
0.54%
0
$0.00
0.00%
24
$150.35
0.07%
26
$276.06
0.07%
11
$65.54
0.03%
79
$779.76
0.21%
8
$64.09
0.02%
TAB 0.5MG
207
$1,116.28
TAB 0.5MG
5
$27.35
0.56%
4
$25.78
0.01%
0.01%
19
$78.20
0.05%
LORAZEPAM
TAB 1MG
8
$106.60
0.02%
10
$106.50
0.03%
00228206310
LORAZEPAM
TAB 2MG
3
$4.50
0.01%
4
$57.65
0.01%
00228206350
LORAZEPAM
TAB 2MG
00228206710
OXAZEPAM
CAP 10MG
3
$10.80
0.01%
2
$61.70
0.01%
136
$2,761.20
0.37%
89
$1,672.97
0.24%
00228206750
OXAZEPAM
CAP 10MG
36
$591.00
0.10%
44
$529.16
0.12%
00228206910
OXAZEPAM
CAP 15MG
236
$6,564.30
0.64%
129
$3,768.54
0.35%
00228206950
OXAZEPAM
00228207310
OXAZEPAM
CAP 15MG
85
$1,541.01
0.23%
131
$1,905.56
0.36%
CAP 30MG
110
$4,289.00
0.30%
52
$1,799.54
0.14%
00228306711
CLORAZ DIPOT TAB 3.75MG
0
$0.00
0.00%
12
$93.75
0.03%
00228306811
0
$0.00
0.00%
6
$145.10
0.02%
00228306850
0
$0.00
0.00%
3
$50.05
0.01%
00364077401
DIAZEPAM
TAB 2MG
7
$13.19
0.02%
0
$0.00
0.00%
00364077402
DIAZEPAM
TAB 2MG
4
$19.15
0.01%
4
$19.91
0.01%
00364077405
DIAZEPAM
TAB 2MG
2
$16.86
0.01%
2
$8.05
0.01%
00364077501
DIAZEPAM
TAB 5MG
2
$7.44
0.01%
0
$0.00
0.00%
00364077502
DIAZEPAM
TAB 5MG
10
$66.66
0.03%
0
$0.00
0.00%
00364077505
DIAZEPAM
TAB 5MG
1
$7.31
0.00%
0
$0.00
0.00%
00364077602
DIAZEPAM
TAB 10MG
0
$0.00
0.00%
1
$4.82
0.00%
00364077605
DIAZEPAM
TAB 10MG
3
$48.30
0.01%
0
$0.00
0.00%
00378003001
38
$465.65
0.10%
36
$494.27
0.10%
145
15
Page 130 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00378003005
25
$364.95
0.07%
7
$101.65
0.02%
00378004001
104
$2,028.85
0.28%
85
$1,696.55
0.23%
00378004005
21
$382.85
0.06%
34
$508.04
0.09%
00378007001
CLORAZ DIPOT TAB 15MG
29
$758.15
0.08%
20
$606.50
0.05%
00378027101
DIAZEPAM
TAB 2MG
92
$342.71
0.25%
97
$399.93
0.27%
00378027105
DIAZEPAM
TAB 2MG
152
$662.70
0.41%
169
$682.08
0.46%
00378032101
LORAZEPAM
TAB 0.5MG
846
$6,047.63
2.29%
452
$3,102.03
1.24%
00378032105
LORAZEPAM
TAB 0.5MG
1,373
$10,130.31
3.72%
1,785
$13,103.26
4.91%
00378034501
DIAZEPAM
TAB 5MG
431
$2,303.41
1.17%
95
$466.80
0.26%
00378034505
DIAZEPAM
TAB 5MG
609
$3,467.96
1.65%
1,542
$8,034.89
4.24%
00378045701
LORAZEPAM
TAB 1MG
611
$4,972.27
1.66%
139
$1,151.27
0.38%
00378045705
LORAZEPAM
TAB 1MG
1,218
$9,654.18
3.30%
1,726
$14,329.07
4.74%
00378045710
LORAZEPAM
TAB 1MG
163
$1,281.28
0.44%
55
$388.19
0.15%
00378047701
DIAZEPAM
TAB 10MG
244
$2,581.17
0.66%
266
$1,855.35
0.73%
00378047705
DIAZEPAM
TAB 10MG
476
$4,702.13
1.29%
403
$2,596.30
1.11%
00378077701
LORAZEPAM
TAB 2MG
340
$5,989.30
0.92%
351
$6,224.94
0.96%
00378077705
LORAZEPAM
TAB 2MG
43
$847.11
0.12%
43
$666.35
0.12%
00378400101
24
$112.59
0.07%
60
$405.88
0.16%
00378400105
871
$3,163.42
2.36%
861
$2,985.03
2.37%
00378400301
9
$58.64
0.02%
54
$452.36
0.15%
00378400305
1,415
$6,646.35
3.84%
1,383
$6,488.02
3.80%
00378400501
ALPRAZOLAM TAB 1MG
943
$5,423.38
2.56%
673
$5,384.26
1.85%
00378400505
ALPRAZOLAM TAB 1MG
126
$771.06
0.34%
356
$2,067.51
0.98%
00378400701
ALPRAZOLAM TAB 2MG
120
$1,077.15
0.33%
106
$943.56
0.29%
00555003302
CHLORDIAZEP CAP 10MG
106
$535.11
0.29%
105
$589.52
0.29%
00555003305
61
$314.37
0.17%
29
$180.51
0.08%
00555015802
CHLORDIAZEP CAP 5MG
73
$495.57
0.20%
43
$321.80
0.12%
Page 131 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
CHLORDIAZEP CAP 5MG
00555015902
00555015904
00555016302
DIAZEPAM
00555016305
$
Market Share*
00555015804
# of Scripts
3
$18.57
0.01%
3
$18.57
0.01%
172
$937.18
0.47%
185
$859.19
0.51%
12
$76.84
0.03%
19
$180.25
0.05%
TAB 2MG
7
$20.12
0.02%
1
$2.12
0.00%
DIAZEPAM
TAB 2MG
31
$114.31
0.08%
21
$77.64
0.06%
00555016402
DIAZEPAM
TAB 10MG
26
$259.60
0.07%
89
$547.52
0.24%
00555016405
DIAZEPAM
TAB 10MG
86
$1,020.20
0.23%
118
$921.92
0.32%
00555036302
DIAZEPAM
TAB 5MG
69
$340.75
0.19%
72
$399.17
0.20%
00555036305
DIAZEPAM
TAB 5MG
120
$699.12
0.33%
151
$896.03
0.42%
00591024001
LORAZEPAM
TAB 0.5MG
45
$364.75
0.12%
9
$65.62
0.02%
00591024005
LORAZEPAM
TAB 0.5MG
748
$4,779.66
2.03%
604
$3,892.41
1.66%
00591024010
LORAZEPAM
TAB 0.5MG
1,840
$12,748.73
4.99%
1,858
$12,465.59
5.11%
00591024101
LORAZEPAM
TAB 1MG
74
$462.82
0.20%
117
$867.99
0.32%
00591024105
LORAZEPAM
TAB 1MG
81
$766.34
0.22%
48
$462.27
0.13%
00591024110
LORAZEPAM
TAB 1MG
2,327
$17,905.03
6.31%
2,163
$16,312.50
5.94%
00591024201
LORAZEPAM
TAB 2MG
329
$5,279.19
0.89%
386
$6,048.22
1.06%
00591024205
LORAZEPAM
TAB 2MG
92
$1,254.60
0.25%
72
$1,014.70
0.20%
00591024210
LORAZEPAM
TAB 2MG
8
$101.80
0.02%
18
$350.80
0.05%
00591036301
0
$0.00
0.00%
20
$265.01
0.05%
00591036401
0
$0.00
0.00%
48
$919.30
0.13%
00591036501
0
$0.00
0.00%
9
$120.45
0.02%
00591078501
CHLORDIAZEP CAP 5MG
2
$17.38
0.01%
16
$124.47
0.04%
00591078601
17
$113.21
0.05%
19
$148.29
0.05%
00591078605
17
$86.34
0.05%
10
$72.23
0.03%
00591078610
9
$83.25
0.02%
13
$96.45
0.04%
00591078701
47
$284.07
0.13%
58
$291.05
0.16%
00591078705
13
$59.97
0.04%
1
$1.25
0.00%
Page 132 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
DIAZEPAM
TAB 5MG
00591561905
DIAZEPAM
TAB 5MG
00591561910
DIAZEPAM
TAB 5MG
00591562001
DIAZEPAM
TAB 10MG
00591562005
DIAZEPAM
00591562010
00591562101
$
Market Share*
00591561901
# of Scripts
$159.73
0.08%
$208.59
0.10%
24
$118.30
0.07%
345
$1,861.18
0.94%
66
$324.96
0.18%
237
$1,340.62
0.65%
55
$606.70
0.15%
74
$442.79
0.20%
TAB 10MG
2
$18.49
0.01%
21
$128.84
0.06%
DIAZEPAM
TAB 10MG
47
DIAZEPAM
TAB 2MG
13
$520.98
0.13%
46
$359.98
0.13%
$88.38
0.04%
10
$60.88
0.03%
00591562105
DIAZEPAM
TAB 2MG
33
$177.90
0.09%
37
$169.60
0.10%
00591562110
DIAZEPAM
TAB 2MG
27
$94.96
0.07%
39
$190.10
0.11%
00641037125
DIAZEPAM
00677105605
LORAZEPAM
INJ 5MG/ML
3
$24.09
0.01%
0
$0.00
0.00%
TAB 0.5MG
7
$52.27
0.02%
83
$653.80
0.23%
00677105705
LORAZEPAM
TAB 1MG
0
$0.00
0.00%
38
$270.56
0.10%
00677105710
LORAZEPAM
TAB 1MG
0
$0.00
0.00%
23
$189.11
0.06%
00781106101
60
$216.58
0.16%
13
$41.20
0.04%
00781106105
507
$1,907.64
1.37%
342
$1,381.03
0.94%
00781106110
137
$573.54
0.37%
26
$98.63
0.07%
00781107701
24
$117.34
0.07%
32
$159.33
0.09%
00781107705
468
$2,200.01
1.27%
344
$1,554.53
0.95%
00781107710
152
$812.82
0.41%
49
$274.47
0.13%
00781107901
ALPRAZOLAM TAB 1MG
249
$1,406.60
0.68%
154
$780.19
0.42%
00781107905
ALPRAZOLAM TAB 1MG
655
$3,969.74
1.78%
170
$1,011.73
0.47%
00781107910
ALPRAZOLAM TAB 1MG
90
$550.10
0.24%
0
$0.00
0.00%
00781108901
ALPRAZOLAM TAB 2MG
65
$706.60
0.18%
75
$762.26
0.21%
00781108905
ALPRAZOLAM TAB 2MG
12
$132.80
0.03%
25
$222.92
0.07%
00781140301
LORAZEPAM
TAB 0.5MG
69
$470.04
0.19%
32
$264.09
0.09%
00781140305
LORAZEPAM
TAB 0.5MG
1,482
$10,453.23
4.02%
1,486
$10,552.16
4.08%
00781140401
LORAZEPAM
TAB 1MG
93
$635.12
0.25%
17
$146.49
0.05%
28
35
Page 133 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00781140405
LORAZEPAM
TAB 1MG
534
00781140410
LORAZEPAM
TAB 1MG
00781140501
LORAZEPAM
TAB 2MG
00781140505
LORAZEPAM
00781280901
$4,703.17
1.45%
68
$531.43
0.18%
80
$1,071.63
0.22%
TAB 2MG
92
$1,165.42
0.25%
OXAZEPAM
CAP 10MG
33
$592.39
00781281001
OXAZEPAM
CAP 15MG
69
00781281005
OXAZEPAM
CAP 15MG
3
00781281101
OXAZEPAM
CAP 30MG
00904009160
$4,252.74
1.39%
7
$48.31
0.02%
28
$364.95
0.08%
41
$496.58
0.11%
0.09%
33
$686.89
0.09%
$2,389.32
0.19%
65
$2,224.18
0.18%
$145.65
0.01%
0
$0.00
0.00%
14
$448.90
0.04%
32
$1,492.30
0.09%
1
$3.77
0.00%
0
$0.00
0.00%
00904009260
1
$8.15
0.00%
0
$0.00
0.00%
00904150040
LORAZEPAM
TAB 0.5MG
3
$28.95
0.01%
0
$0.00
0.00%
00904150260
LORAZEPAM
TAB 2MG
0
$0.00
0.00%
3
$47.55
0.01%
10019010201
LORAZEPAM
INJ 2MG/ML
1
$27.27
0.00%
27
$398.80
0.07%
10019010210
LORAZEPAM
INJ 2MG/ML
0
$0.00
0.00%
8
$330.00
0.02%
51079014120
1
$10.45
0.00%
0
$0.00
0.00%
51079037520
0
$0.00
0.00%
1
$7.15
0.00%
51079041720
LORAZEPAM
TAB 0.5MG
5
$21.63
0.01%
1
$7.31
0.00%
51079041721
LORAZEPAM
TAB 0.5MG
0
$0.00
0.00%
2
$0.44
0.01%
51079078820
1
$3.39
0.00%
4
$13.87
0.01%
51079078821
0
$0.00
0.00%
2
$8.08
0.01%
51672404201
60
$971.70
0.16%
47
$898.05
0.13%
51672404301
144
$2,580.65
0.39%
129
$2,420.65
0.35%
51672404302
3
$70.05
0.01%
2
$49.20
0.01%
51672404401
17
$343.05
0.05%
20
$442.95
0.05%
52544024105
LORAZEPAM
TAB 1MG
16
$90.05
0.04%
0
$0.00
0.00%
52544024201
LORAZEPAM
TAB 2MG
1
$30.85
0.00%
0
$0.00
0.00%
52544024205
LORAZEPAM
TAB 2MG
3
$84.69
0.01%
8
$169.30
0.02%
507
Page 134 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
52544068405
52544078601
$
Market Share*
52544036405
# of Scripts
0
$0.00
0.00%
1
$9.85
0.00%
ALPRAZOLAM TAB 1MG
7
$30.75
0.02%
8
$34.40
0.02%
11
$64.67
0.03%
6
$17.70
0.02%
52544083501
35
$536.80
0.09%
7
$146.65
0.02%
52544083505
6
$107.31
0.02%
0
$0.00
0.00%
52544083601
56
$1,027.10
0.15%
6
$95.10
0.02%
52544083605
14
$194.40
0.04%
0
$0.00
0.00%
52544083701
16
$269.10
0.04%
6
$76.60
0.02%
53265004810
3
$40.35
0.01%
2
$42.00
0.01%
53265004850
3
$42.87
0.01%
1
$15.55
0.00%
53265004910
11
$201.85
0.03%
3
$75.05
0.01%
53265004950
2
$54.20
0.01%
9
$145.15
0.02%
53265005010
0
$0.00
0.00%
1
$7.85
0.00%
53489035705
LORAZEPAM
TAB 0.5MG
18
$99.58
0.05%
12
$79.55
0.03%
53489035801
LORAZEPAM
TAB 1MG
0
$0.00
0.00%
1
$4.69
0.00%
53489035805
LORAZEPAM
TAB 1MG
0
$0.00
0.00%
4
$20.30
0.01%
53489035810
LORAZEPAM
TAB 1MG
18
$133.18
0.05%
8
$71.60
0.02%
53489035901
LORAZEPAM
TAB 2MG
3
$35.05
0.01%
0
$0.00
0.00%
53489035905
LORAZEPAM
TAB 2MG
14
$228.65
0.04%
15
$249.00
0.04%
59762371901
654
$2,392.71
1.77%
793
$2,700.36
2.18%
59762371903
172
$575.87
0.47%
64
$237.86
0.18%
59762371904
184
$836.56
0.50%
339
$1,479.81
0.93%
59762372001
1,594
$7,821.37
4.32%
1,673
$8,080.52
4.60%
59762372003
385
$1,892.79
1.04%
131
$677.99
0.36%
59762372004
558
$2,887.40
1.51%
749
$3,774.99
2.06%
59762372101
ALPRAZOLAM TAB 1MG
61
$309.99
0.17%
55
$273.65
0.15%
59762372103
ALPRAZOLAM TAB 1MG
613
$3,649.26
1.66%
1,350
$7,492.00
3.71%
Page 135 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
59762372104
ALPRAZOLAM TAB 1MG
297
$1,842.09
0.81%
640
$4,021.79
1.76%
59762372201
ALPRAZOLAM TAB 2MG
371
$3,769.96
1.01%
281
$2,625.30
0.77%
59762372203
ALPRAZOLAM TAB 2MG
115
$1,013.81
0.31%
88
$932.69
0.24%
59911587701
OXAZEPAM
3
$28.93
0.01%
0
$0.00
0.00%
63304077201
LORAZEPAM
TAB 0.5MG
23
$142.71
0.06%
24
$153.35
0.07%
63304077205
LORAZEPAM
TAB 0.5MG
922
$6,789.81
2.50%
1,072
$8,096.20
2.95%
63304077301
LORAZEPAM
TAB 1MG
99
$786.53
0.27%
70
$536.90
0.19%
63304077305
LORAZEPAM
TAB 1MG
282
$2,514.55
0.76%
266
$2,443.90
0.73%
63304077310
LORAZEPAM
TAB 1MG
667
$5,731.15
1.81%
900
$7,266.63
2.47%
63304077401
LORAZEPAM
TAB 2MG
79
$1,097.92
0.21%
77
$1,350.85
0.21%
63304077405
LORAZEPAM
TAB 2MG
70
$1,261.75
0.19%
114
$1,688.05
0.31%
63739015501
LORAZEPAM
TAB 1MG
0
$0.00
0.00%
1
$3.47
0.00%
67386040401
0
$0.00
0.00%
5
$1,453.74
0.01%
7
$330.52
20.59%
16
$1,547.20
10.81%
$758.86
41.18%
60
$3,763.10
40.54%
CAP 15MG
ANXIOLYTICS - LONG ACTING
00009005707
XANAX XR
TAB 0.5MG
00009005907
XANAX XR
TAB 1MG
14
00009006607
XANAX XR
TAB 2MG
8
$793.81
23.53%
40
$3,510.50
27.03%
00009006807
XANAX XR
TAB 3MG
5
$1,018.23
14.71%
32
$3,178.67
21.62%
ANXIOLYTICS - MISC.
00049560066
ATARAX
TAB 10MG
1
$19.04
0.01%
0
$0.00
0.00%
00069542066
VISTARIL
CAP 50MG
5
$595.05
0.07%
5
$519.78
0.07%
00069544093
VISTARIL
SUS 25MG/5ML
64
$732.76
0.84%
27
$166.33
0.36%
00069544097
VISTARIL
SUS 25MG/5ML
17
$194.92
0.22%
16
$343.45
0.21%
00087081941
BUSPAR
TAB 10MG
13
$2,321.71
0.17%
3
$607.59
0.04%
00087081944
BUSPAR
TAB 10MG
1
$81.12
0.01%
0
$0.00
0.00%
Page 136 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANXIOLYTICS - MISC.
00087082232
BUSPAR
TAB 15MG
00087082481
BUSPAR
TAB 30MG
00093005301
BUSPIRONE
TAB 5MG
00093005305
BUSPIRONE
TAB 5MG
00093005401
BUSPIRONE
00093005405
00093100301
6
$1,241.26
0.08%
1
$225.43
0.01%
13
$247.87
0.17%
0
$0.00
0.00%
TAB 10MG
51
$1,266.39
0.67%
BUSPIRONE
TAB 10MG
12
$330.44
0.16%
BUSPIRONE
TAB 15MG
97
$2,434.47
1.28%
00093100305
BUSPIRONE
TAB 15MG
45
$1,075.83
0.59%
00093520006
BUSPIRONE
TAB 30MG
0
$0.00
00172290960
HYDROXYZ PAM CAP 50MG
58
00172290970
5
00172291160
00172291170
$1,515.07
0.09%
0
$0.00
0.00%
25
$487.91
0.33%
2
$45.70
0.03%
63
$2,214.35
0.83%
23
$732.59
0.30%
109
$2,370.15
1.43%
49
$1,011.87
0.64%
0.00%
13
$446.00
0.17%
$382.87
0.77%
245
$1,799.54
3.22%
$29.76
0.07%
0
$0.00
0.00%
76
$470.82
1.00%
282
$1,696.82
3.71%
30
$169.51
0.40%
47
$277.58
0.62%
00172566360
BUSPIRONE
TAB 5MG
12
$226.25
0.16%
7
$136.92
0.09%
00172566370
BUSPIRONE
TAB 5MG
58
$1,113.61
0.77%
4
$31.58
0.05%
00172566460
BUSPIRONE
TAB 10MG
39
$1,035.69
0.51%
34
$771.42
0.45%
00172566470
BUSPIRONE
TAB 10MG
103
$2,820.70
1.36%
14
$336.75
0.18%
00172566560
BUSPIRONE
TAB 15MG
65
$1,807.38
0.86%
41
$776.96
0.54%
00172566570
BUSPIRONE
TAB 15MG
8
$339.34
0.11%
5
$109.70
0.07%
00182109989
1
$7.81
0.01%
1
$8.87
0.01%
00182137640
HYDROXYZ HCL SYP 10MG/5ML
5
$67.32
0.07%
5
$60.46
0.07%
00185061301
247
$1,304.64
3.26%
232
$1,239.02
3.05%
00185061305
56
$386.42
0.74%
97
$668.35
1.28%
00185061501
91
$653.98
1.20%
103
$915.33
1.35%
00185061505
12
$112.74
0.16%
16
$101.03
0.21%
00364016101
MEPROBAMATE TAB 400MG
3
$79.40
0.04%
0
$0.00
0.00%
00364048305
2
$6.90
0.03%
0
$0.00
0.00%
7
Page 137 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANXIOLYTICS - MISC.
00364048401
7
00364049405
HYDROXYZ HCL TAB 10MG
00364049502
00364049505
00378114001
BUSPIRONE
00378115001
00378116580
$39.14
0.09%
0
$0.00
0.00%
0
$0.00
0.00%
1
$16.70
0.01%
2
$10.08
0.03%
1
$21.51
0.01%
1
$11.45
0.01%
0
$0.00
0.00%
TAB 5MG
102
$1,973.13
1.35%
92
$1,567.98
1.21%
BUSPIRONE
TAB 10MG
195
$5,094.21
2.57%
216
$5,729.01
2.84%
BUSPIRONE
TAB 15MG
113
$3,172.82
1.49%
58
$1,002.25
0.76%
00378116591
BUSPIRONE
TAB 15MG
482
$14,438.29
6.36%
464
$8,027.80
6.10%
00378117591
BUSPIRONE
TAB 30MG
420
$18,627.07
5.54%
390
$12,420.94
5.13%
00472077116
5
$38.66
0.07%
0
$0.00
0.00%
00517420125
HYDROXYZ HCL INJ 25MG/ML
0
$0.00
0.00%
1
$4.70
0.01%
00555030202
313
$2,268.35
4.13%
170
$1,361.67
2.24%
00555030204
146
$1,160.90
1.93%
112
$866.98
1.47%
00555032302
575
$3,378.44
7.59%
536
$2,974.22
7.05%
00555032304
159
$998.26
2.10%
151
$901.63
1.99%
00555032402
8
$321.70
0.11%
2
$18.78
0.03%
00591065701
BUSPIRONE
TAB 5MG
180
$2,622.80
2.38%
181
$2,774.71
2.38%
00591065705
BUSPIRONE
TAB 5MG
8
$133.92
0.11%
2
$43.80
0.03%
00591065710
BUSPIRONE
TAB 5MG
0
$0.00
0.00%
5
$123.05
0.07%
00591065801
BUSPIRONE
TAB 10MG
448
$10,473.67
5.91%
391
$9,402.02
5.14%
00591065805
BUSPIRONE
TAB 10MG
25
$797.05
0.33%
14
$503.10
0.18%
00591071805
BUSPIRONE
TAB 15MG
19
$559.05
0.25%
1
$8.05
0.01%
00591071818
BUSPIRONE
TAB 15MG
11
$268.05
0.15%
0
$0.00
0.00%
00591071860
BUSPIRONE
TAB 15MG
437
$12,790.67
5.77%
421
$7,150.10
5.54%
00591080101
253
$1,840.15
3.34%
355
$2,313.43
4.67%
00591523801
31
$2,713.04
0.41%
38
$2,989.93
0.50%
00591523810
5
$197.02
0.07%
3
$104.97
0.04%
Page 138 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANXIOLYTICS - MISC.
00591523901
00591523910
00591552201
17
$1,224.72
0.22%
3
$244.98
0.04%
24
$455.28
0.32%
00591552205
13
$216.50
0.17%
00591552301
46
$837.52
0.61%
00591552305
8
$92.90
0.11%
00591552310
77
$1,425.29
1.02%
00591572601
464
$2,498.48
6.12%
00591572605
116
$701.06
00603131058
0
00677059601
2
00677060501
8
00677060601
00677060605
00677060610
$1,180.63
0.17%
0
$0.00
0.00%
30
$726.89
0.39%
21
$532.01
0.28%
19
$271.76
0.25%
1
$15.11
0.01%
22
$210.29
0.29%
574
$3,123.30
7.55%
1.53%
90
$520.74
1.18%
$0.00
0.00%
27
$178.83
0.36%
$10.18
0.03%
3
$20.31
0.04%
$198.79
0.11%
2
$17.38
0.03%
9
$445.06
0.12%
1
$8.77
0.01%
2
$74.56
0.03%
0
$0.00
0.00%
1
$9.49
0.01%
1
$10.00
0.01%
00677142133
8
$113.75
0.11%
0
$0.00
0.00%
00781133601
1
$4.48
0.01%
0
$0.00
0.00%
00904558740
BUSPIRONE
TAB 5MG
12
$234.80
0.16%
12
$216.50
0.16%
00904558840
BUSPIRONE
TAB 10MG
7
$160.71
0.09%
0
$0.00
0.00%
00904558860
BUSPIRONE
TAB 10MG
1
$26.05
0.01%
0
$0.00
0.00%
00904558960
BUSPIRONE
TAB 15MG
1
$51.25
0.01%
0
$0.00
0.00%
00904558993
BUSPIRONE
TAB 15MG
0
$0.00
0.00%
1
$8.05
0.01%
49884070701
BUSPIRONE
TAB 5MG
21
$383.27
0.28%
29
$459.95
0.38%
49884070705
BUSPIRONE
TAB 5MG
3
$42.15
0.04%
7
$135.79
0.09%
49884070801
BUSPIRONE
TAB 10MG
37
$976.60
0.49%
47
$994.56
0.62%
49884070805
BUSPIRONE
TAB 10MG
31
$686.71
0.41%
44
$946.28
0.58%
49884072101
BUSPIRONE
TAB 15MG
30
$774.89
0.40%
10
$248.60
0.13%
13
Page 139 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANXIOLYTICS - MISC.
49884072102
BUSPIRONE
TAB 15MG
42
$1,217.30
0.55%
53
$886.16
0.70%
49884072105
BUSPIRONE
TAB 15MG
89
$2,870.34
1.17%
41
$836.45
0.54%
49884072113
BUSPIRONE
TAB 15MG
17
$518.35
0.22%
40
$687.60
0.53%
49884072501
BUSPIRONE
TAB 7.5MG
45
$2,673.01
0.59%
51
$2,013.05
0.67%
49884072505
BUSPIRONE
TAB 7.5MG
30
$2,778.84
0.40%
26
$1,308.28
0.34%
50111030701
194
$3,966.03
2.56%
215
$4,795.44
2.83%
50111030702
3
$80.71
0.04%
50
$771.26
0.66%
50111030703
12
$551.41
0.16%
29
$594.64
0.38%
50111030801
290
$7,143.49
3.83%
92
$928.72
1.21%
50111030802
42
$1,181.78
0.55%
25
$254.51
0.33%
50111030803
33
$665.06
0.44%
4
$56.30
0.05%
50111030901
98
$2,785.89
1.29%
29
$335.24
0.38%
50111030902
2
$72.00
0.03%
1
$13.22
0.01%
50383079616
110
$1,195.68
1.45%
120
$1,226.70
1.58%
51079099420
BUSPIRONE
TAB 30MG
0
$0.00
0.00%
1
$38.05
0.01%
52152022202
BUSPIRONE
TAB 5MG
0
$0.00
0.00%
1
$9.95
0.01%
52152022204
BUSPIRONE
TAB 5MG
0
$0.00
0.00%
11
$375.75
0.14%
52152022302
BUSPIRONE
TAB 10MG
26
$631.92
0.34%
38
$832.36
0.50%
52152022304
BUSPIRONE
TAB 10MG
40
$1,193.59
0.53%
31
$1,016.19
0.41%
52152022402
BUSPIRONE
TAB 15MG
12
$373.00
0.16%
6
$86.80
0.08%
52152022403
BUSPIRONE
TAB 15MG
14
$496.92
0.18%
35
$575.95
0.46%
52152022422
BUSPIRONE
TAB 15MG
19
$556.76
0.25%
28
$544.24
0.37%
52544065701
BUSPIRONE
TAB 5MG
17
$359.91
0.22%
11
$168.65
0.14%
52544065801
BUSPIRONE
TAB 10MG
28
$704.71
0.37%
0
$0.00
0.00%
52544065805
BUSPIRONE
TAB 10MG
3
$86.55
0.04%
0
$0.00
0.00%
52544069910
0
$0.00
0.00%
1
$5.48
0.01%
53265038710
0
$0.00
0.00%
5
$116.74
0.07%
Page 140 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ANXIOLYTICS - MISC.
53265038810
0
$0.00
0.00%
1
$10.61
0.01%
53489012701
7
$259.14
0.09%
7
$157.13
0.09%
53489012705
5
$32.46
0.07%
6
$78.27
0.08%
53489012710
2
$92.48
0.03%
0
$0.00
0.00%
53489012801
4
$158.22
0.05%
9
$264.38
0.12%
58177026404
BUSPIRONE
TAB 5MG
17
$312.97
0.22%
23
$470.45
0.30%
58177026408
BUSPIRONE
TAB 5MG
11
$103.03
0.15%
82
$1,278.34
1.08%
58177026422
BUSPIRONE
TAB 5MG
1
$20.65
0.01%
0
$0.00
0.00%
58177026504
BUSPIRONE
TAB 10MG
12
$286.33
0.16%
16
$352.00
0.21%
58177026508
BUSPIRONE
TAB 10MG
44
$1,072.85
0.58%
170
$4,067.14
2.24%
58177030904
BUSPIRONE
TAB 15MG
26
$737.25
0.34%
71
$1,323.43
0.93%
58177030908
BUSPIRONE
TAB 15MG
40
$1,165.00
0.53%
129
$2,234.33
1.70%
60432015004
9
$44.19
0.12%
1
$21.77
0.01%
60432015016
147
$1,810.19
1.94%
91
$1,039.42
1.20%
63304050205
BUSPIRONE
TAB 15MG
0
$0.00
0.00%
13
$251.45
0.17%
63304050228
BUSPIRONE
TAB 15MG
0
$0.00
0.00%
3
$67.35
0.04%
63323005101
HYDROXYZ HCL INJ 50MG/ML
1
$18.85
0.01%
3
$20.85
0.04%
ARB'S AND DIURETICS
00006071731
HYZAAR
TAB 50-12.5
166
$6,748.76
10.87%
112
$4,993.60
9.78%
00006071754
HYZAAR
TAB 50-12.5
61
$2,500.23
3.99%
44
$1,989.76
3.84%
00006071758
HYZAAR
TAB 50-12.5
102
$4,177.06
6.68%
24
$1,054.74
2.10%
00006074728
HYZAAR
TAB 100-25
1
$57.22
0.07%
0
$0.00
0.00%
00006074731
HYZAAR
TAB 100-25
229
$12,527.77
15.00%
232
$13,539.10
20.26%
00006074754
HYZAAR
TAB 100-25
0
$0.00
0.00%
56
$3,331.24
4.89%
00006074758
HYZAAR
TAB 100-25
149
$8,364.96
9.76%
77
$5,609.96
6.72%
00078031405
DIOVAN HCT TAB 80/12.5
118
$5,237.43
7.73%
4
$175.73
0.35%
Page 141 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ARB'S AND DIURETICS
00078031406
00078031434
0
00078031505
200
00078031506
2
00078031534
00078038305
00078038334
00087277531
AVALIDE
00087277532
0.00%
3
$74.78
0.26%
$0.00
0.00%
19
$1,056.42
1.66%
$10,652.97
13.10%
13
$726.63
1.14%
$103.26
0.13%
1
$6.94
0.09%
0
$0.00
0.00%
18
$863.53
1.57%
DIOVAN HCT TAB 160-25MG
55
$2,868.25
3.60%
7
$334.81
0.61%
DIOVAN HCT TAB 160-25MG
0
$0.00
0.00%
13
$535.80
1.14%
TAB 150-12.5
19
$1,193.48
1.24%
11
$204.80
0.96%
AVALIDE
TAB 150-12.5
5
$286.53
0.33%
0
$0.00
0.00%
00087277631
AVALIDE
TAB 300-12.5
24
$1,366.86
1.57%
10
$351.05
0.87%
00087277632
AVALIDE
TAB 300-12.5
3
$119.71
0.20%
0
$0.00
0.00%
00186016228
ATACAND HCT TAB 16-12.5
2
$109.38
0.13%
0
$0.00
0.00%
00186016254
12
$591.09
0.79%
1
$17.50
0.09%
00186032228
4
$224.44
0.26%
0
$0.00
0.00%
00186032254
40
$2,034.02
2.62%
16
$826.12
1.40%
00597004328
MICARDIS HCT TAB 40/12.5
39
$1,889.45
2.55%
45
$2,136.62
3.93%
00597004337
0
$0.00
0.00%
1
$97.45
0.09%
00597004428
40
$2,070.74
2.62%
62
$3,471.58
5.41%
00597004437
0
$0.00
0.00%
1
$146.82
0.09%
64455013201
TEVETEN HCT TAB 600-12.5
45
$1,674.25
2.95%
41
$1,653.21
3.58%
64455013301
TEVETEN HCT TAB 600-25MG
13
$442.01
0.85%
26
$901.02
2.27%
65597010530
BENICAR HCT TAB 20-12.5
65
$2,858.90
4.26%
101
$4,515.78
8.82%
65597010590
9
$406.60
0.59%
29
$1,507.82
2.53%
65597010630
85
$3,766.01
5.57%
121
$5,845.39
10.57%
65597010690
17
$858.88
1.11%
23
$1,256.20
2.01%
65597010730
BENICAR HCT TAB 40-25MG
19
$833.57
1.24%
26
$1,239.61
2.27%
65597010790
BENICAR HCT TAB 40-25MG
3
$115.17
0.20%
8
$556.58
0.70%
0
$0.00
Page 142 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ARTHRITIS - MISC.
00025141160
ARTHROTEC 50 TAB
45
$3,912.24
36.00%
26
$1,453.61
40.00%
00025141190
ARTHROTEC 50 TAB
9
$1,177.87
7.20%
0
$0.00
0.00%
00025142160
ARTHROTEC 75 TAB
61
$4,851.97
48.80%
32
$2,115.76
49.23%
63032001160
RIDAURA
CAP 3MG
1
$148.98
0.80%
0
$0.00
0.00%
65483009306
RIDAURA
CAP 3MG
9
$1,472.55
7.20%
7
$1,170.96
10.77%
ARTIFICIAL SALIVA/STIMULANTS
00054376950
SALIVA SUBST SOL
3
$17.62
8.11%
1
$4.73
2.13%
00781510001
PILOCARPINE TAB 5MG
0
$0.00
0.00%
1
$185.02
2.13%
58063070510
SALAGEN
TAB 5MG
12
$1,028.78
32.43%
17
$1,979.61
36.17%
63395020113
EVOXAC
CAP 30MG
22
$2,292.19
59.46%
28
$3,416.77
59.57%
BETA BLOCKERS - ALPHA / BETA
00172436460
LABETALOL
TAB 100MG
68
$619.44
10.10%
67
$640.44
9.80%
00172436470
LABETALOL
TAB 100MG
0
$0.00
0.00%
2
$23.40
0.29%
00172436560
LABETALOL
TAB 200MG
48
$949.66
7.13%
74
$1,464.56
10.82%
00172436570
LABETALOL
TAB 200MG
22
$528.88
3.27%
4
$55.26
0.58%
00172436660
LABETALOL
TAB 300MG
23
$346.35
3.42%
29
$735.05
4.24%
00185001001
LABETALOL
TAB 100MG
111
$1,317.21
16.49%
103
$1,299.28
15.06%
00185001005
LABETALOL
TAB 100MG
7
$60.62
1.04%
3
$31.35
0.44%
00185011701
LABETALOL
TAB 200MG
177
$4,125.47
26.30%
142
$3,417.38
20.76%
00185011705
LABETALOL
TAB 200MG
34
$781.06
5.05%
27
$688.60
3.95%
00185011801
LABETALOL
TAB 300MG
51
$1,151.30
7.58%
35
$1,252.60
5.12%
00185011805
LABETALOL
TAB 300MG
3
$47.55
0.45%
1
$22.45
0.15%
00591060501
LABETALOL
TAB 100MG
23
$270.65
3.42%
25
$240.26
3.65%
00591060505
LABETALOL
TAB 100MG
5
$70.05
0.74%
0
$0.00
0.00%
Page 143 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
BETA BLOCKERS - ALPHA / BETA
00591060601
LABETALOL
TAB 200MG
28
00591060605
LABETALOL
TAB 200MG
00591060701
LABETALOL
TAB 300MG
00677170301
LABETALOL
52544060501
$889.66
4.16%
30
$1,150.52
4.39%
1
$47.42
0.15%
6
$140.10
0.89%
1
$24.13
0.15%
9
$253.85
1.32%
TAB 300MG
2
$76.70
0.30%
1
$36.85
0.15%
LABETALOL
TAB 100MG
14
$132.08
2.08%
4
$32.60
0.58%
52544060601
LABETALOL
TAB 200MG
52544060605
LABETALOL
TAB 200MG
11
$221.17
1.63%
0
$0.00
0.00%
3
$79.89
0.45%
0
$0.00
0.00%
53489035401
LABETALOL
TAB 100MG
5
$59.20
0.74%
40
$498.36
5.85%
53489035405
LABETALOL
TAB 100MG
7
$116.35
1.04%
0
$0.00
0.00%
53489035501
LABETALOL
TAB 200MG
3
$149.76
0.45%
36
$839.31
5.26%
53489035505
LABETALOL
TAB 200MG
6
$110.72
0.89%
11
$197.57
1.61%
53489035601
LABETALOL
TAB 300MG
0
$0.00
0.00%
35
$1,209.11
5.12%
53489035605
LABETALOL
TAB 300MG
6
$105.10
0.89%
0
$0.00
0.00%
59930163601
LABETALOL
TAB 200MG
7
$122.09
1.04%
5
$97.37
0.73%
59930165301
LABETALOL
TAB 300MG
1
$18.35
0.15%
0
$0.00
0.00%
65483039210
TRANDATE
TAB 200MG
1
$1.00
0.15%
0
$0.00
0.00%
BETA BLOCKERS - CARDIO SELECTIVE
00005321834
ATENOLOL
TAB 25MG
1
$1.33
0.00%
0
$0.00
0.00%
00005321843
ATENOLOL
TAB 25MG
1
$2.91
0.00%
0
$0.00
0.00%
00005381638
ZEBETA
2
$57.42
0.01%
0
$0.00
0.00%
00028005101
LOPRESSOR
TAB 50MG
28
$1,802.52
0.08%
13
$746.55
0.04%
00028005110
LOPRESSOR
TAB 50MG
1
$27.03
0.00%
3
$88.30
0.01%
00028007101
LOPRESSOR
TAB 100MG
7
$562.36
0.02%
5
$485.06
0.01%
00093073301
METOPROLOL TAB 50MG
1
$3.55
0.00%
23
$182.39
0.06%
00093073310
METOPROLOL TAB 50MG
3,555
$12,782.94
10.59%
3,100
$11,910.24
8.67%
00093073401
METOPROLOL TAB 100MG
295
$1,699.02
0.88%
316
$2,198.64
0.88%
TAB 5MG
Page 144 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00093075210
ATENOLOL
00093075301
ATENOLOL
$
Market Share*
00093073410
# of Scripts
616
$3,586.83
1.83%
613
$3,468.02
1.71%
TAB 50MG
18
$82.99
0.05%
176
$837.40
0.49%
TAB 100MG
0
$0.00
0.00%
14
$86.73
0.04%
00093527056
BISOPROL FUM TAB 5MG
0
$0.00
0.00%
16
$493.19
0.04%
00185077101
5
$76.25
0.01%
1
$79.84
0.00%
00185077130
34
$584.25
0.10%
21
$588.05
0.06%
00185077401
1
$28.99
0.00%
3
$98.22
0.01%
00185077430
2
$57.98
0.01%
0
$0.00
0.00%
00186108805
TOPROL XL
TAB 25MG
888
$17,957.44
2.64%
1,214
$28,354.17
3.40%
00186108839
TOPROL XL
TAB 25MG
8
$104.91
0.02%
1
$1.21
0.00%
00186109005
TOPROL XL
TAB 50MG
1,728
$37,159.02
5.15%
2,230
$54,213.03
6.24%
00186109039
TOPROL XL
TAB 50MG
3
$6.27
0.01%
1
$1.51
0.00%
00186109205
TOPROL XL
TAB 100MG
998
$35,095.76
2.97%
1,637
$62,844.26
4.58%
00186109239
TOPROL XL
TAB 100MG
2
$68.65
0.01%
0
$0.00
0.00%
00186109405
TOPROL XL
TAB 200MG
309
$16,654.48
0.92%
394
$22,538.66
1.10%
00310010110
TENORMIN
TAB 100MG
3
$232.72
0.01%
0
$0.00
0.00%
00310010510
TENORMIN
TAB 50MG
6
$224.78
0.02%
3
$112.24
0.01%
00310010710
TENORMIN
TAB 25MG
5
$175.15
0.01%
4
$111.51
0.01%
00364251301
ATENOLOL
TAB 50MG
0
$0.00
0.00%
3
$9.75
0.01%
00364251302
ATENOLOL
TAB 50MG
5
$25.75
0.01%
4
$25.40
0.01%
00364251401
ATENOLOL
TAB 100MG
11
$73.70
0.03%
5
$30.32
0.01%
00378001801
METOPROLOL TAB 25MG
0
$0.00
0.00%
1,578
$20,726.70
4.41%
00378003201
METOPROLOL TAB 50MG
654
$2,457.43
1.95%
180
$795.56
0.50%
00378003210
METOPROLOL TAB 50MG
3,118
$14,231.76
9.29%
2,003
$9,378.05
5.60%
00378004701
234
$1,458.75
0.70%
264
$1,579.03
0.74%
00378004710
380
$2,520.71
1.13%
304
$2,049.71
0.85%
00378021801
ATENOLOL
724
$5,439.23
2.16%
453
$3,291.02
1.27%
TAB 25MG
Page 145 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ATENOLOL
TAB 25MG
00378023101
ATENOLOL
00378023110
ATENOLOL
00378075701
ATENOLOL
TAB 100MG
00378120001
$
Market Share*
00378021810
# of Scripts
137
$1,104.74
0.41%
486
$3,822.80
1.36%
TAB 50MG
578
$2,727.82
TAB 50MG
1,315
$6,846.74
1.72%
208
$1,166.27
0.58%
3.92%
1,877
$9,316.12
5.25%
595
$4,742.69
1.77%
645
$5,316.42
1.80%
ACEBUTOLOL CAP 200MG
33
$503.00
0.10%
13
$235.30
0.04%
00378140001
00591046201
11
$249.05
0.03%
9
$393.52
0.03%
METOPROLOL TAB 50MG
4
$13.30
0.01%
0
$0.00
0.00%
00591046210
METOPROLOL TAB 50MG
20
$81.40
0.06%
20
$90.53
0.06%
00591046301
1
$5.05
0.00%
6
$42.44
0.02%
00591046310
0
$0.00
0.00%
3
$27.75
0.01%
00591577701
ATENOLOL
TAB 50MG
27
$122.95
0.08%
52
$237.51
0.15%
00591577710
ATENOLOL
TAB 50MG
371
$1,846.35
1.11%
706
$3,439.19
1.98%
00591577801
ATENOLOL
TAB 100MG
459
$3,610.13
1.37%
164
$1,392.30
0.46%
00677147810
ATENOLOL
TAB 50MG
2
$11.24
0.01%
13
$57.39
0.04%
00677147901
ATENOLOL
TAB 100MG
4
$33.20
0.01%
0
$0.00
0.00%
00677148210
METOPROLOL TAB 50MG
29
$107.65
0.09%
27
$114.84
0.08%
00677148301
0
$0.00
0.00%
1
$7.49
0.00%
00781107801
ATENOLOL
TAB 25MG
1,836
$14,243.67
5.47%
1,780
$13,727.64
4.98%
00781107810
ATENOLOL
TAB 25MG
2,203
$16,871.15
6.56%
2,628
$20,125.82
7.35%
00781122301
METOPROLOL TAB 50MG
1
$3.21
0.00%
0
$0.00
0.00%
00781122310
METOPROLOL TAB 50MG
4
$23.45
0.01%
6
$21.79
0.02%
00781122801
14
$93.03
0.04%
3
$22.53
0.01%
00781122810
6
$45.30
0.02%
0
$0.00
0.00%
00781150601
ATENOLOL
TAB 50MG
120
$550.44
0.36%
36
$165.28
0.10%
00781150610
ATENOLOL
TAB 50MG
3,482
$15,871.22
10.37%
4,241
$19,298.53
11.86%
00781150701
ATENOLOL
TAB 100MG
988
$7,735.27
2.94%
1,237
$9,346.89
3.46%
00781150710
ATENOLOL
TAB 100MG
399
$3,377.42
1.19%
314
$2,504.31
0.88%
Page 146 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00904539260
ATENOLOL
TAB 25MG
0
$0.00
0.00%
3
$24.42
0.01%
00904539280
ATENOLOL
TAB 25MG
4
$19.27
0.01%
0
$0.00
0.00%
00904794660
METOPROLOL TAB 50MG
3
$14.30
0.01%
0
$0.00
0.00%
00904794680
METOPROLOL TAB 50MG
228
$839.57
0.68%
3
$10.65
0.01%
00904794760
0
$0.00
0.00%
1
$4.81
0.00%
00904794780
11
$81.70
0.03%
13
$72.49
0.04%
49884058701
6
$105.90
0.02%
15
$256.35
0.04%
49884058801
6
$82.50
0.02%
9
$123.75
0.03%
51079068420
ATENOLOL
1
$1.40
0.00%
0
$0.00
0.00%
51079080120
METOPROLOL TAB 50MG
14
$60.92
0.04%
12
$47.71
0.03%
51285006001
ZEBETA
0
$0.00
0.00%
3
$175.41
0.01%
52152017902
BETAXOLOL
TAB 10MG
12
$525.09
0.04%
10
$338.08
0.03%
52152018002
BETAXOLOL
TAB 20MG
0
$0.00
0.00%
2
$109.31
0.01%
52544046301
7
$56.51
0.02%
0
$0.00
0.00%
53265041211
ATENOLOL
TAB 25MG
0
$0.00
0.00%
17
$151.63
0.05%
53265041311
ATENOLOL
TAB 50MG
0
$0.00
0.00%
2
$9.00
0.01%
53265041410
ATENOLOL
TAB 100MG
0
$0.00
0.00%
1
$6.68
0.00%
53265041411
ATENOLOL
TAB 100MG
0
$0.00
0.00%
6
$39.78
0.02%
53489036601
METOPROLOL TAB 50MG
7
$24.85
0.02%
2
$4.40
0.01%
53489036610
METOPROLOL TAB 50MG
173
$692.02
0.52%
122
$417.07
0.34%
53489036701
8
$48.04
0.02%
0
$0.00
0.00%
53489036710
47
$259.31
0.14%
31
$201.94
0.09%
53489052901
ATENOLOL
TAB 50MG
105
$503.74
0.31%
119
$545.38
0.33%
53489052910
ATENOLOL
TAB 50MG
1,440
$6,653.71
4.29%
308
$1,502.89
0.86%
53489053001
ATENOLOL
TAB 100MG
13
$90.25
0.04%
7
$55.60
0.02%
53489053010
ATENOLOL
TAB 100MG
2
$11.60
0.01%
135
$1,089.49
0.38%
53489053601
ATENOLOL
TAB 25MG
151
$1,031.26
0.45%
23
$174.34
0.06%
TAB 50MG
TAB 5MG
Page 147 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ATENOLOL
53489055501
53489055507
TAB 25MG
$
Market Share*
53489053610
# of Scripts
817
$5,857.68
2.43%
570
$4,269.50
1.59%
10
$195.55
0.03%
10
$383.85
0.03%
3
$41.25
0.01%
5
$150.75
0.01%
53489055601
3
$193.89
0.01%
1
$169.69
0.00%
57664016608
METOPROLOL TAB 50MG
61
$215.05
0.18%
61
$239.03
0.17%
57664016618
METOPROLOL TAB 50MG
3,213
$12,148.99
9.57%
3,109
$11,805.15
8.70%
57664016708
93
$666.84
0.28%
114
$765.11
0.32%
57664016718
822
$4,867.93
2.45%
861
$5,131.31
2.41%
57664047718
METOPROLOL TAB 50MG
0
$0.00
0.00%
196
$1,172.07
0.55%
57664050608
METOPROLOL TAB 25MG
0
$0.00
0.00%
161
$1,958.11
0.45%
57664050618
METOPROLOL TAB 25MG
0
$0.00
0.00%
754
$9,827.05
2.11%
59772369205
METOPROLOL TAB 50MG
19
$89.35
0.06%
0
$0.00
0.00%
59772369302
3
$15.15
0.01%
0
$0.00
0.00%
62269025630
ATENOLOL
TAB 50MG
3
$10.89
0.01%
0
$0.00
0.00%
62269025724
ATENOLOL
TAB 100MG
2
$10.70
0.01%
0
$0.00
0.00%
62269025930
ATENOLOL
TAB 25MG
3
$21.09
0.01%
0
$0.00
0.00%
63739002801
ATENOLOL
TAB 50MG
2
$5.62
0.01%
0
$0.00
0.00%
63739017301
METOPROLOL TAB 50MG
0
$0.00
0.00%
3
$3.00
0.01%
TAB 40MG
3
$129.88
0.05%
0
$0.00
0.00%
BETA BLOCKERS - NON SELECTIVE
00003020750
CORGARD
00007413920
COREG
TAB 3.125MG
242
$20,836.73
3.74%
271
$23,136.26
4.18%
00007414020
COREG
TAB 6.25MG
301
$26,614.26
4.65%
441
$40,432.97
6.81%
00007414055
COREG
TAB 6.25MG
1
$90.89
0.02%
0
$0.00
0.00%
00007414120
COREG
TAB 12.5MG
187
$16,109.63
2.89%
207
$18,764.40
3.19%
00007414220
COREG
TAB 25MG
145
$12,180.41
2.24%
283
$27,244.34
4.37%
00046042281
INDERAL
1
$68.71
0.02%
0
$0.00
0.00%
TAB 20MG
Page 148 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
INDERAL
TAB 40MG
00046042681
INDERAL
TAB 60MG
00046047081
INDERAL LA CAP 60MG
00046047181
INDERAL LA CAP 80MG
00046047381
$
Market Share*
00046042481
# of Scripts
$445.56
0.09%
$279.87
0.05%
1
$31.31
0.02%
405
$14,184.29
6.25%
0
$0.00
0.00%
428
$16,737.40
6.60%
657
$29,160.15
10.14%
609
$28,918.95
9.40%
INDERAL LA CAP 120MG
331
$19,595.12
5.11%
324
$20,392.12
5.00%
00046047981
INDERAL LA CAP 160MG
188
00054372763
PROPRANOLOL SOL 20MG/5ML
22
$13,578.85
2.90%
193
$15,973.19
2.98%
$261.97
0.34%
14
$192.51
0.22%
00054373063
0
$0.00
0.00%
2
$12.00
0.03%
00054876416
0
$0.00
0.00%
3
$133.80
0.05%
00093106001
00093106101
SOTALOL HCL TAB 120MG
73
$2,037.15
1.13%
43
$1,293.30
0.66%
191
$3,803.53
2.95%
114
$2,360.35
1.76%
00093106201
22
$878.80
0.34%
10
$420.10
0.15%
00093106301
3
$117.75
0.05%
3
$111.04
0.05%
00115271101
4
$140.30
0.06%
13
$231.85
0.20%
00115272201
0
$0.00
0.00%
2
$49.70
0.03%
00172421760
PINDOLOL
TAB 5MG
13
$116.58
0.20%
19
$188.09
0.29%
00172421860
PINDOLOL
TAB 10MG
20
$328.93
0.31%
11
$211.87
0.17%
00172423560
NADOLOL
TAB 20MG
15
$130.89
0.23%
27
$261.75
0.42%
00172423570
NADOLOL
TAB 20MG
13
$101.25
0.20%
2
$15.00
0.03%
00172423660
NADOLOL
TAB 40MG
26
$200.10
0.40%
11
$85.35
0.17%
00172423760
NADOLOL
TAB 80MG
5
$48.75
0.08%
6
$81.08
0.09%
00172423860
NADOLOL
TAB 120MG
3
$33.15
0.05%
4
$42.50
0.06%
00172423960
NADOLOL
TAB 160MG
1
$26.15
0.02%
2
$49.80
0.03%
00182181389
PROPRANOLOL TAB 20MG
0
$0.00
0.00%
2
$10.16
0.03%
00185017001
22
$637.40
0.34%
34
$848.90
0.52%
00185017101
52
$963.78
0.80%
59
$1,207.95
0.91%
00185017105
4
$82.70
0.06%
6
$63.15
0.09%
6
3
Page 149 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00185017701
0
$0.00
0.00%
2
$119.30
0.03%
00364075601
3
$25.86
0.05%
0
$0.00
0.00%
00364075602
1
$5.11
0.02%
0
$0.00
0.00%
00364075701
1
$7.20
0.02%
0
$0.00
0.00%
00364075702
20
$122.15
0.31%
1
$4.50
0.02%
00364075802
20
$149.58
0.31%
11
$91.75
0.17%
00364076001
1
$23.65
0.02%
0
$0.00
0.00%
00378002801
NADOLOL
TAB 20MG
125
$1,108.32
1.93%
89
$805.71
1.37%
00378005201
PINDOLOL
TAB 5MG
31
$300.77
0.48%
18
$208.05
0.28%
00378005501
TIMOLOL MAL TAB 5MG
16
$217.76
0.25%
22
$274.03
0.34%
00378012701
PINDOLOL
21
$281.52
0.32%
25
$280.87
0.39%
00378018201
0
$0.00
0.00%
46
$313.17
0.71%
00378018210
135
$864.00
2.08%
64
$415.60
0.99%
00378018301
2
$18.62
0.03%
50
$395.16
0.77%
00378018310
158
$1,202.59
2.44%
91
$635.47
1.40%
00378018401
3
$18.44
0.05%
31
$319.06
0.48%
00378018410
91
$701.53
1.40%
81
$578.20
1.25%
00378018501
8
$80.62
0.12%
6
$43.38
0.09%
00378018505
18
$230.02
0.28%
24
$208.12
0.37%
00378022101
TIMOLOL MAL TAB 10MG
22
$450.59
0.34%
17
$386.88
0.26%
00378030501
20
$474.36
0.31%
4
$81.48
0.06%
00378031001
11
$276.85
0.17%
5
$142.20
0.08%
00378031401
0
$0.00
0.00%
2
$60.50
0.03%
00378071501
TIMOLOL MAL TAB 20MG
2
$83.60
0.03%
0
$0.00
0.00%
00378113201
NADOLOL
TAB 80MG
54
$535.59
0.83%
43
$536.43
0.66%
00378117101
NADOLOL
TAB 40MG
109
$1,182.94
1.68%
87
$983.45
1.34%
00378117110
NADOLOL
TAB 40MG
2
$13.70
0.03%
3
$32.55
0.05%
TAB 10MG
Page 150 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00591555401
78
$419.62
1.20%
83
$432.50
1.28%
00591555410
56
$321.86
0.86%
53
$301.44
0.82%
00591555501
82
$523.06
1.27%
78
$543.25
1.20%
00591555510
90
$677.44
1.39%
145
$983.27
2.24%
00591555601
57
$435.27
0.88%
67
$644.58
1.03%
00591555610
29
$207.22
0.45%
74
$450.82
1.14%
00591555701
19
$150.19
0.29%
27
$231.53
0.42%
00591555705
12
$105.26
0.19%
13
$100.33
0.20%
00603549132
3
$30.49
0.05%
0
$0.00
0.00%
00603549221
0
$0.00
0.00%
3
$25.80
0.05%
00677145801
PINDOLOL
1
$7.61
0.02%
0
$0.00
0.00%
00677170901
10
$215.08
0.15%
12
$284.40
0.19%
00781138405
4
$19.32
0.06%
0
$0.00
0.00%
00904041280
2
$14.40
0.03%
0
$0.00
0.00%
49884058201
39
$751.37
0.60%
61
$1,084.77
0.94%
49884058210
33
$596.71
0.51%
4
$75.80
0.06%
49884058301
45
$1,084.05
0.69%
24
$598.40
0.37%
49884058310
0
$0.00
0.00%
2
$42.70
0.03%
49884058401
0
$0.00
0.00%
5
$220.05
0.08%
50111046701
42
$283.21
0.65%
87
$489.98
1.34%
50111046703
341
$2,119.46
5.26%
317
$1,890.67
4.89%
50111046801
30
$185.69
0.46%
33
$250.32
0.51%
50111046803
487
$3,338.39
7.52%
433
$2,744.16
6.68%
50111046901
19
$150.66
0.29%
21
$155.69
0.32%
50111046903
461
$3,335.83
7.12%
360
$2,582.59
5.56%
50111047001
87
$669.95
1.34%
99
$732.56
1.53%
50111047101
61
$650.92
0.94%
80
$820.46
1.23%
TAB 10MG
Page 151 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
50419010510
BETAPACE
TAB 80MG
50419010910
BETAPACE
TAB 120MG
50419011506
$
Market Share*
50111047102
# of Scripts
$239.47
0.46%
29
$242.94
0.45%
3
$363.90
0.05%
9
$2,013.39
0.14%
0
$0.00
0.00%
9
$1,967.31
0.14%
BETAPACE AF TAB 80MG
7
$990.50
0.11%
2
$299.94
0.03%
50419011606
4
$1,022.16
0.06%
3
$705.15
0.05%
50419011906
52544030501
4
$817.92
0.06%
3
$599.40
0.05%
0
$0.00
0.00%
1
$6.86
0.02%
59772246101
NADOLOL
TAB 20MG
177
$1,354.32
2.73%
173
$1,416.38
2.67%
59772246201
NADOLOL
TAB 40MG
162
$1,409.40
2.50%
146
$1,315.56
2.25%
59772246203
NADOLOL
TAB 40MG
6
$65.10
0.09%
2
$76.20
0.03%
59772246301
NADOLOL
TAB 80MG
74
$872.35
1.14%
75
$1,001.22
1.16%
59772246303
NADOLOL
TAB 80MG
2
$23.50
0.03%
0
$0.00
0.00%
59772246401
NADOLOL
TAB 120MG
18
$304.30
0.28%
15
$263.60
0.23%
59772246501
NADOLOL
TAB 160MG
6
$179.14
0.09%
4
$85.70
0.06%
59911547001
PROPRANOLOL CAP 60MG LA
1
$19.44
0.02%
0
$0.00
0.00%
59911547101
1
$33.88
0.02%
0
$0.00
0.00%
59911547301
1
$41.79
0.02%
0
$0.00
0.00%
59911547901
1
$42.85
0.02%
0
$0.00
0.00%
60505008000
27
$595.11
0.42%
37
$770.91
0.57%
60505008100
2
$60.50
0.03%
3
$90.75
0.05%
60505015900
9
$251.94
0.14%
7
$149.95
0.11%
60505022201
SOTALOL AF TAB 80MG
3
$414.60
0.05%
4
$431.80
0.06%
60505022301
SOTALOL AF TAB 120MG
1
$208.53
0.02%
2
$496.25
0.03%
61570020101
CORGARD
1
$61.96
0.02%
3
$172.83
0.05%
65726025010
INNOPRAN XL CAP 80MG
8
$198.50
0.12%
2
$69.31
0.03%
65726025025
INNOPRAN XL CAP 80MG
1
$31.84
0.02%
11
$397.02
0.17%
TAB 40MG
30
Page 152 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
BETA BLOCKERS AND DIURETIC COMBO'S
00005323423
ZIAC
TAB 5/6.25MG
1
$38.01
0.14%
0
00005323538
ZIAC
TAB 10/6.25
3
$86.75
0.41%
00006006768
TIMOLIDE
3
$74.61
0.41%
00028003501
LOPRESS HCT TAB 50/25MG
2
$36.10
00028005301
3
00028007301
00185070101
BISOPRL/HCTZ TAB 2.5/6.25
00185070105
00185070130
00185070401
00185070405
$0.00
0.00%
0
$0.00
0.00%
2
$45.88
0.28%
0.27%
0
$0.00
0.00%
$144.84
0.41%
0
$0.00
0.00%
1
$51.15
0.14%
0
$0.00
0.00%
39
$301.60
5.35%
41
$356.85
5.82%
1
$17.95
0.14%
1
$17.95
0.14%
7
$45.85
0.96%
5
$32.75
0.71%
BISOPRL/HCTZ TAB 5/6.25MG
71
$535.73
9.74%
51
$412.45
7.24%
0
$0.00
0.00%
3
$19.65
0.43%
00185070430
0
$0.00
0.00%
4
$88.90
0.57%
00185070701
BISOPRL/HCTZ TAB 10/6.25
42
$401.35
5.76%
31
$279.25
4.40%
00185070705
0
$0.00
0.00%
3
$19.65
0.43%
00185070730
8
$52.40
1.10%
4
$17.71
0.57%
00228236010
PROPRAN/HCTZ TAB 80/25
0
$0.00
0.00%
1
$7.87
0.14%
00310011510
TENORETIC
1
$40.67
0.14%
0
$0.00
0.00%
00378034701
5
$28.82
0.69%
2
$19.40
0.28%
00378050101
50
$375.50
6.86%
41
$349.77
5.82%
00378050301
70
$600.35
9.60%
54
$443.60
7.67%
00378050501
54
$467.79
7.41%
51
$519.10
7.24%
00378073101
4
$12.64
0.55%
6
$25.92
0.85%
00378206301
ATENOL/CHLOR TAB 50-25MG
68
$519.04
9.33%
86
$697.59
12.22%
00378206401
12
$123.76
1.65%
23
$256.81
3.27%
00591084101
12
$105.94
1.65%
12
$92.20
1.70%
00591084105
4
$26.20
0.55%
3
$19.65
0.43%
00591084201
24
$233.76
3.29%
25
$186.55
3.55%
TAB 10/25
TAB -50
Page 153 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00591084301
00591084330
00591578201
00591578301
$
Market Share*
BETA BLOCKERS AND DIURETIC COMBO'S
00591084205
# of Scripts
$19.65
0.41%
$0.00
0.00%
0
$0.00
0.00%
11
$78.41
1.51%
3
$25.35
0.43%
13
$102.35
1.85%
46
$365.43
6.31%
53
$383.87
7.53%
29
$292.33
3.98%
47
$475.79
6.68%
00677148001
4
00677148101
6
$42.63
0.55%
5
$51.84
0.71%
$104.49
0.82%
4
$36.50
0.57%
00781182401
7
$38.77
0.96%
8
$72.40
1.14%
00781183301
14
$118.63
1.92%
8
$75.41
1.14%
00781184101
00904788160
5
$45.25
0.69%
2
$18.10
0.28%
6
$36.84
0.82%
5
$38.20
0.71%
51285004001
ZIAC
TAB 10/6.25
0
$0.00
0.00%
3
$122.78
0.43%
51285004702
ZIAC
TAB 2.5/6.25
4
$132.22
0.55%
7
$242.91
0.99%
51285005002
ZIAC
TAB 5/6.25MG
0
$0.00
0.00%
3
$84.89
0.43%
53489053101
84
$612.77
11.52%
78
$589.84
11.08%
53489053201
24
$221.79
3.29%
16
$181.76
2.27%
61570017501
CORZIDE
1
$51.01
0.14%
0
$0.00
0.00%
TAB 40/5
3
0
BETA-LACTAMS / CLAVULANATE COMBO'S
00003010120
TRIMOX
CAP 250MG
82
$361.97
0.28%
61
$266.42
0.24%
00003010150
TRIMOX
CAP 250MG
8
$37.58
0.03%
6
$30.11
0.02%
00003010151
TRIMOX
CAP 250MG
0
$0.00
0.00%
1
$2.76
0.00%
00003010160
TRIMOX
CAP 250MG
603
$2,627.33
2.07%
105
$443.81
0.42%
00003010920
TRIMOX
CAP 500MG
384
$2,114.51
1.32%
7
$28.41
0.03%
00003010955
TRIMOX
CAP 500MG
10
$51.94
0.03%
0
$0.00
0.00%
00003010960
TRIMOX
CAP 500MG
2,363
$12,394.70
8.11%
66
$328.90
0.26%
00003011550
VEETIDS
TAB 250MG
1
$9.01
0.00%
0
$0.00
0.00%
Page 154 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
VEETIDS
TAB 250MG
00003011650
VEETIDS
TAB 500MG
00003011675
VEETIDS
TAB 500MG
00003012250
PRINCIPEN CAP 250MG
00003012260
$
Market Share*
00003011575
# of Scripts
$558.72
0.24%
$0.00
0.00%
8
$75.99
0.03%
33
$307.19
0.11%
3
$34.95
0.01%
12
$129.10
0.05%
22
$206.99
0.08%
2
$26.49
0.01%
PRINCIPEN CAP 250MG
3
$15.45
0.01%
2
$17.84
0.01%
00003013450
PRINCIPEN CAP 500MG
52
00003013460
PRINCIPEN CAP 500MG
2
$479.75
0.18%
3
$22.27
0.01%
$16.00
0.01%
1
$7.03
0.00%
00003068144
VEETIDS
SOL 125/5ML
3
$22.95
0.01%
2
$11.00
0.01%
00003068154
VEETIDS
SOL 125/5ML
25
$164.24
0.09%
15
$97.65
0.06%
00003068244
VEETIDS
SOL 250/5ML
00003068254
VEETIDS
SOL 250/5ML
90
$534.37
0.31%
52
$295.29
0.21%
224
$1,514.51
0.77%
162
$1,070.08
0.65%
00003097261
PRINCIPEN SUS 250/5ML
0
$0.00
0.00%
2
$18.40
0.01%
00003173730
TRIMOX
SUS 125/5ML
51
$276.45
0.17%
33
$174.81
0.13%
00003173740
TRIMOX
SUS 125/5ML
00003173745
TRIMOX
SUS 125/5ML
76
$441.02
0.26%
50
$297.00
0.20%
365
$2,352.51
1.25%
279
$1,779.14
1.12%
00003173830
TRIMOX
SUS 250/5ML
230
$2,344.78
0.79%
146
$912.94
0.58%
00003173840
TRIMOX
SUS 250/5ML
711
$7,945.80
2.44%
565
$4,365.29
2.26%
00003173845
TRIMOX
00015710328
OXACILLIN
SUS 250/5ML
1,965
$20,252.40
6.74%
1,298
$10,789.76
5.20%
0
$0.00
0.00%
5
$2,714.56
0.02%
00015722620
NAFCILLIN INJ 2GM
1
$12.94
0.00%
0
$0.00
0.00%
00015785640
DYNAPEN
SUS 62.5/5ML
3
$159.14
0.01%
0
$0.00
0.00%
00015798120
OXACILLIN
INJ 1GM
1
$15.01
0.00%
0
$0.00
0.00%
00029600630
AMOXIL
CAP 250MG
6
$37.40
0.02%
0
$0.00
0.00%
00029600632
AMOXIL
CAP 250MG
21
$86.79
0.07%
7
$27.40
0.03%
00029600732
AMOXIL
CAP 500MG
128
$689.33
0.44%
118
$646.81
0.47%
00029600822
AMOXIL
SUS 125/5ML
182
$1,172.28
0.62%
29
$190.75
0.12%
00029600921
AMOXIL
SUS 250/5ML
2
$12.40
0.01%
0
$0.00
0.00%
INJ 10GM
69
0
Page 155 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00029600922
AMOXIL
SUS 250/5ML
906
$8,284.44
3.11%
545
$4,498.75
2.18%
00029600923
AMOXIL
SUS 250/5ML
302
$3,034.93
1.04%
249
$1,775.87
1.00%
00029603520
AMOXIL
DRO 50MG/ML
6
$34.21
0.02%
0
$0.00
0.00%
00029603839
AMOXIL
DRO 50MG/ML
12
$85.20
0.04%
5
$29.84
0.02%
00029604512
AMOXIL
CHW 400MG
3
$45.31
0.01%
3
$49.71
0.01%
00029604520
AMOXIL
CHW 400MG
1
$10.55
0.00%
2
$96.29
0.01%
00029604712
AMOXIL
TAB 875MG
0
$0.00
0.00%
2
$38.96
0.01%
00029604720
AMOXIL
TAB 875MG
10
$175.92
0.03%
1
$17.32
0.00%
00029604854
AMOXIL
SUS 200/5ML
1
$7.79
0.00%
0
$0.00
0.00%
00029604855
AMOXIL
SUS 200/5ML
7
$115.98
0.02%
1
$16.27
0.00%
00029604859
AMOXIL
SUS 200/5ML
79
$1,050.82
0.27%
36
$533.73
0.14%
00029604954
AMOXIL
SUS 400/5ML
50
$637.53
0.17%
11
$117.62
0.04%
00029604955
AMOXIL
SUS 400/5ML
39
$613.20
0.13%
10
$177.45
0.04%
00029604959
AMOXIL
SUS 400/5ML
418
$6,788.45
1.43%
102
$1,522.75
0.41%
00029607112
AUGMENTIN
CHW 200MG
4
$128.25
0.01%
1
$61.66
0.00%
00029607212
AUGMENTIN
CHW 400MG
72
$5,733.12
0.25%
84
$7,640.07
0.34%
00029607347
AUGMENTIN
CHW 125MG
2
$48.41
0.01%
0
$0.00
0.00%
00029607447
AUGMENTIN
CHW 250MG
21
$1,768.86
0.07%
12
$829.32
0.05%
00029607527
AUGMENTIN
TAB 250MG
107
$6,437.56
0.37%
87
$4,800.97
0.35%
00029607531
AUGMENTIN
TAB 250MG
12
$103.80
0.04%
21
$283.23
0.08%
00029608012
AUGMENTIN
TAB 500MG
524
$44,416.17
1.80%
682
$63,457.09
2.73%
00029608031
AUGMENTIN
TAB 500MG
13
$296.09
0.04%
43
$3,142.78
0.17%
00029608522
AUGMENTIN
SUS 125/5ML
36
$1,545.76
0.12%
18
$810.01
0.07%
00029608523
AUGMENTIN
SUS 125/5ML
3
$86.67
0.01%
9
$322.90
0.04%
00029608539
AUGMENTIN
SUS 125/5ML
5
$148.53
0.02%
6
$139.84
0.02%
00029608612
AUGMENTIN
TAB 875MG
1,258
$127,385.87
4.32%
2,202
$233,083.30
8.82%
00029608621
AUGMENTIN
TAB 875MG
4
$398.94
0.01%
20
$2,132.90
0.08%
Page 156 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
AUGMENTIN
SUS 200/5ML
00029608739
AUGMENTIN
SUS 200/5ML
00029608751
AUGMENTIN
SUS 200/5ML
00029609022
AUGMENTIN
SUS 250/5ML
00029609023
AUGMENTIN
00029609039
00029609229
$
Market Share*
00029608729
# of Scripts
$205.67
0.02%
$342.63
0.04%
2
$56.22
0.01%
49
$2,037.18
0.17%
7
$284.87
0.03%
102
$4,695.36
0.41%
155
$12,527.12
0.53%
109
$8,962.03
0.44%
SUS 250/5ML
74
$5,420.09
0.25%
68
$4,605.29
0.27%
AUGMENTIN
SUS 250/5ML
43
AUGMENTIN
SUS 400/5ML
32
$2,230.93
0.15%
31
$1,897.55
0.12%
$1,694.55
0.11%
28
$1,766.87
0.11%
00029609239
AUGMENTIN
SUS 400/5ML
32
$2,131.11
0.11%
38
$2,776.23
0.15%
00029609251
AUGMENTIN
SUS 400/5ML
192
$16,755.40
0.66%
367
$32,542.66
1.47%
00029609422
AUGMENTIN
SUS ES-600
00029609424
AUGMENTIN
SUS ES-600
12
$1,050.59
0.04%
0
$0.00
0.00%
191
$16,928.51
0.66%
197
$18,566.45
0.79%
00029609429
AUGMENTIN
SUS ES-600
6
$493.19
0.02%
4
$212.56
0.02%
00029609439
AUGMENTIN
SUS ES-600
400
$19,114.29
1.37%
310
$15,679.53
1.24%
00029609445
00029609451
AUGMENTIN
SUS ES-600
666
$40,317.55
2.29%
493
$32,234.15
1.97%
AUGMENTIN
SUS ES-600
35
$2,109.95
0.12%
3
$220.12
0.01%
00029609628
AUGMENTIN XR TAB SR 12HR
61
$5,437.00
0.21%
7
$517.09
0.03%
00029609640
272
$23,452.36
0.93%
37
$3,599.14
0.15%
00029609648
30
$2,353.72
0.10%
49
$3,982.53
0.20%
00029609660
329
$28,737.39
1.13%
599
$54,309.87
2.40%
00029657126
TIMENTIN
0
$0.00
0.00%
1
$377.01
0.00%
00093117110
PENICILLN VK TAB 250MG
11
$36.86
0.04%
0
$0.00
0.00%
00093117210
2
$6.53
0.01%
0
$0.00
0.00%
00093117301
5
$22.70
0.02%
0
$0.00
0.00%
00093117310
12
$51.13
0.04%
0
$0.00
0.00%
00093226301
AMOXICILLIN TAB 500
1
$10.45
0.00%
13
$211.77
0.05%
00093226401
AMOXICILLIN TAB 875MG
710
$12,976.48
2.44%
476
$8,004.65
1.91%
00093226701
AMOXICILLIN CHW 125MG
4
$23.20
0.01%
3
$16.53
0.01%
INJ 3.1GM
6
9
Page 157 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
00093226805
00093227434
AMOX/K CLAV TAB 500MG
00093227534
00093310701
$
Market Share*
00093226801
# of Scripts
$2,126.76
0.82%
193
$1,630.16
0.77%
33
$294.59
0.11%
18
$161.80
0.07%
161
$11,414.01
0.55%
20
$61.94
0.08%
361
$28,553.17
1.24%
42
$194.11
0.17%
AMOXICILLIN CAP 250MG
27
$116.70
0.09%
32
$131.95
0.13%
00093310705
238
$934.22
0.82%
212
$807.16
0.85%
00093310905
636
$3,242.05
2.18%
602
$2,978.49
2.41%
00093310953
24
$132.47
0.08%
11
$48.46
0.04%
00093312301
DICLOXACILL CAP 250MG
16
$249.21
0.05%
34
$535.76
0.14%
00093312501
27
$603.61
0.09%
40
$913.95
0.16%
00093412773
PENICILLN VK SOL 250/5ML
2
$16.60
0.01%
0
$0.00
0.00%
00093415073
AMOXICILLIN SUS 125/5ML
17
$98.95
0.06%
14
$78.30
0.06%
00093415079
5
$30.17
0.02%
14
$80.71
0.06%
00093415080
46
$299.24
0.16%
54
$344.29
0.22%
00093415573
149
$1,573.81
0.51%
148
$1,126.67
0.59%
00093415579
65
$631.03
0.22%
31
$214.75
0.12%
00093415580
412
$4,189.25
1.41%
226
$1,829.52
0.90%
00093416073
93
$1,106.35
0.32%
94
$1,209.54
0.38%
00093416078
0
$0.00
0.00%
8
$113.49
0.03%
00093416173
655
$9,907.91
2.25%
697
$10,248.70
2.79%
00093416176
5
$76.44
0.02%
90
$1,176.98
0.36%
00093416178
19
$261.31
0.07%
82
$1,108.35
0.33%
00093514501
AMPICILLIN CAP 250MG
22
$121.33
0.08%
15
$93.16
0.06%
00093514505
29
$129.98
0.10%
21
$116.26
0.08%
00093514601
34
$368.17
0.12%
20
$246.57
0.08%
00093514605
15
$182.31
0.05%
12
$111.73
0.05%
00093519401
115
$795.83
0.39%
77
$525.34
0.31%
238
Page 158 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
00093519501
00093519505
00093519874
00093519973
$
Market Share*
00093519410
# of Scripts
$1,654.41
0.67%
$806.91
0.37%
100
$1,043.93
0.34%
1,420
$13,991.90
4.87%
81
$849.80
0.32%
713
$6,986.13
2.85%
2
$13.03
0.01%
12
$78.05
0.05%
24
$157.99
0.08%
51
$274.98
0.20%
00093519974
142
00093867574
AMOX/K CLAV SUS 600/5ML
0
$952.81
0.49%
124
$803.68
0.50%
$0.00
0.00%
4
$41.84
0.02%
00093867575
0
$0.00
0.00%
27
$676.88
0.11%
00093867578
0
$0.00
0.00%
10
$99.37
0.04%
00172740228
AMOX/K CLAV CHW 400MG
0
$0.00
0.00%
4
$142.28
0.02%
00172740342
0
$0.00
0.00%
43
$546.07
0.17%
00172740442
0
$0.00
0.00%
65
$716.08
0.26%
00172740521
0
$0.00
0.00%
2
$39.95
0.01%
00172740620
0
$0.00
0.00%
2
$50.70
0.01%
00172740621
0
$0.00
0.00%
7
$194.94
0.03%
00172740622
0
$0.00
0.00%
2
$44.20
0.01%
00172740714
0
$0.00
0.00%
14
$361.42
0.06%
00172740722
0
$0.00
0.00%
5
$61.67
0.02%
00172740726
0
$0.00
0.00%
2
$96.85
0.01%
00172741160
0
$0.00
0.00%
115
$2,029.62
0.46%
00172741470
0
$0.00
0.00%
809
$3,945.95
3.24%
00172741723
0
$0.00
0.00%
6
$39.84
0.02%
00172741821
0
$0.00
0.00%
18
$139.35
0.07%
00172741823
0
$0.00
0.00%
61
$518.09
0.24%
00172741921
0
$0.00
0.00%
2
$16.87
0.01%
00172742021
0
$0.00
0.00%
22
$325.27
0.09%
00206862011
ZOSYN
0
$0.00
0.00%
6
$2,801.41
0.02%
INJ
196
92
Page 159 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
ZOSYN
SOL 2G-0.25G
00206882102
ZOSYN
SOL 3-0.375G
00781120501
00781120510
00781161966
00781164366
00781165501
00781165510
00781183120
$
Market Share*
00206882002
# of Scripts
0
$0.00
0.00%
8
$3,006.52
0.03%
75
$677.64
0.26%
375
$3,569.60
1.29%
4
$116.03
0.01%
55
$4,073.38
0.19%
1,787
$18,324.84
6.13%
608
$5,638.62
2.09%
87
$4,609.69
0.30%
00781185220
132
$9,652.74
0.45%
00781202005
1
$2.76
0.00%
00781214401
0
$0.00
0.00%
00781214501
0
$0.00
0.00%
00781224801
0
$0.00
0.00%
00781225801
0
$0.00
0.00%
00781261305
1
$4.67
0.00%
00781261331
0
$0.00
00781261376
0
00781312695
NAFCILLIN INJ 10GM
0
00781610246
00781610446
51079061520
55370088007
55370088008
$130.01
0.00%
1
$52.67
0.00%
216
$1,925.65
0.86%
189
$1,696.34
0.76%
1
$50.55
0.00%
12
$265.49
0.05%
1,795
$18,462.09
7.19%
428
$4,242.10
1.71%
10
$128.23
0.04%
14
$41.27
0.06%
303
$1,289.96
1.21%
17
$131.57
0.07%
46
$510.35
0.18%
4
$49.91
0.02%
69
$2,286.94
0.28%
2,004
$10,153.83
8.02%
0.00%
138
$701.97
0.55%
$0.00
0.00%
103
$527.12
0.41%
$0.00
0.00%
5
$2,253.92
0.02%
55
$2,205.96
0.19%
2
$56.70
0.01%
170
$12,093.37
0.58%
7
$149.78
0.03%
1
$7.73
0.00%
0
$0.00
0.00%
10
$86.22
0.03%
3
$22.48
0.01%
2
$20.93
0.01%
0
$0.00
0.00%
55370088107
19
$198.85
0.07%
15
$175.41
0.06%
55370088108
0
$0.00
0.00%
4
$20.28
0.02%
55370088313
AMPICILLIN SUS 250/5ML
1
$9.20
0.00%
1
$7.44
0.00%
1
Page 160 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
55370088407
4
$12.97
0.01%
1
$4.62
0.00%
55370088408
271
$1,163.47
0.93%
157
$674.83
0.63%
55370088507
0
$0.00
0.00%
20
$111.48
0.08%
55370088508
1,275
$7,186.86
4.37%
244
$1,168.77
0.98%
55370088613
2
$14.74
0.01%
0
$0.00
0.00%
55370088614
42
$270.55
0.14%
24
$152.88
0.10%
55370088680
2
$9.92
0.01%
0
$0.00
0.00%
55370088713
34
$347.83
0.12%
37
$276.45
0.15%
55370088714
136
$1,338.60
0.47%
116
$967.46
0.46%
55370088780
12
$109.62
0.04%
10
$62.56
0.04%
59772604801
96
$1,500.15
0.33%
55
$959.30
0.22%
59772605801
152
$3,600.58
0.52%
12
$259.45
0.05%
61570014610
BICILLIN L-A INJ 600000
0
$0.00
0.00%
1
$20.13
0.00%
61570014710
BICILLIN L-A INJ 600000
2
$582.16
0.01%
0
$0.00
0.00%
63304050901
52
$4,396.01
0.18%
6
$30.21
0.02%
63304050920
53
$4,376.76
0.18%
31
$160.79
0.12%
63304051401
1
$10.55
0.00%
0
$0.00
0.00%
63304051501
551
$5,086.41
1.89%
395
$3,333.81
1.58%
63304051504
37
$341.03
0.13%
32
$262.91
0.13%
63304065401
25
$95.50
0.09%
5
$13.00
0.02%
63304065405
171
$692.58
0.59%
113
$479.77
0.45%
63304065501
62
$309.31
0.21%
62
$302.64
0.25%
63304065505
396
$2,033.96
1.36%
571
$2,784.47
2.29%
63304071320
24
$1,827.69
0.08%
3
$8.65
0.01%
63304076020
0
$0.00
0.00%
1
$6.75
0.00%
63304076101
124
$922.01
0.43%
107
$1,859.15
0.43%
63304076120
212
$1,634.23
0.73%
170
$2,793.14
0.68%
Page 161 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
63304076305
63304076320
63304096901
63304096903
$
Market Share*
63304076301
# of Scripts
$2,395.88
0.46%
$1,669.10
0.34%
2
$30.64
0.01%
63
$985.89
0.22%
2
$30.90
0.01%
42
$639.96
0.17%
4
$60.99
0.01%
9
$104.20
0.04%
1
$11.34
0.00%
2
$17.32
0.01%
63304096904
45
63304097001
42
$566.48
0.15%
53
$659.74
0.21%
$578.70
0.14%
88
$1,164.05
0.35%
63304097003
30
$380.90
0.10%
60
$741.56
0.24%
63304097004
379
$5,181.40
1.30%
584
$8,274.29
2.34%
63304097701
63304097704
0
$0.00
0.00%
1
$1.00
0.00%
3
$104.46
0.01%
1
$28.35
0.00%
63304097901
1
$44.08
0.00%
2
$44.56
0.01%
63304097903
1
$95.09
0.00%
1
$9.09
0.00%
63304097904
15
$886.50
0.05%
7
$112.61
0.03%
66685100100
421
$34,411.38
1.44%
4
$90.38
0.02%
66685100101
0
$0.00
0.00%
2
$28.35
0.01%
66685100200
186
$15,309.98
0.64%
0
$0.00
0.00%
66685101100
8
$226.05
0.03%
1
$15.85
0.00%
66685101101
12
$389.97
0.04%
0
$0.00
0.00%
66685101102
44
$1,444.58
0.15%
6
$125.95
0.02%
66685101200
21
$963.73
0.07%
2
$16.46
0.01%
66685101201
50
$2,717.36
0.17%
7
$91.39
0.03%
66685101202
105
$6,692.53
0.36%
20
$547.00
0.08%
67253020010
3
$29.61
0.01%
72
$597.02
0.29%
67253020011
5
$40.71
0.02%
51
$448.18
0.20%
67253020110
45
$447.12
0.15%
85
$845.71
0.34%
67253020150
118
$1,202.59
0.40%
985
$9,977.30
3.94%
135
85
Page 162 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
BPH
00006007231
PROSCAR
TAB 5MG
62
$4,438.89
1.21%
112
$9,336.87
2.26%
00006007258
PROSCAR
TAB 5MG
269
$18,007.55
5.27%
396
$29,941.17
7.99%
00024420010
UROXATRAL
3
$153.38
0.06%
15
$454.69
0.30%
00049276066
CARDURA
TAB 2MG
1
$47.42
0.02%
1
$11.54
0.02%
00049277066
CARDURA
TAB 4MG
3
$102.82
0.06%
0
$0.00
0.00%
00049278066
CARDURA
TAB 8MG
1
$35.07
0.02%
2
$71.90
0.04%
00074380613
HYTRIN
CAP 2MG
3
$156.47
0.06%
1
$8.49
0.02%
00074380711
HYTRIN
CAP 5MG
1
$60.61
0.02%
0
$0.00
0.00%
00074380713
HYTRIN
CAP 5MG
4
$154.66
0.08%
4
$232.56
0.08%
00074380813
HYTRIN
CAP 10MG
3
$171.48
0.06%
1
$37.50
0.02%
00093076001
TERAZOSIN
CAP 1MG
14
$155.20
0.27%
32
$318.10
0.65%
00093076101
TERAZOSIN
CAP 2MG
50
$515.80
0.98%
45
$509.95
0.91%
00093076201
TERAZOSIN
CAP 5MG
58
$649.30
1.14%
14
$198.40
0.28%
00093076301
TERAZOSIN
CAP 10MG
16
$201.10
0.31%
7
$68.95
0.14%
00093812001
DOXAZOSIN
TAB 1MG
10
$75.80
0.20%
6
$40.00
0.12%
00093812101
DOXAZOSIN
TAB 2MG
17
$117.93
0.33%
20
$143.14
0.40%
00093812201
DOXAZOSIN
TAB 4MG
23
$209.45
0.45%
19
$125.21
0.38%
00093812301
DOXAZOSIN
TAB 8MG
10
$73.50
0.20%
5
$39.25
0.10%
00172368560
DOXAZOSIN
TAB 1MG
58
$469.22
1.14%
6
$48.36
0.12%
00172368660
DOXAZOSIN
TAB 2MG
69
$554.49
1.35%
3
$6.19
0.06%
00172368670
DOXAZOSIN
TAB 2MG
44
$403.28
0.86%
0
$0.00
0.00%
00172368760
DOXAZOSIN
TAB 4MG
61
$527.98
1.19%
8
$85.20
0.16%
00172368770
DOXAZOSIN
TAB 4MG
43
$419.17
0.84%
1
$5.82
0.02%
00172368860
DOXAZOSIN
TAB 8MG
37
$346.05
0.72%
11
$95.85
0.22%
00172368870
DOXAZOSIN
TAB 8MG
10
$91.70
0.20%
0
$0.00
0.00%
00173071200
AVODART
CAP 0.5MG
11
$733.93
0.22%
47
$3,375.47
0.95%
TAB 10MG
Page 163 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
BPH
00173071201
AVODART
CAP 0.5MG
1
00173071215
AVODART
CAP 0.5MG
00228264211
DOXAZOSIN
TAB 1MG
00228264311
DOXAZOSIN
00228264411
$36.60
0.02%
16
$562.04
0.32%
0
$0.00
0.00%
16
$1,201.62
0.32%
5
$31.25
0.10%
1
$6.25
0.02%
TAB 2MG
8
$68.26
0.16%
3
$10.95
0.06%
DOXAZOSIN
TAB 4MG
1
$20.45
0.02%
0
$0.00
0.00%
00378157001
TERAZOSIN
CAP 10MG
68
$823.30
1.33%
59
$757.35
1.19%
00378226001
TERAZOSIN
CAP 1MG
21
$204.25
0.41%
13
$149.75
0.26%
00378226401
TERAZOSIN
CAP 2MG
129
$1,725.08
2.53%
96
$1,374.24
1.94%
00378226801
TERAZOSIN
CAP 5MG
121
$1,512.90
2.37%
87
$1,055.75
1.76%
00378402101
DOXAZOSIN
TAB 1MG
1
$6.25
0.02%
0
$0.00
0.00%
00378402201
DOXAZOSIN
TAB 2MG
2
$17.90
0.04%
6
$52.50
0.12%
00378402401
DOXAZOSIN
TAB 4MG
18
$150.35
0.35%
12
$102.50
0.24%
00597005801
FLOMAX
CAP 0.4MG
983
$52,945.61
19.25%
660
$31,841.67
13.32%
00781205101
TERAZOSIN
CAP 1MG
255
$2,795.17
4.99%
248
$2,606.22
5.01%
00781205201
TERAZOSIN
CAP 2MG
537
$7,090.16
10.52%
689
$9,280.54
13.91%
00781205205
TERAZOSIN
CAP 2MG
1
$9.85
0.02%
6
$82.10
0.12%
00781205301
TERAZOSIN
CAP 5MG
327
$3,811.29
6.40%
389
$4,783.11
7.85%
00781205305
TERAZOSIN
CAP 5MG
0
$0.00
0.00%
4
$44.40
0.08%
00781205401
TERAZOSIN
CAP 10MG
129
$1,620.10
2.53%
143
$1,910.94
2.89%
00781500201
DOXAZOSIN
TAB 2MG
34
$283.12
0.67%
0
$0.00
0.00%
00781500301
DOXAZOSIN
TAB 4MG
30
$294.18
0.59%
0
$0.00
0.00%
00781500401
DOXAZOSIN
TAB 8MG
7
$66.75
0.14%
0
$0.00
0.00%
00904552260
DOXAZOSIN
TAB 1MG
6
$43.62
0.12%
0
$0.00
0.00%
00904552360
DOXAZOSIN
TAB 2MG
11
$79.15
0.22%
0
$0.00
0.00%
00904552460
DOXAZOSIN
TAB 4MG
18
$181.35
0.35%
8
$59.90
0.16%
00904552560
DOXAZOSIN
TAB 8MG
13
$136.75
0.25%
0
$0.00
0.00%
49884055201
DOXAZOSIN
TAB 1MG
19
$125.20
0.37%
19
$179.95
0.38%
Page 164 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
BPH
49884055301
DOXAZOSIN
TAB 2MG
44
$354.82
0.86%
33
$336.60
0.67%
49884055401
DOXAZOSIN
TAB 4MG
62
$626.04
1.21%
57
$600.92
1.15%
49884055501
DOXAZOSIN
TAB 8MG
9
$70.65
0.18%
30
$305.70
0.61%
50111065101
DOXAZOSIN
TAB 1MG
22
$120.78
0.43%
7
$71.99
0.14%
50111065201
DOXAZOSIN
TAB 2MG
62
$437.74
1.21%
4
$41.00
0.08%
50111065301
DOXAZOSIN
TAB 4MG
97
$826.07
1.90%
5
$51.81
0.10%
50111065401
DOXAZOSIN
TAB 8MG
38
$322.10
0.74%
19
$145.45
0.38%
58177026604
DOXAZOSIN
TAB 1MG
93
$763.77
1.82%
164
$1,399.60
3.31%
58177026704
DOXAZOSIN
TAB 2MG
185
$1,382.03
3.62%
294
$2,484.89
5.93%
58177026722
DOXAZOSIN
TAB 2MG
3
$42.45
0.06%
0
$0.00
0.00%
58177026804
DOXAZOSIN
TAB 4MG
231
$1,979.25
4.52%
379
$3,195.49
7.65%
58177026808
DOXAZOSIN
TAB 4MG
0
$0.00
0.00%
48
$433.42
0.97%
58177026904
DOXAZOSIN
TAB 8MG
119
$1,085.95
2.33%
143
$1,332.05
2.89%
60505009300
DOXAZOSIN
TAB 1MG
71
$543.62
1.39%
52
$429.31
1.05%
60505009400
DOXAZOSIN
TAB 2MG
107
$821.82
2.10%
103
$833.37
2.08%
60505009401
DOXAZOSIN
TAB 2MG
5
$41.25
0.10%
7
$53.75
0.14%
60505009500
DOXAZOSIN
TAB 4MG
72
$714.04
1.41%
92
$850.96
1.86%
60505009501
DOXAZOSIN
TAB 4MG
5
$44.15
0.10%
3
$19.65
0.06%
60505009600
DOXAZOSIN
TAB 8MG
25
$278.25
0.49%
56
$567.10
1.13%
60505011500
TERAZOSIN
CAP 1MG
13
$189.29
0.25%
19
$214.75
0.38%
60505011600
TERAZOSIN
CAP 2MG
44
$611.00
0.86%
79
$1,196.85
1.59%
60505011700
TERAZOSIN
CAP 5MG
45
$608.25
0.88%
95
$1,233.35
1.92%
60505011800
TERAZOSIN
CAP 10MG
12
$152.70
0.24%
20
$267.50
0.40%
63304066201
TERAZOSIN
CAP 1MG
36
$393.62
0.71%
4
$46.90
0.08%
63304066301
TERAZOSIN
CAP 2MG
26
$432.30
0.51%
0
$0.00
0.00%
63304066305
TERAZOSIN
CAP 2MG
2
$22.20
0.04%
0
$0.00
0.00%
63304066401
TERAZOSIN
CAP 5MG
40
$481.80
0.78%
3
$47.55
0.06%
Page 165 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
BPH
63304066501
TERAZOSIN
CAP 10MG
12
$138.50
0.24%
5
$49.25
0.10%
67253038610
DOXAZOSIN
TAB 4MG
0
$0.00
0.00%
2
$15.60
0.04%
Calcimimetic Agents
55513007330
SENSIPAR
TAB 30MG
0
$0.00
0.00%
63
$13,027.01
92.65%
55513007430
SENSIPAR
TAB 60MG
0
$0.00
0.00%
4
$1,001.73
5.88%
55513007530
SENSIPAR
TAB 90MG
0
$0.00
0.00%
1
$775.41
1.47%
711
$29,146.20
7.90%
732
$31,228.23
7.46%
CALCIUM CHANNEL BLOCKERS--Amlodipines
00069152068
NORVASC
TAB 2.5MG
00069153041
NORVASC
TAB 5MG
6
$240.14
0.07%
0
$0.00
0.00%
00069153068
NORVASC
TAB 5MG
3,614
$152,731.83
40.17%
3,621
$160,644.36
36.92%
00069153072
NORVASC
TAB 5MG
844
$34,668.05
9.38%
1,064
$45,224.02
10.85%
00069154041
NORVASC
TAB 10MG
8
$284.13
0.09%
16
$402.36
0.16%
00069154068
NORVASC
TAB 10MG
3,813
$223,964.14
42.39%
4,374
$266,145.98
44.60%
CALCIUM CHANNEL BLOCKERS--Diltiazems
00088177147
CARDIZEM
TAB 30MG
2
$94.86
0.03%
3
$144.08
0.05%
00088177247
CARDIZEM
TAB 60MG
1
$147.03
0.02%
0
$0.00
0.00%
00088177747
CARDIZEM
CAP 60MG SR
4
$331.31
0.06%
0
$0.00
0.00%
00088177847
CARDIZEM
CAP 90MG SR
2
$102.18
0.03%
0
$0.00
0.00%
00088177947
CARDIZEM
CAP 120MG SR
1
$86.00
0.02%
0
$0.00
0.00%
00088179530
CARDIZEM CD CAP 120MG/24
7
$273.13
0.11%
0
$0.00
0.00%
00088179542
5
$194.95
0.08%
6
$225.72
0.10%
00088179630
13
$589.75
0.20%
8
$381.22
0.13%
00088179642
7
$414.74
0.11%
3
$155.95
0.05%
00088179730
3
$196.08
0.05%
3
$191.64
0.05%
Page 166 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00088179742
17
00088179830
00088179842
00088179942
$1,370.15
0.26%
8
$512.98
0.13%
1
$61.80
0.02%
0
$0.00
0.00%
3
$255.96
0.05%
0
$0.00
0.00%
16
$1,319.13
0.24%
10
$831.88
0.16%
00093031801
DILTIAZEM
TAB 30MG
13
$75.17
0.20%
15
$85.13
0.24%
00093031805
DILTIAZEM
TAB 30MG
6
$36.60
0.09%
1
$6.35
0.02%
00093031901
DILTIAZEM
TAB 60MG
23
$206.80
0.35%
4
$35.95
0.07%
00093031905
DILTIAZEM
TAB 60MG
1
$8.95
0.02%
0
$0.00
0.00%
00093032001
DILTIAZEM
TAB 90MG
2
$11.56
0.03%
2
$29.30
0.03%
00093032101
DILTIAZEM
TAB 120MG
5
$91.81
0.08%
1
$20.80
0.02%
00093511298
DILTIAZEM
CAP 120MG ER
28
$713.58
0.42%
19
$470.97
0.31%
00093511798
DILTIAZEM
CAP 180MG ER
30
$916.67
0.45%
7
$236.35
0.11%
00093511898
DILTIAZEM
CAP 240MG ER
30
$1,170.44
0.45%
10
$596.43
0.16%
00093511998
DILTIAZEM
CAP 300MG ER
80
$3,757.83
1.21%
80
$3,887.79
1.30%
00228257703
DILTIAZEM
CAP 180MG CD
0
$0.00
0.00%
2
$127.70
0.03%
00228257709
DILTIAZEM
CAP 180MG CD
39
$999.68
0.59%
8
$250.32
0.13%
00228257750
DILTIAZEM
CAP 180MG CD
12
$298.42
0.18%
3
$3.00
0.05%
00228257809
DILTIAZEM
CAP 240MG CD
62
$2,205.80
0.94%
16
$303.09
0.26%
00228257850
DILTIAZEM
CAP 240MG CD
25
$646.51
0.38%
5
$120.63
0.08%
00228257903
DILTIAZEM
CAP 300MG CD
1
$50.45
0.02%
12
$525.34
0.20%
00228257909
DILTIAZEM
CAP 300MG CD
68
$3,144.83
1.03%
59
$2,395.94
0.96%
00228257950
DILTIAZEM
CAP 300MG CD
6
$302.70
0.09%
1
$8.06
0.02%
00228258803
DILTIAZEM
CAP 120MG CD
1
$23.65
0.02%
0
$0.00
0.00%
00228258809
DILTIAZEM
CAP 120MG CD
51
$1,192.00
0.77%
9
$97.37
0.15%
00228258850
DILTIAZEM
CAP 120MG CD
19
$317.25
0.29%
2
$49.30
0.03%
00258368790
DILTIAZEM
CAP 120MG
87
$2,258.11
1.32%
9
$145.80
0.15%
00258368890
DILTIAZEM
CAP 180MG
146
$4,659.15
2.21%
6
$42.69
0.10%
Page 167 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00258368990
DILTIAZEM
CAP 240MG
163
$7,039.82
2.47%
19
00258369090
DILTIAZEM
CAP 300MG
193
$11,635.32
2.93%
00258369190
DILTIAZEM ER CAP 360MG/24
345
$21,601.65
5.23%
00378002301
DILTIAZEM
TAB 30MG
18
$94.86
00378002305
DILTIAZEM
TAB 30MG
26
00378004501
DILTIAZEM
TAB 60MG
00378004505
DILTIAZEM
TAB 60MG
00378013501
DILTIAZEM
00378013505
$737.75
0.31%
140
$6,848.12
2.28%
338
$17,362.62
5.51%
0.27%
10
$77.00
0.16%
$176.28
0.39%
25
$157.19
0.41%
23
$183.04
0.35%
15
$83.72
0.24%
34
$282.82
0.52%
17
$140.56
0.28%
TAB 90MG
5
$64.45
0.08%
2
$24.63
0.03%
DILTIAZEM
TAB 90MG
7
$80.90
0.11%
1
$3.47
0.02%
00378052501
DILTIAZEM
TAB 120MG
2
$26.50
0.03%
7
$79.86
0.11%
00378522001
DILTIAZEM
CAP 120MG ER
240
$4,321.50
3.64%
232
$3,777.11
3.78%
00378522005
DILTIAZEM
CAP 120MG ER
68
$1,254.08
1.03%
23
$370.45
0.37%
00378528001
DILTIAZEM
CAP 180MG ER
216
$4,986.05
3.27%
241
$4,362.46
3.93%
00378528005
DILTIAZEM
CAP 180MG ER
8
$165.87
0.12%
29
$504.60
0.47%
00378534001
DILTIAZEM
CAP 240MG ER
246
$5,706.49
3.73%
264
$5,181.68
4.30%
00378534005
DILTIAZEM
CAP 240MG ER
40
$978.18
0.61%
28
$552.80
0.46%
00378606001
DILTIAZEM
CAP 60MG ER
22
$714.23
0.33%
15
$424.15
0.24%
00378609001
DILTIAZEM
CAP 90MG ER
22
$508.65
0.33%
17
$327.42
0.28%
00378612001
DILTIAZEM
CAP 120MG ER
15
$499.25
0.23%
0
$0.00
0.00%
00456261230
TIAZAC
CAP 120MG/24
36
$1,281.66
0.55%
5
$260.95
0.08%
00456261290
TIAZAC
CAP 120MG/24
89
$2,607.86
1.35%
14
$442.80
0.23%
00456261330
TIAZAC
CAP 180MG/24
15
$656.69
0.23%
7
$296.42
0.11%
00456261363
TIAZAC
CAP 180MG/24
1
$39.22
0.02%
0
$0.00
0.00%
00456261390
TIAZAC
CAP 180MG/24
113
$3,923.23
1.71%
7
$279.04
0.11%
00456261430
TIAZAC
CAP 240MG/24
25
$1,269.79
0.38%
0
$0.00
0.00%
00456261490
TIAZAC
CAP 240MG/24
154
$8,275.66
2.33%
22
$1,392.81
0.36%
00456261530
TIAZAC
CAP 300MG/24
14
$1,225.38
0.21%
1
$75.72
0.02%
Page 168 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00456261590
TIAZAC
CAP 300MG/24
40
$2,384.73
0.61%
4
00456261630
TIAZAC
CAP 360MG/24
15
$1,149.10
0.23%
00456261690
TIAZAC
CAP 360MG/24
35
$2,081.61
0.53%
00456261730
TIAZAC
CAP 420MG/24
14
$1,048.26
00456261790
TIAZAC
CAP 420MG/24
10
00904538260
DILTIAZEM
CAP 240MG XR
51079092420
DILTIAZEM
CAP 60MG ER
51079092520
DILTIAZEM
51079092620
$398.27
0.07%
0
$0.00
0.00%
2
$144.86
0.03%
0.21%
3
$173.17
0.05%
$738.10
0.15%
3
$164.52
0.05%
20
$475.50
0.30%
2
$37.70
0.03%
5
$115.86
0.08%
3
$65.31
0.05%
CAP 90MG ER
4
$85.10
0.06%
3
$110.55
0.05%
DILTIAZEM
CAP 120MG ER
2
$91.70
0.03%
0
$0.00
0.00%
51079094708
DILTIAZEM
CAP 120MG ER
1
$7.17
0.02%
0
$0.00
0.00%
52544048201
DILACOR XR CAP 120MG/24
1
$44.07
0.02%
0
$0.00
0.00%
52544048401
DILACOR XR CAP 240MG/24
0
$0.00
0.00%
3
$176.31
0.05%
52544077501
DILTIAZEM
TAB 30MG
2
$12.70
0.03%
0
$0.00
0.00%
52544077505
DILTIAZEM
TAB 30MG
1
$5.35
0.02%
0
$0.00
0.00%
52544077601
DILTIAZEM
TAB 60MG
1
$14.15
0.02%
1
$4.79
0.02%
60505001406
DILTIAZEM
CAP 120MG ER
61
$1,107.79
0.92%
86
$1,407.95
1.40%
60505001506
DILTIAZEM
CAP 180MG ER
52
$1,110.91
0.79%
118
$2,090.54
1.92%
60505001606
DILTIAZEM
CAP 240MG ER
76
$1,812.44
1.15%
165
$3,276.67
2.69%
60505001608
DILTIAZEM
CAP 240MG ER
0
$0.00
0.00%
7
$100.87
0.11%
62037054801
DILTIA XT
CAP 120MG/24
372
$6,739.37
5.64%
489
$8,226.40
7.97%
62037054901
DILTIA XT
CAP 180MG/24
488
$11,141.64
7.40%
467
$8,702.57
7.61%
62037054910
DILTIA XT
CAP 180MG/24
3
$73.95
0.05%
0
$0.00
0.00%
62037055001
DILTIA XT
CAP 240MG/24
519
$12,610.89
7.87%
670
$13,288.57
10.92%
62037059790
CARTIA XT
CAP 120/24HR
33
$705.18
0.50%
5
$33.35
0.08%
62037059890
CARTIA XT
CAP 180/24HR
19
$552.40
0.29%
22
$361.78
0.36%
62037059990
CARTIA XT
CAP 240/24HR
37
$1,541.10
0.56%
20
$377.04
0.33%
62037060090
CARTIA XT
CAP 300/24HR
8
$301.96
0.12%
0
$0.00
0.00%
Page 169 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
TAZTIA XT
CAP 120MG/24
62037069690
TAZTIA XT
CAP 120MG/24
62037069730
TAZTIA XT
CAP 180MG/24
62037069790
TAZTIA XT
CAP 180MG/24
62037069830
TAZTIA XT
CAP 240MG/24
62037069890
TAZTIA XT
62037069930
TAZTIA XT
62037069990
$
Market Share*
62037069630
# of Scripts
$347.86
0.18%
4
$70.90
0.07%
6
$81.99
0.09%
13
$485.09
0.20%
0
$0.00
0.00%
2
$101.52
0.03%
9
$278.96
0.14%
0
$0.00
0.00%
24
$1,248.37
0.36%
1
$71.58
0.02%
CAP 240MG/24
CAP 300MG/24
6
$285.64
0.09%
0
$0.00
0.00%
10
$603.52
0.15%
0
$0.00
0.00%
TAZTIA XT
CAP 300MG/24
1
$1.00
0.02%
0
$0.00
0.00%
62037070030
TAZTIA XT
CAP 360MG/24
6
$353.78
0.09%
0
$0.00
0.00%
62037070090
62584097490
TAZTIA XT
CAP 360MG/24
3
$186.58
0.05%
0
$0.00
0.00%
DILTIAZEM
CAP 120MG CD
2
$47.30
0.03%
0
$0.00
0.00%
62584097630
DILTIAZEM
CAP 240MG CD
1
$40.55
0.02%
0
$0.00
0.00%
62584097730
DILTIAZEM
CAP 300MG CD
10
$359.49
0.15%
0
$0.00
0.00%
62584097790
DILTIAZEM
CAP 300MG CD
3
$143.85
0.05%
8
$309.35
0.13%
64455010030
CARDIZEM LA TAB 120MG
290
$10,038.16
4.40%
377
$13,822.24
6.14%
64455010090
2
$72.06
0.03%
26
$1,311.18
0.42%
64455010110
3
$113.16
0.05%
3
$110.61
0.05%
64455010130
587
$22,902.90
8.90%
593
$24,415.16
9.66%
64455010190
0
$0.00
0.00%
33
$1,925.17
0.54%
64455010230
608
$25,465.71
9.21%
723
$31,610.27
11.78%
64455010290
1
$40.65
0.02%
29
$2,050.12
0.47%
64455010330
1
$55.66
0.02%
44
$2,542.77
0.72%
64455010390
3
$174.48
0.05%
21
$1,496.26
0.34%
64455010430
185
$11,352.39
2.80%
340
$21,463.43
5.54%
64455010490
2
$123.06
0.03%
17
$1,687.27
0.28%
64455010510
0
$0.00
0.00%
1
$67.79
0.02%
64455010530
33
$2,288.88
0.50%
50
$3,563.72
0.81%
12
Page 170 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
$
Market Share*
64455010590
# of Scripts
1
$69.36
0.02%
1
$69.13
0.02%
CALCIUM CHANNEL BLOCKERS--Felodipines
00186045031
PLENDIL
TAB 2.5MG CR
1
$19.25
2.38%
0
$0.00
0.00%
00186045058
PLENDIL
TAB 2.5MG CR
3
$204.78
7.14%
0
$0.00
0.00%
00186045131
PLENDIL
TAB 5MG CR
3
$97.95
7.14%
0
$0.00
0.00%
00186045158
PLENDIL
TAB 5MG CR
24
$802.16
57.14%
15
$520.13
55.56%
00186045231
PLENDIL
TAB 10MG CR
1
$57.96
2.38%
0
$0.00
0.00%
00186045258
PLENDIL
TAB 10MG CR
10
$563.30
23.81%
11
$546.30
40.74%
53489036901
FELODIPINE TAB 5MG ER
0
$0.00
0.00%
1
$7.51
3.70%
CALCIUM CHANNEL BLOCKERS--Isradipines
00078022605
DYNACIRC
CAP 2.5MG
1
$51.99
0.40%
0
$0.00
0.00%
65726022615
DYNACIRC
CAP 2.5MG
1
$73.08
0.40%
0
$0.00
0.00%
65726022625
DYNACIRC
CAP 2.5MG
1
$71.88
0.40%
0
$0.00
0.00%
65726022715
DYNACIRC
CAP 5MG
9
$433.33
3.64%
1
$60.09
0.43%
65726022725
DYNACIRC
CAP 5MG
4
$212.74
1.62%
4
$467.31
1.72%
65726023510
DYNACIRC CR TAB 5MG
101
$5,377.74
40.89%
115
$7,127.54
49.57%
65726023525
DYNACIRC CR TAB 5MG
70
$3,598.97
28.34%
28
$1,646.31
12.07%
65726023610
DYNACIRC CR TAB 10MG
51
$4,145.01
20.65%
58
$5,153.66
25.00%
65726023625
DYNACIRC CR TAB 10MG
9
$650.91
3.64%
26
$2,086.23
11.21%
CALCIUM CHANNEL BLOCKERS--Nifedipines
00026884148
ADALAT CC
TAB 30MG ER
1
$44.21
0.03%
3
$134.58
0.12%
00026884151
ADALAT CC
TAB 30MG ER
1,192
$51,597.04
40.24%
667
$27,727.78
26.47%
00026884154
ADALAT CC
TAB 30MG ER
85
$3,559.79
2.87%
2
$80.78
0.08%
00026885148
ADALAT CC
TAB 60MG ER
2
$147.26
0.07%
2
$149.60
0.08%
Page 171 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00026885151
ADALAT CC
TAB 60MG ER
815
$62,216.03
27.52%
476
00026885154
ADALAT CC
TAB 60MG ER
36
$2,754.74
1.22%
00026886148
ADALAT CC
TAB 90MG ER
7
$356.51
0.24%
00026886151
ADALAT CC
TAB 90MG ER
536
$44,748.27
00069260066
PROCARDIA
CAP 10MG
0
00069265066
PROCARDIA XL TAB 30MG CR
00069265072
00069266066
$37,455.18
18.89%
0
$0.00
0.00%
3
$262.59
0.12%
18.10%
347
$29,242.74
13.77%
$0.00
0.00%
5
$126.48
0.20%
6
$637.95
0.20%
3
$260.40
0.12%
7
$270.45
0.24%
7
$275.54
0.28%
16
$1,199.26
0.54%
17
$1,620.87
0.67%
00069266072
1
$74.90
0.03%
0
$0.00
0.00%
00069267066
16
$1,156.94
0.54%
6
$519.90
0.24%
00093081901
NIFEDICAL XL TAB 30MG
22
$793.34
0.74%
55
$1,391.25
2.18%
00093081955
0
$0.00
0.00%
1
$25.45
0.04%
00093102101
NIFEDIPINE TAB 30MG CR
13
$457.08
0.44%
4
$82.34
0.16%
00093102201
NIFEDIAC CC TAB 60MG ER
7
$585.85
0.24%
90
$4,588.99
3.57%
00093102255
0
$0.00
0.00%
3
$126.23
0.12%
00093102301
9
$523.88
0.30%
73
$5,005.60
2.90%
00093517301
8
$416.80
0.27%
25
$1,149.49
0.99%
00093527201
0
$0.00
0.00%
103
$2,835.60
4.09%
00093817101
NIFEDIPINE CAP 10MG
8
$103.88
0.27%
0
$0.00
0.00%
00093817155
NIFEDIPINE CAP 10MG
1
$38.68
0.03%
2
$28.55
0.08%
00228249710
NIFEDIPINE CAP 10MG
31
$580.51
1.05%
49
$779.11
1.94%
00228249730
NIFEDIPINE CAP 10MG
11
$158.82
0.37%
13
$187.69
0.52%
00228253010
NIFEDIPINE CAP 20MG
20
$249.86
0.68%
25
$421.38
0.99%
00228253030
NIFEDIPINE CAP 20MG
2
$24.60
0.07%
3
$35.89
0.12%
00378347501
NIFEDIPINE TAB 30MG ER
26
$953.35
0.88%
74
$2,067.37
2.94%
00378347530
11
$287.06
0.37%
34
$930.78
1.35%
00378348201
19
$1,243.59
0.64%
69
$3,980.36
2.74%
Page 172 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00378348230
2
$91.70
0.07%
7
$407.95
0.28%
00378349501
16
$1,016.59
0.54%
72
$4,542.91
2.86%
00591066001
5
$133.53
0.17%
8
$285.40
0.32%
00591066101
10
$331.96
0.34%
3
$132.79
0.12%
00591319301
AFEDITAB
TAB 30MG CR
13
$380.04
0.44%
135
$3,305.65
5.36%
00591319401
AFEDITAB
TAB 60MG CR
8
$401.70
0.27%
132
$6,719.96
5.24%
00904040961
NIFEDIPINE CAP 10MG
0
$0.00
0.00%
2
$20.50
0.08%
CALCIUM CHANNEL BLOCKERS--Nisoldipine
00310089110
SULAR
TAB 10MG CR
145
$5,207.13
33.80%
12
$405.32
4.12%
00310089210
SULAR
TAB 20MG CR
130
$4,638.72
30.30%
22
$796.65
7.56%
00310089239
SULAR
TAB 20MG CR
13
$574.00
3.03%
0
$0.00
0.00%
00310089310
SULAR
TAB 30MG CR
80
$3,903.08
18.65%
5
$229.75
1.72%
00310089410
SULAR
TAB 40MG CR
61
$2,333.96
14.22%
6
$228.10
2.06%
59630044010
SULAR
TAB 10MG CR
0
$0.00
0.00%
80
$3,134.19
27.49%
59630044110
SULAR
TAB 20MG CR
0
$0.00
0.00%
77
$3,123.67
26.46%
59630044210
SULAR
TAB 30MG CR
0
$0.00
0.00%
43
$3,028.59
14.78%
59630044310
SULAR
TAB 40MG CR
0
$0.00
0.00%
46
$2,346.44
15.81%
CALCIUM CHANNEL BLOCKERS--Verapamils
00025177131
CALAN
TAB 40MG
3
$127.26
0.11%
5
$175.33
0.20%
00025185131
CALAN
TAB 80MG
3
$149.56
0.11%
0
$0.00
0.00%
00025185152
CALAN
TAB 80MG
2
$173.80
0.07%
0
$0.00
0.00%
00025186131
CALAN
TAB 120MG
3
$286.49
0.11%
1
$86.97
0.04%
00025189131
CALAN SR
TAB 240MG
5
$384.72
0.18%
3
$176.19
0.12%
00025189151
CALAN SR
TAB 240MG
3
$163.77
0.11%
2
$117.46
0.08%
00025191131
CALAN SR
TAB 180MG
3
$83.66
0.11%
2
$105.28
0.08%
Page 173 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
COVERA-HS
00025202131
COVERA-HS
00091249023
VERELAN
00091249123
VERELAN
00091249523
VERELAN
00091408501
00091408601
$
Market Share*
00025201131
# of Scripts
TAB 180MG
20
$1,273.65
0.73%
0
$0.00
0.00%
TAB 240MG
15
$797.79
0.55%
0
$0.00
0.00%
CAP 120MG SR
1
$51.87
0.04%
0
$0.00
0.00%
CAP 240MG SR
3
$221.48
0.11%
4
$279.60
0.16%
CAP 360MG SR
1
$93.34
0.04%
0
$0.00
0.00%
VERELAN PM CAP 100MG
5
$209.65
0.18%
0
$0.00
0.00%
10
$490.96
0.36%
7
$431.44
0.29%
00091408701
4
$331.64
0.15%
8
$572.88
0.33%
00172428060
VERAPAMIL
TAB 240MG ER
89
$1,360.66
3.25%
85
$1,565.94
3.48%
00172428070
VERAPAMIL
TAB 240MG ER
406
$7,392.82
14.81%
342
$5,575.68
13.98%
00172428560
VERAPAMIL
TAB 120MG SR
102
$2,204.10
3.72%
115
$2,527.04
4.70%
00172428660
VERAPAMIL
TAB 180MG ER
184
$3,363.41
6.71%
196
$3,488.10
8.01%
00172428670
VERAPAMIL
TAB 180MG ER
50
$961.99
1.82%
45
$622.04
1.84%
00228247310
VERAPAMIL
TAB 80MG
3
$11.13
0.11%
1
$5.53
0.04%
00228247350
VERAPAMIL
TAB 80MG
12
$72.37
0.44%
0
$0.00
0.00%
00228247396
VERAPAMIL
TAB 80MG
5
$26.58
0.18%
3
$14.88
0.12%
00228247510
VERAPAMIL
TAB 120MG
6
$41.80
0.22%
1
$5.57
0.04%
00228247550
VERAPAMIL
TAB 120MG
0
$0.00
0.00%
6
$60.06
0.25%
00364288401
VERAPAMIL
CAP 240MG SR
1
$33.05
0.04%
0
$0.00
0.00%
00364288601
VERAPAMIL
CAP 360MG SR
3
$155.55
0.11%
0
$0.00
0.00%
00378041101
VERAPAMIL
TAB 240MG CR
316
$6,043.97
11.52%
314
$5,154.75
12.84%
00378041105
VERAPAMIL
TAB 240MG CR
545
$10,953.27
19.88%
483
$8,271.78
19.75%
00378051201
VERAPAMIL
TAB 80MG
30
$125.62
1.09%
20
$62.30
0.82%
00378051210
VERAPAMIL
TAB 80MG
8
$47.39
0.29%
7
$34.64
0.29%
00378077201
VERAPAMIL
TAB 120MG
15
$153.25
0.55%
20
$206.56
0.82%
00378077205
VERAPAMIL
TAB 120MG
2
$8.36
0.07%
0
$0.00
0.00%
00378112001
VERAPAMIL
TAB 120MG ER
294
$6,764.34
10.72%
271
$6,384.63
11.08%
Page 174 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00378118001
VERAPAMIL
TAB 180MG ER
411
$7,734.28
14.99%
356
$5,891.04
14.55%
00378118005
VERAPAMIL
TAB 180MG ER
34
$732.50
1.24%
50
$872.07
2.04%
00378632001
VERAPAMIL
CAP 120MG ER
12
$183.64
0.44%
5
$70.75
0.20%
00378638001
VERAPAMIL
CAP 180MG ER
16
$451.94
0.58%
6
$94.88
0.25%
00378644001
VERAPAMIL
CAP 240MG ER
23
$927.01
0.84%
1
$59.61
0.04%
00591034301
VERAPAMIL
TAB 80MG
29
$106.67
1.06%
26
$105.37
1.06%
00591034305
VERAPAMIL
TAB 80MG
0
$0.00
0.00%
4
$12.19
0.16%
00591034501
VERAPAMIL
TAB 120MG
6
$73.57
0.22%
10
$84.82
0.41%
00591034505
VERAPAMIL
TAB 120MG
0
$0.00
0.00%
3
$40.02
0.12%
00591040401
VERAPAMIL
TAB 40MG
17
$148.44
0.62%
30
$245.81
1.23%
00591288001
VERAPAMIL
CAP 120MG SR
1
$11.65
0.04%
0
$0.00
0.00%
00591288601
VERAPAMIL
CAP 360MG SR
6
$311.10
0.22%
6
$311.10
0.25%
00781101401
VERAPAMIL
TAB 40MG
22
$316.28
0.80%
4
$31.54
0.16%
00781101705
VERAPAMIL
TAB 120MG
0
$0.00
0.00%
1
$1.00
0.04%
00904292460
VERAPAMIL
TAB 120MG
4
$45.86
0.15%
0
$0.00
0.00%
52544034301
VERAPAMIL
TAB 80MG
4
$17.92
0.15%
0
$0.00
0.00%
52544034305
VERAPAMIL
TAB 80MG
2
$3.03
0.07%
1
$2.18
0.04%
52544034410
VERAPAMIL
TAB 80MG
2
$8.88
0.07%
0
$0.00
0.00%
52544034501
VERAPAMIL
TAB 120MG
1
$2.52
0.04%
2
$8.36
0.08%
2
$219.10
100.00%
1
$321.88
100.00%
CARBAPENEMS
00006384371
INVANZ
INJ 1GM
CARDIAC GLYCOSIDES
00054319246
DIGOXIN PED DRO 0.05/ML
35
$556.63
0.59%
35
$485.63
0.71%
00173024255
LANOXIN
TAB 0.125MG
96
$721.29
1.63%
55
$391.16
1.11%
00173024256
LANOXIN
TAB 0.125MG
12
$70.84
0.20%
18
$97.32
0.36%
Page 175 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CARDIAC GLYCOSIDES
00173024275
LANOXIN
TAB 0.125MG
00173024955
LANOXIN
TAB 0.25MG
00173024975
LANOXIN
TAB 0.25MG
00173024980
LANOXIN
TAB 0.25MG
00173026427
LANOXIN PED ELX 0.05/ML
00173027055
LANOXICAPS CAP 0.05MG
00173027255
00173027455
00527132401
DIGOXIN
00527132410
00527132501
$5,369.51
14.15%
$3,971.67
12.50%
78
$585.96
1.32%
426
$2,685.78
7.21%
51
$430.17
1.03%
286
$1,819.94
5.77%
32
$204.06
0.54%
29
$180.63
0.58%
36
$1,302.74
0.61%
26
$1,068.68
0.52%
0
$0.00
0.00%
27
$265.23
0.46%
1
$7.72
0.02%
20
$180.42
0.40%
11
$84.72
0.19%
9
$88.58
0.18%
TAB 0.125MG
65
$531.18
1.10%
133
$970.76
2.68%
DIGOXIN
TAB 0.125MG
152
DIGOXIN
TAB 0.25MG
42
$1,123.72
2.57%
277
$2,225.46
5.58%
$310.90
0.71%
44
$350.22
0.89%
00527132510
DIGOXIN
TAB 0.25MG
136
$1,014.84
2.30%
168
$1,321.28
3.39%
51285091502
DIGOXIN
TAB 0.25MG
1
$17.19
0.02%
0
$0.00
0.00%
51285091505
51285091602
DIGOXIN
TAB 0.25MG
75
$459.85
1.27%
5
$26.61
0.10%
DIGOXIN
TAB 0.125MG
4
$40.69
0.07%
0
$0.00
0.00%
51285091605
DIGOXIN
TAB 0.125MG
116
$797.95
1.96%
8
$49.33
0.16%
57664043718
DIGOXIN
TAB 0.125MG
5
$41.24
0.08%
29
$203.47
0.58%
57664043788
DIGOXIN
TAB 0.125MG
2
$11.64
0.03%
4
$25.78
0.08%
57664044118
DIGOXIN
TAB 0.25MG
3
$17.47
0.05%
40
$272.87
0.81%
57664044188
DIGOXIN
TAB 0.25MG
0
$0.00
0.00%
3
$15.53
0.06%
62794014501
DIGITEK
TAB 0.125MG
1,072
$8,180.82
18.15%
1,014
$7,607.47
20.44%
62794014510
DIGITEK
TAB 0.125MG
641
$4,674.24
10.85%
788
$5,472.99
15.89%
62794014556
DIGITEK
TAB 0.125MG
599
$3,854.53
10.14%
119
$717.70
2.40%
62794014601
DIGITEK
TAB 0.25MG
881
$6,990.08
14.91%
787
$6,254.20
15.87%
62794014610
DIGITEK
TAB 0.25MG
304
$1,992.25
5.15%
343
$2,254.68
6.92%
62794014656
DIGITEK
TAB 0.25MG
220
$1,411.76
3.72%
48
$299.63
0.97%
836
620
Page 176 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CCB / LIPID
00069215030
CADUET
TAB 5MG/10MG
0
$0.00
0.00%
00069216030
CADUET
TAB 10/10MG
0
$0.00
0.00%
4
$297.95
8.89%
00069217030
CADUET
TAB 5MG/20MG
0
$0.00
0.00%
12
$1,475.84
26.67%
00069218030
CADUET
TAB 10/20MG
0
$0.00
0.00%
4
$737.42
8.89%
00069219030
CADUET
TAB 5MG/40MG
0
$0.00
0.00%
8
$780.32
17.78%
00069225030
CADUET
TAB 10/40MG
0
$0.00
0.00%
3
$379.32
6.67%
00069226030
CADUET
TAB 5MG/80MG
0
$0.00
0.00%
3
$379.32
6.67%
11
$1,019.15
24.44%
CEPHALOSPORINS
00002306102
CECLOR
CAP 250MG
0
$0.00
0.00%
1
$60.30
0.01%
00002306215
CECLOR
CAP 500MG
0
$0.00
0.00%
2
$167.75
0.02%
00003074950
CEPHALEXIN CAP 250MG
0
$0.00
0.00%
1
$9.35
0.01%
00003087460
4
$28.70
0.04%
3
$17.93
0.03%
00003220230
CEPHALEXIN SUS 250/5ML
1
$38.79
0.01%
4
$117.40
0.05%
00004196202
ROCEPHIN
INJ 250MG
6
$112.68
0.06%
1
$18.42
0.01%
00004196301
ROCEPHIN
INJ 500MG
5
$481.17
0.05%
6
$902.05
0.07%
00004196302
ROCEPHIN
INJ 500MG
0
$0.00
0.00%
1
$109.19
0.01%
00004196401
ROCEPHIN
INJ 1GM
223
$23,988.82
2.34%
201
$27,612.30
2.30%
00004196404
ROCEPHIN
INJ 1GM
117
$12,928.01
1.23%
70
$7,326.21
0.80%
00004196405
ROCEPHIN
INJ 1GM
4
$472.47
0.04%
1
$137.90
0.01%
00004196501
ROCEPHIN
INJ 2GM
11
$4,132.37
0.12%
12
$4,082.66
0.14%
00004196505
ROCEPHIN
INJ 2GM
3
$2,546.08
0.03%
0
$0.00
0.00%
00004197101
ROCEPHIN
INJ 10GM
0
$0.00
0.00%
17
$9,022.57
0.19%
00004200278
ROCEPHIN/DEX INJ 1GM
4
$648.64
0.04%
14
$1,183.69
0.16%
00004200378
ROCEPHIN/DEX INJ 2GM
6
$1,315.29
0.06%
8
$2,423.68
0.09%
00005389718
SUPRAX
TAB 400MG
6
$382.43
0.06%
0
$0.00
0.00%
00005389840
SUPRAX
SUS 100/5ML
5
$248.43
0.05%
0
$0.00
0.00%
Page 177 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
SUPRAX
00005389846
00009353101
$
Market Share*
CEPHALOSPORINS
00005389842
# of Scripts
SUS 100/5ML
4
$200.31
0.04%
0
SUPRAX
SUS 100/5ML
5
$409.82
0.05%
VANTIN
SUS 50MG/5ML
1
$45.38
0.01%
00009353103
VANTIN
SUS 50MG/5ML
0
$0.00
00009361501
VANTIN
SUS 100/5ML
35
00009361502
VANTIN
SUS 100/5ML
00009361503
VANTIN
SUS 100/5ML
00009361701
VANTIN
00009361702
$0.00
0.00%
0
$0.00
0.00%
5
$285.31
0.06%
0.00%
1
$26.88
0.01%
$3,000.19
0.37%
40
$3,544.73
0.46%
1
$61.10
0.01%
0
$0.00
0.00%
7
$372.31
0.07%
5
$777.67
0.06%
TAB 100MG
12
$648.85
0.13%
13
$932.24
0.15%
VANTIN
TAB 100MG
3
$207.40
0.03%
0
$0.00
0.00%
00009361801
VANTIN
TAB 200MG
131
$12,370.47
1.38%
84
$8,441.23
0.96%
00009361802
VANTIN
TAB 200MG
44
$3,739.78
0.46%
49
$3,689.08
0.56%
00009361803
VANTIN
TAB 200MG
0
$0.00
0.00%
2
$61.30
0.02%
00015733999
CEFAZOLIN
INJ 1GM
1
$33.80
0.01%
0
$0.00
0.00%
00074376930
OMNICEF
CAP 300MG
5
$330.15
0.05%
6
$391.16
0.07%
00074376960
OMNICEF
CAP 300MG
70
$5,362.47
0.73%
159
$12,957.82
1.82%
00074377113
OMNICEF
SUS 125MG/5
261
$18,562.48
2.74%
297
$21,922.30
3.39%
00074377160
OMNICEF
SUS 125MG/5
185
$9,231.83
1.94%
219
$11,463.98
2.50%
00074508216
TAZICEF
INJ 1GM
0
$0.00
0.00%
1
$111.64
0.01%
00074509216
TAZICEF
INJ 1GM
1
$210.85
0.01%
0
$0.00
0.00%
00074615113
OMNICEF
SUS 250MG/5
0
$0.00
0.00%
23
$2,859.84
0.26%
00074615160
OMNICEF
SUS 250MG/5
0
$0.00
0.00%
35
$2,888.87
0.40%
00087078241
DURICEF
SUS 250/5ML
27
$1,194.05
0.28%
0
$0.00
0.00%
00087078242
DURICEF
SUS 250/5ML
5
$143.65
0.05%
0
$0.00
0.00%
00087078305
DURICEF
SUS 500/5ML
3
$206.37
0.03%
0
$0.00
0.00%
00087078341
DURICEF
SUS 500/5ML
11
$501.64
0.12%
2
$103.74
0.02%
00087078446
DURICEF
CAP 500MG
1
$75.16
0.01%
0
$0.00
0.00%
00087771840
CEFZIL
SUS 125/5ML
10
$370.68
0.10%
2
$64.72
0.02%
Page 178 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
00087771862
CEFZIL
SUS 125/5ML
11
$564.20
0.12%
5
$247.68
0.06%
00087771864
CEFZIL
SUS 125/5ML
69
$2,798.37
0.72%
65
$3,053.08
0.74%
00087771940
CEFZIL
SUS 250/5ML
59
$3,271.79
0.62%
31
$1,745.30
0.35%
00087771962
CEFZIL
SUS 250/5ML
57
$4,264.76
0.60%
58
$3,758.07
0.66%
00087771964
CEFZIL
SUS 250/5ML
371
$27,451.85
3.90%
340
$26,056.97
3.88%
00087772060
CEFZIL
TAB 250MG FC
139
$12,232.95
1.46%
97
$9,847.18
1.11%
00087772150
CEFZIL
TAB 500MG FC
29
$5,261.02
0.30%
38
$6,054.31
0.43%
00087772160
CEFZIL
TAB 500MG FC
46
$7,391.05
0.48%
50
$6,633.96
0.57%
00093108701
CEFACLOR ER TAB
1
$66.85
0.01%
0
$0.00
0.00%
00093121501
CEFACLOR ER TAB
1
$69.35
0.01%
0
$0.00
0.00%
00093223801
CEPHALEXIN TAB 250MG
1
$7.33
0.01%
0
$0.00
0.00%
00093224001
CEPHALEXIN TAB 500MG
1
$53.71
0.01%
3
$200.14
0.03%
00093314501
351
$3,354.27
3.69%
366
$3,242.07
4.18%
00093314505
294
$1,799.81
3.09%
56
$492.59
0.64%
00093314701
1,833
$20,345.32
19.24%
1,738
$14,389.04
19.85%
00093314705
149
$1,689.46
1.56%
63
$543.21
0.72%
00093417573
16
$201.05
0.17%
30
$392.11
0.34%
00093417574
17
$284.83
0.18%
12
$223.16
0.14%
00093417773
118
$2,253.69
1.24%
113
$1,621.23
1.29%
00093417774
316
$9,380.96
3.32%
196
$3,818.90
2.24%
00172405843
CEFADROXIL CAP 500MG
4
$103.70
0.04%
2
$54.90
0.02%
00172405848
111
$3,071.27
1.17%
167
$3,900.30
1.91%
00172405860
100
$3,390.41
1.05%
124
$2,841.82
1.42%
00172405948
CEFADROXIL TAB 1000MG
4
$167.20
0.04%
0
$0.00
0.00%
00172407360
183
$1,676.72
1.92%
7
$49.80
0.08%
00172407370
56
$430.38
0.59%
194
$981.12
2.22%
00172407460
710
$7,480.30
7.45%
143
$1,178.82
1.63%
Page 179 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
00172407470
00172477060
CEFACLOR
00172477160
CEFACLOR
00172477321
243
$2,724.14
2.55%
324
$3,006.62
3.70%
CAP 250MG
3
$55.88
0.03%
0
$0.00
0.00%
CAP 500MG
3
$77.07
0.03%
0
$0.00
0.00%
CEFACLOR
SUS 187/5ML
1
$15.35
0.01%
0
$0.00
0.00%
00172477422
CEFACLOR
SUS 250/5ML
2
$23.20
0.02%
0
$0.00
0.00%
00172477423
CEFACLOR
SUS 250/5ML
10
$196.00
0.10%
1
$8.26
0.01%
00172477521
CEFACLOR
SUS 375/5ML
6
$44.20
0.06%
0
$0.00
0.00%
00173037835
FORTAZ
INJ 1GM
5
$511.85
0.05%
4
$557.58
0.05%
00173037934
FORTAZ
INJ 2GM
0
$0.00
0.00%
1
$245.20
0.01%
00173038237
FORTAZ
INJ 6GM
1
$144.42
0.01%
0
$0.00
0.00%
00173038700
CEFTIN
TAB 250MG
7
$657.04
0.07%
0
$0.00
0.00%
00173038742
CEFTIN
TAB 250MG
5
$529.40
0.05%
0
$0.00
0.00%
00173039400
CEFTIN
TAB 500MG
1
$174.04
0.01%
0
$0.00
0.00%
00173039442
CEFTIN
TAB 500MG
4
$250.54
0.04%
2
$333.17
0.02%
00173040600
CEFTIN
SUS 125/5ML
24
$1,234.91
0.25%
6
$284.42
0.07%
00173041200
FORTAZ
INJ 1GM
4
$543.50
0.04%
1
$104.06
0.01%
00173041300
FORTAZ
INJ 2GM
2
$949.20
0.02%
0
$0.00
0.00%
00173043400
FORTAZ
2
$224.22
0.02%
0
$0.00
0.00%
00173055400
CEFTIN
SUS 250/5ML
22
$931.45
0.23%
4
$166.53
0.05%
00173055500
CEFTIN
SUS 250/5ML
122
$9,228.70
1.28%
17
$1,152.10
0.19%
00173074100
CEFTIN
SUS 250MG
0
$0.00
0.00%
6
$407.67
0.07%
00173074110
CEFTIN
SUS 250MG
0
$0.00
0.00%
1
$96.63
0.01%
00182268915
CEFUROXIME TAB 250MG
3
$385.89
0.03%
2
$44.20
0.02%
00182268926
54
$2,906.73
0.57%
72
$971.87
0.82%
00182269015
4
$424.40
0.04%
4
$122.90
0.05%
00182269026
22
$2,045.83
0.23%
28
$856.80
0.32%
00338350341
CEFAZOLIN
4
$115.78
0.04%
0
$0.00
0.00%
INJ 1GM
INJ 1GM/50ML
Page 180 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
00378725001
CEFACLOR
CAP 250MG
9
$148.07
0.09%
0
$0.00
0.00%
00378750001
CEFACLOR
CAP 500MG
2
$36.72
0.02%
1
$7.09
0.01%
00378761006
CEFACLOR
SUS 250/5ML
3
$59.55
0.03%
0
$0.00
0.00%
00430278215
DURICEF
SUS 250/5ML
0
$0.00
0.00%
5
$237.86
0.06%
00430278217
DURICEF
SUS 250/5ML
21
$1,003.10
0.22%
24
$1,347.18
0.27%
00430278317
DURICEF
SUS 500/5ML
16
$876.58
0.17%
12
$749.04
0.14%
00555058202
21
$565.05
0.22%
0
$0.00
0.00%
00555058210
13
$338.75
0.14%
0
$0.00
0.00%
00591236668
CEFAZOLIN
1
$148.31
0.01%
0
$0.00
0.00%
00591322415
150
$11,235.71
1.57%
121
$2,745.10
1.38%
00591322515
80
$10,539.69
0.84%
105
$3,382.66
1.20%
00777087102
KEFLEX
CAP 500MG
2
$170.68
0.02%
0
$0.00
0.00%
00777087120
KEFLEX
CAP 500MG
1
$60.04
0.01%
0
$0.00
0.00%
51079060420
4
$12.55
0.04%
0
$0.00
0.00%
51479005430
MAXIPIME
INJ 1GM
0
$0.00
0.00%
3
$479.55
0.03%
51479005530
MAXIPIME
INJ 2GM
1
$376.16
0.01%
12
$4,579.10
0.14%
55370090108
19
$205.34
0.20%
0
$0.00
0.00%
59772727103
23
$829.25
0.24%
10
$225.40
0.11%
59772727104
96
$2,908.18
1.01%
14
$367.30
0.16%
59911596302
CEFOXITIN INJ 1GM
2
$250.28
0.02%
0
$0.00
0.00%
60505120100
39
$4,380.55
0.41%
8
$248.25
0.09%
60505120103
19
$1,683.45
0.20%
12
$396.30
0.14%
60505120200
87
$5,361.24
0.91%
12
$272.70
0.14%
60505120203
15
$934.65
0.16%
28
$648.95
0.32%
63304052020
CEFPODOXIME TAB 100MG
0
$0.00
0.00%
2
$90.62
0.02%
63304052101
0
$0.00
0.00%
3
$99.75
0.03%
63304052120
0
$0.00
0.00%
6
$421.69
0.07%
INJ 10GM
Page 181 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
63304058201
63304065601
63304065605
63304065701
63304065705
63304065801
CEFACLOR
63304065901
CEFACLOR
63304075120
$268.86
0.05%
$136.40
0.07%
55
$516.55
0.58%
120
$1,188.74
1.26%
77
$678.10
0.88%
129
$1,161.70
1.47%
81
$962.34
0.85%
392
$3,186.62
4.48%
712
$7,717.68
7.48%
987
$8,371.41
11.27%
CAP 250MG
46
CAP 500MG
21
$760.87
0.48%
3
$18.28
0.03%
$430.48
0.22%
4
$39.15
0.05%
172
$11,026.14
1.81%
130
$2,937.90
1.49%
63304075160
0
$0.00
0.00%
2
$61.70
0.02%
63304075220
127
$13,566.82
1.33%
117
$4,096.40
1.34%
63304075260
0
$0.00
0.00%
1
$68.05
0.01%
63304095401
CEFACLOR
SUS 125/5ML
1
$8.96
0.01%
0
$0.00
0.00%
63304095402
CEFACLOR
SUS 125/5ML
2
$33.70
0.02%
3
$50.55
0.03%
63304095503
CEFACLOR
SUS 187/5ML
1
$27.35
0.01%
0
$0.00
0.00%
63304095504
CEFACLOR
SUS 187/5ML
1
$15.35
0.01%
0
$0.00
0.00%
63304095601
CEFACLOR
SUS 250/5ML
4
$46.40
0.04%
2
$23.20
0.02%
63304095602
CEFACLOR
SUS 250/5ML
59
$1,233.12
0.62%
8
$140.04
0.09%
63304095703
CEFACLOR
SUS 375/5ML
2
$31.35
0.02%
0
$0.00
0.00%
63304095704
CEFACLOR
SUS 375/5ML
12
$251.20
0.13%
0
$0.00
0.00%
63304095801
11
$91.17
0.12%
10
$81.97
0.11%
63304095802
7
$117.75
0.07%
19
$280.80
0.22%
63304095901
46
$781.68
0.48%
45
$636.72
0.51%
63304095902
66
$1,843.28
0.69%
98
$1,874.47
1.12%
63323023861
CEFAZOLIN
INJ 10GM
0
$0.00
0.00%
1
$47.88
0.01%
63323044661
CEFAZOLIN
INJ 20GM
0
$0.00
0.00%
1
$29.12
0.01%
64455069101
CEDAX
CAP 400MG
8
$746.96
0.08%
5
$364.89
0.06%
64455077701
CEDAX
SUS 90MG/5ML
3
$168.29
0.03%
8
$49.04
0.09%
5
6
Page 182 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CEPHALOSPORINS
64455077702
CEDAX
SUS 90MG/5ML
1
$83.13
0.01%
3
64455077703
CEDAX
SUS 90MG/5ML
4
$60.68
0.04%
64455077704
CEDAX
SUS 90MG/5ML
0
$0.00
0.00%
64860010407
12
$127.58
64860010408
39
64860010507
64860010508
64860030640
64860030740
$90.00
0.03%
0
$0.00
0.00%
1
$65.13
0.01%
0.13%
12
$96.64
0.14%
$388.83
0.41%
22
$187.14
0.25%
22
$249.95
0.23%
105
$949.93
1.20%
430
$4,981.00
4.51%
167
$1,417.59
1.91%
0
$0.00
0.00%
2
$116.30
0.02%
0
$0.00
0.00%
4
$93.40
0.05%
65939038742
CEFTIN
TAB 250MG
2
$87.35
0.02%
0
$0.00
0.00%
65939040600
CEFTIN
SUS 125/5ML
1
$34.74
0.01%
0
$0.00
0.00%
65939055500
CEFTIN
SUS 250/5ML
9
$644.83
0.09%
1
$15.00
0.01%
67253030010
0
$0.00
0.00%
136
$1,105.97
1.55%
67253030110
0
$0.00
0.00%
194
$1,611.52
2.22%
67253030150
0
$0.00
0.00%
23
$177.01
0.26%
67253078102
0
$0.00
0.00%
2
$39.40
0.02%
100.00%
10
$977.81
71.43%
CHELATING AGENTS
00006060268
CUPRIMINE
CAP 250MG
10
$895.28
00006067268
CUPRIMINE
CAP 125MG
0
$0.00
0.00%
1
$24.05
7.14%
00037440101
DEPEN TITRA TAB 250MG
0
$0.00
0.00%
3
$762.00
21.43%
CHOLESTEROL - BILE SEQUESTRANTS
00009026001
COLESTID
POW 5GM
48
$3,163.63
5.05%
85
$6,049.76
9.20%
00009026002
COLESTID
GRA 5GM
7
$481.89
0.74%
12
$1,093.00
1.30%
00009026004
COLESTID
POW 5GM
1
$97.32
0.11%
0
$0.00
0.00%
00009026017
COLESTID
GRA 5GM
4
$240.39
0.42%
2
$123.12
0.22%
Page 183 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
COLESTID FLA GRA 5/7.5GM
00009037005
COLESTID FLA GRA 5GM
00009045003
COLESTID
00015058011
QUESTRAN
00015944214
$
Market Share*
CHOLESTEROL - BILE SEQUESTRANTS
00009037003
# of Scripts
1
$232.01
0.11%
0
$0.00
0.00%
7
$563.99
0.74%
5
$360.78
0.54%
272
$11,740.54
28.63%
270
$14,027.15
29.22%
POW 4GM
3
$296.58
0.32%
0
$0.00
0.00%
QUESTRAN
POW 4GM LITE
2
$294.68
0.21%
0
$0.00
0.00%
00087058005
QUESTRAN
POW 4GM
3
$78.18
0.32%
0
$0.00
0.00%
00093809667
CHOLESTYRAM POW 4GM
10
$291.74
1.05%
0
$0.00
0.00%
00093809682
CHOLESTYRAM POW 4GM
6
$230.02
0.63%
0
$0.00
0.00%
00093811183
CHOLESTYRAM POW 4GM LITE
1
$21.64
0.11%
0
$0.00
0.00%
00185093997
45
$1,524.64
4.74%
27
$653.31
2.92%
00185093998
23
$1,785.57
2.42%
11
$772.65
1.19%
00185094097
CHOLESTYRAM POW 4GM
118
$4,183.22
12.42%
79
$3,645.86
8.55%
00185094098
CHOLESTYRAM POW 4GM
34
$1,834.35
3.58%
58
$3,031.70
6.28%
00245003623
PREVALITE
POW 4GM
2
$43.28
0.21%
1
$21.64
0.11%
00245003642
PREVALITE
POW 4GM
1
$68.75
0.11%
0
$0.00
0.00%
00245003660
PREVALITE
POW 4GM
7
$234.45
0.74%
0
$0.00
0.00%
49884079165
QUESTRAN
POW 4GM
1
$7.00
0.11%
0
$0.00
0.00%
49884079166
QUESTRAN
POW 4GM
1
$64.65
0.11%
2
$2.00
0.22%
49884079289
QUESTRAN
POW 4GM LITE
5
$325.06
0.53%
1
$136.27
0.11%
59772558501
CHOLESTYRAM POW 4GM
88
$5,601.21
9.26%
96
$5,664.43
10.39%
59772558502
CHOLESTYRAM POW 4GM
149
$5,459.50
15.68%
174
$9,788.54
18.83%
59772558901
35
$2,869.90
3.68%
26
$1,458.24
2.81%
59772558902
23
$652.19
2.42%
37
$845.54
4.00%
65597070118
WELCHOL
53
$5,806.52
5.58%
38
$4,052.35
4.11%
449
$15,246.17
10.40%
539
$19,362.18
11.35%
TAB 1GM
TAB 625MG
CHOLESTEROL - FIBRIC ACID DERIVATIVES
00074400990
TRICOR
TAB 54MG
Page 184 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
TRICOR
TAB 160MG
00074612290
TRICOR
00074612390
TRICOR
00093067005
$
Market Share*
CHOLESTEROL - FIBRIC ACID DERIVATIVES
00074401390
# of Scripts
1,261
$104,992.47
29.20%
1,602
$149,447.08
33.75%
TAB 48MG
0
$0.00
TAB 145MG
0
$0.00
0.00%
7
$149.05
0.15%
0.00%
14
$644.04
0.29%
GEMFIBROZIL TAB 600MG
1,473
$27,466.79
34.11%
1,134
$22,115.21
23.89%
00093067006
106
$1,992.15
2.45%
71
$1,603.26
1.50%
00904537940
00904537952
53
$1,012.12
1.23%
4
$47.96
0.08%
13
$247.29
0.30%
1
$18.68
0.02%
00904773240
1
$13.67
0.02%
0
$0.00
0.00%
51079078720
1
$54.33
0.02%
0
$0.00
0.00%
60505003404
116
$2,508.83
2.69%
189
$3,701.39
3.98%
60505003408
845
$16,699.78
19.57%
1,186
$22,993.05
24.98%
CHOLESTEROL - HGM COA + ABSORB INHIBITORS
00003515405
PRAVACHOL
TAB 10MG
43
$3,434.15
0.10%
77
$6,181.70
0.15%
00003517805
PRAVACHOL
TAB 20MG
149
$11,376.18
0.34%
133
$10,586.46
0.27%
00003519410
PRAVACHOL
TAB 40MG
145
$16,090.43
0.33%
169
$19,646.62
0.34%
00003519510
PRAVACHOL
TAB 80MG
27
$2,891.23
0.06%
38
$3,906.32
0.08%
00006054328
ZOCOR
TAB 80MG
14
$1,509.51
0.03%
44
$11,133.47
0.09%
00006054331
ZOCOR
TAB 80MG
572
$68,109.02
1.29%
658
$78,132.05
1.32%
00006054354
ZOCOR
TAB 80MG
445
$52,038.20
1.00%
480
$56,310.91
0.96%
00006054361
ZOCOR
TAB 80MG
1
$17.00
0.00%
0
$0.00
0.00%
00006072628
ZOCOR
TAB 5MG
0
$0.00
0.00%
3
$445.20
0.01%
00006072631
ZOCOR
TAB 5MG
62
$3,309.10
0.14%
57
$3,097.67
0.11%
00006072654
ZOCOR
TAB 5MG
129
$6,805.15
0.29%
115
$5,782.93
0.23%
00006072661
ZOCOR
TAB 5MG
27
$1,438.97
0.06%
0
$0.00
0.00%
00006073528
ZOCOR
TAB 10MG
0
$0.00
0.00%
32
$5,415.39
0.06%
00006073531
ZOCOR
TAB 10MG
892
$62,667.67
2.01%
731
$49,484.97
1.47%
Page 185 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00006073554
ZOCOR
TAB 10MG
866
$60,584.04
1.95%
810
00006073561
ZOCOR
TAB 10MG
161
$11,088.60
0.36%
00006073582
ZOCOR
TAB 10MG
2
$141.91
0.00%
00006074028
ZOCOR
TAB 20MG
0
$0.00
00006074031
ZOCOR
TAB 20MG
2,787
00006074054
ZOCOR
TAB 20MG
00006074061
ZOCOR
TAB 20MG
00006074082
ZOCOR
00006074928
$56,287.26
1.63%
1
$10.97
0.00%
3
$212.46
0.01%
0.00%
98
$33,931.61
0.20%
$339,298.21
6.29%
2,408
$292,145.89
4.83%
2,026
$245,255.70
4.57%
2,119
$252,634.70
4.25%
913
$110,622.40
2.06%
1
$2.91
0.00%
TAB 20MG
47
$5,340.41
0.11%
122
$14,589.64
0.24%
ZOCOR
TAB 40MG
0
$0.00
0.00%
78
$26,975.19
0.16%
00006074931
ZOCOR
TAB 40MG
1,818
$219,408.73
4.10%
1,820
$221,153.48
3.65%
00006074954
ZOCOR
TAB 40MG
1,133
$137,358.88
2.56%
1,660
$202,534.86
3.33%
00006074961
ZOCOR
TAB 40MG
612
$70,204.82
1.38%
0
$0.00
0.00%
00006074982
ZOCOR
TAB 40MG
3
$138.73
0.01%
4
$394.15
0.01%
00071015523
LIPITOR
TAB 10MG
13,260
$844,048.24
29.91%
13,726
$915,330.58
27.56%
00071015534
LIPITOR
TAB 10MG
24
$1,388.44
0.05%
44
$2,682.76
0.09%
00071015540
LIPITOR
TAB 10MG
33
$2,047.65
0.07%
9
$642.00
0.02%
00071015623
LIPITOR
TAB 20MG
8,176
$771,930.61
18.44%
9,319
$896,172.22
18.71%
00071015640
LIPITOR
TAB 20MG
0
$0.00
0.00%
22
$2,257.22
0.04%
00071015723
LIPITOR
TAB 40MG
3,570
$341,538.30
8.05%
4,611
$454,597.10
9.26%
00071015823
LIPITOR
TAB 80MG
1,150
$108,581.38
2.59%
1,737
$168,910.76
3.49%
00078017605
LESCOL
CAP 20MG
443
$21,647.65
1.00%
394
$21,168.50
0.79%
00078017615
LESCOL
CAP 20MG
34
$1,654.26
0.08%
19
$1,015.35
0.04%
00078023405
LESCOL
CAP 40MG
578
$31,557.92
1.30%
440
$25,214.31
0.88%
00078023415
LESCOL
CAP 40MG
25
$1,282.66
0.06%
16
$1,010.30
0.03%
00078035405
LESCOL XL
TAB 80MG
445
$27,555.07
1.00%
463
$31,394.77
0.93%
00078035415
LESCOL XL
TAB 80MG
52
$3,087.58
0.12%
67
$4,416.67
0.13%
00093057606
LOVASTATIN TAB 20MG
325
$8,260.02
0.73%
331
$6,494.08
0.66%
Page 186 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00093057610
LOVASTATIN TAB 20MG
13
$305.75
0.03%
6
00093092606
LOVASTATIN TAB 10MG
103
$1,646.61
0.23%
00093092806
LOVASTATIN TAB 40MG
204
$9,375.96
0.46%
00185007060
LOVASTATIN TAB 10MG
0
$0.00
00185007201
LOVASTATIN TAB 20MG
1
00185007210
LOVASTATIN TAB 20MG
00185007260
LOVASTATIN TAB 20MG
00185007401
$137.30
0.01%
100
$1,621.70
0.20%
267
$10,048.35
0.54%
0.00%
20
$229.60
0.04%
$25.25
0.00%
0
$0.00
0.00%
0
$0.00
0.00%
25
$475.10
0.05%
1
$25.25
0.00%
5
$96.25
0.01%
LOVASTATIN TAB 40MG
1
$40.25
0.00%
1
$18.11
0.00%
00185007460
LOVASTATIN TAB 40MG
0
$0.00
0.00%
2
$57.70
0.00%
00228263306
LOVASTATIN TAB 10MG
15
$239.40
0.03%
17
$280.45
0.03%
00228263406
LOVASTATIN TAB 20MG
104
$2,540.44
0.23%
147
$2,496.88
0.30%
00228263450
LOVASTATIN TAB 20MG
4
$98.50
0.01%
11
$232.10
0.02%
00228263506
LOVASTATIN TAB 40MG
27
$1,092.59
0.06%
93
$2,939.95
0.19%
00310075139
CRESTOR
TAB 10MG
14
$883.29
0.03%
54
$3,455.68
0.11%
00310075190
CRESTOR
TAB 10MG
495
$33,268.54
1.12%
2,287
$169,843.35
4.59%
00310075290
CRESTOR
TAB 20MG
98
$6,830.92
0.22%
547
$41,449.66
1.10%
00310075430
CRESTOR
TAB 40MG
60
$4,107.00
0.14%
218
$16,626.75
0.44%
00310075590
CRESTOR
TAB 5MG
15
$1,052.04
0.03%
124
$9,524.94
0.25%
00378651091
LOVASTATIN TAB 10MG
87
$1,577.89
0.20%
75
$1,089.00
0.15%
00378652005
LOVASTATIN TAB 20MG
29
$737.95
0.07%
29
$517.25
0.06%
00378652091
LOVASTATIN TAB 20MG
328
$8,005.87
0.74%
338
$6,553.08
0.68%
00378654005
LOVASTATIN TAB 40MG
4
$298.60
0.01%
14
$681.70
0.03%
00378654091
LOVASTATIN TAB 40MG
229
$10,726.71
0.52%
236
$8,041.40
0.47%
00781121060
LOVASTATIN TAB 20MG
103
$2,505.93
0.23%
99
$1,695.59
0.20%
00781121360
LOVASTATIN TAB 40MG
60
$2,605.89
0.14%
57
$1,630.35
0.11%
00781132360
LOVASTATIN TAB 10MG
26
$437.30
0.06%
9
$134.80
0.02%
00904558252
LOVASTATIN TAB 20MG
1
$25.25
0.00%
0
$0.00
0.00%
Page 187 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
LOVASTATIN TAB 40MG
49884075401
LOVASTATIN TAB 10MG
49884075501
LOVASTATIN TAB 20MG
49884075510
LOVASTATIN TAB 20MG
49884075601
LOVASTATIN TAB 40MG
51079097520
LOVASTATIN TAB 20MG
60598000690
ADVICOR
TAB 500-20MG
60598000790
ADVICOR
TAB 750-20MG
60598000890
ADVICOR
TAB 1000-20
62022062830
ALTOPREV
62022062930
ALTOPREV
62022063030
$
Market Share*
00904558352
# of Scripts
$26.30
0.00%
4
$156.40
0.01%
5
$77.25
0.01%
5
$64.25
0.01%
13
$298.25
0.03%
5
$83.75
0.01%
15
$353.22
0.03%
4
$74.50
0.01%
7
$237.49
0.02%
5
$238.75
0.01%
3
$65.70
0.01%
3
$47.70
0.01%
42
$2,705.18
0.09%
64
$5,083.16
0.13%
6
$361.62
0.01%
1
$67.92
0.00%
3
$375.21
0.01%
15
$1,311.14
0.03%
TAB 20MG ER
0
$0.00
0.00%
9
$351.78
0.02%
TAB 40MG ER
0
$0.00
0.00%
17
$943.15
0.03%
ALTOPREV
TAB 60MG ER
0
$0.00
0.00%
21
$1,294.61
0.04%
62022077030
ALTOCOR
TAB 20MG CR
19
$931.63
0.04%
1
$28.92
0.00%
62022078030
ALTOCOR
TAB 40MG CR
35
$1,946.21
0.08%
1
$61.10
0.00%
62022078130
ALTOCOR
TAB 60MG CR
39
$2,220.69
0.09%
0
$0.00
0.00%
62037079101
LOVASTATIN TAB 10MG
7
$132.85
0.02%
10
$142.10
0.02%
62037079201
LOVASTATIN TAB 20MG
10
$251.68
0.02%
30
$592.69
0.06%
62037079301
LOVASTATIN TAB 40MG
15
$559.34
0.03%
24
$803.10
0.05%
66582031128
VYTORIN
TAB 10-10MG
0
$0.00
0.00%
1
$77.94
0.00%
66582031131
VYTORIN
TAB 10-10MG
0
$0.00
0.00%
3
$198.32
0.01%
66582031228
VYTORIN
TAB 10-20MG
0
$0.00
0.00%
5
$375.31
0.01%
66582031231
VYTORIN
TAB 10-20MG
0
$0.00
0.00%
78
$6,188.48
0.16%
66582031254
VYTORIN
TAB 10-20MG
0
$0.00
0.00%
6
$455.14
0.01%
66582031331
VYTORIN
TAB 10-40MG
0
$0.00
0.00%
96
$7,561.94
0.19%
66582031354
VYTORIN
TAB 10-40MG
0
$0.00
0.00%
1
$75.44
0.00%
66582031531
VYTORIN
TAB 10-80MG
0
$0.00
0.00%
19
$1,572.02
0.04%
66582041428
ZETIA
1
$63.82
0.00%
0
$0.00
0.00%
TAB 10MG
1
Page 188 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
66582041431
ZETIA
TAB 10MG
885
$57,969.58
2.00%
1,260
$87,534.83
2.53%
66582041454
ZETIA
TAB 10MG
212
$13,705.50
0.48%
479
$30,820.02
0.96%
CHOLINERGIC
00006045768
URECHOLINE TAB 25MG
5
$462.60
4.81%
1
$178.02
1.69%
65473069701
URECHOLINE TAB 5MG
6
$614.30
5.77%
2
$82.98
3.39%
65473070001
URECHOLINE TAB 50MG
8
$1,468.05
7.69%
12
$2,820.19
20.34%
65473070301
URECHOLINE TAB 10MG
8
$778.72
7.69%
3
$696.39
5.08%
65473070401
URECHOLINE TAB 25MG
77
$12,248.68
74.04%
41
$7,955.78
69.49%
11
$469.06
61.11%
15
$687.21
62.50%
7
$133.97
38.89%
9
$82.24
37.50%
123
$2,872.93
100.00%
18
$416.25
100.00%
CONTRACEPTIVES - BI-PHASIC COMBINATIONS
00062177115
ORTHO-NOVUM TAB 10/11-28
52544055428
NECON
TAB 10/11-28
CONTRACEPTIVES - EMERGENCY CONTRACEPTIVE
63955001001
PREVEN EMERG KIT CONTRCPT
CONTRACEPTIVES - INJECTABLE
00009074630
DEPO-PROVERA INJ 150MG/ML
906
$48,650.02
52.86%
978
$59,934.45
49.29%
00009074635
74
$3,947.81
4.32%
58
$3,081.92
2.92%
00009737601
127
$6,383.26
7.41%
39
$1,988.15
1.97%
00009737602
10
$521.60
0.58%
3
$153.12
0.15%
00009737603
3
$156.48
0.18%
1
$12.22
0.05%
00009737604
594
$32,078.47
34.66%
845
$46,678.19
42.59%
00703680101
MEDROXYPR AC INJ 150MG/ML
0
$0.00
0.00%
25
$1,082.06
1.26%
00703680104
0
$0.00
0.00%
1
$49.50
0.05%
59762453701
0
$0.00
0.00%
34
$1,273.24
1.71%
Page 189 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CONTRACEPTIVES - PROGESTIN ONLY
00008006201
OVRETTE 28 TAB 0.075MG
00062141101
7
$244.30
0.71%
3
$109.74
0.28%
ORTHO MICRON TAB DIALPAK
61
$2,401.77
6.22%
36
$1,455.32
3.35%
00062141116
ORTHO MICRON TAB DIALPAK
808
$36,610.31
82.45%
971
$46,949.46
90.41%
00555034458
ERRIN
20
$608.79
2.04%
30
$1,141.20
2.79%
00555071558
CAMILA
TAB 0.35MG
23
$726.18
2.35%
13
$345.12
1.21%
52544023528
NOR-QD
TAB 0.35MG
22
$902.77
2.24%
0
$0.00
0.00%
52544062928
NORA-BE
TAB 0.35MG
18
$618.88
1.84%
10
$255.57
0.93%
52544089228
JOLIVETTE
TAB 0.35MG
21
$612.43
2.14%
11
$294.36
1.02%
784
$24,887.12
7.15%
768
$25,487.42
7.03%
TAB 0.35MG
CONTRACEPTIVES - TRI-PHASIC COMBINATIONS
00008253601
TRIPHASIL 28 TAB
00008253603
TRIPHASIL 28 TAB
7
$182.14
0.06%
0
$0.00
0.00%
00008253605
TRIPHASIL 28 TAB
20
$516.93
0.18%
18
$596.62
0.16%
00052028306
CYCLESSA
32
$1,042.45
0.29%
11
$419.60
0.10%
00062125101
ORTHO TRI-CY TAB LO
37
$1,276.91
0.34%
0
$0.00
0.00%
00062125115
ORTHO TRI-CY TAB LO
298
$10,665.20
2.72%
215
$6,337.93
1.97%
00062178115
ORTHO-NOVUM TAB 7/7/7-28
880
$34,510.66
8.02%
871
$35,035.91
7.97%
00062178120
16
$288.83
0.15%
2
$81.04
0.02%
00062178122
2
$12.70
0.02%
7
$281.68
0.06%
00062190315
ORTHO TRI- TAB CYCLEN
8,459
$328,197.94
77.14%
8,320
$334,289.95
76.16%
00071092847
ESTROSTEP FE TAB
40
$1,342.35
0.36%
17
$502.61
0.16%
00093531581
TRI-PREVIFEM TAB
0
$0.00
0.00%
5
$160.24
0.05%
00555901258
NORTREL7/7/7 TAB 28 DAYS
27
$635.33
0.25%
11
$117.46
0.10%
00555901858
TRI-SPRINTEC TAB
0
$0.00
0.00%
53
$1,030.57
0.49%
00555904758
ENPRESSE-28 TAB 28 DAY
36
$650.19
0.33%
11
$145.68
0.10%
00555905158
VELIVET
0
$0.00
0.00%
5
$97.26
0.05%
PAK
PAK
Page 190 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CONTRACEPTIVES - TRI-PHASIC COMBINATIONS
50419043303
TRI-LEVLEN TAB 28
51
$1,615.70
0.47%
89
$2,795.02
0.81%
50419043306
TRI-LEVLEN TAB 28
101
$3,039.49
0.92%
95
$2,947.39
0.87%
51285051428
ENPRESSE-28 TAB
1
$25.47
0.01%
0
$0.00
0.00%
52544027428
TRI-NORINYL TAB 28
13
$514.20
0.12%
3
$127.14
0.03%
52544029128
TRIVORA-28 TAB
93
$2,123.73
0.85%
49
$816.72
0.45%
52544093528
TRINESSA
0
$0.00
0.00%
342
$8,823.66
3.13%
52544093628
NECON 7/7/7 TAB 28 DAY
69
$2,030.52
0.63%
32
$831.11
0.29%
TAB
CONTRACEPTIVES -MONOPHASIC COMBINATION O/C'S
00008007501
NORDETTE-21 TAB
00008007801
LO/OVRAL
00008251101
OVRAL
00008251102
OVRAL
00008251401
LO/OVRAL
TAB -28
9
$319.05
0.08%
2
$73.16
0.02%
00008251402
LO/OVRAL
TAB -28
1,446
$50,832.23
12.99%
1,988
$72,501.10
16.61%
00008253301
NORDETTE-28 TAB
1
$35.75
0.01%
0
$0.00
0.00%
00008253302
NORDETTE-28 TAB
9
$296.00
0.08%
3
$105.03
0.03%
00008257601
ALESSE
TAB -28
15
$530.40
0.13%
10
$365.80
0.08%
00008257602
ALESSE
TAB -28
1,615
$56,924.25
14.51%
2,284
$83,100.77
19.09%
00025008109
DEMULEN
TAB 1/50-28
45
$1,603.35
0.40%
75
$2,791.66
0.63%
00025008124
DEMULEN
TAB 1/50-28
0
$0.00
0.00%
4
$152.68
0.03%
00025016109
DEMULEN
TAB 1/35-28
240
$7,751.77
2.16%
308
$10,655.39
2.57%
00025016124
DEMULEN
TAB 1/35-28
9
$277.91
0.08%
7
$242.27
0.06%
00052026106
DESOGEN-28 TAB
771
$24,416.80
6.93%
897
$29,350.85
7.50%
00052028106
MIRCETTE
82
$2,848.97
0.74%
39
$1,472.28
0.33%
00062133215
113
$4,340.65
1.02%
130
$5,440.95
1.09%
00062133220
6
$237.72
0.05%
0
$0.00
0.00%
2
$71.18
0.02%
0
$0.00
0.00%
18
$669.12
0.16%
8
$213.03
0.07%
TAB -28
4
$166.86
0.04%
0
$0.00
0.00%
TAB -28
17
$874.46
0.15%
9
$296.84
0.08%
TAB -21
TAB 28
Page 191 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
MODICON
TAB 0.5/35
00062176115
00062176120
00062179615
ORTHO-CEPT TAB 28
00062190115
ORTHO-CYCLEN TAB 0.25/35
00071091315
LOESTRIN FE TAB 1/20
00071091345
00071091347
$
Market Share*
00062171415
# of Scripts
47
$1,980.10
0.42%
49
$2,243.22
0.41%
1,222
$48,288.70
10.98%
1,540
$65,087.08
12.87%
11
$255.86
0.10%
0
$0.00
0.00%
523
$20,147.27
4.70%
665
$27,761.61
5.56%
1,359
$53,517.34
12.21%
1,490
$60,221.72
12.45%
0
$0.00
0.00%
3
$88.71
0.03%
4
$138.12
0.04%
0
$0.00
0.00%
0
$0.00
0.00%
6
$176.52
0.05%
00071091348
364
$12,223.34
3.27%
225
$9,230.75
1.88%
00071091548
LOESTRIN
TAB 1/20-21
19
$623.62
0.17%
3
$139.37
0.03%
00071091648
LOESTRIN 21 TAB 1.5/30
8
$277.06
0.07%
7
$290.78
0.06%
00071091715
LOESTRIN FE TAB 1.5/30
0
$0.00
0.00%
1
$29.83
0.01%
00071091745
3
$104.49
0.03%
0
$0.00
0.00%
00071091747
0
$0.00
0.00%
1
$28.78
0.01%
00071091748
365
$12,490.22
3.28%
205
$8,446.18
1.71%
00087057841
OVCON-35 28 TAB
1
$30.87
0.01%
0
$0.00
0.00%
00430058214
OVCON-35 28 TAB
367
$12,810.08
3.30%
617
$23,690.22
5.16%
00430058311
OVCON-35 21 TAB
00430058514
OVCON 50
00555900858
0
$0.00
0.00%
1
$32.23
0.01%
85
$3,316.32
0.76%
52
$2,232.28
0.43%
NORTREL 28 TAB 0.5/35
11
$249.37
0.10%
10
$135.82
0.08%
00555901058
NORTREL (28) TAB 1/35
60
$1,422.55
0.54%
54
$964.87
0.45%
00555901458
LESSINA-28 TAB
9
$227.97
0.08%
9
$231.75
0.08%
00555901658
SPRINTEC 28 TAB 28 DAY
94
$1,936.07
0.84%
42
$818.11
0.35%
00555902058
PORTIA-28
TAB
21
$471.47
0.19%
9
$153.70
0.08%
00555902658
JUNEL FE
TAB 1/20
9
$272.98
0.08%
4
$40.00
0.03%
00555902757
JUNEL 1.5/30 TAB
0
$0.00
0.00%
1
$28.52
0.01%
00555902858
JUNEL FE
2
$20.00
0.02%
7
$177.82
0.06%
TAB 28
TAB 1.5-30
Page 192 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
APRI
TAB
00555904558
AVIANE
00555904958
00555905058
KARIVA
50419040203
YASMIN 28
50419040803
LEVLITE
50419041112
LEVLEN
50419041128
LEVLEN-28
51285001728
AVIANE
51285054628
CRYSELLE-28 TAB 28 TABS
51285057628
APRI
52544025428
BREVICON
52544025928
NORINYL
52544027928
LEVORA-28
52544038328
ZOVIA 1/35E TAB
52544038428
$
Market Share*
00555904358
# of Scripts
180
$3,608.41
1.62%
35
$468.93
0.29%
TAB
200
$5,115.77
1.80%
135
$2,218.41
1.13%
CRYSELLE-28 TAB 28 TABS
48
$781.60
0.43%
37
$666.88
0.31%
201
$5,290.04
1.81%
63
$909.96
0.53%
630
$20,557.74
5.66%
167
$5,397.48
1.40%
TAB -28
3
$102.93
0.03%
0
$0.00
0.00%
TAB CONTR PK
0
$0.00
0.00%
2
$67.70
0.02%
238
$7,869.84
2.14%
402
$13,589.51
3.36%
6
$174.90
0.05%
0
$0.00
0.00%
TAB 28 DAY
TAB 3-0.03MG
TAB
TAB
2
$50.94
0.02%
0
$0.00
0.00%
10
$195.92
0.09%
3
$63.70
0.03%
TAB 0.5/35
5
$188.50
0.04%
2
$24.42
0.02%
TAB 1+35-28
3
$109.05
0.03%
0
$0.00
0.00%
TAB 0.15/30
58
$1,262.53
0.52%
28
$388.21
0.23%
46
$1,152.53
0.41%
30
$424.15
0.25%
ZOVIA 1/50E TAB
12
$356.99
0.11%
5
$150.26
0.04%
52544052628
MONONESSA
38
$1,132.76
0.34%
23
$526.42
0.19%
52544055028
NECON
TAB 0.5/35
6
$179.42
0.05%
4
$123.16
0.03%
52544055228
NECON
TAB 1/35-28
156
$4,346.42
1.40%
76
$2,008.73
0.64%
52544055628
NECON
TAB 1/50-28
31
$676.00
0.28%
4
$109.72
0.03%
52544063028
MICROGESTIN TAB FE 1/20
39
$959.75
0.35%
26
$562.66
0.22%
52544063128
MICROGESTIN TAB FE1.5/30
44
$1,032.81
0.40%
29
$562.78
0.24%
52544084728
LOW-OGESTREL TAB
158
$3,332.40
1.42%
93
$1,870.48
0.78%
52544084828
OGESTREL
27
$1,074.35
0.24%
5
$152.29
0.04%
52544095021
MICROGESTIN TAB 1/20
6
$131.13
0.05%
4
$54.17
0.03%
66993061128
SOLIA
0
$0.00
0.00%
29
$373.85
0.24%
TAB
TAB
TAB
TAB
Page 193 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
CONTRACEPTIVES -PATCHES/ VAGINAL PRODUCTS
00052027301
NUVARING
MIS
00062192001
ORTHO EVRA DIS WEEK
28
$650.17
1.93%
27
$711.54
1.78%
00062192015
ORTHO EVRA DIS WEEK
1,306
$45,508.75
90.13%
1,412
$50,879.66
92.89%
2
$14.92
0.10%
0
$0.00
0.00%
115
$4,153.16
7.94%
81
$2,838.73
5.33%
COUGH/COLD
00031228378
DIMETAPP PED DRO 7.5/0.8
00031868512
ROBITUSSIN SYP DM
576
$3,561.15
27.39%
474
$3,049.02
26.20%
00031868518
ROBITUSSIN SYP DM
449
$3,795.19
21.35%
425
$3,327.82
23.49%
00031868522
ROBITUSSIN SYP DM
141
$1,393.19
6.70%
78
$685.43
4.31%
00031868525
ROBITUSSIN SYP DM
00031868612
ROBITUSSIN SYP SUGAR FR
00054474325
28
$223.29
1.33%
11
$69.15
0.61%
206
$2,057.00
9.80%
168
$1,376.02
9.29%
PSEUDOEPHEDR TAB 30MG
45
$204.99
2.14%
50
$209.49
2.76%
00054474425
131
$608.87
6.23%
131
$638.19
7.24%
00081067013
SUDAFED 12HR TAB 120MG CR
10
$157.53
0.48%
17
$307.17
0.94%
00113043262
0
$0.00
0.00%
1
$7.70
0.06%
00121042104
PSEUDOEPHEDR SYP 30MG/5ML
13
$70.22
0.62%
11
$60.90
0.61%
00182145916
GENAPHED
4
$17.17
0.19%
3
$16.36
0.17%
00258365401
BENZONATATE CAP 100MG
1
$9.00
0.05%
0
$0.00
0.00%
00472151704
DECOFED
SYP 30MG/5ML
1
$5.08
0.05%
0
$0.00
0.00%
00472151716
DECOFED
SYP 30MG/5ML
1
$2.28
0.05%
0
$0.00
0.00%
00472151794
DECOFED
SYP 30MG/5ML
1
$5.53
0.05%
0
$0.00
0.00%
00472159591
12 HR NASAL SPR 0.05%
0
$0.00
0.00%
1
$1.99
0.06%
00501278710
11
$174.66
0.52%
3
$64.17
0.17%
00501278720
65
$960.96
3.09%
19
$251.58
1.05%
00501286548
SUDAFED
1
$6.45
0.05%
0
$0.00
0.00%
00501288004
CHILD SUDAFE LIQ 15MG/5ML
1
$7.27
0.05%
0
$0.00
0.00%
00536185085
21
$135.76
1.00%
40
$244.59
2.21%
TAB 30MG
TAB 30MG
Page 194 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
00536185097
00536439101
00536439135
00603554328
Q-BID-LA
00677164301
GUAIFENESIN TAB 1200 LA
00677178501
GG/PSE
00781153301
00781153501
00904505324
SUDOGEST
00904512559
00904536720
11822040230
6
$36.49
0.29%
2
$12.18
0.11%
3
$13.12
0.14%
15
$84.58
0.71%
0
$0.00
0.00%
7
$12.33
0.39%
2
$27.38
0.10%
0
$0.00
0.00%
4
$109.56
0.19%
0
$0.00
0.00%
1
$12.02
0.05%
0
$0.00
0.00%
69
$404.29
3.28%
87
$474.38
4.81%
101
$640.53
4.80%
73
$407.28
4.04%
TAB 30MG
7
$19.11
0.33%
5
$15.13
0.28%
SUDOGEST
TAB 60MG
6
$37.66
0.29%
7
$47.94
0.39%
SUDOGEST
LIQ 15MG/5ML
1
$4.20
0.05%
0
$0.00
0.00%
RA SUPHEDRIN TAB 30MG
5
$44.68
0.24%
3
$15.85
0.17%
11822386780
RA SUPHEDRIN TAB 120MG CR
6
$85.74
0.29%
9
$155.86
0.50%
11845086107
PSEUDO
0
$0.00
0.00%
1
$12.25
0.06%
17236026301
0
$0.00
0.00%
1
$1.99
0.06%
17236026324
1
$4.24
0.05%
0
$0.00
0.00%
17236026701
3
$2.72
0.14%
0
$0.00
0.00%
24385043262
SUPHEDRIN TAB 30MG
3
$16.67
0.14%
0
$0.00
0.00%
37205030410
0
$0.00
0.00%
4
$15.56
0.22%
37205044426
CHILD PSEUPH LIQ 15MG/5ML
10
$53.66
0.48%
10
$75.54
0.55%
37205044562
24
$165.41
1.14%
17
$121.44
0.94%
37205044580
54
$403.06
2.57%
50
$379.12
2.76%
37205044652
PSEUDOEPHEDR CAP 120MG CR
53
$902.61
2.52%
73
$1,263.35
4.04%
49348002404
SM SUPHEDRIN TAB 30MG
0
$0.00
0.00%
3
$13.49
0.17%
49348019727
SM NOSE DROP SOL 1%
1
$4.32
0.05%
0
$0.00
0.00%
50111085101
BENZONATATE CAP 100MG
2
$14.06
0.10%
0
$0.00
0.00%
50383067730
OXYMETAZOLIN SPR 0.05%
0
$0.00
0.00%
4
$4.50
0.22%
TAB 600MG
TAB 1200/120
TAB 30MG
Page 195 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
COUGH/COLD
50428125740
DECONGESTANT TAB 30MG
2
$25.73
0.10%
6
$24.44
0.33%
50428144665
12HR DECONGE TAB 120MG CR
4
$63.92
0.19%
2
$15.58
0.11%
50428360131
NASAL DECONG TAB 30MG
0
$0.00
0.00%
4
$20.86
0.22%
50580019304
SIMPLY STUFF LIQ 15MG/5ML
0
$0.00
0.00%
1
$7.13
0.06%
52735063641
PSEUDOEPHEDR LIQ 15MG/5ML
1
$6.28
0.05%
0
$0.00
0.00%
52959026104
CHILD'S PSEU LIQ 30MG/5ML
1
$7.41
0.05%
2
$14.96
0.11%
53746022101
0
$0.00
0.00%
4
$12.06
0.22%
57664015213
GUAIFENESIN TAB 600MG LA
3
$18.42
0.14%
0
$0.00
0.00%
58177020504
GUAIFENEX LA TAB 600MG
1
$10.90
0.05%
0
$0.00
0.00%
59390003613
2
$7.51
0.10%
1
$3.29
0.06%
59606044506
SUPHEDRINE TAB 30MG
0
$0.00
0.00%
1
$4.54
0.06%
60242050101
4
$8.42
0.19%
0
$0.00
0.00%
COX 2 INHIBITORS
00006007428
VIOXX
TAB 12.5MG
21
$1,435.05
0.14%
1
$43.62
0.01%
00006007431
VIOXX
TAB 12.5MG
73
$5,420.40
0.49%
4
$161.04
0.04%
00006007468
VIOXX
TAB 12.5MG
648
$50,595.65
4.38%
26
$1,128.52
0.27%
00006011028
VIOXX
TAB 25MG
12
$1,047.66
0.08%
7
$270.48
0.07%
00006011031
VIOXX
TAB 25MG
31
$1,945.26
0.21%
0
$0.00
0.00%
00006011068
VIOXX
TAB 25MG
3,749
$294,907.91
25.36%
55
$2,478.23
0.58%
00006011082
VIOXX
TAB 25MG
3
$238.73
0.02%
0
$0.00
0.00%
00006011428
VIOXX
TAB 50MG
1
$115.72
0.01%
0
$0.00
0.00%
00006011431
VIOXX
TAB 50MG
8
$873.33
0.05%
0
$0.00
0.00%
00006011468
VIOXX
TAB 50MG
888
$94,249.27
6.01%
10
$662.04
0.11%
00006378464
VIOXX
SUS 12.5MG
7
$1,043.97
0.05%
0
$0.00
0.00%
00006378564
VIOXX
SUS 25MG
16
$1,214.88
0.11%
0
$0.00
0.00%
00025152031
CELEBREX
449
$25,247.77
3.04%
532
$25,066.85
5.62%
CAP 100MG
Page 196 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
COX 2 INHIBITORS
00025152051
CELEBREX
CAP 100MG
89
$4,295.20
0.60%
148
$7,466.18
1.56%
00025152531
CELEBREX
CAP 200MG
5,875
$593,871.67
39.73%
5,521
$568,399.66
58.33%
00025152534
CELEBREX
CAP 200MG
0
$0.00
0.00%
12
$278.44
0.13%
00025152551
CELEBREX
CAP 200MG
865
$82,824.56
5.85%
859
$78,654.36
9.08%
00025153001
CELEBREX
CAP 400MG
5
$834.22
0.03%
3
$372.75
0.03%
00025153002
CELEBREX
27
$4,851.44
0.18%
44
$6,966.82
0.46%
00025197531
BEXTRA
TAB 10MG
768
$65,674.47
5.19%
996
$81,775.56
10.52%
00025198031
BEXTRA
TAB 20MG
1,251
$104,383.88
8.46%
1,247
$112,245.48
13.17%
15
$21,249.43
93.75%
20
$32,799.79
100.00%
CAP 250MG
1
$7.42
6.25%
0
$0.00
0.00%
CAP 400MG
CYTO-MEGALOVIRUS AGENTS
00004003822
VALCYTE
00004026948
CYTOVENE
TAB 450MG
DENTAL PRODUCTS
00126007534
PREVIDENT
GEL 5000 BST
0
$0.00
0.00%
8
$85.56
1.11%
00126007634
PREVIDENT
GEL 5000 BST
0
$0.00
0.00%
1
$10.87
0.14%
00126008802
PREVIDENT
GEL 1.1% MIN
80
$880.40
10.84%
46
$486.37
6.40%
00126013066
PHOS-FLUR
GEL 1.1%
1
$8.92
0.14%
0
$0.00
0.00%
00126013166
PHOS-FLUR
GEL 1.1%
3
$28.59
0.41%
2
$21.37
0.28%
00126013516
PHOS FLUR
SOL 0.044%
0
$0.00
0.00%
1
$11.63
0.14%
00126013816
PHOS FLUR
SOL 0.044%
0
$0.00
0.00%
2
$23.24
0.28%
00126014416
PHOS FLUR
SOL 0.044%
0
$0.00
0.00%
1
$11.63
0.14%
00126014446
PHOS FLUR
SOL 0.044%
1
$11.80
0.14%
1
$11.19
0.14%
00126017916
PREVIDENT
SOL RINSE
17
$182.64
2.30%
36
$394.71
5.01%
00126017999
PREVIDENT
SOL RINSE
17
$149.15
2.30%
4
$43.44
0.56%
00126019293
GEL-KAM
2
$19.30
0.27%
1
$8.24
0.14%
00126028666
PREVIDENT
0
$0.00
0.00%
12
$136.32
1.67%
GEL 0.4%
CRE 5000 PLS
Page 197 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DENTAL PRODUCTS
00126028733
PREVIDENT
CRE 5000 PLS
29
$490.19
3.93%
46
$795.65
6.40%
00126028766
PREVIDENT
CRE 5000 PLS
197
$2,173.27
26.69%
291
$3,158.11
40.47%
00126028802
PREVIDENT
GEL 1.1% BER
17
$182.69
2.30%
15
$165.02
2.09%
00126028866
PREVIDENT
CRE 5000 PLS
55
$637.99
7.45%
44
$486.41
6.12%
00126029002
PREVIDENT
GEL 1.1% CHR
3
$29.75
0.41%
4
$35.32
0.56%
00126231068
GEL-KAM
58177083537
ETHEDENT
CRE DENTAL
58177083803
ETHEDENT
CON 0.63%
1
$17.87
0.14%
1
$17.54
0.14%
84
$881.19
11.38%
94
$980.86
13.07%
GEL 1.1%
0
$0.00
0.00%
13
$128.28
1.81%
60258015001
SF 5000 PLUS CRE 1.1%
104
$1,022.18
14.09%
7
$68.53
0.97%
60258015101
SF
127
$1,299.06
17.21%
85
$843.72
11.82%
64980030550
DENTA 5000 CRE PLUS
0
$0.00
0.00%
4
$24.03
0.56%
1,370
$136,873.16
10.36%
291
$24,214.88
2.04%
286
$27,947.03
2.16%
57
$4,089.38
0.40%
3
$255.50
0.02%
0
$0.00
0.00%
781
$29,939.77
5.91%
65
$2,281.34
0.46%
GEL 1.1%
DIABETIC - INSULIN
00002751001
HUMALOG
00002751101
HUMALOG MIX SUS 75/25
INJ 100/ML
00002821101
ILETIN II RG INJ U100PORK
00002821501
HUMULIN R
00002831101
ILETIN II
28
$1,893.60
0.21%
12
$838.34
0.08%
00002831501
HUMULIN N
INJ U-100
1,709
$83,069.95
12.92%
103
$4,938.89
0.72%
00002841501
HUMULIN L
INJ U-100
94
$3,592.39
0.71%
50
$1,919.23
0.35%
00002850101
HUMULIN R
INJ U-500
5
$1,340.76
0.04%
17
$4,309.87
0.12%
00002861501
HUMULIN U
15
$656.00
0.11%
16
$663.87
0.11%
00002871501
HUMULIN
INJ 70/30
858
$47,857.37
6.49%
48
$2,498.64
0.34%
00002951501
HUMULIN
INJ 50/50
16
$422.83
0.12%
6
$127.32
0.04%
00088222033
LANTUS
4,115
$286,027.23
31.11%
5,039
$410,843.35
35.28%
00169007011
VELOSULIN BR INJ 100/ML
2
$266.36
0.02%
0
$0.00
0.00%
00169183311
NOVOLIN R
666
$20,982.22
5.04%
1,265
$45,375.26
8.86%
INJ U-100
INJ NPH PORK
INJ U-100
INJ 100/ML
INJ U-100
Page 198 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIABETIC - INSULIN
00169183318
RELION R
INJ U-100
00169183411
NOVOLIN N
00169183418
RELION N
00169183511
NOVOLIN L
00169183711
NOVOLIN
00169183718
00169368512
00169750111
NOVOLOG
59060183302
RELION R
59060183402
RELION N
59060183702
RELION 70/30 INJ 100/ML
40
$930.42
0.30%
2
$48.46
0.01%
1,200
$49,937.47
9.07%
2,366
$102,264.00
16.56%
15
$382.36
0.11%
4
$150.37
0.03%
18
$737.71
0.14%
6
$170.68
0.04%
850
$41,033.72
6.43%
1,633
$87,111.34
11.43%
RELION 70/30 INJ 70/30
38
$1,228.65
0.29%
1
$15.32
0.01%
NOVOLOG MIX SUS 70/30
43
$4,367.23
0.33%
265
$33,364.90
1.86%
969
$90,051.16
7.33%
2,654
$265,326.81
18.58%
INJ 100/ML
4
$63.78
0.03%
117
$4,669.36
0.82%
INJ 100/ML
86
$1,973.08
0.65%
178
$8,026.08
1.25%
15
$626.83
0.11%
89
$4,664.53
0.62%
INJ U-100
INJ U-100
INJ U-100
INJ 70/30
INJ 100/ML
DIABETIC - PENFILLS
00002751559
HUMALOG
INJ 100/ML
21
$2,180.79
2.18%
1
$20.00
0.17%
00002751659
HUMALOG
INJ 100/ML
11
$2,597.63
1.14%
13
$2,687.89
2.15%
00002872559
HUMALOG PEN INJ 100/ML
263
$32,383.57
27.28%
64
$6,923.44
10.58%
00002873001
HUMULIN N PN INJ U-100
0
$0.00
0.00%
1
$89.58
0.17%
00002873059
HUMULIN N PN INJ U-100
88
$9,289.16
9.13%
24
$3,299.40
3.97%
00002877059
HUMULIN PEN INJ 70/30
46
$4,503.99
4.77%
3
$261.21
0.50%
00002879459
HUMALOG PEN INJ 75/25
125
$21,711.68
12.97%
50
$7,745.86
8.26%
00169001771
NOVOLIN
3
$104.98
0.31%
0
$0.00
0.00%
00169004571
NOVOLIN N
INJ U-100
3
$273.36
0.31%
0
$0.00
0.00%
00169183417
NOVOLIN N
INJ U-100
3
$180.28
0.31%
0
$0.00
0.00%
00169183717
NOVOLIN
1
$24.71
0.10%
0
$0.00
0.00%
00169231321
NOVOLIN R
INJ INNOLET
3
$156.85
0.31%
5
$388.57
0.83%
00169231421
NOVOLIN N
INJ INNOLET
20
$1,307.95
2.07%
13
$829.99
2.15%
00169231721
NOVOLIN 70/ INJ 30 INNLT
24
$1,527.77
2.49%
31
$2,130.56
5.12%
INJ 70/30
INJ 70/30
Page 199 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIABETIC - PENFILLS
00169330312
NOVOLOG
INJ PENFILL
126
$14,042.68
13.07%
00169347318
NOVOLIN R
INJ PENFILL
14
$1,542.94
1.45%
00169347418
NOVOLIN N
INJ PENFILL
56
$6,996.63
5.81%
00169347718
NOVOLIN 70/ INJ 30 PNFIL
49
$5,959.28
5.08%
00169368213
NOVOLOG MIX INJ CARTRIDG
6
$881.20
0.62%
00169369619
NOVOLOG MIX INJ SYRINGE
22
$3,001.94
2.28%
33
$5,633.39
5.45%
00169633910
NOVOLOG
80
$10,733.04
8.30%
131
$20,675.94
21.65%
59060231404
RELION N
0
$0.00
0.00%
3
$129.66
0.50%
59060231704
RELION 70/30 INJ INNOLET
0
$0.00
0.00%
2
$116.40
0.33%
INJ FLEXPEN
INJ INNOLET
136
$15,193.40
22.48%
8
$704.06
1.32%
54
$5,349.85
8.93%
28
$4,568.09
4.63%
5
$564.40
0.83%
DIABETIC - / THIAZOL
00029315818
AVANDIA
TAB 2MG
312
$17,046.96
3.91%
376
$22,224.33
4.79%
00029315913
AVANDIA
TAB 4MG
417
$31,584.41
5.23%
384
$40,444.33
4.89%
00029315918
AVANDIA
TAB 4MG
183
$13,850.18
2.30%
268
$21,332.30
3.41%
00029315920
AVANDIA
TAB 4MG
2,138
$166,116.91
26.82%
2,015
$158,315.88
25.67%
00029316013
AVANDIA
TAB 8MG
2,006
$281,351.91
25.16%
2,260
$350,557.69
28.79%
00029316020
AVANDIA
TAB 8MG
892
$125,438.81
11.19%
1,041
$152,056.16
13.26%
64764015104
ACTOS
TAB 15MG
958
$139,965.43
12.02%
634
$89,396.65
8.08%
64764015105
ACTOS
TAB 15MG
652
$93,681.72
8.18%
411
$54,892.09
5.24%
64764015106
ACTOS
TAB 15MG
34
$3,238.87
0.43%
12
$1,123.51
0.15%
64764030114
ACTOS
TAB 30MG
114
$14,450.28
1.43%
72
$6,145.08
0.92%
64764030115
ACTOS
TAB 30MG
87
$7,967.81
1.09%
27
$2,590.21
0.34%
64764045124
ACTOS
TAB 45MG
113
$14,994.60
1.42%
245
$40,495.89
3.12%
64764045125
ACTOS
TAB 45MG
66
$9,445.12
0.83%
105
$16,371.58
1.34%
81
$4,105.70
39.32%
99
$5,835.54
44.39%
DIABETIC - ALPHAGLUCOSIDASE
00009501201
GLYSET
TAB 25MG
Page 200 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIABETIC - ALPHAGLUCOSIDASE
00009501301
GLYSET
TAB 50MG
52
$3,306.95
00009501401
GLYSET
TAB 100MG
18
00026286151
PRECOSE
TAB 50MG
34
00026286251
PRECOSE
TAB 100MG
00026286351
PRECOSE
TAB 25MG
25.24%
86
$5,470.86
38.57%
$1,216.65
8.74%
21
$1,665.17
9.42%
$1,897.26
16.50%
6
$228.74
2.69%
3
$161.24
1.46%
0
$0.00
0.00%
18
$813.74
8.74%
11
$577.06
4.93%
DIABETIC - MEGLITINIDES
00169008181
PRANDIN
TAB 0.5MG
24
$1,896.73
21.05%
4
$284.22
8.16%
00169008281
PRANDIN
TAB 1MG
26
$1,340.49
22.81%
24
$2,065.24
48.98%
00169008481
PRANDIN
TAB 2MG
64
$7,007.48
56.14%
21
$3,584.04
42.86%
DIABETIC - ORAL SULFONYLUREAS
00009017105
MICRONASE
TAB 5MG
5
$350.96
0.04%
6
$593.61
0.05%
00009017107
MICRONASE
TAB 5MG
1
$25.23
0.01%
1
$1.00
0.01%
00009017112
MICRONASE
TAB 5MG
1
$56.00
0.01%
0
$0.00
0.00%
00009035201
GLYNASE
TAB 3MG
2
$104.36
0.01%
0
$0.00
0.00%
00039005210
DIABETA
TAB 5MG
5
$234.92
0.04%
0
$0.00
0.00%
00039005305
DIABETA
TAB 1.25MG
3
$23.32
0.02%
0
$0.00
0.00%
00039022110
AMARYL
TAB 1MG
56
$547.78
0.41%
16
$173.51
0.13%
00039022210
AMARYL
TAB 2MG
134
$2,169.58
0.97%
53
$883.94
0.41%
00039022310
AMARYL
TAB 4MG
341
$13,438.43
2.47%
117
$5,505.23
0.91%
00049155066
GLUCOTROL XL TAB 5MG
401
$7,111.85
2.91%
27
$530.66
0.21%
00049155073
40
$696.55
0.29%
2
$18.95
0.02%
00049156066
551
$19,403.64
3.99%
43
$1,985.96
0.34%
00049156073
64
$1,922.60
0.46%
0
$0.00
0.00%
00049162030
GLUCOTROL XL TAB 2.5MG
124
$1,571.69
0.90%
7
$69.08
0.05%
00049411066
GLUCOTROL
1
$37.32
0.01%
0
$0.00
0.00%
TAB 5MG
Page 201 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
GLUCOTROL
TAB 5MG
00078035105
STARLIX
TAB 60MG
00078035205
STARLIX
TAB 120MG
00093803401
GLYBURID MCR TAB 1.5MG
00093803501
GLYBURID MCR TAB 3MG
00093803601
00093834201
GLYBURIDE
TAB 1.25MG
00093834301
GLYBURIDE
TAB 2.5MG
00093834305
GLYBURIDE
00093834310
00093834401
$
Market Share*
00049411073
# of Scripts
$14.90
0.01%
$0.00
0.00%
25
$2,100.07
0.18%
161
$13,053.24
1.17%
35
$2,769.10
0.27%
153
$14,337.84
1.20%
3
$19.05
0.02%
2
$10.70
0.02%
30
$307.21
0.22%
27
$352.76
0.21%
12
$106.10
0.09%
256
$2,177.51
1.85%
13
$87.85
0.10%
216
$1,848.62
1.69%
586
$5,718.87
4.25%
499
$5,002.43
3.90%
TAB 2.5MG
82
$632.31
0.59%
51
$448.03
0.40%
GLYBURIDE
TAB 2.5MG
292
GLYBURIDE
TAB 5MG
483
$2,814.10
2.12%
336
$3,184.59
2.63%
$8,449.25
3.50%
457
$8,323.08
3.57%
00093834405
GLYBURIDE
TAB 5MG
230
$3,826.03
1.67%
196
$3,061.01
1.53%
00093834410
GLYBURIDE
TAB 5MG
1,911
$34,355.11
13.85%
1,725
$31,132.74
13.48%
00093936401
00093936405
GLYBURIDE
TAB 5MG
128
$2,433.81
0.93%
236
$7,142.78
1.84%
GLYBURIDE
TAB 5MG
67
$1,285.45
0.49%
98
$1,644.49
0.77%
00093936410
GLYBURIDE
TAB 5MG
209
$3,952.75
1.51%
156
$2,750.81
1.22%
00093943301
GLYBURIDE
TAB 2.5MG
57
$464.07
0.41%
85
$943.22
0.66%
00093943305
GLYBURIDE
TAB 2.5MG
53
$477.31
0.38%
50
$413.42
0.39%
00093947753
GLYBURIDE
TAB 1.25MG
34
$221.42
0.25%
20
$216.97
0.16%
00172297860
TOLAZAMIDE TAB 100MG
4
$30.95
0.03%
6
$60.03
0.05%
00172297960
11
$134.98
0.08%
3
$26.82
0.02%
00172364960
GLIPIZIDE
TAB 5MG
473
$1,513.44
3.43%
561
$1,804.26
4.38%
00172364970
GLIPIZIDE
TAB 5MG
7
$28.43
0.05%
20
$91.59
0.16%
00172365060
GLIPIZIDE
TAB 10MG
358
$1,883.74
2.59%
461
$2,472.99
3.60%
00172365070
GLIPIZIDE
TAB 10MG
9
$65.55
0.07%
20
$105.93
0.16%
00378019701
CHLORPROPAM TAB 100MG
2
$11.50
0.01%
2
$61.54
0.02%
00378021001
12
$173.34
0.09%
7
$81.68
0.05%
1
0
Page 202 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00378021501
TOLBUTAMIDE TAB 500MG
29
$477.37
0.21%
13
$307.22
0.10%
00378021505
TOLBUTAMIDE TAB 500MG
15
$295.85
0.11%
6
$95.53
0.05%
00378021701
2
$35.26
0.01%
5
$59.57
0.04%
00378110501
GLIPIZIDE
TAB 5MG
626
$2,103.56
4.54%
599
$2,059.92
4.68%
00378110505
GLIPIZIDE
TAB 5MG
405
$1,813.74
2.93%
452
$2,041.47
3.53%
00378111001
GLIPIZIDE
TAB 10MG
426
$2,382.37
3.09%
426
$2,369.51
3.33%
00378111005
GLIPIZIDE
TAB 10MG
251
$1,572.19
1.82%
226
$1,461.64
1.77%
00378111301
30
$150.43
0.22%
18
$96.31
0.14%
00378112501
53
$396.85
0.38%
63
$480.83
0.49%
00378112510
23
$148.67
0.17%
23
$183.75
0.18%
00378114201
20
$226.30
0.14%
33
$220.29
0.26%
00591046001
GLIPIZIDE
TAB 5MG
86
$299.25
0.62%
128
$487.68
1.00%
00591046005
GLIPIZIDE
TAB 5MG
0
$0.00
0.00%
6
$22.00
0.05%
00591046010
GLIPIZIDE
TAB 5MG
68
$272.90
0.49%
21
$67.55
0.16%
00591046101
GLIPIZIDE
TAB 10MG
83
$429.67
0.60%
116
$601.55
0.91%
00591046105
GLIPIZIDE
TAB 10MG
21
$101.09
0.15%
31
$197.58
0.24%
00591046110
GLIPIZIDE
TAB 10MG
68
$379.69
0.49%
38
$209.49
0.30%
00591084401
GLIPIZIDE ER TAB 5MG
6
$141.07
0.04%
8
$54.93
0.06%
00591084410
0
$0.00
0.00%
1
$14.78
0.01%
00591084501
4
$111.00
0.03%
2
$45.26
0.02%
00781113801
GLYBURIDE
TAB 1.25MG
14
$89.09
0.10%
47
$380.47
0.37%
00781114601
GLYBURIDE
TAB 2.5MG
23
$235.06
0.17%
262
$2,617.75
2.05%
00781119101
GLYBURIDE
TAB 5MG
0
$0.00
0.00%
65
$1,003.75
0.51%
00781119110
GLYBURIDE
TAB 5MG
87
$1,659.03
0.63%
575
$10,426.49
4.49%
00781145201
GLIPIZIDE
TAB 5MG
517
$1,836.65
3.75%
488
$1,859.09
3.81%
00781145210
GLIPIZIDE
TAB 5MG
86
$335.09
0.62%
136
$589.15
1.06%
00781145301
GLIPIZIDE
TAB 10MG
337
$1,929.82
2.44%
313
$1,761.11
2.45%
Page 203 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00781145310
GLIPIZIDE
TAB 10MG
13
$89.95
0.09%
124
$974.25
0.97%
00904792460
GLIPIZIDE
TAB 5MG
7
$18.65
0.05%
0
$0.00
0.00%
00904792560
GLIPIZIDE
TAB 10MG
4
$16.00
0.03%
0
$0.00
0.00%
00904792580
GLIPIZIDE
TAB 10MG
11
$79.20
0.08%
18
$89.60
0.14%
50111037201
5
$54.82
0.04%
8
$74.88
0.06%
50111037301
21
$455.25
0.15%
18
$378.03
0.14%
50111037303
1
$13.55
0.01%
1
$13.55
0.01%
51079087320
GLYBURIDE
0
$0.00
0.00%
13
$119.99
0.10%
51285059802
GLIPIZIDE
2
$7.80
0.01%
0
$0.00
0.00%
52152013402
GLYBURIDE
TAB 3MG
0
$0.00
0.00%
7
$61.65
0.05%
52152013502
GLYBURIDE
TAB 6MG
0
$0.00
0.00%
2
$19.70
0.02%
52544046110
GLIPIZIDE
2
$10.10
0.01%
0
$0.00
0.00%
55370014607
12
$67.70
0.09%
0
$0.00
0.00%
55370014608
1
$9.35
0.01%
0
$0.00
0.00%
55370014707
100
$930.45
0.72%
6
$90.40
0.05%
55370014708
22
$230.90
0.16%
2
$30.50
0.02%
55370050607
88
$1,030.50
0.64%
10
$78.50
0.08%
55370050608
12
$85.20
0.09%
17
$122.45
0.13%
59762372501
GLYBURIDE
TAB 1.25MG
146
$1,264.35
1.06%
138
$993.60
1.08%
59762372603
GLYBURIDE
TAB 2.5MG
457
$4,514.81
3.31%
203
$2,056.66
1.59%
59762372704
GLYBURIDE
TAB 5MG
54
$1,055.00
0.39%
15
$409.65
0.12%
59762372706
GLYBURIDE
TAB 5MG
152
$2,440.89
1.10%
187
$3,190.28
1.46%
59762372707
GLYBURIDE
TAB 5MG
1,770
$33,262.09
12.82%
1,381
$25,978.09
10.79%
59762378101
23
$130.29
0.17%
18
$84.88
0.14%
59762378201
47
$428.20
0.34%
38
$319.40
0.30%
59762378203
11
$121.85
0.08%
2
$22.78
0.02%
59762378301
106
$994.10
0.77%
76
$639.30
0.59%
TAB 5MG
TAB 5MG
TAB 10MG
Page 204 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
59762378302
15
$109.75
0.11%
12
$116.70
0.09%
59762378303
24
$249.90
0.17%
22
$301.30
0.17%
59762503301
GLIPIZIDE XL TAB 10MG
0
$0.00
0.00%
5
$9.51
0.04%
60505014100
GLIPIZIDE
TAB 5MG
58
$255.22
0.42%
128
$467.53
1.00%
60505014101
GLIPIZIDE
TAB 5MG
13
$88.91
0.09%
106
$544.17
0.83%
60505014102
GLIPIZIDE
TAB 5MG
0
$0.00
0.00%
27
$152.89
0.21%
60505014200
GLIPIZIDE
TAB 10MG
28
$126.36
0.20%
72
$401.78
0.56%
60505014201
GLIPIZIDE
TAB 10MG
25
$153.79
0.18%
78
$592.54
0.61%
60505014202
GLIPIZIDE
TAB 10MG
0
$0.00
0.00%
18
$182.79
0.14%
60951071470
GLIPIZIDE
TAB 10MG
3
$18.05
0.02%
0
$0.00
0.00%
62037087130
GLIPIZIDE ER TAB 2.5MG
7
$84.88
0.05%
18
$187.63
0.14%
62037087201
24
$358.86
0.17%
24
$267.79
0.19%
62037087205
0
$0.00
0.00%
12
$107.21
0.09%
62037087301
27
$810.23
0.20%
33
$324.29
0.26%
62037087305
6
$205.07
0.04%
8
$57.26
0.06%
67253046010
0
$0.00
0.00%
11
$69.35
0.09%
67253046110
GLYBURIDE
0
$0.00
0.00%
69
$619.80
0.54%
67253046210
0
$0.00
0.00%
51
$687.05
0.40%
67253046211
0
$0.00
0.00%
4
$48.40
0.03%
67253046250
0
$0.00
0.00%
5
$31.25
0.04%
TAB 3MG
DIABETIC - SULFONYLUREA / BIGUANIDE
00087607211
GLUCOVANCE TAB 1.25/250
21
$917.91
14.19%
3
$83.31
4.29%
00087607311
GLUCOVANCE TAB 2.5/500
34
$2,158.46
22.97%
7
$463.96
10.00%
00087607411
GLUCOVANCE TAB 5/500MG
88
$6,439.72
59.46%
28
$2,653.71
40.00%
00087607731
METAGLIP
TAB 2.5-500M
2
$64.87
1.35%
0
$0.00
0.00%
00087607831
METAGLIP
TAB 5-500MG
3
$139.41
2.03%
6
$226.02
8.57%
Page 205 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
METAGLIP
00172571160
00172571260
49884096801
TAB 2.5-250M
$
Market Share*
DIABETIC - SULFONYLUREA / BIGUANIDE
00087608131
# of Scripts
0
$0.00
0.00%
1
$6.94
1.43%
GLYB/METFORM TAB 2.5/500
0
$0.00
0.00%
2
$9.74
2.86%
GLYB/METFORM TAB 5/500MG
0
$0.00
0.00%
20
$355.86
28.57%
GLYB/METFORM TAB 2.5/500
0
$0.00
0.00%
3
$123.15
4.29%
DIABETIC - THIAZOL / BIGUANIDE COMBO
00007316318
AVANDAMET
TAB 2-1000MG
6
$681.92
1.63%
67
$7,476.56
8.47%
00007316418
AVANDAMET
TAB 4-1000MG
16
$2,702.22
4.36%
187
$34,736.98
23.64%
00007316618
AVANDAMET
TAB 1-500MG
13
$1,178.97
3.54%
55
$4,706.75
6.95%
00007316620
AVANDAMET
TAB 1-500MG
7
$438.46
1.91%
19
$2,034.66
2.40%
00007316718
AVANDAMET
TAB 2-500MG
162
$18,771.10
44.14%
238
$28,226.70
30.09%
00007316720
AVANDAMET
TAB 2-500MG
32
$3,449.24
8.72%
57
$7,302.09
7.21%
00007316818
AVANDAMET
TAB 4-500MG
99
$11,352.82
26.98%
131
$16,708.43
16.56%
00007316820
AVANDAMET
TAB 4-500MG
32
$4,505.93
8.72%
37
$5,512.51
4.68%
70
$4,900.75
0.49%
48
$3,581.79
0.33%
DIABETIC -ORAL BIGUANIDES
00087606005
GLUCOPHAGE TAB 500MG
00087606010
9
$641.62
0.06%
0
$0.00
0.00%
00087606313
GLUCOPHAGE TAB XR 500MG
407
$21,196.79
2.87%
177
$11,930.05
1.23%
00087606413
GLUCOPHAGE TAB XR 750MG
12
$551.77
0.08%
15
$925.28
0.10%
00087607005
12
$1,064.39
0.08%
11
$1,139.15
0.08%
00087607111
26
$2,123.44
0.18%
12
$1,117.49
0.08%
00093104801
METFORMIN
TAB 500MG
65
$915.86
0.46%
42
$640.65
0.29%
00093104805
METFORMIN
TAB 500MG
44
$681.20
0.31%
7
$100.25
0.05%
00093104901
METFORMIN
TAB 850MG
11
$160.55
0.08%
17
$264.75
0.12%
00093104905
METFORMIN
TAB 850MG
3
$59.25
0.02%
0
$0.00
0.00%
00093721401
METFORMIN
TAB 1000MG
165
$11,267.10
1.16%
25
$1,022.97
0.17%
Page 206 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
METFORMIN
TAB 500MG ER
00093726710
METFORMIN
TAB 500MG ER
00172433060
METFORMIN
TAB 850MG
00172433110
METFORMIN
TAB 500MG
00172433160
METFORMIN
TAB 500MG
00172433170
METFORMIN
TAB 500MG
00172443260
METFORMIN
TAB 1000MG
00172443560
METFORMIN
00185021301
$
Market Share*
00093726701
# of Scripts
0
$0.00
0.00%
0
$0.00
0.00%
220
$3,366.51
1.55%
0
$0.00
0.00%
2,263
$33,510.33
15.96%
2
$41.82
0.01%
2
$57.30
0.01%
187
$3,036.71
1.30%
2
$22.10
0.01%
2,194
$32,781.81
15.31%
4
$61.20
0.03%
1
$63.00
0.01%
573
$10,848.10
4.04%
856
$16,213.37
5.97%
TAB 500MG ER
5
$198.32
0.04%
74
$3,169.85
0.52%
METFORMIN
TAB 500MG
9
$126.65
0.06%
24
$283.05
0.17%
00185021305
METFORMIN
TAB 500MG
0
$0.00
0.00%
23
$363.65
0.16%
00185021501
METFORMIN
TAB 850MG
4
$72.70
0.03%
0
$0.00
0.00%
00185022101
METFORMIN
TAB 1000MG
19
$392.09
0.13%
13
$242.05
0.09%
00185022105
METFORMIN
TAB 1000MG
5
$88.25
0.04%
10
$187.40
0.07%
00228265711
METFORMIN
TAB 500MG
133
$2,104.06
0.94%
4
$46.60
0.03%
00228265750
METFORMIN
TAB 500MG
47
$656.60
0.33%
4
$31.04
0.03%
00228271511
METFORMIN
TAB 850MG
36
$615.48
0.25%
4
$72.70
0.03%
00228271550
METFORMIN
TAB 850MG
20
$266.40
0.14%
3
$47.85
0.02%
00228271811
METFORMIN
TAB 1000MG
26
$552.82
0.18%
8
$151.20
0.06%
00378023401
METFORMIN
TAB 500MG
555
$8,582.80
3.91%
8
$157.10
0.06%
00378023405
METFORMIN
TAB 500MG
0
$0.00
0.00%
499
$7,421.10
3.48%
00378024001
METFORMIN
TAB 850MG
66
$1,116.70
0.47%
66
$1,033.72
0.46%
00378024401
METFORMIN
TAB 1000MG
218
$3,988.68
1.54%
193
$3,600.24
1.35%
00555038502
METFORMIN
TAB 500MG
6
$40.95
0.04%
0
$0.00
0.00%
00555038702
METFORMIN
TAB 1000MG
1
$20.15
0.01%
0
$0.00
0.00%
00591245501
METFORMIN
TAB 1000MG
183
$3,256.16
1.29%
122
$2,199.47
0.85%
00591271301
METFORMIN
TAB 500MG
411
$6,165.84
2.90%
283
$4,029.10
1.97%
00591271305
METFORMIN
TAB 500MG
0
$0.00
0.00%
4
$7.03
0.03%
Page 207 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00591277501
METFORMIN
TAB 850MG
00591277525
METFORMIN
TAB 850MG
2
$38.20
0.01%
0
$0.00
0.00%
00781505001
METFORMIN
TAB 500MG
1,598
$21,588.66
11.27%
1,772
$28,659.09
12.36%
00781505101
METFORMIN
TAB 850MG
145
$2,315.52
1.02%
165
$3,126.44
1.15%
00781505201
METFORMIN
TAB 1000MG
603
$10,502.56
4.25%
753
$16,441.27
5.25%
49884073601
METFORMIN
TAB 500MG
35
$542.05
0.25%
10
$156.30
0.07%
49884073801
METFORMIN
TAB 1000MG
11
$261.03
0.08%
0
$0.00
0.00%
49884073805
METFORMIN
TAB 1000MG
0
$0.00
0.00%
1
$17.65
0.01%
49884073905
METFORMIN
TAB 500MG
0
$0.00
0.00%
7
$67.15
0.05%
49884074001
METFORMIN
TAB 850MG
14
$241.61
0.10%
0
$0.00
0.00%
49884074005
METFORMIN
TAB 850MG
0
$0.00
0.00%
8
$126.50
0.06%
49884074101
METFORMIN
TAB 1000MG
15
$162.90
0.11%
4
$78.10
0.03%
49884074105
METFORMIN
TAB 1000MG
7
$76.40
0.05%
13
$274.25
0.09%
49884092101
METFORMIN
TAB 500MG ER
0
$0.00
0.00%
18
$679.72
0.13%
53489046701
METFORMIN
TAB 500MG
428
$6,141.55
3.02%
378
$4,899.58
2.64%
53489046705
METFORMIN
TAB 500MG
657
$8,721.21
4.63%
400
$4,894.06
2.79%
53489046710
METFORMIN
TAB 500MG
308
$4,842.74
2.17%
267
$4,021.57
1.86%
53489046801
METFORMIN
TAB 850MG
198
$3,235.80
1.40%
71
$1,123.75
0.50%
53489046805
METFORMIN
TAB 850MG
70
$978.57
0.49%
40
$581.02
0.28%
53489046810
METFORMIN
TAB 850MG
1
$15.95
0.01%
8
$117.60
0.06%
53489046901
METFORMIN
TAB 1000MG
472
$8,716.75
3.33%
252
$4,878.80
1.76%
53489046905
METFORMIN
TAB 1000MG
177
$3,391.61
1.25%
176
$3,075.88
1.23%
53489046910
METFORMIN
TAB 1000MG
16
$319.90
0.11%
50
$830.42
0.35%
57664039713
METFORMIN
TAB 500MG
44
$701.73
0.31%
247
$3,620.07
1.72%
57664039718
METFORMIN
TAB 500MG
9
$165.75
0.06%
430
$6,559.80
3.00%
57664039788
METFORMIN
TAB 500MG
72
$862.15
0.51%
1,523
$22,663.76
10.63%
57664043513
METFORMIN
TAB 850MG
0
$0.00
0.00%
24
$321.80
0.17%
83
$1,367.27
0.59%
56
$903.05
Page 208 of 505
0.39%
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
57664043518
METFORMIN
TAB 850MG
0
$0.00
0.00%
9
$158.85
0.06%
57664043588
METFORMIN
TAB 850MG
2
$39.50
0.01%
187
$3,132.89
1.30%
57664047413
METFORMIN
TAB 1000MG
0
$0.00
0.00%
92
$1,716.00
0.64%
57664047418
METFORMIN
TAB 1000MG
23
$390.71
0.16%
158
$2,900.09
1.10%
57664047488
METFORMIN
TAB 1000MG
44
$878.94
0.31%
486
$9,577.39
3.39%
60505019000
METFORMIN
TAB 500MG
2
$27.20
0.01%
31
$464.80
0.22%
60505019001
METFORMIN
TAB 500MG
584
$9,392.45
4.12%
565
$8,299.80
3.94%
60505019100
METFORMIN
TAB 850MG
52
$910.95
0.37%
51
$810.89
0.36%
60505019101
METFORMIN
TAB 850MG
3
$40.35
0.02%
27
$422.65
0.19%
60505019200
METFORMIN
TAB 1000MG
190
$3,711.92
1.34%
215
$4,194.39
1.50%
60505019201
METFORMIN
TAB 1000MG
0
$0.00
0.00%
82
$1,529.09
0.57%
62022057560
FORTAMET
0
$0.00
0.00%
2
$30.77
0.01%
62037057101
METFORMIN
TAB 500MG ER
0
$0.00
0.00%
30
$828.19
0.21%
62037067401
METFORMIN
TAB 500MG
1,833
$27,574.22
12.92%
164
$2,292.45
1.14%
62037067410
METFORMIN
TAB 500MG
121
$1,753.78
0.85%
239
$3,271.58
1.67%
62037067501
METFORMIN
TAB 850MG
48
$792.00
0.34%
21
$340.65
0.15%
62037067510
METFORMIN
TAB 850MG
9
$126.05
0.06%
30
$547.00
0.21%
62037067601
METFORMIN
TAB 1000MG
660
$12,692.59
4.65%
256
$4,849.10
1.79%
62037067610
METFORMIN
TAB 1000MG
18
$212.75
0.13%
73
$1,316.31
0.51%
63304020602
RIOMET
0
$0.00
0.00%
2
$98.41
0.01%
TAB 1000MG
SOL
DIURETICS
00003060650
NATURETIN TAB 5MG
2
$38.50
0.00%
0
$0.00
0.00%
00004012101
BUMEX
TAB 1MG
0
$0.00
0.00%
1
$20.40
0.00%
00004016201
BUMEX
TAB 2MG
6
$257.19
0.01%
3
$194.90
0.01%
00004026401
DEMADEX
TAB 20MG
5
$151.65
0.01%
0
$0.00
0.00%
00004026449
DEMADEX
TAB 20MG
1
$27.33
0.00%
0
$0.00
0.00%
Page 209 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00004026501
DEMADEX
TAB 100MG
2
$233.41
0.00%
0
$0.00
0.00%
00005075323
DIAMOX
00005375234
HYDROCHLOROT TAB 25MG
CAP 500MG CR
12
$1,052.57
0.03%
2
$220.98
0.00%
40
$83.74
0.09%
1
$1.01
0.00%
00005375334
19
$64.98
0.04%
0
$0.00
0.00%
00006006568
EDECRIN
0
$0.00
0.00%
5
$99.50
0.01%
00006091768
MODURETIC
00006323966
DIURIL
00007365022
DYAZIDE
00025100131
ALDACTONE
00025171001
INSPRA
00025172001
INSPRA
00025172003
INSPRA
00039006013
LASIX
00039006070
00039006710
TAB 25MG
TAB 5-50
1
$17.95
0.00%
1
$17.56
0.00%
SUS 250/5ML
15
$128.07
0.03%
9
$82.71
0.02%
CAP 37.5-25
18
$318.39
0.04%
14
$321.11
0.03%
1
$5.60
0.00%
0
$0.00
0.00%
TAB 25MG
0
$0.00
0.00%
11
$1,073.78
0.03%
TAB 50MG
0
$0.00
0.00%
1
$6.20
0.00%
TAB 50MG
0
$0.00
0.00%
4
$768.40
0.01%
TAB 40MG
3
$44.83
0.01%
3
$21.45
0.01%
LASIX
TAB 40MG
3
$27.06
0.01%
0
$0.00
0.00%
LASIX
TAB 20MG
3
$26.36
0.01%
3
$5.00
0.01%
00039006750
LASIX
TAB 20MG
1
$9.25
0.00%
1
$1.00
0.00%
00054329446
FUROSEMIDE SOL 10MG/ML
12
$112.05
0.03%
8
$65.80
0.02%
00054329450
10
$104.70
0.02%
1
$15.35
0.00%
00054329863
3
$20.59
0.01%
1
$10.96
0.00%
00054429725
FUROSEMIDE TAB 20MG
9
$16.29
0.02%
13
$32.49
0.03%
00054429731
FUROSEMIDE TAB 20MG
724
$2,437.06
1.68%
556
$1,975.43
1.29%
00054429925
FUROSEMIDE TAB 40MG
1
$7.25
0.00%
8
$24.08
0.02%
00054429931
FUROSEMIDE TAB 40MG
618
$1,883.98
1.44%
248
$740.10
0.57%
00054430125
FUROSEMIDE TAB 80MG
1
$10.00
0.00%
0
$0.00
0.00%
00054430129
FUROSEMIDE TAB 80MG
80
$524.06
0.19%
150
$1,015.09
0.35%
00070300000
INDAPAMIDE TAB 2.5MG
2
$10.96
0.00%
0
$0.00
0.00%
00074610104
FUROSEMIDE INJ 10MG/ML
4
$20.78
0.01%
4
$28.94
0.01%
TAB 25MG
Page 210 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00074610202
18
$64.85
0.04%
9
$33.15
0.02%
00074610204
32
$185.31
0.07%
20
$85.18
0.05%
00074610210
2
$6.29
0.00%
4
$23.06
0.01%
00093712701
TORSEMIDE
TAB 5MG
2
$34.80
0.00%
0
$0.00
0.00%
00093712801
TORSEMIDE
TAB 10MG
14
$274.10
0.03%
10
$284.87
0.02%
00093712901
TORSEMIDE
TAB 20MG
224
$7,005.04
0.52%
132
$4,010.46
0.31%
00093713001
TORSEMIDE
TAB 100MG
16
$1,848.13
0.04%
11
$825.02
0.03%
00093721501
METOLAZONE TAB 2.5MG
0
$0.00
0.00%
5
$69.20
0.01%
00093721601
METOLAZONE TAB 5MG
0
$0.00
0.00%
4
$127.78
0.01%
00093941101
METHAZOLAMID TAB 25MG
3
$82.30
0.01%
8
$183.20
0.02%
00093942401
9
$387.09
0.02%
13
$338.18
0.03%
00143120901
CHLOROTHIAZ TAB 250MG
0
$0.00
0.00%
9
$86.41
0.02%
00143121001
4
$32.24
0.01%
11
$102.73
0.03%
00172208360
75
$253.17
0.17%
36
$106.83
0.08%
00172208380
6,636
$20,673.40
15.44%
4,766
$15,376.79
11.02%
00172208960
32
$142.84
0.07%
71
$283.13
0.16%
00172208980
773
$3,000.37
1.80%
472
$1,954.14
1.09%
00172208985
2
$5.42
0.00%
0
$0.00
0.00%
00172290760
FUROSEMIDE TAB 40MG
0
$0.00
0.00%
7
$19.39
0.02%
00172290770
FUROSEMIDE TAB 40MG
1
$1.81
0.00%
0
$0.00
0.00%
00172290780
FUROSEMIDE TAB 40MG
2,720
$11,152.79
6.33%
2,512
$10,287.70
5.81%
00172290870
FUROSEMIDE TAB 20MG
1
$1.33
0.00%
0
$0.00
0.00%
00172290880
FUROSEMIDE TAB 20MG
2,789
$11,213.81
6.49%
2,668
$10,804.22
6.17%
00172295060
TRIAMT/HCTZ CAP 50-25MG
6
$116.40
0.01%
16
$307.11
0.04%
00172295080
78
$1,596.16
0.18%
64
$1,191.64
0.15%
00172423260
BUMETANIDE TAB 0.5MG
12
$93.95
0.03%
34
$209.70
0.08%
00172423280
2
$13.70
0.00%
0
$0.00
0.00%
Page 211 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00172423360
BUMETANIDE TAB 1MG
00172423370
BUMETANIDE TAB 1MG
00172423380
BUMETANIDE TAB 1MG
00172423460
BUMETANIDE TAB 2MG
00172423480
$458.03
0.11%
$703.16
0.21%
3
$48.55
0.01%
78
$683.60
0.18%
0
$0.00
0.00%
72
$565.43
0.17%
50
$918.93
0.12%
106
$2,096.68
0.25%
BUMETANIDE TAB 2MG
37
$656.72
0.09%
62
$967.21
0.14%
00172425960
14
00172425980
3
$86.20
0.03%
16
$88.62
0.04%
$22.80
0.01%
5
$31.26
0.01%
00172426260
7
$34.99
0.02%
3
$26.03
0.01%
00182055689
1
$2.21
0.00%
3
$3.00
0.01%
00182116189
FUROSEMIDE TAB 40MG
3
$7.35
0.01%
0
$0.00
0.00%
00182117089
FUROSEMIDE TAB 20MG
3
$5.43
0.01%
0
$0.00
0.00%
00185005501
METOLAZONE TAB 5MG
0
$0.00
0.00%
73
$2,672.01
0.17%
00185012801
12
$62.70
0.03%
16
$91.26
0.04%
00185012901
BUMETANIDE TAB 1MG
116
$1,163.13
0.27%
71
$678.50
0.16%
00185013001
BUMETANIDE TAB 2MG
110
$2,184.38
0.26%
43
$1,066.09
0.10%
00185505001
0
$0.00
0.00%
92
$2,120.94
0.21%
00185560001
METOLAZONE TAB 10MG
0
$0.00
0.00%
11
$541.62
0.03%
00228222196
40
$131.36
0.09%
234
$832.29
0.54%
00228222296
19
$72.53
0.04%
28
$96.46
0.06%
00228257111
32
$168.48
0.07%
21
$122.42
0.05%
00228257196
2
$20.20
0.00%
8
$43.95
0.02%
00228259711
21
$114.97
0.05%
9
$47.25
0.02%
00228267211
SPIRONOLACT TAB 50MG
234
$9,208.32
0.54%
22
$119.18
0.05%
00228267250
103
$2,355.90
0.24%
8
$27.30
0.02%
00228267311
117
$7,979.75
0.27%
147
$5,470.61
0.34%
00228267350
3
$144.10
0.01%
5
$82.26
0.01%
00364224205
TRIAMT/HCTZ TAB 75-50MG
2
$9.62
0.00%
0
$0.00
0.00%
48
92
Page 212 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00378006901
74
$309.63
0.17%
54
$229.44
0.12%
00378008001
41
$227.09
0.10%
57
$343.06
0.13%
00378008010
0
$0.00
0.00%
3
$33.39
0.01%
00378014101
SPIRONO/HCTZ TAB 25/25
88
$919.14
0.20%
62
$731.43
0.14%
00378014105
73
$798.81
0.17%
88
$1,048.30
0.20%
00378015001
21
$189.96
0.05%
13
$101.16
0.03%
00378016001
METHYCLOTHIA TAB 5MG
45
$688.65
0.10%
45
$693.54
0.10%
00378016201
22
$190.25
0.05%
13
$103.69
0.03%
00378020801
FUROSEMIDE TAB 20MG
416
$1,121.71
0.97%
198
$736.69
0.46%
00378020810
FUROSEMIDE TAB 20MG
2,674
$7,646.86
6.22%
2,746
$7,907.40
6.35%
00378021301
CHLORTHALID TAB 50MG
16
$52.27
0.04%
20
$79.57
0.05%
00378021601
FUROSEMIDE TAB 40MG
103
$290.07
0.24%
58
$162.25
0.13%
00378021610
FUROSEMIDE TAB 40MG
3,773
$11,872.89
8.78%
3,664
$11,641.76
8.48%
00378022201
61
$179.15
0.14%
76
$212.17
0.18%
00378022210
13
$40.01
0.03%
15
$64.82
0.03%
00378023201
FUROSEMIDE TAB 80MG
757
$4,742.89
1.76%
810
$5,658.50
1.87%
00378023205
FUROSEMIDE TAB 80MG
1,109
$7,021.30
2.58%
460
$2,859.10
1.06%
00378024301
44
$1,848.52
0.10%
6
$31.38
0.01%
00378024501
40
$326.70
0.09%
37
$302.09
0.09%
00378037001
BUMETANIDE TAB 1MG
148
$1,334.05
0.34%
149
$1,366.20
0.34%
00378041701
BUMETANIDE TAB 2MG
117
$2,335.55
0.27%
110
$1,932.06
0.25%
00378043701
4
$351.50
0.01%
11
$615.05
0.03%
00378057701
AMILOR/HCTZ TAB 5-50
102
$425.85
0.24%
90
$364.88
0.21%
00378057705
4
$22.77
0.01%
3
$15.99
0.01%
00378081001
HYDROCHLOROT CAP 12.5MG
572
$7,946.61
1.33%
749
$10,519.33
1.73%
00378135201
TRIAMT/HCTZ TAB 37.5-25
123
$941.78
0.29%
107
$778.81
0.25%
00378135205
39
$323.76
0.09%
27
$208.84
0.06%
Page 213 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00378135501
00378135505
00378214601
00378214605
00378253701
$241.36
0.19%
$227.20
0.19%
21
$58.78
0.05%
607
$7,523.66
1.41%
14
$45.70
0.03%
816
$13,720.66
1.89%
718
$8,588.18
1.67%
845
$11,719.87
1.95%
TRIAM/HCTZ CAP 37.5-25
233
$2,505.71
0.54%
103
$1,186.62
0.24%
00378253710
594
00378617201
0
$6,651.05
1.38%
737
$8,031.50
1.70%
$0.00
0.00%
1
$46.18
0.00%
00517570225
22
$92.43
0.05%
2
$10.38
0.00%
00517570425
8
$57.05
0.02%
8
$55.55
0.02%
00517571025
00527105001
5
$191.44
0.01%
1
$5.34
0.00%
ACETAZOLAMID TAB 250MG
61
$645.70
0.14%
57
$579.39
0.13%
00555044402
9
$26.30
0.02%
7
$26.91
0.02%
00555044404
6
$21.36
0.01%
4
$7.78
0.01%
00555048302
48
$181.87
0.11%
37
$148.18
0.09%
00555048802
14
$171.55
0.03%
26
$275.10
0.06%
00555048805
88
$794.06
0.20%
32
$317.20
0.07%
00555064304
3
$19.95
0.01%
2
$12.55
0.00%
00591034701
410
$5,482.76
0.95%
106
$1,325.20
0.25%
00591034705
0
$0.00
0.00%
4
$45.52
0.01%
00591034801
29
$93.26
0.07%
27
$73.98
0.06%
00591034805
28
$117.26
0.07%
15
$63.69
0.03%
00591042401
76
$630.98
0.18%
51
$366.25
0.12%
00591042405
3
$39.25
0.01%
1
$17.68
0.00%
00591543001
50
$451.20
0.12%
34
$310.41
0.08%
00603125052
9
$114.15
0.02%
5
$46.75
0.01%
00603373932
FUROSEMIDE TAB 20MG
0
$0.00
0.00%
274
$1,088.45
0.63%
00603373934
FUROSEMIDE TAB 20MG
0
$0.00
0.00%
90
$394.23
0.21%
83
83
Page 214 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00603374032
FUROSEMIDE TAB 40MG
0
$0.00
0.00%
558
$2,590.51
1.29%
00603374034
FUROSEMIDE TAB 40MG
0
$0.00
0.00%
69
$300.50
0.16%
00603374121
FUROSEMIDE TAB 80MG
0
$0.00
0.00%
1
$3.98
0.00%
00603374128
FUROSEMIDE TAB 80MG
0
$0.00
0.00%
116
$739.10
0.27%
00603374132
FUROSEMIDE TAB 80MG
0
$0.00
0.00%
2
$16.72
0.00%
00603385521
48
$691.53
0.11%
407
$5,718.64
0.94%
00603385525
16
$222.34
0.04%
24
$408.35
0.06%
00603385532
0
$0.00
0.00%
12
$202.97
0.03%
00603385621
11
$47.78
0.03%
224
$843.07
0.52%
00603385632
3,558
$10,152.35
8.28%
6,196
$17,211.83
14.33%
00603385721
16
$48.36
0.04%
30
$98.10
0.07%
00603385732
508
$1,862.96
1.18%
791
$2,836.40
1.83%
00603447121
3
$139.80
0.01%
0
$0.00
0.00%
00677062401
6
$62.70
0.01%
3
$24.15
0.01%
00677062501
17
$286.95
0.04%
3
$50.05
0.01%
00677062510
41
$532.35
0.10%
26
$296.35
0.06%
00677124801
8
$59.14
0.02%
4
$19.30
0.01%
00677170701
8
$633.70
0.02%
0
$0.00
0.00%
00677170706
4
$80.20
0.01%
0
$0.00
0.00%
00677170801
4
$416.87
0.01%
2
$62.70
0.00%
00677170807
0
$0.00
0.00%
1
$20.35
0.00%
00781100801
18
$58.08
0.04%
27
$75.59
0.06%
00781100805
5
$17.41
0.01%
1
$2.31
0.00%
00781107101
5
$278.95
0.01%
2
$113.79
0.00%
00781107201
7
$138.80
0.02%
6
$105.15
0.01%
00781112301
158
$1,205.56
0.37%
105
$763.96
0.24%
00781112305
57
$477.38
0.13%
52
$394.16
0.12%
Page 215 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
00781144601
FUROSEMIDE TAB 80MG
39
$274.84
0.09%
33
$251.62
0.08%
00781144605
FUROSEMIDE TAB 80MG
156
$1,052.93
0.36%
535
$3,430.20
1.24%
00781159901
49
$989.75
0.11%
20
$351.75
0.05%
00781159910
36
$448.80
0.08%
63
$1,066.65
0.15%
00781181801
FUROSEMIDE TAB 20MG
37
$138.95
0.09%
8
$18.58
0.02%
00781181810
FUROSEMIDE TAB 20MG
1,853
$5,537.83
4.31%
1,945
$5,372.65
4.50%
00781196601
FUROSEMIDE TAB 40MG
73
$249.86
0.17%
10
$36.72
0.02%
00781196610
FUROSEMIDE TAB 40MG
2,630
$8,167.31
6.12%
2,299
$6,940.01
5.32%
00781207401
555
$6,399.38
1.29%
574
$6,228.06
1.33%
00781207410
456
$5,094.01
1.06%
466
$5,093.72
1.08%
00781254010
1
$25.06
0.00%
0
$0.00
0.00%
00781271501
165
$3,029.13
0.38%
148
$2,878.10
0.34%
00781271510
37
$474.78
0.09%
32
$505.40
0.07%
00904034380
1
$8.35
0.00%
0
$0.00
0.00%
00904034460
0
$0.00
0.00%
1
$4.45
0.00%
00904208380
106
$308.82
0.25%
39
$116.65
0.09%
00904208980
20
$63.21
0.05%
0
$0.00
0.00%
10019050645
BUMETANIDE INJ 0.25/ML
0
$0.00
0.00%
23
$936.60
0.05%
49884011701
AMILORIDE
TAB 5MG
48
$987.78
0.11%
68
$1,462.13
0.16%
49884011705
AMILORIDE
TAB 5MG
0
$0.00
0.00%
3
$43.39
0.01%
49884058901
5
$38.89
0.01%
9
$46.70
0.02%
49884059001
27
$149.56
0.06%
15
$90.60
0.03%
49884059010
4
$16.92
0.01%
0
$0.00
0.00%
49884065101
TORSEMIDE
TAB 5MG
0
$0.00
0.00%
3
$52.20
0.01%
49884065201
TORSEMIDE
TAB 10MG
5
$132.95
0.01%
8
$198.19
0.02%
49884065301
TORSEMIDE
TAB 20MG
22
$786.46
0.05%
24
$894.40
0.06%
49884065401
TORSEMIDE
TAB 100MG
19
$2,612.91
0.04%
3
$199.41
0.01%
Page 216 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
50111036201
29
$76.46
0.07%
50111036301
4
$16.78
50111050501
6
$16.36
50111050502
5
50111053401
50111053402
50111091501
39
$105.00
0.09%
0.01%
7
$20.99
0.02%
0.01%
13
$47.96
0.03%
$14.48
0.01%
3
$6.93
0.01%
3
$27.13
0.01%
25
$195.05
0.06%
0
$0.00
0.00%
25
$174.66
0.06%
TORSEMIDE
TAB 5MG
0
$0.00
0.00%
1
$33.97
0.00%
50111091701
TORSEMIDE
TAB 20MG
0
$0.00
0.00%
18
$684.05
0.04%
51079007220
FUROSEMIDE TAB 20MG
16
$59.68
0.04%
33
$107.47
0.08%
51079007320
FUROSEMIDE TAB 40MG
7
$27.32
0.02%
17
$50.40
0.04%
51079052720
FUROSEMIDE TAB 80MG
1
$5.55
0.00%
0
$0.00
0.00%
51285048805
7
$108.45
0.02%
0
$0.00
0.00%
51285075402
DIAMOX
11
$611.08
0.03%
18
$1,412.62
0.04%
51672402201
16
$109.71
0.04%
17
$99.70
0.04%
51672402301
127
$1,278.16
0.30%
127
$1,226.01
0.29%
52544030110
FUROSEMIDE TAB 40MG
18
$58.83
0.04%
11
$30.99
0.03%
52544030205
FUROSEMIDE TAB 80MG
3
$13.54
0.01%
0
$0.00
0.00%
52544031110
FUROSEMIDE TAB 20MG
10
$32.90
0.02%
13
$42.91
0.03%
52544034701
1
$34.09
0.00%
1
$14.43
0.00%
52544034805
0
$0.00
0.00%
11
$47.91
0.03%
52544068501
1
$7.44
0.00%
0
$0.00
0.00%
53014083571
ZAROXOLYN
TAB 10MG
28
$1,346.03
0.07%
1
$51.11
0.00%
53014085071
ZAROXOLYN
TAB 5MG
273
$11,249.78
0.64%
42
$1,765.74
0.10%
53014097571
ZAROXOLYN
TAB 2.5MG
314
$9,664.62
0.73%
54
$1,924.75
0.12%
53489014301
29
$469.65
0.07%
35
$658.75
0.08%
53489014305
3
$40.05
0.01%
10
$155.92
0.02%
53489014310
259
$3,381.62
0.60%
307
$5,100.12
0.71%
CAP 500MG CR
Page 217 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
DIURETICS
53489014401
53489014405
53489014410
53489016601
53489032801
53489032805
53489032901
55390050010
55390050110
59746011106
59762501101
59762501102
59762501201
59762501301
59762501401
60432061304
60432061360
62269024724
63323028002
63323028004
8
$76.40
0.02%
10
$109.60
0.02%
0
$0.00
0.00%
16
$136.30
0.04%
1
$5.75
0.00%
3
$31.65
0.01%
2
$11.74
0.00%
1
$5.89
0.00%
58
$2,163.28
0.13%
5
$19.65
0.01%
3
$67.55
0.01%
0
$0.00
0.00%
19
$1,331.81
0.04%
34
$1,538.50
0.08%
4
$297.57
0.01%
0
$0.00
0.00%
1
$79.47
0.00%
0
$0.00
0.00%
0
$0.00
0.00%
1
$9.65
0.00%
498
$6,509.48
1.16%
535
$8,077.01
1.24%
163
$1,941.48
0.38%
159
$2,231.77
0.37%
170
$6,956.03
0.40%
8
$66.74
0.02%
7
$457.22
0.02%
24
$594.70
0.06%
66
$739.84
0.15%
54
$635.82
0.12%
47
$614.32
0.11%
64
$879.63
0.15%
79
$743.75
0.18%
32
$323.31
0.07%
2
$8.46
0.00%
0
$0.00
0.00%
2
$12.05
0.00%
24
$145.72
0.06%
1
$4.54
0.00%
2
$11.48
0.00%
65580064371
65
$2,007.11
0.15%
177
$5,354.59
0.41%
65580064471
METOLAZONE TAB 5MG
52
$2,708.76
0.12%
138
$6,116.87
0.32%
65580064571
METOLAZONE TAB 10MG
1
$92.41
0.00%
9
$518.73
0.02%
00026431202
DOMEBORO
SOL 2% OTIC
1
$19.41
0.04%
0
$0.00
0.00%
00034549006
CERUMENEX
SOL OTIC
6
$167.53
0.23%
1
$25.41
0.04%
EAR
Page 218 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
EAR
00034549012
CERUMENEX
SOL OTIC
00065853110
CIPRO HC
00065853302
CIPRODEX
SUS 0.3-0.1%
00182117533
ALLERGEN
SOL OTIC
00254901043
A/B OTIC
00472001699
AUROTO
00472088282
ACETASOL HC SOL OTIC
00603702073
A/B OTIC
3
$125.89
0.12%
275
$19,354.97
10.62%
85
$5,815.10
3.72%
128
$9,203.31
4.94%
406
$30,602.55
17.78%
12
$69.51
0.46%
5
$28.93
0.22%
1
$6.03
0.04%
0
$0.00
0.00%
175
$914.20
6.76%
116
$637.31
5.08%
137
$3,248.04
5.29%
76
$1,794.48
3.33%
SOL
48
$271.80
1.85%
73
$413.93
3.20%
00603703541
ACETIC ACID SOL 2% OTIC
4
$22.19
0.15%
0
$0.00
0.00%
00603723873
OTICAINE
12
$162.04
0.46%
9
$127.17
0.39%
00603749539
ZOLENE HC
DRO
0
$0.00
0.00%
2
$33.36
0.09%
00603749639
ZOTANE HC
DRO AQUEOUS
2
$29.27
0.08%
1
$15.00
0.04%
00904079335
AURODEX
SOL OTIC
7
$33.79
0.27%
4
$17.60
0.18%
00904301710
CORTOMYCIN SUS 1% OTIC
26
$675.97
1.00%
31
$853.62
1.36%
00904314110
CORTOMYCIN SOL 1% OTIC
12
$282.68
0.46%
6
$131.04
0.26%
00904322035
CARBAMIDE
1
$5.26
0.04%
0
$0.00
0.00%
24208042015
ANTIPY/BENZO SOL OTIC
1
$3.78
0.04%
0
$0.00
0.00%
24208056162
ANTIPY/BENZO SOL OTIC
297
$1,682.67
11.47%
270
$1,582.52
11.83%
24208061577
ACE ACD/ALUM SOL 2% OTIC
14
$108.96
0.54%
5
$43.03
0.22%
24208063110
NEO/POLY/HC SOL 1% OTIC
195
$4,991.10
7.53%
130
$3,310.83
5.69%
24208063562
NEO/POLY/HC SUS 1% OTIC
611
$16,522.35
23.59%
416
$11,564.15
18.22%
37205045705
EAR WAX DROP SOL 6.5% OT
39
$224.15
1.51%
42
$259.29
1.84%
45802031156
A/B OTIC
2
$9.34
0.08%
1
$3.42
0.04%
45802049756
EAR DROPS
0
$0.00
0.00%
1
$6.00
0.04%
49158017830
EAR DROPS RX SOL OTIC
5
$29.03
0.19%
4
$20.85
0.18%
49158019743
ACETIC ACID SOL /HC OTIC
1
$24.16
0.04%
2
$40.15
0.09%
51674011601
CORTANE-B
0
$0.00
0.00%
1
$21.16
0.04%
SUS OTIC
DRO
SOL OTIC
SOL 20% OTIC
SOL 6.5% OT
SOL
SOL 6.5% OT
DRO OTIC
1
$42.70
Page 219 of 505
0.04%
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
EAR
53807013301
CARBAMOXIDE SOL 6.5% OT
0
$0.00
0.00%
4
$11.82
0.18%
59630013501
ZOTO-HC
6
$131.34
0.23%
2
$50.62
0.09%
60258045110
CYOTIC
DRO
2
$29.04
0.08%
0
$0.00
0.00%
60432074115
ACETIC ACID SOL 2% OTIC
27
$104.51
1.04%
24
$95.35
1.05%
61314063810
81
$2,084.45
3.13%
4
$90.85
0.18%
61314063910
17
$454.19
0.66%
2
$55.30
0.09%
61314064510
81
$2,106.51
3.13%
239
$6,532.89
10.47%
61314064610
14
$342.26
0.54%
110
$2,792.73
4.82%
61570003310
CORTISPORIN SUS 1% OTIC
2
$101.64
0.08%
0
$0.00
0.00%
61570003410
CORTISPORIN SOL 1% OTIC
1
$49.57
0.04%
1
$55.83
0.04%
61570003875
PEDIOTIC
9
$392.01
0.35%
3
$137.88
0.13%
61570009010
CORTISPORIN SUS -TC OTIC
12
$631.34
0.46%
4
$176.20
0.18%
63395010105
FLOXIN OTIC SOL 0.3%
195
$8,149.74
7.53%
126
$5,587.57
5.52%
63395010110
FLOXIN OTIC SOL 0.3%
117
$7,918.56
4.52%
65
$4,228.26
2.85%
64029314101
COLY-MYCIN-S SUS OTIC
5
$219.64
0.19%
1
$36.80
0.04%
66424052035
AUROGUARD
SOL
6
$35.22
0.23%
9
$49.68
0.39%
66440376701
AERO OTIC HC SOL
0
$0.00
0.00%
1
$13.26
0.04%
8
$4,625.38
0.55%
1
$717.83
0.08%
SOL OTIC
SUS 1% OTIC
ELECTROLYTES/ NUTRITIONALS
00065901470
PEPTAMEN
LIQ UNFLAVOR
00065902570
NUTREN 1.0 LIQ /FIB VAN
4
$297.70
0.28%
2
$466.20
0.16%
00065903170
NUTREN 1.0 LIQ /FIB UNF
4
$177.08
0.28%
0
$0.00
0.00%
00065903870
NUTREN 1.5 LIQ UNFLAV
3
$138.38
0.21%
0
$0.00
0.00%
00065904070
NUTREN 2.0 LIQ VANILLA
3
$592.95
0.21%
4
$725.31
0.33%
00065904270
VHC 2.25
0
$0.00
0.00%
2
$181.92
0.16%
00065906770
PEPTAMEN
15
$7,458.37
1.04%
12
$4,162.63
0.98%
00065906970
PEPTAMEN JR LIQ UNFLAVRD
8
$3,850.51
0.55%
3
$1,081.77
0.24%
LIQ VANILLA
LIQ VANILLA
Page 220 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
PEPTAMEN JR LIQ VANILLA
00065907170
00065908070
00065908770
$
Market Share*
00065907070
# of Scripts
26
$21,633.04
1.80%
15
$10,270.11
1.22%
PEPTAMEN VHP LIQ VANILLA
1
$2,311.85
0.07%
2
$2,217.04
0.16%
NUTRIVENT
2
$2.00
0.14%
0
$0.00
0.00%
PEPTAMEN 1.5 LIQ VANILLA
1
$1,374.35
0.07%
1
$1,074.95
0.08%
00065908870
PEPTAMEN 1.5 LIQ UNFLAVOR
4
$3,533.33
0.28%
1
$660.94
0.08%
00065916270
PROBALANCE LIQ VANILLA
7
$965.73
0.48%
4
$1,323.50
0.33%
00074024001
PEDIALYTE
SOL GRAPE
1
$12.63
0.07%
1
$14.07
0.08%
00074549820
PEDIALYTE
SOL SINGLES
0
$0.00
0.00%
1
$6.25
0.08%
00074647008
PEDIALYTE
SOL UNFLAVOR
6
$572.70
0.41%
2
$196.23
0.16%
00074647032
PEDIALYTE
SOL UNFLAVOR
2
$192.32
0.14%
1
$8.71
0.08%
00074647132
PEDIALYTE
SOL FRUIT
0
$0.00
0.00%
1
$8.71
0.08%
00074664802
DEXTROSE
INJ 50%
0
$0.00
0.00%
3
$15.86
0.24%
00074792209
DEXTROSE
INJ 5%
1
$8.42
0.07%
0
$0.00
0.00%
00087001943
ENFAMIL ENFA POW LIPIL
4
$134.98
0.28%
0
$0.00
0.00%
00087001944
ENFAMIL ENFA POW LIPIL
4
$386.11
0.28%
0
$0.00
0.00%
00087004042
MAGNACAL
1
$66.38
0.07%
3
$247.84
0.24%
00087008041
PHENYL-FREE POW 2
2
$1,020.02
0.14%
5
$1,997.11
0.41%
00087008141
PHENYL-FREE POW 2HP
11
$3,893.62
0.76%
6
$2,344.66
0.49%
00087008742
MICROLIPID EMU 50%
3
$77.58
0.21%
6
$679.03
0.49%
00087020373
ENFAMIL A.R. LIQ LIPIL
1
$9.87
0.07%
5
$211.48
0.41%
00087026943
ENFAMIL/IRON LIQ 24
0
$0.00
0.00%
1
$835.36
0.08%
00087030274
ENFAMIL LIP LIQ LOW IRON
0
$0.00
0.00%
2
$235.90
0.16%
00087030801
PROSOBEE
4
$454.35
0.28%
5
$253.45
0.41%
00087030974
ENFA PROSOBE LIQ LIPIL
5
$1,072.67
0.35%
0
$0.00
0.00%
00087033178
ENFAMIL/IRON POW
3
$49.83
0.21%
0
$0.00
0.00%
00087033801
NUTRAMIGEN POW
3
$633.03
0.21%
17
$1,500.40
1.38%
00087035501
ISOCAL
3
$495.27
0.21%
0
$0.00
0.00%
LIQ 1.5 VAN
LIQ RENAL
CON
LIQ
Page 221 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
MCT
00087036701
00087036842
OIL
$
Market Share*
00087036503
# of Scripts
3
$111.09
0.21%
1
$36.19
0.08%
PREGESTIMIL POW
20
$2,789.74
1.38%
8
$509.72
0.65%
PHENYL-FREE POW
2
$628.86
0.14%
0
$0.00
0.00%
00087037943
PREGESTIMIL LIQ 24CAL
3
$1,073.78
0.21%
4
$1,030.08
0.33%
00087038701
PORTAGEN
0
$0.00
0.00%
12
$488.76
0.98%
00087039040
CASEC
6
$170.46
0.41%
0
$0.00
0.00%
00087042042
PRODUCT80056 POW
0
$0.00
0.00%
1
$24.96
0.08%
00087047142
LIPISORB
8
$2,748.98
0.55%
4
$1,352.36
0.33%
00087049801
NUTRAMIGEN CON
1
$86.14
0.07%
0
$0.00
0.00%
00087049901
NUTRAMIGEN LIQ
4
$977.33
0.28%
0
$0.00
0.00%
00087060741
KINDERCAL TF LIQ VANILLA
3
$402.51
0.21%
3
$349.69
0.24%
00087060841
KINDERCAL
0
$0.00
0.00%
1
$94.36
0.08%
00087061441
ENFAMIL LACT CON LIPIL
0
$0.00
0.00%
2
$140.28
0.16%
00087061647
ENFAMIL LACT POW LIPIL
3
$125.01
0.21%
4
$208.42
0.33%
00087066045
CHOICE DM
1
$42.03
0.07%
0
$0.00
0.00%
00087067066
BOOST
LIQ CHOC/MLT
0
$0.00
0.00%
3
$271.68
0.24%
00087067442
BOOST
LIQ VANILLA
1
$153.49
0.07%
5
$754.23
0.41%
00087067444
BOOST
LIQ VANILLA
0
$0.00
0.00%
4
$229.91
0.33%
00087067445
BOOST
LIQ VANILLA
42
$2,441.45
2.90%
12
$1,199.08
0.98%
00087067457
BOOST
LIQ VANILLA
11
$892.96
0.76%
7
$355.36
0.57%
00087067466
BOOST
LIQ VANILLA
11
$780.81
0.76%
17
$1,737.64
1.38%
00087067476
BOOST
LIQ VANILLA
0
$0.00
0.00%
2
$246.44
0.16%
00087067542
BOOST
LIQ CHOCOLAT
2
$275.52
0.14%
3
$223.36
0.24%
00087067544
BOOST
LIQ CHOCOLAT
0
$0.00
0.00%
3
$267.00
0.24%
00087067545
BOOST
LIQ CHOCOLAT
23
$1,700.35
1.59%
8
$763.76
0.65%
00087067557
BOOST
LIQ CHOCOLAT
0
$0.00
0.00%
2
$329.10
0.16%
00087067566
BOOST
LIQ CHOCOLAT
6
$284.24
0.41%
15
$1,135.38
1.22%
POW
POW
LIQ
LIQ CHOCOLTE
LIQ CHOCOLAT
Page 222 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00087067645
BOOST
LIQ STRWBRRY
5
00087067666
BOOST
LIQ STRWBRRY
00087067745
BOOST
LIQ MOCHA
00087067766
BOOST
LIQ MOCHA
00087069446
$791.35
0.35%
0
$0.00
0.00%
1
$68.76
0.07%
2
$170.23
0.16%
6
$1,275.84
0.41%
2
$402.96
0.16%
0
$0.00
0.00%
2
$170.24
0.16%
KINDERCAL TF LIQ FIBER
1
$98.62
0.07%
1
$96.63
0.08%
00087069541
CHOICE DM
LIQ VANILLA
2
$295.65
0.14%
0
$0.00
0.00%
00087093142
BOOST PLUS LIQ VANILLA
0
$0.00
0.00%
3
$125.40
0.24%
00087093145
8
$893.26
0.55%
0
$0.00
0.00%
00087093166
3
$388.76
0.21%
3
$295.77
0.24%
00087093245
BOOST PLUS LIQ CHOCOLAT
4
$432.83
0.28%
0
$0.00
0.00%
00087093251
0
$0.00
0.00%
2
$738.02
0.16%
00087093266
5
$354.68
0.35%
4
$589.12
0.33%
00087094046
BOOST HIGH LIQ PROTEIN
1
$83.99
0.07%
2
$166.60
0.16%
00087094047
3
$475.46
0.21%
0
$0.00
0.00%
00087094166
0
$0.00
0.00%
3
$561.96
0.24%
00087094445
0
$0.00
0.00%
2
$83.46
0.16%
00087094447
4
$773.64
0.28%
0
$0.00
0.00%
00087094543
BOOST PUDDIN MIS VANILLA
1
$120.74
0.07%
4
$288.91
0.33%
00087095144
BOOST/FIBER LIQ VANILLA
3
$187.62
0.21%
0
$0.00
0.00%
00087127341
ENFAMIL LIP POW W/IRON
4
$1,431.24
0.28%
0
$0.00
0.00%
00087140602
ENFAMIL PREM LIQ LIPIL
0
$0.00
0.00%
1
$54.76
0.08%
00087140941
NEXT STEP
POW SOY
2
$132.37
0.14%
0
$0.00
0.00%
00087140943
NEXT STEP
POW PROS LIP
0
$0.00
0.00%
1
$129.47
0.08%
00087201343
ENFAMIL 24 LIQ
2
$148.54
0.14%
0
$0.00
0.00%
00087270242
BOOST BREEZE LIQ BERRY
1
$84.49
0.07%
0
$0.00
0.00%
00087270343
BOOST BREEZE LIQ
3
$291.21
0.21%
8
$183.50
0.65%
00087405741
PKU 3
12
$5,415.81
0.83%
5
$2,818.32
0.41%
POW
Page 223 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
HOM 1
POW
00212140151
COMPLEAT
00212142451
COMPLEAT PED LIQ
00212175762
$
Market Share*
00087406541
# of Scripts
3
$1,984.82
0.21%
0
$0.00
0.00%
3
$226.69
0.21%
1
$144.95
0.08%
0
$0.00
0.00%
3
$904.82
0.24%
RESOURCE SUP LIQ STRAWBER
1
$281.06
0.07%
0
$0.00
0.00%
00212337162
RESOURCE
2
$199.98
0.14%
0
$0.00
0.00%
00212338162
RESOURCE PLU LIQ VANILLA
0
$0.00
0.00%
1
$109.97
0.08%
00212338262
RESOURCE PLU LIQ CHOCOLAT
0
$0.00
0.00%
1
$109.97
0.08%
00212458072
TOLEREX
POW
2
$3,460.64
0.14%
1
$1,690.63
0.08%
00212598475
RESOURCE ARG PAK CHERRY
1
$11.86
0.07%
0
$0.00
0.00%
00212727873
VIVONEX
1
$124.31
0.07%
0
$0.00
0.00%
00212729818
VIVONEX PLUS POW
2
$2,522.04
0.14%
1
$1,229.61
0.08%
00264151032
DEXTROSE
INJ 5%
1
$4.75
0.07%
0
$0.00
0.00%
00338001702
DEXTROSE
INJ 5%
7
$32.55
0.48%
2
$9.30
0.16%
00338001704
DEXTROSE
INJ 5%
3
$19.05
0.21%
1
$3.60
0.08%
00338001718
DEXTROSE
INJ 5%
2
$9.38
0.14%
1
$2.19
0.08%
00338001731
DEXTROSE
INJ 5%
0
$0.00
0.00%
3
$16.64
0.24%
00338049104
INTRALIPID INJ 20%
0
$0.00
0.00%
4
$340.02
0.33%
00338050206
CLINISOL SF INJ 15%
3
$5,140.35
0.21%
0
$0.00
0.00%
00338051903
INTRALIPID INJ 20%
0
$0.00
0.00%
9
$747.46
0.73%
00338064404
TRAVASOL
2
$209.76
0.14%
0
$0.00
0.00%
00847095112
PHENYLADE
POW CHOCOLAT
0
$0.00
0.00%
2
$584.56
0.16%
00847095222
PHENYLADE
POW VANILLA
0
$0.00
0.00%
1
$252.40
0.08%
00847095332
PHENYLADE
POW ORANGE C
0
$0.00
0.00%
1
$252.40
0.08%
00847095442
PHENYLADE
POW STRAWBER
0
$0.00
0.00%
1
$252.40
0.08%
00847095960
PHENYLADE
POW MTE
13
$4,474.33
0.90%
11
$3,005.14
0.90%
00847095964
PHENYLADE
PAK AMINO
0
$0.00
0.00%
3
$120.00
0.24%
00904404360
FISH OIL
7
$74.89
0.48%
56
$411.30
4.56%
LIQ
LIQ VANILLA
POW T.E.N.
INJ 10%
CAP 1000MG
Page 224 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
FISH OIL
24385015134
24385033572
37205022008
CAP 500MG
$
Market Share*
00904560413
# of Scripts
0
$0.00
0.00%
3
$12.62
0.24%
NUTR SUPPLE LIQ PL CHOC
2
$157.22
0.14%
7
$328.44
0.57%
FISH OIL
0
$0.00
0.00%
1
$3.69
0.08%
PED ELCTRLYT SOL FRUIT
3
$380.55
0.21%
0
$0.00
0.00%
37205022108
PED ELCTRLYT SOL GRAPE
0
$0.00
0.00%
1
$118.45
0.08%
49348016162
PED ELCTRLYT SOL GRAPE
1
$25.69
0.07%
0
$0.00
0.00%
49735010077
PHLEXY-10
BAR
2
$185.04
0.14%
2
$185.04
0.16%
49735010280
DUOCAL
POW
18
$1,008.56
1.24%
8
$194.61
0.65%
49735010375
XP MAXAMAID POW ORANGE
3
$877.38
0.21%
3
$877.38
0.24%
49735010804
NEOCATE FORM POW INFANT
39
$6,118.29
2.69%
21
$2,691.91
1.71%
49735011047
NEOCATE ONE POW
6
$2,954.16
0.41%
3
$1,443.37
0.24%
49735011050
PEDIATRIC
LIQ EO28
2
$1,093.82
0.14%
5
$2,753.29
0.41%
49735011467
PHLEXY-10
POW
1
$1,016.75
0.07%
1
$1,523.63
0.08%
49735011790
NEOCATE
POW JUNIOR
0
$0.00
0.00%
3
$66.54
0.24%
49735011880
XPHE ANALOG POW
0
$0.00
0.00%
3
$306.45
0.24%
49735011882
XLYS-XTRP
POW ANALOG
0
$0.00
0.00%
2
$418.92
0.16%
49735011910
PHLEXY-10
POW
1
$103.40
0.07%
0
$0.00
0.00%
54391005009
L-CARNITINE CAP 250MG
13
$923.43
0.90%
6
$586.36
0.49%
58914080044
SCANDISHAKE POW VANILLA
4
$280.54
0.28%
3
$171.70
0.24%
58914080144
SCANDISHAKE POW CHOCOLAT
0
$0.00
0.00%
2
$195.40
0.16%
58914081044
SCANDISHAKE POW VANILLA
0
$0.00
0.00%
4
$755.32
0.33%
58914082118
SCANDISHAKE POW CHOC
1
$94.13
0.07%
0
$0.00
0.00%
58914083008
SCANDICAL
POW
0
$0.00
0.00%
1
$7.69
0.08%
59781022551
JUVEN/HMB
POW
1
$62.91
0.07%
0
$0.00
0.00%
70074011105
ENSURE
10
$1,009.02
0.69%
3
$370.13
0.24%
70074011107
ENSURE PLUS LIQ CHOCOLAT
10
$1,857.91
0.69%
5
$629.24
0.41%
70074011108
ENSURE PLUS LIQ VANILLA
9
$1,432.61
0.62%
2
$504.94
0.16%
CAP 1000MG
LIQ VANILLA
Page 225 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
70074011111
ENSURE PLUS LIQ STRWBERY
2
$458.28
0.14%
0
$0.00
0.00%
70074011112
ENSURE PLUS LIQ BUT PECN
0
$0.00
0.00%
1
$158.78
0.08%
70074011114
ENSURE/FIBER LIQ CHOCOLAT
0
$0.00
0.00%
2
$332.74
0.16%
70074011116
ENSURE LIGHT LIQ FREN VAN
4
$265.38
0.28%
2
$260.14
0.16%
70074011120
ENSURE HP
0
$0.00
0.00%
2
$104.36
0.16%
70074020107
ISOMIL/IRON POW
4
$57.60
0.28%
0
$0.00
0.00%
70074040108
RCF
0
$0.00
0.00%
2
$741.84
0.16%
70074040143
JEVITY 1 CAL LIQ
60
$21,280.39
4.14%
35
$8,303.35
2.85%
70074040160
PEDIALYTE
0
$0.00
0.00%
2
$8.72
0.16%
70074040373
PEDIASURE
LIQ PEDIATRI
71
$11,255.55
4.90%
62
$10,440.96
5.05%
70074040701
ENSURE
LIQ CHOCOLAT
58
$7,003.70
4.01%
46
$5,074.62
3.75%
70074040702
24
$2,879.45
1.66%
16
$1,738.68
1.30%
70074040703
ENSURE
LIQ BLK WALN
2
$404.88
0.14%
1
$119.74
0.08%
70074040704
ENSURE
LIQ COFFEE
70074040705
ENSURE
LIQ STRWBERY
70074040707
70074040709
OSMOLITE
70074040710
ENSURE
70074040711
ENSURE
70074040717
ENSURE PLUS LIQ COFFEE
70074040718
70074040721
ENSURE PLUS LIQ HN VANIL
70074040729
TWOCAL HN
70074040735
OSMOLITE 1 LIQ CAL
70074040759
LIQ CHOCOLAT
CON LOW-IRON
SOL UNFLAVOR
6
$230.22
0.41%
8
$333.95
0.65%
34
$2,698.09
2.35%
19
$2,094.60
1.55%
55
$5,933.29
3.80%
32
$4,613.96
2.61%
4
$1,029.14
0.28%
4
$1,361.80
0.33%
LIQ EGGNOG
5
$1,400.53
0.35%
3
$512.58
0.24%
LIQ VANILLA
110
$9,606.27
7.60%
103
$8,905.65
8.39%
1
$155.22
0.07%
2
$310.44
0.16%
16
$1,039.07
1.10%
11
$1,071.90
0.90%
5
$880.89
0.35%
3
$544.38
0.24%
12
$2,727.62
0.83%
11
$1,486.07
0.90%
9
$2,499.09
0.62%
11
$2,771.75
0.90%
ENSURE/FIBER LIQ VANILLA
2
$258.70
0.14%
0
$0.00
0.00%
70074040766
VITAL HN
1
$1,044.48
0.07%
0
$0.00
0.00%
70074050241
GLUCERNA
12
$2,207.15
0.83%
10
$2,749.38
0.81%
LIQ
LIQ
POW
LIQ VANILLA
Page 226 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ENSURE
LIQ VANILLA
70074050463
ENSURE
LIQ CHOCOLAT
70074050465
70074050467
$
Market Share*
70074050461
# of Scripts
16
$1,569.40
1.10%
5
$981.43
0.41%
9
$781.67
0.62%
6
$298.23
0.49%
14
$1,853.03
0.97%
9
$1,437.33
0.73%
1
$181.25
0.07%
13
$1,320.68
1.06%
70074050629
PERATIVE
1
$236.87
0.07%
0
$0.00
0.00%
70074050633
NEPRO
12
$2,206.92
0.83%
12
$3,098.99
0.98%
70074050647
2
$226.96
0.14%
4
$682.32
0.33%
70074050649
ENSURE
LIQ STRWBERY
0
$0.00
0.00%
3
$175.05
0.24%
70074050653
PEDIASURE
LIQ W/FIBER
21
$4,787.32
1.45%
22
$5,310.27
1.79%
70074050775
PROMOTE
LIQ -RTU
1
$177.97
0.07%
1
$61.08
0.08%
70074050789
1
$37.37
0.07%
1
$214.78
0.08%
70074050793
ENSURE
LIQ CHOCOLAT
1
$80.05
0.07%
0
$0.00
0.00%
70074050795
ENSURE
LIQ VANILLA
3
$362.42
0.21%
2
$307.71
0.16%
70074051119
HOMINEX-2
0
$0.00
0.00%
2
$734.66
0.16%
70074051122
PHENEX-2
POW
3
$303.66
0.21%
2
$101.22
0.16%
70074051123
PHENEX-2
POW
0
$0.00
0.00%
2
$1,249.35
0.16%
70074051137
I-VALEX-1
POW
3
$753.09
0.21%
3
$373.41
0.24%
70074051138
I-VALEX-2
POW
2
$923.50
0.14%
0
$0.00
0.00%
70074051139
I-VALEX-2
POW
0
$0.00
0.00%
4
$1,628.59
0.33%
70074051147
CYCLINEX-2 POW
0
$0.00
0.00%
1
$162.57
0.08%
70074051741
ENSURE PLUS LIQ RTU COFF
1
$112.19
0.07%
0
$0.00
0.00%
70074051785
ENSURE
9
$1,157.30
0.62%
0
$0.00
0.00%
70074051787
0
$0.00
0.00%
2
$457.30
0.16%
70074051805
PEDIASURE
LIQ RTU VANI
54
$12,599.48
3.73%
38
$7,795.01
3.09%
70074051807
PEDIASURE
LIQ W/FIBER
30
$6,234.78
2.07%
36
$7,742.49
2.93%
70074051809
PEDIASURE
LIQ BAN CREA
2
$360.82
0.14%
3
$581.03
0.24%
70074051811
PEDIASURE
LIQ STRWBERY
23
$1,564.24
1.59%
9
$707.43
0.73%
LIQ
LIQ
POW
LIQ BUT PECN
Page 227 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
70074051813
PEDIASURE
LIQ CHOCOLAT
30
$3,197.86
2.07%
26
$2,615.43
2.12%
70074051873
PROMOTE W/FB LIQ VANILLA
11
$2,559.83
0.76%
10
$2,062.25
0.81%
70074051881
PEDIASURE
LIQ STRWBERY
0
$0.00
0.00%
4
$400.96
0.33%
70074051883
PEDIASURE
LIQ CHOCOLAT
4
$302.31
0.28%
5
$641.72
0.41%
70074051895
1
$173.85
0.07%
0
$0.00
0.00%
70074052069
ENSURE HP
LIQ CHOCOLAT
1
$255.76
0.07%
0
$0.00
0.00%
70074052071
ENSURE HP
LIQ VANILLA
1
$202.77
0.07%
0
$0.00
0.00%
70074052073
ENSURE HP
LIQ WLD BERY
2
$83.50
0.14%
2
$61.96
0.16%
70074052099
ENSURE HP
LIQ CHOCOLAT
0
$0.00
0.00%
1
$163.71
0.08%
70074052637
ENSURE
LIQ VANILLA
10
$577.70
0.69%
0
$0.00
0.00%
70074052639
ENSURE
LIQ CHOCOLAT
6
$647.48
0.41%
0
$0.00
0.00%
70074052771
ENSURE LIGHT LIQ FREN VAN
0
$0.00
0.00%
2
$203.85
0.16%
70074053119
JEVITY 1.2 LIQ CAL
20
$4,477.33
1.38%
20
$4,988.23
1.63%
70074054107
NEPRO
3
$195.58
0.21%
0
$0.00
0.00%
70074054325
GLUCERNA
1
$156.07
0.07%
8
$2,079.95
0.65%
70074054327
GLUCERNA SHK LIQ BUT PECN
12
$901.38
0.83%
3
$311.47
0.24%
70074054545
GLUCERNA SHK LIQ CHOC
0
$0.00
0.00%
2
$324.98
0.16%
70074054555
GLUCERNA
0
$0.00
0.00%
7
$1,318.97
0.57%
70074054556
GLUCERNA SHK LIQ CHOC
2
$308.42
0.14%
3
$462.63
0.24%
70074054568
SIMILAC ALIM POW IRON
3
$282.45
0.21%
0
$0.00
0.00%
70074054569
GLUCERNA SHK LIQ VANILLA
6
$1,227.99
0.41%
0
$0.00
0.00%
70074054666
ELECARE
11
$3,584.69
0.76%
7
$4,110.33
0.57%
70074054777
ENSURE ENLIV LIQ APPLE
3
$80.04
0.21%
8
$213.44
0.65%
70074054845
ENSURE PUDD MIS VANILLA
1
$199.19
0.07%
1
$195.30
0.08%
70074054847
ENSURE PUDDI MIS CHOCOLAT
1
$157.52
0.07%
0
$0.00
0.00%
70074055756
PHENEX-2
POW
2
$869.12
0.14%
1
$422.73
0.08%
70074055775
PROSURE
LIQ VANILLA
5
$355.88
0.35%
3
$327.08
0.24%
LIQ CHERRY
LIQ VANILLA
LIQ CHOCOLAT
POW PED
Page 228 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
PEDIASURE
LIQ VANILLA
70074055904
GLUCERNA SHK LIQ STRAWBER
70074055905
GLUCERNA
70074055958
$
Market Share*
70074055898
# of Scripts
$324.32
0.21%
16
$2,033.53
1.30%
2
$83.16
0.14%
1
$40.67
0.08%
2
$456.20
0.14%
0
$0.00
0.00%
SIMILA ADVAN POW IRON
0
$0.00
0.00%
2
$475.80
0.16%
70074055962
SIMILAC ADVA LIQ IRON
8
$552.32
0.55%
1
$97.00
0.08%
70074056012
ENSURE
BAR CK/CREAM
3
$266.04
0.21%
0
$0.00
0.00%
70074056017
ENSURE
LIQ COF-LATT
1
$13.45
0.07%
4
$154.73
0.33%
70074056818
PEDIASURE
0
$0.00
0.00%
5
$1,038.42
0.41%
70074057226
PROSURE
6
$565.92
0.41%
0
$0.00
0.00%
70074057334
JEVITY 1.5 LIQ CAL
0
$0.00
0.00%
14
$989.14
1.14%
70074057634
PROMOTE W/FB LIQ VANILLA
0
$0.00
0.00%
1
$526.59
0.08%
70074057646
GLUCERNA SHK LIQ CHOCOLAT
1
$1.14
0.07%
0
$0.00
0.00%
70074060237
ALIMENTUM
LIQ RTF
4
$205.43
0.28%
0
$0.00
0.00%
70074060733
ENSURE
LIQ VANILLA
1
$71.49
0.07%
3
$396.07
0.24%
70074060746
POLYCOSE
8
$240.63
0.55%
16
$240.28
1.30%
70074060775
PROMOD
9
$330.32
0.62%
14
$319.91
1.14%
70074060799
ENSURE
1
$30.15
0.07%
0
$0.00
0.00%
70074060850
SIMILAC PM POW 60/40
5
$795.43
0.35%
3
$100.40
0.24%
70074080240
PEDIALYTE
SOL GRAPE
0
$0.00
0.00%
1
$9.35
0.08%
70074080336
PEDIALYTE
SOL UNFLAVOR
2
$120.70
0.14%
0
$0.00
0.00%
70074080365
PEDIALYTE
SOL FRUIT
1
$21.35
0.07%
0
$0.00
0.00%
70074080792
ENSURE PUDD MIS VANILLA
5
$289.35
0.35%
1
$57.64
0.08%
82028000080
PROCEL
4
$55.80
0.28%
1
$13.26
0.08%
LIQ STRAWBER
LIQ
LIQ VANILLA
POW
POW
LIQ CHOCOLAT
POW
3
ERYTHROPOEITINS
55513001004
ARANESP
INJ 25MCG/ML
12
$560.31
2.16%
1
$228.07
0.19%
55513001104
ARANESP
INJ 40MCG/ML
3
$1,296.95
0.54%
1
$722.45
0.19%
Page 229 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ERYTHROPOEITINS
55513001201
ARANESP
SOL 60MCG/ML
0
$0.00
0.00%
1
$270.51
0.19%
55513001204
ARANESP
SOL 60MCG/ML
2
$1,043.24
0.36%
1
$273.01
0.19%
55513001301
ARANESP
SOL 100MCG
2
$2,176.26
0.36%
1
$452.79
0.19%
55513001304
ARANESP
SOL 100MCG
3
$937.73
0.54%
0
$0.00
0.00%
55513001401
ARANESP
INJ 200MCG
1
$1,736.50
0.18%
0
$0.00
0.00%
55513003901
ARANESP
INJ 60MCG
0
$0.00
0.00%
1
$273.01
0.19%
55513004104
ARANESP
INJ 100MCG
0
$0.00
0.00%
1
$3,598.85
0.19%
55513004401
ARANESP
INJ 200MCG
0
$0.00
0.00%
1
$1,801.10
0.19%
55513004601
ARANESP
INJ 300MCG
0
$0.00
0.00%
1
$1,351.66
0.19%
55513014410
EPOGEN
INJ 10000/ML
4
$3,179.73
0.72%
8
$363.54
1.51%
55513026710
EPOGEN
INJ 3000/ML
0
$0.00
0.00%
1
$36.60
0.19%
55513028310
EPOGEN
INJ 10000/ML
3
$1,705.17
0.54%
0
$0.00
0.00%
55513047810
EPOGEN
INJ 20000/ML
3
$3,155.47
0.54%
1
$1,028.54
0.19%
55513082310
EPOGEN
INJ 40000/ML
6
$12,363.98
1.08%
2
$3,112.92
0.38%
59676030201
PROCRIT
INJ 2000/ML
8
$1,367.18
1.44%
9
$554.51
1.70%
59676030202
PROCRIT
INJ 2000/ML
2
$143.64
0.36%
4
$313.04
0.75%
59676030301
PROCRIT
INJ 3000/ML
14
$4,603.29
2.52%
15
$4,080.94
2.83%
59676030302
PROCRIT
INJ 3000/ML
15
$2,863.81
2.70%
15
$5,031.52
2.83%
59676030401
PROCRIT
INJ 4000/ML
38
$13,327.97
6.83%
17
$6,152.11
3.21%
59676030402
PROCRIT
INJ 4000/ML
24
$3,991.30
4.32%
28
$7,130.03
5.28%
59676031001
PROCRIT
INJ 10000/ML
107
$40,610.10
19.24%
98
$66,309.25
18.49%
59676031002
PROCRIT
INJ 10000/ML
40
$19,523.96
7.19%
52
$23,517.10
9.81%
59676031201
PROCRIT
INJ 10000/ML
42
$23,942.25
7.55%
33
$17,616.05
6.23%
59676032001
PROCRIT
INJ 20000/ML
126
$106,872.46
22.66%
102
$94,646.41
19.25%
59676034001
PROCRIT
INJ 40000/ML
101
$170,679.27
18.17%
136
$221,664.76
25.66%
ESTROGEN COMBO'S
Page 230 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ESTROGEN COMBO'S
00009517401
ACTIVELLA
TAB 1-0.5MG
00009517402
ACTIVELLA
TAB 1-0.5MG
00032102301
ESTRATEST HS TAB
00032102601
ESTRATEST
00046087501
PREMPRO
00046087505
00046087506
58
$1,560.68
3.13%
11
$337.46
1.00%
54
$1,458.89
2.91%
3
$89.34
0.27%
113
$4,444.84
6.09%
0
$0.00
0.00%
186
$9,249.72
10.02%
0
$0.00
0.00%
TAB .625-2.5
11
$226.29
0.59%
0
$0.00
0.00%
PREMPRO
TAB .625-2.5
115
$3,913.68
6.20%
78
$2,808.51
7.08%
PREMPRO
TAB .625-2.5
639
$22,684.29
34.43%
428
$16,028.03
38.84%
00046093708
PREMPRO
TAB 0.45-1.5
9
$318.77
0.48%
14
$511.80
1.27%
00046093709
PREMPRO
TAB 0.45-1.5
69
$2,465.21
3.72%
100
$3,564.32
9.07%
00046093808
PREMPRO
TAB 0.3-1.5
0
$0.00
0.00%
14
$509.32
1.27%
00046093809
PREMPRO
TAB 0.3-1.5
0
$0.00
0.00%
90
$3,278.50
8.17%
00046097505
PREMPRO
TAB 0.625-5
18
$617.42
0.97%
12
$427.97
1.09%
00046097506
PREMPRO
TAB 0.625-5
160
$5,635.98
8.62%
110
$4,131.32
9.98%
00046257305
PREMPHASE
TAB
14
$312.29
0.75%
2
$61.40
0.18%
00046257306
PREMPHASE
TAB
79
$2,731.95
4.26%
62
$2,344.00
5.63%
00062184015
ORTHO-PREFES TAB
60
$1,816.59
3.23%
0
$0.00
0.00%
00071014423
FEMHRT 1/5 TAB
16
$469.14
0.86%
0
$0.00
0.00%
00071014445
FEMHRT 1/5 TAB
176
$4,574.92
9.48%
40
$1,160.54
3.63%
00078037742
COMBIPATCH DIS .05/.14
2
$75.83
0.11%
2
$69.24
0.18%
00078037745
31
$1,088.52
1.67%
17
$588.54
1.54%
00078037842
4
$144.96
0.22%
0
$0.00
0.00%
00078037845
12
$434.88
0.65%
7
$248.01
0.64%
00169517401
ACTIVELLA
TAB 1-0.5MG
0
$0.00
0.00%
8
$274.02
0.73%
00169517402
ACTIVELLA
TAB 1-0.5MG
0
$0.00
0.00%
20
$678.05
1.81%
00430054414
FEMHRT 1/5 TAB
0
$0.00
0.00%
33
$1,128.74
2.99%
00430054423
FEMHRT 1/5 TAB
5
$149.73
0.27%
22
$909.15
2.00%
61570012563
PREFEST
0
$0.00
0.00%
29
$908.80
2.63%
TAB
TAB
Page 231 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ESTROGEN COMBO'S
66576023001
SYNTEST H.S. TAB
9
$367.70
0.48%
0
$0.00
0.00%
66576023101
SYNTEST D.S. TAB
16
$706.83
0.86%
0
$0.00
0.00%
ESTROGENS - PATCHES
00051102858
ESTROGEL
0
$0.00
0.00%
3
$251.19
0.71%
00078034342
VIVELLE-DOT DIS 0.0375MG
GEL
3
$82.40
0.49%
9
$295.72
2.13%
00078034345
10
$300.80
1.63%
11
$353.22
2.60%
00078034442
6
$190.62
0.98%
0
$0.00
0.00%
00078034445
23
$748.67
3.75%
21
$704.82
4.96%
00078034542
2
$64.86
0.33%
3
$101.58
0.71%
00078034545
18
$583.74
2.93%
13
$407.44
3.07%
00078034562
0
$0.00
0.00%
2
$67.66
0.47%
00078034642
2
$66.18
0.33%
1
$101.98
0.24%
00078034645
32
$1,121.26
5.21%
18
$603.04
4.26%
00078034862
VIVELLE
1
$23.02
0.16%
0
$0.00
0.00%
00078036542
0
$0.00
0.00%
1
$32.33
0.24%
00078036545
2
$61.92
0.33%
1
$32.33
0.24%
00083231008
ESTRADERM
DIS 0.05MG
19
$487.18
3.09%
4
$148.08
0.95%
00083231062
ESTRADERM
DIS 0.05MG
70
$2,261.87
11.40%
60
$2,012.19
14.18%
00083232008
ESTRADERM
DIS 0.1MG
3
$98.11
0.49%
0
$0.00
0.00%
00083232062
ESTRADERM
DIS 0.1MG
42
$1,432.11
6.84%
32
$1,123.50
7.57%
00083232508
VIVELLE
DIS 0.0375MG
11
$343.20
1.79%
0
$0.00
0.00%
00083232562
VIVELLE
DIS 0.0375MG
2
$57.40
0.33%
0
$0.00
0.00%
00083232608
VIVELLE
DIS 0.05MG
17
$534.79
2.77%
14
$474.52
3.31%
00083232662
VIVELLE
DIS 0.05MG
3
$45.80
0.49%
0
$0.00
0.00%
00083232708
VIVELLE
DIS 0.075MG
3
$99.79
0.49%
0
$0.00
0.00%
00083232801
VIVELLE
DIS 0.1MG
3
$96.71
0.49%
2
$52.08
0.47%
DIS 0.025MG
Page 232 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ESTROGENS - PATCHES
00083232808
VIVELLE
DIS 0.1MG
00083232862
VIVELLE
DIS 0.1MG
8
$361.76
1.30%
00378335099
ESTRADIOL
DIS 0.05/24H
72
$1,507.78
11.73%
00378335299
ESTRADIOL
DIS 0.1MG/24
39
$843.27
6.35%
50419045104
CLIMARA
DIS 0.05MG
56
$1,742.74
50419045204
CLIMARA
DIS 0.1MG
74
50419045304
CLIMARA
DIS 0.075MG
28
50419045404
CLIMARA
DIS 0.025MG
50419045604
CLIMARA
DIS 0.0375MG
52544047108
ALORA
52544047208
ALORA
64248031001
10
$330.90
1.63%
16
$687.62
3.78%
0
$0.00
0.00%
38
$833.46
8.98%
17
$358.35
4.02%
9.12%
37
$1,235.62
8.75%
$3,043.70
12.05%
45
$1,806.59
10.64%
$910.25
4.56%
29
$969.73
6.86%
27
$692.70
4.40%
29
$1,051.03
6.86%
2
$65.20
0.33%
2
$66.52
0.47%
DIS 0.05MG
9
$285.57
1.47%
8
$261.03
1.89%
DIS 0.075MG
8
$263.26
1.30%
4
$142.04
0.95%
ESCLIM
DIS 0.025MG
4
$110.68
0.65%
1
$31.86
0.24%
64248033001
ESCLIM
DIS 0.05MG
2
$58.00
0.33%
0
$0.00
0.00%
64248035001
ESCLIM
DIS 0.1MG
3
$86.88
0.49%
2
$124.64
0.47%
$0.00
0.00%
ESTROGENS - TABS
00003025150
DELESTROGEN INJ 40MG/ML
1
$123.74
0.01%
0
00009377201
OGEN
TAB 0.625
3
$89.35
0.04%
0
$0.00
0.00%
00009377301
OGEN
TAB 1.25
2
$67.82
0.03%
3
$104.31
0.05%
00009377401
OGEN
TAB 2.5
4
$255.50
0.05%
3
$57.65
0.05%
00046086481
PREMARIN
TAB 0.9MG
477
$15,216.84
6.19%
358
$12,859.32
5.57%
00046086681
PREMARIN
TAB 1.25MG
852
$34,085.11
11.06%
308
$11,770.98
4.79%
00046086691
PREMARIN
TAB 1.25MG
55
$2,142.16
0.71%
22
$791.20
0.34%
00046086781
PREMARIN
TAB 0.625MG
2,160
$59,050.79
28.04%
1,989
$71,371.64
30.94%
00046086791
PREMARIN
TAB 0.625MG
1,461
$39,515.80
18.97%
936
$29,115.66
14.56%
00046086795
PREMARIN
TAB 0.625MG
3
$63.06
0.04%
3
$61.65
0.05%
00046086799
PREMARIN
TAB 0.625MG
16
$435.81
0.21%
20
$575.98
0.31%
Page 233 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ESTROGENS - TABS
00046086881
PREMARIN
TAB 0.3MG
689
$15,906.18
8.95%
702
00046086891
PREMARIN
TAB 0.3MG
30
$748.12
0.39%
00046093681
PREMARIN
TAB 0.45MG
18
$487.78
0.23%
00046110481
PREMARIN
TAB 1.25MG
0
$0.00
00046110491
PREMARIN
TAB 1.25MG
0
00046386781
PREMARIN
TAB 0.625MG
00087002141
ESTRACE
TAB 0.5MG
00087075501
ESTRACE
00087075601
ESTRACE
00378145201
ESTRADIOL
00378145205
ESTRADIOL
00378145401
$20,212.24
10.92%
32
$978.40
0.50%
74
$2,349.75
1.15%
0.00%
105
$4,216.26
1.63%
$0.00
0.00%
11
$383.79
0.17%
2
$54.42
0.03%
2
$54.03
0.03%
2
$26.78
0.03%
0
$0.00
0.00%
TAB 1MG
8
$144.48
0.10%
1
$9.91
0.02%
TAB 2MG
1
$27.33
0.01%
0
$0.00
0.00%
TAB 0.5MG
52
$342.92
0.68%
34
$189.42
0.53%
TAB 0.5MG
16
$131.04
0.21%
9
$73.89
0.14%
ESTRADIOL
TAB 1MG
43
$379.50
0.56%
29
$223.55
0.45%
00378145405
ESTRADIOL
TAB 1MG
22
$199.68
0.29%
23
$183.84
0.36%
00378145801
ESTRADIOL
TAB 2MG
85
$596.00
1.10%
31
$190.55
0.48%
00378145805
ESTRADIOL
TAB 2MG
25
$136.33
0.32%
21
$131.35
0.33%
00378455101
ESTROPIPATE TAB 0.75MG
26
$131.90
0.34%
24
$136.75
0.37%
00378455301
1
$7.75
0.01%
20
$173.80
0.31%
00430002324
ESTRACE
TAB 1MG
0
$0.00
0.00%
3
$42.63
0.05%
00430002424
ESTRACE
TAB 2MG
0
$0.00
0.00%
3
$107.52
0.05%
00555072702
63
$342.01
0.82%
7
$33.25
0.11%
00555072802
45
$455.21
0.58%
16
$158.50
0.25%
00555072902
ESTROPIPATE TAB 3MG
5
$23.75
0.06%
4
$24.00
0.06%
00555088602
ESTRADIOL
TAB 1MG
303
$2,742.34
3.93%
180
$1,603.37
2.80%
00555088604
ESTRADIOL
TAB 1MG
28
$250.85
0.36%
15
$121.72
0.23%
00555088702
ESTRADIOL
TAB 2MG
88
$569.78
1.14%
106
$748.72
1.65%
00555088704
ESTRADIOL
TAB 2MG
4
$30.95
0.05%
5
$29.25
0.08%
00555089902
ESTRADIOL
TAB 0.5MG
140
$974.42
1.82%
89
$576.28
1.38%
Page 234 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ESTROGENS - TABS
00591041401
65
$371.73
0.84%
50
$320.12
0.78%
00591041501
41
$369.03
0.53%
38
$381.87
0.59%
00591041601
ESTROPIPATE TAB 3MG
36
$218.54
0.47%
22
$178.46
0.34%
00591048701
ESTRADIOL
TAB 1MG
213
$1,880.68
2.77%
365
$3,147.91
5.68%
00591048705
ESTRADIOL
TAB 1MG
4
$25.60
0.05%
29
$278.20
0.45%
00591048801
ESTRADIOL
TAB 2MG
111
$749.10
1.44%
204
$1,469.26
3.17%
00591048805
ESTRADIOL
TAB 2MG
2
$11.60
0.03%
1
$14.35
0.02%
00591052801
ESTRADIOL
TAB 0.5MG
50
$367.83
0.65%
124
$775.18
1.93%
38779086904
ESTRADIOL
POW MICRONIZ
0
$0.00
0.00%
1
$22.50
0.02%
51285044102
CENESTIN
TAB 0.3MG
51285044202
CENESTIN
TAB 0.625MG
51285044302
CENESTIN
51285044402
23
$475.76
0.30%
17
$540.05
0.26%
123
$3,176.25
1.60%
130
$3,845.62
2.02%
TAB 0.9MG
59
$1,699.80
0.77%
49
$1,596.90
0.76%
CENESTIN
TAB 1.25MG
76
$2,515.47
0.99%
76
$2,652.73
1.18%
51285044602
CENESTIN
TAB 0.45MG
0
$0.00
0.00%
5
$141.40
0.08%
51285050202
ESTRADIOL
TAB 1MG
1
$8.90
0.01%
0
$0.00
0.00%
51552038105
ESTRIOL
1
$41.65
0.01%
0
$0.00
0.00%
51552038405
ESTRADIOL
1
$23.35
0.01%
0
$0.00
0.00%
52544041401
1
$4.45
0.01%
1
$4.45
0.02%
52544041501
6
$62.60
0.08%
2
$15.50
0.03%
52544048701
ESTRADIOL
TAB 1MG
7
$51.19
0.09%
6
$43.96
0.09%
52544048705
ESTRADIOL
TAB 1MG
3
$19.20
0.04%
2
$12.80
0.03%
59772002503
ESTRADIOL
TAB 0.5MG
10
$49.87
0.13%
1
$13.27
0.02%
59772002603
ESTRADIOL
TAB 1MG
16
$112.40
0.21%
13
$114.30
0.20%
59772002604
ESTRADIOL
TAB 1MG
23
$180.50
0.30%
16
$116.28
0.25%
59772002703
ESTRADIOL
TAB 2MG
24
$135.70
0.31%
8
$28.40
0.12%
59772002704
ESTRADIOL
TAB 2MG
3
$30.05
0.04%
2
$10.70
0.03%
61570007201
MENEST
TAB 0.3MG
10
$115.10
0.13%
9
$103.81
0.14%
POW MICRONIZ
POW
Page 235 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
ESTROGENS - TABS
61570007301
MENEST
TAB 0.625MG
35
$571.25
0.45%
42
$697.23
0.65%
61570007401
MENEST
TAB 1.25MG
22
$598.53
0.29%
20
$492.33
0.31%
61570007550
MENEST
TAB 2.5MG
3
$115.70
0.04%
3
$130.45
0.05%
61570018101
1
$74.92
0.01%
3
$340.11
0.05%
61570018201
1
$136.03
0.01%
2
$281.70
0.03%
64248010101
ORTHO-EST
1
$24.32
0.01%
0
$0.00
0.00%
1
$44.17
3.85%
0
$0.00
0.00%
TAB 0.625
FERTILITY REGULATORS
00052031510
PREGNYL
INJ 10000UNT
00093004103
CLOMIPHENE TAB 50MG
4
$64.40
15.38%
0
$0.00
0.00%
00093004156
CLOMIPHENE TAB 50MG
2
$39.95
7.69%
0
$0.00
0.00%
00591078130
CLOMIPHENE TAB 50MG
7
$91.48
26.92%
2
$31.93
50.00%
44087025001
OVIDREL
1
$64.49
3.85%
0
$0.00
0.00%
49884070155
CLOMIPHENE TAB 50MG
11
$133.76
42.31%
2
$47.60
50.00%
TAB 400MG
15
$1,022.41
0.17%
11
$751.16
0.14%
TAB 400MG
INJ 250MCG
FLUOROQUINOLONES
00006070520
NOROXIN
00006070568
NOROXIN
24
$1,925.86
0.28%
21
$1,585.49
0.26%
00015111750
TEQUIN
TAB 200MG
45
$2,821.30
0.52%
8
$221.89
0.10%
00015117719
TEQUIN
TAB 400MG
4
$202.06
0.05%
0
$0.00
0.00%
00015117721
TEQUIN
TAB 400MG
1
$52.43
0.01%
0
$0.00
0.00%
00015117760
TEQUIN
TAB 400MG
272
$18,294.79
3.17%
51
$1,858.83
0.63%
00015118080
TEQUIN
INJ 2MG/ML
1
$47.33
0.01%
0
$0.00
0.00%
00026851106
CIPRO CYSTIT TAB 100MG
22
$1,005.35
0.26%
20
$1,012.63
0.25%
00026851248
CIPRO
TAB 250MG
94
$1,057.36
1.10%
16
$215.38
0.20%
00026851251
CIPRO
TAB 250MG
1,140
$52,576.46
13.29%
52
$2,024.09
0.65%
00026851348
CIPRO
TAB 500MG
93
$6,832.92
1.08%
1
$5.21
0.01%
Page 236 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
FLUOROQUINOLONES
00026851351
CIPRO
TAB 500MG
00026851448
CIPRO
TAB 750MG
00026851450
CIPRO
TAB 750MG
00026852763
CIPRO I.V. SOL 400MG
00026855136
CIPRO
00026855336
CIPRO
00026855463
CIPRO I.V. SOL 400MG
00026858141
AVELOX ABC TAB 400MG
00026858169
AVELOX
00026858231
AVELOX
INJ
00026888950
CIPRO XR
TAB 500MG
00026888951
CIPRO XR
TAB 500MG
00026889750
CIPRO XR
00026889751
CIPRO XR
00045006601
LEVAQUIN/D5W INJ 750/150
00045006801
$99,817.00
13.44%
39
$2,523.68
0.49%
2
$198.12
0.02%
75
$9,410.23
0.87%
0
$0.00
0.00%
2
$153.34
0.02%
0
$0.00
0.00%
1
$255.95
0.01%
SUS 5G/100ML
16
$1,635.12
0.19%
17
$1,622.20
0.21%
SUS 10GM/100
30
$4,005.33
0.35%
18
$1,987.51
0.22%
7
$1,169.37
0.08%
5
$1,792.45
0.06%
24
$1,628.68
0.28%
2
$95.16
0.02%
1,073
$85,057.66
12.50%
1,698
$142,698.64
21.14%
2
$458.30
0.02%
0
$0.00
0.00%
164
$9,555.24
1.91%
175
$10,511.82
2.18%
18
$1,062.24
0.21%
13
$591.22
0.16%
TAB 1000MG
35
$3,198.19
0.41%
19
$525.90
0.24%
TAB 1000MG
2
$87.50
0.02%
1
$32.41
0.01%
0
$0.00
0.00%
4
$1,450.44
0.05%
LEVAQUIN/D5W INJ 500/100
6
$1,012.85
0.07%
0
$0.00
0.00%
00045006951
LEVAQUIN
INJ 25MG/ML
1
$270.92
0.01%
0
$0.00
0.00%
00045152010
LEVAQUIN
TAB 250MG
30
$542.25
0.35%
15
$403.81
0.19%
00045152050
LEVAQUIN
TAB 250MG
543
$33,195.60
6.33%
209
$7,865.02
2.60%
00045152510
LEVAQUIN
TAB 500MG
8
$613.78
0.09%
3
$132.83
0.04%
00045152550
LEVAQUIN
TAB 500MG
1,408
$108,971.63
16.41%
479
$22,142.63
5.96%
00045153005
LEVAQUIN
TAB LEVA-PAK
0
$0.00
0.00%
9
$572.66
0.11%
00045153020
LEVAQUIN
TAB 750MG
0
$0.00
0.00%
16
$1,153.69
0.20%
00045153050
LEVAQUIN
TAB 750MG
19
$3,508.93
0.22%
15
$1,590.29
0.19%
00062154002
FLOXIN
TAB 200MG
14
$1,591.02
0.16%
0
$0.00
0.00%
00062154102
FLOXIN
TAB 300MG
13
$1,383.42
0.15%
5
$173.47
0.06%
00062154201
FLOXIN
TAB 400MG
37
$5,093.44
0.43%
1
$48.89
0.01%
TAB 400MG
1,153
Page 237 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
FLUOROQUINOLONES
00093086301
CIPROFLOXACN TAB 250MG
0
$0.00
0.00%
1
$6.83
0.01%
00093086401
0
$0.00
0.00%
94
$1,371.39
1.17%
00093718101
OFLOXACIN
TAB 300MG
0
$0.00
0.00%
1
$139.53
0.01%
00093718201
OFLOXACIN
TAB 400MG
0
$0.00
0.00%
6
$475.10
0.07%
00143992701
0
$0.00
0.00%
94
$999.57
1.17%
00143992801
0
$0.00
0.00%
86
$1,096.62
1.07%
00143992950
0
$0.00
0.00%
10
$139.90
0.12%
00172531160
0
$0.00
0.00%
759
$6,668.09
9.45%
00172531260
0
$0.00
0.00%
408
$6,110.01
5.08%
00172531270
0
$0.00
0.00%
12
$172.68
0.15%
00172531360
0
$0.00
0.00%
8
$191.80
0.10%
00555037987
CIPROFLOXACN SUS 5%
3
$466.64
0.03%
5
$1,066.85
0.06%
00555038087
CIPROFLOXACN SUS 10%
10
$1,415.84
0.12%
4
$272.36
0.05%
00555069402
0
$0.00
0.00%
326
$2,990.66
4.06%
00555069502
0
$0.00
0.00%
866
$11,437.87
10.78%
00555069610
0
$0.00
0.00%
19
$405.95
0.24%
00555081402
570
$35,320.93
6.64%
56
$691.69
0.70%
00555081502
1,549
$132,141.69
18.05%
75
$1,179.15
0.93%
00555081610
48
$5,421.35
0.56%
7
$117.25
0.09%
49884063701
0
$0.00
0.00%
127
$1,286.43
1.58%
49884063801
0
$0.00
0.00%
167
$2,365.65
2.08%
49884063805
0
$0.00
0.00%
10
$76.45
0.12%
49884063903
0
$0.00
0.00%
2
$56.90
0.02%
49884068301
OFLOXACIN
TAB 300MG
0
$0.00
0.00%
1
$70.19
0.01%
49884068401
OFLOXACIN
TAB 400MG
7
$499.19
0.08%
10
$701.25
0.12%
52555077001
0
$0.00
0.00%
3
$34.12
0.04%
55111012601
0
$0.00
0.00%
389
$3,737.02
4.84%
Page 238 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
FLUOROQUINOLONES
55111012701
0
$0.00
0.00%
55111012850
0
$0.00
63304070901
0
$0.00
63304071001
0
63304071150
0
63304071550
OFLOXACIN
TAB 300MG
63304071650
OFLOXACIN
TAB 200MG
63304071701
OFLOXACIN
TAB 400MG
67767013701
1,066
$14,164.60
13.27%
0.00%
62
$1,342.65
0.77%
0.00%
103
$1,265.24
1.28%
$0.00
0.00%
247
$3,932.69
3.08%
$0.00
0.00%
7
$124.50
0.09%
0
$0.00
0.00%
2
$241.95
0.02%
1
$25.82
0.01%
9
$776.68
0.11%
2
$299.20
0.02%
9
$602.25
0.11%
0
$0.00
0.00%
41
$410.86
0.51%
67767013801
0
$0.00
0.00%
11
$168.24
0.14%
67767013911
0
$0.00
0.00%
3
$58.55
0.04%
GI - ANTI - FLATULENTS / GI STIMULANTS
00003087823
GLYCERIN
00031670163
REGLAN
SUP 3GM
1
$4.48
0.02%
0
$0.00
0.00%
TAB 10MG
1
$105.55
0.02%
2
$206.30
0.03%
00043001336
GAS-X
1
$24.10
0.02%
0
$0.00
0.00%
00054348663
LACTULOSE
4
$83.11
0.06%
1
$14.30
0.01%
00054356363
METOCLOPRAM SYP 5MG/5ML
00074341401
METOCLOPRAM INJ 5MG/ML
5
$44.50
0.08%
0
$0.00
0.00%
5
$122.53
0.08%
1
$6.19
0.01%
00093220301
METOCLOPRAM TAB 10MG
140
$1,057.15
2.22%
108
$1,252.95
1.52%
00093220305
123
$1,032.29
1.95%
166
$1,432.40
2.33%
00093220310
11
$95.25
0.17%
7
$63.75
0.10%
00093220401
METOCLOPRAM TAB 5MG
93
$1,476.45
1.47%
63
$1,078.80
0.88%
00093220405
METOCLOPRAM TAB 5MG
282
$4,199.11
4.46%
99
$1,327.84
1.39%
00121057616
33
$229.61
0.52%
27
$191.50
0.38%
00121057716
LACTULOSE
1
$161.03
0.02%
0
$0.00
0.00%
00132007924
GLYCERIN
1
$5.07
0.02%
1
$4.79
0.01%
CHW 80MG
SOL 10GM/15
SOL 10GM/15
SUP 3GM
Page 239 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
GLYCERIN
00132018001
FLEET
00182146001
GENASYME
CHW 80MG
00182219166
GENASYME
00182607240
$
Market Share*
00132008112
# of Scripts
SUP 1.5GM
1
$1.96
0.02%
2
$5.89
0.03%
ENE BABYLAX
1
$4.69
0.02%
1
$8.61
0.01%
1
$4.80
0.02%
0
$0.00
0.00%
DRO 40/0.6ML
18
$85.62
0.28%
0
$0.00
0.00%
LACTULOSE
SOL 10GM/15
5
$239.91
0.08%
1
$11.21
0.01%
00182607558
LACTULOSE
SOL 10GM/15
1
$24.50
0.02%
0
$0.00
0.00%
00182864389
SIMETHICONE CHW 80MG
1
$20.25
0.02%
0
$0.00
0.00%
00228226910
74
$627.26
1.17%
1
$12.35
0.01%
00228226950
148
$1,395.27
2.34%
233
$1,953.74
3.27%
00364234716
LACTULOSE
SYP 10GM/15
54
$765.64
0.85%
0
$0.00
0.00%
00364234764
LACTULOSE
SYP 10GM/15
3
$91.64
0.05%
0
$0.00
0.00%
00364251932
LACTULOSE
SYP 10GM/15
3
$254.85
0.05%
0
$0.00
0.00%
00378333174
LACTULOSE
SYP 10GM/15
3
$37.44
0.05%
0
$0.00
0.00%
00472045416
31
$285.05
0.49%
17
$152.74
0.24%
00472135808
CONSTULOSE SOL 10GM/15
0
$0.00
0.00%
1
$8.36
0.01%
00472135832
CONSTULOSE SOL 10GM/15
1
$27.34
0.02%
7
$197.74
0.10%
00472136016
ENULOSE
470
$10,469.38
7.44%
295
$6,025.12
4.14%
00536453301
8
$51.86
0.13%
20
$163.68
0.28%
00536453408
0
$0.00
0.00%
3
$21.53
0.04%
00591234716
LACTULOSE
SOL 10GM/15
138
$2,271.92
2.18%
330
$6,208.61
4.63%
00591234764
LACTULOSE
SOL 10GM/15
7
$116.08
0.11%
8
$449.37
0.11%
00591251938
LACTULOSE
SOL 10GM/15
2
$13.93
0.03%
10
$151.00
0.14%
00591251965
LACTULOSE
SOL 10GM/15
110
$2,592.65
1.74%
117
$2,768.67
1.64%
00603051235
GLYCERIN
0
$0.00
0.00%
1
$0.73
0.01%
00603137856
LACTULOSE
SOL 10GM/15
6
$51.66
0.09%
0
$0.00
0.00%
00603137858
LACTULOSE
SOL 10GM/15
128
$2,395.02
2.03%
206
$3,248.85
2.89%
00603137859
LACTULOSE
SOL 10GM/15
3
$108.94
0.05%
12
$223.53
0.17%
SOL 10GM/15
SUP 1.5GM
Page 240 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
LACTULOSE
SOL 10GM/15
00603143558
00603461621
METOCLOPRAM TAB 5MG
00677103901
$
Market Share*
00603137865
# of Scripts
0
$0.00
0.00%
2
$28.60
0.03%
13
$94.02
0.21%
63
$431.49
0.88%
2
$24.70
0.03%
0
$0.00
0.00%
5
$40.25
0.08%
0
$0.00
0.00%
00677103905
26
$221.51
0.41%
0
$0.00
0.00%
00677132301
METOCLOPRAM TAB 5MG
28
$371.80
0.44%
31
$490.85
0.44%
00703450204
0
$0.00
0.00%
3
$44.32
0.04%
00713010102
GLYCERIN
SUP 3GM
2
$16.36
0.03%
1
$8.34
0.01%
00713010151
GLYCERIN
SUP 3GM
1
$36.17
0.02%
0
$0.00
0.00%
00781503001
METOCLOPRAM TAB 5MG
33
$467.71
0.52%
0
$0.00
0.00%
00781503005
METOCLOPRAM TAB 5MG
4
$80.90
0.06%
170
$2,894.40
2.39%
00781601324
SIMETHICONE DRO 40/0.6ML
0
$0.00
0.00%
4
$13.72
0.06%
00781630116
1
$8.29
0.02%
0
$0.00
0.00%
00781640516
LACTULOSE
SYP 10GM/15
15
$312.00
0.24%
7
$135.27
0.10%
00904106940
METOCLOPRAM TAB 5MG
59
$1,063.05
0.93%
6
$100.10
0.08%
00904106960
METOCLOPRAM TAB 5MG
3
$47.55
0.05%
0
$0.00
0.00%
00904107040
0
$0.00
0.00%
11
$89.45
0.15%
00904107060
0
$0.00
0.00%
1
$5.35
0.01%
00904107080
41
$427.39
0.65%
7
$46.45
0.10%
00904107316
1
$5.21
0.02%
0
$0.00
0.00%
00904211516
CALULOSE
SYP 10GM/15
2
$56.61
0.03%
1
$42.90
0.01%
00904211769
CALULOSE
SYP 10GM/15
2
$100.26
0.03%
0
$0.00
0.00%
00904266617
GLYCERIN
SUP 1.5GM
0
$0.00
0.00%
1
$5.44
0.01%
10019045002
2
$44.78
0.03%
4
$108.00
0.06%
17236044301
1
$3.75
0.02%
1
$1.80
0.01%
37205011910
SIMETHICONE DRO 40/0.6ML
3
$29.53
0.05%
3
$33.42
0.04%
37205032063
GLYCERIN
4
$23.28
0.06%
1
$5.25
0.01%
SUP 3GM
Page 241 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
50111043001
167
$1,449.67
2.64%
139
$1,012.24
1.95%
50111043002
879
$7,126.31
13.91%
743
$6,174.50
10.44%
50111043003
601
$4,928.20
9.51%
807
$6,624.97
11.33%
50111051701
METOCLOPRAM TAB 5MG
221
$3,381.06
3.50%
387
$6,174.87
5.44%
50111051702
METOCLOPRAM TAB 5MG
192
$2,892.31
3.04%
294
$4,445.31
4.13%
50383077908
LACTULOSE
SOL 10GM/15
34
$795.84
0.54%
29
$664.20
0.41%
50383077932
LACTULOSE
SOL 10GM/15
22
$751.13
0.35%
56
$1,621.71
0.79%
50383079516
LACTULOSE
SOL 10GM/15
172
$4,186.48
2.72%
226
$4,858.05
3.17%
51285058502
METOCLOPRAM TAB 5MG
4
$85.40
0.06%
0
$0.00
0.00%
51285058504
METOCLOPRAM TAB 5MG
1
$14.35
0.02%
0
$0.00
0.00%
52268080002
MIRALAX
POW 3350 NF
412
$9,924.16
6.52%
147
$3,680.84
2.06%
52268080003
MIRALAX
POW 3350 NF
585
$23,998.70
9.26%
284
$11,823.68
3.99%
52268080005
MIRALAX
POW 3350 NF
11
$376.84
0.17%
2
$81.44
0.03%
52735050506
GLYCERIN
SUP 3GM
53014067870
GASTROCROM CON 100/5ML
53489038401
1
$2.19
0.02%
0
$0.00
0.00%
26
$4,655.27
0.41%
17
$4,685.44
0.24%
METOCLOPRAM TAB 5MG
146
$2,220.38
2.31%
72
$1,229.70
1.01%
53489038405
METOCLOPRAM TAB 5MG
21
$398.35
0.33%
38
$646.95
0.53%
59911581501
1
$7.60
0.02%
0
$0.00
0.00%
59911581502
1
$9.85
0.02%
0
$0.00
0.00%
60432003708
LACTULOSE
SOL 10GM/15
2
$13.06
0.03%
15
$510.86
0.21%
60432003732
LACTULOSE
SOL 10GM/15
14
$469.45
0.22%
13
$430.79
0.18%
60432003816
GENERLAC
SOL 10GM/15
68
$1,525.06
1.08%
79
$1,526.45
1.11%
60432062216
429
$3,275.17
6.79%
294
$2,444.64
4.13%
60505036000
LACTULOSE
SOL 10GM/15
0
$0.00
0.00%
2
$17.22
0.03%
60505036001
LACTULOSE
SOL 10GM/15
84
$1,532.80
1.33%
164
$2,738.37
2.30%
60505036002
LACTULOSE
SOL 10GM/15
25
$584.89
0.40%
26
$805.30
0.37%
61703021007
0
$0.00
0.00%
1
$37.97
0.01%
Page 242 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
62175044214
GLYCOLAX
POW 3350 NF
0
$0.00
0.00%
3
$63.42
0.04%
62175044215
GLYCOLAX
POW 3350 NF
0
$0.00
0.00%
631
$13,003.36
8.86%
62175044231
GLYCOLAX
POW 3350 NF
0
$0.00
0.00%
557
$19,359.68
7.82%
62794050117
KRISTALOSE PAK 10GM
7
$210.75
0.11%
1
$29.11
0.01%
62794050193
KRISTALOSE PAK 10GM
11
$434.90
0.17%
13
$383.03
0.18%
62794050217
KRISTALOSE PAK 20GM
0
$0.00
0.00%
1
$40.63
0.01%
62794050293
KRISTALOSE PAK 20GM
15
$962.10
0.24%
22
$1,678.39
0.31%
GI - ANTIDIARRHEAL / ANTACID - MISC.
00002202902
SODIUM BICAR TAB 650MG
6
$81.52
0.23%
4
$34.65
0.16%
00009378501
KAOPECTATE LIQ REGULAR
2
$13.98
0.08%
0
$0.00
0.00%
00009521301
KAOPECTATE SUS 262/15
1
$3.59
0.04%
1
$7.22
0.04%
00009521402
KAOPECTATE SUS 262/15
1
$4.72
0.04%
0
$0.00
0.00%
00045029412
IMODIUM ADV CHW 2-125MG
00054472125
PROPANTHELIN TAB 15MG
00067033044
MAALOX
00067033071
MAALOX
00067033171
MAALOX
00068012361
BENTYL
TAB 20MG
00068012516
BENTYL
00089010510
ALU-CAP
00091311101
00091353101
00091353201
LEVSIN/SL
00091353801
LEVBID
00091453815
LEVSIN
00121073312
ALUM HYDROX SUS 320/5ML
1
$13.56
0.04%
0
$0.00
0.00%
11
$491.64
0.43%
5
$266.38
0.21%
SUS
1
$6.46
0.04%
0
$0.00
0.00%
SUS
14
$136.64
0.55%
22
$235.81
0.90%
SUS
1
$4.61
0.04%
3
$10.88
0.12%
1
$39.96
0.04%
4
$149.86
0.16%
SYP 10MG/5ML
5
$132.95
0.20%
8
$151.30
0.33%
CAP 400MG
4
$133.06
0.16%
4
$110.85
0.16%
NULEV
TAB 0.125MG
13
$597.89
0.51%
1
$13.80
0.04%
LEVSIN
TAB 0.125MG
2
$229.70
0.08%
3
$377.91
0.12%
4
$388.05
0.16%
3
$364.38
0.12%
TAB 0.375 ER
4
$74.00
0.16%
1
$37.50
0.04%
DRO 0.125/ML
1
$34.31
0.04%
0
$0.00
0.00%
2
$46.74
0.08%
3
$89.55
0.12%
SUB 0.125MG
Page 243 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00143122701
DICYCLOMINE TAB 20MG
0
$0.00
0.00%
2
$17.04
0.08%
00143122710
5
$73.74
0.20%
13
$128.20
0.53%
00143312601
DICYCLOMINE CAP 10MG
1
$9.40
0.04%
2
$10.50
0.08%
00143312610
34
$312.55
1.33%
22
$223.69
0.90%
00165002210
MAG-OX 400 TAB 400MG
3
$8.00
0.12%
0
$0.00
0.00%
00165002212
45
$302.90
1.76%
54
$392.70
2.21%
00165002241
0
$0.00
0.00%
1
$11.14
0.04%
00165005441
URO-MAG
CAP 140MG
3
$65.73
0.12%
2
$19.13
0.08%
00182080939
ALAMAG
SUS
0
$0.00
0.00%
1
$3.24
0.04%
00182109117
PINK BISMUTH CHW 262MG
0
$0.00
0.00%
1
$12.51
0.04%
00182113694
X-S ANTACID CHW 750MG
26
$149.50
1.02%
4
$23.00
0.16%
00182113920
ANTACID
6
$33.86
0.23%
0
$0.00
0.00%
00182181144
PINK BISMUTH SUS 527/30ML
13
$64.92
0.51%
24
$130.36
0.98%
00182199301
HYOSCYAMINE CAP 0.375 TR
2
$49.34
0.08%
0
$0.00
0.00%
00378161001
211
$1,629.32
8.26%
199
$1,859.01
8.16%
00378161005
15
$136.56
0.59%
11
$104.91
0.45%
00378162001
345
$2,879.07
13.50%
283
$2,368.50
11.60%
00378162005
21
$292.59
0.82%
25
$378.09
1.03%
00482006101
PAMINE
4
$209.20
0.16%
3
$252.53
0.12%
00517101025
ATROPINE SUL INJ 1MG/ML
3
$21.49
0.12%
2
$27.90
0.08%
00517460125
GLYCOPYRROL INJ 0.2MG/ML
1
$3.83
0.04%
0
$0.00
0.00%
00527058601
64
$515.39
2.50%
18
$98.76
0.74%
00527058610
4
$24.19
0.16%
7
$67.57
0.29%
00527128201
66
$749.30
2.58%
76
$803.19
3.12%
00527128210
1
$6.89
0.04%
10
$101.38
0.41%
00536009185
ALUM HYDROX SUS 320/5ML
1
$11.03
0.04%
0
$0.00
0.00%
00536341410
CALCIUM CARB TAB 650MG
20
$60.52
0.78%
18
$57.83
0.74%
CHW 500MG
TAB 2.5MG
Page 244 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00536454410
00536474297
CAL-GEST
00536688908
$
Market Share*
00536454010
# of Scripts
3
$7.95
0.12%
0
$0.00
0.00%
3
$6.48
0.12%
2
$9.54
0.08%
99
$605.76
3.87%
53
$357.88
2.17%
CALCIUM CARB CHW 500MG
50
$231.89
1.96%
41
$194.28
1.68%
00574704512
BELLADONNA & SUP OPIUM
3
$93.24
0.12%
0
$0.00
0.00%
00591079401
147
$1,330.36
5.75%
186
$1,704.47
7.63%
00591079410
31
$219.29
1.21%
16
$124.75
0.66%
00591079501
144
$1,412.92
5.63%
99
$962.50
4.06%
00591079510
10
$95.20
0.39%
13
$135.51
0.53%
00603009526
CALC ANTACID CHW 500MG
0
$0.00
0.00%
5
$23.40
0.21%
00603020922
MAG OXIDE
1
$4.91
0.04%
1
$5.56
0.04%
00603131473
HYOSCYAMINE DRO 0.125/ML
1
$14.98
0.04%
0
$0.00
0.00%
00603400421
HYOSCYAMINE CAP 0.375 CR
2
$58.36
0.08%
0
$0.00
0.00%
00677013110
15
$42.64
0.59%
8
$19.72
0.33%
00677051032
ALAMAG
SUS
0
$0.00
0.00%
1
$6.05
0.04%
00677166201
4
$125.48
0.16%
1
$31.37
0.04%
00677168510
HAPONAL
2
$14.55
0.08%
1
$8.99
0.04%
00677171701
HYOSCYAMINE TAB 0.375 TR
1
$58.38
0.04%
0
$0.00
0.00%
00766073923
TUMS E-X
CHW 750MG
6
$28.32
0.23%
2
$20.01
0.08%
00766073966
TUMS E-X
CHW 750MG
18
$102.48
0.70%
14
$99.86
0.57%
00766074052
TUMS
CHW 500MG
33
$159.64
1.29%
36
$188.17
1.48%
00766074120
TUMS
CHW 500MG
0
$0.00
0.00%
1
$2.76
0.04%
00766074151
TUMS
CHW 500MG
17
$92.02
0.67%
22
$118.14
0.90%
00766074152
TUMS
CHW 500MG
11
$70.73
0.43%
23
$146.67
0.94%
00766074565
TUMS ULTRA CHW 1000MG
10
$62.84
0.39%
7
$41.31
0.29%
00766074575
8
$55.33
0.31%
7
$50.51
0.29%
00766074585
2
$24.81
0.08%
3
$22.95
0.12%
CHW 500MG
TAB 400MG
TAB
Page 245 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00766074610
TUMS ULTRA CHW ASST FRT
1
$6.79
0.04%
1
$9.58
0.04%
00766074625
TUMS ULTRA CHW TRP FRUT
2
$17.16
0.08%
3
$21.24
0.12%
00766074655
TUMS ULTRA CHW ASST BRY
6
$58.80
0.23%
0
$0.00
0.00%
00766074730
TUMS CAL/LIF CHW 750MG
30
$237.69
1.17%
30
$229.09
1.23%
00766738896
TUMS E-X
8
$77.79
0.31%
6
$51.79
0.25%
00766738996
TUMS E-X S/F CHW 750MG
1
$4.55
0.04%
5
$23.55
0.21%
00766739196
TUMS E-X
CHW 750MG
2
$13.66
0.08%
5
$34.15
0.21%
00766739466
TUMS E-X
CHW 750MG
10
$54.15
0.39%
3
$18.91
0.12%
00904019560
1
$7.12
0.04%
0
$0.00
0.00%
00904125792
1
$2.96
0.04%
0
$0.00
0.00%
00904125892
19
$82.09
0.74%
22
$119.52
0.90%
00904131546
BISMATROL
1
$15.52
0.04%
10
$123.19
0.41%
00904249660
1
$13.48
0.04%
0
$0.00
0.00%
00904789660
3
$60.15
0.12%
0
$0.00
0.00%
00904789680
1
$9.05
0.04%
1
$9.05
0.04%
01490003908
PEPTO-BISMOL SUS 262/15ML
1
$5.25
0.04%
0
$0.00
0.00%
10019001617
0
$0.00
0.00%
4
$190.11
0.16%
10019001663
0
$0.00
0.00%
3
$28.31
0.12%
16837081024
MYLANTA
0
$0.00
0.00%
1
$6.36
0.04%
16837086012
ALTERNAGEL SUS 600/5ML
0
$0.00
0.00%
1
$12.37
0.04%
24385047847
ANTACID
CHW 500MG
2
$9.18
0.08%
1
$4.59
0.04%
37205020047
ANTACID
CHW 500MG
15
$78.97
0.59%
16
$96.23
0.66%
37205020580
ANTACID X-ST CHW 750MG
37205021047
ANTACID
37205030234
CHW 750MG
CHW 262MG
CHW 400MG
9
$41.25
0.35%
5
$27.25
0.21%
23
$113.70
0.90%
27
$137.79
1.11%
7
$77.19
0.27%
5
$35.37
0.21%
37205030240
1
$5.25
0.04%
1
$5.25
0.04%
37205033734
2
$8.58
0.08%
0
$0.00
0.00%
CHW 500MG
Page 246 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ANTACID XTRA CHW 750MG
37205072065
49348017021
49348036234
$
Market Share*
37205070680
# of Scripts
3
$9.75
0.12%
6
$34.50
0.25%
PINK BISMUTH CHW 262MG
2
$17.11
0.08%
9
$72.84
0.37%
SM ANTACID CHW 500MG
11
$69.84
0.43%
3
$17.09
0.12%
SM ANTACID CHW 750MG XS
7
$25.25
0.27%
1
$5.75
0.04%
49614046965
MEDI-BISMUTH CHW 262MG
1
$0.48
0.04%
0
$0.00
0.00%
50428642686
CVS BISMUTH CHW 262MG
1
$3.99
0.04%
1
$4.69
0.04%
50580029406
0
$0.00
0.00%
1
$41.65
0.04%
50580029418
0
$0.00
0.00%
1
$9.12
0.04%
51285093702
HYOSCYAMINE TAB 0.375 SR
3
$45.06
0.12%
0
$0.00
0.00%
51991008136
MAG OXIDE
0
$0.00
0.00%
48
$328.62
1.97%
52152014302
10
$226.53
0.39%
19
$352.95
0.78%
52152015502
HYOSCYAMINE SUB 0.125MG
15
$331.39
0.59%
15
$252.59
0.62%
52152015602
HYOSCYAMINE TAB 0.375 SR
1
$8.22
0.04%
17
$379.54
0.70%
52152016302
HYOSCYAMINE CAP 0.375 SR
8
$292.25
0.31%
45
$929.83
1.85%
52544079401
6
$46.90
0.23%
2
$22.60
0.08%
52544079410
4
$28.61
0.16%
0
$0.00
0.00%
52544079501
4
$40.82
0.16%
0
$0.00
0.00%
52735051915
ANTACID
CHW 500MG
16
$96.12
0.63%
13
$70.68
0.53%
54569381700
BISMUTH
CHW 262MG
1
$11.63
0.04%
0
$0.00
0.00%
54738010230
BISMUTH
CHW 262MG
0
$0.00
0.00%
1
$5.49
0.04%
55370087907
1
$5.57
0.04%
0
$0.00
0.00%
58177001704
HYOSCYAMINE CAP 0.375 ER
60
$1,643.66
2.35%
47
$1,337.47
1.93%
58177023704
HYOSCYAMINE TAB 0.375 ER
23
$710.28
0.90%
36
$1,479.44
1.48%
58177025504
39
$757.08
1.53%
45
$872.12
1.85%
58177027404
60
$1,468.77
2.35%
55
$989.14
2.26%
58177042304
4
$127.80
0.16%
29
$1,462.14
1.19%
59630020010
ROBINUL
111
$5,099.81
4.34%
119
$8,240.63
4.88%
TAB 400MG
TAB 1MG
Page 247 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
59630020510
ROBINUL FORT TAB 2MG
40
$2,459.87
1.56%
38
$3,175.54
1.56%
60258017101
MAG OXIDE
44
$354.44
1.72%
66
$454.83
2.71%
60258080116
HYOSCYAMINE ELX 0.125/5
1
$23.41
0.04%
0
$0.00
0.00%
60258080215
11
$187.45
0.43%
1
$16.39
0.04%
60267074230
SAL-TROPINE TAB 0.4MG
42
$811.99
1.64%
26
$549.31
1.07%
60432010315
5
$80.25
0.20%
0
$0.00
0.00%
61451501607
B & O 16-A SUP SUPPRETT
1
$59.04
0.04%
0
$0.00
0.00%
62175010101
107
$2,201.09
4.19%
101
$2,461.22
4.14%
62175010201
78
$2,097.06
3.05%
108
$2,798.94
4.43%
62175010301
HYOSCYAMINE CAP 0.375 ER
40
$1,228.32
1.56%
0
$0.00
0.00%
62175010416
HYOSCYAMINE ELX 0.125/5
6
$242.07
0.23%
5
$228.38
0.21%
62175010801
HYOSCYAMINE TAB 0.375 ER
44
$1,404.32
1.72%
45
$1,319.67
1.85%
63323023401
ATROPINE SUL INJ 0.4MG/ML
3
$46.07
0.12%
1
$6.41
0.04%
63323024601
ATROPINE SUL INJ 1MG/ML
4
$20.28
0.16%
0
$0.00
0.00%
63323026801
SCOPOLAMINE INJ 0.4MG/ML
3
$15.34
0.12%
0
$0.00
0.00%
68013000501
0
$0.00
0.00%
2
$32.85
0.08%
68585000612
MAG-OXIDE
0
$0.00
0.00%
1
$5.49
0.04%
2
$106.69
0.12%
2
$85.58
0.12%
$0.00
0.00%
1
$32.19
0.06%
TAB 400MG
TAB 400MG
GI - ANTIPERISTALTIC AGENTS
00025006131
LOMOTIL
00045029518
IMODIUM A-D TAB 2MG
0
00054319446
DIPHEN/ATROP LIQ 2.5/5
2
$29.00
0.12%
2
$78.14
0.12%
00054353550
LOPERAMIDE LIQ 1MG/5ML
4
$110.12
0.24%
3
$82.59
0.19%
00054819116
DIPHEN/ATROP LIQ 2.5/5
0
$0.00
0.00%
1
$39.70
0.06%
00093031101
LOPERAMIDE CAP 2MG
273
$2,206.36
16.21%
201
$1,486.71
12.45%
00093031105
LOPERAMIDE CAP 2MG
42
$321.95
2.49%
20
$136.41
1.24%
00172396660
DIPHEN/ATROP TAB 2.5MG
34
$303.82
2.02%
44
$285.11
2.72%
TAB 2.5MG
Page 248 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00182108211
ANTI-DIARRHE TAB 2MG
00185002405
00185002410
00378041501
$
Market Share*
00172396680
# of Scripts
$1,108.54
5.64%
234
$2,587.30
14.49%
9
$53.70
0.53%
29
$215.86
1.80%
30
$433.31
1.78%
9
$99.08
0.56%
11
$102.85
0.65%
1
$3.03
0.06%
122
$1,389.85
7.24%
187
$2,250.72
11.58%
00378041510
109
$1,093.42
6.47%
121
$1,526.81
7.49%
00378210001
LOPERAMIDE CAP 2MG
235
$2,569.72
13.95%
229
$2,379.11
14.18%
00378210005
LOPERAMIDE CAP 2MG
174
$1,482.16
10.33%
256
$2,252.66
15.85%
00406046301
18
$216.26
1.07%
9
$71.09
0.56%
00406046310
37
$509.23
2.20%
11
$87.12
0.68%
00472080216
PAREGORIC
18
$2,009.98
1.07%
13
$417.55
0.80%
00527117010
LOFENE
TAB 2.5MG
9
$63.55
0.53%
1
$7.85
0.06%
00781126201
LONOX
TAB 2.5MG
9
$81.13
0.53%
12
$40.95
0.74%
00781126205
LONOX
TAB 2.5MG
2
$10.95
0.12%
2
$12.72
0.12%
00781126210
LONOX
TAB 2.5MG
110
$883.70
6.53%
12
$41.15
0.74%
00904003620
LOPERAMIDE LIQ 1MG/5ML
9
$74.34
0.53%
0
$0.00
0.00%
00904080216
PAREGORIC
1
$13.03
0.06%
0
$0.00
0.00%
00904772512
1
$10.29
0.06%
2
$16.29
0.12%
10135015801
LOPERAMIDE TAB 2MG
1
$3.19
0.06%
1
$0.69
0.06%
11822351990
0
$0.00
0.00%
1
$7.48
0.06%
37205037053
3
$45.93
0.18%
0
$0.00
0.00%
37205037089
0
$0.00
0.00%
1
$23.64
0.06%
49348027734
ANTI-DIARRHE LIQ 1MG/5ML
0
$0.00
0.00%
6
$55.80
0.37%
49348052902
2
$16.35
0.12%
0
$0.00
0.00%
49884077101
45
$462.99
2.67%
53
$597.84
3.28%
49884077110
176
$1,936.84
10.45%
67
$680.75
4.15%
50580029512
IMODIUM A-D TAB 2MG
1
$9.36
0.06%
0
$0.00
0.00%
TIN 2MG/5ML
TIN 2MG/5ML
95
Page 249 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
50580029514
IMODIUM A-D TAB 2MG
1
$9.21
0.06%
0
50580029524
IMODIUM A-D TAB 2MG
1
$27.78
0.06%
50580029584
IMODIUM A-D TAB 2MG
0
$0.00
0.00%
51079006720
2
$29.70
51079069020
LOPERAMIDE CAP 2MG
1
52735054417
53265023710
53265023711
$0.00
0.00%
0
$0.00
0.00%
3
$40.65
0.19%
0.12%
3
$18.65
0.19%
$4.45
0.06%
1
$1.00
0.06%
1
$6.08
0.06%
0
$0.00
0.00%
1
$2.25
0.06%
11
$129.74
0.68%
21
$305.25
1.25%
15
$146.32
0.93%
60432045716
PAREGORIC
12
$1,270.42
0.71%
14
$2,139.22
0.87%
63304020301
OPIUM
TIN 10%
15
$426.89
0.89%
12
$567.25
0.74%
63304020302
OPIUM
TIN 10%
3
$42.14
0.18%
0
$0.00
0.00%
65162030110
11
$154.05
0.65%
4
$39.39
0.25%
65162030111
16
$224.32
0.95%
12
$167.15
0.74%
65234007410
MOTOFEN
15
$886.35
0.89%
9
$565.36
0.56%
11
$527.31
2.03%
1
$11.29
0.19%
TIN 2MG/5ML
TAB
GI - DIGESTIVE ENZYMES
00032120501
CREON 5
CAP
00032120507
CREON 5
CAP
3
$323.59
0.55%
1
$83.61
0.19%
00032121001
CREON 10
CAP EC
53
$14,631.64
9.76%
40
$8,228.70
7.63%
00032121007
CREON 10
CAP EC
10
$1,089.76
1.84%
17
$5,934.55
3.24%
00032122001
CREON 20
CAP
45
$19,198.22
8.29%
38
$20,374.91
7.25%
00032122007
CREON 20
CAP
16
$9,169.45
2.95%
16
$7,742.88
3.05%
00045008002
LACTAID
TAB 3000UNIT
1
$14.01
0.18%
4
$57.95
0.76%
00045009560
PANCREASE
CAP EC
20
$2,304.89
3.68%
26
$3,420.92
4.96%
00045009569
PANCREASE
CAP EC
21
$4,504.44
3.87%
28
$4,302.49
5.34%
00045018550
LACTAID
0
$0.00
0.00%
2
$28.70
0.38%
00045034160
PANCREASE MT CAP 4
7
$471.55
1.29%
12
$764.42
2.29%
TAB 4500UNIT
Page 250 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00045034260
PANCREASE MT CAP 10
00045034360
00045034660
00045090012
20
$3,643.11
3.68%
PANCREASE MT CAP 16
5
$1,213.25
0.92%
PANCREASE MT CAP 20
14
$7,255.30
2.58%
LACTAID ULTR TAB 9000UNIT
1
$43.65
0.18%
00045090060
12
$204.24
00045090090
1
00045090512
LACTAID ULTR CHW 9000UNIT
1
00045090532
LACTAID ULTR CHW 9000UNIT
00091350501
LACTRASE
$1,510.01
1.91%
2
$838.63
0.38%
10
$7,201.00
1.91%
7
$285.28
1.34%
2.21%
12
$220.27
2.29%
$17.53
0.18%
0
$0.00
0.00%
$23.83
0.18%
1
$24.70
0.19%
8
$163.43
1.47%
13
$409.84
2.48%
15
$697.11
2.76%
11
$526.18
2.10%
00091412201
KU-ZYME
00091417501
KUTRASE
CAP
1
$101.61
0.18%
2
$348.70
0.38%
CAP
1
$64.19
0.18%
0
$0.00
0.00%
00115702301
LIPRAM-PN16 CAP
2
$316.20
0.37%
0
$0.00
0.00%
00115702401
LIPRAM-CR20 CAP
9
$1,513.57
1.66%
7
$1,622.09
1.34%
00115702405
LIPRAM-CR20 CAP
4
$1,148.15
0.74%
3
$279.57
0.57%
00115702901
PANCRELIPASE TAB
9
$656.53
1.66%
1
$11.41
0.19%
00115702902
PANCRELIPASE TAB
7
$479.57
1.29%
2
$292.10
0.38%
00115703501
LIPRAM 4500 CAP
68
$2,531.70
12.52%
47
$3,425.82
8.97%
00115703505
LIPRAM 4500 CAP
21
$407.57
3.87%
11
$714.47
2.10%
00115703601
LIPRAM-CR10 CAP
17
$629.55
3.13%
24
$1,013.36
4.58%
00115703605
LIPRAM-CR10 CAP
4
$270.97
0.74%
2
$163.70
0.38%
00115704001
LIPRAM-PN10 CAP
5
$207.65
0.92%
4
$226.60
0.76%
00115704301
LIPRAM-UL20 CAP
3
$178.05
0.55%
0
$0.00
0.00%
00115704302
LIPRAM-UL20 CAP
3
$1,302.70
0.55%
3
$1,627.55
0.57%
00115705501
LIPRAM-PN20 CAP
2
$336.50
0.37%
1
$23.17
0.19%
00115705701
LIPRAM-CR5 CAP
2
$67.99
0.37%
1
$92.93
0.19%
00115705801
PANCRELIPASE TAB
1
$133.99
0.18%
1
$156.80
0.19%
00536781106
LAC-DOSE
1
$9.30
0.18%
5
$41.55
0.95%
CAP 250MG
TAB 3000UNIT
10
Page 251 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00904347260
PANCRELIPASE TAB
2
00904522452
LACTASE ENZ TAB 3000UNIT
00904541360
PANCRELIPASE CAP 4500UNIT
00904541370
$41.30
0.37%
5
$76.85
0.95%
0
$0.00
0.00%
9
$193.60
1.72%
2
$59.35
0.37%
3
$177.95
0.57%
PANCRELIPASE CAP 4500UNIT
1
$71.05
0.18%
0
$0.00
0.00%
37205011472
DAIRY DIGEST TAB ULTRA
1
$37.25
0.18%
0
$0.00
0.00%
51991065501
PANOKASE
0
$0.00
0.00%
5
$78.03
0.95%
58177002804
PANGES MT 16 CAP
2
$100.30
0.37%
3
$369.12
0.57%
58177002904
PANGES CN 10 CAP
2
$163.70
0.37%
0
$0.00
0.00%
58177003004
PANGES CN 20 CAP
5
$846.99
0.92%
5
$924.10
0.95%
58177003104
PANGESTYM EC CAP
16
$605.57
2.95%
26
$1,607.79
4.96%
58177003106
PANGESTYM EC CAP
12
$576.07
2.21%
19
$970.77
3.63%
58177004804
PANGES UL 12 CAP
2
$138.02
0.37%
0
$0.00
0.00%
58177004904
PANGES UL 18 CAP
1
$217.46
0.18%
0
$0.00
0.00%
58177005004
PANGES UL 20 CAP
1
$293.35
0.18%
1
$16.45
0.19%
58177041604
PLARETASE
TAB 8000
8
$817.70
1.47%
5
$125.25
0.95%
58177041608
PLARETASE
TAB 8000
0
$0.00
0.00%
1
$146.05
0.19%
58914000210
ULTRASE MT12 CAP
10
$2,953.20
1.84%
18
$6,081.82
3.44%
58914000410
ULTRASE MT20 CAP
15
$10,150.81
2.76%
14
$10,313.49
2.67%
58914000450
ULTRASE MT20 CAP
7
$5,310.45
1.29%
11
$7,038.37
2.10%
58914001810
ULTRASE MT18 CAP
11
$5,493.87
2.03%
10
$3,831.19
1.91%
58914004510
ULTRASE
CAP
2
$747.70
0.37%
3
$545.05
0.57%
58914011110
VIOKASE 8
TAB
2
$76.08
0.37%
5
$325.09
0.95%
58914011150
VIOKASE 8
TAB
5
$259.52
0.92%
0
$0.00
0.00%
58914011610
VIOKASE 16 TAB
6
$938.83
1.10%
9
$662.17
1.72%
59767000101
PANCRECARB CAP MS-8
4
$621.66
0.74%
4
$1,759.85
0.76%
59767000102
PANCRECARB CAP MS-8
2
$82.16
0.37%
2
$61.30
0.38%
59767000301
PANCRECARB CAP MS-16
0
$0.00
0.00%
1
$25.00
0.19%
TAB
Page 252 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - H2-ANTAGONISTS
00006096328
PEPCID
TAB 20MG
1
$109.21
0.01%
0
$0.00
0.00%
00006096331
PEPCID
TAB 20MG
9
$546.95
0.06%
6
$395.45
0.04%
00006096358
PEPCID
TAB 20MG
18
$1,723.15
0.11%
5
$526.35
0.04%
00006096431
PEPCID
TAB 40MG
4
$826.84
0.03%
3
$602.25
0.02%
00006096458
PEPCID
TAB 40MG
10
$2,476.20
0.06%
10
$1,919.99
0.07%
00006353892
PEPCID
SUS 40MG/5ML
169
$16,240.52
1.07%
144
$12,120.68
1.05%
00006353904
PEPCID I.V. INJ 20MG/2ML
1
$124.40
0.01%
0
$0.00
0.00%
00093011101
CIMETIDINE TAB 200MG
5
$92.24
0.03%
0
$0.00
0.00%
00093011201
65
$618.47
0.41%
8
$53.30
0.06%
00093011301
6
$42.94
0.04%
0
$0.00
0.00%
00093011305
5
$54.96
0.03%
0
$0.00
0.00%
00093012201
32
$535.09
0.20%
7
$80.62
0.05%
00093050687
CIMETIDINE SOL 300/5ML
7
$100.90
0.04%
0
$0.00
0.00%
00093089601
FAMOTIDINE TAB 20MG
906
$8,645.24
5.75%
850
$7,966.27
6.22%
00093089701
FAMOTIDINE TAB 40MG
164
$1,842.14
1.04%
188
$2,205.26
1.37%
00093819201
0
$0.00
0.00%
17
$166.55
0.12%
00093819205
0
$0.00
0.00%
3
$23.30
0.02%
00093820401
0
$0.00
0.00%
77
$626.07
0.56%
00093820405
0
$0.00
0.00%
2
$25.17
0.01%
00093830501
0
$0.00
0.00%
23
$439.18
0.17%
00093854401
RANITIDINE TAB 150MG
4
$23.90
0.03%
95
$1,885.70
0.69%
00093854405
522
$4,624.15
3.32%
406
$3,530.10
2.97%
00093854406
203
$1,657.37
1.29%
220
$1,882.01
1.61%
00093854410
671
$5,855.49
4.26%
367
$3,033.50
2.68%
00093854701
5
$71.75
0.03%
12
$314.35
0.09%
00093854752
19
$200.30
0.12%
18
$248.80
0.13%
Page 253 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - H2-ANTAGONISTS
00093854756
00108501320
TAGAMET
00108501325
TAGAMET
00108502618
TAGAMET
159
$1,556.81
1.01%
111
$1,109.28
0.81%
TAB 300MG
11
$663.29
0.07%
9
$735.12
0.07%
TAB 300MG
1
$9.75
0.01%
0
$0.00
0.00%
TAB 400MG
7
$941.64
0.04%
7
$787.64
0.05%
00172435749
0
$0.00
0.00%
50
$434.70
0.37%
00172435770
0
$0.00
0.00%
120
$1,097.29
0.88%
00172435846
0
$0.00
0.00%
155
$1,457.35
1.13%
00172435860
0
$0.00
0.00%
17
$156.45
0.12%
00172562360
NIZATIDINE CAP 150MG
1
$109.84
0.01%
0
$0.00
0.00%
00172572810
FAMOTIDINE TAB 20MG
2
$9.90
0.01%
0
$0.00
0.00%
00172572860
FAMOTIDINE TAB 20MG
187
$1,830.14
1.19%
207
$1,978.63
1.51%
00172572870
FAMOTIDINE TAB 20MG
190
$1,846.16
1.21%
88
$703.79
0.64%
00172572880
FAMOTIDINE TAB 20MG
82
$750.13
0.52%
2
$11.39
0.01%
00172572960
FAMOTIDINE TAB 40MG
49
$531.92
0.31%
35
$378.55
0.26%
00172572970
FAMOTIDINE TAB 40MG
6
$56.90
0.04%
0
$0.00
0.00%
00172711760
18
$137.05
0.11%
10
$112.36
0.07%
00172711770
5
$46.15
0.03%
1
$11.23
0.01%
00172717149
5
$41.75
0.03%
0
$0.00
0.00%
00172717160
10
$122.67
0.06%
9
$149.78
0.07%
00172717170
41
$476.33
0.26%
20
$227.74
0.15%
00172771160
2
$35.00
0.01%
2
$35.00
0.01%
00173034414
ZANTAC
TAB 150MG
3
$286.85
0.02%
0
$0.00
0.00%
00173034442
ZANTAC
TAB 150MG
00173038354
ZANTAC
SYP 75MG/5ML
00173039340
ZANTAC
00173042702
ZANTAC
00182266115
RANITIDINE TAB 75MG
29
$3,402.81
0.18%
18
$1,989.13
0.13%
731
$45,715.38
4.64%
806
$50,583.17
5.89%
TAB 300MG
7
$1,042.79
0.04%
5
$1,107.07
0.04%
TAB 150MG EF
0
$0.00
0.00%
1
$17.78
0.01%
6
$72.36
0.04%
24
$353.35
0.18%
Page 254 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - H2-ANTAGONISTS
00182266117
RANITIDINE TAB 75MG
1
$12.73
0.01%
5
$52.40
0.04%
00182266126
RANITIDINE TAB 75MG
4
$35.76
0.03%
15
$143.04
0.11%
00182266217
FAMOTIDINE TAB 10MG
1
$2.98
0.01%
0
$0.00
0.00%
00185015060
1
$58.27
0.01%
0
$0.00
0.00%
00228264196
FAMOTIDINE TAB 40MG
0
$0.00
0.00%
5
$71.35
0.04%
00378005301
10
$86.81
0.06%
15
$153.00
0.11%
00378031701
11
$118.91
0.07%
12
$75.76
0.09%
00378031705
15
$127.68
0.10%
12
$160.80
0.09%
00378037201
19
$186.73
0.12%
29
$209.99
0.21%
00378037205
37
$432.49
0.24%
4
$41.91
0.03%
00378054101
16
$221.23
0.10%
14
$178.80
0.10%
00378302001
FAMOTIDINE TAB 20MG
438
$4,437.73
2.78%
346
$3,398.96
2.53%
00378302005
FAMOTIDINE TAB 20MG
99
$1,010.08
0.63%
54
$469.35
0.39%
00378304001
FAMOTIDINE TAB 40MG
11
$103.79
0.07%
14
$152.00
0.10%
00378325205
1
$10.55
0.01%
0
$0.00
0.00%
00378325291
2
$30.50
0.01%
0
$0.00
0.00%
00378325493
3
$38.55
0.02%
0
$0.00
0.00%
00378515091
22
$1,988.29
0.14%
5
$58.70
0.04%
00472051408
19
$576.46
0.12%
5
$100.35
0.04%
00472051416
9
$233.42
0.06%
2
$63.99
0.01%
00501520004
ZANTAC 75
TAB
0
$0.00
0.00%
1
$15.72
0.01%
00501520030
ZANTAC 75
TAB
2
$17.48
0.01%
1
$17.98
0.01%
00501520060
ZANTAC 75
TAB
0
$0.00
0.00%
2
$18.90
0.01%
00536592608
RANITIDINE TAB 75MG
0
$0.00
0.00%
2
$23.18
0.01%
00591076005
47
$384.02
0.30%
136
$1,242.42
0.99%
00591076130
0
$0.00
0.00%
1
$12.85
0.01%
00591312401
FAMOTIDINE TAB 40MG
3
$20.75
0.02%
0
$0.00
0.00%
Page 255 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - H2-ANTAGONISTS
00591313760
9
$714.87
0.06%
3
$83.55
0.02%
00781173601
FAMOTIDINE TAB 20MG
20
$223.30
0.13%
13
$128.19
0.10%
00781174601
FAMOTIDINE TAB 40MG
12
$124.26
0.08%
0
$0.00
0.00%
00781188305
167
$1,487.75
1.06%
25
$239.55
0.18%
00781188310
216
$1,419.60
1.37%
2
$8.29
0.01%
00781188313
3
$24.15
0.02%
3
$24.15
0.02%
00781188360
12
$123.00
0.08%
1,061
$8,986.99
7.76%
00781188425
3
$29.55
0.02%
1
$12.85
0.01%
00781188431
9
$105.15
0.06%
90
$875.79
0.66%
00781285505
RANITIDINE CAP 150MG
1,063
$9,149.75
6.75%
1,038
$8,947.52
7.59%
00781285560
570
$4,742.61
3.62%
529
$4,558.77
3.87%
00781286505
8
$74.80
0.05%
2
$28.35
0.01%
00781286531
174
$1,656.60
1.11%
171
$1,608.28
1.25%
00904526140
381
$3,237.93
2.42%
57
$542.81
0.42%
00904526152
3
$24.15
0.02%
0
$0.00
0.00%
00904526247
1
$21.35
0.01%
0
$0.00
0.00%
00904526270
11
$94.85
0.07%
8
$79.30
0.06%
00904539946
RANITIDINE TAB 75MG
0
$0.00
0.00%
1
$9.61
0.01%
00904539952
RANITIDINE TAB 75MG
2
$30.18
0.01%
1
$9.22
0.01%
00904544540
1
$13.98
0.01%
0
$0.00
0.00%
00904544560
0
$0.00
0.00%
1
$4.01
0.01%
00904544640
0
$0.00
0.00%
8
$97.91
0.06%
00904544760
2
$46.10
0.01%
0
$0.00
0.00%
00904555346
FAMOTIDINE TAB 20MG
5
$28.57
0.03%
6
$72.10
0.04%
00904555360
FAMOTIDINE TAB 20MG
3
$29.05
0.02%
0
$0.00
0.00%
11822030280
ACID REDUCER TAB 75MG
0
$0.00
0.00%
2
$20.96
0.01%
16837087230
PEPCID AC
2
$39.26
0.01%
0
$0.00
0.00%
TAB 10MG
Page 256 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
PEPCID AC
17236044760
37205052965
$
Market Share*
GI - H2-ANTAGONISTS
16837087330
# of Scripts
CHW 10MG
0
$0.00
0.00%
1
$18.63
0.01%
2
$25.14
0.01%
0
$0.00
0.00%
RANITIDINE TAB 75MG
4
$34.29
0.03%
0
$0.00
0.00%
37205052972
RANITIDINE TAB 75MG
2
$21.32
0.01%
1
$8.16
0.01%
37205053165
RANITIDINE TAB 75MG
0
$0.00
0.00%
3
$22.59
0.02%
37205053172
RANITIDINE TAB 75MG
0
$0.00
0.00%
2
$21.32
0.01%
49348034312
1
$11.52
0.01%
2
$21.82
0.01%
49614022065
0
$0.00
0.00%
1
$12.32
0.01%
49884054401
78
$713.10
0.50%
26
$231.66
0.19%
49884054402
100
$795.25
0.64%
108
$886.78
0.79%
49884054405
83
$687.37
0.53%
43
$368.78
0.31%
49884054410
314
$2,323.57
1.99%
441
$3,466.16
3.23%
49884054501
49
$462.15
0.31%
97
$875.81
0.71%
49884054504
0
$0.00
0.00%
5
$36.75
0.04%
49884054511
36
$314.73
0.23%
66
$524.94
0.48%
49884060801
FAMOTIDINE TAB 20MG
295
$2,851.98
1.87%
255
$2,315.56
1.86%
49884060810
FAMOTIDINE TAB 20MG
251
$2,165.13
1.59%
292
$2,423.72
2.14%
49884060811
FAMOTIDINE TAB 20MG
12
$111.40
0.08%
9
$142.75
0.07%
49884060901
FAMOTIDINE TAB 40MG
151
$1,669.56
0.96%
120
$1,377.71
0.88%
49884060910
FAMOTIDINE TAB 40MG
19
$221.05
0.12%
20
$211.70
0.15%
49884060911
FAMOTIDINE TAB 40MG
2
$12.15
0.01%
3
$25.95
0.02%
49884064705
6
$49.70
0.04%
1
$8.05
0.01%
49884064801
4
$53.90
0.03%
3
$38.55
0.02%
49884076601
4
$578.32
0.03%
0
$0.00
0.00%
49884076701
1
$135.85
0.01%
3
$828.39
0.02%
50111055103
0
$0.00
0.00%
1
$7.28
0.01%
50111055201
0
$0.00
0.00%
1
$9.18
0.01%
Page 257 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - H2-ANTAGONISTS
50383005008
1
50428536722
50428695189
RANITIDINE TAB 75MG
50428697847
$51.19
0.01%
0
$0.00
0.00%
1
$5.80
0.01%
0
$0.00
0.00%
1
$13.63
0.01%
1
$6.99
0.01%
RANITIDINE TAB 75MG
1
$15.85
0.01%
1
$10.81
0.01%
50962020360
RANITIDINE SYP 75MG/5ML
5
$149.11
0.03%
0
$0.00
0.00%
51079087920
2
$12.22
0.01%
15
$136.47
0.11%
55370013507
3
$49.83
0.02%
2
$25.34
0.01%
55370013508
5
$47.59
0.03%
0
$0.00
0.00%
55370013607
4
$46.25
0.03%
3
$32.13
0.02%
55390002810
FAMOTIDINE INJ 10MG/ML
0
$0.00
0.00%
5
$50.29
0.04%
55390002910
FAMOTIDINE INJ 10MG/ML
1
$42.24
0.01%
2
$81.98
0.01%
58437000218
158
$1,527.28
1.00%
76
$673.49
0.56%
60432000708
17
$307.24
0.11%
22
$568.35
0.16%
60505001904
2
$27.96
0.01%
5
$51.65
0.04%
60505001906
7
$84.74
0.04%
9
$129.53
0.07%
60505002004
42
$512.07
0.27%
26
$222.06
0.19%
60505002006
15
$162.46
0.10%
26
$229.07
0.19%
60505002008
40
$461.08
0.25%
28
$266.60
0.20%
60505002103
15
$144.69
0.10%
3
$27.54
0.02%
60505002504
117
$1,023.15
0.74%
112
$980.30
0.82%
60505002506
13
$132.45
0.08%
18
$160.90
0.13%
60505002508
2,787
$24,023.17
17.70%
2,389
$20,679.68
17.47%
60505002602
236
$2,556.15
1.50%
53
$531.55
0.39%
60505002603
96
$987.16
0.61%
69
$620.25
0.50%
60505002607
173
$1,753.90
1.10%
165
$1,674.60
1.21%
60505016000
RANITIDINE TAB 75MG
1
$9.99
0.01%
0
$0.00
0.00%
60505023004
0
$0.00
0.00%
1
$1.00
0.01%
Page 258 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - H2-ANTAGONISTS
60505035302
16
$526.32
0.10%
1
$31.83
0.01%
60951063070
3
$24.84
0.02%
3
$29.84
0.02%
60951063270
1
$12.57
0.01%
2
$15.00
0.01%
60951063330
2
$35.01
0.01%
0
$0.00
0.00%
60951063535
6
$275.09
0.04%
3
$91.02
0.02%
62037095501
FAMOTIDINE TAB 20MG
70
$540.79
0.44%
68
$683.47
0.50%
62037095510
FAMOTIDINE TAB 20MG
90
$831.61
0.57%
79
$807.83
0.58%
62037095601
FAMOTIDINE TAB 40MG
25
$339.15
0.16%
36
$451.30
0.26%
62037095610
FAMOTIDINE TAB 40MG
2
$17.30
0.01%
17
$247.85
0.12%
63304074560
12
$101.48
0.08%
0
$0.00
0.00%
63304077001
3
$21.21
0.02%
0
$0.00
0.00%
63304077005
3
$32.75
0.02%
0
$0.00
0.00%
63304077060
4
$30.96
0.03%
0
$0.00
0.00%
63304077101
1
$6.00
0.01%
0
$0.00
0.00%
63304083801
0
$0.00
0.00%
17
$140.80
0.12%
63304083805
47
$489.39
0.30%
34
$294.64
0.25%
63304083860
2,020
$17,217.20
12.83%
736
$6,152.81
5.38%
63304083901
0
$0.00
0.00%
17
$175.25
0.12%
63304083904
0
$0.00
0.00%
3
$29.05
0.02%
63304083930
282
$2,917.73
1.79%
144
$1,340.86
1.05%
65726014415
AXID
CAP 150MG
9
$1,290.34
0.06%
9
$1,198.77
0.07%
65726014510
AXID
CAP 300MG
1
$313.93
0.01%
0
$0.00
0.00%
66685170200
15
$225.71
0.10%
15
$196.23
0.11%
66685170201
2
$21.40
0.01%
7
$61.11
0.05%
66685170301
100
$1,020.89
0.64%
53
$480.94
0.39%
66685170302
27
$335.50
0.17%
20
$193.45
0.15%
66685170303
3
$30.21
0.02%
0
$0.00
0.00%
Page 259 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - H2-ANTAGONISTS
66685170401
15
66685170402
67253034110
$300.81
0.10%
13
$181.48
0.10%
0
$0.00
0.00%
1
$17.50
0.01%
1
$14.68
0.01%
0
$0.00
0.00%
GI - INFLAMMATORY BOWEL AGENTS
00013010201
AZULFIDINE TAB 500MG EN
40
$2,109.26
3.91%
23
$1,403.75
2.18%
00013010220
AZULFIDINE TAB 500MG EN
0
$0.00
0.00%
1
$42.21
0.09%
00013010501
DIPENTUM
5
$753.10
0.49%
0
$0.00
0.00%
00032192428
ROWASA
ENE 4GM
0
$0.00
0.00%
2
$799.88
0.19%
00032192482
ROWASA
ENE 4GM
26
$6,968.45
2.54%
19
$5,249.47
1.80%
00093688871
MESALAMINE ENE 4GM
0
$0.00
0.00%
7
$910.20
0.66%
00149075202
ASACOL
TAB 400MG DR
549
$94,910.38
53.72%
269
$47,415.16
25.45%
00149075215
ASACOL
TAB 400MG DR
0
$0.00
0.00%
317
$56,686.01
29.99%
00591079601
SULFASALAZIN TAB 500MG
16
$287.75
1.57%
14
$335.63
1.32%
00591079605
41
$1,011.82
4.01%
49
$968.63
4.64%
00591079610
0
$0.00
0.00%
5
$146.83
0.47%
00603580321
SULFAZINE EC TAB 500MG
3
$162.97
0.29%
1
$6.20
0.09%
00603580325
SULFAZINE EC TAB 500MG
1
$58.59
0.10%
0
$0.00
0.00%
00677048301
1
$57.19
0.10%
0
$0.00
0.00%
00677048305
6
$68.94
0.59%
2
$25.48
0.19%
52544079610
3
$58.05
0.29%
0
$0.00
0.00%
53014072671
DIPENTUM
8
$1,256.53
0.78%
6
$1,025.64
0.57%
53489014701
4
$60.94
0.39%
0
$0.00
0.00%
53489014705
28
$549.98
2.74%
7
$115.89
0.66%
54092018980
PENTASA
CAP 250MG CR
2
$50.00
0.20%
0
$0.00
0.00%
54092018981
PENTASA
CAP 250MG CR
127
$18,967.45
12.43%
122
$22,596.73
11.54%
58914050056
CANASA
SUP 500MG
33
$3,562.99
3.23%
40
$5,825.02
3.78%
CAP 250MG
CAP 250MG
Page 260 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
$
Market Share*
GI - INFLAMMATORY BOWEL AGENTS
59762500001
67
59762500002
65649010102
COLAZAL
CAP 750MG
# of Scripts
$1,606.93
6.56%
87
$2,061.98
8.23%
33
$669.88
3.23%
46
$1,189.24
4.35%
29
$4,985.07
2.84%
40
$7,834.00
3.78%
GI - IRRITABLE BOWEL SYNDROME AGENTS
00078035580
ZELNORM
TAB 2MG
17
$1,382.08
9.19%
17
$1,526.03
9.14%
00078035680
ZELNORM
TAB 6MG
164
$19,992.20
88.65%
165
$19,263.48
88.71%
00173069005
LOTRONEX
TAB 1MG
4
$1,196.72
2.16%
4
$1,104.61
2.15%
00005250033
FIBERCON
TAB 625MG
10
$121.97
0.14%
10
$126.26
0.13%
00005250086
FIBERCON
TAB 625MG
10
$131.24
0.14%
2
$17.18
0.03%
00034120020
SENOKOT
TAB 8.6MG
1
$11.01
0.01%
0
$0.00
0.00%
00034120050
SENOKOT
TAB 8.6MG
4
$47.09
0.06%
0
$0.00
0.00%
00034120080
SENOKOT
TAB 8.6MG
16
$304.11
0.23%
8
$86.56
0.10%
00034120081
SENOKOT
TAB 8.6MG
2
$40.26
0.03%
9
$175.84
0.12%
00034120091
SENOKOT
TAB 8.6MG
0
$0.00
0.00%
1
$10.84
0.01%
00034120112
SENOKOT XTRA TAB 17MG
1
$25.04
0.01%
1
$26.98
0.01%
00034120163
SENOKOT XTRA TAB 17MG
0
$0.00
0.00%
2
$25.36
0.03%
00034180020
SENOKOT
SYP 8.8MG/5M
2
$24.92
0.03%
0
$0.00
0.00%
00034180080
SENOKOT
SYP 8.8MG/5M
3
$61.05
0.04%
6
$155.32
0.08%
00034181025
SENOKOT
SYP CHILDREN
3
$36.90
0.04%
0
$0.00
0.00%
00054356761
MILK OF MAGN SUS
0
$0.00
0.00%
1
$11.05
0.01%
00067000330
EX-LAX
TAB 15MG
0
$0.00
0.00%
1
$5.43
0.01%
00067000518
EX-LAX
CHW 15MG
0
$0.00
0.00%
2
$10.66
0.03%
00067001624
EX-LAX
TAB MAX ST
0
$0.00
0.00%
1
$5.43
0.01%
00067004216
BENEFIBER
5
$89.03
0.07%
3
$41.78
0.04%
GI - MISC.
POW
Page 261 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
00067004296
BENEFIBER
POW
00067602560
PERDIEM OVER TAB 15MG
00067610050
DULCOLAX
00068041830
CITRUCEL
00078031905
ACTIGALL
00084009014
BISACODYL
TAB 5MG EC
00088170015
CARAFATE
SUS 1GM/10ML
00088171247
CARAFATE
00088171253
CARAFATE
00091044723
TRILYTE
00091440123
COLYTE
00091440305
COLYTE-FLAV SOL
00091703623
COLYTE/FLAVR SOL PACKS
00093221001
00093221005
$0.00
0.00%
1
$20.56
0.01%
7
$57.95
0.10%
4
$38.44
0.05%
4
$132.20
0.06%
2
$67.12
0.03%
POW ORANGE
7
$184.61
0.10%
5
$62.60
0.06%
CAP 300MG
1
$249.89
0.01%
0
$0.00
0.00%
SUP 10MG
0
0
$0.00
0.00%
1
$0.29
0.01%
107
$4,435.94
1.53%
55
$1,833.71
0.71%
TAB 1GM
6
$516.70
0.09%
0
$0.00
0.00%
TAB 1GM
3
$30.00
0.04%
1
$10.00
0.01%
SOL
0
$0.00
0.00%
9
$210.40
0.12%
SOL
0
$0.00
0.00%
2
$42.02
0.03%
1
$2.99
0.01%
0
$0.00
0.00%
21
$653.50
0.30%
8
$155.55
0.10%
SUCRALFATE TAB 1GM
237
$6,748.69
3.38%
323
$8,217.65
4.20%
SUCRALFATE TAB 1GM
229
$6,492.42
3.27%
169
$4,554.88
2.20%
00093938001
URSODIOL
128
$19,419.70
1.83%
59
$8,713.76
0.77%
00113033240
MILK OF MAGN SUS MINT
1
$5.10
0.01%
0
$0.00
0.00%
00113047775
FIBER LAX TAB 625MG
0
$0.00
0.00%
2
$6.98
0.03%
00121043416
DOCUSATE SOD SYP 60/15ML
1
$7.47
0.01%
0
$0.00
0.00%
00121045816
DOC SOD/CAS SYP 60-30/15
2
$6.30
0.03%
0
$0.00
0.00%
00121054410
DOCUSATE SOD LIQ 50MG/5ML
0
$0.00
0.00%
1
$2.03
0.01%
00121054416
DOCUSATE SOD LIQ 50MG/5ML
58
$873.91
0.83%
35
$382.93
0.45%
00121074316
DOCUSATE SOD SYP 20MG/5ML
12
$72.78
0.17%
11
$63.15
0.14%
00132010803
FL PHOSPHO SOL SODA-REG
2
$566.28
0.03%
0
$0.00
0.00%
00132020140
FLEET
ENE
11
$101.03
0.16%
15
$118.34
0.19%
00132020142
FLEET
ENE
2
$24.78
0.03%
2
$75.58
0.03%
00132070504
FLEET LAXATI SUP 10MG
0
$0.00
0.00%
1
$4.72
0.01%
CAP 300MG
Page 262 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
00182018201
D.O.S.
CAP 250MG
0
$0.00
0.00%
2
00182028701
D.O.S.
CAP 100MG
127
$643.93
1.81%
00182028710
D.O.S.
CAP 100MG
348
$878.02
4.97%
00182083339
MILK OF MAGN SUS
3
$10.57
00182083340
MILK OF MAGN SUS
4
00182109301
SENNA-GEN TAB 8.6MG
00182109310
SENNA-GEN TAB 8.6MG
00182111301
SENNA S
00182111310
SENNA S
00182138026
FIBER-LAX TAB 625MG
00182151376
GENFIBER
POW 50%
00182151476
GENFIBER
POW ORANGE
00182177440
DIOCTO
00182199201
00182199210
$0.18
0.03%
110
$488.25
1.43%
401
$1,713.83
5.21%
0.04%
19
$91.75
0.25%
$23.56
0.06%
1
$5.89
0.01%
204
$1,006.98
2.91%
357
$1,649.45
4.64%
124
$364.07
1.77%
18
$64.00
0.23%
TAB 8.6-50MG
18
$171.23
0.26%
7
$47.47
0.09%
TAB 8.6-50MG
0
$0.00
0.00%
10
$77.82
0.13%
13
$95.93
0.19%
27
$264.83
0.35%
15
$100.58
0.21%
8
$60.80
0.10%
2
$15.20
0.03%
1
$7.60
0.01%
12
$98.10
0.17%
20
$143.73
0.26%
RELIABLE GEN TAB 5MG EC
5
$15.33
0.07%
4
$16.01
0.05%
RELIABLE GEN TAB 5MG EC
6
$12.08
0.09%
1
$4.86
0.01%
00182608439
0
$0.00
0.00%
2
$74.76
0.03%
00182616039
ANTACID
0
$0.00
0.00%
3
$16.86
0.04%
00182821589
SENNAGEN
00245002016
SORBITOL
00245010405
BISACODYL
00245010412
LIQ 150/15ML
SUS
TAB 8.6MG
0
$0.00
0.00%
1
$8.04
0.01%
17
$263.97
0.24%
12
$300.35
0.16%
SUP 10MG
6
$16.02
0.09%
5
$15.47
0.06%
BISACODYL
SUP 10MG
1
$3.95
0.01%
2
$9.26
0.03%
00245010450
BISACODYL
SUP 10MG
6
$26.32
0.09%
51
$175.32
0.66%
00395060010
MAGN CITRATE SOL
3
$35.12
0.04%
3
$10.00
0.04%
00395265510
SENNA
POW
1
$16.33
0.01%
0
$0.00
0.00%
00395421010
MAG CITRATE SOL LEMON
0
$0.00
0.00%
20
$119.17
0.26%
00395421110
MAG CITRATE SOL CHERRY
3
$8.34
0.04%
2
$4.82
0.03%
00472092416
DIOCTO
10
$59.99
0.14%
6
$40.22
0.08%
SOL 70%
SYP 60/15ML
Page 263 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
00472093616
DIOCTO
LIQ 150/15ML
00472510012
BISACODYL
00536059085
DIOCTO
LIQ 150/15ML
00536060085
DIOCTO
$327.78
0.29%
30
$579.84
0.39%
0
$0.00
0.00%
7
$63.22
0.10%
2
$3.64
0.03%
5
$39.89
0.06%
SYP 60/15ML
8
$77.88
0.11%
14
$111.21
0.18%
00536112701
SUCRALFATE TAB 1GM
3
$63.15
0.04%
0
$0.00
0.00%
00536135501
BISACODYL
SUP 10MG
00536135512
BISACODYL
SUP 10MG
6
$28.13
0.09%
3
$14.52
0.04%
4
$17.57
0.06%
6
$31.35
0.08%
00536247083
MILK OF MAGN SUS
4
$13.73
0.06%
0
$0.00
0.00%
00536338101
BISACODYL
0
$0.00
0.00%
5
$17.98
0.06%
00536375110
DOC SOD/CAS CAP 100-30
2
$10.17
0.03%
0
$0.00
0.00%
00536375601
DOCUSATE SOD CAP 100MG
155
$488.48
2.21%
168
$554.89
2.18%
00536375610
50
$172.35
0.71%
119
$283.13
1.55%
00536375701
2
$5.78
0.03%
0
$0.00
0.00%
00536430605
FIBER-LAX TAB 500MG
1
$8.01
0.01%
0
$0.00
0.00%
00536430611
FIBER-LAX TAB 500MG
2
$16.48
0.03%
4
$40.98
0.05%
00536590401
SENEXON
16
$72.83
0.23%
11
$69.07
0.14%
00536741551
ENEMA DISPOS ENE
4
$45.48
0.06%
1
$4.24
0.01%
00574000401
BISACODYL
TAB 5MG EC
15
$56.26
0.21%
14
$58.85
0.18%
00574000411
BISACODYL
TAB 5MG EC
1
$2.01
0.01%
0
$0.00
0.00%
00574001816
MILK OF MAGN SUS
3
$12.90
0.04%
0
$0.00
0.00%
00574010101
0
$0.00
0.00%
4
$2.55
0.05%
00574016816
SORBITOL
11
$143.52
0.16%
8
$80.14
0.10%
00574705012
BISACODYL
SUP 10MG
2
$5.50
0.03%
1
$2.34
0.01%
00574705050
BISACODYL
SUP 10MG
4
$28.42
0.06%
1
$7.22
0.01%
00591078001
SUCRALFATE TAB 1GM
41
$1,263.94
0.59%
49
$1,114.41
0.64%
00591078005
SUCRALFATE TAB 1GM
111
$3,273.69
1.58%
149
$4,111.00
1.94%
00591315901
URSODIOL
11
$2,839.77
0.16%
48
$8,411.72
0.62%
SUP 10MG
TAB 5MG EC
TAB 8.6MG
SOL 70%
CAP 300MG
20
Page 264 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
00603005435
BISACODYL
00603014621
00603014632
00603014721
DOC-Q-LAX
00603018120
FIBERTAB
00603028021
SENNA LAX
00603028032
SENNA LAX
00603028132
TAB 5MG EC
0
$0.00
0.00%
1
$1.82
0.01%
DOC-Q-LACE CAP 100MG
122
$318.36
1.74%
175
$479.09
2.27%
DOC-Q-LACE CAP 100MG
133
$432.24
1.90%
112
$438.35
1.45%
CAP 100-30
0
$0.00
0.00%
1
$0.69
0.01%
TAB 625MG
0
$0.00
0.00%
1
$6.09
0.01%
TAB 8.6MG
126
$510.13
1.80%
105
$468.17
1.36%
TAB 8.6MG
59
$290.38
0.84%
13
$45.38
0.17%
SENNALAX-S TAB 8.6-50MG
0
$0.00
0.00%
1
$10.77
0.01%
00603030621
SUR-Q-LAX
2
$13.16
0.03%
2
$15.66
0.03%
00603074758
DOC-Q-LACE SYP 60/15ML
15
$137.06
0.21%
17
$79.80
0.22%
00603078757
MILK OF MAGN SUS 400/5ML
2
$8.11
0.03%
0
$0.00
0.00%
00603090058
SORBITOL
6
$278.01
0.09%
3
$74.42
0.04%
00603248121
BISACODYL
TAB 5MG EC
31
$65.55
0.44%
26
$76.94
0.34%
00603248132
BISACODYL
TAB 5MG EC
0
$0.00
0.00%
3
$6.03
0.04%
00603808611
BISACODYL
SUP 10MG
1
$2.14
0.01%
0
$0.00
0.00%
00677019101
170
$623.08
2.43%
210
$787.22
2.73%
00677019110
1,003
$3,781.89
14.31%
1,221
$4,650.10
15.86%
00677019201
0
$0.00
0.00%
1
$3.95
0.01%
00677057801
BISACODYL
TAB 5MG EC
49
$127.62
0.70%
36
$101.42
0.47%
00677057810
BISACODYL
TAB 5MG EC
8
$20.73
0.11%
11
$31.20
0.14%
00677062801
DOC SOD/CAS CAP 100-30
3
$10.22
0.04%
0
$0.00
0.00%
00677078001
BISACODYL
SUP 10MG
5
$26.42
0.07%
9
$35.67
0.12%
00677078012
BISACODYL
SUP 10MG
24
$116.84
0.34%
27
$89.10
0.35%
00677081832
MILK OF MAGN SUS
8
$37.54
0.11%
5
$21.25
0.06%
00677092406
UNI-EASE
0
$0.00
0.00%
2
$4.60
0.03%
00677171901
UNI-CENNA
TAB 8.6MG
11
$50.17
0.16%
9
$35.71
0.12%
00677188142
UNI-CENNA
SYP
0
$0.00
0.00%
19
$424.54
0.25%
CAP 240MG
SOL 70%
CAP 100MG
Page 265 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
00677188910
SENNA-DOCUSA TAB 8.6-50MG
00713010901
00713010912
0
$0.00
0.00%
10
$257.66
0.13%
BISAC-EVAC SUP 10MG
23
$96.41
0.33%
17
$91.24
0.22%
BISAC-EVAC SUP 10MG
3
$11.31
0.04%
3
$9.38
0.04%
00713041601
BISAC-EVAC TAB 5MG EC
1
$2.78
0.01%
0
$0.00
0.00%
00766042050
CITRUCEL
POW SF ORANG
0
$0.00
0.00%
4
$124.65
0.05%
00766042520
CITRUCEL
TAB 500MG
8
$153.00
0.11%
11
$139.13
0.14%
00766739260
TUMS PLUS
1
$12.63
0.01%
0
$0.00
0.00%
00781240801
16
$55.84
0.23%
3
$14.30
0.04%
00781240810
6
$7.32
0.09%
0
$0.00
0.00%
00781258501
DOCUSATE CAL CAP 240MG
1
$6.01
0.01%
0
$0.00
0.00%
00869068638
MAGN CITRATE SOL LEMON
0
$0.00
0.00%
4
$13.26
0.05%
00904078814
MILK OF MAGN SUS
5
$6.43
0.07%
7
$27.49
0.09%
00904078816
MILK OF MAGN SUS
0
$0.00
0.00%
4
$22.48
0.05%
00904093616
DIOCTO
LIQ 50MG/5ML
1
$5.52
0.01%
2
$29.92
0.03%
00904312860
SENNA CONC TAB 187MG
0
$0.00
0.00%
2
$11.54
0.03%
00904505812
BISCOLAX
SUP 10MG
3
$8.83
0.04%
2
$9.37
0.03%
00904505860
BISCOLAX
SUP 10MG
3
$11.69
0.04%
0
$0.00
0.00%
00904516559
SENNA
TAB 8.6MG
103
$492.16
1.47%
254
$1,220.99
3.30%
00904516561
SENNA
TAB 8.6MG
0
$0.00
0.00%
3
$15.20
0.04%
00904516580
SENNA
TAB 8.6MG
105
$373.62
1.50%
204
$821.98
2.65%
00904520066
NAT FIBER
0
$0.00
0.00%
4
$37.13
0.05%
00904524909
KAO-TIN
6
$34.86
0.09%
0
$0.00
0.00%
00904543840
SUCRALFATE TAB 1GM
10
$317.07
0.14%
5
$144.25
0.06%
00904543860
SUCRALFATE TAB 1GM
5
$159.06
0.07%
1
$30.85
0.01%
00904545209
SENNA
60
$1,231.10
0.86%
23
$482.13
0.30%
00904551252
SENNA PLUS TAB 8.6-50MG
1
$9.43
0.01%
0
$0.00
0.00%
00904564380
DOK PLUS
0
$0.00
0.00%
4
$85.12
0.05%
CHW
POW THERAPY
LIQ ADV FORM
SYP
TAB NEW FORM
Page 266 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
00904788959
DOK
CAP 100MG
00904788960
DOK
CAP 100MG
00904788980
DOK
CAP 100MG
00904789080
DOK PLUS
00904792717
BISACODYL
00904792760
00904792780
10135011101
$4.58
0.03%
$0.00
0.00%
6
$23.80
0.09%
50
$159.50
0.71%
8
$27.27
0.10%
97
$355.26
1.26%
9
$38.50
0.13%
2
$8.97
0.03%
TAB 5MG EC
3
$6.49
0.04%
1
$0.93
0.01%
BISACODYL
TAB 5MG EC
13
BISACODYL
TAB 5MG EC
12
$35.31
0.19%
16
$64.56
0.21%
$32.97
0.17%
9
$40.68
0.12%
9
$26.31
0.13%
10
$10.93
0.13%
10135011110
244
$803.71
3.48%
83
$265.95
1.08%
10135011130
0
$0.00
0.00%
1
$4.80
0.01%
10135015410
BISACODYL
TAB 5MG EC
0
$0.00
0.00%
7
$13.14
0.09%
10742003201
FLETCHERS
LIQ CASTORIA
2
$12.58
0.03%
4
$17.96
0.05%
11822001780
RA COL-RITE CAP 100MG
0
$0.00
0.00%
67
$184.31
0.87%
11822003960
0
$0.00
0.00%
48
$110.10
0.62%
11822165230
RA SENNA
0
$0.00
0.00%
30
$130.58
0.39%
11822316500
0
$0.00
0.00%
26
$52.57
0.34%
11822323960
50
$88.20
0.71%
13
$31.27
0.17%
11822323990
23
$82.90
0.33%
17
$52.06
0.22%
11822331100
RA SENNA-LAX TAB 217MG
51
$172.99
0.73%
40
$176.16
0.52%
11822331780
34
$84.15
0.49%
10
$24.22
0.13%
11822331790
20
$61.55
0.29%
1
$3.69
0.01%
11822334070
RA BISACODYL TAB 5MG EC
4
$8.22
0.06%
1
$1.82
0.01%
11822359220
RA SENNA
CAP
0
$0.00
0.00%
1
$4.99
0.01%
12333903301
DSS
CAP 100MG
1
$4.80
0.01%
0
$0.00
0.00%
12843035302
PH MILK MAGN SUS
3
$19.46
0.04%
2
$15.56
0.03%
12843036305
PH MILK MAGN SUS MINT
2
$11.10
0.03%
1
$11.24
0.01%
12843039324
PH MILK MAGN SUS CHERRY
4
$20.01
0.06%
5
$30.85
0.06%
CAP 100-30
TAB
2
0
Page 267 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
17236012110
BISACODYL
TAB 5MG EC
1
17236044001
17236044010
17236061401
DIOCTYN
17236061410
DIOCTYN
20254021501
SENNA
24385012478
CA STOOL SOF CAP 240MG
24385040478
$4.30
0.01%
7
$27.93
0.09%
0
$0.00
0.00%
16
$62.56
0.21%
7
$15.35
0.10%
17
$36.59
0.22%
CAP 100MG
0
$0.00
0.00%
1
$3.26
0.01%
CAP 100MG
48
$94.12
0.69%
9
$15.12
0.12%
0
$0.00
0.00%
3
$9.07
0.04%
0
$0.00
0.00%
2
$15.66
0.03%
SENNA-LAX TAB 8.6MG
5
$24.60
0.07%
0
$0.00
0.00%
24385048672
STOOL SOFTEN CAP 100MG
2
$4.60
0.03%
0
$0.00
0.00%
24385048678
10
$30.49
0.14%
6
$18.80
0.08%
24385067016
MILK OF MAGN SUS 400MG/5M
0
$0.00
0.00%
1
$4.45
0.01%
37000001008
METAMUCIL
POW 48.57%
4
$75.34
0.06%
2
$37.65
0.03%
37000002304
METAMUCIL
POW 28% ORNG
0
$0.00
0.00%
2
$34.20
0.03%
37000002306
METAMUCIL
POW 28%
2
$22.38
0.03%
1
$11.01
0.01%
37000002307
METAMUCIL
POW 28%
1
$7.35
0.01%
1
$6.85
0.01%
37000002402
METAMUCIL
POW 58.6% OR
1
$9.16
0.01%
3
$37.01
0.04%
37000002404
METAMUCIL
POW 58.6 ORG
0
$0.00
0.00%
2
$27.81
0.03%
37000002406
METAMUCIL
POW 58.6% OR
2
$16.98
0.03%
0
$0.00
0.00%
37000003001
METAMUCIL
WAF 1.7GM
4
$15.14
0.06%
4
$23.52
0.05%
37000004805
METAMUCIL
POW 58.6%
1
$10.05
0.01%
0
$0.00
0.00%
37000040514
METAMUCIL
CAP 0.52GM
2
$10.47
0.03%
1
$8.17
0.01%
37000074009
METAMUCIL
POW
1
$7.59
0.01%
3
$30.27
0.04%
37000074012
METAMUCIL
POW 30.9%
1
$5.43
0.01%
0
$0.00
0.00%
37000074078
METAMUCIL
POW 28.3%ORG
2
$19.36
0.03%
3
$27.23
0.04%
37000074084
METAMUCIL
POW 58.6% OR
0
$0.00
0.00%
2
$20.44
0.03%
37000074087
METAMUCIL
POW 28% ORNG
1
$29.00
0.01%
1
$28.36
0.01%
37000074134
METAMUCIL
POW 28.3%ORG
0
$0.00
0.00%
1
$14.01
0.01%
TAB 8.6MG
Page 268 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
37205003011
READY-TO-USE ENE COMPLETE
37205010253
BISACODYL
37205011038
MAGN CITRATE SOL
37205012863
BISACODYL
0
$0.00
0.00%
2
$10.25
0.03%
50
$231.04
0.71%
33
$170.70
0.43%
14
$49.46
0.20%
16
$58.79
0.21%
TAB 5MG EC
4
$13.00
0.06%
6
$17.60
0.08%
37205021375
FIBER LAXATI TAB 625MG
14
$114.86
0.20%
18
$247.78
0.23%
37205024178
SENNA
344
$1,643.74
4.91%
266
$1,359.41
3.45%
37205025172
SENNA-PLUS TAB 8.6-50MG
9
$54.62
0.13%
9
$59.34
0.12%
37205026501
73
$236.60
1.04%
91
$309.33
1.18%
37205030127
NATURAL VEG POW 33%
9
$64.90
0.13%
4
$34.93
0.05%
37205030327
NATURAL VEG POW ORANGE
4
$30.48
0.06%
1
$7.59
0.01%
37205034727
NAT VEGETABL POW 33% ORAN
2
$14.72
0.03%
3
$22.08
0.04%
37205034978
STOOL SOFTEN TAB LAXATIVE
0
$0.00
0.00%
8
$45.44
0.10%
37205036238
MAGN CITRATE SOL LEMON
1
$9.65
0.01%
2
$11.55
0.03%
37205036638
NATURAL VEG POW 58.6%
2
$17.68
0.03%
1
$8.84
0.01%
37205048778
STOOL SOFTEN CAP STIM LAX
1
$8.52
0.01%
0
$0.00
0.00%
37205053040
ANTACID/
SUS SIMETH
2
$10.50
0.03%
0
$0.00
0.00%
37205053540
ANTACID
SUS ANTI-GAS
3
$17.82
0.04%
2
$11.88
0.03%
37205083143
MINERAL
OIL
1
$5.80
0.01%
0
$0.00
0.00%
37205083340
26
$144.07
0.37%
17
$104.64
0.22%
37205083440
2
$11.25
0.03%
15
$79.38
0.19%
41163033235
MILK OF MAGN SUS 400MG/5M
0
$0.00
0.00%
1
$4.54
0.01%
41163039635
MILK OF MAGN SUS REGULAR
1
$10.28
0.01%
0
$0.00
0.00%
41163039640
1
$4.92
0.01%
1
$4.92
0.01%
45802071030
BISACODYL
SUP 10MG
20
$82.71
0.29%
13
$56.23
0.17%
45802071032
BISACODYL
SUP 10MG
2
$9.98
0.03%
6
$33.10
0.08%
45802071033
BISACODYL
SUP 10MG
12
$61.70
0.17%
2
$4.93
0.03%
46287050001
SORBITOL
24
$304.80
0.34%
27
$329.60
0.35%
SUP 10MG
TAB 187MG
SOL 70%
Page 269 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
49348059867
SM LAXATIVE SUP 10MG
7
$35.60
0.10%
4
$25.66
0.05%
49348061610
4
$15.08
0.06%
3
$3.27
0.04%
49348069649
MAGN CITRATE SOL
0
$0.00
0.00%
1
$2.89
0.01%
49348080438
SM MINERAL OIL
1
$5.39
0.01%
0
$0.00
0.00%
49614013442
MAG CITRATE SOL LEMON
0
$0.00
0.00%
1
$2.48
0.01%
50383077116
DOCU
3
$20.14
0.04%
6
$32.43
0.08%
50428166363
BISACODYL
TAB 5MG EC
1
$2.78
0.01%
1
$1.39
0.01%
50428166371
BISACODYL
SUP 10MG
0
$0.00
0.00%
5
$18.72
0.06%
50428209452
MAGN CITRATE SOL
0
$0.00
0.00%
1
$1.89
0.01%
50428214916
5
$15.45
0.07%
2
$10.18
0.03%
50428218420
CVS SENNA-C TAB 8.6MG
9
$40.92
0.13%
10
$66.93
0.13%
50428231522
CVS FIBER LA TAB 625MG
0
$0.00
0.00%
1
$6.49
0.01%
50428310425
4
$6.36
0.06%
13
$38.75
0.17%
50428606624
4
$2.56
0.06%
10
$25.49
0.13%
51079001920
0
$0.00
0.00%
3
$12.86
0.04%
51079001940
70
$243.34
1.00%
21
$86.96
0.27%
51079001960
5
$2.70
0.07%
0
$0.00
0.00%
51079052120
60
$338.59
0.86%
29
$200.03
0.38%
52152006002
URSODIOL
CAP 300MG
12
$1,924.17
0.17%
32
$4,302.56
0.42%
52268010001
GOLYTELY
SOL
21
$599.40
0.30%
21
$450.13
0.27%
52268010101
GOLYTELY
SOL PINEAPPL
2
$36.95
0.03%
11
$192.21
0.14%
52268030001
NULYTELY
SOL
6
$127.15
0.09%
2
$47.72
0.03%
52268030101
NULYTELY
SOL CHERRY
7
$156.28
0.10%
3
$66.59
0.04%
52268030201
NULYTELY
SOL LMN/LIME
3
$69.39
0.04%
1
$22.61
0.01%
52268030301
NULYTELY
SOL ORANGE
16
$366.95
0.23%
1
$25.11
0.01%
52268040001
NULYTELY
SOL
0
$0.00
0.00%
2
$25.64
0.03%
52268070001
GOLYTELY
SOL
0
$0.00
0.00%
2
$20.20
0.03%
LIQ 150/15ML
Page 270 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
52297048672
52544078001
SUCRALFATE TAB 1GM
52544078005
SUCRALFATE TAB 1GM
52544093001
ACTIGALL
CAP 300MG
52555005701
$6.90
0.04%
$0.00
0.00%
7
$175.25
0.10%
45
$1,041.80
0.64%
2
$6.66
0.03%
33
$534.96
0.43%
4
$733.88
0.06%
7
$1,531.24
0.09%
SUCRALFATE TAB 1GM
23
$633.13
0.33%
9
$415.75
0.12%
52555005705
SUCRALFATE TAB 1GM
134
52735050129
ANTACID
0
$3,935.92
1.91%
30
$819.83
0.39%
$0.00
0.00%
1
$5.94
0.01%
52735050829
MILK OF MAGN SUS
0
$0.00
0.00%
4
$19.00
0.05%
52735051401
4
$15.80
0.06%
5
$14.38
0.06%
52735052201
SENNA
TAB 187MG
0
$0.00
0.00%
3
$16.62
0.04%
52735052213
FP SENNA
TAB PLUS
0
$0.00
0.00%
1
$13.05
0.01%
53807012501
MILK OF MAGN SUS
1
$4.91
0.01%
0
$0.00
0.00%
54092005310
COLACE
CAP 100MG
1
$11.64
0.01%
0
$0.00
0.00%
54092005330
COLACE
CAP 100MG
4
$109.68
0.06%
0
$0.00
0.00%
54092005360
COLACE
CAP 100MG
3
$41.70
0.04%
0
$0.00
0.00%
54569238502
1
$2.30
0.01%
0
$0.00
0.00%
54629060001
0
$0.00
0.00%
2
$7.00
0.03%
54838011680
SILACE
LIQ 10MG/ML
0
$0.00
0.00%
1
$4.28
0.01%
54868233700
COLACE
CAP 100MG
0
$0.00
0.00%
2
$39.06
0.03%
55966010228
BISACODYL
TAB 5MG EC
3
$3.10
0.04%
1
$3.83
0.01%
57648000201
MAGIC BULLET SUP 10MG
1
$13.76
0.01%
2
$18.48
0.03%
57648000212
MAGIC BULLET SUP 10MG
11
$83.37
0.16%
0
$0.00
0.00%
57896040101
49
$118.99
0.70%
83
$207.56
1.08%
57896040110
392
$1,139.92
5.59%
606
$1,842.66
7.87%
58298013001
BISACODYL
SUP 10MG
1
$1.82
0.01%
0
$0.00
0.00%
58914017014
CARAFATE
SUS 1GM/10ML
0
$0.00
0.00%
20
$775.45
0.26%
58914078510
URSO 250
35
$8,232.48
0.50%
61
$11,546.36
0.79%
SUS SIMETH
TAB 250MG
3
0
Page 271 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - MISC.
59016009016
UNIFIBER
59606028821
59606040514
POW
6
$103.66
0.09%
3
$55.23
0.04%
EQUATE STOOL CAP SOFTENER
14
$20.23
0.20%
17
$21.75
0.22%
NAT VEG LAX TAB 8.6MG
12
$45.13
0.17%
9
$46.64
0.12%
59606040520
NAT VEG LAX TAB 8.6MG
1
$6.04
0.01%
0
$0.00
0.00%
59741030640
BISACODYL
SUP 10MG
1
$7.99
0.01%
0
$0.00
0.00%
59741030650
BISACODYL
SUP 10MG
0
$0.00
0.00%
1
$3.43
0.01%
59930153201
SUCRALFATE TAB 1GM
113
$3,504.99
1.61%
43
$913.70
0.56%
59930153202
SUCRALFATE TAB 1GM
31
$815.89
0.44%
51
$1,390.68
0.66%
60242057501
SENNACON
0
$0.00
0.00%
2
$2.98
0.03%
60258095501
0
$0.00
0.00%
1
$4.80
0.01%
60258095510
0
$0.00
0.00%
33
$93.57
0.43%
61073001101
SENNA
TAB 187MG
9
$48.28
0.13%
23
$149.53
0.30%
61607010040
VISICOL
TAB 1.5GM
0
$0.00
0.00%
1
$36.97
0.01%
62107003301
DOCUSIL
CAP 100MG
0
$0.00
0.00%
2
$6.52
0.03%
62107003310
DOCUSIL
CAP 100MG
70
$322.08
1.00%
37
$162.68
0.48%
62175044601
PEG 3350
61
$974.90
0.87%
51
$924.70
0.66%
63739008903
0
$0.00
0.00%
18
$83.49
0.23%
65779050170
MAG CITRATE SOL
1
$2.75
0.01%
0
$0.00
0.00%
66375020501
SENNA
0
$0.00
0.00%
1
$0.43
0.01%
66993083002
SUCRALFATE TAB 1GM
0
$0.00
0.00%
99
$2,446.81
1.29%
66993083004
SUCRALFATE TAB 1GM
0
$0.00
0.00%
13
$328.55
0.17%
67618010130
COLACE
CAP 100MG
21
$363.02
0.30%
10
$178.79
0.13%
67618010160
COLACE
CAP 100MG
0
$0.00
0.00%
5
$79.93
0.06%
67618030010
SENOKOT
TAB 8.6MG
0
$0.00
0.00%
11
$131.45
0.14%
67618030050
SENOKOT
TAB 8.6MG
0
$0.00
0.00%
12
$161.97
0.16%
TAB 8.6MG
SOL ELECTROL
TAB 187MG
GI - PROSTAGLANDINS
Page 272 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GI - PROSTAGLANDINS
00025145160
CYTOTEC
TAB 100MCG
4
$333.17
1.49%
4
$233.66
1.94%
00025146131
CYTOTEC
TAB 200MCG
4
$163.74
1.49%
0
$0.00
0.00%
00025146160
CYTOTEC
TAB 200MCG
2
$162.50
0.75%
0
$0.00
0.00%
00172443049
MISOPROSTOL TAB 100MCG
21
$569.10
7.84%
36
$1,056.61
17.48%
00172443059
27
$1,124.27
10.07%
5
$205.01
2.43%
00172443149
76
$2,962.98
28.36%
42
$2,047.74
20.39%
00172443160
75
$3,378.45
27.99%
74
$2,827.08
35.92%
59762500701
13
$620.85
4.85%
12
$525.92
5.83%
59762500801
45
$1,736.83
16.79%
33
$1,247.95
16.02%
59762500802
1
$38.05
0.37%
0
$0.00
0.00%
28,071
$2,931,152.39
52.41%
27,939
$3,037,080.84
47.66%
GI - PROTON PUMP INHIBITOR
00008084181
PROTONIX
TAB 40MG
00008084199
PROTONIX
TAB 40MG
82
$8,413.13
0.15%
77
$5,928.83
0.13%
00008084381
PROTONIX
TAB 20MG
126
$13,923.06
0.24%
244
$26,867.47
0.42%
00008092355
PROTONIX
INJ 40MG
0
$0.00
0.00%
5
$3,749.25
0.01%
00186060628
PRILOSEC
CAP 10MG CR
1
$108.74
0.00%
0
$0.00
0.00%
00186060631
PRILOSEC
CAP 10MG CR
7
$1,096.05
0.01%
6
$312.36
0.01%
00186060668
PRILOSEC
CAP 10MG CR
2
$217.48
0.00%
1
$24.43
0.00%
00186074231
PRILOSEC
CAP 20MG CR
91
$12,792.19
0.17%
14
$1,454.54
0.02%
00186074282
PRILOSEC
CAP 20MG CR
7
$1,093.87
0.01%
1
$333.23
0.00%
00186074328
PRILOSEC
CAP 40MG CR
3
$523.54
0.01%
2
$51.72
0.00%
00186074331
PRILOSEC
CAP 40MG CR
168
$26,819.94
0.31%
104
$12,467.07
0.18%
00186074368
PRILOSEC
CAP 40MG CR
13
$1,310.40
0.02%
6
$913.74
0.01%
00186502031
NEXIUM
CAP 20MG
101
$11,231.07
0.19%
288
$34,163.18
0.49%
00186502054
NEXIUM
CAP 20MG
3
$369.42
0.01%
25
$2,967.85
0.04%
00186502228
NEXIUM
CAP 20MG
0
$0.00
0.00%
2
$254.96
0.00%
Page 273 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00186504031
NEXIUM
CAP 40MG
1,311
$160,531.65
2.45%
3,763
$510,320.56
6.42%
00186504054
NEXIUM
CAP 40MG
298
$36,600.55
0.56%
908
$122,393.51
1.55%
00186504228
NEXIUM
CAP 40MG
0
$0.00
0.00%
3
$376.93
0.01%
00300154111
PREVACID
CAP 15MG DR
2
$250.94
0.00%
3
$375.01
0.01%
00300154119
PREVACID
CAP 15MG DR
117
$13,247.15
0.22%
137
$15,924.96
0.23%
00300154130
PREVACID
CAP 15MG DR
1,514
$181,037.09
2.83%
1,417
$172,731.76
2.42%
00300154330
PREVACID
TAB 15MG STB
0
$0.00
0.00%
25
$1,585.68
0.04%
00300154430
PREVACID
TAB 30MG STB
0
$0.00
0.00%
152
$12,644.16
0.26%
00300304611
PREVACID
CAP 30MG DR
9
$962.64
0.02%
7
$901.42
0.01%
00300304613
PREVACID
CAP 30MG DR
15,739
$2,053,622.24
29.39%
16,817
$2,356,912.34
28.69%
00300304619
PREVACID
CAP 30MG DR
2,284
$289,250.86
4.26%
2,586
$337,979.28
4.41%
00300730930
PREVACID
GRA 15MG
23
$2,300.86
0.04%
50
$4,468.98
0.09%
00300731130
PREVACID
GRA 30MG
41
$3,924.35
0.08%
37
$3,502.52
0.06%
00378521193
OMEPRAZOLE CAP 10MG
2
$199.40
0.00%
1
$51.89
0.00%
00378615001
OMEPRAZOLE CAP 20MG
0
$0.00
0.00%
1
$90.85
0.00%
00378615093
OMEPRAZOLE CAP 20MG
161
$18,662.82
0.30%
81
$4,002.11
0.14%
37000045502
PRILOSEC OTC TAB 20MG
2
$80.79
0.00%
21
$469.08
0.04%
37000045503
7
$255.30
0.01%
53
$1,122.07
0.09%
37000045504
1,705
$40,693.89
3.18%
2,600
$55,124.35
4.44%
60505006502
OMEPRAZOLE CAP 20MG
0
$0.00
0.00%
18
$896.95
0.03%
62175011832
OMEPRAZOLE CAP 20MG
435
$58,681.73
0.81%
106
$6,890.38
0.18%
62175011837
OMEPRAZOLE CAP 20MG
0
$0.00
0.00%
39
$1,600.95
0.07%
62175011843
OMEPRAZOLE CAP 20MG
0
$0.00
0.00%
56
$2,057.22
0.10%
62856024330
ACIPHEX
TAB 20MG
913
$115,453.70
1.70%
701
$94,444.19
1.20%
62856024341
ACIPHEX
TAB 20MG
1
$117.12
0.00%
5
$602.35
0.01%
62856024390
ACIPHEX
TAB 20MG
298
$39,481.83
0.56%
237
$30,523.07
0.40%
66685042200
OMEPRAZOLE CAP 20MG
5
$611.33
0.01%
51
$1,832.88
0.09%
Page 274 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
OMEPRAZOLE CAP 20MG
$
Market Share*
66685042201
# of Scripts
14
$1,859.58
0.03%
28
$1,238.80
0.05%
GI - ULCER ANTI-INFECTIVE
00300370201
PREVPAC
MIS
134
$33,346.45
91.16%
133
$33,322.57
89.26%
65483049514
HELIDAC
MIS
13
$2,310.06
8.84%
16
$3,134.77
10.74%
1
$24.55
0.01%
0
$0.00
0.00%
GLUCOCORTICOIDS/ MINERALOCORTICOIDS
00003029305
KENALOG-40 INJ 40MG/ML
00003042950
FLORINEF
14
$272.41
0.11%
3
$72.58
0.03%
00003049420
KENALOG-10 INJ 10MG/ML
1
$37.45
0.01%
0
$0.00
0.00%
00006061968
HYDROCORTONE TAB 10MG
54
$1,141.12
0.42%
5
$83.07
0.04%
00009001201
CORTEF
91
$1,949.51
0.70%
109
$2,795.40
0.91%
00009002201
MEDROL
TAB 8MG
1
$11.40
0.01%
0
$0.00
0.00%
00009003101
CORTEF
TAB 10MG
29
$844.04
0.22%
14
$342.66
0.12%
00009003201
DELTASONE
9
$45.73
0.07%
1
$3.83
0.01%
00009004401
CORTEF
2
$60.38
0.02%
4
$80.48
0.03%
00009004501
DELTASONE
TAB 5MG
3
$5.86
0.02%
0
$0.00
0.00%
00009004502
DELTASONE
TAB 5MG
19
$64.15
0.15%
18
$85.88
0.15%
00009004516
DELTASONE
TAB 5MG
1
$1.43
0.01%
0
$0.00
0.00%
00009004902
MEDROL
TAB 2MG
1
$50.51
0.01%
0
$0.00
0.00%
00009005602
MEDROL
TAB 4MG
0
$0.00
0.00%
1
$16.86
0.01%
00009005604
MEDROL
PAK 4MG
1
$19.91
0.01%
0
$0.00
0.00%
00009007301
MEDROL
TAB 16MG
8
$166.98
0.06%
3
$27.57
0.03%
00009011312
SOLU-MEDROL INJ 40MG
4
$42.48
0.03%
1
$8.41
0.01%
00009016501
DELTASONE
TAB 20MG
79
$264.34
0.61%
6
$31.03
0.05%
00009016502
DELTASONE
TAB 20MG
7
$15.39
0.05%
0
$0.00
0.00%
00009017601
MEDROL
9
$70.88
0.07%
4
$31.74
0.03%
TAB 0.1MG
TAB 5MG
TAB 2.5MG
TAB 20MG
TAB 32MG
Page 275 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00009019301
DELTASONE
00009019302
DELTASONE
00009028002
DEPO-MEDROL INJ 40MG/ML
00009038801
DELTASONE
00009069801
00009082501
$
Market Share*
00009019009
# of Scripts
1
$2.44
0.01%
0
$0.00
0.00%
TAB 10MG
112
$441.12
0.86%
31
$124.21
0.26%
TAB 10MG
168
$602.80
1.29%
2
$6.85
0.02%
0
$0.00
0.00%
2
$48.00
0.02%
34
$105.73
0.26%
15
$48.20
0.13%
1
$31.36
0.01%
2
$22.04
0.02%
SOLU-CORTEF INJ 100MG
1
$2.75
0.01%
3
$19.32
0.03%
00009090013
9
$30.06
0.07%
6
$34.95
0.05%
00009090020
3
$20.46
0.02%
1
$7.24
0.01%
00009307301
4
$55.12
0.03%
1
$7.70
0.01%
00009307303
0
$0.00
0.00%
1
$10.20
0.01%
00009347501
2
$29.90
0.02%
1
$14.68
0.01%
00054001820
PREDNISONE TAB 20MG
0
$0.00
0.00%
9
$32.19
0.08%
00054001825
PREDNISONE TAB 20MG
0
$0.00
0.00%
203
$657.82
1.69%
00054001829
PREDNISONE TAB 20MG
0
$0.00
0.00%
27
$84.40
0.23%
00054001925
PREDNISONE TAB 50MG
0
$0.00
0.00%
16
$68.71
0.13%
00054317644
DEXAMETHASON CON 1MG/ML
9
$128.73
0.07%
5
$79.96
0.04%
00054317763
DEXAMETHASON SOL 0.5/5ML
1
$6.72
0.01%
4
$18.09
0.03%
00054372144
PREDNISONE CON 5MG/ML
0
$0.00
0.00%
3
$80.00
0.03%
00054372250
PREDNISONE SOL 5MG/5ML
4
$213.07
0.03%
6
$71.00
0.05%
00054372263
PREDNISONE SOL 5MG/5ML
13
$403.84
0.10%
15
$426.39
0.13%
00054417925
DEXAMETHASON TAB 0.5MG
10
$32.94
0.08%
33
$102.50
0.28%
00054418025
0
$0.00
0.00%
1
$2.83
0.01%
00054418125
DEXAMETHASON TAB 1MG
48
$679.69
0.37%
61
$640.00
0.51%
00054418325
46
$1,355.15
0.35%
44
$850.87
0.37%
00054418425
159
$1,288.27
1.22%
276
$1,687.27
2.30%
00054418625
0
$0.00
0.00%
1
$54.96
0.01%
TAB 50MG
Page 276 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
PREDNISONE TAB 5MG
00054472831
PREDNISONE TAB 5MG
00054472925
PREDNISONE TAB 20MG
00054472929
PREDNISONE TAB 20MG
00054473025
$
Market Share*
00054472825
# of Scripts
0
$0.00
0.00%
22
$90.15
0.18%
353
$1,024.13
2.72%
1,131
$3,084.63
8.71%
282
$799.66
2.35%
721
$1,901.88
6.01%
48
$153.54
0.37%
36
$92.12
0.30%
PREDNISONE TAB 10MG
889
$3,185.47
6.85%
646
$2,255.82
5.38%
00054473029
PREDNISONE TAB 10MG
00054473325
PREDNISONE TAB 50MG
52
$207.74
0.40%
81
$333.69
0.68%
81
$322.72
0.62%
93
$319.11
0.78%
00054474125
PREDNISONE TAB 1MG
237
$4,405.03
1.82%
215
$4,160.71
1.79%
00054474131
PREDNISONE TAB 1MG
150
$2,456.69
1.16%
159
$2,713.01
1.33%
00054474225
PREDNISONE TAB 2.5MG
137
$701.65
1.05%
173
$814.69
1.44%
00054817425
1
$1.15
0.01%
0
$0.00
0.00%
00054817525
9
$40.10
0.07%
5
$34.96
0.04%
00054817925
2
$7.09
0.02%
0
$0.00
0.00%
00054872925
PREDNISONE TAB 50MG
2
$4.38
0.02%
9
$25.47
0.08%
00054873925
PREDNISONE TAB 1MG
8
$131.06
0.06%
2
$28.88
0.02%
00093611816
PREDNISOLONE SYP 15MG/5ML
71
$1,136.38
0.55%
49
$663.29
0.41%
00093611887
82
$1,087.91
0.63%
39
$543.31
0.33%
00115703301
FLUDROCORT TAB 0.1MG
225
$6,393.62
1.73%
174
$4,112.06
1.45%
00121068716
0
$0.00
0.00%
1
$6.47
0.01%
00121071104
PRED SOD PHO LIQ 6.7/5ML
0
$0.00
0.00%
1
$26.19
0.01%
00143120201
CORTISONE AC TAB 25MG
4
$149.40
0.03%
4
$118.26
0.03%
00143125401
HYDROCORT
73
$540.02
0.56%
71
$618.02
0.59%
00143147301
PREDNISONE TAB 10MG
9
$25.05
0.07%
1
$3.04
0.01%
00143147310
PREDNISONE TAB 10MG
75
$240.25
0.58%
148
$507.42
1.23%
00143147501
PREDNISONE TAB 5MG
0
$0.00
0.00%
1
$1.84
0.01%
00143147510
PREDNISONE TAB 5MG
99
$287.31
0.76%
170
$539.50
1.42%
00143147701
PREDNISONE TAB 20MG
17
$52.86
0.13%
3
$5.88
0.03%
TAB 20MG
Page 277 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00143147705
PREDNISONE TAB 20MG
7
00143147710
PREDNISONE TAB 20MG
00186070210
ENTOCORT EC CAP 3MG/24HR
00254421628
$26.68
0.05%
56
$165.06
0.47%
23
$78.73
0.18%
66
$9,113.53
0.51%
23
$78.28
0.19%
62
$10,628.25
0.52%
METHYLPRED TAB 4MG
1
$5.41
0.01%
0
$0.00
0.00%
00259039021
STERAPRED
1
$9.99
0.01%
0
$0.00
0.00%
00364021701
PREDNISOLONE TAB 5MG
00364021802
PREDNISONE TAB 5MG
2
$30.96
0.02%
0
$0.00
0.00%
1
$3.38
0.01%
3
$10.31
0.03%
00364044201
PREDNISONE TAB 20MG
0
$0.00
0.00%
1
$4.65
0.01%
00364044202
PREDNISONE TAB 20MG
9
$20.99
0.07%
6
$19.79
0.05%
00364046101
PREDNISONE TAB 10MG
0
$0.00
0.00%
2
$13.28
0.02%
00451150008
PRELONE
SYP 15MG/5ML
4
$59.40
0.03%
0
$0.00
0.00%
00451150016
PRELONE
SYP 15MG/5ML
2
$33.39
0.02%
0
$0.00
0.00%
00451220104
PRELONE
SYP 5MG/5ML
6
$57.93
0.05%
0
$0.00
0.00%
00472021208
5
$67.72
0.04%
1
$13.76
0.01%
00472021216
1
$25.20
0.01%
6
$105.57
0.05%
00472025008
17
$215.91
0.13%
19
$255.32
0.16%
00472025016
6
$62.85
0.05%
51
$573.00
0.43%
00472097208
DEXAMETHASON ELX 0.5/5ML
7
$57.01
0.05%
2
$43.73
0.02%
00517490125
DEXAMETH PHO INJ 4MG/ML
2
$9.77
0.02%
6
$65.51
0.05%
00517490525
4
$29.85
0.03%
2
$20.98
0.02%
00517493025
7
$57.88
0.05%
4
$35.00
0.03%
00527129607
METHYLPRED PAK 4MG
0
$0.00
0.00%
2
$16.16
0.02%
00555030102
METHYLPRED TAB 4MG
25
$365.59
0.19%
17
$163.42
0.14%
00555030138
METHYLPRED PAK 4MG
301
$2,193.98
2.32%
332
$2,368.17
2.77%
00555099702
FLUDROCORT TAB 0.1MG
39
$1,198.65
0.30%
123
$3,286.39
1.03%
00574040810
DEXAMETH SOD POW PHOSPHAT
0
$0.00
0.00%
1
$21.99
0.01%
00591052038
11
$152.35
0.08%
0
$0.00
0.00%
PAK 5MG
Page 278 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
METHYLPRED TAB 4MG
00591079021
METHYLPRED PAK 4MG
00591505201
PREDNISONE TAB 5MG
00591505210
PREDNISONE TAB 5MG
00591505901
PREDNISOLONE TAB 5MG
00591544201
00591544205
$
Market Share*
00591079001
# of Scripts
$0.00
0.00%
$5.41
0.01%
0
$0.00
0.00%
64
$209.41
0.49%
4
$32.32
0.03%
102
$368.66
0.85%
1,157
$4,141.89
8.91%
977
$3,511.65
8.14%
5
$31.38
0.04%
1
$5.49
0.01%
PREDNISONE TAB 10MG
292
PREDNISONE TAB 10MG
524
$1,073.20
2.25%
397
$1,375.03
3.31%
$1,907.15
4.03%
505
$1,852.46
4.21%
00591544210
PREDNISONE TAB 10MG
809
$3,172.05
6.23%
754
$2,964.84
6.28%
00591544301
PREDNISONE TAB 20MG
775
$2,190.96
5.97%
679
$1,915.33
5.66%
00591544305
PREDNISONE TAB 20MG
306
$1,073.62
2.36%
261
$933.12
2.18%
00591544310
PREDNISONE TAB 20MG
325
$1,001.53
2.50%
370
$1,034.18
3.08%
00603459315
METHYLPRED PAK 4MG
240
$1,770.56
1.85%
246
$1,800.84
2.05%
00603459321
METHYLPRED TAB 4MG
24
$270.38
0.18%
13
$156.76
0.11%
00603533215
PREDNISONE PAK 5MG
1
$24.34
0.01%
0
$0.00
0.00%
00603533232
PREDNISONE TAB 5MG
0
$0.00
0.00%
2
$5.99
0.02%
00603533721
PREDNISONE TAB 5MG
5
$29.80
0.04%
62
$245.88
0.52%
00603533732
PREDNISONE TAB 5MG
3
$4.28
0.02%
8
$21.36
0.07%
00603533815
PREDNISONE PAK 10MG
1
$19.01
0.01%
1
$8.68
0.01%
00603533821
PREDNISONE TAB 10MG
0
$0.00
0.00%
372
$1,673.35
3.10%
00603533832
PREDNISONE TAB 10MG
0
$0.00
0.00%
1
$7.82
0.01%
00603533921
PREDNISONE TAB 20MG
0
$0.00
0.00%
394
$1,627.27
3.28%
00603533928
PREDNISONE TAB 20MG
0
$0.00
0.00%
30
$94.86
0.25%
00677007601
HYDROCORT
5
$42.83
0.04%
14
$104.12
0.12%
00677011701
PREDNISONE TAB 5MG
33
$129.18
0.25%
10
$26.54
0.08%
00677011710
PREDNISONE TAB 5MG
17
$48.03
0.13%
29
$67.37
0.24%
00677042701
PREDNISONE TAB 20MG
9
$28.95
0.07%
13
$33.38
0.11%
00677042705
PREDNISONE TAB 20MG
0
$0.00
0.00%
1
$1.50
0.01%
TAB 20MG
0
1
Page 279 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00677042710
PREDNISONE TAB 20MG
0
$0.00
0.00%
8
$50.51
0.07%
00677069801
PREDNISONE TAB 10MG
16
$51.53
0.12%
12
$29.45
0.10%
00677069805
PREDNISONE TAB 10MG
7
$29.45
0.05%
5
$13.99
0.04%
00677069810
PREDNISONE TAB 10MG
38
$128.33
0.29%
22
$63.98
0.18%
00677084901
4
$29.90
0.03%
0
$0.00
0.00%
00677183101
METHYLPRED TAB 4MG
5
$42.96
0.04%
0
$0.00
0.00%
00677183113
METHYLPRED PAK 4MG
0
$0.00
0.00%
2
$18.66
0.02%
00781502201
METHYLPRED TAB 4MG
5
$149.42
0.04%
9
$459.08
0.08%
00781502207
METHYLPRED PAK 4MG
59
$406.27
0.45%
79
$577.07
0.66%
00904217519
METHYLPRED PAK 4MG
23
$163.23
0.18%
0
$0.00
0.00%
00904267460
HYDROCORT
0
$0.00
0.00%
1
$5.25
0.01%
49884008301
3
$8.69
0.02%
1
$3.44
0.01%
49884008401
11
$39.52
0.08%
10
$36.56
0.08%
49884008501
7
$28.35
0.05%
3
$8.31
0.03%
49884008701
107
$637.45
0.82%
24
$150.11
0.20%
49884008703
6
$31.12
0.05%
0
$0.00
0.00%
49884012901
1
$97.77
0.01%
0
$0.00
0.00%
50383004004
50383004248
51285030102
TAB 20MG
0
$0.00
0.00%
1
$8.73
0.01%
26
$228.98
0.20%
80
$1,066.76
0.67%
METHYLPRED TAB 4MG
0
$0.00
0.00%
4
$41.52
0.03%
51285030121
METHYLPRED PAK 4MG
53
$377.20
0.41%
12
$89.50
0.10%
51991018821
METHYLPRED PAK 4MG
1
$9.33
0.01%
0
$0.00
0.00%
52544052016
21
$406.50
0.16%
7
$81.71
0.06%
52544052038
2
$15.98
0.02%
0
$0.00
0.00%
52544079021
METHYLPRED PAK 4MG
2
$18.66
0.02%
1
$5.34
0.01%
53014025001
PEDIAPRED
19
$377.69
0.15%
6
$121.58
0.05%
53489013801
PREDNISONE TAB 5MG
291
$927.32
2.24%
178
$555.83
1.48%
LIQ 6.7/5ML
Page 280 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
53489013810
PREDNISONE TAB 5MG
22
$77.91
0.17%
31
53489013901
PREDNISONE TAB 10MG
465
$1,654.22
3.58%
53489013905
PREDNISONE TAB 10MG
61
$212.66
0.47%
53489013910
PREDNISONE TAB 10MG
20
$66.81
53489014001
PREDNISONE TAB 20MG
642
53489014005
PREDNISONE TAB 20MG
53489014010
PREDNISONE TAB 20MG
58177091005
$105.62
0.26%
24
$89.68
0.20%
82
$268.81
0.68%
0.15%
32
$120.72
0.27%
$1,829.05
4.94%
153
$422.87
1.28%
1
$3.74
0.01%
0
$0.00
0.00%
7
$16.61
0.05%
17
$55.27
0.14%
213
$2,864.54
1.64%
184
$2,543.42
1.53%
58177091007
106
$1,127.11
0.82%
46
$598.53
0.38%
58177091203
18
$181.11
0.14%
19
$229.34
0.16%
59196001024
6
$113.75
0.05%
2
$92.65
0.02%
59196001048
11
$163.08
0.08%
3
$31.73
0.03%
59196001224
PREDNISOLONE SOL SOD PHOS
0
$0.00
0.00%
5
$72.43
0.04%
59439045502
ORAPRED
602
$15,219.33
4.64%
616
$14,849.71
5.13%
59746000103
METHYLPRED PAK 4MG
14
$94.26
0.11%
22
$157.07
0.18%
59746000106
METHYLPRED PAK 4MG
1
$10.30
0.01%
1
$9.40
0.01%
59762332701
METHYLPRED PAK 4MG
80
$571.68
0.62%
29
$183.34
0.24%
59762332702
METHYLPRED TAB 4MG
20
$322.65
0.15%
20
$280.85
0.17%
60432008904
67
$1,213.71
0.52%
62
$1,224.32
0.52%
60432013708
0
$0.00
0.00%
2
$16.67
0.02%
60432021208
PREDNISOLONE SOL 15MG/5ML
0
$0.00
0.00%
87
$1,846.52
0.73%
60432046608
DEXAMETHASON ELX 0.5/5ML
13
$85.70
0.10%
19
$94.93
0.16%
61570019001
FLORINEF
0
$0.00
0.00%
2
$53.52
0.02%
62269035121
METHYLPRED PAK 4MG
6
$43.36
0.05%
2
$16.16
0.02%
62269035124
METHYLPRED TAB 4MG
4
$36.11
0.03%
1
$17.94
0.01%
63304059122
METHYLPRED PAK 4MG
0
$0.00
0.00%
21
$152.01
0.18%
63323016501
1
$3.92
0.01%
0
$0.00
0.00%
SOL 15MG/5ML
TAB 0.1MG
Page 281 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
65580025101
66440015008
PRELONE
66993084021
66993084225
$
Market Share*
63323016530
# of Scripts
2
$19.10
0.02%
4
$43.20
0.03%
40
$723.13
0.31%
35
$591.24
0.29%
2
$46.92
0.02%
1
$10.18
0.01%
METHYLPRED PAK 4MG
0
$0.00
0.00%
1
$6.83
0.01%
METHYLPRED TAB 8MG
0
$0.00
0.00%
1
$13.70
0.01%
00074378101
COLCHICINE TAB 0.6MG
6
$64.15
0.21%
0
$0.00
0.00%
00143120101
64
$409.53
2.23%
70
$471.59
2.44%
00172219060
PROBENECID TAB 500MG
7
$290.91
0.24%
30
$1,003.35
1.05%
00172219360
PROBEN/COLCH TAB 500-0.5
1
$44.85
0.03%
1
$22.35
0.03%
00364007401
9
$68.17
0.31%
0
$0.00
0.00%
00364063202
ALLOPURINOL TAB 100MG
14
$87.21
0.49%
17
$101.84
0.59%
00378013701
227
$1,236.37
7.90%
274
$1,363.69
9.55%
00378013710
237
$1,454.96
8.24%
251
$1,460.96
8.75%
00378015601
11
$503.35
0.38%
10
$265.80
0.35%
00378018101
204
$1,542.04
7.10%
146
$992.90
5.09%
00378018105
108
$842.84
3.76%
105
$797.32
3.66%
00555027102
SULFINPYRAZ TAB 100MG
2
$200.98
0.07%
0
$0.00
0.00%
00591094401
88
$621.79
3.06%
78
$552.40
2.72%
00591094410
60
$383.94
2.09%
45
$300.76
1.57%
00591532501
PROBEN/COLCH TAB 500-0.5
45
$1,435.08
1.57%
30
$797.02
1.05%
00591534701
68
$2,121.20
2.37%
49
$1,608.67
1.71%
00591534710
6
$160.50
0.21%
0
$0.00
0.00%
00591554301
123
$706.92
4.28%
162
$996.85
5.65%
00591554310
99
$514.02
3.44%
95
$460.45
3.31%
00591554401
45
$333.33
1.57%
100
$866.07
3.49%
SYP 15MG/5ML
GOUT
Page 282 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GOUT
00591554405
109
$829.11
3.79%
110
$829.46
3.84%
00603211521
172
$877.09
5.98%
211
$1,103.44
7.36%
00603211532
0
$0.00
0.00%
4
$24.86
0.14%
00603211621
172
$1,355.71
5.98%
248
$1,848.45
8.65%
00603211628
0
$0.00
0.00%
4
$42.64
0.14%
00603211828
2
$11.72
0.07%
3
$20.08
0.10%
00603305221
160
$1,022.27
5.57%
166
$1,092.03
5.79%
00603305232
39
$275.40
1.36%
19
$117.15
0.66%
00677087001
11
$58.66
0.38%
11
$69.75
0.38%
00677087101
5
$56.88
0.17%
5
$55.49
0.17%
00677087105
9
$52.74
0.31%
16
$92.70
0.56%
00677168301
5
$30.50
0.17%
7
$32.20
0.24%
00677168310
12
$93.95
0.42%
1
$1.00
0.03%
00904261360
19
$91.24
0.66%
0
$0.00
0.00%
00904261380
8
$34.60
0.28%
1
$3.20
0.03%
00904261440
5
$46.83
0.17%
0
$0.00
0.00%
00904261480
32
$225.10
1.11%
6
$37.66
0.21%
49884010401
10
$51.87
0.35%
3
$14.60
0.10%
49884010410
7
$46.66
0.24%
1
$7.91
0.03%
49884010501
7
$49.56
0.24%
4
$24.56
0.14%
49884010505
1
$15.89
0.03%
1
$5.86
0.03%
49884010510
9
$50.54
0.31%
2
$10.55
0.07%
49884060201
42
$219.31
1.46%
20
$79.07
0.70%
49884060210
40
$182.85
1.39%
55
$295.92
1.92%
49884060301
26
$235.26
0.90%
22
$162.36
0.77%
49884060305
62
$499.98
2.16%
70
$498.33
2.44%
49884060310
37
$296.86
1.29%
39
$334.63
1.36%
Page 283 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GOUT
51079020620
4
$20.04
0.14%
0
$0.00
0.00%
53489015601
67
$320.85
2.33%
10
$41.41
0.35%
53489015605
4
$22.51
0.14%
2
$11.10
0.07%
53489015610
78
$388.48
2.71%
105
$510.54
3.66%
53489015701
79
$610.20
2.75%
12
$97.91
0.42%
53489015705
48
$317.98
1.67%
28
$195.82
0.98%
53489015710
37
$227.41
1.29%
60
$436.47
2.09%
59743008510
13
$116.45
0.45%
6
$57.60
0.21%
64125010401
41
$303.50
1.43%
68
$472.95
2.37%
64125010410
75
$513.74
2.61%
85
$626.61
2.96%
64731018710
4
$20.90
0.14%
0
$0.00
0.00%
GRANULOCYTE CSF
55513019001
NEULASTA
INJ 6MG/0.6M
5
$8,479.27
9.26%
0
$0.00
0.00%
55513020901
NEUPOGEN
INJ 480/0.8
1
$3,473.72
1.85%
0
$0.00
0.00%
55513020910
NEUPOGEN
INJ 480/0.8
2
$9,781.70
3.70%
17
$44,280.26
27.42%
55513053001
NEUPOGEN
INJ 300/ML
4
$4,157.98
7.41%
1
$1,526.63
1.61%
55513053010
NEUPOGEN
INJ 300/ML
25
$33,559.18
46.30%
34
$40,423.84
54.84%
55513054601
NEUPOGEN
INJ 480/1.6
2
$5,759.66
3.70%
0
$0.00
0.00%
55513054610
NEUPOGEN
INJ 480/1.6
1
$2,304.50
1.85%
1
$893.77
1.61%
55513092401
NEUPOGEN
INJ 300/0.5
0
$0.00
0.00%
1
$618.54
1.61%
55513092410
NEUPOGEN
INJ 300/0.5
13
$20,215.53
24.07%
4
$4,519.77
6.45%
58406005014
LEUKINE
SOL 500MCG
1
$3,729.21
1.85%
4
$7,293.84
6.45%
GROWTH HORMONE
00002733501
HUMATROPE
INJ 5MG
0
$0.00
0.00%
1
$929.33
0.47%
00002733516
HUMATROPE
INJ 5MG
13
$9,852.17
8.61%
5
$103.28
2.33%
Page 284 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
GROWTH HORMONE
00002808901
HUMATROPE
INJ 6MG
5
$828.71
3.31%
5
$1,436.37
2.33%
00002809001
HUMATROPE
INJ 12MG
2
$5,273.06
1.32%
0
$0.00
0.00%
00002809101
HUMATROPE
INJ 24MG
2
$8,635.90
1.32%
0
$0.00
0.00%
00013261681
GENOTROPIN INJ 5.8MG
0
$0.00
0.00%
2
$878.16
0.93%
00013262681
16
$21,839.07
10.60%
41
$45,697.93
19.07%
00013264681
46
$109,302.80
30.46%
82
$191,109.31
38.14%
00013264902
4
$729.31
2.65%
7
$1,731.59
3.26%
00013265002
0
$0.00
0.00%
3
$551.54
1.40%
00013265102
0
$0.00
0.00%
2
$1,470.76
0.93%
00013265202
2
$162.10
1.32%
5
$4,897.00
2.33%
00013265302
GENOTROPIN INJ 1MG
4
$4,807.40
2.65%
15
$11,061.38
6.98%
00013265402
3
$4,220.63
1.99%
5
$5,870.36
2.33%
00013265502
0
$0.00
0.00%
12
$20,537.04
5.58%
00013265602
3
$5,621.01
1.99%
3
$5,866.32
1.40%
00013265802
GENOTROPIN INJ 2MG
0
$0.00
0.00%
3
$7,330.26
1.40%
00169776811
NORDITROPIN INJ 5/1.5ML
2
$18.00
1.32%
2
$4.98
0.93%
00169777011
NORDITROPIN INJ 15/1.5ML
3
$2,113.58
1.99%
5
$5.00
2.33%
44087108801
SAIZEN
50242001821
NUTROPIN
50242002220
NUTROPIN AQ INJ 10MG/2ML
50242003441
NUTROPIN
50242003654
NUTROPIN
50242004314
50242007203
INJ 8.8MG
5
$7,024.27
3.31%
4
$9,344.28
1.86%
13
$32,548.95
8.61%
4
$18,918.37
1.86%
12
$25,528.69
7.95%
5
$8,345.72
2.33%
KIT DEPOT
3
$4,669.10
1.99%
0
$0.00
0.00%
KIT DEPOT
2
$3,859.00
1.32%
0
$0.00
0.00%
NUTROPIN AQ INJ 10MG/2ML
8
$16,493.26
5.30%
1
$1.00
0.47%
NUTROPIN
3
$2,511.44
1.99%
3
$122.07
1.40%
4
$1,562.40
100.00%
6
$4,403.68
37.50%
INJ 10MG
INJ 5MG
HEMOSTATIC
61748004416
AMINOCAPR AC SYP 25%
Page 285 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
HEMOSTATIC
61748004501
AMINOCAPR AC TAB 500MG
0
$0.00
0.00%
5
66479002182
AMICAR
TAB 500MG
0
$0.00
0.00%
66479002356
AMICAR
SYP 25%
0
$0.00
0.00%
$408.52
31.25%
2
$450.70
12.50%
3
$1,618.30
18.75%
HEPATITIS B ONLY
00781204304
RIBAVIRIN
CAP 200MG
0
$0.00
0.00%
2
$76.85
6.45%
00781204367
RIBAVIRIN
CAP 200MG
0
$0.00
0.00%
2
$2.00
6.45%
49884085694
RIBASPHERE CAP 200MG
0
$0.00
0.00%
1
$1.00
3.23%
59930152301
RIBAVIRIN
0
$0.00
0.00%
1
$93.35
3.23%
59930152302
RIBAVIRIN
CAP 200MG
61958050101
HEPSERA
TAB 10MG
66435010118
RIBASPHERE CAP 200MG
CAP 200MG
0
$0.00
21
$9,806.55
0.00%
1
$1.00
3.23%
100.00%
23
$11,153.07
74.19%
0
$0.00
0.00%
1
$1.00
3.23%
HEPATITIS C AGENTS
00004008694
COPEGUS
TAB 200MG
12
$10,760.21
2.23%
0
$0.00
0.00%
00004035009
PEGASYS
INJ 180MCG/M
13
$14,331.82
2.42%
11
$13,420.16
2.11%
00004035039
PEGASYS
KIT 180MCG/M
41
$52,031.93
7.62%
2
$2,728.74
0.38%
00004035239
PEGASYS
KIT
00085119403
REBETOL
CAP 200MG
00085127901
0
$0.00
0.00%
7
$5,834.30
1.34%
114
$150,709.41
21.19%
98
$139,284.94
18.81%
PEG-INTRON KIT 150MCG
114
$152,376.30
21.19%
42
$56,334.79
8.06%
00085129101
39
$49,172.60
7.25%
17
$21,441.10
3.26%
00085129701
PEG-INTRON KIT 120 RP
00085130401
00085131601
0
$0.00
0.00%
89
$107,328.32
17.08%
71
$95,120.80
13.20%
34
$45,000.90
6.53%
PEG-INTRON KIT 80MCG RP
0
$0.00
0.00%
26
$34,264.73
4.99%
00085132301
PEG-INTRON KIT 50MCG RP
0
$0.00
0.00%
3
$3,769.96
0.58%
00085132704
REBETOL
CAP 200MG
8
$11,530.29
1.49%
12
$19,042.25
2.30%
00085135105
REBETOL
CAP 200MG
35
$51,781.21
6.51%
52
$64,987.82
9.98%
Page 286 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
HEPATITIS C AGENTS
00085136801
00085137001
PEG-INTRON KIT 150 RP
0
00085138507
REBETOL
CAP 200MG
84
64116003106
INFERGEN
INJ 15MCG
1
64116003906
INFERGEN
INJ 9MCG
6
$7,350.26
1.12%
3
$3,767.46
0.58%
$0.00
0.00%
61
$75,821.24
11.71%
$108,492.29
15.61%
60
$82,251.51
11.52%
$1,828.89
0.19%
1
$5.74
0.19%
0
$0.00
0.00%
3
$1,262.79
0.58%
HERPES AGENTS
00007411713
FAMVIR
TAB 500MG
2
$231.32
0.08%
4
$326.90
0.14%
00078036615
FAMVIR
TAB 125MG
23
$1,306.81
0.91%
9
$312.33
0.32%
00078036715
FAMVIR
TAB 250MG
47
$5,536.98
1.87%
30
$4,538.53
1.05%
00078036815
FAMVIR
TAB 500MG
92
$14,118.57
3.66%
43
$3,922.78
1.51%
00093894001
ACYCLOVIR
CAP 200MG
124
$1,087.60
4.93%
144
$1,187.40
5.05%
00093894301
ACYCLOVIR
TAB 400MG
225
$2,687.55
8.95%
281
$3,418.00
9.86%
00093894305
ACYCLOVIR
TAB 400MG
2
$48.20
0.08%
2
$28.10
0.07%
00093894701
ACYCLOVIR
TAB 800MG
55
$616.41
2.19%
88
$1,034.73
3.09%
00172426660
ACYCLOVIR
CAP 200MG
22
$134.17
0.87%
47
$421.83
1.65%
00172426670
ACYCLOVIR
CAP 200MG
1
$10.74
0.04%
7
$51.17
0.25%
00172426760
ACYCLOVIR
TAB 400MG
54
$687.98
2.15%
17
$175.22
0.60%
00172426770
ACYCLOVIR
TAB 400MG
5
$70.65
0.20%
4
$59.00
0.14%
00172426860
ACYCLOVIR
TAB 800MG
22
$250.18
0.87%
18
$196.88
0.63%
00173056500
VALTREX
TAB 1GM
2
$173.71
0.08%
0
$0.00
0.00%
00173056502
VALTREX
TAB 1GM
428
$57,136.20
17.02%
599
$94,353.92
21.02%
00173093303
VALTREX
TAB 500MG
177
$19,838.63
7.04%
94
$8,928.15
3.30%
00173093308
VALTREX
TAB 500MG
875
$80,548.70
34.79%
1,167
$117,995.88
40.96%
00173093356
VALTREX
TAB 500MG
12
$1,155.74
0.48%
4
$423.51
0.14%
00173095396
ZOVIRAX
SUS 200/5ML
2
$51.27
0.08%
1
$40.00
0.04%
00173099155
ZOVIRAX
CAP 200MG
1
$167.03
0.04%
1
$75.43
0.04%
Page 287 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
HERPES AGENTS
00228260511
ACYCLOVIR
CAP 200MG
7
$44.36
0.28%
3
$30.33
0.11%
00228260611
ACYCLOVIR
TAB 400MG
11
$81.52
0.44%
3
$47.15
0.11%
00228260711
ACYCLOVIR
TAB 800MG
5
$37.35
0.20%
1
$6.94
0.04%
00364269001
ACYCLOVIR
TAB 800MG
1
$11.47
0.04%
0
$0.00
0.00%
00364269201
ACYCLOVIR
CAP 200MG
2
$19.12
0.08%
0
$0.00
0.00%
00378220001
ACYCLOVIR
CAP 200MG
3
$42.56
0.12%
0
$0.00
0.00%
00472008216
ACYCLOVIR
SUS 200/5ML
36
$2,042.79
1.43%
37
$1,860.94
1.30%
00591033501
ACYCLOVIR
TAB 400MG
0
$0.00
0.00%
44
$503.50
1.54%
00591033601
ACYCLOVIR
TAB 800MG
12
$409.21
0.48%
11
$322.77
0.39%
00591269201
ACYCLOVIR
CAP 200MG
27
$228.00
1.07%
20
$194.31
0.70%
49884056501
ACYCLOVIR
CAP 200MG
1
$4.55
0.04%
1
$9.72
0.04%
49884056601
ACYCLOVIR
TAB 400MG
0
$0.00
0.00%
4
$58.18
0.14%
49884056701
ACYCLOVIR
TAB 800MG
4
$52.30
0.16%
2
$8.95
0.07%
52544033501
ACYCLOVIR
TAB 400MG
37
$452.94
1.47%
3
$51.85
0.11%
52544033601
ACYCLOVIR
TAB 800MG
3
$27.49
0.12%
6
$84.05
0.21%
55370055507
ACYCLOVIR
TAB 400MG
8
$105.00
0.32%
1
$9.95
0.04%
55370055607
ACYCLOVIR
TAB 800MG
5
$141.20
0.20%
0
$0.00
0.00%
63304050401
ACYCLOVIR
TAB 400MG
109
$1,222.76
4.33%
117
$1,495.14
4.11%
63304050501
ACYCLOVIR
TAB 800MG
5
$55.04
0.20%
7
$79.17
0.25%
63304065201
ACYCLOVIR
CAP 200MG
67
$594.57
2.66%
29
$230.89
1.02%
63323032510
ACYCLOVIR NA INJ 50MG/ML
1
$261.35
0.04%
0
$0.00
0.00%
IMMUNOSUPPRESSANTS
00004025901
CELLCEPT
CAP 250MG
35
$11,334.62
4.38%
35
$13,296.37
2.74%
00004025943
CELLCEPT
CAP 250MG
26
$11,482.31
3.25%
76
$10,111.90
5.96%
00004026001
CELLCEPT
TAB 500MG
112
$57,670.14
14.00%
109
$51,536.17
8.54%
00004026043
CELLCEPT
TAB 500MG
39
$15,655.94
4.88%
143
$35,210.27
11.21%
Page 288 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
IMMUNOSUPPRESSANTS
00004026129
CELLCEPT
SUS 200MG/ML
00008103006
RAPAMUNE
SOL 1MG/ML
00008103105
RAPAMUNE
TAB 1MG
00008103110
RAPAMUNE
TAB 1MG
00008103205
RAPAMUNE
00074646332
00074647932
00078010901
$3,936.56
1.00%
$6,797.30
1.41%
0
$0.00
0.00%
17
$6,971.77
2.13%
2
$112.00
0.16%
35
$22,245.07
2.74%
9
$6,554.59
1.13%
63
$24,421.24
4.94%
TAB 2MG
16
$15,967.24
2.00%
10
$9,461.85
0.78%
GENGRAF
CAP 25MG
19
GENGRAF
CAP 100MG
20
$2,711.58
2.38%
23
$1,292.85
1.80%
$6,848.90
2.50%
19
$2,539.85
1.49%
SANDIMMUNE INJ 50MG/ML
0
$0.00
0.00%
1
$75.20
0.08%
00078011022
SANDIMMUNE SOL 100MG/ML
1
$589.10
0.13%
0
$0.00
0.00%
00078024015
SANDIMMUNE CAP 25MG
00078024115
SANDIMMUNE CAP 100MG
26
$5,268.68
3.25%
15
$3,082.83
1.18%
26
$15,335.89
3.25%
16
$9,039.57
1.25%
00078024615
NEORAL
CAP 25MG
121
$24,064.23
15.13%
179
$23,260.13
14.03%
00078024815
NEORAL
CAP 100MG
128
$38,940.71
16.00%
179
$36,972.59
14.03%
00078027422
NEORAL
SOL 100MG/ML
20
$5,292.82
2.50%
17
$4,863.92
1.33%
00185093230
CYCLOSPORINE CAP MOD 25MG
10
$2,542.04
1.25%
11
$1,432.67
0.86%
00185093330
CYCLOSPORINE CAP MD 100MG
11
$2,592.43
1.38%
15
$1,932.52
1.18%
00469060773
PROGRAF
CAP 0.5MG
4
$420.68
0.50%
38
$4,007.56
2.98%
00469061710
PROGRAF
CAP 1MG
1
$260.47
0.13%
0
$0.00
0.00%
00469061711
PROGRAF
CAP 1MG
0
$0.00
0.00%
1
$205.13
0.08%
00469061771
PROGRAF
CAP 1MG
3
$1,283.13
0.38%
0
$0.00
0.00%
00469061773
PROGRAF
CAP 1MG
99
$42,418.45
12.38%
231
$68,479.35
18.10%
00469065711
PROGRAF
CAP 5MG
3
$2,701.23
0.38%
1
$1,005.60
0.08%
00469065773
PROGRAF
CAP 5MG
27
$17,165.85
3.38%
25
$17,951.99
1.96%
50111090943
CYCLOSPORINE CAP MOD 25MG
6
$866.58
0.75%
5
$784.25
0.39%
50111092043
CYCLOSPORINE CAP MD 100MG
10
$2,767.30
1.25%
5
$844.40
0.39%
60505013300
CYCLOSPORINE CAP 25MG
2
$169.62
0.25%
4
$437.42
0.31%
60505013400
CYCLOSPORINE CAP 100MG
1
$328.68
0.13%
0
$0.00
0.00%
8
18
Page 289 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
IMPOTENCE AGENTS
00002446330
CIALIS
TAB 10MG
0
$0.00
0.00%
4
$37.80
0.77%
00002446430
CIALIS
TAB 20MG
0
$0.00
0.00%
36
$753.82
6.91%
00009377813
CAVERJECT
KIT 10MCG
1
$135.66
0.13%
0
$0.00
0.00%
00009518101
CAVERJECT
KIT 10MCG
5
$346.27
0.63%
2
$109.43
0.38%
00009518201
CAVERJECT
KIT 20MCG
10
$1,069.06
1.26%
12
$973.93
2.30%
00009768604
CAVERJECT
INJ 40MCG
3
$387.51
0.38%
3
$102.24
0.58%
00026872069
LEVITRA
TAB 5MG
2
$202.67
0.25%
0
$0.00
0.00%
00026873069
LEVITRA
TAB 10MG
22
$1,424.85
2.77%
25
$735.43
4.80%
00026874069
LEVITRA
TAB 20MG
6
$409.54
0.76%
11
$243.87
2.11%
00069420030
VIAGRA
TAB 25MG
3
$108.27
0.38%
4
$2,717.24
0.77%
00069421030
VIAGRA
TAB 50MG
252
$9,085.08
31.78%
109
$5,193.88
20.92%
00069421066
VIAGRA
TAB 50MG
2
$38.67
0.25%
1
$9.89
0.19%
00069422030
VIAGRA
TAB 100MG
477
$17,472.71
60.15%
310
$10,260.97
59.50%
00069422066
VIAGRA
TAB 100MG
2
$72.18
0.25%
0
$0.00
0.00%
00091144044
EDEX
KIT 40MCG
1
$17.50
0.13%
0
$0.00
0.00%
62541011006
MUSE
SUP 125MCG
1
$75.23
0.13%
0
$0.00
0.00%
62541012006
MUSE
SUP 250MCG
2
$159.92
0.25%
0
$0.00
0.00%
62541013006
MUSE
SUP 500MCG
2
$209.95
0.25%
2
$44.10
0.38%
62541014006
MUSE
SUP 1000MCG
2
$181.36
0.25%
2
$115.92
0.38%
213
$12,599.89
29.71%
55
$3,435.40
74.32%
33
$1,310.78
4.60%
9
$482.11
12.16%
INFLUENZA AGENTS
00004080085
TAMIFLU
CAP 75MG
00004081095
TAMIFLU
SUS 12MG/ML
00115191101
RIMANTADINE TAB 100MG
33
$453.25
4.60%
3
$36.45
4.05%
00258371101
237
$3,856.84
33.05%
0
$0.00
0.00%
00456052101
FLUMADINE
82
$2,057.64
11.44%
0
$0.00
0.00%
TAB 100MG
Page 290 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
INFLUENZA AGENTS
00456052708
FLUMADINE
00781502901
66019010001
SYP 50MG/5ML
3
$36.43
0.42%
0
$0.00
0.00%
113
$1,783.84
15.76%
7
$74.96
9.46%
FLUMIST NASA LIQ 2003-04
3
$160.14
0.42%
0
$0.00
0.00%
K REMOVING RESINS
00024107501
KAYEXALATE POW
12
$1,804.55
7.59%
5
$578.18
2.51%
00054380563
SOD POLY SUL SUS 15GM/60
52
$2,112.82
32.91%
87
$2,706.70
43.72%
00054881611
SOD POLY SUL SUS 15GM/60
13
$969.08
8.23%
51
$2,530.21
25.63%
00574200416
KIONEX
POW USP
2
$340.48
1.27%
7
$1,210.13
3.52%
46287000601
SPS
SUS 15GM/60M
53
$1,436.85
33.54%
23
$789.05
11.56%
46287000660
SPS
SUS 15GM/60M
23
$343.27
14.56%
22
$740.90
11.06%
46287001216
SOD POLY SUL POW
3
$221.97
1.90%
4
$258.91
2.01%
LINCOSAMIDES / OXAZOLIDINONES / LEPROSTATICS
00009033102
CLEOCIN
CAP 75MG
3
$114.31
0.15%
0
$0.00
0.00%
00009039513
CLEOCIN
CAP 300MG
0
$0.00
0.00%
1
$13.39
0.05%
00009039514
CLEOCIN
CAP 300MG
2
$300.00
0.10%
0
$0.00
0.00%
00009076004
CLEOCIN PED SOL 75MG/5ML
46
$2,294.89
2.32%
52
$3,085.90
2.43%
00009337502
CLEOCIN
INJ 600MG
2
$333.58
0.10%
2
$185.37
0.09%
00009338202
CLEOCIN
INJ 900MG
1
$233.24
0.05%
1
$244.62
0.05%
00009513502
ZYVOX
TAB 600MG
27
$25,876.92
1.36%
56
$41,260.30
2.62%
00009513503
ZYVOX
TAB 600MG
00009513601
ZYVOX
SUS 100MG/5M
00009514001
ZYVOX
SOL 2MG/ML
00074405201
7
$16,177.39
0.35%
1
$3,288.58
0.05%
14
$7,439.29
0.71%
5
$1,659.36
0.23%
1
$424.37
0.05%
0
$0.00
0.00%
CLINDAMYCIN INJ 150MG/ML
7
$1,758.60
0.35%
0
$0.00
0.00%
00074419701
CLINDAMYCIN INJ 150MG/ML
0
$0.00
0.00%
3
$211.56
0.14%
00074962113
CLINDAMYCIN INJ IN D5W
2
$263.43
0.10%
0
$0.00
0.00%
Page 291 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
LINCOSAMIDES / OXAZOLIDINONES / LEPROSTATICS
00093317101
CLINDAMYCIN CAP 150MG
268
00364233701
00591312001
00591570801
$5,234.64
13.54%
302
$5,961.71
14.13%
3
$92.09
0.15%
1
$5.39
0.05%
5
$582.46
0.25%
1
$1.00
0.05%
105
$1,826.55
5.31%
149
$2,621.45
6.97%
00781211201
0
$0.00
0.00%
351
$6,040.22
16.42%
00781211301
0
$0.00
0.00%
10
$165.60
0.47%
00781211317
0
$0.00
0.00%
1
$15.25
0.05%
49938010101
DAPSONE
TAB 100MG
84
$530.08
4.24%
68
$442.75
3.18%
49938010201
DAPSONE
TAB 25MG
25
$293.41
1.26%
32
$422.76
1.50%
59762332801
786
$13,051.73
39.72%
858
$15,447.66
40.15%
59762501001
17
$1,571.16
0.86%
1
$34.45
0.05%
59762501002
5
$389.26
0.25%
2
$67.90
0.09%
63304069201
140
$2,117.47
7.07%
197
$3,293.66
9.22%
63304069301
124
$11,676.02
6.27%
11
$278.64
0.51%
63304069316
305
$33,126.33
15.41%
32
$495.38
1.50%
LITHIUM
00007400720
ESKALITH
8
$192.65
0.17%
7
$155.01
0.15%
00007401020
ESKALITH CR TAB 450MG
932
$31,636.33
19.65%
398
$14,022.96
8.32%
00032449201
LITHOBID
417
$16,800.44
8.79%
181
$7,656.17
3.79%
00054002025
LITHIUM CARB TAB 450MG ER
0
$0.00
0.00%
101
$2,889.09
2.11%
00054252625
LITHIUM CARB CAP 150MG
256
$2,335.76
5.40%
244
$2,221.15
5.10%
00054252725
222
$3,263.88
4.68%
191
$2,809.11
3.99%
00054252731
1,052
$14,443.31
22.18%
1,076
$14,711.90
22.50%
00054253125
27
$620.09
0.57%
53
$1,140.67
1.11%
00054352763
LITHIUM CITR SYP 8MEQ/5ML
11
$137.54
0.23%
17
$198.02
0.36%
00054452725
LITHIUM CARB TAB 300MG
54
$906.94
1.14%
86
$1,150.78
1.80%
CAP 300MG
TAB 300MG SR
Page 292 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
LITHIUM
00054452731
30
$391.99
0.63%
31
00054852625
7
$55.85
0.15%
00054852725
0
$0.00
0.00%
00054852825
0
$0.00
00054853125
7
00143127701
00143318801
00143318901
$518.75
0.65%
0
$0.00
0.00%
1
$17.48
0.02%
0.00%
3
$49.56
0.06%
$182.45
0.15%
1
$24.78
0.02%
330
$9,648.81
6.96%
831
$22,056.10
17.38%
5
$37.12
0.11%
11
$114.86
0.23%
3
$37.39
0.06%
19
$325.41
0.40%
00143318910
0
$0.00
0.00%
10
$104.16
0.21%
00182178101
0
$0.00
0.00%
23
$290.37
0.48%
00555034502
230
$7,519.37
4.85%
50
$1,688.97
1.05%
00781610016
3
$36.51
0.06%
0
$0.00
0.00%
00904556860
3
$23.28
0.06%
1
$25.40
0.02%
00904556880
34
$454.02
0.72%
0
$0.00
0.00%
00904564960
0
$0.00
0.00%
17
$537.31
0.36%
51672406301
FLUOROURACIL SOL 5%
0
$0.00
0.00%
3
$344.98
0.06%
53265027010
226
$3,519.59
4.76%
272
$3,907.49
5.69%
53265027011
401
$5,585.71
8.45%
392
$5,430.75
8.20%
53265028303
0
$0.00
0.00%
3
$135.09
0.06%
53265028310
447
$15,980.76
9.42%
726
$25,069.78
15.18%
53265035510
0
$0.00
0.00%
2
$33.37
0.04%
53265035610
0
$0.00
0.00%
2
$25.24
0.04%
60432061616
39
$601.63
0.82%
30
$498.76
0.63%
18
$503.99
0.09%
20
$540.12
0.12%
2,201
$89,712.02
11.10%
1,869
$74,669.73
11.28%
MACROLIDES / ERYTHROMYCIN'S
00069305175
ZITHROMAX
POW 1GM PAK
00069306030
ZITHROMAX
TAB 250MG
Page 293 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ZITHROMAX
TAB Z-PAK
00069306086
ZITHROMAX
00069307030
ZITHROMAX
00069307075
$
Market Share*
00069306075
# of Scripts
8,758
$363,958.93
44.19%
TAB 250MG
98
$3,007.25
0.49%
TAB 500MG
123
$7,881.55
0.62%
ZITHROMAX
TAB TRI-PAK
538
$24,839.34
2.71%
00069307086
ZITHROMAX
TAB 500MG
0
$0.00
0.00%
00069308030
ZITHROMAX
TAB 600MG
39
$6,555.21
0.20%
00069311019
ZITHROMAX
SUS 100/5ML
1,139
$45,770.08
5.75%
00069312019
ZITHROMAX
SUS 200/5ML
1,853
$64,070.29
9.35%
00069313019
ZITHROMAX
SUS 200/5ML
736
$26,513.53
00069314019
ZITHROMAX
SUS 200/5ML
959
00074258611
BIAXIN
TAB 500MG
2
00074258660
BIAXIN
TAB 500MG
00074258913
ERYTHROM ETH TAB 400MG
00074258953
00074316313
BIAXIN
SUS 125/5ML
00074316350
BIAXIN
SUS 125/5ML
00074316511
BIAXIN XL
00074316514
00074316541
$320,765.45
45.65%
22
$849.31
0.13%
223
$11,789.27
1.35%
691
$31,328.71
4.17%
4
$201.95
0.02%
28
$4,207.25
0.17%
962
$40,326.01
5.81%
1,424
$51,274.53
8.60%
3.71%
578
$22,224.33
3.49%
$32,634.31
4.84%
620
$21,309.00
3.74%
$173.02
0.01%
0
$0.00
0.00%
464
$37,224.09
2.34%
97
$4,339.08
0.59%
108
$1,117.40
0.54%
86
$802.17
0.52%
0
$0.00
0.00%
1
$10.11
0.01%
38
$1,512.37
0.19%
6
$219.45
0.04%
2
$62.92
0.01%
1
$15.00
0.01%
TAB 500MG
4
$299.70
0.02%
0
$0.00
0.00%
BIAXIN XL
TAB PAC 500
10
$756.70
0.05%
26
$2,053.10
0.16%
BIAXIN XL
TAB PAC 500
62
$5,428.12
0.31%
90
$6,782.61
0.54%
00074316560
BIAXIN XL
TAB 500MG
288
$23,608.75
1.45%
588
$48,422.28
3.55%
00074318813
BIAXIN
SUS 250/5ML
69
$5,728.42
0.35%
20
$1,067.71
0.12%
00074318850
BIAXIN
SUS 250/5ML
9
$538.51
0.05%
1
$20.92
0.01%
00074336811
BIAXIN
TAB 250MG
2
$20.60
0.01%
1
$12.03
0.01%
00074336860
BIAXIN
TAB 250MG
119
$8,787.91
0.60%
19
$766.31
0.11%
00074338913
PCE
4
$163.98
0.02%
0
$0.00
0.00%
00074374716
ERYTHROM ETH SUS 200/5ML
117
$1,399.25
0.59%
132
$1,479.68
0.80%
00074374816
85
$1,236.38
0.43%
71
$1,022.72
0.43%
TAB 500MG EC
7,561
Page 294 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00074572913
E.E.S. 400 TAB 400MG
18
$182.12
0.09%
12
$130.35
0.07%
00074622713
ERYTHROMYCIN TAB BS 500MG
85
$743.51
0.43%
58
$506.22
0.35%
00074629060
PCE
TAB 333MG EC
4
$213.33
0.02%
0
$0.00
0.00%
00074630113
ERYTHROMYCIN CAP 250MG EC
21
$131.76
0.11%
28
$416.62
0.17%
00074630213
ERYPED 200 SUS 200/5ML
11
$120.45
0.06%
4
$52.34
0.02%
00074630253
2
$31.48
0.01%
6
$97.46
0.04%
00074630413
ERY-TAB
TAB 250MG EC
161
$1,838.49
0.81%
136
$1,796.11
0.82%
00074630453
ERY-TAB
TAB 250MG EC
257
$2,782.39
1.30%
184
$2,214.47
1.11%
00074630513
4
$106.92
0.02%
5
$86.18
0.03%
00074630553
5
$147.42
0.03%
4
$102.64
0.02%
00074630613
E.E.S. 200 SUS 200/5ML
1
$9.58
0.01%
0
$0.00
0.00%
00074630616
E.E.S. 200 SUS 200/5ML
9
$137.02
0.05%
3
$47.65
0.02%
00074631613
ERYTHROCIN TAB 500MG
3
$8.38
0.02%
4
$14.04
0.02%
00074632013
ERY-TAB
TAB 333MG EC
349
$4,029.25
1.76%
258
$3,140.95
1.56%
00074632053
ERY-TAB
TAB 333MG EC
564
$6,084.16
2.85%
352
$4,144.33
2.13%
00074632113
ERY-TAB
TAB 500MG EC
257
$3,785.70
1.30%
226
$3,260.16
1.36%
00074632613
ERYTHROMYCIN TAB 250MG
80
$644.86
0.40%
74
$597.58
0.45%
00074632653
ERYTHROMYCIN TAB 250MG
4
$31.31
0.02%
19
$162.27
0.11%
00074634620
8
$70.39
0.04%
7
$50.70
0.04%
00074634653
0
$0.00
0.00%
2
$5.31
0.01%
00074636902
E.E.S. GRAN SUS 200/5ML
1
$17.95
0.01%
0
$0.00
0.00%
00074636910
E.E.S. GRAN SUS 200/5ML
2
$47.44
0.01%
0
$0.00
0.00%
00074637316
E.E.S. 400 SUS 400/5ML
2
$60.60
0.01%
1
$43.32
0.01%
00378010601
ERYTHROM ST TAB 250MG
1
$8.15
0.01%
0
$0.00
0.00%
00378010605
1
$21.14
0.01%
0
$0.00
0.00%
00378010701
1
$4.50
0.01%
4
$64.10
0.02%
00378640001
9
$102.92
0.05%
7
$93.24
0.04%
Page 295 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00378640005
2
00430069624
ERYC
00451049060
DYNABAC
00472097116
$18.50
0.01%
1
$10.23
0.01%
1
$10.87
0.01%
0
$0.00
0.00%
5
$687.17
0.03%
0
$0.00
0.00%
29
$316.42
0.15%
13
$177.68
0.08%
00472097416
8
$93.83
0.04%
5
$93.44
0.03%
00472097716
ERYTHROM EST SUS 125/5ML
11
$277.44
0.06%
0
$0.00
0.00%
00472097916
ERYTHROM EST SUS 250/5ML
30
$637.12
0.15%
7
$114.02
0.04%
00555021522
0
$0.00
0.00%
1
$10.36
0.01%
00555021523
2
$32.62
0.01%
0
$0.00
0.00%
00555058402
13
$118.77
0.07%
1
$6.14
0.01%
00555058404
13
$144.70
0.07%
0
$0.00
0.00%
00904246216
1
$11.51
0.01%
0
$0.00
0.00%
CAP 250MG EC
TAB 250MG EC
MICELLANEOUS
00002803101
GLUCAGON
KIT 1MG
178
$15,249.83
0.83%
187
$21,250.86
0.76%
00002808501
GLUCAGON
KIT 1MG
11
$839.95
0.05%
5
$1,411.36
0.02%
00003633717
DROXIA
CAP 400MG
1
$34.40
0.00%
0
$0.00
0.00%
00004025001
VESANOID
CAP 10 MG
0
$0.00
0.00%
3
$6,962.85
0.01%
00004110020
XELODA
TAB 150MG
0
$0.00
0.00%
1
$241.77
0.00%
00004110051
XELODA
TAB 150MG
10
$1,646.90
0.05%
0
$0.00
0.00%
00004110116
XELODA
TAB 500MG
41
$31,324.54
0.19%
24
$16,512.92
0.10%
00004110150
XELODA
TAB 500MG
0
$0.00
0.00%
20
$19,540.09
0.08%
00005450723
METHOTREXATE TAB 2.5MG
5
$43.00
0.02%
0
$0.00
0.00%
00006007131
PROPECIA
TAB 1MG
3
$139.97
0.01%
0
$0.00
0.00%
00006007161
PROPECIA
TAB PRO-PAK
1
$45.33
0.00%
0
$0.00
0.00%
00006069068
DEMSER
CAP 250MG
1
$20.00
0.00%
3
$60.00
0.01%
00006468100
M-M-R II
6
$190.02
0.03%
10
$372.25
0.04%
INJ LIVE
Page 296 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00006473900
PNEUMOVAX 23 INJ 25/0.5
00006474100
PNEUMOVAX 23 INJ 25MCG/.5
00006474900
M-M-R II
INJ LIVE
00006477300
RECOMBIVA-HB INJ 10MCG/ML
00006477500
3
$271.33
0.01%
0
$0.00
0.00%
13
$570.08
0.06%
1
$194.97
0.00%
4
$267.44
00006483100
VAQTA
INJ 25/0.5ML
1
00006484400
VAQTA
INJ 50/1ML
0
00006487200
00006489400
3
$327.23
0.01%
2
$24.22
0.01%
10
$444.89
0.04%
1
$64.07
0.00%
0.02%
0
$0.00
0.00%
$37.48
0.00%
0
$0.00
0.00%
$0.00
0.00%
1
$67.02
0.00%
0
$0.00
0.00%
2
$126.96
0.01%
0
$0.00
0.00%
1
$21.59
0.00%
00006494300
53
$1,217.33
0.25%
60
$1,596.89
0.24%
00006498000
RECOMBIVA HB INJ 5MCG/0.5
0
$0.00
0.00%
1
$29.10
0.00%
00006499500
21
$1,519.84
0.10%
8
$458.84
0.03%
00006499541
3
$194.85
0.01%
3
$192.94
0.01%
00008034101
TET/DIP ADLT INJ 5-1.5LF
1
$4.65
0.00%
0
$0.00
0.00%
00008914501
TUBEX INJECT MIS
1
$4.79
0.00%
1
$7.42
0.00%
00008914901
SYNVISC
INJ 8MG/ML
2
$1,282.74
0.01%
2
$1,047.20
0.01%
00008914902
SYNVISC
INJ 8MG/ML
5
$3,206.87
0.02%
6
$3,674.14
0.02%
00009062601
DEPO-PROVERA INJ 400/ML
00009766304
AROMASIN
00013013202
EMCYT
00013105694
ADRUCIL
00013700112
0
$0.00
0.00%
2
$147.39
0.01%
21
$4,472.52
0.10%
33
$6,217.58
0.13%
4
$1,336.78
0.02%
1
$607.64
0.00%
INJ 50MG/ML
2
$2.00
0.01%
0
$0.00
0.00%
DOSTINEX
TAB 0.5MG
47
$7,047.74
0.22%
66
$9,829.11
0.27%
00013872589
ZINECARD
INJ 500MG
3
$2,687.97
0.01%
2
$878.94
0.01%
00015050301
CYTOXAN
TAB 50MG
19
$2,515.39
0.09%
11
$2,306.81
0.04%
00015050302
CYTOXAN
TAB 50MG
1
$206.88
0.00%
0
$0.00
0.00%
00015050401
CYTOXAN
TAB 25MG
5
$516.52
0.02%
0
$0.00
0.00%
00015050842
MEGACE ORAL SUS 40MG/ML
4
$709.05
0.02%
1
$139.28
0.00%
TAB 25MG
CAP 140MG
Page 297 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
MEGACE
00015303020
CEENU
00015303220
CEENU
00015309145
$
Market Share*
MICELLANEOUS
00015059501
# of Scripts
TAB 20MG
1
$38.77
0.00%
0
$0.00
0.00%
CAP 10MG
1
$29.75
0.00%
0
$0.00
0.00%
CAP 100MG
2
$84.42
0.01%
0
$0.00
0.00%
VEPESID
CAP 50MG
3
$1,445.09
0.01%
0
$0.00
0.00%
00015356512
MESNEX
TAB 400MG
1
$914.35
0.00%
0
$0.00
0.00%
00024033301
CHEMET
CAP 100MG
2
$237.51
0.01%
2
$431.78
0.01%
00024061030
ELIGARD
KIT 30MG
1
$2,099.12
0.00%
0
$0.00
0.00%
00026063605
BAYHEP B
INJ
4
$2,482.92
0.02%
3
$1,715.05
0.01%
00026064515
GAMUNEX
INJ 10%
0
$0.00
0.00%
4
$894.28
0.02%
00026064520
GAMUNEX
INJ 10%
1
$443.79
0.00%
12
$12,921.12
0.05%
00026064524
GAMUNEX
INJ 10%
0
$0.00
0.00%
3
$26,098.97
0.01%
00026064571
GAMUNEX
INJ 10%
1
$1,765.09
0.00%
5
$12,343.93
0.02%
00026064815
GAMIMUNE N INJ 10%
3
$890.94
0.01%
0
$0.00
0.00%
00026064820
GAMIMUNE N INJ 10%
14
$8,949.26
0.07%
0
$0.00
0.00%
00026064824
GAMIMUNE N INJ 10%
2
$5,238.22
0.01%
0
$0.00
0.00%
00026064871
GAMIMUNE N INJ 10%
3
$3,807.57
0.01%
0
$0.00
0.00%
00043011908
TAVIST-1
TAB 1.34MG
1
$17.58
0.00%
0
$0.00
0.00%
00043011916
TAVIST-1
TAB 1.34MG
1
$19.72
0.00%
0
$0.00
0.00%
00052060202
TICE BCG
INJ
1
$460.60
0.00%
0
$0.00
0.00%
00054224725
HYDROXYUREA CAP 500MG
26
$599.10
0.12%
6
$145.10
0.02%
00054302502
ACETYLCYST SOL 10%
1
$93.80
0.00%
2
$52.94
0.01%
00054302602
ACETYLCYST SOL 20%
1
$12.29
0.00%
8
$324.68
0.03%
00054302702
ACETYLCYST SOL 10%
10
$1,058.36
0.05%
27
$1,891.79
0.11%
00054302802
ACETYLCYST SOL 20%
1
$10.14
0.00%
8
$229.64
0.03%
00054354258
MEGESTROL AC SUS 40MG/ML
28
$5,108.28
0.13%
47
$7,464.78
0.19%
00054413025
CYCLOPHOSPH TAB 50MG
0
$0.00
0.00%
3
$299.60
0.01%
00054449613
LEUCOVOR CA TAB 5MG
3
$30.23
0.01%
0
$0.00
0.00%
Page 298 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00054449625
LEUCOVOR CA TAB 5MG
00054455015
00054455025
00054458111
MERCAPTOPUR TAB 50MG
00054458127
$36.96
0.01%
$19.73
0.00%
4
$29.90
0.02%
15
$101.00
0.07%
3
$3.00
0.01%
29
$260.40
0.12%
0
$0.00
0.00%
5
$186.22
0.02%
0
$0.00
0.00%
1
$15.00
0.00%
00054483121
TAMOXIFEN TAB 10MG
1
$27.85
0.00%
00054483413
TAMOXIFEN TAB 20MG
1
$48.85
0.00%
1
$27.35
0.00%
48
$866.50
0.19%
00062330100
ORTHO FLEX DPR KIT 55
0
$0.00
0.00%
1
$31.36
0.00%
00062330200
0
$0.00
0.00%
1
$31.36
0.00%
00062330300
5
00062330400
10
$151.30
0.02%
1
$33.86
0.00%
$297.60
0.05%
5
$161.80
0.02%
00062330500
6
$174.46
0.03%
10
$295.14
0.04%
00062330600
0
$0.00
0.00%
5
$156.80
0.02%
00062330700
0
$0.00
0.00%
1
$8.85
0.00%
00062334300
ORTHO COIL DPR KIT 65
0
$0.00
0.00%
1
$33.86
0.00%
00062334400
0
$0.00
0.00%
1
$33.86
0.00%
00062334500
0
$0.00
0.00%
1
$31.36
0.00%
00066006306
ZETAR
2
$29.60
0.01%
1
$14.48
0.00%
00066027517
PSORCON E
OIN 0.05%
0
$0.00
0.00%
1
$34.90
0.00%
00066027531
PSORCON E
OIN 0.05%
1
$31.00
0.00%
0
$0.00
0.00%
00066027560
PSORCON E
OIN 0.05%
4
$373.90
0.02%
0
$0.00
0.00%
00071233317
BENADRYL
ELX ALLERGY
1
$4.88
0.00%
0
$0.00
0.00%
00071425903
BENADRYL
INJ 50MG/ML
0
$0.00
0.00%
3
$154.64
0.01%
00071425945
BENADRYL
INJ 50MG/ML
3
$16.53
0.01%
0
$0.00
0.00%
00072150030
VANIQA
CRE 13.9%
9
$462.50
0.04%
0
$0.00
0.00%
00072230001
LOWILA
BAR
1
$16.30
0.00%
0
$0.00
0.00%
00074196604
SOD CHLORIDE INJ 0.9%BACT
15
$176.47
0.07%
10
$93.37
0.04%
SHA 1%
2
1
Page 299 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00074196607
39
00074196614
00074330703
ACETYLCYST SOL 10%
00074330803
$325.62
0.18%
25
$81.92
0.10%
0
$0.00
0.00%
5
$179.06
0.02%
1
$4.31
0.00%
5
$172.37
0.02%
ACETYLCYST SOL 20%
1
$8.66
0.00%
0
$0.00
0.00%
00074397703
BACTER WATER INJ
1
$4.28
0.00%
1
$3.82
0.00%
00074450810
INSULIN SYRG MIS 1ML/29G
00074454102
LEUCOVOR CA INJ 10MG/ML
2
$23.02
0.01%
0
$0.00
0.00%
5
$33.50
0.02%
0
$0.00
0.00%
00074472901
DOBUTAMINE INJ 12.5/ML
1
$125.85
0.00%
0
$0.00
0.00%
00074488710
STERIL WATER INJ
4
$46.24
0.02%
2
$14.61
0.01%
00074488720
STERIL WATER INJ
0
$0.00
0.00%
1
$4.13
0.00%
00074488750
STERIL WATER INJ
1
$5.37
0.00%
0
$0.00
0.00%
00074613903
STERIL WATER SOL IRRIG
0
$0.00
0.00%
4
$25.00
0.02%
00074613922
0
$0.00
0.00%
2
$16.46
0.01%
00074683801
ENDURONYL
1
$47.46
0.00%
0
$0.00
0.00%
00074713909
19
$185.25
0.09%
19
$209.47
0.08%
00074724101
EPINEPHRINE INJ 1MG/ML
5
$16.43
0.02%
0
$0.00
0.00%
00074790209
KCL/D5W/NACL INJ .15/.45%
7
$260.85
0.03%
0
$0.00
0.00%
00074794109
D5W/NACL
0
$0.00
0.00%
6
$66.56
0.02%
00074795309
LACTATED RIN INJ
3
$18.91
0.01%
0
$0.00
0.00%
00078005405
METHERGINE TAB 0.2MG
47
$803.52
0.22%
74
$1,161.34
0.30%
00078014923
MIACALCIN INJ 200/ML
27
$2,478.36
0.13%
13
$1,679.48
0.05%
00078024915
FEMARA
TAB 2.5MG
61
$11,983.90
0.29%
129
$27,543.45
0.52%
00078037366
GLEEVEC
CAP 100MG
10
$11,868.36
0.05%
0
$0.00
0.00%
00078040105
GLEEVEC
TAB 100MG
8
$3,585.60
0.04%
14
$15,043.87
0.06%
00078040215
GLEEVEC
TAB 400MG
6
$120.00
0.03%
6
$11,535.88
0.02%
00085052506
EULEXIN
CAP 125MG
11
$3,294.66
0.05%
9
$2,562.45
0.04%
00085053901
INTRON-A
INJ 50MU
3
$6,389.01
0.01%
4
$17,307.91
0.02%
TAB
INJ 0.9%
Page 300 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00085057102
INTRON-A
INJ 10MU
1
$284.64
0.00%
0
00085111001
INTRON-A
INJ 18MU
2
$3,066.98
0.01%
00085113301
INTRON-A
INJ 25MU
1
$33.94
0.00%
00085116801
INTRON-A
INJ 18MU
3
$3,836.66
00085124201
INTRON-A
INJ 3MU PEN
0
00085124401
TEMODAR
CAP 20MG
00085124402
TEMODAR
CAP 20MG
00085124801
TEMODAR
00085124802
$0.00
0.00%
0
$0.00
0.00%
2
$3,462.68
0.01%
0.01%
1
$1,041.54
0.00%
$0.00
0.00%
2
$60.00
0.01%
4
$3,655.42
0.02%
11
$5,497.46
0.04%
5
$5,481.60
0.02%
3
$6,045.96
0.01%
CAP 5MG
1
$424.39
0.00%
4
$325.32
0.02%
TEMODAR
CAP 5MG
5
$2,954.44
0.02%
0
$0.00
0.00%
00085125201
TEMODAR
CAP 250MG
5
$7,044.90
0.02%
8
$18,783.77
0.03%
00085125202
TEMODAR
CAP 250MG
2
$2.36
0.01%
0
$0.00
0.00%
00085125401
INTRON-A
INJ 10MU PEN
0
$0.00
0.00%
2
$6,923.48
0.01%
00085125901
TEMODAR
CAP 100MG
4
$12,356.50
0.02%
9
$22,325.38
0.04%
00085125902
TEMODAR
CAP 100MG
15
$38,343.99
0.07%
7
$26,964.76
0.03%
00085141002
A/D ZINC OXI CRE
4
$57.12
0.02%
0
$0.00
0.00%
00085460202
INSPIREASE MIS DD SYST
0
$0.00
0.00%
39
$1,017.00
0.16%
00087057003
MUCOMYST
SOL 20%
2
$31.76
0.01%
1
$19.22
0.00%
00087057007
MUCOMYST
SOL 20%
4
$227.34
0.02%
1
$14.75
0.00%
00087057009
MUCOMYST
SOL 20%
3
$79.20
0.01%
0
$0.00
0.00%
00087057201
MUCOMYST-10 SOL 10%
7
$745.04
0.03%
0
$0.00
0.00%
00087057202
MUCOMYST-10 SOL 10%
0
$0.00
0.00%
1
$58.93
0.00%
00087057203
MUCOMYST-10 SOL 10%
1
$434.73
0.00%
0
$0.00
0.00%
00093078201
TAMOXIFEN TAB 20MG
30
$818.10
0.14%
26
$581.30
0.11%
00093078256
TAMOXIFEN TAB 20MG
83
$2,516.75
0.39%
74
$1,652.10
0.30%
00093078406
TAMOXIFEN TAB 10MG
114
$3,325.40
0.53%
84
$2,125.25
0.34%
00093078486
TAMOXIFEN TAB 10MG
27
$758.40
0.13%
8
$201.30
0.03%
00093712086
FLUTAMIDE
0
$0.00
0.00%
2
$321.01
0.01%
CAP 125 MG
Page 301 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00093963487
MEGESTROL
SUS 40MG/ML
00168020502
SURGILUBE
GEL
00168020536
SURGILUBE
GEL
00169185250
0
$0.00
0.00%
9
$1,438.46
0.04%
0
$0.00
0.00%
1
$13.10
0.00%
2
$12.04
0.01%
0
$0.00
0.00%
NOVOFINE 30 MIS DISPOS
214
$6,223.06
1.00%
107
$2,912.26
0.43%
00169185255
NOVOFINE 31 MIS DISPOS
73
$2,365.63
0.34%
64
$2,234.65
0.26%
00169185258
NOVOPEN JR MIS DEVICE
00169185290
NOVOPEN 3
00172565649
1
$35.97
0.00%
3
$96.64
0.01%
32
$971.54
0.15%
2
$58.42
0.01%
TAMOXIFEN TAB 10MG
5
$112.25
0.02%
42
$1,023.70
0.17%
00172565658
TAMOXIFEN TAB 10MG
87
$2,288.50
0.41%
83
$2,003.52
0.34%
00172565670
TAMOXIFEN TAB 10MG
0
$0.00
0.00%
4
$147.40
0.02%
00172565746
TAMOXIFEN TAB 20MG
0
$0.00
0.00%
3
$56.55
0.01%
00172565760
TAMOXIFEN TAB 20MG
68
$1,798.15
0.32%
63
$1,462.75
0.26%
00173004535
ALKERAN
8
$150.24
0.04%
4
$232.98
0.02%
00173051800
STERILE DILU SOL FLOLAN
2
$1,304.66
0.01%
1
$25.08
0.00%
00173051801
STERILE DILU SOL FLOLAN
4
$2,552.83
0.02%
0
$0.00
0.00%
00173063535
LEUKERAN
TAB 2MG
19
$2,113.04
0.09%
16
$1,165.54
0.06%
00173071325
MYLERAN
TAB 2MG
0
$0.00
0.00%
1
$86.53
0.00%
00173080725
PURINETHOL TAB 50MG
121
$16,769.24
0.57%
8
$1,135.40
0.03%
00173080765
PURINETHOL TAB 50MG
20
$3,010.06
0.09%
2
$611.92
0.01%
00173500001
ELLIPSE CMPT MIS SPACER
0
$0.00
0.00%
39
$415.05
0.16%
00182512852
CAPSICUM OLE CRE 0.025%
8
$75.12
0.04%
0
$0.00
0.00%
00182512952
2
$21.71
0.01%
3
$36.34
0.01%
00185004301
MIDODRINE
TAB 5MG
6
$2,564.09
0.03%
20
$5,331.81
0.08%
00185014901
MIDODRINE
TAB 10MG
0
$0.00
0.00%
3
$1,900.83
0.01%
00185515601
PAPAVERINE CAP 150MG CR
3
$15.84
0.01%
0
$0.00
0.00%
00187074633
INSTA-GLUCOS GEL 40%
0
$0.00
0.00%
8
$70.72
0.03%
00193280221
DIASTIX
0
$0.00
0.00%
1
$13.04
0.00%
MIS
TAB 2MG
TES STRIPS
Page 302 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
CLINISTIX
00193288221
00193288250
$
Market Share*
MICELLANEOUS
00193284450
# of Scripts
TES STRIPS
5
$74.32
0.02%
4
$60.64
0.02%
KETO-DIASTIX TES
6
$116.78
KETO-DIASTIX TES
3
$30.29
0.03%
6
$139.29
0.02%
0.01%
10
$149.79
0.04%
00193341601
MICROLET DEV MIS VACULANC
0
$0.00
0.00%
2
$45.80
0.01%
00193361050
ASCENSIA
TES AUTODISC
141
$7,144.63
0.66%
119
$6,404.33
0.48%
00193362250
GLUCO DEX
00193362350
GLUCO DEX
TES SENSORS
5
$257.81
0.02%
11
$830.81
0.04%
TES SENSORS
3
$218.05
0.01%
0
$0.00
0.00%
00193362721
ASCENSIA
TES AUTODISC
173
$12,956.49
0.81%
147
$10,193.93
0.60%
00193387050
GLUCO ELITE TES
4
$396.40
0.02%
9
$613.65
0.04%
00193387150
GLUCO ELITE TES
6
$160.37
0.03%
7
$644.95
0.03%
00193388501
GLUCOMETER KIT CLASSIC
8
$318.78
0.04%
3
$114.12
0.01%
00193390101
ASCENSIA
KIT DIAB XL
14
$611.09
0.07%
13
$592.34
0.05%
00193391125
ASCENSIA
TES ELITE
10
$509.03
0.05%
2
$235.10
0.01%
00193391850
ASCENSIA
TES ELITE
261
$14,029.61
1.22%
290
$11,144.84
1.17%
00193394221
ASCENSIA
TES ELITE
283
$19,946.45
1.32%
208
$13,821.94
0.84%
00193395201
ASCENSIA DEX KIT SYS
3
$192.70
0.01%
2
$123.94
0.01%
00193397201
GLUCOMETER LIQ ELITE
0
$0.00
0.00%
3
$24.28
0.01%
00193550921
AMES GLU SYS MIS
7
$35.55
0.03%
4
$42.69
0.02%
00193596531
FINGERSTIX MIS LANCETS
0
$0.00
0.00%
34
$326.82
0.14%
00193611701
ASCENSIA
KIT BREEZE
12
$576.51
0.06%
16
$745.32
0.06%
00193654621
MICROLET
MIS
128
$776.13
0.60%
240
$2,237.12
0.97%
00193708050
ASCENSIA
TES MICROFIL
0
$0.00
0.00%
118
$5,415.14
0.48%
00193709021
ASCENSIA
TES MICROFIL
0
$0.00
0.00%
170
$12,470.03
0.69%
00193715101
ASCENSIA
KIT CONTOUR
0
$0.00
0.00%
16
$980.30
0.06%
00264210100
2
$30.81
0.01%
2
$28.64
0.01%
00264210110
1
$19.98
0.00%
0
$0.00
0.00%
00264761000
D5W/NACL
0
$0.00
0.00%
1
$12.35
0.00%
INJ 0.9%
Page 303 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00300210801
LUPR DEP-PED INJ 7.5MG
2
$82.51
0.01%
6
00300228201
LUPR DEP-PED INJ 11.25MG
4
$4,324.60
0.02%
00300244001
LUPR DEP-PED INJ 15MG
3
$3,571.29
0.01%
00300334601
LUPRON DEPOT INJ 22.5MG
3
$5,350.55
00300364101
150
00300364201
00300366301
00300368301
LUPRON DEPOT INJ 30MG
00310020130
ARIMIDEX
00310048230
IRESSA
00310060060
NOLVADEX
TAB 10MG
00310060430
NOLVADEX
TAB 20MG
00310070510
CASODEX
00310070530
CASODEX
00310073060
TAMOXIFEN TAB 10MG
00310073130
$1,905.15
0.02%
11
$9,210.98
0.04%
21
$17,277.16
0.09%
0.01%
3
$3,599.83
0.01%
$70,943.28
0.70%
140
$65,468.03
0.57%
11
$4,341.66
0.05%
9
$5,482.95
0.04%
28
$38,595.68
0.13%
25
$37,855.75
0.10%
2
$4,755.19
0.01%
2
$4,860.30
0.01%
TAB 1MG
259
$53,421.77
1.21%
365
$77,672.84
1.48%
TAB 250MG
14
$23,766.20
0.07%
31
$68,834.34
0.13%
2
$66.14
0.01%
0
$0.00
0.00%
1
$114.57
0.00%
0
$0.00
0.00%
TAB 50MG
11
$4,185.37
0.05%
10
$3,898.30
0.04%
TAB 50MG
49
$19,163.91
0.23%
52
$18,473.47
0.21%
40
$2,886.36
0.19%
1
$17.67
0.00%
TAMOXIFEN TAB 20MG
9
$306.04
0.04%
0
$0.00
0.00%
00310095036
ZOLADEX
IMP 3.6MG
3
$1,229.22
0.01%
3
$1,201.02
0.01%
00310095130
ZOLADEX
IMP 10.8MG
6
$6,210.15
0.03%
8
$8,407.28
0.03%
00310096036
ZOLADEX
IMP 3.6MG
4
$1,638.96
0.02%
0
$0.00
0.00%
00310096130
ZOLADEX
IMP 10.8MG
4
$4,878.18
0.02%
0
$0.00
0.00%
00338000403
1
$59.05
0.00%
0
$0.00
0.00%
00338000404
7
$823.58
0.03%
14
$1,630.95
0.06%
00338008503
D5W/NACL
INJ 0.45%
0
$0.00
0.00%
1
$6.65
0.00%
00338008504
D5W/NACL
INJ 0.45%
24
$289.70
0.11%
9
$89.05
0.04%
00338008904
D5W/NACL
INJ 0.9%
12
$110.50
0.06%
1
$14.75
0.00%
00338011104
D5W/RINGER'S INJ
0
$0.00
0.00%
8
$1,054.69
0.03%
00338011704
LACTATED RIN INJ
6
$427.00
0.03%
0
$0.00
0.00%
Page 304 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00338066104
00338067104
00378001401
00378014405
2
$240.30
0.01%
0
$0.00
0.00%
2
$50.50
0.01%
0
$0.00
0.00%
121
$1,178.53
0.57%
287
$2,727.29
1.16%
TAMOXIFEN TAB 10MG
6
$167.10
0.03%
8
$174.80
0.03%
00378014491
TAMOXIFEN TAB 10MG
68
$2,002.10
0.32%
46
$1,149.90
0.19%
00378027401
TAMOXIFEN TAB 20MG
19
$522.65
0.09%
7
$137.95
0.03%
00378027493
TAMOXIFEN TAB 20MG
30
$818.79
0.14%
21
$563.00
0.09%
00378190101
MIDODRINE
TAB 2.5MG
10
$336.96
0.05%
8
$107.82
0.03%
00378190201
MIDODRINE
TAB 5MG
12
$2,141.88
0.06%
20
$2,724.44
0.08%
00378190301
MIDODRINE
TAB 10MG
0
$0.00
0.00%
2
$1,137.67
0.01%
00378326694
ETOPOSIDE
CAP 50MG
6
$4,237.44
0.03%
3
$1,345.00
0.01%
00406292434
TRICHLOROACE CRY ACID
1
$15.16
0.00%
0
$0.00
0.00%
00456052321
BANALG
2
$47.50
0.01%
0
$0.00
0.00%
00456074413
AEROCHAMBER/ MIS MASK-SM
0
$0.00
0.00%
65
$2,920.01
0.26%
00456074513
AEROCHAMBER/ MIS MASK
0
$0.00
0.00%
104
$4,704.50
0.42%
00456074613
AEROCHAMBER/ MIS MASK-LG
0
$0.00
0.00%
9
$374.14
0.04%
00456315467
AEROCHAMBER MIS
0
$0.00
0.00%
579
$19,764.95
2.34%
00472075516
CYPROHEPTAD SYP 2MG/5ML
57
$1,290.11
0.27%
67
$1,281.70
0.27%
00501200024
BENADRYL
CAP 25MG
3
$20.22
0.01%
0
$0.00
0.00%
00501200048
BENADRYL
CAP 25MG
1
$17.36
0.00%
0
$0.00
0.00%
00501201024
BENADRYL
CHW ALLERGY
6
$70.77
0.03%
0
$0.00
0.00%
00501205004
BENADRYL ALL SYP 12.5/5ML
10
$65.09
0.05%
2
$8.28
0.01%
00501205008
BENADRYL ALL SYP 12.5/5ML
2
$11.01
0.01%
0
$0.00
0.00%
00501205304
BENADRYL ALL LIQ 12.5/5ML
1
$7.61
0.00%
1
$10.79
0.00%
00517064825
1
$5.85
0.00%
0
$0.00
0.00%
00517066225
BACTER WATER INJ BENZ ALC
1
$4.71
0.00%
0
$0.00
0.00%
00517300525
STERIL WATER INJ
189
$836.71
0.88%
433
$1,891.84
1.75%
LIQ
Page 305 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00517301025
STERIL WATER INJ
00517750412
00517750425
11
$129.93
0.05%
0
$0.00
0.00%
ACETYLCYST SOL 10%
3
$149.53
0.01%
ACETYLCYST SOL 10%
0
$0.00
0.00%
0
$0.00
0.00%
5
$278.00
0.02%
00517751003
ACETYLCYST SOL 10%
11
$201.34
0.05%
11
$373.12
0.04%
00517760425
ACETYLCYST SOL 20%
0
$0.00
0.00%
2
$44.17
0.01%
00517761003
ACETYLCYST SOL 20%
00517763003
ACETYLCYST SOL 20%
3
$25.31
0.01%
10
$938.44
0.04%
7
$215.24
0.03%
2
$392.96
0.01%
00525674801
PALGIC
TAB 4MG
0
$0.00
0.00%
1
$7.50
0.00%
00536992001
ALCOHOL PREP PAD
0
$0.00
0.00%
1
$5.77
0.00%
00555044609
TAMOXIFEN TAB 10MG
131
$4,471.89
0.61%
61
$1,611.85
0.25%
00555044663
TAMOXIFEN TAB 10MG
30
$723.52
0.14%
13
$446.09
0.05%
00555048401
LEUCOVOR CA TAB 5MG
32
$1,182.56
0.15%
40
$927.43
0.16%
00555048402
LEUCOVOR CA TAB 5MG
16
$159.69
0.07%
15
$268.41
0.06%
00555048527
LEUCOVOR CA TAB 25MG
2
$2.00
0.01%
3
$126.75
0.01%
00555057202
685
$6,035.85
3.21%
499
$5,760.22
2.02%
00555057235
9
$59.70
0.04%
4
$27.40
0.02%
00555060602
MEGESTROL AC TAB 20MG
21
$170.67
0.10%
29
$369.77
0.12%
00555060702
59
$1,194.19
0.28%
63
$1,648.28
0.26%
00555060703
6
$86.32
0.03%
1
$38.05
0.00%
00555060704
1
$19.45
0.00%
1
$28.75
0.00%
00555087063
FLUTAMIDE
2
$656.22
0.01%
3
$267.87
0.01%
00555088202
53
$1,740.30
0.25%
54
$1,445.10
0.22%
00555090401
TAMOXIFEN TAB 20MG
100
$3,139.50
0.47%
42
$878.90
0.17%
00555090414
TAMOXIFEN TAB 20MG
18
$594.17
0.08%
8
$150.80
0.03%
00555092701
TREXALL
TAB 5MG
0
$0.00
0.00%
1
$205.06
0.00%
00555092801
TREXALL
TAB 7.5MG
0
$0.00
0.00%
3
$232.29
0.01%
00555092901
TREXALL
TAB 10MG
3
$328.53
0.01%
4
$396.28
0.02%
CAP 125MG
Page 306 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
00562780706
RHOGAM HUMAN INJ 300MCG
1
$113.09
0.00%
00562780806
MICRHOGAM
4
$190.96
00574006930
GLUTOSE
9
$63.13
00575620030
PROGLYCEM
2
00585118401
ASSESS METER MIS LOW
00585118402
00603504321
5
$547.85
0.02%
0.02%
4
$191.68
0.02%
0.04%
14
$135.80
0.06%
$133.82
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
5
$106.86
0.02%
ASSESS METER MIS STANDARD
0
$0.00
0.00%
10
$200.98
0.04%
PAPAVERINE CAP 150MG CR
0
$0.00
0.00%
2
$10.56
0.01%
00603699521
INSULIN SYRG MIS 0.5/28G
0
$0.00
0.00%
1
$12.08
0.00%
00603699621
0
$0.00
0.00%
2
$21.28
0.01%
00603699721
3
$57.10
0.01%
3
$58.43
0.01%
00603699821
0
$0.00
0.00%
1
$20.31
0.00%
00603699921
5
$105.30
0.02%
0
$0.00
0.00%
00603700021
7
$142.92
0.03%
0
$0.00
0.00%
00603700121
0
$0.00
0.00%
2
$46.49
0.01%
00603700221
0
$0.00
0.00%
1
$21.21
0.00%
00703401418
LEUPROLIDE INJ 1MG/0.2
1
$322.67
0.00%
2
$645.34
0.01%
00713062504
MUSCLE RUB CRE ULT STR
0
$0.00
0.00%
1
$6.88
0.00%
00904174960
6
$48.10
0.03%
4
$39.80
0.02%
00944262003
GAMMAGARD SD INJ 5GM HU
2
$3,660.37
0.01%
8
$4,285.80
0.03%
00944262004
GAMMAGARD SD INJ 10GM HU
0
$0.00
0.00%
15
$40,817.25
0.06%
04351078710
AERO PLS MSK MIS MEDIUM
0
$0.00
0.00%
10
$169.50
0.04%
04351088710
AERCHMBR PLS MIS SM MASK
0
$0.00
0.00%
2
$33.90
0.01%
08189609600
E-Z JECT
3
$11.17
0.01%
1
$0.95
0.00%
08189610000
E-Z JECT JR MIS
5
$29.01
0.02%
1
$9.63
0.00%
08189610001
E-Z JECT
MIS
10
$49.75
0.05%
20
$123.34
0.08%
08189610010
E-Z JECT
MIS
3
$8.85
0.01%
2
$2.00
0.01%
08189610601
E-Z JECT
MIS THIN 26G
23
$108.32
0.11%
16
$66.27
0.06%
INJ 50MCG RH
GEL 40%
SUS 50MG/ML
MIS THIN 26G
Page 307 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
08189750220
RELI ON STAN MIS LANCETS
0
$0.00
0.00%
1
$4.18
0.00%
08189850320
RELI ON THIN MIS LANCETS
1
$6.55
0.00%
2
$13.10
0.01%
08193008912
LANCETS
0
$0.00
0.00%
1
$10.85
0.00%
08214053501
UNILET EX II MIS 28G
5
$19.60
0.02%
0
$0.00
0.00%
08214070201
UNISTIK 2
1
$17.71
0.00%
0
$0.00
0.00%
08271036100
VITALET 26 MIS LANCETS
11
$33.57
0.05%
0
$0.00
0.00%
08287126111
3ML LL SYRNG MIS 25GX1"
2
$2.58
0.01%
0
$0.00
0.00%
08290005500
1ML SYRINGE MIS 28GX1/2"
3
$27.32
0.01%
1
$5.08
0.00%
08290006893
B-D SWABS
1
$0.49
0.00%
3
$1.47
0.01%
08290008410
B-D MF SYRG MIS 1CC/28G
2
$42.48
0.01%
0
$0.00
0.00%
08290301603
5ML SYRINGE MIS SLIP TIP
0
$0.00
0.00%
1
$10.35
0.00%
08290301604
0
$0.00
0.00%
1
$10.86
0.00%
08290305106
YALE NEEDLES MIS 30GX1/2"
7
$267.85
0.03%
7
$364.50
0.03%
08290305109
YALE NEEDLES MIS 27GX1/2"
2
$7.84
0.01%
2
$12.68
0.01%
08290305125
HYPO NEEDLE MIS 25GX1"
2
$6.41
0.01%
0
$0.00
0.00%
08290305127
YALE NEEDLES MIS 25GX1.5"
0
$0.00
0.00%
2
$17.68
0.01%
08290305155
YALE NEEDLES MIS 22GX1"
4
$42.66
0.02%
4
$19.60
0.02%
08290305156
4
$9.32
0.02%
1
$2.20
0.00%
08290305167
YALE NEEDLES MIS 21X1.5"
1
$0.25
0.00%
1
$0.93
0.00%
08290305175
2
$20.50
0.01%
0
$0.00
0.00%
08290305195
2
$24.21
0.01%
0
$0.00
0.00%
08290305196
1
$10.25
0.00%
0
$0.00
0.00%
08290305198
1
$7.26
0.00%
0
$0.00
0.00%
08290305200
B-D FIL NEED MIS 5 MICRON
0
$0.00
0.00%
1
$17.15
0.00%
08290305500
2
$13.51
0.01%
1
$5.01
0.00%
08290305520
1ML ALLERGIS MIS 27GX1/2"
2
$7.62
0.01%
0
$0.00
0.00%
08290305540
ALLERGIST
3
$16.47
0.01%
3
$16.47
0.01%
MIS ORANGE
MIS 2.4MM
PAD BUTTRFLY
KIT 27GX1/2"
Page 308 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
08290305541
1ML ALLERGIS KIT TRAY SYR
0
08290305553
1ML TB SYRNG MIS 27GX1/2"
08290305554
SAFETY SYRNG MIS 25GX5/8"
08290305595
$0.00
0.00%
2
$8.76
0.01%
1
$5.35
0.00%
5
$59.42
0.02%
3
$20.74
0.01%
1
$6.61
0.00%
3ML SYRINGE MIS 23GX1"
1
$2.76
0.00%
0
$0.00
0.00%
08290305620
1/2ML TB SYR MIS 27GX1/2"
0
$0.00
0.00%
2
$2.94
0.01%
08290305903
1
$4.49
0.00%
0
$0.00
0.00%
08290305930
0
$0.00
0.00%
8
$257.45
0.03%
08290305932
124
$5,244.81
0.58%
137
$4,858.56
0.55%
08290305935
3
$94.61
0.01%
7
$258.95
0.03%
08290309570
3ML LL SYRNG MIS 25GX5/8"
60
$265.08
0.28%
46
$442.79
0.19%
08290309571
2
$3.85
0.01%
3
$0.84
0.01%
08290309572
4
$8.91
0.02%
8
$36.99
0.03%
08290309573
3ML LL SYRNG MIS 22GX1.25
1
$1.19
0.00%
0
$0.00
0.00%
08290309574
3ML LL SYRNG MIS 22GX1.5"
39
$134.16
0.18%
28
$91.54
0.11%
08290309575
5
$15.71
0.02%
3
$12.81
0.01%
08290309577
5
$18.91
0.02%
3
$5.07
0.01%
08290309578
3
$5.00
0.01%
0
$0.00
0.00%
08290309579
6
$17.34
0.03%
1
$1.97
0.00%
08290309580
1
$1.19
0.00%
0
$0.00
0.00%
08290309581
13
$73.84
0.06%
30
$159.56
0.12%
08290309582
9
$50.94
0.04%
8
$43.07
0.03%
08290309585
3ML SYRINGE MIS LUER-LOK
7
$65.06
0.03%
9
$101.03
0.04%
08290309587
0
$0.00
0.00%
1
$4.69
0.00%
08290309588
1
$1.19
0.00%
3
$7.35
0.01%
08290309589
B-D LL SYRNG MIS 23GX1.5"
3
$9.29
0.01%
1
$0.48
0.00%
08290309592
4
$54.88
0.02%
10
$76.84
0.04%
08290309593
0
$0.00
0.00%
1
$22.40
0.00%
Page 309 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
08290309594
3
$15.90
0.01%
2
$6.67
0.01%
08290309602
6
$30.74
0.03%
3
$8.19
0.01%
08290309603
2
$23.07
0.01%
1
$3.92
0.00%
08290309604
2
$24.72
0.01%
9
$52.79
0.04%
08290309623
51
$231.72
0.24%
52
$259.36
0.21%
08290309625
16
$65.21
0.07%
20
$101.77
0.08%
08290309626
65
$387.83
0.30%
49
$209.64
0.20%
08290309628
INSULIN SYRG MIS 1ML
0
$0.00
0.00%
2
$61.56
0.01%
08290309634
2
$3.48
0.01%
3
$42.90
0.01%
08290309637
LUER-LOK SYR MIS 1ML/20G
1
$19.66
0.00%
0
$0.00
0.00%
08290309642
10ML LL SYRN MIS 21GX1"
0
$0.00
0.00%
1
$26.53
0.00%
08290309644
10ML LL SYRN MIS 20GX1"
0
$0.00
0.00%
5
$776.65
0.02%
08290309650
1
$53.95
0.00%
0
$0.00
0.00%
08290309653
2
$44.13
0.01%
1
$24.71
0.00%
08290309661
1
$20.84
0.00%
0
$0.00
0.00%
08290309663
50-60ML SYRN MIS LUER LCK
3
$40.96
0.01%
0
$0.00
0.00%
08290309664
60ML SYRINGE MIS CATH TIP
1
$35.37
0.00%
0
$0.00
0.00%
08290320096
08290320109
B-D UF SHORT MIS PENNEEDL
08290320119
B-D UF MINI MIS PENNEEDL
08290321951
2
$14.98
0.01%
0
$0.00
0.00%
276
$7,963.06
1.29%
133
$4,113.16
0.54%
59
$1,895.20
0.28%
75
$2,046.21
0.30%
B-D PEN MINI MIS
1
$72.95
0.00%
0
$0.00
0.00%
08290322051
B-D LOGIC
0
$0.00
0.00%
1
$63.54
0.00%
08290322053
B-D TEST
TES
8
$1,262.89
0.04%
41
$3,499.95
0.17%
08290322054
BD TEST
MIS
0
$0.00
0.00%
2
$432.70
0.01%
08290322057
B-D ULTRA FI MIS 33G
5
$31.89
0.02%
4
$25.38
0.02%
08290322062
B-D ULTRA-FI MIS 33G
0
$0.00
0.00%
1
$2.78
0.00%
08290322065
B-D ULTRA-FI MIS DME/33G
0
$0.00
0.00%
2
$17.80
0.01%
KIT MONITOR
Page 310 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
08290325772
B-D ULT FINE MIS LANCETS
7
$56.45
0.03%
11
$141.03
0.04%
08290325773
B-D ULT FINE MIS LANCETS
63
$387.42
0.29%
55
$410.67
0.22%
08290325775
B-D LANCET MIS DEVICE
7
$74.30
0.03%
3
$31.47
0.01%
08290326895
B-D SWABS
24
$76.48
0.11%
77
$319.23
0.31%
08290328203
B-D UF ORIG MIS PENNEEDL
116
$2,815.62
0.54%
54
$1,363.85
0.22%
08290328230
B-D GLUCOSE CHW 5GM
5
$22.41
0.02%
7
$22.60
0.03%
08290328233
B-D MAGNI- MIS GUIDE
1
$5.30
0.00%
1
$3.49
0.00%
08290328245
INJECT-EASE MIS AUTO INJ
0
$0.00
0.00%
2
$38.88
0.01%
08290328410
65
$1,423.91
0.30%
62
$1,394.67
0.25%
08290328411
617
$15,155.61
2.89%
612
$14,289.22
2.48%
08290328418
299
$6,956.62
1.40%
342
$8,393.57
1.38%
08290328430
22
$516.78
0.10%
16
$366.42
0.06%
08290328431
272
$6,283.24
1.27%
183
$4,031.65
0.74%
08290328438
378
$9,176.04
1.77%
399
$9,990.59
1.62%
08290328440
17
$538.48
0.08%
34
$972.50
0.14%
08290328465
114
$2,401.12
0.53%
65
$1,410.11
0.26%
08290328466
901
$21,470.09
4.22%
745
$18,108.96
3.02%
08290328468
710
$17,622.03
3.32%
734
$18,327.92
2.97%
08290329411
0
$0.00
0.00%
6
$169.28
0.02%
08290329424
2
$51.16
0.01%
2
$50.14
0.01%
08290329461
0
$0.00
0.00%
3
$70.81
0.01%
08290329464
71
$2,373.50
0.33%
78
$2,490.64
0.32%
08290329466
6
$172.85
0.03%
14
$347.78
0.06%
08290329651
1
$5.00
0.00%
0
$0.00
0.00%
08290366579
B-D GENIE LA MIS NCETS
2
$18.70
0.01%
5
$114.25
0.02%
08290550002
4
$15.52
0.02%
4
$25.76
0.02%
08290550003
6
$91.96
0.03%
4
$51.15
0.02%
PAD REG
Page 311 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
08290823000
B-D GLUCOSE TAB
08290841002
08290841003
08290841101
08290841103
$3.66
0.00%
$0.00
0.00%
0
$0.00
0.00%
12
$226.47
0.06%
1
$21.85
0.00%
12
$263.55
0.05%
4
$90.95
0.02%
4
$56.55
0.02%
184
$4,541.98
0.86%
119
$2,758.20
0.48%
08290841203
1
08290841801
0
$18.97
0.00%
1
$21.64
0.00%
$0.00
0.00%
1
$7.86
0.00%
08290841803
34
$828.00
0.16%
66
$1,567.96
0.27%
08290843003
B-D MF SYRG MIS .3CC/28G
1
$9.73
0.00%
2
$87.36
0.01%
08290843101
08290843103
3
$77.19
0.01%
0
$0.00
0.00%
32
$839.47
0.15%
42
$1,101.08
0.17%
08290843801
1
$7.56
0.00%
2
$51.10
0.01%
08290843803
41
$1,169.72
0.19%
62
$1,754.01
0.25%
08290846503
B-D MF SYRG MIS .5CC/28G
7
$145.63
0.03%
22
$464.25
0.09%
08290846601
2
$48.96
0.01%
2
$51.50
0.01%
08290846603
150
$3,701.89
0.70%
187
$4,423.80
0.76%
08290846801
0
$0.00
0.00%
1
$14.37
0.00%
08290846803
90
$2,243.88
0.42%
172
$4,133.75
0.70%
08317220602
ASSURE II
LIQ LEVEL1-2
0
$0.00
0.00%
2
$23.70
0.01%
08317225050
ASSURE II
TES
0
$0.00
0.00%
8
$393.89
0.03%
08317880100
TECHLITE
MIS LANCETS
5
$21.75
0.02%
1
$7.05
0.00%
08317950000
HAEMOLANCE MIS LOW FLOW
0
$0.00
0.00%
3
$46.39
0.01%
08317955000
HAEMOLANCE MIS LOW FLOW
0
$0.00
0.00%
5
$44.40
0.02%
08326280001
ULTILET
0
$0.00
0.00%
1
$5.95
0.00%
08329290110
0
$0.00
0.00%
1
$23.75
0.00%
08329290150
1
$11.49
0.00%
1
$62.05
0.00%
08347100010
LANCETS
1
$6.35
0.00%
0
$0.00
0.00%
MIS LANCETS
MIS
1
0
Page 312 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
08373071800
ASSESS METER MIS FULL RNG
0
$0.00
0.00%
08373074200
ASTHMAMENTOR MIS
0
$0.00
0.00%
08373075500
PERSONAL BES MIS FULL RNG
0
$0.00
0.00%
08373075600
PERSONAL BES MIS LOW RNG
0
$0.00
0.00%
08373076500
OPTIHALER
MIS
0
$0.00
08373076510
OPTIHALER
MIS
0
08373076550
OPTIHALER
MIS
0
08373080010
OPTICHAMBER MIS ADVANTAG
08373080110
2
$41.72
0.01%
1
$21.82
0.00%
25
$481.12
0.10%
17
$345.44
0.07%
0.00%
19
$258.44
0.08%
$0.00
0.00%
40
$567.90
0.16%
$0.00
0.00%
1
$14.26
0.00%
0
$0.00
0.00%
46
$855.02
0.19%
OPTICHAMBER MIS ADV SM
0
$0.00
0.00%
1
$29.02
0.00%
08373080210
OPTICHAMBER MIS ADV MED
0
$0.00
0.00%
2
$58.04
0.01%
08373080310
OPTICHAMBER MIS ADV LRG
0
$0.00
0.00%
1
$27.63
0.00%
08373081210
OPTICHAMBER MIS FACE MAS
0
$0.00
0.00%
1
$11.85
0.00%
08385086701
PRECISION MIS 28G
0
$0.00
0.00%
1
$2.60
0.00%
08418992001
0
$0.00
0.00%
3
$44.97
0.01%
08418992101
6
$79.64
0.03%
2
$24.98
0.01%
08470053501
UNILET EX II MIS 28G
0
$0.00
0.00%
3
$14.55
0.01%
08470359001
UNIFINE PNTP MIS 6MM
0
$0.00
0.00%
2
$31.30
0.01%
08881501608
1ML TB SYRNG MIS 28GX1/2
1
$8.40
0.00%
0
$0.00
0.00%
08881511110
17
$663.55
0.08%
15
$576.63
0.06%
08881511136
12
$515.94
0.06%
16
$655.65
0.06%
08881511144
0
$0.00
0.00%
1
$77.43
0.00%
08881513207
PHARMACY TRA MIS 3ML
1
$1.41
0.00%
0
$0.00
0.00%
08881560141
60ML SYRINGE MIS CATH TIP
08881600004
08881600228
0
$0.00
0.00%
4
$85.72
0.02%
28
$554.95
0.13%
15
$317.25
0.06%
INSULIN SYRG MIS .5CC/28G
2
$45.78
0.01%
8
$174.36
0.03%
08881600251
0
$0.00
0.00%
18
$444.18
0.07%
08881600350
27
$516.35
0.13%
35
$764.94
0.14%
Page 313 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
08881600392
1
$13.28
0.00%
0
08881600700
1
$9.59
0.00%
08881601036
INSULIN SYRG MIS 1CC/28G
0
$0.00
0.00%
08881601044
INSULIN SYRG MIS 1CC/29G
3
$76.93
08881601101
31
08881601358
08881602018
MONOLET
MIS LANCETS
08881602034
MONOLET
08881602075
MONOLET
08881602125
08881602141
$0.00
0.00%
1
$21.17
0.00%
6
$134.52
0.02%
0.01%
9
$193.03
0.04%
$606.45
0.15%
13
$279.91
0.05%
34
$696.57
0.16%
30
$611.32
0.12%
10
$77.70
0.05%
10
$106.29
0.04%
MIS LANCETS
30
$128.85
0.14%
15
$77.79
0.06%
MIS LANCETS
12
$50.84
0.06%
8
$53.88
0.03%
MONOLET THIN MIS LANCETS
2
$9.34
0.01%
6
$17.58
0.02%
0
$0.00
0.00%
2
$16.44
0.01%
08881602190
1
$6.85
0.00%
3
$13.76
0.01%
08881602208
3
$28.74
0.01%
0
$0.00
0.00%
08881602216
2
$14.25
0.01%
0
$0.00
0.00%
08881608022
ULTRA COMFOR MIS .3ML/29G
0
$0.00
0.00%
1
$10.08
0.00%
08881609350
16
$394.88
0.07%
13
$294.14
0.05%
08881609358
16
$361.00
0.07%
10
$248.92
0.04%
08881609600
0
$0.00
0.00%
1
$22.99
0.00%
08881609700
1
$21.64
0.00%
0
$0.00
0.00%
08881713153
3ML SYRINGE MIS 21GX1.5"
1
$5.01
0.00%
0
$0.00
0.00%
08970201031
1
$14.30
0.00%
0
$0.00
0.00%
08970501021
ALLERGY SYRN MIS 1ML/27G
0
$0.00
0.00%
2
$5.27
0.01%
11822321570
0
$0.00
0.00%
2
$31.48
0.01%
11822321580
0
$0.00
0.00%
3
$48.47
0.01%
11822399280
RA LANCETS MIS
166
$704.36
0.78%
147
$553.98
0.60%
11822801460
RA GLUCOSE MIS MONITOR
1
$9.89
0.00%
1
$9.68
0.00%
11822801770
RA BLOOD
0
$0.00
0.00%
4
$216.06
0.02%
TES GLUCOSE
Page 314 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
11822801870
RA BLOOD
TES GLUCOSE
1
$40.84
0.00%
2
$78.18
0.01%
11822871860
LANCETS
MIS COLORED
5
$31.80
0.02%
10
$39.91
0.04%
11822989400
RA LANCET
8
$41.78
0.04%
4
$23.47
0.02%
18270010030
INJEX 30 AMP MIS
1
$44.35
0.00%
0
$0.00
0.00%
24385006576
ALCOHOL PREP PAD SWABS
1
$2.14
0.00%
0
$0.00
0.00%
24385065178
LANCETS
0
$0.00
0.00%
2
$18.71
0.01%
25294000804
EZ-LETS 28G MIS LANCETS
0
$0.00
0.00%
12
$58.70
0.05%
25294087100
EZ-LETS
0
$0.00
0.00%
1
$7.79
0.00%
30142009682
THIN LANCETS MIS
1
$6.85
0.00%
0
$0.00
0.00%
36652030108
THIN LANCETS MIS
7
$31.59
0.03%
7
$47.07
0.03%
36652030112
LANCETS
1
$3.85
0.00%
2
$14.28
0.01%
36652030208
THIN LANCETS MIS
3
$16.89
0.01%
0
$0.00
0.00%
36652030508
SUPER THIN MIS LANCET
6
$23.10
0.03%
21
$142.76
0.09%
36652040412
0
$0.00
0.00%
3
$39.84
0.01%
36652400003
3
$48.62
0.01%
0
$0.00
0.00%
36652402602
1
$10.08
0.00%
19
$186.82
0.08%
36652402703
3
$32.74
0.01%
0
$0.00
0.00%
36652402805
2
$20.16
0.01%
0
$0.00
0.00%
36652403608
1
$10.08
0.00%
0
$0.00
0.00%
36652403806
4
$40.32
0.02%
46
$430.80
0.19%
36652404901
RELION THIN MIS LANCETS
8
$13.92
0.04%
2
$4.73
0.01%
37205011882
LANCETS
1
$6.35
0.00%
1
$5.41
0.00%
37205014278
LANCETS THIN MIS
23
$120.77
0.11%
5
$23.09
0.02%
37205014282
LANCETS THIN MIS
4
$24.40
0.02%
0
$0.00
0.00%
37205022873
ALLERHIST-1 TAB 1.34MG
12
$163.47
0.06%
3
$38.67
0.01%
38396030108
THIN LANCETS MIS
0
$0.00
0.00%
2
$7.70
0.01%
38396030316
LANCETS
0
$0.00
0.00%
2
$8.90
0.01%
MIS THIN
MIS
MIS LANCETS
MIS THIN
MIS
MIS 26G
Page 315 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
38396030416
LANCETS
MIS THIN 30G
0
$0.00
0.00%
38396040102
0
$0.00
0.00%
38396040202
0
$0.00
0.00%
38396040302
0
$0.00
0.00%
38396040325
0
$0.00
38396040506
0
38396040525
0
38396040625
38396040725
$16.96
0.01%
4
$60.40
0.02%
21
$294.62
0.09%
5
$52.88
0.02%
0.00%
1
$12.49
0.00%
$0.00
0.00%
8
$171.86
0.03%
$0.00
0.00%
2
$24.98
0.01%
0
$0.00
0.00%
2
$27.48
0.01%
0
$0.00
0.00%
2
$27.48
0.01%
38396040825
0
$0.00
0.00%
1
$12.49
0.00%
38396041908
0
$0.00
0.00%
5
$115.85
0.02%
38396042008
0
$0.00
0.00%
4
$85.50
0.02%
38396042108
0
$0.00
0.00%
3
$74.84
0.01%
38396044902
4
$9.46
0.02%
2
$3.48
0.01%
38396045002
RELION
3
$16.41
0.01%
1
$6.42
0.00%
38396045102
9
$23.16
0.04%
38
$80.82
0.15%
38396045202
5
$29.85
0.02%
9
$50.25
0.04%
38396047001
RELION PEN MIS 29G/12MM
0
$0.00
0.00%
2
$14.86
0.01%
38396047002
RELION PEN MIS 31G/8MM
0
$0.00
0.00%
7
$131.49
0.03%
44229014006
PARI MASK
0
$0.00
0.00%
1
$4.51
0.00%
44229014013
TUBING SET/ MIS ADAPTER
0
$0.00
0.00%
1
$6.06
0.00%
44229044004
CONVERSION MIS BABY SZ2
0
$0.00
0.00%
1
$16.05
0.00%
44229085002
PRONEB ULTRA MIS 3YR WARR
0
$0.00
0.00%
27
$2,255.70
0.11%
47360017201
MICROSPACER MIS
0
$0.00
0.00%
10
$61.91
0.04%
49281025010
IMOVAX RABIE INJ 2.5/ML
3
$978.97
0.01%
0
$0.00
0.00%
49281027183
TET/DIP ADLT INJ 5-2LF
0
$0.00
0.00%
1
$111.84
0.00%
49281037211
FLUZONE SPLT INJ 2003-04
3
$43.94
0.01%
0
$0.00
0.00%
MIS LANCETS
MIS PED PVC
3
Page 316 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
49281037215
14
49281037415
49281048901
MENOMUNE
INJ A/C/Y/W
49281048905
MENOMUNE
INJ A/C/Y/W
49281054505
ACTHIB
49281075221
TUBERSOL
49281079001
TYPHIM VI
49281080083
$275.30
0.07%
0
$0.00
0.00%
0
$0.00
0.00%
1
$73.24
0.00%
14
$250.34
0.06%
17
$1,968.03
0.07%
1
$64.46
0.00%
0
$0.00
0.00%
0
$0.00
0.00%
1
$23.83
0.00%
INJ 5/0.1ML
INJ
1
$27.40
0.00%
0
$0.00
0.00%
0
$0.00
0.00%
1
$43.85
0.00%
TETANUS TOX INJ 5LF ADS
1
$88.61
0.00%
1
$132.96
0.00%
49281088001
THERACYS
0
$0.00
0.00%
1
$977.50
0.00%
49348024110
THIN LANCETS MIS
1
$3.85
0.00%
0
$0.00
0.00%
49348036810
2
$26.56
0.01%
1
$10.99
0.00%
49348036910
0
$0.00
0.00%
8
$133.46
0.03%
49348037010
0
$0.00
0.00%
1
$14.44
0.00%
49348056322
SM LANCETS MIS
1
$6.35
0.00%
0
$0.00
0.00%
49348068603
V-R DAILYHST TAB 1.34MG
3
$48.27
0.01%
0
$0.00
0.00%
49348090910
1
$16.08
0.00%
0
$0.00
0.00%
49348091010
2
$32.16
0.01%
0
$0.00
0.00%
49483001901
PARA-TIME
0
$0.00
0.00%
1
$5.28
0.00%
49502020001
ASTECH PEAK MIS FLOW MTR
0
$0.00
0.00%
8
$145.38
0.03%
49502020701
EASIVENT
MIS
0
$0.00
0.00%
318
$5,569.85
1.29%
49502020725
EASIVENT
MIS
0
$0.00
0.00%
1
$16.95
0.00%
49502083003
SOD CHLORIDE NEB 0.9%
45
$702.34
0.21%
48
$711.97
0.19%
49502083005
0
$0.00
0.00%
9
$182.75
0.04%
49884014301
HYDRAL/HCTZ CAP 25/25
2
$47.70
0.01%
1
$23.33
0.00%
49884028901
39
$477.71
0.18%
22
$296.26
0.09%
49884029001
58
$1,339.42
0.27%
20
$430.76
0.08%
49884029004
8
$324.40
0.04%
0
$0.00
0.00%
INJ
INJ
CAP 150MG ER
Page 317 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
49884029005
49884072401
49884090738
49884090788
49884092202
$1,331.54
0.28%
$1,265.22
0.20%
6
$228.60
0.03%
302
$38,226.07
1.41%
29
$1,017.45
0.12%
240
$29,263.81
0.97%
0
$0.00
0.00%
1
$113.75
0.00%
0
$0.00
0.00%
22
$704.43
0.09%
50242004164
CATHFLO ACTI INJ VASE
0
50428001771
CVS LANCETS MIS THIN
3
$0.00
0.00%
1
$134.68
0.00%
$11.55
0.01%
0
$0.00
0.00%
50428001772
0
$0.00
0.00%
1
$10.43
0.00%
50428001773
CVS LANCETS MIS ORIGINAL
1
$6.85
0.00%
0
$0.00
0.00%
50428235155
50428235157
ULTRA THIN MIS LANCETS
0
$0.00
0.00%
1
$7.93
0.00%
ULTRA THIN MIS LANCETS
3
$9.34
0.01%
3
$25.83
0.01%
50486007822
BRONCHO SAL AER 0.9%
1
$6.74
0.00%
4
$36.05
0.02%
50486007823
140
$1,203.01
0.66%
97
$885.45
0.39%
50486008320
PEAK FLOW
0
$0.00
0.00%
12
$158.68
0.05%
50486008321
POCKETPEAK MIS MTR LOW
0
$0.00
0.00%
3
$38.42
0.01%
50486008410
ASSESS METER MIS FULL
0
$0.00
0.00%
51
$846.33
0.21%
50486008413
PERSONAL BES MIS FULL RNG
0
$0.00
0.00%
2
$44.58
0.01%
50486008415
ASSESS METER MIS LOW
0
$0.00
0.00%
22
$397.56
0.09%
50486008420
OPTIHALER
MIS
0
$0.00
0.00%
8
$132.17
0.03%
50924001901
ACCU-CHEK
KIT COMPACT
17
$1,636.45
0.08%
23
$1,366.38
0.09%
50924008310
ACCU-CHEK
TES COMFORT
0
$0.00
0.00%
11
$792.85
0.04%
50924010401
ACCU-CHEK
KIT ADVANTAG
1
$44.35
0.00%
0
$0.00
0.00%
50924012850
ACCU-CHEK
TES COMFORT
10
$835.39
0.05%
0
$0.00
0.00%
50924012910
ACCU-CHECK TES COMFORT
4
$281.11
0.02%
0
$0.00
0.00%
50924023150
ACTIVE
0
$0.00
0.00%
3
$187.55
0.01%
50924026801
ACCU-CHEK S SOL CONTROLS
0
$0.00
0.00%
1
$8.02
0.00%
50924027650
ACCU-CHEK
8
$440.62
0.04%
1
$36.35
0.00%
MIS METER
TES
TES SIMPLICI
59
49
Page 318 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
50924030202
ACCU-CHEK
LIQ CPT/GLUC
1
$7.22
0.00%
0
50924031410
ACCU-CHEK
TES SIMPLICI
4
$274.27
0.02%
50924036550
ACCU-CHEK
TES COMFORT
1
$36.35
0.00%
50924037350
ACCU-CHEK
TES COMFORT
256
$14,121.95
50924038110
ACCU-CHEK
TES COMFORT
697
50924041102
ACCU-CHEK
SOL COMFORT
50924047550
ACCU-CHEK
TES ACTIVE
50924047701
ACCU-CHEK
KIT ACTIVE
50924050125
CHEMSTRIP BG TES VISL STR
50924051501
ACCU-CHEK
50924055201
GLUCOSE CONT SOL ADVANTAG
50924055350
ACCU-CHEK
50924058001
$0.00
0.00%
0
$0.00
0.00%
6
$208.52
0.02%
1.20%
229
$10,373.67
0.93%
$53,937.40
3.26%
672
$45,599.53
2.72%
0
$0.00
0.00%
4
$20.77
0.02%
114
$5,283.51
0.53%
136
$6,033.31
0.55%
9
$158.22
0.04%
15
$216.78
0.06%
1
$71.85
0.00%
0
$0.00
0.00%
10
$1,042.31
0.05%
8
$656.57
0.03%
3
$16.06
0.01%
0
$0.00
0.00%
42
$2,069.04
0.20%
44
$2,090.80
0.18%
SOFT TOUCH MIS LAN DEVC
1
$12.81
0.00%
1
$12.54
0.00%
50924058510
SOFT TOUCH MIS LANCETS
15
$83.36
0.07%
14
$121.34
0.06%
50924064101
COMPACT
0
$0.00
0.00%
1
$111.98
0.00%
50924084810
ACCU-CHEK
TES COMFORT
3
$211.44
0.01%
0
$0.00
0.00%
50924086001
ACCU-CHEK
KIT ADVANTAG
54
$3,131.95
0.25%
61
$3,254.83
0.25%
50924087001
ACCU-CHEK AD MIS METER
0
$0.00
0.00%
1
$41.41
0.00%
50924087710
ACCU-CHEK
0
$0.00
0.00%
3
$108.48
0.01%
50924088250
COMFORT
TES CURVE
0
$0.00
0.00%
3
$111.55
0.01%
50924088401
ACCU-CHEK
TES DRUM
48
$3,817.26
0.22%
154
$12,050.46
0.62%
50924090001
ACCU-CHEK
TES COMFORT
0
$0.00
0.00%
1
$71.85
0.00%
50924091350
ACCU-CHEK
TES INST GLC
27
$1,256.90
0.13%
21
$1,162.10
0.09%
50924091901
ACCU-CHEK IN LIQ CONTROL
2
$7.26
0.01%
1
$4.25
0.00%
50924093720
SOFT TOUCH MIS LANCETS
1
$0.96
0.00%
0
$0.00
0.00%
50924095120
SAFE-T-PRO MIS LANCETS
1
$6.85
0.00%
3
$16.14
0.01%
50924095701
SOFTCLIX LAN MIS DEVICE
2
$49.81
0.01%
5
$102.65
0.02%
KIT COMPLETE
TES ADVANTAG
TES
TES INST GLC
Page 319 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ACCU-CHEK
50924097110
SOFTCLIX
50924098820
SOFTCLIX
50924098850
ACCU-CHEK
51079058205
$
Market Share*
MICELLANEOUS
50924096610
# of Scripts
TES ADVANTAG
103
$7,106.23
0.48%
106
$7,284.50
0.43%
MIS LANCETS
351
$2,252.14
1.64%
399
$3,963.79
1.62%
MIS LANCETS
34
$341.26
0.16%
31
$454.43
0.13%
184
$12,414.66
0.86%
227
$12,076.30
0.92%
LEUCOVOR CA TAB 25MG
1
$311.35
0.00%
1
$797.80
0.00%
51285005866
SEASONALE
5
$541.25
0.02%
15
$929.68
0.06%
51285050902
6
$29.35
0.03%
0
$0.00
0.00%
52735089301
FP LANCETS MIS THIN
2
$6.98
0.01%
0
$0.00
0.00%
52735089402
LANCET SUPER MIS THIN
0
$0.00
0.00%
3
$14.05
0.01%
52769047180
POLYGAM S/D SOL 10GM
9
$48,749.24
0.04%
2
$6,151.60
0.01%
53885004610
LIFESCAN FIN MIS LANCETS
79
$530.99
0.37%
78
$674.35
0.32%
53885004810
FASTTAKE
TES
22
$1,511.00
0.10%
30
$2,859.22
0.12%
53885005210
SURESTEP
TES
140
$10,408.46
0.66%
79
$5,671.98
0.32%
53885010198
ONE TOUCH
TES
0
$0.00
0.00%
4
$145.40
0.02%
53885010207
ONE TOUCH
MIS LANCETS
5
$37.35
0.02%
1
$16.99
0.00%
53885010374
ONE TOUCH
TES
0
$0.00
0.00%
6
$369.47
0.02%
53885019725
ONE TOUCH
TES
11
$386.69
0.05%
14
$685.82
0.06%
53885019850
ONE TOUCH
TES
289
$14,971.58
1.35%
243
$11,051.39
0.98%
53885020701
LANCETS
1
$3.85
0.00%
1
$10.13
0.00%
53885024450
ONE TOUCH
TES ULTRA
463
$29,339.00
2.17%
686
$41,766.01
2.78%
53885024510
ONE TOUCH
TES ULTRA
1,446
$124,961.34
6.77%
1,945
$160,659.61
7.87%
53885024701
ONE TOUCH
KIT ULTRA
139
$7,802.36
0.65%
195
$10,066.87
0.79%
53885027202
ONE TOUCH
SOL NORM CON
4
$19.89
0.02%
4
$16.24
0.02%
53885028425
ONE TOUCH
SOL NORM CON
1
$2.25
0.00%
1
$5.90
0.00%
53885028550
ONE TOUCH
TES
25
$1,314.21
0.12%
14
$773.46
0.06%
53885032501
ONE TOUCH
KIT BASIC
66
$2,754.26
0.31%
65
$2,529.80
0.26%
53885034101
SURESTEP
KIT W/METER
8
$424.40
0.04%
5
$213.20
0.02%
TES COMPACT
TAB
MIS
Page 320 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
53885035601
PENLET II
KIT BLOOD
53885035702
ONE TOUCH
53885035950
SURESTEP
53885037201
ONE TOUCH
KIT PROFILE
53885037410
ONE TOUCH
TES
53885039310
ONE TOUCH US MIS LANCETS
53885044450
FASTTAKE
53885045802
ONE TOUCH
53885052401
SOL HIGH/LOW
5
$85.05
0.02%
6
$100.74
0.02%
0
$0.00
0.00%
2
$9.68
0.01%
65
$3,585.63
0.30%
57
$3,104.04
0.23%
1
$100.03
0.00%
0
$0.00
0.00%
662
$46,153.79
3.10%
524
$33,147.55
2.12%
477
$3,057.47
2.23%
797
$7,148.74
3.23%
32
$1,883.65
0.15%
26
$1,544.32
0.11%
SOL ULT CONT
4
$26.52
0.02%
6
$32.08
0.02%
ONE TOUCH
KIT ULT SMRT
26
$1,909.73
0.12%
25
$1,743.73
0.10%
53885053701
ONE TOUCH
KIT INDUO
0
$0.00
0.00%
1
$87.29
0.00%
53885053810
ONE TOUCH UL KIT BONUS
1
$67.87
0.00%
0
$0.00
0.00%
53885063610
UNISTIK II MIS LANCETS
2
$7.35
0.01%
2
$24.20
0.01%
53885063702
SURESTEP
SOL CONTROL
0
$0.00
0.00%
2
$7.94
0.01%
53885099425
ONE TOUCH
TES ULTRA
12
$816.45
0.06%
22
$715.03
0.09%
53905050101
RABAVERT
INJ
3
$762.04
0.01%
2
$612.80
0.01%
54092000301
PROAMATINE TAB 2.5MG
6
$376.16
0.03%
4
$195.49
0.02%
54092000401
PROAMATINE TAB 5MG
34
$5,841.90
0.16%
8
$2,173.67
0.03%
54092000701
PROAMATINE TAB 10MG
4
$1,384.55
0.02%
10
$2,333.89
0.04%
54092017030
FARESTON
6
$643.98
0.03%
3
$314.64
0.01%
54482005301
MATULANE
CAP 50MG
6
$157.71
0.03%
0
$0.00
0.00%
54482014407
CARNITOR
TAB 330MG
89
$6,887.89
0.42%
70
$4,929.26
0.28%
54482014508
CARNITOR
SOL 10%
214
$13,175.36
1.00%
106
$5,568.07
0.43%
54569263000
2
$131.22
0.01%
0
$0.00
0.00%
54569279000
ENGERIX-B
3
$167.38
0.01%
0
$0.00
0.00%
54569403700
3
$27.71
0.01%
0
$0.00
0.00%
54569519000
ONE TOUCH
2
$7.70
0.01%
0
$0.00
0.00%
54569537100
HAVRIX
1
$59.09
0.00%
0
$0.00
0.00%
TES
TES
TAB 60MG
INJ 20MCG/ML
MIS LANCETS
INJ
Page 321 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
55283086501
THIN GP LANC MIS 26 GAUGE
55390000401
GLUCAGEN
55390003110
METHOTREXATE INJ 25MG/ML
55390003210
55390003310
1
$6.35
0.00%
0
$0.00
0.00%
6
$430.73
0.03%
38
$3,199.55
0.15%
13
$79.90
0.06%
23
$231.98
0.09%
0
$0.00
0.00%
12
$144.73
0.05%
0
$0.00
0.00%
2
$10.46
0.01%
55390003410
9
$54.79
0.04%
11
$66.41
0.04%
55390023701
ADRIAMYCIN INJ 2MG/ML
3
$208.23
0.01%
4
$145.52
0.02%
55390029201
ETOPOSIDE
2
$163.74
0.01%
0
$0.00
0.00%
55390087501
EPHEDRINE SU INJ 50MG/ML
0
$0.00
0.00%
4
$70.36
0.02%
56151014201
PRESTIGE LIT MIS TOUCH
0
$0.00
0.00%
2
$16.96
0.01%
56151014260
PRES SMART MIS LANCETS
5
$22.75
0.02%
3
$17.23
0.01%
56151020201
BLOOD GLUCOS KIT SYSTEM
1
$13.49
0.00%
1
$14.04
0.00%
56151030201
BLOOD GLUCOS TES
6
$327.07
0.03%
0
$0.00
0.00%
56151030250
BLOOD GLUCOS TES
9
$425.43
0.04%
0
$0.00
0.00%
56151030750
CVS BLOOD
0
$0.00
0.00%
4
$82.86
0.02%
56151055001
PRESTIGE
TES
3
$153.08
0.01%
1
$49.34
0.00%
56151055050
PRESTIGE
TES
12
$468.26
0.06%
11
$415.69
0.04%
56151060101
KETOCARE
0
$0.00
0.00%
1
$14.40
0.00%
56151071001
TRUETRACK
TES
0
$0.00
0.00%
7
$378.75
0.03%
56151075050
TRUETRACK
TES
0
$0.00
0.00%
3
$124.98
0.01%
56151077770
TRUETRACK
KIT SYSTEM
0
$0.00
0.00%
7
$15.92
0.03%
56151081001
TRUETRACK
TES
0
$0.00
0.00%
4
$232.52
0.02%
56151083003
TRUETRACK
TES
1
$45.99
0.00%
0
$0.00
0.00%
56151086101
TRUETRACK
LIQ GLUCOSE
0
$0.00
0.00%
1
$3.68
0.00%
56151086301
TRUETRACK
LIQ GLUCOSE
0
$0.00
0.00%
1
$3.68
0.00%
56151091001
PRESTIG SMRT TES
7
$303.96
0.03%
17
$949.78
0.07%
56151095050
PRESTIG SMRT TES
0
$0.00
0.00%
5
$258.07
0.02%
INJ 1MG
INJ 20MG/ML
TES GLUCOSE
TES
Page 322 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
56151099902
PRESTIGE SMT KIT SYS/METR
1
$44.34
0.00%
0
$0.00
0.00%
57565006100
E-Z JECT
MIS LANCETS
2
$9.31
0.01%
4
$30.38
0.02%
57565006101
E-Z JECT
MIS LANCETS
1
$3.85
0.00%
2
$2.00
0.01%
57599004305
THIN LANCETS MIS
0
$0.00
0.00%
5
$21.40
0.02%
57599055001
CONTROL SOL LIQ HIGH/LOW
0
$0.00
0.00%
4
$15.78
0.02%
57599740004
PRECISION TES QID
25
$1,213.98
0.12%
25
$1,625.90
0.10%
57599740105
PRECISION TES QID
72
$4,635.92
0.34%
50
$3,333.69
0.20%
57599740201
PRECISION MIS QID TEST
3
$88.49
0.01%
1
$43.30
0.00%
57599833501
PRECISION TES QID
3
$116.55
0.01%
3
$116.55
0.01%
57599854801
33
$590.57
0.15%
11
$207.38
0.04%
57599854901
21
$380.59
0.10%
4
$111.20
0.02%
57599855001
3
$48.71
0.01%
4
$73.60
0.02%
57599868105
THIN LANCETS MIS
5
$25.92
0.02%
0
$0.00
0.00%
57599868206
THIN LANCETS MIS
2
$14.37
0.01%
1
$13.37
0.00%
57599881401
PRECISION MIS XTRA
1
$65.94
0.00%
0
$0.00
0.00%
57599881508
PRECISN XTRA TES KETONE
22
$612.54
0.10%
12
$560.02
0.05%
57599889401
4
$87.93
0.02%
1
$23.24
0.00%
57599889501
2
$57.59
0.01%
0
$0.00
0.00%
57599895601
PRECISION XT TES STRIPS
28
$2,807.59
0.13%
3
$220.55
0.01%
57599913404
OPTIUM
TES
0
$0.00
0.00%
1
$109.85
0.00%
57599958601
PRECISION TES SOF-TACT
0
$0.00
0.00%
3
$33.16
0.01%
57599958604
PRECISION TES SOF-TACT
2
$217.20
0.01%
2
$321.35
0.01%
57599969405
PRECISION TES XTRA
3
$215.55
0.01%
3
$218.05
0.01%
57599969504
PRECISION TES XTRA
2
$143.70
0.01%
0
$0.00
0.00%
57599972804
PRECISION TES XTRA
44
$3,124.35
0.21%
28
$2,031.58
0.11%
57599983804
PRECISION TES XTRA
0
$0.00
0.00%
8
$179.91
0.03%
57599987705
PRECISION TES XTRA
64
$5,223.11
0.30%
64
$6,142.48
0.26%
Page 323 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
57599987805
PRECISION TES XTRA
57844052206
PURINETHOL TAB 50MG
57844052207
PURINETHOL TAB 50MG
57844052252
PURINETHOL TAB 50MG
58160083501
HAVRIX
INJ 1440UNIT
58160083532
HAVRIX
INJ 1440 U
58160083541
HAVRIX
INJ 1440UNIT
58160083546
HAVRIX
58160083701
$511.86
0.13%
60
$9,310.81
0.24%
97
$17,257.57
0.39%
0.00%
0
$0.00
0.00%
$2,136.38
0.16%
30
$1,775.19
0.12%
0
$0.00
0.00%
1
$59.03
0.00%
7
$407.38
0.03%
3
$172.02
0.01%
INJ 1440UNIT
1
$57.84
0.00%
0
$0.00
0.00%
HAVRIX
INJ
3
$99.21
0.01%
13
$440.90
0.05%
58160083705
HAVRIX
INJ 720U/0.5
1
$29.22
0.00%
0
$0.00
0.00%
58160085001
TWINRIX
INJ
0
$0.00
0.00%
6
$498.18
0.02%
58160085046
TWINRIX
INJ
0
$0.00
0.00%
2
$166.44
0.01%
58160085601
ENGERIX-B
INJ 10/0.5ML
1
$47.00
0.00%
1
$23.40
0.00%
58160085701
ENGERIX-B
INJ 20MCG/ML
165
$9,067.95
0.77%
138
$8,666.50
0.56%
58160085716
ENGERIX-B
INJ 20MCG/ML
1
$53.59
0.00%
2
$107.82
0.01%
58160085746
ENGERIX-B
INJ 20MCG/ML
1
$53.88
0.00%
1
$54.19
0.00%
58160085750
ENGERIX-B
INJ 20MCG/ML
1
$56.38
0.00%
0
$0.00
0.00%
58160086001
ENGERIX-B
INJ 20MCG/ML
5
$246.44
0.02%
1
$47.69
0.00%
58337000301
VIVOTIF BERN CAP EC
6
$233.78
0.03%
10
$357.71
0.04%
58468004001
FABRAZYME
INJ 35MG
3
$97,552.50
0.01%
0
$0.00
0.00%
58468184904
THYROGEN
INJ 1.1MG
1
$1,202.54
0.00%
3
$4,196.05
0.01%
59366269306
14
$171.95
0.07%
8
$94.19
0.03%
59572020514
THALOMID
CAP 50MG
2
$4,814.98
0.01%
4
$19,273.75
0.02%
59572020594
THALOMID
CAP 50MG
19
$16,787.07
0.09%
5
$10,414.88
0.02%
59572030250
ALKERAN
0
$0.00
0.00%
1
$11.55
0.00%
59779032301
9
$47.21
0.04%
6
$29.44
0.02%
59779032304
CVS LANCETS MIS ORIGINAL
2
$14.78
0.01%
3
$16.86
0.01%
TAB 2MG
1
$14.49
0.00%
32
0
$0.00
0.00%
47
$5,915.03
0.22%
1
$209.04
35
Page 324 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
59779114796
7
$87.43
0.03%
11
$128.39
0.04%
59779114799
7
$88.43
0.03%
4
$43.96
0.02%
59779114803
0
$0.00
0.00%
3
$32.97
0.01%
59779114811
7
$76.95
0.03%
9
$112.91
0.04%
59911587401
1
$10.85
0.00%
0
$0.00
0.00%
59930160901
55
$1,210.72
0.26%
48
$973.60
0.19%
59930160902
2
$91.10
0.01%
1
$45.55
0.00%
60492002301
WINRHO SDF INJ 1500UNIT
11
$4,409.46
0.05%
2
$801.72
0.01%
60598000101
NIASPAN
TAB 500MG ER
379
$17,539.50
1.77%
517
$30,732.96
2.09%
60598000201
NIASPAN
TAB 750MG ER
60598000301
NIASPAN
TAB 1000 ER
61059007715
16
$1,228.68
0.07%
22
$1,927.58
0.09%
169
$11,024.98
0.79%
215
$18,139.68
0.87%
UNISTIK II MIS 2.4MM
0
$0.00
0.00%
80
$1,110.78
0.32%
61570041881
ADRENALIN
INJ 1MG/ML
1
$22.67
0.00%
0
$0.00
0.00%
61703030906
VINCRISTINE INJ 1MG/ML
16
$113.92
0.07%
7
$49.84
0.03%
61703030916
VINCRISTINE INJ 1MG/ML
23
$229.08
0.11%
22
$215.82
0.09%
62107006701
3
$65.04
0.01%
0
$0.00
0.00%
62107006801
3
$46.71
0.01%
0
$0.00
0.00%
62161000420
CYSTADANE
62161000820
XYREM
62592049603
BUPHENYL
63323011710
POW
4
$894.14
0.02%
3
$753.81
0.01%
SOL 500MG/ML
3
$1,585.95
0.01%
9
$3,755.81
0.04%
TAB 500MG
0
$0.00
0.00%
3
$7,918.77
0.01%
FLUOROURACIL INJ 50MG/ML
15
$150.30
0.07%
27
$361.40
0.11%
63323011720
11
$113.15
0.05%
0
$0.00
0.00%
63323011751
0
$0.00
0.00%
3
$33.87
0.01%
63323011761
0
$0.00
0.00%
4
$39.94
0.02%
63323012102
8
$95.75
0.04%
15
$160.85
0.06%
63323012110
1
$11.19
0.00%
2
$24.88
0.01%
63323012302
8
$70.20
0.04%
23
$405.15
0.09%
Page 325 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
63323012310
63323018510
STERIL WATER INJ
63323025930
64116001112
ACTIMMUNE
64248015030
VANIQA
64894082550
HECTOROL
64980050312
LEVOCARNITIN SOL 10%
65197000101
5
$71.28
0.02%
6
$69.18
0.02%
10
$45.42
0.05%
3
$27.35
0.01%
1
$5.50
0.00%
0
$0.00
0.00%
8
$25,698.71
0.04%
5
$16,251.80
0.02%
0
$0.00
0.00%
1
$43.17
0.00%
7
$519.50
0.03%
7
$838.02
0.03%
0
$0.00
0.00%
2
$27.90
0.01%
DIBENZYLINE CAP 10MG
0
$0.00
0.00%
2
$677.54
0.01%
66004005501
ULTIMA
KIT MONITOR
0
$0.00
0.00%
1
$6.38
0.00%
66004012205
ULTIMA
TES
0
$0.00
0.00%
6
$324.83
0.02%
66004953904
RELION BLOOD TES GLUCOSE
4
$195.90
0.02%
5
$228.84
0.02%
66004969105
RELION BLOOD TES GLUCOSE
22
$1,186.92
0.10%
11
$574.22
0.04%
66479013501
106
$1,179.09
0.50%
9
$315.18
0.04%
66479013509
23
$427.21
0.11%
5
$91.33
0.02%
66479013611
10
$128.80
0.05%
8
$60.92
0.03%
66479013613
0
$0.00
0.00%
14
$324.08
0.06%
66479013619
3
$54.57
0.01%
3
$69.39
0.01%
66521010501
FLUVIRIN
INJ 2002-03
6
$71.50
0.03%
0
$0.00
0.00%
66607100206
ORFADIN
CAP 2MG
3
$4,312.68
0.01%
0
$0.00
0.00%
66607101006
ORFADIN
CAP 10MG
13
$21,929.23
0.06%
2
$80.00
0.01%
67386020111
CHEMET
CAP 100MG
0
$0.00
0.00%
2
$413.58
0.01%
68115071800
ONE TOUCH
TES ULTRA
0
$0.00
0.00%
2
$143.70
0.01%
72058004075
DIAFOODS
POW THICK-IT
47
$1,467.55
0.22%
41
$1,453.30
0.17%
72058004076
DIAFOODS
POW THICK-IT
34
$773.89
0.16%
45
$981.20
0.18%
72058004080
DIAFOODS #2 POW THICK-IT
12
$183.49
0.06%
7
$106.05
0.03%
72058004081
DIAFOODS #2 POW THICK-IT
1
$17.54
0.00%
3
$167.24
0.01%
73796069940
PEAK AIR FLO MIS ADLT/PED
0
$0.00
0.00%
18
$244.14
0.07%
INJ 2MU/0.5
CRE 13.9%
CAP 2.5MCG
Page 326 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
75537030381
ACCU-CK COMF TES CURVE
36
$2,519.14
0.17%
21
$1,131.78
0.09%
81306051413
11
$118.38
0.05%
14
$146.12
0.06%
81306051423
29
$350.50
0.14%
43
$547.34
0.17%
81306051513
71
$808.40
0.33%
67
$707.94
0.27%
81306051523
95
$1,134.59
0.44%
98
$1,159.51
0.40%
81306051613
47
$525.24
0.22%
45
$494.91
0.18%
81306051623
43
$479.00
0.20%
76
$833.08
0.31%
86227090055
0
$0.00
0.00%
8
$185.78
0.03%
87701095987
LANCETS THIN MIS
0
$0.00
0.00%
1
$13.13
0.00%
93815097137
ULTRA TLC
MIS LANCETS
1
$1.00
0.00%
0
$0.00
0.00%
93815097138
ULTRA TLC
MIS LANCETS
5
$20.54
0.02%
1
$8.89
0.00%
94542051150
SURELITE
1
$3.85
0.00%
0
$0.00
0.00%
99073011001
FS SYSTEM KT KIT
32
$2,095.71
0.15%
43
$2,391.46
0.17%
99073011003
FS SYSTEM KT KIT
3
$198.30
0.01%
0
$0.00
0.00%
99073011004
FS SYSTEM KT KIT
5
$335.50
0.02%
1
$64.60
0.00%
99073012001
FREESTYLE
TES
231
$18,869.62
1.08%
152
$14,486.10
0.62%
99073012050
FREESTYLE
TES
190
$12,435.48
0.89%
271
$17,099.65
1.10%
99073012051
FREESTYLE
KIT SIDEKICK
1
$61.80
0.00%
1
$74.43
0.00%
99073012101
FREESTYLE
TES
244
$19,245.77
1.14%
526
$41,939.22
2.13%
99073012301
FREESTYLE
TES
1
$47.50
0.00%
2
$214.70
0.01%
99073012350
FREESTYLE
TES
0
$0.00
0.00%
1
$108.54
0.00%
99073012401
FREESTYLE
TES
13
$805.45
0.06%
3
$218.05
0.01%
99073012450
FREESTYLE
TES
15
$1,209.20
0.07%
106
$5,838.63
0.43%
99073013001
FREESTYLE
MIS LANCETS
209
$1,355.14
0.98%
341
$3,187.25
1.38%
99073014001
FREESTYLE
LIQ CONTROL
3
$36.11
0.01%
1
$14.14
0.00%
99073014002
FREESTYLE
LIQ NORMAL
0
$0.00
0.00%
6
$32.49
0.02%
99073017001
FREESTYLE
KIT FLASH
6
$392.56
0.03%
20
$7,494.36
0.08%
MIS LANCETS
Page 327 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MICELLANEOUS
99073041001
FS SYSTEM KT KIT
0
$0.00
0.00%
99073042001
FREESTYLE
TES
0
$0.00
0.00%
99073042050
FREESTYLE
TES
0
$0.00
0.00%
1
$64.60
0.00%
2
$93.91
0.01%
12
$1,227.40
0.05%
MIGRAINE - CARBOXYLIC ACID DERIVATIVES
00074382611
DEPAKOTE ER TAB 250 MG
2
$52.89
0.06%
5
$352.79
0.10%
00074382613
DEPAKOTE ER TAB 250 MG
507
$23,712.48
14.20%
955
$58,433.50
19.67%
00074712611
DEPAKOTE ER TAB 500MG
0
$0.00
0.00%
2
$498.90
0.04%
00074712613
3,051
$390,652.31
85.46%
3,833
$568,101.89
78.97%
00074712653
10
$1,054.63
0.28%
59
$8,998.81
1.22%
1
$110.28
16.67%
0
$0.00
0.00%
3
$2,831.65
50.00%
0
$0.00
0.00%
2
$131.82
33.33%
13
$1,846.31
100.00%
MIGRAINE - ERGOTAMINE DERIVATIVES
00078024598
MIGRANAL
66490004101
D.H.E. 45
66490024598
MIGRANAL
SPR 4MG/ML
INJ 1MG/ML
SPR 4MG/ML
MIGRAINE - MISC.
00078003302
CAFERGOT
SUP 2/100
19
$954.02
21.35%
12
$2,161.01
15.19%
00078034905
CAFERGOT
TAB 1-100MG
63
$1,843.74
70.79%
47
$1,482.63
59.49%
00574085005
DIHYDROERGOT INJ 1MG/ML
0
$0.00
0.00%
2
$1,329.10
2.53%
00677177501
BEL-TABS
TAB
1
$42.56
1.12%
0
$0.00
0.00%
51991004501
SPASTRIN
TAB
6
$90.42
6.74%
7
$123.96
8.86%
51991039501
MIGRAZONE
0
$0.00
0.00%
10
$134.94
12.66%
53746014101
ISOMETH/APAP CAP DICHLOR
0
$0.00
0.00%
1
$11.29
1.27%
$0.00
0.00%
1
$203.75
0.35%
CAP
MIGRAINE - SELECTIVE SEROTONIN AGONISTS (5HT)--Injectables
00173044901
IMITREX
KIT 6MG/0.5
0
Page 328 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
IMITREX
INJ 6MG/0.5
00173047800
IMITREX
KIT RF
00173047900
IMITREX
KIT 6MG/0.5
00173052300
IMITREX
00173052400
IMITREX
00310020860
ZOMIG
$
Market Share*
MIGRAINE - SELECTIVE SEROTONIN AGONISTS (5HT)--Injectables
00173044902
# of Scripts
1
$265.99
0.30%
0
$0.00
0.00%
167
$63,073.91
50.15%
158
$68,440.98
56.03%
91
$25,903.86
27.33%
99
$22,744.67
35.11%
SPR 20MG/ACT
62
$7,899.57
18.62%
13
$1,710.05
4.61%
SPR 5MG/ACT
11
$1,837.96
3.30%
4
$899.07
1.42%
1
$138.29
0.30%
7
$512.20
2.48%
98
$13,082.99
3.43%
66
$8,921.34
2.09%
SPR 5MG
MIGRAINE - SELECTIVE SEROTONIN AGONISTS (5HT)--Tabs
00006026606
MAXALT
TAB 5MG
00006026609
MAXALT
TAB 5MG
0
$0.00
0.00%
2
$259.87
0.06%
00006026706
MAXALT
TAB 10MG
338
$49,170.49
11.85%
316
$47,876.73
10.02%
00006026709
MAXALT
TAB 10MG
0
$0.00
0.00%
201
$29,947.71
6.37%
00006380006
MAXALT-MLT TAB 5MG
56
$6,277.46
1.96%
64
$7,942.59
2.03%
00006380009
MAXALT-MLT TAB 5MG
0
$0.00
0.00%
3
$322.12
0.10%
00006380106
MAXALT-MLT TAB 10MG
249
$33,547.90
8.73%
194
$28,496.94
6.15%
00006380109
MAXALT-MLT TAB 10MG
0
$0.00
0.00%
73
$10,339.43
2.31%
00025208006
AXERT
TAB 6.25MG
12
$2,519.76
0.42%
0
$0.00
0.00%
00025208506
AXERT
TAB 12.5MG
58
$9,139.41
2.03%
22
$2,975.80
0.70%
00037721020
ZOMIG
TAB 2.5MG
0
$0.00
0.00%
12
$1,219.51
0.38%
00037721125
ZOMIG
TAB 5MG
0
$0.00
0.00%
18
$2,273.13
0.57%
00049233034
RELPAX
TAB 20MG
10
$1,346.04
0.35%
14
$1,684.10
0.44%
00049234034
RELPAX
TAB 40MG
72
$8,992.99
2.52%
71
$8,411.32
2.25%
00062208006
AXERT
TAB 6.25MG
0
$0.00
0.00%
1
$40.17
0.03%
00062208506
AXERT
TAB 12.5MG
0
$0.00
0.00%
36
$6,488.25
1.14%
00173045003
IMITREX
TAB 100MG
379
$53,067.66
13.28%
71
$11,434.27
2.25%
00173045900
IMITREX
TAB 50MG
847
$123,640.27
29.69%
57
$8,413.40
1.81%
00173046002
IMITREX
TAB 25MG
331
$54,913.49
11.60%
48
$8,116.81
1.52%
Page 329 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
AMERGE
TAB 1MG
00173056200
AMERGE
00173073500
IMITREX
TAB 25MG
00173073601
IMITREX
00173073701
IMITREX
00310020920
ZOMIG ZMT
00310021020
ZOMIG
TAB 2.5MG
00310021125
ZOMIG
TAB 5MG
00310021321
ZOMIG ZMT
59075074089
FROVA
$
Market Share*
MIGRAINE - SELECTIVE SEROTONIN AGONISTS (5HT)--Tabs
00173056100
# of Scripts
5
$1,020.08
0.18%
67
$13,612.78
2.35%
25
$3,736.35
0.79%
0
$0.00
0.00%
328
$53,810.91
10.40%
TAB 50MG
0
$0.00
0.00%
793
$114,243.66
25.13%
TAB 100MG
0
$0.00
0.00%
670
$94,009.90
21.24%
22
$2,386.72
0.77%
3
$316.53
0.10%
102
$13,402.61
3.58%
15
$1,332.92
0.48%
165
$26,240.25
5.78%
31
$4,101.79
0.98%
16
$2,645.60
0.56%
7
$890.74
0.22%
26
$2,893.30
0.91%
13
$2,169.70
0.41%
0
$0.00
0.00%
2
$13.92
0.01%
TAB 2.5MG
TAB 2.5 MG
TAB 5MG
TAB 2.5MG
1
$70.73
0.03%
MINERALS
00002202402
SOD CHLORIDE TAB 1GM
00005550919
CALTRATE 600 TAB PLUS-D
138
$864.12
0.66%
160
$1,002.43
0.77%
00005550924
CALTRATE 600 TAB PLUS-D
80
$554.77
0.38%
127
$824.48
0.61%
00005551019
CALTRATE 600 TAB
72
$253.49
0.34%
77
$269.70
0.37%
00005555619
CALTRATE PLS TAB
4
$33.48
0.02%
5
$36.18
0.02%
00005556719
CALTRATE
00024101510
FERGON
TAB 240MG
00045010203
VIACTIV
00045010303
CHW PLUS
4
$31.02
0.02%
4
$33.04
0.02%
11
$40.15
0.05%
12
$41.04
0.06%
CHW MILK CHO
6
$52.76
0.03%
4
$31.32
0.02%
VIACTIV
CHW CARAMEL
0
$0.00
0.00%
4
$24.36
0.02%
00045010403
VIACTIV
CHW MOCHACCI
0
$0.00
0.00%
3
$21.87
0.01%
00045043760
VIACTIV
CHW CHOC MNT
1
$9.21
0.00%
0
$0.00
0.00%
00054311763
CALCIUM CARB SUS 1250/5ML
89
$1,286.19
0.42%
90
$1,027.70
0.43%
00054371663
POT CHLORIDE LIQ 10%
2
$7.36
0.01%
0
$0.00
0.00%
00054412025
6
$21.30
0.03%
4
$13.68
0.02%
00054412125
CALCIUM GLUC TAB 500MG
14
$29.65
0.07%
18
$108.17
0.09%
Page 330 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00054811616
CALCIUM CARB SUS 1250/5ML
0
$0.00
0.00%
4
$56.80
0.02%
00067012547
SLOW FE
TAB 160MG CR
7
$93.92
0.03%
4
$40.82
0.02%
00067012574
SLOW FE
TAB 160MG CR
1
$12.79
0.00%
1
$12.52
0.00%
00074113002
SOD CHLORIDE INJ 23.4%
5
$28.64
0.02%
0
$0.00
0.00%
00074114101
2
$11.62
0.01%
0
$0.00
0.00%
00074151302
POT CHLORIDE INJ 2MEQ/ML
0
$0.00
0.00%
1
$6.19
0.00%
00074191835
0
$0.00
0.00%
2
$14.70
0.01%
00074488810
13
$524.64
0.06%
17
$917.21
0.08%
00074488812
10
$100.94
0.05%
8
$163.67
0.04%
00074488820
0
$0.00
0.00%
1
$5.57
0.00%
00074488850
1
$4.38
0.00%
0
$0.00
0.00%
00074662502
SOD BICARB INJ 8.4%
3
$10.14
0.01%
0
$0.00
0.00%
00074665106
4
$55.10
0.02%
0
$0.00
0.00%
00074665305
1
$1.73
0.00%
0
$0.00
0.00%
00074710102
1
$9.11
0.00%
0
$0.00
0.00%
00074710166
2
$24.40
0.01%
0
$0.00
0.00%
00074710167
9
$322.20
0.04%
0
$0.00
0.00%
00074729601
POT PHOSPHAT INJ 3MM/ML
1
$7.05
0.00%
0
$0.00
0.00%
00074780413
K-TABS
TAB 10MEQ CR
7
$56.45
0.03%
0
$0.00
0.00%
00074780419
K-TABS
TAB 10MEQ CR
20
$258.83
0.10%
1
$3.79
0.00%
00074798303
0
$0.00
0.00%
1
$2.15
0.00%
00074798309
3
$17.30
0.01%
0
$0.00
0.00%
00083012575
SLOW FE
2
$12.04
0.01%
0
$0.00
0.00%
00085026301
K-DUR
TAB 10MEQ CR
0
$0.00
0.00%
3
$18.09
0.01%
00085078701
K-DUR
TAB 20MEQ CR
10
$279.98
0.05%
1
$17.76
0.00%
00087010243
VIACTIV
CHW MILK CHO
3
$27.00
0.01%
2
$17.74
0.01%
00087010343
VIACTIV
CHW CARAMEL
3
$18.27
0.01%
0
$0.00
0.00%
TAB 160MG CR
Page 331 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00087010443
VIACTIV
CHW MOCHACIN
00087074002
FER-IN-SOL DRO 15/0.6ML
00087077141
K-LYTE DS
00088165141
3
$27.00
0.01%
0
$0.00
0.00%
10
$126.22
0.05%
14
$202.92
0.07%
1
$135.72
0.00%
3
$212.34
0.01%
OS-CAL 500 TAB
4
$83.91
0.02%
0
$0.00
0.00%
00088165148
OS-CAL 500 TAB
0
$0.00
0.00%
1
$21.47
0.00%
00088165175
OS-CAL 500 TAB
5
$45.37
0.02%
3
$43.26
0.01%
00088165441
OS-CAL
TAB 500 + D
15
$130.14
0.07%
13
$106.44
0.06%
00088165453
OS-CAL
TAB 500 + D
2
$12.84
0.01%
0
$0.00
0.00%
00088165475
OS-CAL
TAB 500 + D
20
$110.41
0.10%
9
$42.12
0.04%
00093531001
POT CHLORIDE TAB 10MEQ CR
0
$0.00
0.00%
23
$233.56
0.11%
00093531010
0
$0.00
0.00%
148
$2,442.86
0.71%
00093531101
0
$0.00
0.00%
6
$64.70
0.03%
00093531105
0
$0.00
0.00%
92
$1,457.92
0.44%
00093531110
00093913110
FLUORIDE
00093922501
TAB 50MEQ OR
0
$0.00
0.00%
187
$2,928.14
0.90%
455
$2,994.76
2.16%
337
$2,125.37
1.61%
POT CHLORIDE TAB 8MEQ SA
28
$155.60
0.13%
16
$71.90
0.08%
00093922510
POT CHLORIDE TAB 8MEQ SA
8
$57.27
0.04%
7
$46.42
0.03%
00093965457
SOD FLUORIDE DRO 0.5MG/ML
227
$2,919.02
1.08%
225
$2,940.18
1.08%
00121053005
FERROUS SULF SYP 300/5ML
1
$35.12
0.00%
0
$0.00
0.00%
00126000262
LURIDE
DRO 0.5MG/ML
1
$11.23
0.00%
1
$11.23
0.00%
00126000621
LURIDE
CHW 1MG
0
$0.00
0.00%
8
$39.36
0.04%
00126001421
LURIDE
CHW 0.5MG
2
$9.92
0.01%
3
$15.00
0.01%
00126018621
LURIDE
CHW 0.25MG
252
$1,263.19
1.20%
203
$989.78
0.97%
00131220086
NIFEREX
TAB 50MG
4
$44.15
0.02%
1
$5.82
0.00%
00131422009
NIFEREX-150 CAP 150MG
16
$352.12
0.08%
7
$113.65
0.03%
00131506668
NIFEREX
ELX 100/5ML
6
$124.25
0.03%
5
$44.89
0.02%
00178080001
CITRACAL
TAB 200 MG
6
$52.51
0.03%
10
$85.37
0.05%
CHW 1MG
Page 332 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00178080020
CITRACAL
00178081512
00178081560
TAB 200 MG
19
$120.10
0.09%
14
$117.84
0.07%
CITRACAL + D TAB
5
$43.91
0.02%
6
$47.34
0.03%
CITRACAL + D TAB
12
$99.63
0.06%
4
$34.30
0.02%
00178082515
CITRACAL PLS TAB
1
$5.87
0.00%
0
$0.00
0.00%
00178083715
CITRACAL + D TAB
2
$14.76
0.01%
4
$31.18
0.02%
00178390360
CALCIUM/D
1
$0.48
0.00%
0
$0.00
0.00%
00182036201
CALCIUM LACT TAB 650MG
3
$11.40
0.01%
3
$11.40
0.01%
00182041801
OYST-CAL D TAB 250MG
16
$53.52
0.08%
39
$181.67
0.19%
00182041809
1
$4.92
0.00%
0
$0.00
0.00%
00182041810
9
$22.88
0.04%
9
$38.97
0.04%
00182113801
SELENIUM
2
$12.58
0.01%
3
$14.89
0.01%
00182120140
FERROUS SULF ELX 220/5ML
5
$33.92
0.02%
5
$24.77
0.02%
00182138167
FER-GEN-SOL DRO 15/0.6ML
20
$108.95
0.10%
19
$114.21
0.09%
00182149717
POT BICARBON TAB 25MEQ EF
2
$22.62
0.01%
3
$33.93
0.01%
00182157607
OYST-CAL
TAB 500MG
5
$43.69
0.02%
2
$27.22
0.01%
00182157626
OYST-CAL
TAB 500MG
2
$3.68
0.01%
2
$3.68
0.01%
00182184005
POT CHLORIDE TAB 10MEQ SR
8
$46.81
0.04%
0
$0.00
0.00%
00182402801
FERROUS SULF TAB 325MG
89
$344.34
0.42%
162
$553.77
0.78%
00182402810
571
$1,194.83
2.72%
543
$1,933.23
2.60%
00182402889
7
$40.88
0.03%
17
$90.35
0.08%
00182402901
115
$396.46
0.55%
123
$415.93
0.59%
00182403010
FERROUS SULF TAB 325MG EC
319
$823.11
1.52%
188
$555.29
0.90%
00182408201
FERROUS GLUC TAB 225MG
4
$16.34
0.02%
0
$0.00
0.00%
00182414005
CALCARB 600 TAB
144
$410.30
0.68%
98
$373.75
0.47%
00182414026
CALCARB 600 TAB
184
$718.87
0.88%
145
$572.20
0.69%
00182414126
CALCARB/D
414
$2,063.54
1.97%
485
$2,692.06
2.32%
00182415101
CALCIUM CIT TAB 950MG
3
$5.79
0.01%
5
$9.87
0.02%
TAB 600MG
TAB 50MCG
TAB 600
Page 333 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00182438501
MAGNESIUM
00182443910
00182443926
00245000308
SSKI
00245000331
SSKI
00245003501
KLOR-CON
00245003530
KLOR-CON
00245003730
TAB 30MG
3
$6.30
0.01%
0
$0.00
0.00%
OYST-CAL-D TAB 500MG
75
$314.87
0.36%
138
$604.65
0.66%
OYST-CAL-D TAB 500MG
132
$666.90
0.63%
102
$537.33
0.49%
SOL 1GM/ML
3
$63.77
0.01%
5
$58.44
0.02%
SOL 1GM/ML
6
$62.90
0.03%
0
$0.00
0.00%
POW 20MEQ
16
$213.30
0.08%
17
$159.31
0.08%
POW 20MEQ
19
$222.42
0.09%
27
$354.34
0.13%
KLOR-CON-25 POW 25MEQ
2
$19.58
0.01%
0
$0.00
0.00%
00245003901
KLOR-CON/EF TAB 25MEQ FR
4
$38.53
0.02%
10
$113.70
0.05%
00245003930
KLOR-CON/EF TAB 25MEQ FR
35
$521.01
0.17%
16
$260.25
0.08%
00245004001
KLOR-CON 8 TAB 8MEQ ER
4
$21.92
0.02%
0
$0.00
0.00%
00245004011
51
$293.88
0.24%
34
$192.19
0.16%
00245004015
8
$85.98
0.04%
10
$106.21
0.05%
00245004111
256
$1,987.17
1.22%
243
$2,804.68
1.16%
00245004115
954
$8,481.01
4.54%
927
$10,162.91
4.44%
00245005710
KLOR-CON M10 TAB 10MEQ ER
97
$750.59
0.46%
3
$26.97
0.01%
00245005711
695
$4,856.84
3.31%
629
$4,272.49
3.01%
00245005801
13
$165.69
0.06%
7
$95.39
0.03%
00245005810
32
$438.36
0.15%
5
$165.05
0.02%
00245005811
2,131
$36,372.32
10.14%
1,990
$32,123.37
9.53%
00245005815
229
$3,895.69
1.09%
190
$3,523.88
0.91%
00245006101
12
$42.83
0.06%
14
$90.55
0.07%
00245008011
ZINC SULFATE CAP 220MG
29
$189.44
0.14%
25
$195.26
0.12%
00245010801
3
$14.22
0.01%
2
$9.48
0.01%
00245010810
0
$0.00
0.00%
22
$86.42
0.11%
00245024210
POT CHLORIDE TAB 8MEQ ER
8
$39.26
0.04%
24
$151.92
0.11%
00254938158
2
$12.36
0.01%
0
$0.00
0.00%
Page 334 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00256018401
MAGONATE
LIQ 54MG/5ML
00259029101
NU-IRON 150 CAP 150MG
00281320351
KAON
00288551001
FLUORITAB
00338004304
00338004402
00338004902
00338004903
00338004904
0
$0.00
0.00%
1
$15.30
0.00%
38
$717.83
0.18%
7
$148.37
0.03%
0
$0.00
0.00%
1
$25.05
0.00%
1
$6.30
0.00%
2
$12.80
0.01%
3
$110.95
0.01%
19
$1,511.25
0.09%
1
$9.34
0.00%
0
$0.00
0.00%
11
$58.63
0.05%
6
$34.25
0.03%
1
$14.15
0.00%
1
$22.25
0.00%
44
$429.65
0.21%
18
$135.50
0.09%
00338004918
1
$8.03
0.00%
0
$0.00
0.00%
00338004938
1
$131.99
0.00%
0
$0.00
0.00%
00338004948
1
$4.69
0.00%
4
$15.07
0.02%
00338802072
23
$1,906.88
0.11%
0
$0.00
0.00%
00364114657
FERROUS SULF DRO 75/0.6ML
0
$0.00
0.00%
1
$6.56
0.00%
00364301247
INFED
5
$299.45
0.02%
0
$0.00
0.00%
00364737830
POT CHLORIDE POW 20MEQ
3
$28.50
0.01%
3
$27.70
0.01%
00456037263
FEOSTAT
5
$49.00
0.02%
3
$63.91
0.01%
00472100016
POT CHLORIDE LIQ 10% SF
178
$1,140.61
0.85%
132
$905.53
0.63%
00472100028
2
$12.02
0.01%
2
$24.36
0.01%
00472100116
9
$34.48
0.04%
4
$14.91
0.02%
00472146516
3
$17.76
0.01%
15
$107.57
0.07%
00472146995
12
$91.29
0.06%
0
$0.00
0.00%
00486111101
K-PHOS
TAB
00486112501
K-PHOS
TAB NEUTRAL
00517013410
DEXFERRUM
00517023410
DEXFERRUM
00517155025
SOD BICARB INJ 8.4%
ELX 20MEQ/15
CHW CHERRY
INJ 50MG/ML
CHW 100MG
2
$19.10
0.01%
2
$19.00
0.01%
12
$340.62
0.06%
12
$291.70
0.06%
INJ 50MG/ML
4
$306.13
0.02%
3
$202.35
0.01%
INJ 50MG/ML
8
$566.93
0.04%
2
$65.80
0.01%
0
$0.00
0.00%
1
$14.05
0.00%
Page 335 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00517260225
MAGNESIUM SU INJ 50%
0
$0.00
0.00%
1
$8.34
0.00%
00517261025
MAGNESIUM SU INJ 50%
3
$5.01
0.01%
1
$1.67
0.00%
00517293025
SOD CHLORIDE INJ 4MEQ/ML
0
$0.00
0.00%
1
$5.00
0.00%
00517611025
ZINC SULFATE INJ 1MG/ML
3
$60.00
0.01%
0
$0.00
0.00%
00536065085
8
$45.17
0.04%
25
$113.36
0.12%
00536071080
FER-IRON
DRO 15/0.6ML
0
$0.00
0.00%
7
$45.41
0.03%
00536322301
CIT CALCIUM TAB 200MG
1
$16.64
0.00%
0
$0.00
0.00%
00536322408
CIT CALCIUM TAB 1500 + D
5
$38.90
0.02%
9
$64.74
0.04%
00536341610
CALCIUM GLUC TAB 650MG
3
$5.13
0.01%
3
$5.04
0.01%
00536342408
CALCIUM 600 TAB -D
168
$989.87
0.80%
193
$1,152.89
0.92%
00536342608
CALCIUM
92
$334.77
0.44%
87
$339.27
0.42%
00536347808
FERROUS SULF TAB 160MG CR
0
$0.00
0.00%
4
$42.84
0.02%
00536410602
OYSCO 500
1
$4.32
0.00%
3
$10.26
0.01%
00536589001
425
$1,807.84
2.02%
522
$1,972.40
2.50%
00536781708
OYSCO 500/D TAB
13
$79.05
0.06%
6
$19.50
0.03%
00574050801
168
$484.05
0.80%
248
$700.15
1.19%
00574050810
75
$212.17
0.36%
71
$186.73
0.34%
00574050811
35
$98.06
0.17%
55
$147.21
0.26%
00574060801
174
$787.17
0.83%
89
$354.69
0.43%
00574060810
72
$273.29
0.34%
149
$528.46
0.71%
00574060811
28
$163.29
0.13%
15
$57.79
0.07%
00574916701
ZINCATE
3
$19.53
0.01%
2
$13.36
0.01%
00591603530
14
$181.69
0.07%
14
$183.72
0.07%
00591737830
15
$233.29
0.07%
9
$85.61
0.04%
00603017929
FERR SULFATE TAB 325MG FC
34
$581.98
0.16%
53
$886.29
0.25%
00603076247
18
$157.12
0.09%
21
$169.54
0.10%
00603076358
11
$44.83
0.05%
7
$37.35
0.03%
TAB 600MG
TAB
CAP 220MG
Page 336 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00603124447
SOD FLOURIDE DRO 1.1MG/ML
00603153258
00603153458
00603153460
00603153558
$161.28
0.10%
$955.60
0.59%
19
$117.34
0.09%
232
$1,432.00
1.10%
23
$125.22
0.11%
274
$1,671.28
1.31%
1
$6.51
0.00%
1
$5.49
0.00%
40
$231.96
0.19%
5
$19.41
0.02%
00603153658
18
00603350816
POT CHLORIDE TAB 25MEQ EF
0
$97.12
0.09%
13
$75.01
0.06%
$0.00
0.00%
2
$73.40
0.01%
00603362232
FLUORIDE
CHW 0.5MG
268
$1,564.48
1.27%
482
$2,815.85
2.31%
00603362332
FLUORIDE
CHW 1MG
38
$220.31
0.18%
37
$187.47
0.18%
00603417016
00603417316
K-EFFERVESCE TAB 25MEQ EF
0
$0.00
0.00%
2
$36.66
0.01%
K+ POTASSIUM POW 20MEQ
0
$0.00
0.00%
1
$8.14
0.00%
00603523721
1
$7.61
0.00%
0
$0.00
0.00%
00603523728
2
$23.74
0.01%
0
$0.00
0.00%
00603524121
10
$71.20
0.05%
11
$126.35
0.05%
00603524128
54
$522.42
0.26%
18
$196.95
0.09%
00603524132
282
$2,666.15
1.34%
31
$353.50
0.15%
00603524332
119
$1,016.07
0.57%
18
$121.37
0.09%
00603524428
29
$443.56
0.14%
0
$0.00
0.00%
00603524432
159
$2,593.90
0.76%
38
$551.24
0.18%
00615064553
18
$99.80
0.09%
0
$0.00
0.00%
00615064563
115
$676.80
0.55%
3
$13.82
0.01%
00615131853
POT CHLORIDE CAP 10MEQ CR
164
$2,074.12
0.78%
0
$0.00
0.00%
00615131863
POT CHLORIDE CAP 10MEQ CR
52
$700.52
0.25%
0
$0.00
0.00%
00677006901
28
$79.92
0.13%
30
$88.82
0.14%
00677007001
128
$412.71
0.61%
116
$357.86
0.56%
00677007010
222
$512.98
1.06%
241
$609.85
1.15%
00677007101
102
$246.88
0.49%
62
$126.25
0.30%
21
124
Page 337 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00677007110
00677052733
00677054033
00677062201
376
$1,105.20
1.79%
320
$860.49
1.53%
22
$152.68
5
$23.64
0.10%
9
$48.05
0.04%
0.02%
13
$71.55
0.06%
ZINC SULFATE CAP 220MG
1
$8.41
0.00%
2
$5.76
0.01%
00677081907
POT EFFERVES TAB 25MEQ EF
1
$9.59
0.00%
2
$19.18
0.01%
00677103507
00677109701
0
$0.00
0.00%
5
$45.21
0.02%
6
$42.30
0.03%
0
$0.00
0.00%
00677159701
IRON COMPLEX CAP 150MG
36
$440.63
0.17%
30
$432.96
0.14%
00677167810
SOD FLUORIDE CHW 2.2MG
112
$577.70
0.53%
127
$644.22
0.61%
00761012920
CALCIUM/D
TAB 500MG
1
$0.48
0.00%
3
$4.53
0.01%
00761081212
CALCIUM/D
TAB 600MG
6
$10.96
0.03%
0
$0.00
0.00%
00766073560
TUMS 500
CHW ASSORTED
1
$11.58
0.00%
0
$0.00
0.00%
00766073660
TUMS 500
CHW PEPPRMNT
9
$60.62
0.04%
4
$32.34
0.02%
00766165160
OS-CAL
TAB 1250MG
1
$15.47
0.00%
0
$0.00
0.00%
00766165460
OS-CAL
TAB 500 + D
78
$427.70
0.37%
99
$564.08
0.47%
00766165820
OS-CAL ULTRA TAB
0
$0.00
0.00%
1
$8.74
0.00%
00781116213
2
$3.38
0.01%
0
$0.00
0.00%
00781152531
1
$7.79
0.00%
0
$0.00
0.00%
00781152601
37
$379.18
0.18%
51
$545.40
0.24%
00781152610
522
$4,857.80
2.48%
696
$8,804.87
3.33%
00904098950
1
$9.88
0.00%
0
$0.00
0.00%
00904100716
8
$47.20
0.04%
7
$40.61
0.03%
00904188352
OYSTER CAL TAB 500MG
2
$8.48
0.01%
0
$0.00
0.00%
00904188372
3
$13.27
0.01%
2
$8.18
0.01%
00904188380
4
$15.26
0.02%
5
$23.65
0.02%
00904188552
OYSTER SHELL TAB /D 500MG
21
$112.01
0.10%
19
$97.36
0.09%
00904188580
3
$5.91
0.01%
0
$0.00
0.00%
Page 338 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00904188592
0
$0.00
0.00%
1
$6.54
0.00%
00904213761
6
$24.90
0.03%
16
$56.42
0.08%
00904213782
0
$0.00
0.00%
2
$5.80
0.01%
00904272046
K-VESCENT
TAB 25MEQ EF
5
$50.05
0.02%
3
$28.53
0.01%
00904272060
K-VESCENT
TAB 25MEQ EF
2
$15.92
0.01%
0
$0.00
0.00%
00904316260
SELENIUM
TAB 50MCG
3
$13.71
0.01%
0
$0.00
0.00%
00904323252
22
$47.39
0.10%
15
$39.06
0.07%
00904323261
6
$27.10
0.03%
2
$11.45
0.01%
00904323292
43
$145.59
0.20%
95
$385.39
0.45%
00904323352
CALCIUM/D
TAB 600MG
212
$1,090.87
1.01%
238
$1,243.78
1.14%
00904323362
CALCIUM/D
TAB 600MG
0
$0.00
0.00%
2
$0.96
0.01%
00904323392
CALCIUM/D
TAB 600MG
102
$429.77
0.49%
179
$829.85
0.86%
00904323852
CHEW CALCIUM CHW 500MG
1
$6.70
0.00%
4
$43.52
0.02%
00904336140
3
$27.12
0.01%
0
$0.00
0.00%
00904423960
MAGNESIUM
1
$1.71
0.00%
0
$0.00
0.00%
00904539561
FERREX 150 CAP 150MG
5
$52.00
0.02%
0
$0.00
0.00%
00904540080
102
$526.64
0.49%
20
$107.63
0.10%
00904540180
28
$154.06
0.13%
5
$28.22
0.02%
00904546052
10
$58.20
0.05%
17
$103.12
0.08%
00904546072
36
$128.74
0.17%
34
$121.80
0.16%
00904546080
4
$17.46
0.02%
22
$64.30
0.11%
00904546092
2
$6.42
0.01%
15
$70.19
0.07%
00904547760
FERATE
0
$0.00
0.00%
1
$3.75
0.00%
00904759082
32
$167.69
0.15%
20
$108.13
0.10%
00904759083
0
$0.00
0.00%
55
$165.62
0.26%
00904759161
16
$94.87
0.08%
6
$30.54
0.03%
00904759182
15
$60.78
0.07%
42
$169.30
0.20%
TAB 500MG
TAB 240MG
Page 339 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
00904759183
00904791152
MAG-DELAY
08290033005
NORML SALINE INJ FLUSH
08290033010
$81.67
0.15%
0
$0.00
0.00%
0
$0.00
0.00%
3
$110.13
0.01%
4
$81.79
0.02%
0
$0.00
0.00%
NORML SALINE INJ FLUSH
378
$36,459.21
1.80%
5
$29.94
0.02%
10267164004
SOD FLUORIDE TAB 1.1MG
13
$46.62
0.06%
6
$22.50
0.03%
10267164104
SOD FLUORIDE TAB 2.2MG
2
$11.41
0.01%
7
$33.25
0.03%
11822330050
RA CALCIUM+D TAB 600MG
6
$13.66
0.03%
3
$4.07
0.01%
11845013771
CALCIUM 500 TAB /VITMN D
5
$18.31
0.02%
1
$4.32
0.00%
11845013775
CALCIUM 500 TAB /VITMN D
0
$0.00
0.00%
1
$7.11
0.00%
11845075501
0
$0.00
0.00%
1
$2.63
0.00%
11845075505
25
$154.91
0.12%
1
$3.59
0.00%
17236038960
CALCIUM/D
4
$5.06
0.02%
42
$207.60
0.20%
17236040610
0
$0.00
0.00%
47
$123.51
0.23%
17236043410
OYSTER SHELL TAB 500MG
17314931102
NEUTRA-PHOS POW
17314931302
TAB
TAB 600MG
31
2
$11.84
0.01%
0
$0.00
0.00%
21
$830.36
0.10%
19
$608.52
0.09%
NEUTRA-PHOS POW -K
0
$0.00
0.00%
3
$112.19
0.01%
17714002410
0
$0.00
0.00%
1
$3.57
0.00%
24385013778
IRON
TAB 325MG
1
$2.26
0.00%
0
$0.00
0.00%
24385087578
IRON
TAB 325MG
1
$4.52
0.00%
0
$0.00
0.00%
24385088072
CALCIUM/D
TAB 600MG
9
$32.19
0.04%
0
$0.00
0.00%
43292055585
CALCIUM/D
TAB 600MG
0
$0.00
0.00%
4
$2.96
0.02%
43292055643
CALCIUM/D
TAB 600MG
7
$22.41
0.03%
8
$25.76
0.04%
44184001602
3
$26.31
0.01%
0
$0.00
0.00%
44184001702
4
$39.44
0.02%
3
$30.57
0.01%
44184001704
1
$11.15
0.00%
0
$0.00
0.00%
48107004923
CALCIUM
15
$48.97
0.07%
23
$82.41
0.11%
49348011012
SM CALCIUM TAB 600 +D
15
$117.64
0.07%
8
$51.30
0.04%
TAB
Page 340 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
49348018010
1
$3.99
0.00%
1
$4.49
0.00%
49348023312
SM CALCIUM TAB 600
2
$4.70
0.01%
3
$9.55
0.01%
49348026412
SM OYST SHL TAB /D 500MG
1
$2.49
0.00%
0
$0.00
0.00%
49348026443
3
$20.55
0.01%
2
$18.64
0.01%
49348032310
1
$6.59
0.00%
8
$66.35
0.04%
49348032412
CALCIUM CIT TAB + VIT D
0
$0.00
0.00%
1
$5.49
0.00%
49692094113
FEOSOL
TAB 45MG
1
$7.28
0.00%
0
$0.00
0.00%
49692094160
FEOSOL
TAB 45MG
2
$36.00
0.01%
3
$18.28
0.01%
49692094220
FEOSOL
TAB 200MG
2
$9.76
0.01%
5
$23.32
0.02%
50383062930
SOD FLUORIDE DRO 0.275MG
1
$7.92
0.00%
0
$0.00
0.00%
50383063050
5
$37.38
0.02%
11
$92.48
0.05%
50383065650
SOD FLOURIDE DRO 1.1MG/ML
483
$4,558.39
2.30%
327
$3,101.42
1.57%
50383077816
5
$19.93
0.02%
8
$42.38
0.04%
50428122864
CALCIUM/D
0
$0.00
0.00%
1
$1.19
0.00%
50428145485
CALCIUM + D TAB
1
$6.99
0.00%
3
$6.87
0.01%
50428145625
OYSTER SHELL TAB W/VIT D
9
$45.95
0.04%
10
$64.61
0.05%
50428269530
CALCIUM CARB TAB /VIT D
2
$8.44
0.01%
4
$17.46
0.02%
50428537845
CALCIUM CARB TAB /VIT D
1
$11.10
0.00%
6
$23.54
0.03%
50428901330
CALCIUM/D
6
$12.72
0.03%
10
$26.10
0.05%
51817060216
FLUOR-A-DAY CHW 0.25MG
56
$368.61
0.27%
70
$418.79
0.34%
51817061116
FLUOR-A-DAY CHW 0.5MG
16
$86.54
0.08%
11
$72.45
0.05%
51817062216
FLUOR-A-DAY CHW 1MG
0
$0.00
0.00%
2
$11.13
0.01%
51817065661
FLUOR-A-DAY DRO 0.125MG
9
$69.52
0.04%
6
$44.92
0.03%
51991020311
FERREX 150 CAP 150MG
109
$1,777.29
0.52%
98
$1,400.10
0.47%
52152012705
345
$2,192.24
1.64%
224
$1,435.89
1.07%
52152012805
48
$338.24
0.23%
129
$888.48
0.62%
52297055572
HM CALCIUM TAB 600MG
7
$18.34
0.03%
0
$0.00
0.00%
TAB 600MG
TAB 600MG
Page 341 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
52544093102
INFED
INJ 50MG/ML
52735000613
CALCIUM/D
52735007501
54092002760
SLOW-MAG
54391002703
3
$1,205.25
0.01%
9
$528.80
0.04%
2
$10.03
0.01%
2
$2.90
0.01%
4
$21.92
0.02%
0
$0.00
0.00%
12
$294.63
0.06%
0
$0.00
0.00%
CALCI-MIX CAP POWDER
0
$0.00
0.00%
1
$8.59
0.00%
54629068110
0
$0.00
0.00%
8
$14.29
0.04%
54838000180
2
$9.44
0.01%
0
$0.00
0.00%
54868484500
CALTRATE 600 TAB
1
$37.36
0.00%
0
$0.00
0.00%
55289034701
CALCIUM/D
4
$43.52
0.02%
0
$0.00
0.00%
55654001402
SOD FLUORIDE DRO 0.275MG
13
$137.12
0.06%
12
$126.84
0.06%
57896070110
16
$29.10
0.08%
24
$38.90
0.11%
57896070301
32
$75.82
0.15%
30
$68.35
0.14%
57896070310
20
$58.60
0.10%
154
$483.52
0.74%
58177000104
POT CHLORIDE CAP 10MEQ ER
371
$4,807.30
1.76%
313
$3,741.73
1.50%
58177000108
314
$4,316.18
1.49%
347
$5,228.36
1.66%
58177000109
2,021
$26,768.34
9.61%
2,599
$33,947.25
12.45%
58177000111
4
$74.06
0.02%
0
$0.00
0.00%
58177002409
FE-TINIC
CAP 150MG
9
$95.36
0.04%
0
$0.00
0.00%
58177002411
FE-TINIC
CAP 150MG
27
$409.92
0.13%
3
$56.04
0.01%
58177020204
21
$345.83
0.10%
31
$432.97
0.15%
58177020208
126
$1,941.73
0.60%
103
$1,325.97
0.49%
58177020209
277
$4,282.88
1.32%
332
$4,927.29
1.59%
58177020211
4
$36.42
0.02%
0
$0.00
0.00%
58177043240
ETHEDENT
CHW 0.25MG
46
$271.84
0.22%
50
$305.68
0.24%
58177043309
ETHEDENT
CHW 0.5MG
192
$1,322.08
0.91%
170
$1,071.37
0.81%
58177043340
ETHEDENT
CHW 0.5MG
8
$47.15
0.04%
6
$38.43
0.03%
58177043409
ETHEDENT
CHW 1MG
79
$542.99
0.38%
86
$563.92
0.41%
TAB 600MG
TAB
TAB 500MG
Page 342 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
58177043440
ETHEDENT
CHW 1MG
59528041605
MAGNEBIND TAB 400
59772691001
59772691002
59930171401
$0.00
0.00%
3
$17.29
0.01%
0
$0.00
0.00%
1
$28.13
0.00%
13
$111.40
0.06%
5
$14.78
0.02%
57
$524.73
0.27%
13
$118.11
0.06%
247
$4,182.59
1.17%
247
$3,529.74
1.18%
59930171402
159
$2,445.86
0.76%
49
$751.53
0.23%
59930171403
215
$3,633.69
1.02%
65
$799.97
0.31%
59930171501
38
$267.52
0.18%
40
$292.49
0.19%
60258012106
CALCIUM/D
0
$0.00
0.00%
2
$24.08
0.01%
60258017201
MAG-G
TAB 500MG
4
$45.12
0.02%
7
$91.78
0.03%
60258017306
MAG-SR
TAB 535MG
0
$0.00
0.00%
5
$51.50
0.02%
60258018201
FERROUS FUM TAB 324MG
0
$0.00
0.00%
1
$18.75
0.00%
60258018501
POLY-IRON
7
$121.60
0.03%
16
$204.30
0.08%
60432005750
25
$208.94
0.12%
16
$120.26
0.08%
60432006616
54
$425.31
0.26%
21
$192.91
0.10%
62037071001
20
$157.40
0.10%
10
$65.92
0.05%
62037071010
107
$823.91
0.51%
152
$1,329.02
0.73%
62037072001
37
$611.87
0.18%
17
$325.14
0.08%
62037072005
109
$1,999.14
0.52%
172
$2,272.38
0.82%
62037072010
38
$667.13
0.18%
77
$1,082.73
0.37%
62107004206
CALCIUM 600 TAB
86
$395.66
0.41%
42
$206.95
0.20%
62107005801
FERRONATE
16
$60.16
0.08%
20
$75.76
0.10%
63044020361
IFEREX 150 CAP
0
$0.00
0.00%
1
$14.94
0.00%
63323014403
P.T.E. -5
1
$120.80
0.00%
0
$0.00
0.00%
63323018610
1
$4.15
0.00%
1
$43.35
0.00%
64011000904
MICRO-K
CAP 10MEQ CR
13
$421.56
0.06%
5
$338.86
0.02%
64011001004
MICRO-K
CAP 8MEQ CR
17
$1,632.09
0.08%
16
$1,331.83
0.08%
TAB 600MG
CAP 150MG
TAB 325MG
INJ
0
Page 343 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MINERALS
64054090502
64054091002
64253011130
NORML SALINE INJ IV FLUSH
64253011133
64253011135
$0.00
0.00%
22
$1,323.70
0.11%
0
$0.00
0.00%
271
$17,290.78
1.30%
105
$6,098.31
0.50%
102
$4,846.39
0.49%
26
$398.23
0.12%
33
$437.90
0.16%
99
$5,392.20
0.47%
75
$1,629.13
0.36%
64727880101
MAGNESIUM GL TAB 500MG
1
$14.68
0.00%
0
$0.00
0.00%
64980010401
PHOSPHA 250 TAB NEUTRAL
5
$67.59
0.02%
2
$25.22
0.01%
65162038906
CALCIUM/D
TAB 600MG
0
$0.00
0.00%
1
$6.47
0.00%
66375010501
CALCIUM + D TAB 600MG
6
$31.50
0.03%
7
$35.29
0.03%
67618010760
SLOW-MAG
1
$42.87
0.00%
10
$215.57
0.05%
74312003900
OYSTERCAL-D TAB 250MG
1
$3.65
0.00%
0
$0.00
0.00%
74312004230
CALCIUM/D
TAB 600MG
36
$148.02
0.17%
107
$648.95
0.51%
74312004233
CALCIUM/D
TAB 600MG
5
$26.21
0.02%
12
$38.58
0.06%
74312007090
OYSTERCAL
TAB 500 + D
45
$242.99
0.21%
75
$503.19
0.36%
$0.00
0.00%
TAB
0
MONO-NITRATES
00085115303
IMDUR
TAB 120MG ER
3
$232.23
0.10%
0
00085330603
IMDUR
TAB 30MG ER
4
$204.48
0.13%
0
$0.00
0.00%
00085411003
IMDUR
TAB 60MG ER
7
$376.57
0.22%
5
$445.07
0.16%
00091362001
MONOKET
1
$15.70
0.03%
0
$0.00
0.00%
00143133301
ISOSORB MONO TAB 20MG
0
$0.00
0.00%
9
$172.46
0.29%
00172502660
9
$107.15
0.29%
0
$0.00
0.00%
00172502760
7
$281.38
0.22%
0
$0.00
0.00%
00182268789
1
$5.95
0.03%
0
$0.00
0.00%
00228262011
115
$4,251.66
3.68%
72
$2,273.56
2.35%
00228263111
2
$143.66
0.06%
7
$419.06
0.23%
00228271311
269
$3,364.20
8.60%
95
$1,230.73
3.11%
TAB 20MG
Page 344 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MONO-NITRATES
00228271350
405
$5,259.38
12.95%
474
$6,029.68
58177020104
240
$6,109.74
7.67%
212
$5,644.38
6.93%
58177022204
187
$2,067.65
5.98%
381
$4,418.54
12.46%
58177022211
0
$0.00
0.00%
5
$50.56
0.16%
59930150201
957
$11,742.39
30.59%
631
$7,904.80
20.63%
59930158701
450
$11,243.03
14.39%
385
$10,133.85
12.59%
62175010601
8
$281.75
0.26%
7
$362.71
0.23%
62175010701
117
$4,086.35
3.74%
83
$3,129.52
2.71%
62175012837
275
$3,422.77
8.79%
620
$7,772.20
20.27%
62175012937
71
$2,013.25
2.27%
73
$2,098.25
2.39%
4
$221.94
0.22%
0
$0.00
0.00%
15.50%
MOUTH ANTI-INFECTIVES
00003054320
MYCOSTATIN LOZ 200000
00054350049
LIDOCAINE
26
$131.59
1.46%
29
$187.22
1.71%
00054414622
CLOTRIMAZOLE TRO 10MG
0
$0.00
0.00%
72
$4,590.74
4.24%
00054414623
0
$0.00
0.00%
8
$518.89
0.47%
00054814622
0
$0.00
0.00%
2
$128.50
0.12%
00168003760
NYSTATIN
SUS 100000
0
$0.00
0.00%
1
$13.89
0.06%
00364207516
NYSTATIN
SUS 100000U
1
$13.60
0.06%
33
$653.75
1.94%
00472099633
LIDOCAINE
SOL 2% VISC
2
$15.04
0.11%
3
$16.03
0.18%
00472132002
NYSTATIN
SUS 100000
89
$1,340.05
4.99%
187
$3,064.21
11.00%
00472132016
NYSTATIN
SUS 100000
93
$2,904.66
5.22%
435
$13,490.79
25.59%
00603148058
NYSTATIN
SUS 100000
2
$36.84
0.11%
0
$0.00
0.00%
00677083625
NYSTATIN
SUS 100000
2
$61.44
0.11%
0
$0.00
0.00%
00677083633
NYSTATIN
SUS 100000
10
$317.50
0.56%
10
$379.01
0.59%
00677101527
LIDOCAINE
SOL 2% VISC
3
$18.76
0.17%
0
$0.00
0.00%
00781610561
NYSTATIN
SUS 100000U
1
$22.25
0.06%
0
$0.00
0.00%
SOL 2% VISC
Page 345 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MOUTH ANTI-INFECTIVES
00904086304
LIDOCAINE
SOL 2% VISC
00904276116
NYSTATIN
SUS 100000
17314940001
MYCELEX
TRO 10MG
17314940003
MYCELEX
TRO 10MG
50383077504
LIDOCAINE
60432046400
60432053716
60432053760
1
$8.35
0.06%
3
$83.00
0.17%
86
$5,930.12
4.82%
19
$2,066.73
1.07%
SOL 2% VISC
130
$680.50
LIDOCAINE
SOL 2% VISC
172
NYSTATIN
SUS 100000
876
NYSTATIN
SUS 100000
263
0
$0.00
0.00%
1
$38.49
0.06%
14
$2,037.57
0.82%
1
$163.84
0.06%
7.29%
153
$844.24
9.00%
$1,153.93
9.65%
129
$935.56
7.59%
$25,698.79
49.13%
490
$15,265.70
28.82%
$3,845.83
14.75%
132
$2,041.83
7.76%
MOUTH ANTISEPTICS
00093001416
CHLORHEX GLU SOL 0.12%
300
$2,349.37
36.19%
330
$2,624.66
42.42%
00116200116
113
$950.78
13.63%
272
$2,055.63
34.96%
00126027116
PERIOGARD
SOL 0.12%
3
$24.59
0.36%
3
$25.87
0.39%
00186036001
XYLOCAINE
SOL 2% VISC
1
$21.85
0.12%
0
$0.00
0.00%
00186036011
XYLOCAINE
SOL 2% VISC
1
$65.23
0.12%
0
$0.00
0.00%
00472003616
271
$2,215.67
32.69%
71
$639.26
9.13%
00603787069
TRIAMCIN/ORA PST 0.1%
2
$14.98
0.24%
0
$0.00
0.00%
00677120036
1
$7.49
0.12%
1
$4.99
0.13%
00904514516
3
$24.75
0.36%
0
$0.00
0.00%
10158005901
APHTHASOL
6
$126.62
0.72%
1
$21.10
0.13%
50383072016
0
$0.00
0.00%
9
$74.14
1.16%
51672126705
110
$764.03
13.27%
91
$593.06
11.70%
60505035500
18
$137.41
2.17%
0
$0.00
0.00%
PST 5%
MULTIPLE SCLEROSIS AGENTS
00088115003
COPAXONE
INJ 20MG
00088115330
COPAXONE
KIT 20MG/ML
1
$964.04
0.14%
0
$0.00
0.00%
220
$220,507.03
31.34%
221
$256,142.31
30.23%
Page 346 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MULTIPLE SCLEROSIS AGENTS
44087002203
REBIF
INJ 22/0.5
11
$11,501.79
1.57%
10
$12,741.86
1.37%
44087004403
REBIF
INJ 44/0.5
53
$64,441.02
7.55%
80
$127,602.87
10.94%
50419052115
BETASERON INJ 0.3MG
1
$982.10
0.14%
0
$0.00
0.00%
50419052315
BETASERON INJ 0.3MG
110
$114,078.29
15.67%
24
$20,339.20
3.28%
50419052325
BETASERON INJ 0.3MG
0
$0.00
0.00%
82
$97,734.25
11.22%
59627000103
AVONEX
INJ 30MCG
59627000205
AVONEX
KIT
60
$56,263.90
8.55%
50
$57,621.88
6.84%
246
$238,706.23
35.04%
264
$295,826.99
36.11%
MUSCLE RELAXANT -COMBINATIONS
00037210301
SOMA CPD
TAB
0
$0.00
0.00%
1
$28.29
6.67%
00089023310
NORGESIC
TAB FORTE
2
$99.55
5.71%
0
$0.00
0.00%
00185071401
ORPHEN CPD TAB DS
3
$83.25
8.57%
8
$346.69
53.33%
00185072401
CARISOPR/ASA TAB 200-325
10
$142.13
28.57%
0
$0.00
0.00%
00185074901
CARISOPRODOL TAB ASA/COD
2
$323.27
5.71%
2
$76.41
13.33%
00378335401
ORPH/ASA/CAF TAB
0
$0.00
0.00%
1
$12.85
6.67%
00378335601
ORPH/ASA/CAF TAB
4
$138.50
11.43%
0
$0.00
0.00%
49884024601
CARISOPR/ASA TAB 200-325
7
$113.00
20.00%
1
$10.00
6.67%
49884047201
ORPHENGESIC TAB
0
$0.00
0.00%
1
$16.65
6.67%
49884047301
ORPHENGESIC TAB FORTE
7
$380.70
20.00%
1
$13.49
6.67%
MUSCLE RELAXANTS
00031744963
ROBAXIN-750 TAB 750MG
1
$94.30
0.01%
0
$0.00
0.00%
00037200101
SOMA
2
$827.57
0.01%
0
$0.00
0.00%
00045032560
PARAFON FORT TAB DSC
1
$67.93
0.01%
0
$0.00
0.00%
00086006210
SKELAXIN
TAB 400MG
350
$23,996.83
2.08%
0
$0.00
0.00%
00086006250
SKELAXIN
TAB 400MG
2
$60.83
0.01%
1
$18.49
0.01%
00089022110
NORFLEX
TAB 100MG CR
2
$271.00
0.01%
0
$0.00
0.00%
TAB 350MG
Page 347 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MUSCLE RELAXANTS
00093054201
CHLORZOXAZON TAB 500MG
00093516051
00093516351
111
$999.90
0.66%
78
$538.97
0.48%
TIZANIDINE TAB 4MG
70
$4,909.95
0.42%
60
$2,860.88
0.37%
TIZANIDINE TAB 2MG
21
$875.12
0.12%
24
$707.56
0.15%
00115201101
ORPHENADRINE TAB 100MG ER
30
$675.40
0.18%
39
$655.50
0.24%
00115201102
0
$0.00
0.00%
4
$57.30
0.02%
00143117601
CARISOPRODOL TAB 350MG
19
$260.05
0.11%
0
$0.00
0.00%
00143117605
20
$215.50
0.12%
0
$0.00
0.00%
00143117610
128
$1,473.19
0.76%
40
$715.47
0.25%
00143129001
METHOCARBAM TAB 500MG
40
$532.02
0.24%
67
$817.30
0.41%
00143129005
5
$89.01
0.03%
18
$450.60
0.11%
00143129201
116
$2,420.89
0.69%
72
$1,121.32
0.44%
00143129205
31
$626.49
0.18%
10
$95.58
0.06%
00149003005
DANTRIUM
CAP 25MG
42
$2,761.77
0.25%
41
$2,598.38
0.25%
00149003105
DANTRIUM
CAP 50MG
41
$5,146.32
0.24%
30
$3,197.53
0.18%
00149003305
DANTRIUM
CAP 100MG
15
$2,159.96
0.09%
14
$2,198.26
0.09%
00172409660
BACLOFEN
TAB 10MG
471
$13,094.88
2.79%
217
$5,908.19
1.33%
00172409680
BACLOFEN
TAB 10MG
184
$6,503.77
1.09%
288
$8,382.69
1.77%
00172409760
BACLOFEN
TAB 20MG
202
$13,585.68
1.20%
133
$6,333.30
0.82%
00185002201
6
$101.78
0.04%
15
$247.50
0.09%
00185440051
TIZANIDINE TAB 4MG
81
$6,211.00
0.48%
43
$2,535.90
0.26%
00228274115
TIZANIDINE TAB 4MG
38
$2,575.91
0.23%
24
$1,109.55
0.15%
00228274150
TIZANIDINE TAB 4MG
1
$71.05
0.01%
0
$0.00
0.00%
00228274215
TIZANIDINE TAB 2MG
34
$2,521.10
0.20%
9
$1,119.15
0.06%
00364034601
3
$62.45
0.02%
0
$0.00
0.00%
00364047501
9
$123.65
0.05%
2
$5.90
0.01%
00364047502
0
$0.00
0.00%
3
$37.05
0.02%
00364047505
1
$3.85
0.01%
0
$0.00
0.00%
Page 348 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MUSCLE RELAXANTS
00364231201
BACLOFEN
TAB 10MG
39
$1,161.17
0.23%
11
00364231301
BACLOFEN
TAB 20MG
6
$138.53
0.04%
00364234802
CYCLOBENZAPR TAB 10MG
4
$39.08
0.02%
00364234805
4
$46.30
00364283001
1
00378075101
00378075110
00378335801
$275.83
0.07%
0
$0.00
0.00%
1
$13.45
0.01%
0.02%
1
$15.95
0.01%
$33.85
0.01%
1
$33.85
0.01%
1,013
$9,420.99
6.01%
1,129
$11,021.04
6.94%
688
$7,803.01
4.08%
762
$8,195.13
4.69%
139
$3,154.60
0.82%
20
$431.20
0.12%
00378335805
1
$33.85
0.01%
0
$0.00
0.00%
00555058502
213
$1,912.62
1.26%
190
$1,431.64
1.17%
00555058504
25
$256.50
0.15%
20
$179.47
0.12%
00591283001
ORPHENADRINE TAB 100MG CR
1
$33.85
0.01%
0
$0.00
0.00%
00591538101
63
$855.13
0.37%
82
$1,108.60
0.50%
00591538105
10
$187.40
0.06%
1
$5.05
0.01%
00591538201
78
$1,376.94
0.46%
89
$1,289.00
0.55%
00591538205
12
$315.08
0.07%
11
$201.81
0.07%
00591551301
220
$2,345.68
1.31%
51
$607.01
0.31%
00591551305
63
$702.71
0.37%
9
$92.85
0.06%
00591551310
28
$403.90
0.17%
11
$153.53
0.07%
00591565801
245
$2,828.52
1.45%
113
$1,269.46
0.69%
00591565805
160
$1,846.65
0.95%
180
$2,011.45
1.11%
00591565810
1,673
$19,552.18
9.92%
1,112
$13,007.13
6.84%
00591573001
BACLOFEN
TAB 10MG
439
$12,415.69
2.60%
414
$10,469.93
2.55%
00591573005
BACLOFEN
TAB 10MG
16
$582.84
0.09%
25
$968.85
0.15%
00591573101
BACLOFEN
TAB 20MG
192
$10,729.80
1.14%
162
$7,367.26
1.00%
00591573105
BACLOFEN
TAB 20MG
8
$621.12
0.05%
40
$2,065.88
0.25%
00603240821
BACLOFEN
TAB 10MG
36
$1,079.58
0.21%
0
$0.00
0.00%
Page 349 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MUSCLE RELAXANTS
00603240828
BACLOFEN
TAB 10MG
00603240832
BACLOFEN
00603240921
BACLOFEN
00603258221
4
$134.60
0.02%
0
$0.00
0.00%
TAB 10MG
9
$225.65
0.05%
0
$0.00
0.00%
TAB 20MG
10
$506.89
0.06%
0
$0.00
0.00%
9
$74.30
0.05%
30
$370.25
0.18%
00603258228
1
$5.35
0.01%
1
$16.85
0.01%
00603258232
15
$145.65
0.09%
4
$61.70
0.02%
00603448521
283
$3,279.71
1.68%
204
$2,779.25
1.25%
00603448528
36
$543.74
0.21%
25
$426.65
0.15%
00603448621
198
$3,834.13
1.17%
326
$5,170.44
2.00%
00603448628
21
$418.85
0.12%
26
$472.75
0.16%
00603448721
6
$77.90
0.04%
0
$0.00
0.00%
00603448821
3
$40.60
0.02%
0
$0.00
0.00%
00677043001
3
$38.65
0.02%
0
$0.00
0.00%
00677043101
5
$55.00
0.03%
4
$60.90
0.02%
00677058901
3
$31.05
0.02%
2
$8.40
0.01%
00781105005
2
$28.70
0.01%
0
$0.00
0.00%
00781105010
8
$74.30
0.05%
0
$0.00
0.00%
00781132410
0
$0.00
0.00%
19
$293.48
0.12%
00781164901
59
$1,081.65
0.35%
38
$846.15
0.23%
00781175001
83
$1,504.13
0.49%
63
$1,199.47
0.39%
00781175005
2
$41.60
0.01%
0
$0.00
0.00%
00781176001
85
$1,196.75
0.50%
61
$1,011.12
0.38%
00781500510
1
$6.95
0.01%
0
$0.00
0.00%
00832102400
BACLOFEN
TAB 10MG
830
$21,919.10
4.92%
1,049
$28,330.05
6.45%
00832102450
BACLOFEN
TAB 10MG
49
$1,273.12
0.29%
66
$1,592.75
0.41%
00832102500
BACLOFEN
TAB 20MG
300
$19,201.29
1.78%
473
$25,745.12
2.91%
00832102550
BACLOFEN
TAB 20MG
1
$19.39
0.01%
5
$229.09
0.03%
Page 350 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MUSCLE RELAXANTS
00904236540
0
00904236560
00904565460
00904780940
$0.00
0.00%
7
$138.92
0.04%
0
$0.00
0.00%
24
$392.70
0.15%
3
$57.52
0.02%
3
$37.53
0.02%
1
$21.85
0.01%
0
$0.00
0.00%
00904780960
12
$113.78
0.07%
3
$24.33
0.02%
00904780980
4
$36.16
0.02%
0
$0.00
0.00%
49884078210
TIZANIDINE TAB 2MG
0
$0.00
0.00%
2
$94.20
0.01%
49884078253
TIZANIDINE TAB 2MG
118
$5,948.84
0.70%
69
$2,657.29
0.42%
49884078353
TIZANIDINE TAB 4MG
287
$20,775.55
1.70%
129
$7,080.06
0.79%
50111056301
5,013
$54,675.70
29.74%
5,516
$59,469.24
33.92%
50111056302
28
$286.79
0.17%
33
$328.19
0.20%
50111056303
794
$8,746.04
4.71%
1,872
$21,007.45
11.51%
50580028010
FLEXERIL
TAB 5MG
240
$9,714.14
1.42%
88
$1,538.86
0.54%
50580087411
FLEXERIL
TAB 10MG
5
$414.37
0.03%
2
$223.10
0.01%
51079064420
2
$26.90
0.01%
7
$75.25
0.04%
52152005302
2
$10.34
0.01%
0
$0.00
0.00%
52152013604
1
$9.85
0.01%
0
$0.00
0.00%
52152013605
7
$86.60
0.04%
0
$0.00
0.00%
52544068601
BACLOFEN
5
$140.40
0.03%
2
$52.10
0.01%
52544069301
4
$43.34
0.02%
4
$42.48
0.02%
52555069501
BACLOFEN
TAB 10MG
4
$66.20
0.02%
0
$0.00
0.00%
52555069505
BACLOFEN
TAB 10MG
3
$358.95
0.02%
1
$101.65
0.01%
53265026450
0
$0.00
0.00%
14
$162.07
0.09%
53265026510
0
$0.00
0.00%
35
$413.55
0.22%
53265026550
0
$0.00
0.00%
3
$52.95
0.02%
53265026610
196
$1,819.59
1.16%
14
$173.00
0.09%
53265026611
48
$566.55
0.28%
7
$79.51
0.04%
TAB 10MG
Page 351 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
MUSCLE RELAXANTS
53265026650
14
$234.05
0.08%
4
$51.10
0.02%
53489011001
346
$3,682.31
2.05%
107
$940.44
0.66%
53489011005
3
$40.65
0.02%
3
$29.55
0.02%
53489011010
60
$765.15
0.36%
3
$29.05
0.02%
57664050313
TIZANIDINE TAB 4MG
0
$0.00
0.00%
5
$49.85
0.03%
57664050389
TIZANIDINE TAB 4MG
0
$0.00
0.00%
3
$215.05
0.02%
58281056104
LIORESAL INT INJ 10MG/5ML
2
$1,583.14
0.01%
1
$773.45
0.01%
58281056301
LIORESAL INT INJ 40MG/20
0
$0.00
0.00%
2
$1,546.90
0.01%
59075006810
SKELAXIN
TAB 800MG
82
$6,123.39
0.49%
15
$378.81
0.09%
59075059215
ZANAFLEX
TAB 2MG
2
$46.86
0.01%
0
$0.00
0.00%
59075059415
ZANAFLEX
TAB 4MG
10
$1,239.43
0.06%
7
$877.50
0.04%
60505025103
TIZANIDINE TAB 2MG
0
$0.00
0.00%
8
$168.04
0.05%
60505025203
TIZANIDINE TAB 4MG
0
$0.00
0.00%
36
$1,474.90
0.22%
60793013501
SKELAXIN
TAB 400MG
0
$0.00
0.00%
32
$850.53
0.20%
60793013601
SKELAXIN
TAB 800MG
0
$0.00
0.00%
79
$3,923.44
0.49%
60793013605
SKELAXIN
TAB 800MG
0
$0.00
0.00%
2
$197.09
0.01%
65162010615
TIZANIDINE TAB 2MG
8
$177.33
0.05%
12
$561.00
0.07%
65162013811
TIZANIDINE TAB 4MG
0
$0.00
0.00%
5
$381.25
0.03%
65162013815
TIZANIDINE TAB 4MG
73
$2,891.85
0.43%
33
$1,414.41
0.20%
65162013850
TIZANIDINE TAB 4MG
0
$0.00
0.00%
8
$884.30
0.05%
NARCOTIC - ANTAGONISTS
00056001130
REVIA
TAB 50MG
2
$271.96
0.77%
0
$0.00
0.00%
00056001170
REVIA
TAB 50MG
1
$135.98
0.38%
0
$0.00
0.00%
00074121201
NALOXONE
2
$10.16
0.77%
0
$0.00
0.00%
00185003901
NALTREXONE TAB 50MG
3
$214.35
1.15%
12
$568.45
4.20%
00185003930
NALTREXONE TAB 50MG
0
$0.00
0.00%
1
$28.85
0.35%
INJ 0.4MG/ML
Page 352 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
NALTREXONE TAB 50MG
00406117003
00555090201
$
Market Share*
NARCOTIC - ANTAGONISTS
00406117001
# of Scripts
18
$743.96
6.92%
52
$3,619.85
18.18%
NALTREXONE TAB 50MG
20
$1,464.14
7.69%
9
$627.65
3.15%
NALTREXONE TAB 50MG
118
$8,678.32
45.38%
156
$11,543.45
54.55%
00555090202
NALTREXONE TAB 50MG
77
$5,778.94
29.62%
42
$3,272.52
14.69%
52152010502
NALTREXONE TAB 50MG
10
$903.80
3.85%
6
$372.60
2.10%
52152010530
NALTREXONE TAB 50MG
9
$678.45
3.46%
8
$789.30
2.80%
NARCOTICS - MICS.
00002035102
DARVOCET-N TAB 50
42
$672.50
0.05%
0
$0.00
0.00%
00002035302
DARVON-N
TAB 100MG
30
$1,149.47
0.03%
8
$171.12
0.01%
00002035333
DARVON-N
TAB 100MG
1
$35.52
0.00%
0
$0.00
0.00%
00002036302
DARVOCET-N TAB 100
12
$683.49
0.01%
1
$174.05
0.00%
00002036303
DARVOCET-N TAB 100
2
$307.18
0.00%
0
$0.00
0.00%
00002036333
DARVOCET-N TAB 100
0
$0.00
0.00%
2
$347.90
0.00%
00002080302
DARVON
CAP 65MG
23
$1,005.95
0.03%
0
$0.00
0.00%
00002311102
DARVON
CAP CPD 65
7
$436.64
0.01%
1
$54.86
0.00%
00024033504
DEMEROL
TAB 50MG
0
$0.00
0.00%
3
$48.58
0.00%
00024195104
TALWIN NX TAB
2
$74.64
0.00%
0
$0.00
0.00%
00034051810
MSIR
TAB 15MG
3
$52.24
0.00%
0
$0.00
0.00%
00034051910
MSIR
TAB 30MG
6
$80.38
0.01%
1
$18.85
0.00%
00034052301
MSIR
SOL 20MG/ML
1
$20.60
0.00%
0
$0.00
0.00%
00044101706
DILAUDID-HP INJ 10MG/ML
1
$600.65
0.00%
0
$0.00
0.00%
00044102202
DILAUDID
TAB 2MG
1
$11.94
0.00%
0
$0.00
0.00%
00044102402
DILAUDID
TAB 4MG
1
$21.87
0.00%
0
$0.00
0.00%
00044105301
DILAUDID
SUP 3MG
1
$38.12
0.00%
0
$0.00
0.00%
00044108501
DILAUDID-5 LIQ 1MG/ML
2
$57.84
0.00%
0
$0.00
0.00%
00045051560
TYLENOL/COD TAB #4
9
$416.98
0.01%
0
$0.00
0.00%
Page 353 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
TYLOX
00054279525
00054300563
$
Market Share*
NARCOTICS - MICS.
00045052660
# of Scripts
CAP 5-500MG
3
$152.74
0.00%
0
$0.00
0.00%
OXYCOD/APAP CAP 5-500MG
63
$808.01
0.07%
38
$720.18
0.04%
APAP/CODEINE ELX 120-12/5
1
$5.27
0.00%
1
$6.55
0.00%
00054316163
CODEINE PHOS SOL 15MG/5ML
9
$91.02
0.01%
6
$33.57
0.01%
00054354563
MEPERIDINE SYP 50MG/5ML
1
$34.17
0.00%
0
$0.00
0.00%
00054368263
ROXICODONE SOL 5MG/5ML
36
$811.85
0.04%
24
$661.58
0.03%
00054368344
ROXICODONE CON 20MG/ML
6
$229.95
0.01%
8
$254.83
0.01%
00054368663
ROXICET
99
$2,759.48
0.12%
93
$2,142.79
0.10%
00054375144
ROXANOL
SOL 20MG/ML
7
$142.37
0.01%
3
$126.07
0.00%
00054375150
ROXANOL
SOL 20MG/ML
11
$877.47
0.01%
1
$1.00
0.00%
00054375158
ROXANOL
SOL 20MG/ML
2
$43.02
0.00%
0
$0.00
0.00%
00054377450
ROXANOL-T
1
$37.26
0.00%
0
$0.00
0.00%
00054415625
CODEINE SULF TAB 30MG
100
$2,835.29
0.12%
130
$3,736.75
0.15%
00054415725
15
$1,245.16
0.02%
15
$676.21
0.02%
00054437025
HYDROMORPHON TAB 8MG
17
$4,774.55
0.02%
37
$9,741.45
0.04%
00054439225
28
$399.10
0.03%
13
$228.52
0.01%
00054439425
40
$3,305.04
0.05%
24
$1,128.70
0.03%
00054458225
MORPHINE SUL TAB 15MG
375
$5,165.02
0.44%
312
$4,587.27
0.35%
00054458325
193
$4,378.90
0.22%
198
$4,455.90
0.22%
00054459525
MEPERIDINE TAB 50MG
8
$452.33
0.01%
4
$83.95
0.00%
00054465025
ROXICET
TAB 5-325MG
1,277
$9,038.65
1.48%
773
$7,398.40
0.87%
00054465029
ROXICET
TAB 5-325MG
229
$1,948.77
0.27%
221
$2,283.20
0.25%
00054465725
ROXICODONE TAB 5MG
168
$5,596.78
0.20%
63
$2,501.71
0.07%
00054465825
ROXICODONE TAB 15MG
560
$54,281.02
0.65%
632
$63,982.12
0.71%
00054466525
ROXICODONE TAB 30MG
493
$88,567.85
0.57%
560
$121,953.35
0.63%
00054478425
ROXICET
TAB 5-500MG
2
$169.06
0.00%
1
$25.33
0.00%
00054815524
15
$223.74
0.02%
16
$203.59
0.02%
SOL 5-325/5
SOL 20MG/ML
Page 354 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
00054815624
1
$9.77
0.00%
0
$0.00
0.00%
00054839224
1
$40.28
0.00%
1
$9.60
0.00%
00054858224
1
$1.09
0.00%
0
$0.00
0.00%
00054865024
ROXICET
17
$24.73
0.02%
19
$41.92
0.02%
00054865724
ROXICODONE TAB 5MG
16
$57.26
0.02%
32
$81.57
0.04%
00054866524
ROXICODONE TAB 30MG
2
$97.30
0.00%
4
$493.73
0.00%
00074117630
DEMEROL
INJ 25MG/ML
0
$0.00
0.00%
1
$11.43
0.00%
00074117801
DEMEROL
INJ 50MG/ML
0
$0.00
0.00%
4
$29.40
0.00%
00074117830
DEMEROL
INJ 50MG/ML
0
$0.00
0.00%
2
$26.75
0.00%
00074117902
DEMEROL
INJ 75MG/ML
15
$686.07
0.02%
46
$1,546.36
0.05%
00074118002
DEMEROL
INJ 100MG/ML
1
$13.92
0.00%
0
$0.00
0.00%
00074118069
DEMEROL
INJ 100MG/ML
1
$9.82
0.00%
2
$8.92
0.00%
00074118130
DEMEROL
INJ 50MG/ML
1
$21.97
0.00%
0
$0.00
0.00%
00074125301
DEMEROL
INJ 50MG/ML
1
$1.00
0.00%
0
$0.00
0.00%
00074130401
HYDROMORPHON INJ 4MG/ML
1
$29.42
0.00%
5
$47.45
0.01%
00074130431
5
$103.84
0.01%
0
$0.00
0.00%
00074131230
1
$14.88
0.00%
0
$0.00
0.00%
00074194914
VICODIN
TAB 5-500MG
3
$94.00
0.00%
1
$16.26
0.00%
00074197314
VICODIN ES TAB 7.5-750
1
$9.46
0.00%
0
$0.00
0.00%
00074227714
VICOPROFEN TAB
35
$1,722.72
0.04%
6
$377.45
0.01%
00074241514
DILAUDID
TAB 2MG
4
$75.07
0.00%
0
$0.00
0.00%
00074241614
DILAUDID
TAB 4MG
1
$21.87
0.00%
0
$0.00
0.00%
00074242614
DILAUDID
TAB 8MG
1
$110.48
0.00%
0
$0.00
0.00%
00074245107
DILAUDID
SUP 3MG
1
$86.80
0.00%
0
$0.00
0.00%
00074245202
DILAUDID-5 LIQ 1MG/ML
6
$68.75
0.01%
1
$18.18
0.00%
00074245351
DILAUDID-HP INJ 10MG/ML
4
$3,457.63
0.00%
1
$612.73
0.00%
00074245531
DILAUDID-HP INJ 250MG
1
$710.67
0.00%
0
$0.00
0.00%
TAB 5-325MG
Page 355 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
00074909422
FENTANYL CIT INJ 0.05MG/1
0
00078010705
FIORINAL/COD CAP 30MG
00078024305
FIORICET/COD CAP
00086004616
$0.00
0.00%
11
$565.47
0.01%
1
$25.00
0.00%
8
$895.18
0.01%
6
$513.53
0.01%
3
$119.97
0.00%
CAPITAL/COD SUS 120-12/5
0
$0.00
0.00%
1
$9.69
0.00%
00093003301
OXYCODONE
0
$0.00
0.00%
304
$159,357.56
0.34%
00093005001
APAP/CODEINE TAB 300-15MG
30
$205.50
0.03%
42
$281.90
0.05%
00093015001
120
$994.65
0.14%
120
$1,032.54
0.14%
00093015010
1,418
$10,446.00
1.65%
1,023
$8,633.26
1.15%
00093035001
50
$1,031.73
0.06%
32
$865.51
0.04%
00093035005
4
$169.48
0.00%
0
$0.00
0.00%
00093049001
PROPO-N/APAP TAB 100-650
55
$623.48
0.06%
38
$451.52
0.04%
00093049005
578
$6,304.09
0.67%
423
$4,833.59
0.48%
00093074101
PROPOXY HCL CAP 65MG
45
$1,021.07
0.05%
79
$2,213.48
0.09%
00093074105
10
$391.74
0.01%
18
$280.89
0.02%
00093074110
5
$268.11
0.01%
0
$0.00
0.00%
00093089001
1
$3.40
0.00%
3
$25.35
0.00%
00093089005
1,224
$14,060.14
1.42%
1,139
$13,365.72
1.28%
00093516101
HYDROCOD/IBU TAB 7.5-200
271
$8,797.72
0.31%
58
$746.14
0.07%
00121050416
42
$231.14
0.05%
196
$1,079.92
0.22%
00121065504
HYDROCODONE/ SOL APAP
1
$15.52
0.00%
0
$0.00
0.00%
00143300001
BUT/APAP/CAF CAP CODEINE
49
$2,163.31
0.06%
15
$442.44
0.02%
00172218660
102
$2,334.68
0.12%
56
$1,252.91
0.06%
00172218680
0
$0.00
0.00%
62
$845.05
0.07%
00172398460
ASA/CODEINE TAB 325-30MG
2
$6.24
0.00%
3
$33.09
0.00%
00172498060
0
$0.00
0.00%
728
$6,339.66
0.82%
00172498070
853
$7,565.62
0.99%
212
$2,182.98
0.24%
00172498080
630
$7,024.61
0.73%
289
$3,078.70
0.33%
TAB 80MG
Page 356 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
00172564370
HYDROCO/APAP TAB 5-500MG
9
$29.30
0.01%
0
$0.00
0.00%
00182107840
1
$4.15
0.00%
0
$0.00
0.00%
00185047401
1
$4.78
0.00%
0
$0.00
0.00%
00228208510
0
$0.00
0.00%
1
$5.95
0.00%
00228208550
17
$202.90
0.02%
30
$420.55
0.03%
00228302096
7
$104.11
0.01%
15
$130.49
0.02%
00228305696
16
$90.82
0.02%
14
$84.43
0.02%
00228305811
0
$0.00
0.00%
1
$17.72
0.00%
00254360128
2
$2.00
0.00%
0
$0.00
0.00%
00254511335
17
$176.82
0.02%
0
$0.00
0.00%
00258365805
7
$70.70
0.01%
5
$85.75
0.01%
00378012901
22
$431.37
0.03%
13
$210.59
0.01%
00378012905
21
$547.68
0.02%
0
$0.00
0.00%
00378013001
PROPOXY/APAP TAB 65-650MG
27
$268.99
0.03%
18
$208.42
0.02%
00378013005
16
$172.71
0.02%
15
$145.12
0.02%
00378015501
10
$221.12
0.01%
8
$127.26
0.01%
00378015505
2,664
$31,390.95
3.09%
2,229
$26,042.62
2.51%
00378115505
26
$251.73
0.03%
1
$6.41
0.00%
00406035701
188
$793.91
0.22%
425
$1,515.62
0.48%
00406035705
22,168
$87,565.50
25.75%
23,075
$105,163.78
25.99%
00406035801
HYDROCO/APAP TAB 7.5-500
1,382
$12,595.97
1.61%
1,594
$14,228.07
1.80%
00406035805
924
$8,878.31
1.07%
845
$8,535.62
0.95%
00406035862
1
$2.30
0.00%
0
$0.00
0.00%
00406035901
102
$592.26
0.12%
68
$463.64
0.08%
00406035905
13
$75.63
0.02%
18
$129.70
0.02%
00406036001
632
$4,643.17
0.73%
528
$4,084.70
0.59%
00406036005
3,447
$23,204.55
4.00%
3,274
$24,214.32
3.69%
Page 357 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
00406036101
1,033
$11,959.24
1.20%
884
00406036105
414
$5,309.25
0.48%
00406036201
HYDROCO/APAP TAB 10/660MG
468
$9,669.14
0.54%
00406036301
869
$14,895.24
00406036305
143
00406036501
00406036601
00406036701
$11,061.82
1.00%
343
$4,341.77
0.39%
428
$10,498.56
0.48%
1.01%
994
$16,640.97
1.12%
$2,652.03
0.17%
150
$3,260.86
0.17%
179
$4,048.50
0.21%
450
$8,642.72
0.51%
95
$4,453.69
0.11%
216
$5,840.74
0.24%
762
$19,768.11
0.89%
841
$23,165.21
0.95%
00406036705
81
$2,222.45
0.09%
101
$3,121.92
0.11%
00406036762
00406037516
00406048301
2
$30.82
0.00%
1
$16.45
0.00%
189
$5,149.56
0.22%
185
$5,374.28
0.21%
31
$209.00
0.04%
41
$276.95
0.05%
00406048401
44
$294.88
0.05%
34
$401.69
0.04%
00406048410
2,691
$19,734.78
3.13%
2,368
$17,493.32
2.67%
00406048501
91
$1,510.73
0.11%
93
$1,544.28
0.10%
00406048505
1
$4.22
0.00%
3
$61.29
0.00%
00406051201
OXYCOD/APAP TAB 5-325MG
1,919
$12,732.10
2.23%
6,917
$60,708.07
7.79%
00406051205
449
$3,536.51
0.52%
1,380
$12,090.63
1.55%
00406051262
4
$17.15
0.00%
2
$8.80
0.00%
00406052201
OXYCOD-APAP TAB 7.5-325
0
$0.00
0.00%
2
$2.00
0.00%
00406053201
781
$8,608.06
0.91%
764
$8,460.94
0.86%
00406053205
27
$233.73
0.03%
55
$617.60
0.06%
00406055201
OXYCODONE
TAB 5MG
4,774
$108,952.20
5.55%
6,491
$147,544.62
7.31%
00406055262
OXYCODONE
TAB 5MG
10
$174.82
0.01%
10
$387.40
0.01%
00406055401
OXYCODONE
CAP 5MG
85
$2,037.60
0.10%
169
$3,429.55
0.19%
00406056201
OXYCO/APAP TAB 10-650
0
$0.00
0.00%
2
$2.00
0.00%
00406058201
OXYCO/APAP TAB 7.5-500
0
$0.00
0.00%
4
$85.30
0.00%
Page 358 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
00406172101
1
$21.25
0.00%
6
$56.10
0.01%
00406172105
207
$2,127.10
0.24%
192
$2,209.78
0.22%
00406172110
0
$0.00
0.00%
23
$205.73
0.03%
00406177201
0
$0.00
0.00%
9
$43.90
0.01%
00406177205
3,389
$37,737.78
3.94%
2,977
$33,661.34
3.35%
00406177210
9
$83.07
0.01%
151
$1,813.64
0.17%
00406177260
1
$23.60
0.00%
0
$0.00
0.00%
00406324301
219
$4,423.36
0.25%
283
$4,750.38
0.32%
00406324401
167
$13,624.65
0.19%
202
$9,832.79
0.23%
00406435701
HYDROCO/APAP CAP 5-500MG
9
$103.29
0.01%
8
$106.14
0.01%
00406711301
MEPERIDINE TAB 50MG
35
$711.94
0.04%
44
$985.07
0.05%
00406711501
MEPERIDINE TAB 100MG
9
$233.56
0.01%
6
$177.64
0.01%
00406851501
OXYCODONE
TAB 15MG
0
$0.00
0.00%
64
$4,502.53
0.07%
00406853001
OXYCODONE
TAB 30MG
0
$0.00
0.00%
9
$2,220.03
0.01%
00406855550
OXYCODONE
SOL 5MG/5ML
36
$1,586.05
0.04%
69
$1,895.45
0.08%
00406855830
OXYCODONE
CON 20MG/ML
62
$2,051.60
0.07%
13
$349.70
0.01%
00472141904
4
$22.10
0.00%
1
$4.31
0.00%
00472141916
443
$2,281.68
0.51%
404
$2,108.66
0.46%
00527131201
BUT/ASA/CAF/ CAP COD 30MG
113
$6,398.10
0.13%
98
$6,889.48
0.11%
00555030302
9
$106.35
0.01%
0
$0.00
0.00%
00555030305
139
$1,213.31
0.16%
39
$340.51
0.04%
00555030402
1
$14.91
0.00%
0
$0.00
0.00%
00555038102
MEPERIDINE TAB 50MG
164
$3,683.96
0.19%
127
$4,426.82
0.14%
00555038202
35
$1,946.31
0.04%
18
$1,406.78
0.02%
00555065802
569
$6,232.57
0.66%
276
$3,080.18
0.31%
00555089602
1
$22.41
0.00%
0
$0.00
0.00%
00574711012
MORPHINE SUL SUP 5MG
29
$464.20
0.03%
6
$167.61
0.01%
Page 359 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
00574722406
HYDROMORPHON SUP 3MG
00591034901
00591034905
00591038501
00591038505
00591038701
00591038705
00591038801
00591039501
PENTAZOCINE/ TAB NALOXONE
00591039601
PENTA/APAP TAB 25-650MG
00591042501
$
Market Share*
NARCOTICS - MICS.
00574711612
# of Scripts
0
$0.00
0.00%
0.02%
6
$1,645.46
0.01%
0.27%
233
$1,127.59
0.26%
$12,924.82
3.37%
3,173
$13,314.41
3.57%
$1,590.02
0.16%
74
$995.96
0.08%
94
$954.97
0.11%
154
$1,766.98
0.17%
267
$1,660.90
0.31%
205
$1,591.86
0.23%
391
$2,911.70
0.45%
245
$2,053.57
0.28%
148
$1,905.63
0.17%
77
$666.70
0.09%
74
$3,276.54
0.09%
83
$4,084.19
0.09%
6
$303.50
0.01%
1
$67.16
0.00%
69
$5,434.13
0.08%
48
$3,635.96
0.05%
00591042505
0
$0.00
0.00%
1
$19.01
0.00%
00591050201
55
$360.24
0.06%
24
$298.07
0.03%
00591050205
17
$118.76
0.02%
8
$50.91
0.01%
00591050301
161
$2,514.90
0.19%
189
$2,457.71
0.21%
00591050305
330
$4,810.61
0.38%
188
$3,405.50
0.21%
00591054001
102
$1,894.21
0.12%
64
$1,413.32
0.07%
00591054005
248
$5,009.08
0.29%
219
$4,272.26
0.25%
00591071401
0
$0.00
0.00%
6
$47.28
0.01%
00591072601
MEPERIDINE TAB 50MG
99
$3,132.85
0.12%
128
$4,086.74
0.14%
00591072701
15
$1,248.63
0.02%
13
$915.79
0.01%
00591073701
45
$467.47
0.05%
61
$580.12
0.07%
00591073705
1
$5.65
0.00%
0
$0.00
0.00%
00591074901
5
$20.72
0.01%
60
$382.81
0.07%
00591074905
5
$12.53
0.01%
0
$0.00
0.00%
00591082001
OXYCOD/ASA TAB
17
$298.28
0.02%
21
$639.44
0.02%
1
$52.70
0.00%
17
$793.55
235
$972.19
2,903
136
Page 360 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
OXYCO/APAP TAB 7.5-500
00591082501
00591085301
00591085305
00591093201
$
Market Share*
NARCOTICS - MICS.
00591082401
# of Scripts
116
$4,902.71
0.13%
56
$3,514.62
0.07%
107
$3,601.04
0.12%
143
$3,845.77
0.17%
OXYCODO-APAP TAB 10-325
37
$3,429.13
00591093301
OXYCOD-APAP TAB 7.5-325
39
00591320201
0
00591320301
00591322001
$283.15
0.03%
2
$20.05
0.00%
166
$5,709.90
0.19%
153
$3,319.50
0.17%
0.04%
27
$332.49
0.03%
$2,912.03
0.05%
11
$200.54
0.01%
$0.00
0.00%
5
$168.97
0.01%
0
$0.00
0.00%
16
$459.56
0.02%
1
$65.67
0.00%
0
$0.00
0.00%
00603102058
4
$22.04
0.00%
5
$34.99
0.01%
00603129558
0
$0.00
0.00%
32
$607.24
0.04%
00603233721
2
$12.10
0.00%
0
$0.00
0.00%
00603233832
3
$16.25
0.00%
0
$0.00
0.00%
00603236121
4
$10.54
0.00%
0
$0.00
0.00%
00603255321
22
$1,280.11
0.03%
5
$389.26
0.01%
00603388021
1
$19.17
0.00%
22
$249.90
0.02%
00603388128
199
$880.49
0.23%
283
$1,077.42
0.32%
00603388132
0
$0.00
0.00%
240
$1,206.89
0.27%
00603388221
0
$0.00
0.00%
6
$65.20
0.01%
00603388232
8
$77.70
0.01%
38
$387.70
0.04%
00603388321
40
$255.84
0.05%
206
$1,523.88
0.23%
00603388328
0
$0.00
0.00%
13
$82.06
0.01%
00603388332
0
$0.00
0.00%
10
$99.55
0.01%
00603388428
6
$68.10
0.01%
6
$68.10
0.01%
00603388521
0
$0.00
0.00%
101
$1,263.30
0.11%
00603388528
4
$57.15
0.00%
35
$482.75
0.04%
00603388532
0
$0.00
0.00%
10
$159.13
0.01%
24
Page 361 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
00603388621
00603388628
00603388721
00603388728
00603388732
$489.75
0.03%
$2,752.20
0.12%
0
$0.00
0.00%
34
$1,017.70
0.04%
9
$210.45
0.01%
265
$8,276.66
0.30%
30
$811.60
0.03%
47
$1,241.35
0.05%
1
$26.85
0.00%
0
$0.00
0.00%
00603388821
0
$0.00
0.00%
00603388828
3
$78.15
0.00%
4
$55.45
0.00%
34
$644.41
0.04%
00603388832
39
$631.45
0.05%
21
$445.23
0.02%
00603441521
MEPERITAB
7
$447.68
0.01%
7
$297.71
0.01%
00603499721
5
$29.85
0.01%
00603499821
0
$0.00
0.00%
1
$4.05
0.00%
15
$178.68
0.02%
00603499828
63
$514.59
0.07%
42
$334.41
0.05%
00603545921
267
$6,025.60
0.31%
264
$6,318.66
0.30%
00603545928
20
$680.63
00603546521
PROPO-N/APAP TAB 50/325
121
$1,863.25
0.02%
55
$1,839.98
0.06%
0.14%
171
$3,369.91
0.19%
00603546621
30
$261.41
0.03%
2
$10.20
0.00%
00603546628
132
$1,482.05
0.15%
56
$657.41
0.06%
00603546632
00603546721
12
$147.22
0.01%
43
$474.12
0.05%
0
$0.00
0.00%
31
$317.68
0.03%
00603546728
25
$239.30
0.03%
26
$220.45
0.03%
00603546732
96
$1,153.39
0.11%
108
$1,273.17
0.12%
00603546821
23
$278.90
0.03%
10
$107.79
0.01%
00603546828
13
$138.30
0.02%
9
$128.05
0.01%
00603546832
88
$803.57
0.10%
399
$5,034.05
0.45%
00615040063
23
$99.82
0.03%
0
$0.00
0.00%
00641012125
1
$10.09
0.00%
0
$0.00
0.00%
00641113035
MEPERIDINE INJ 50MG/ML
0
$0.00
0.00%
9
$133.88
0.01%
TAB 50MG
24
108
Page 362 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
00677064701
1
$1.87
0.00%
0
$0.00
0.00%
00677099633
2
$11.02
0.00%
2
$8.86
0.00%
00677118405
8
$17.24
0.01%
0
$0.00
0.00%
00785112201
LORCET PLUS TAB 7.5-650
3
$571.03
0.00%
0
$0.00
0.00%
00785635001
LORCET
2
$183.92
0.00%
0
$0.00
0.00%
00904763160
7
$100.53
0.01%
0
$0.00
0.00%
00904770240
42
$358.63
0.05%
14
$148.16
0.02%
00904770280
7
$56.95
0.01%
11
$156.59
0.01%
10019015668
0
$0.00
0.00%
13
$205.28
0.01%
10019016001
0
$0.00
0.00%
2
$23.44
0.00%
10019016201
0
$0.00
0.00%
1
$3.53
0.00%
12496127802
SUBUTEX
24
$2,414.37
0.03%
34
$2,850.07
0.04%
12496128302
SUBOXONE
SUB 2-0.5MG
487
$47,729.74
0.57%
451
$46,693.92
0.51%
12496130602
SUBOXONE
SUB 8-2MG
516
$69,601.72
0.60%
1,704
$244,758.56
1.92%
12496131002
SUBUTEX
18
$2,247.39
0.02%
46
$6,946.73
0.05%
50383007916
0
$0.00
0.00%
56
$264.97
0.06%
50474090201
LORTAB 5
TAB
5
$111.17
0.01%
0
$0.00
0.00%
50474090916
LORTAB
ELX
2
$106.39
0.00%
0
$0.00
0.00%
50474092501
LORTAB 2.5 TAB
1
$12.76
0.00%
0
$0.00
0.00%
51079032220
0
$0.00
0.00%
6
$40.16
0.01%
51079093420
8
$72.87
0.01%
0
$0.00
0.00%
51285030302
15
$90.79
0.02%
0
$0.00
0.00%
51285030305
71
$484.34
0.08%
0
$0.00
0.00%
51285030402
7
$45.30
0.01%
0
$0.00
0.00%
51285065802
58
$813.91
0.07%
0
$0.00
0.00%
51991007401
ASCOMP
33
$1,436.44
0.04%
8
$131.81
0.01%
52152004102
3
$63.03
0.00%
5
$42.81
0.01%
TAB 10/650
SUB 2MG
SUB 8MG
CAP COD 30MG
Page 363 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
52152015802
MEPERIDINE TAB 50MG
52152016502
OXYCODONE
52152016511
OXYCODONE
52152018702
OXYCODONE
52152021102
PENTAZOCINE/ TAB NALOXONE
52152021302
52152021402
0
$0.00
0.00%
3
$104.21
0.00%
TAB 5MG
87
$2,939.66
0.10%
71
$1,824.55
0.08%
TAB 5MG
1
$53.65
0.00%
1
$9.35
0.00%
CAP 5MG
14
$644.30
0.02%
4
$242.80
0.00%
21
$837.00
0.02%
27
$1,288.11
0.03%
PENTA/APAP TAB 25-650MG
1
$41.40
0.00%
0
$0.00
0.00%
OXYCODONE
TAB 15MG
0
$0.00
0.00%
339
$23,557.47
0.38%
52152021502
OXYCODONE
TAB 30MG
0
$0.00
0.00%
264
$30,274.73
0.30%
52544034901
2
$8.38
0.00%
0
$0.00
0.00%
52544034905
87
$418.62
0.10%
0
$0.00
0.00%
52544038501
38
$455.44
0.04%
1
$3.75
0.00%
52544038505
2
$21.31
0.00%
2
$27.29
0.00%
52544038701
26
$184.95
0.03%
0
$0.00
0.00%
52544038705
8
$52.89
0.01%
0
$0.00
0.00%
52544038801
2
$23.06
0.00%
11
$141.33
0.01%
52544050201
18
$128.18
0.02%
0
$0.00
0.00%
52544050301
11
$121.95
0.01%
0
$0.00
0.00%
52544050305
1
$11.75
0.00%
0
$0.00
0.00%
52544072901
NORCO
3
$364.06
0.00%
0
$0.00
0.00%
52544082401
OXYCO/APAP TAB 7.5-500M
2
$20.46
0.00%
0
$0.00
0.00%
52544082501
1
$50.51
0.00%
0
$0.00
0.00%
52544085110
1
$12.95
0.00%
13
$109.15
0.01%
52544085201
20
$316.92
0.02%
0
$0.00
0.00%
52544091301
NORCO
10
$247.26
0.01%
2
$14.70
0.00%
53265024010
0
$0.00
0.00%
13
$740.07
0.01%
53265025611
1,335
$16,496.63
1.55%
945
$12,108.90
1.06%
53265025650
206
$2,671.96
0.24%
328
$4,038.40
0.37%
TAB 7.5-325
TAB 5-325MG
Page 364 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
53265026110
53265026111
53265026150
53265028510
53265028511
$42.35
0.00%
0
$0.00
0.00%
7
$64.50
0.01%
22
$260.51
0.02%
47
$551.24
0.05%
39
$374.26
0.04%
0
$0.00
0.00%
16
$84.42
0.02%
45
$416.44
0.05%
574
$4,300.91
0.65%
53265028550
20
$153.34
0.02%
0
$0.00
0.00%
53265028610
0
$0.00
0.00%
22
$371.44
0.02%
53265028650
4
$59.64
0.00%
0
$0.00
0.00%
53265032810
11
$247.25
0.01%
21
$504.73
0.02%
53265032850
16
$495.34
0.02%
104
$3,783.66
0.12%
53265032910
0
$0.00
0.00%
75
$316.41
0.08%
53265032950
229
$923.85
0.27%
219
$953.83
0.25%
53265033010
0
$0.00
0.00%
2
$24.66
0.00%
53265033011
0
$0.00
0.00%
1
$23.81
0.00%
53265033050
0
$0.00
0.00%
7
$114.99
0.01%
53265033110
0
$0.00
0.00%
8
$170.50
0.01%
53265033150
0
$0.00
0.00%
49
$1,030.05
0.06%
53265033350
2
$35.04
0.00%
11
$217.31
0.01%
53265033450
62
$499.18
0.07%
31
$207.31
0.03%
53265033510
40
$1,451.60
0.05%
94
$2,810.04
0.11%
53265033550
0
$0.00
0.00%
86
$1,075.86
0.10%
53265034510
111
$2,762.68
0.13%
217
$3,734.62
0.24%
53265034550
15
$357.37
0.02%
12
$185.90
0.01%
54569549600
SUBOXONE
3
$443.17
0.00%
0
$0.00
0.00%
58177004104
OXYCODONE
256
$6,811.13
0.30%
148
$3,881.12
0.17%
58177029804
4
$80.58
0.00%
44
$517.67
0.05%
58177029811
6
$124.74
0.01%
0
$0.00
0.00%
SUB 2-0.5MG
CAP 5MG
3
Page 365 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
58177029904
58177031304
58177031404
58177031504
OXYCODONE
58177031511
OXYCODONE
58177088601
58177088603
0
$0.00
0.00%
8
$60.20
0.01%
32
$422.30
0.04%
36
$638.30
0.04%
30
$506.35
0.03%
35
$814.85
0.04%
TAB 5MG
725
$13,861.33
0.84%
513
$9,999.82
0.58%
TAB 5MG
5
$115.65
0.01%
0
$0.00
0.00%
MORPHINE SUL SOL 20MG/ML
125
$2,856.99
0.15%
124
$1,473.78
0.14%
MORPHINE SUL SOL 20MG/ML
28
$2,174.84
0.03%
48
$3,017.55
0.05%
58177090907
84
$2,001.80
0.10%
79
$2,378.86
0.09%
58177091401
OXYDOSE
91
$4,972.58
0.11%
123
$3,919.51
0.14%
59011020110
OXYIR
11
$346.88
0.01%
1
$8.70
0.00%
59011022520
OXYFAST
CON 20MG/ML
26
$1,991.50
0.03%
0
$0.00
0.00%
60258072016
1
$28.70
0.00%
0
$0.00
0.00%
60432024516
586
$3,064.94
0.68%
289
$1,630.33
0.33%
60951060270
ENDOCET
TAB 5-325MG
5,530
$40,106.14
6.42%
1,985
$18,267.94
2.24%
60951060275
ENDOCET
TAB 5-325MG
6
$41.10
0.01%
3
$14.40
0.00%
60951060285
ENDOCET
TAB 5-325MG
3,145
$23,624.17
3.65%
1,310
$13,751.33
1.48%
60951061070
ENDODAN
TAB
63
$1,760.94
0.07%
41
$1,261.59
0.05%
60951067570
12
$866.54
0.01%
0
$0.00
0.00%
60951070070
ENDOCET
TAB 7.5-325M
0
$0.00
0.00%
16
$224.19
0.02%
60951071270
ENDOCET
TAB 10-325MG
0
$0.00
0.00%
10
$191.58
0.01%
60951075270
13
$278.48
0.02%
23
$377.40
0.03%
60951075770
14
$813.77
0.02%
1
$4.45
0.00%
60951079670
ENDOCET
TAB 7.5-500M
184
$8,376.94
0.21%
22
$427.42
0.02%
60951079770
ENDOCET
TAB 10-650MG
87
$6,107.68
0.10%
9
$131.70
0.01%
61703024345
0
$0.00
0.00%
1
$184.80
0.00%
61703024350
2
$1,507.46
0.00%
5
$1,078.09
0.01%
62037052201
0
$0.00
0.00%
12
$77.26
0.01%
CON 20MG/ML
CAP 5MG
Page 366 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
62037052210
62037052401
HYDROCOD/IBU TAB 7.5-200
63304056101
63304056105
63304056201
63304056205
63304056210
63304070601
63304070801
$407.54
0.06%
81
$678.95
0.09%
0
$0.00
0.00%
26
$375.77
0.03%
24
$455.31
0.03%
11
$93.49
0.01%
16
$599.93
0.02%
26
$480.80
0.03%
36
$212.01
0.04%
57
$487.63
0.06%
4
$18.70
0.00%
5
$30.57
0.01%
1,356
$9,485.30
1.58%
874
$6,519.11
0.98%
21
$831.03
0.02%
13
$269.80
0.01%
4
$163.64
0.00%
3
$110.94
0.00%
63304074801
CODEINE PHOS TAB SOL 30MG
1
$20.46
0.00%
0
$0.00
0.00%
63459050230
ACTIQ
LOZ 200MCG
5
$916.31
0.01%
5
$1,242.23
0.01%
63459050430
ACTIQ
LOZ 400MCG
1
$108.64
0.00%
5
$1,829.37
0.01%
63459050630
ACTIQ
LOZ 600MCG
0
$0.00
0.00%
2
$75.00
0.00%
63459050830
ACTIQ
LOZ 800MCG
0
$0.00
0.00%
1
$54.59
0.00%
63459051630
ACTIQ
LOZ 1600MCG
7
$8,177.09
0.01%
4
$9,139.58
0.00%
63481012775
PERCOCET
TAB 5-325MG
0
$0.00
0.00%
2
$75.00
0.00%
63481013570
PERCODAN
TAB
2
$100.66
0.00%
0
$0.00
0.00%
63481062270
PERCOCET
TAB 10-650MG
3
$491.23
0.00%
4
$771.08
0.00%
63481062370
PERCOCET
TAB 5-325MG
19
$2,818.77
0.02%
1
$35.33
0.00%
63481062770
PERCOCET
TAB 2.5-325
26
$542.94
0.03%
5
$168.81
0.01%
63481062870
PERCOCET
TAB 7.5-325M
113
$8,100.56
0.13%
2
$49.42
0.00%
63481062970
PERCOCET
TAB 10-325MG
126
$12,631.67
0.15%
3
$144.31
0.00%
63481066870
ZYDONE
TAB 5-400MG
13
$384.65
0.02%
3
$28.67
0.00%
63481066970
ZYDONE
TAB 7.5-400
12
$413.01
0.01%
2
$47.29
0.00%
63481069870
ZYDONE
TAB 10-400MG
10
$662.69
0.01%
2
$73.47
0.00%
63739014115
1
$17.22
0.00%
0
$0.00
0.00%
64248041910
SYNALGOS DC CAP
7
$119.53
0.01%
0
$0.00
0.00%
53
Page 367 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - MICS.
65234004616
CAPITAL/COD SUS 120-12/5
1
$6.54
0.00%
10
$255.10
0.01%
65234006110
PHRENILIN/ CAP CAFF/COD
3
$124.57
0.00%
3
$237.27
0.00%
66479057416
HYCET
0
$0.00
0.00%
1
$37.09
0.00%
66591061241
DARVON
0
$0.00
0.00%
7
$513.49
0.01%
66591063141
DARVON-N
0
$0.00
0.00%
1
$16.95
0.00%
66591064141
DARVOCET-N TAB 100-650
0
$0.00
0.00%
1
$30.85
0.00%
66591065141
DARVOCET-N TAB 50
0
$0.00
0.00%
4
$61.05
0.00%
SOL 7.5-325
CAP CPD 65
TAB 100MG
NARCOTICS - SELECTED
00045065010
ULTRACET
TAB
4
$395.68
0.06%
0
$0.00
0.00%
00045065060
ULTRACET
TAB
540
$23,054.09
7.64%
168
$4,131.54
2.17%
00045065960
ULTRAM
TAB 50MG
12
$1,239.69
0.17%
1
$13.60
0.01%
00045065970
ULTRAM
TAB 50MG
5
$105.22
0.07%
0
$0.00
0.00%
00054309036
BUTORPHANOL SOL 10MG/ML
8
$518.96
0.11%
6
$824.43
0.08%
00087565041
STADOL NS
SOL 10MG/ML
1
$90.12
0.01%
1
$94.21
0.01%
00093005801
TRAMADOL HCL TAB 50MG
388
$5,944.35
5.49%
583
$11,247.28
7.54%
00093005805
509
$7,972.64
7.20%
504
$8,414.79
6.51%
00172651560
58
$859.74
0.82%
139
$2,239.41
1.80%
00172651570
356
$4,665.54
5.03%
329
$4,538.90
4.25%
00185031101
1
$6.25
0.01%
1
$17.05
0.01%
00185031110
0
$0.00
0.00%
2
$51.00
0.03%
00228271411
4
$58.48
0.06%
4
$24.44
0.05%
00378415101
70
$1,043.66
0.99%
2,390
$36,137.61
30.89%
00378415105
364
$5,437.82
5.15%
345
$5,691.67
4.46%
00378963943
8
$479.96
0.11%
9
$361.10
0.12%
00406717101
126
$1,433.70
1.78%
105
$1,830.98
1.36%
00406717105
118
$1,920.00
1.67%
15
$267.53
0.19%
Page 368 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NARCOTICS - SELECTED
00591046601
18
00591046605
00591046610
00904555640
$346.85
0.25%
27
$463.19
0.35%
0
$0.00
0.00%
11
$111.01
0.14%
2
$39.50
0.03%
29
$289.60
0.37%
148
$2,222.70
2.09%
2
$53.90
0.03%
00904555660
4
$94.80
0.06%
2
$34.10
0.03%
49884074201
1,920
$29,472.22
27.15%
34
$759.17
0.44%
50111061601
5
$152.57
0.07%
2
$18.75
0.03%
50111061603
9
$294.85
0.13%
0
$0.00
0.00%
53489049901
134
$2,054.79
1.89%
47
$774.47
0.61%
53489049905
267
$4,555.26
3.78%
201
$2,501.72
2.60%
53489049910
1
$4.28
0.01%
159
$2,354.23
2.06%
57664037708
229
$3,561.63
3.24%
269
$4,022.03
3.48%
57664037713
238
$3,921.70
3.37%
1,159
$18,406.98
14.98%
57664037718
37
$563.51
0.52%
212
$3,750.14
2.74%
60505017101
131
$1,597.19
1.85%
168
$2,524.69
2.17%
60505017102
38
$887.95
0.54%
127
$2,113.54
1.64%
60505081301
4
$284.12
0.06%
1
$29.68
0.01%
63481050805
NUBAIN
7
$1,635.06
0.10%
7
$1,597.61
0.09%
65162012710
87
$957.36
1.23%
19
$255.25
0.25%
65162012711
199
$2,530.19
2.81%
497
$7,832.48
6.42%
65162012750
1,022
$17,497.98
14.45%
161
$2,466.84
2.08%
INJ 10MG/ML
NARCOTICS-LONG ACTING
00034051310
MS CONTIN
TAB 200MG CR
4
$2,356.41
0.02%
4
$2,046.88
0.03%
00034051410
MS CONTIN
TAB 15MG CR
20
$416.63
0.12%
2
$103.32
0.01%
00034051510
MS CONTIN
TAB 30MG CR
20
$976.71
0.12%
14
$2,064.82
0.10%
00034051512
MS CONTIN
TAB 30MG CR
1
$37.50
0.01%
5
$177.71
0.03%
Page 369 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00034051545
MS CONTIN
TAB 30MG CR
1
00034051610
MS CONTIN
TAB 60MG CR
00034051710
MS CONTIN
TAB 100MG CR
00054355344
METHADONE
00054355563
$19.32
0.01%
0
$0.00
0.00%
27
$3,672.99
0.16%
32
$15,577.64
0.19%
19
$2,744.22
0.13%
37
$13,329.44
0.25%
CON 10MG/ML
1
$44.96
0.01%
2
$94.91
0.01%
METHADONE
SOL 5MG/5ML
14
$333.59
0.08%
8
$211.63
0.05%
00054355663
METHADONE
SOL 10MG/5ML
00054378549
MORPHINE SUL SOL 10MG/5ML
11
$1,088.13
0.07%
3
$9.49
0.02%
1
$84.71
0.01%
3
$25.64
0.02%
00054378563
172
$2,815.56
1.02%
126
$2,398.60
0.86%
00054378663
22
$569.38
0.13%
9
$291.90
0.06%
00054453825
METHADONE
TAB 40MG
12
$330.43
0.07%
1
$3.12
0.01%
00054454725
METHADONE
TAB 40MG
1
$29.16
0.01%
0
$0.00
0.00%
00054457025
METHADONE
TAB 5MG
391
$3,187.82
2.33%
222
$1,761.02
1.52%
00054457125
METHADONE
TAB 10MG
1,094
$21,980.65
6.52%
771
$20,105.42
5.29%
00054479025
ORAMORPH SR TAB 15MG
2
$36.82
0.01%
0
$0.00
0.00%
00054479225
1
$1.00
0.01%
1
$175.11
0.01%
00054479325
1
$229.49
0.01%
0
$0.00
0.00%
00054480525
2
$116.72
0.01%
1
$90.16
0.01%
00054855324
METHADONE
TAB 5MG
1
$40.81
0.01%
3
$71.17
0.02%
00054855424
METHADONE
TAB 10MG
1
$46.51
0.01%
1
$2.50
0.01%
00054858516
2
$8.70
0.01%
10
$81.08
0.07%
00054858616
MORPHINE SUL SOL 20MG/10
0
$0.00
0.00%
2
$8.55
0.01%
00074113403
MORPHINE SUL INJ 50MG/ML
5
$140.58
0.03%
1
$21.64
0.01%
00074113405
7
$619.77
0.04%
8
$818.99
0.05%
00074113422
1
$101.22
0.01%
0
$0.00
0.00%
00074125801
41
$317.37
0.24%
34
$297.68
0.23%
00074125802
15
$157.96
0.09%
4
$32.19
0.03%
00074125830
22
$237.76
0.13%
74
$832.04
0.51%
Page 370 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00074125831
1
$7.16
0.01%
0
$0.00
0.00%
00074125901
2
$14.89
0.01%
0
$0.00
0.00%
00074126101
1
$7.39
0.01%
0
$0.00
0.00%
00074126102
52
$552.87
0.31%
2
$26.25
0.01%
00074126130
267
$2,499.43
1.59%
138
$1,701.27
0.95%
00074126131
19
$122.04
0.11%
1
$11.09
0.01%
00074126201
15
$285.38
0.09%
0
$0.00
0.00%
00074126301
100
$870.23
0.60%
1
$6.64
0.01%
00074126431
1
$12.38
0.01%
0
$0.00
0.00%
00074176201
13
$112.33
0.08%
0
$0.00
0.00%
00074176202
13
$150.69
0.08%
5
$28.14
0.03%
00074176230
0
$0.00
0.00%
24
$281.61
0.16%
00245016012
RMS
SUP 5MG
45
$570.50
0.27%
49
$549.91
0.34%
00245016112
RMS
SUP 10MG
15
$254.84
0.09%
55
$1,296.78
0.38%
00245016212
RMS
SUP 20MG
1
$39.12
0.01%
0
$0.00
0.00%
00245016312
RMS
SUP 30MG
0
$0.00
0.00%
4
$71.26
0.03%
00378326001
METHADONE
2
$15.08
0.01%
4
$26.32
0.03%
00378327201
METHADONE
TAB 10MG
3
$28.21
0.02%
0
$0.00
0.00%
00406054034
METHADOSE
TAB 40MG
317
$8,350.66
1.89%
598
$16,380.60
4.10%
00406345434
METHADOSE
TAB 10MG
1,948
$36,746.52
11.61%
2,385
$44,714.20
16.36%
00406697434
METHADOSE
TAB 5MG
339
$2,783.77
2.02%
419
$3,538.80
2.87%
00406831501
MORPHINE SUL TAB 15MG ER
1
$24.18
0.01%
38
$949.91
0.26%
00406832001
0
$0.00
0.00%
3
$479.55
0.02%
00406833001
3
$244.07
0.02%
30
$1,913.60
0.21%
00406838001
1
$173.84
0.01%
28
$3,019.45
0.19%
00406839001
5
$342.22
0.03%
18
$2,268.35
0.12%
00406872510
METHADOSE SF CON 10MG/ML
0
$0.00
0.00%
1
$45.30
0.01%
TAB 5MG
Page 371 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00574711212
00641018025
00641019025
10
$234.30
0.06%
6
$100.86
0.04%
272
$2,243.27
1.62%
9
$67.83
0.06%
1
$8.08
0.01%
0
$0.00
0.00%
00641118035
0
$0.00
0.00%
1
$19.02
0.01%
00641234341
8
$111.47
0.05%
5
$52.43
0.03%
00641234541
9
$342.34
0.05%
1
$13.67
0.01%
10019017844
18
$130.65
0.11%
431
$3,175.81
2.96%
10019017862
9
$86.20
0.05%
4
$32.65
0.03%
10019017963
37
$905.01
0.22%
20
$727.73
0.14%
50458003305
DURAGESIC
DIS 25MCG/HR
635
$47,465.40
3.78%
524
$44,590.06
3.59%
50458003405
DURAGESIC
DIS 50MCG/HR
727
$108,139.98
4.33%
564
$101,929.40
3.87%
50458003505
DURAGESIC
DIS 75MCG/HR
400
$98,079.95
2.38%
346
$107,038.64
2.37%
50458003605
DURAGESIC
DIS 100MCG/H
531
$255,089.39
3.16%
509
$288,977.05
3.49%
51079089840
METHADONE
0
$0.00
0.00%
3
$15.79
0.02%
59011010010
OXYCONTIN TAB 10MG CR
435
$25,725.34
2.59%
293
$18,244.90
2.01%
59011010025
0
$0.00
0.00%
1
$88.68
0.01%
59011010310
769
$104,529.49
4.58%
567
$80,736.17
3.89%
59011010325
0
$0.00
0.00%
3
$752.09
0.02%
59011010510
691
$206,350.90
4.12%
516
$147,917.21
3.54%
59011010525
0
$0.00
0.00%
1
$435.16
0.01%
59011010710
485
$323,875.98
2.89%
169
$122,123.36
1.16%
59011010725
0
$0.00
0.00%
1
$618.27
0.01%
60951065270
84
$2,140.94
0.50%
67
$1,428.24
0.46%
60951065370
106
$6,150.61
0.63%
71
$5,929.12
0.49%
60951065570
65
$11,175.23
0.39%
54
$5,359.80
0.37%
60951065870
24
$5,737.96
0.14%
19
$2,940.53
0.13%
60951065970
19
$2,606.00
0.11%
7
$991.75
0.05%
TAB 40MG
Page 372 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
61703022521
4
61703022672
61703022676
63857032206
KADIAN
63857032211
$1,347.45
0.02%
29
$1,227.27
0.20%
1
$1.00
0.01%
0
$0.00
0.00%
3
$10,176.70
0.02%
0
$0.00
0.00%
CAP 20MG CR
1,563
$153,533.17
9.31%
1,098
$117,181.66
7.53%
KADIAN
CAP 20MG CR
0
$0.00
0.00%
56
$6,195.43
0.38%
63857032306
KADIAN
CAP 50MG CR
603
$111,857.74
3.59%
426
$100,060.48
2.92%
63857032311
KADIAN
CAP 50MG CR
0
$0.00
0.00%
11
$1,372.66
0.08%
63857032406
KADIAN
CAP 100MG CR
678
$283,368.03
4.04%
419
$239,930.48
2.87%
63857032411
KADIAN
CAP 100MG CR
0
$0.00
0.00%
16
$7,295.50
0.11%
63857032506
KADIAN
CAP 30MG CR
975
$93,559.11
5.81%
715
$81,232.68
4.90%
63857032511
KADIAN
CAP 30MG CR
0
$0.00
0.00%
23
$2,256.86
0.16%
63857032606
KADIAN
CAP 60MG CR
710
$151,018.26
4.23%
589
$147,269.77
4.04%
63857032611
KADIAN
CAP 60MG CR
0
$0.00
0.00%
11
$1,990.77
0.08%
64019053825
METHADONE
TAB 40MG
44
$1,290.96
0.26%
44
$1,114.74
0.30%
64019055367
METHADONE
CON 10MG/ML
0
$0.00
0.00%
10
$151.93
0.07%
64019055467
METHADONE
CON 10MG/ML
1
$5.26
0.01%
2
$52.39
0.01%
64365050503
AVINZA
CAP 30MG CR
625
$40,598.02
3.72%
644
$54,585.43
4.42%
64365050603
AVINZA
CAP 60MG CR
543
$74,870.43
3.24%
578
$109,685.36
3.96%
64365050702
AVINZA
CAP 90MG CR
265
$57,487.79
1.58%
251
$72,206.28
1.72%
64365050802
AVINZA
CAP 120MG CR
309
$111,189.44
1.84%
294
$158,236.74
2.02%
66591069141
DARVOCET
9
$534.30
0.05%
2
$27.87
0.01%
66689089840
METHADONE
25
$625.76
0.15%
0
$0.00
0.00%
TAB A500
TAB 40MG
NEUROLOGICS - MISC.
00187301030
MESTINON
TAB 60MG
28
$1,643.72
24.35%
41
$2,128.53
39.05%
00187301040
MESTINON
TAB 60MG
0
$0.00
0.00%
2
$109.94
1.90%
00187301330
MESTINON
TAB TIMESPAN
11
$455.65
9.57%
4
$342.57
3.81%
Page 373 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NEUROLOGICS - MISC.
00187310010
PROSTIGMIN TAB 15MG
00591319101
00781501501
57844015101
ORAP
57844018701
ORAP
1
$26.16
0.87%
0
$0.00
0.00%
PYRIDOSTIGM TAB 60MG
4
$240.84
3.48%
PYRIDOSTIGM TAB 60MG
10
$239.89
8.70%
0
$0.00
0.00%
5
$147.66
4.76%
TAB 1MG
6
$193.13
5.22%
4
$176.22
3.81%
TAB 2MG
55
$4,320.08
47.83%
49
$4,520.29
46.67%
NICARDIPINES
00004018022
CARDENE SR CAP 30MG
1
$17.13
20.00%
0
$0.00
0.00%
00004018222
CARDENE SR CAP 60MG
0
$0.00
0.00%
2
$318.02
66.67%
00093079301
NICARDIPINE CAP 20MG
1
$3.19
20.00%
0
$0.00
0.00%
00378102005
0
$0.00
0.00%
1
$12.55
33.33%
00378102077
2
$25.10
40.00%
0
$0.00
0.00%
49884049805
1
$18.40
20.00%
0
$0.00
0.00%
NICOTINE PATCHES / TABLETS
00009519702
NICOTROL
DIS STEP 1
1
$24.20
0.03%
0
$0.00
0.00%
00009519707
NICOTROL
DIS STEP 1
1
$81.17
0.03%
0
$0.00
0.00%
00009527001
NICOTROL
DIS STEP 2
1
$83.67
0.03%
0
$0.00
0.00%
00067021407
NICOTINE
DIS 14MG/24H
2
$117.09
0.05%
0
$0.00
0.00%
00067021414
NICOTINE
DIS 14MG/24H
1
$31.96
0.03%
0
$0.00
0.00%
00067021507
NICOTINE
DIS 21MG/24H
6
$328.71
0.15%
0
$0.00
0.00%
00067021514
NICOTINE
DIS 21MG/24H
7
$433.21
0.18%
0
$0.00
0.00%
00093570301
BUPROBAN
TAB 150MG
0
$0.00
0.00%
22
$1,690.30
0.51%
00173055601
ZYBAN
TAB 150MG SR
59
$5,975.48
1.49%
1
$10.67
0.02%
00173055602
ZYBAN
TAB 150MG SR
85
$8,651.80
2.15%
4
$71.55
0.09%
00364289030
NICOTINE TD DIS 7MG/24HR
41
$2,467.01
1.04%
1
$57.12
0.02%
00364289330
NICOTINE TD DIS 14MG/24H
92
$6,549.32
2.32%
1
$1.00
0.02%
Page 374 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
00591086760
BUPROPION
00591086776
BUPROPION
00591289030
$
Market Share*
NICOTINE PATCHES / TABLETS
00364290130
# of Scripts
164
$11,428.60
4.14%
0
$0.00
0.00%
TAB 150MG
0
$0.00
0.00%
55
$5,203.69
1.27%
TAB 150MG
0
$0.00
0.00%
14
$1,332.52
0.32%
NICOTINE
DIS 7MG/24HR
11
$1,224.12
0.28%
5
$185.83
0.12%
00591289330
NICOTINE
DIS 14MG/24H
0
$0.00
0.00%
8
$74.40
0.18%
00591290130
NICOTINE
DIS 21MG/24H
18
$2,207.92
0.45%
16
$538.49
0.37%
00766142020
NICODERM CQ DIS 21MG/24H
361
$25,546.89
9.12%
723
$46,410.70
16.66%
00766142050
9
$587.03
0.23%
22
$1,340.89
0.51%
00766143020
341
$21,875.42
8.61%
842
$51,981.18
19.40%
00766144020
NICODERM CQ DIS 7MG/24HR
174
$10,675.73
4.39%
427
$24,359.62
9.84%
00766145010
153
$10,027.07
3.86%
111
$7,789.90
2.56%
00766145020
1,559
$109,253.84
39.37%
1,633
$105,578.19
37.63%
00766146010
125
$8,997.52
3.16%
28
$1,872.37
0.65%
00766146020
479
$30,666.74
12.10%
301
$17,733.49
6.94%
00766147010
85
$5,893.51
2.15%
13
$1,065.03
0.30%
00766147012
180
$11,427.36
4.55%
112
$6,525.35
2.58%
37205035874
1
$36.69
0.03%
0
$0.00
0.00%
37205036174
1
$44.54
0.03%
0
$0.00
0.00%
37205036374
NICOTINE TD DIS 7MG/24HR
2
$82.66
0.05%
1
$75.04
0.02%
52735094052
FP NICOTINE DIS 21MG/24H
1
$34.13
0.03%
0
$0.00
0.00%
NICOTINE REPLACEMENT - OTHER
00009519401
NICOTROL NS SPR 10MG/ML
18
$928.41
1.80%
1
$34.85
0.13%
00009519402
NICOTROL NS SPR 10MG/ML
3
$636.29
0.30%
0
$0.00
0.00%
00009519501
NICOTROL
INH
344
$20,542.74
34.43%
3
$110.91
0.38%
00009519508
NICOTROL
INH
20
$2,184.02
2.00%
20
$1,560.65
2.51%
00135017107
NICORETTE ST GUM 4MG
2
$97.02
0.20%
0
$0.00
0.00%
Page 375 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
NICORETTE
GUM 2MG
00135020801
COMMIT
00135020803
COMMIT
00135020903
COMMIT
00536310618
NICOTINE POL GUM 2MG
00536310623
00536310643
00536310718
00536310723
$
Market Share*
00135019707
# of Scripts
2
$166.68
0.20%
0
$0.00
0.00%
LOZ 2MG
3
$108.94
0.30%
0
$0.00
0.00%
LOZ 2MG
1
$23.52
0.10%
0
$0.00
0.00%
LOZ 4MG
1
$20.17
0.10%
0
$0.00
0.00%
92
$4,029.89
9.21%
48
$1,791.55
6.02%
0
$0.00
0.00%
150
$5,366.63
18.80%
41
$1,926.23
4.10%
108
$4,360.98
13.53%
159
$7,306.01
15.92%
49
$2,233.69
6.14%
0
$0.00
0.00%
236
$11,929.63
29.57%
00536310743
34
$1,916.80
3.40%
43
$2,174.10
5.39%
00766004320
10
$465.43
1.00%
0
$0.00
0.00%
00766004330
NICORETTE
6
$306.81
0.60%
1
$26.73
0.13%
00766004350
3
$128.57
0.30%
0
$0.00
0.00%
00766004420
9
$432.58
0.90%
0
$0.00
0.00%
00766004430
NICORETTE
6
$335.84
0.60%
2
$55.51
0.25%
00766004450
4
$194.37
0.40%
0
$0.00
0.00%
00766004460
NICORETTE
0
$0.00
0.00%
2
$83.15
0.25%
00766004508
40
$2,011.52
4.00%
2
$125.10
0.25%
00766004548
NICORETTE
11
$394.45
1.10%
2
$53.46
0.25%
00766004560
3
$168.34
0.30%
1
$35.10
0.13%
00766004708
30
$1,493.86
3.00%
3
$92.20
0.38%
00766004748
NICORETTE
14
$584.06
1.40%
0
$0.00
0.00%
00766004760
2
$225.38
0.20%
0
$0.00
0.00%
00766150010
COMMIT
LOZ 2MG
10
$396.94
1.00%
1
$67.05
0.13%
00766150020
COMMIT
LOZ 4MG
15
$1,130.97
1.50%
1
$34.69
0.13%
00766784350
NICORETTE
0
$0.00
0.00%
1
$19.05
0.13%
37205020323
NICOTINE
32
$1,682.73
3.20%
42
$2,224.53
5.26%
GUM 2MG REF
GUM 4MG REF
GUM 4MG REF
GUM 2MG REF
GUM 4MG REF
GUM 2MG
GUM 2MG
Page 376 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
37205020367
NICOTINE
GUM 2MG
3
$189.59
0.30%
13
$547.71
1.63%
37205020423
NICOTINE
GUM 4MG
40
$2,232.32
4.00%
47
$2,855.30
5.89%
37205020467
NICOTINE
GUM 4MG
41
$1,784.96
4.10%
22
$1,026.69
2.76%
NITRO - OINTMENT/CAP/CR
00168032630
NITROBID
OIN 2%
10
$133.04
3.97%
18
$185.35
8.45%
00168032660
NITROBID
OIN 2%
34
$491.62
13.49%
33
$573.30
15.49%
00182070289
NITROGLYCER CAP 2.5MG TD
2
$16.34
0.79%
1
$11.83
0.47%
00185121701
NITROGLYCER CAP 9MG CR
1
$12.15
0.40%
1
$12.15
0.47%
00185121760
NITROGLYCER CAP 9MG CR
4
$37.30
1.59%
0
$0.00
0.00%
00185123501
NITROGLYCER CAP 6.5MG CR
42
$276.77
16.67%
15
$102.02
7.04%
00185123560
5
$42.49
1.98%
1
$8.09
0.47%
00185517401
NITROGLYCER CAP 2.5MG SR
17
$101.31
6.75%
5
$27.43
2.35%
00185517460
NITROGLYCER CAP 2.5MG SR
5
$33.65
1.98%
5
$31.70
2.35%
00281003856
NITROL
OIN 2%
1
$7.88
0.40%
0
$0.00
0.00%
00603478221
1
$17.32
0.40%
0
$0.00
0.00%
00677048501
3
$20.85
1.19%
3
$20.85
1.41%
00677048601
10
$75.48
3.97%
1
$7.40
0.47%
00904064360
0
$0.00
0.00%
1
$6.95
0.47%
00904064460
5
$27.95
1.98%
3
$16.77
1.41%
49483022110
NITRO-TIME CAP 2.5MG CR
0
$0.00
0.00%
6
$42.06
2.82%
49483022210
8
$53.78
3.17%
9
$66.05
4.23%
58177000403
NITROGLYCER CAP 2.5MG ER
7
$51.08
2.78%
3
$11.82
1.41%
58177000404
40
$225.80
15.87%
40
$258.11
18.78%
58177000503
9
$87.00
3.57%
9
$75.32
4.23%
58177000504
42
$325.27
16.67%
55
$367.85
25.82%
58177000603
NITROGLYCER CAP 9MG ER
2
$15.26
0.79%
1
$7.63
0.47%
Page 377 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
NITROGLYCER CAP 9MG ER
$
Market Share*
NITRO - OINTMENT/CAP/CR
58177000604
# of Scripts
4
$30.52
1.59%
3
$22.89
1.41%
$7,399.85
2.37%
105
$7,849.33
2.90%
NITRO - PATCHES
00085081930
NITRO-DUR
DIS 0.8MG/HR
103
00085081935
NITRO-DUR
DIS 0.8MG/HR
1
$75.31
0.02%
3
$226.14
0.08%
00085330530
NITRO-DUR
DIS 0.1MG/HR
2
$123.36
0.05%
0
$0.00
0.00%
00085331030
NITRO-DUR
DIS 0.2MG/HR
7
$378.21
0.16%
0
$0.00
0.00%
00085331530
NITRO-DUR
DIS 0.3MG/HR
22
$1,380.11
0.51%
9
$344.32
0.25%
00085331535
NITRO-DUR
DIS 0.3MG/HR
1
$69.70
0.02%
0
$0.00
0.00%
00085332030
NITRO-DUR
DIS 0.4MG/HR
24
$1,486.96
0.55%
4
$278.24
0.11%
00085333030
NITRO-DUR
DIS 0.6MG/HR
1
$75.31
0.02%
0
$0.00
0.00%
00089030102
MINITRAN
DIS 0.1MG/HR
19
$380.95
0.44%
6
$114.90
0.17%
00089030202
MINITRAN
DIS 0.2MG/HR
201
$8,850.23
4.62%
43
$1,003.05
1.19%
00089030302
MINITRAN
DIS 0.4MG/HR
324
$17,463.56
7.44%
59
$1,468.47
1.63%
00089030402
MINITRAN
DIS 0.6MG/HR
135
$6,388.32
3.10%
28
$826.75
0.77%
00089130130
NITROGLYCER DIS 0.1MG/HR
5
$102.75
0.11%
0
$0.00
0.00%
00089130230
72
$3,034.45
1.65%
4
$126.40
0.11%
00089130330
121
$2,546.90
2.78%
12
$240.30
0.33%
00089130430
11
$417.05
0.25%
5
$228.23
0.14%
00378910293
122
$2,554.09
2.80%
123
$2,617.45
3.39%
00378910493
643
$25,433.47
14.77%
718
$19,231.09
19.81%
00378911293
958
$21,380.56
22.01%
1,007
$22,978.38
27.79%
00378911693
268
$10,005.51
6.16%
303
$10,462.17
8.36%
00904065446
2
$80.10
0.05%
0
$0.00
0.00%
00904549546
29
$1,166.13
0.67%
13
$337.90
0.36%
00904549646
24
$511.20
0.55%
23
$463.35
0.63%
00904549746
1
$31.25
0.02%
2
$64.20
0.06%
Page 378 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NITRO - PATCHES
49730011130
NITRO-TRANSD DIS 0.2MG/HR
23
$889.46
0.53%
43
$1,054.80
1.19%
49730011230
NITROGLYCERN DIS 0.4MG/HR
198
$4,349.94
4.55%
153
$3,605.61
4.22%
49730011330
NITROGLYCERI DIS 0.6MG/HR
87
$3,320.38
2.00%
49
$1,566.09
1.35%
62794020293
NITREK
DIS 0.2MG/HR
368
$15,684.20
8.45%
312
$7,885.73
8.61%
62794020493
NITREK
DIS 0.4MG/HR
464
$10,112.61
10.66%
475
$9,810.36
13.11%
62794020693
NITREK
DIS 0.6MG/HR
117
$3,902.25
2.69%
125
$3,687.85
3.45%
NITRO - SUBLINGUAL/ SPRAY
00071041724
NITROSTAT
SUB 0.3MG
46
$1,352.39
1.93%
74
$854.40
3.02%
00071041813
NITROSTAT
SUB 0.4MG
653
$5,422.38
27.46%
1,175
$10,478.33
47.98%
00071041824
NITROSTAT
SUB 0.4MG
382
$3,951.60
16.06%
417
$4,325.75
17.03%
00071041924
NITROSTAT
SUB 0.6MG
3
$31.96
0.13%
5
$57.85
0.20%
53265024910
NITROTAB
SUB 0.3MG
44
$300.02
1.85%
33
$207.46
1.35%
53265025004
NITROTAB
SUB 0.4MG
622
$3,893.83
26.16%
457
$3,050.37
18.66%
53265025010
NITROTAB
SUB 0.4MG
213
$1,582.36
8.96%
133
$935.12
5.43%
53265025110
NITROTAB
SUB 0.6MG
8
$55.80
0.34%
4
$25.40
0.16%
58177032304
NITROQUICK SUB 0.3MG
20
$144.61
0.84%
3
$19.05
0.12%
58177032404
95
$796.60
3.99%
7
$61.45
0.29%
58177032418
144
$900.71
6.06%
18
$90.32
0.73%
58177032504
2
$15.20
0.08%
0
$0.00
0.00%
59630030020
NITROLINGUAL SPR PUMPSPRA
122
$5,075.43
5.13%
113
$5,441.18
4.61%
59630030065
NITROLINGUAL SPR PUMPSPRA
5
$208.95
0.21%
0
$0.00
0.00%
60951071862
NITROGLYCER SUB 0.4MG
8
$54.24
0.34%
1
$7.44
0.04%
60951071870
NITROGLYCER SUB 0.4MG
11
$73.47
0.46%
9
$82.56
0.37%
2
$7.52
66.67%
0
$0.00
0.00%
NON-SEDATING ANTIHISTIMINES / DECONGESTANTS
00069163066
ZYRTEC-D
TAB 5-120MG
Page 379 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
$
Market Share*
NON-SEDATING ANTIHISTIMINES / DECONGESTANTS
00088109047
# of Scripts
ALLEGRA-D TAB 60-120ER
1
$65.72
33.33%
0
$0.00
0.00%
00004002828
NAPROSYN
6
$289.44
0.02%
5
$159.44
0.02%
00004027301
TORADOL ORAL TAB 10MG
1
$24.20
0.00%
0
$0.00
0.00%
00004620001
ANAPROX DS TAB 550MG
3
$258.78
0.01%
0
$0.00
0.00%
00004631401
NAPROSYN
1
$77.50
0.00%
0
$0.00
0.00%
00004641601
EC-NAPROSYN TAB 500MG
2
$73.02
0.01%
1
$13.10
0.00%
00004692709
TORADOL
1
$3.02
0.00%
0
$0.00
0.00%
00005328443
KETOPROFEN CAP 25MG
1
$26.10
0.00%
0
$0.00
0.00%
00006094268
CLINORIL
TAB 200MG
4
$237.96
0.02%
5
$273.47
0.02%
00006337666
INDOCIN
SUS 25MG/5ML
0
$0.00
0.00%
1
$9.93
0.00%
00008069001
ORUVAIL
CAP 200MG ER
1
$57.50
0.00%
0
$0.00
0.00%
00008082101
ORUVAIL
CAP 100MG ER
3
$196.50
0.01%
0
$0.00
0.00%
00009738501
MOTRIN
TAB 400MG
1
$14.83
0.00%
0
$0.00
0.00%
00009738701
MOTRIN
TAB 800MG
2
$45.44
0.01%
0
$0.00
0.00%
00009738702
MOTRIN
TAB 800MG
1
$4.95
0.00%
0
$0.00
0.00%
00025138131
DAYPRO
TAB 600MG
19
$1,967.27
0.07%
2
$218.46
0.01%
00028015101
CATAFLAM
2
$211.70
0.01%
3
$428.00
0.01%
00028020501
VOLTAREN-XR TAB 100MG
6
$1,484.80
0.02%
0
$0.00
0.00%
00028026401
VOLTAREN
7
$619.38
0.03%
0
$0.00
0.00%
00029485120
RELAFEN
TAB 500MG
12
$1,230.25
0.05%
0
$0.00
0.00%
00029485220
RELAFEN
TAB 750MG
14
$1,501.16
0.06%
2
$217.37
0.01%
00045041660
TOLECTIN
TAB 600MG
1
$111.83
0.00%
0
$0.00
0.00%
00045044804
MOTRIN
SUS 100/5ML
5
$63.90
0.02%
0
$0.00
0.00%
00045048102
MOTRIN IB
TAB 200MG
1
$6.89
0.00%
2
$12.86
0.01%
00046083981
LODINE XL
TAB 500MG
1
$93.87
0.00%
0
$0.00
0.00%
NSAIDS
SUS 125/5ML
TAB 375MG
INJ 30MG/ML
TAB 50MG
TAB 75MG EC
Page 380 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00054363063
NAPROXEN
SUS 125/5ML
00054422225
DICLOFENAC TAB 75MG EC
00054463929
NAPROXEN SOD TAB 550MG
00069322066
FELDENE
00074228702
KETOROLAC
00074228731
00074379301
$2,049.01
0.20%
32
$1,137.43
0.11%
0
$0.00
0.00%
1
$10.75
0.00%
1
$12.22
0.00%
0
$0.00
0.00%
2
$104.78
0.01%
2
$122.68
0.01%
INJ 30MG/ML
1
$9.03
0.00%
0
$0.00
0.00%
KETOROLAC
INJ 30MG/ML
3
$121.15
0.01%
0
$0.00
0.00%
KETOROLAC
INJ 15MG/ML
0
$0.00
0.00%
1
$19.29
0.00%
00074379501
KETOROLAC
INJ 30MG/ML
1
$14.51
0.00%
2
$10.79
0.01%
00074379601
KETOROLAC
INJ 30MG/ML
1
$115.85
0.00%
0
$0.00
0.00%
00086009010
NAPRELAN
TAB 375MG CR
1
$38.41
0.00%
0
$0.00
0.00%
00086009175
NAPRELAN
TAB 500MG CR
1
$12.25
0.00%
0
$0.00
0.00%
00093014701
NAPROXEN
TAB 250MG
171
$1,038.21
0.67%
173
$1,050.87
0.61%
00093014705
NAPROXEN
TAB 250MG
31
$217.21
0.12%
36
$260.51
0.13%
00093014710
NAPROXEN
TAB 250MG
2
$16.30
0.01%
10
$96.00
0.04%
00093014801
NAPROXEN
TAB 375MG
417
$2,924.77
1.64%
359
$2,465.86
1.27%
00093014805
NAPROXEN
TAB 375MG
10
$68.93
0.04%
16
$161.60
0.06%
00093014810
NAPROXEN
TAB 375MG
8
$59.35
0.03%
19
$181.55
0.07%
00093014901
NAPROXEN
TAB 500MG
1,746
$16,510.65
6.86%
1,974
$18,663.00
6.98%
00093014905
NAPROXEN
TAB 500MG
204
$1,859.20
0.80%
131
$1,242.58
0.46%
00093014910
NAPROXEN
TAB 500MG
401
$3,927.03
1.58%
500
$5,895.39
1.77%
00093031401
KETOROLAC
TAB 10MG
122
$1,459.68
0.48%
71
$596.36
0.25%
00093053601
46
$795.00
0.18%
32
$470.45
0.11%
00093053605
5
$85.90
0.02%
1
$5.49
0.00%
00093053701
534
$9,306.18
2.10%
416
$7,717.82
1.47%
00093053705
42
$788.78
0.17%
40
$814.77
0.14%
00093053710
1
$8.45
0.00%
3
$24.05
0.01%
00093071101
FLURBIPROFEN TAB 100MG
55
$1,242.55
0.22%
40
$775.13
0.14%
CAP 10MG
51
Page 381 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00093071105
00093075601
PIROXICAM
CAP 10MG
00093075701
PIROXICAM
CAP 20MG
00093075705
PIROXICAM
00093089201
$1,731.86
0.35%
71
$1,203.06
0.25%
102
$559.27
0.40%
483
$1,856.67
1.90%
136
$805.38
0.48%
672
$2,567.34
2.38%
CAP 20MG
50
$192.24
0.20%
62
$213.52
0.22%
ETODOLAC
TAB 400MG
61
$1,022.73
0.24%
70
$1,499.70
0.25%
00093092401
OXAPROZIN
TAB 600MG
00093094801
DICLOFEN POT TAB 50MG
0
$0.00
0.00%
1
$11.35
0.00%
9
$206.69
0.04%
19
$560.00
0.07%
00093094805
6
$151.20
0.02%
0
$0.00
0.00%
00093100501
NAPROXEN DR TAB 375MG
6
$168.25
0.02%
2
$14.24
0.01%
00093100601
67
$2,468.35
0.26%
107
$3,713.95
0.38%
00093100605
0
$0.00
0.00%
5
$213.25
0.02%
00093101501
NABUMETONE TAB 500MG
409
$13,448.07
1.61%
640
$19,211.97
2.26%
00093101601
360
$13,065.03
1.41%
629
$21,305.82
2.22%
00093104101
DICLOFENAC TAB 100MG ER
24
$1,308.50
0.09%
22
$1,119.75
0.08%
00093111801
ETODOLAC ER TAB 600MG
13
$995.48
0.05%
11
$1,112.26
0.04%
00093112201
ETODOLAC ER TAB 400
109
$4,643.22
0.43%
91
$2,859.10
0.32%
00093319301
KETOPROFEN CAP 50MG
40
$892.63
0.16%
34
$657.75
0.12%
00093319501
KETOPROFEN CAP 75MG
91
$644.11
0.36%
84
$565.25
0.30%
00093319505
KETOPROFEN CAP 75MG
0
$0.00
0.00%
3
$38.60
0.01%
00093717201
88
$4,438.82
0.35%
52
$2,464.65
0.18%
00093839701
ETODOLAC
52
$1,374.86
0.20%
84
$1,253.65
0.30%
00093881501
TOLMETIN SOD CAP 400MG
7
$594.28
0.03%
7
$684.52
0.02%
00113005705
IBUPROFEN
0
$0.00
0.00%
2
$13.62
0.01%
00113036871
1
$4.01
0.00%
0
$0.00
0.00%
00113060471
IBUPROFEN
TAB 200MG
1
$5.18
0.00%
0
$0.00
0.00%
00113060478
IBUPROFEN
TAB 200MG
1
$5.13
0.00%
0
$0.00
0.00%
00113060485
IBUPROFEN
TAB 200MG
0
$0.00
0.00%
1
$4.18
0.00%
CAP 300MG
SUS INFANTS
90
Page 382 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00113064762
IBUPROFEN
TAB 200MG
0
$0.00
0.00%
2
$13.88
0.01%
00113064771
IBUPROFEN
TAB 200MG
0
$0.00
0.00%
1
$3.71
0.00%
00113064778
IBUPROFEN
TAB 200MG
1
$1.85
0.00%
1
$3.09
0.00%
00143134601
NAPROXEN
TAB 250MG
0
$0.00
0.00%
14
$106.59
0.05%
00143134701
NAPROXEN
TAB 375MG
0
$0.00
0.00%
13
$118.89
0.05%
00143134705
NAPROXEN
TAB 375MG
0
$0.00
0.00%
26
$240.86
0.09%
00143134801
NAPROXEN
TAB 500MG
0
$0.00
0.00%
35
$418.89
0.12%
00143134805
NAPROXEN
TAB 500MG
0
$0.00
0.00%
767
$7,256.90
2.71%
00143990801
276
$4,850.45
1.08%
129
$2,236.83
0.46%
00143990805
173
$3,068.30
0.68%
97
$1,763.85
0.34%
00143991601
18
$430.45
0.07%
32
$617.58
0.11%
00172402960
INDOMETHACIN CAP 25MG
358
$6,059.34
1.41%
409
$4,220.35
1.45%
00172402970
1
$8.84
0.00%
0
$0.00
0.00%
00172402980
30
$697.53
0.12%
50
$418.70
0.18%
00172403060
271
$7,123.09
1.06%
310
$3,455.00
1.10%
00172403070
16
$381.78
0.06%
45
$603.50
0.16%
00172409860
0
$0.00
0.00%
137
$3,747.82
0.48%
00172409960
0
$0.00
0.00%
18
$588.40
0.06%
00172414160
FENOPROFEN TAB 600MG
2
$20.90
0.01%
11
$170.15
0.04%
00172417460
ETODOLAC
TAB 500MG
4
$120.35
0.02%
1
$20.85
0.00%
00172434860
OXAPROZIN
TAB 600MG
2
$81.95
0.01%
3
$63.00
0.01%
00182103901
IBUPROFEN
TAB 200MG
14
$75.21
0.06%
16
$81.05
0.06%
00182103910
IBUPROFEN
TAB 200MG
2
$6.77
0.01%
0
$0.00
0.00%
00182109719
1
$3.69
0.00%
2
$15.93
0.01%
00182110616
1
$1.00
0.00%
0
$0.00
0.00%
00182240101
GENPRIL
0
$0.00
0.00%
1
$7.19
0.00%
00182868889
IBUPROFEN
0
$0.00
0.00%
1
$19.37
0.00%
TAB 200MG
TAB 200MG
Page 383 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00185013901
ETODOLAC
TAB 500MG
00185014001
ETODOLAC
TAB 400MG
00185014101
OXAPROZIN
TAB 600MG
00185014105
OXAPROZIN
TAB 600MG
00185014501
$1,027.22
0.09%
$312.65
0.04%
9
$288.42
0.04%
65
$2,360.25
0.26%
27
$542.85
0.10%
107
$2,158.06
0.38%
4
$165.60
0.02%
17
$342.59
0.06%
59
$1,877.91
0.23%
78
$2,325.30
0.28%
00185014601
41
00185072001
INDOMETHACIN CAP 75MG ER
20
$1,571.95
0.16%
135
$4,489.34
0.48%
$942.19
0.08%
12
$291.84
0.04%
00185072060
28
$1,505.27
0.11%
29
$450.98
0.10%
00228255011
3
$51.15
0.01%
8
$158.30
0.03%
00228255106
0
$0.00
0.00%
1
$20.65
0.00%
00228255111
0
$0.00
0.00%
32
$548.15
0.11%
00228259911
ETODOLAC
TAB 400MG
228
$4,440.63
0.90%
246
$4,744.94
0.87%
00228259950
ETODOLAC
TAB 400MG
13
$373.75
0.05%
23
$455.55
0.08%
00228261450
OXAPROZIN
TAB 600MG
1
$21.12
0.00%
4
$87.40
0.01%
00228263211
ETODOLAC
TAB 500MG
96
$4,161.01
0.38%
82
$2,129.22
0.29%
00228267111
ETODOLAC CR TAB 400MG
12
$534.30
0.05%
7
$222.95
0.02%
00228274306
0
$0.00
0.00%
7
$111.50
0.02%
00228274311
12
$284.40
0.05%
4
$100.40
0.01%
00228274406
7
$79.40
0.03%
5
$66.15
0.02%
00228274411
22
$277.13
0.09%
2
$37.20
0.01%
00228274496
11
$140.20
0.04%
0
$0.00
0.00%
00228274610
1
$36.85
0.00%
0
$0.00
0.00%
00364076601
IBUPROFEN
TAB 600MG
10
$59.14
0.04%
0
$0.00
0.00%
00364076605
IBUPROFEN
TAB 600MG
6
$25.99
0.02%
0
$0.00
0.00%
00364244101
SULINDAC
TAB 150MG
17
$299.70
0.07%
2
$27.30
0.01%
00364244105
SULINDAC
TAB 150MG
0
$0.00
0.00%
1
$19.10
0.00%
00364244201
SULINDAC
TAB 200MG
3
$66.54
0.01%
0
$0.00
0.00%
23
12
Page 384 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00364244205
SULINDAC
TAB 200MG
00364256401
NAPROXEN
00364266701
KETOPROFEN CAP 200MG ER
00378007601
$0.00
0.00%
10
$226.53
0.04%
2
$16.30
0.01%
6
$397.54
0.02%
0
$0.00
0.00%
1
$41.35
0.00%
0
$0.00
0.00%
4
$105.52
0.01%
00378009301
12
$220.60
0.05%
12
$91.55
0.04%
00378014301
00378014310
152
$2,567.85
0.60%
127
$1,165.89
0.45%
22
$428.63
0.09%
22
$258.84
0.08%
00378014701
120
$2,736.16
0.47%
131
$1,514.08
0.46%
00378014705
3
$85.65
0.01%
4
$51.40
0.01%
00378023701
ETODOLAC
00378031301
TOLMETIN SOD TAB 600MG
00378035501
00378037701
NAPROXEN
00378037705
NAPROXEN
00378042701
SULINDAC
00378045101
NAPROXEN
00378045105
NAPROXEN
00378047101
FENOPROFEN TAB 600MG
00378053101
SULINDAC
00378053701
TAB 500MG
TAB 400MG
TAB 250MG
TAB 250MG
0
2
$26.60
0.01%
0
$0.00
0.00%
15
$1,670.76
0.06%
6
$614.30
0.02%
0
$0.00
0.00%
22
$473.10
0.08%
49
$345.22
0.19%
14
$77.60
0.05%
5
$28.35
0.02%
4
$32.28
0.01%
45
$727.15
0.18%
84
$1,526.48
0.30%
TAB 500MG
93
$900.37
0.37%
165
$1,579.37
0.58%
TAB 500MG
135
$1,343.41
0.53%
33
$341.71
0.12%
31
$612.45
0.12%
19
$389.18
0.07%
98
$2,196.27
0.39%
223
$5,294.47
0.79%
1
$15.85
0.00%
0
$0.00
0.00%
00378053705
4
$39.65
0.02%
0
$0.00
0.00%
00378055501
NAPROXEN
23
$156.05
0.09%
24
$204.35
0.08%
00378055505
NAPROXEN
TAB 375MG
00378101001
PIROXICAM
CAP 10MG
00378113401
KETOROLAC
00378117701
00378124201
TAB 150MG
TAB 200MG
TAB 375MG
8
$62.45
0.03%
4
$25.48
0.01%
119
$625.10
0.47%
173
$955.32
0.61%
TAB 10MG
182
$2,792.66
0.72%
193
$1,577.32
0.68%
OXAPROZIN
TAB 600MG
1
$41.40
0.00%
0
$0.00
0.00%
ETODOLAC
TAB 500MG
2
$29.00
0.01%
2
$49.70
0.01%
Page 385 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00378160105
IBUPROFEN
TAB 600MG
00378202001
PIROXICAM
00378202005
PIROXICAM
00378215001
1
$6.79
0.00%
0
$0.00
0.00%
CAP 20MG
242
$940.05
0.95%
372
$1,480.68
1.32%
CAP 20MG
66
$245.12
0.26%
75
$290.85
0.27%
MECLOFEN SOD CAP 50MG
2
$263.39
0.01%
15
$1,187.49
0.05%
00378247401
16
$425.56
0.06%
48
$1,180.79
0.17%
00378300001
10
$941.38
0.04%
16
$1,572.32
0.06%
00378300005
0
$0.00
0.00%
1
$182.77
0.00%
00378407001
KETOPROFEN CAP 50MG
7
$91.25
0.03%
3
$56.34
0.01%
00378520001
TOLMETIN SOD CAP 400MG
7
$499.71
0.03%
4
$345.36
0.01%
00378575001
KETOPROFEN CAP 75MG
45
$513.88
0.18%
34
$225.15
0.12%
00378720001
ETODOLAC
CAP 200MG
5
$120.47
0.02%
2
$59.30
0.01%
00378723301
ETODOLAC
CAP 300MG
12
$257.55
0.05%
10
$144.80
0.04%
00378820001
1
$74.00
0.00%
24
$824.79
0.08%
00472127016
IBUPROFEN
SUS 100/5ML
199
$4,698.93
0.78%
202
$4,258.61
0.71%
00472127094
IBUPROFEN
SUS 100/5ML
6
$64.27
0.02%
7
$83.25
0.02%
00536393902
IBUPROFEN
TAB 200MG
0
$0.00
0.00%
1
$5.29
0.00%
00536393910
IBUPROFEN
TAB 200MG
1
$1.09
0.00%
1
$0.39
0.00%
00573015040
ADVIL
2
$17.55
0.01%
0
$0.00
0.00%
00573017030
CHILD ADVIL SUS 100/5ML
3
$36.87
0.01%
1
$7.82
0.00%
00573017910
ADVIL JR STR CHW 100MG
1
$8.79
0.00%
0
$0.00
0.00%
00591033801
DICLOFENAC TAB 50MG
59
$1,449.14
0.23%
124
$2,871.90
0.44%
00591033860
DICLOFENAC TAB 50MG
15
$242.05
0.06%
30
$532.42
0.11%
00591033901
DICLOFENAC TAB 75MG DR
111
$1,401.39
0.44%
220
$5,101.91
0.78%
00591033910
3
$56.14
0.01%
1
$20.65
0.00%
00591033960
23
$557.46
0.09%
58
$1,161.53
0.21%
00591067601
0
$0.00
0.00%
3
$101.55
0.01%
00591079101
NAPROXEN
2
$38.50
0.01%
0
$0.00
0.00%
TAB 200MG
TAB 500MG
Page 386 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00591079105
NAPROXEN
00591079201
00591079205
TAB 500MG
1
$8.15
0.00%
0
$0.00
0.00%
14
$211.60
0.06%
10
$129.17
0.04%
5
$101.75
0.02%
0
$0.00
0.00%
00591079301
127
$2,488.64
0.50%
136
$2,756.13
0.48%
00591079305
18
$282.22
0.07%
23
$395.77
0.08%
00591213705
IBUPROFEN
TAB 800MG
160
$1,023.17
0.63%
102
$672.67
0.36%
00591401001
IBUPROFEN
TAB 400MG
3
$18.93
0.01%
20
$139.52
0.07%
00591401005
IBUPROFEN
TAB 400MG
57
$309.94
0.22%
56
$316.97
0.20%
00591401101
IBUPROFEN
TAB 600MG
13
$88.17
0.05%
2
$9.79
0.01%
00591401105
IBUPROFEN
TAB 600MG
110
$653.49
0.43%
105
$631.74
0.37%
00591566001
SULINDAC
TAB 200MG
223
$4,642.06
0.88%
102
$2,156.08
0.36%
00591566005
SULINDAC
TAB 200MG
21
$503.70
0.08%
14
$300.36
0.05%
00591566101
SULINDAC
TAB 150MG
121
$1,935.15
0.48%
33
$528.69
0.12%
00591566105
SULINDAC
14
$237.74
0.06%
13
$216.82
0.05%
00597002901
MOBIC
TAB 7.5MG
229
$19,921.29
0.90%
353
$25,995.80
1.25%
00597003001
MOBIC
TAB 15MG
142
$13,361.34
0.56%
303
$29,183.82
1.07%
00603401821
IBUPROFEN
TAB 400MG
1
$2.92
0.00%
0
$0.00
0.00%
00603401828
IBUPROFEN
TAB 400MG
5
$26.35
0.02%
1
$9.27
0.00%
00603402028
IBUPROFEN
TAB 800MG
12
$79.86
0.05%
6
$36.60
0.02%
00677103205
IBUPROFEN
TAB 600MG
16
$98.64
0.06%
1
$4.50
0.00%
00677109001
IBUPROFEN
TAB 200MG
1
$3.69
0.00%
0
$0.00
0.00%
00677117301
SULINDAC
TAB 150MG
12
$209.08
0.05%
44
$708.41
0.16%
00677117306
SULINDAC
TAB 150MG
5
$83.00
0.02%
1
$16.60
0.00%
00677117401
SULINDAC
TAB 200MG
4
$72.40
0.02%
6
$135.58
0.02%
00677117405
SULINDAC
TAB 200MG
0
$0.00
0.00%
1
$7.96
0.00%
00677117406
SULINDAC
TAB 200MG
0
$0.00
0.00%
11
$188.19
0.04%
00677142501
2
$123.70
0.01%
6
$263.86
0.02%
TAB 150MG
Page 387 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00781116301
NAPROXEN
TAB 250MG
1
$4.85
0.00%
0
$0.00
0.00%
00781116401
NAPROXEN
TAB 375MG
18
$132.50
0.07%
3
$19.05
0.01%
00781116405
NAPROXEN
TAB 375MG
1
$6.65
0.00%
1
$7.45
0.00%
00781116410
NAPROXEN
TAB 375MG
4
$30.40
0.02%
0
$0.00
0.00%
00781116501
NAPROXEN
TAB 500MG
12
$143.70
0.05%
24
$252.99
0.08%
00781116505
NAPROXEN
TAB 500MG
4
$44.50
0.02%
6
$70.20
0.02%
00781118801
7
$157.95
0.03%
4
$128.80
0.01%
00781130601
54
$1,840.92
0.21%
15
$399.42
0.05%
00781130801
37
$1,387.07
0.15%
2
$29.70
0.01%
00781134901
IBUPROFEN
TAB 200MG
1
$5.63
0.00%
0
$0.00
0.00%
00781136201
IBUPROFEN
TAB 600MG
4
$26.54
0.02%
3
$33.48
0.01%
00781138101
DICLOFENAC TAB 100MG XR
12
$675.72
0.05%
17
$753.95
0.06%
00781164601
8
$265.80
0.03%
5
$147.35
0.02%
00781165301
116
$3,699.29
0.46%
97
$2,972.90
0.34%
00781178501
4
$76.30
0.02%
5
$114.75
0.02%
00781178560
1
$27.85
0.00%
0
$0.00
0.00%
00781178701
130
$2,924.02
0.51%
131
$2,979.16
0.46%
00781178760
14
$251.88
0.06%
0
$0.00
0.00%
00781178901
162
$1,827.36
0.64%
234
$4,259.00
0.83%
00781178910
1
$1.00
0.00%
0
$0.00
0.00%
00781178960
11
$147.63
0.04%
0
$0.00
0.00%
00781501701
95
$2,556.72
0.37%
84
$1,831.23
0.30%
00904174751
IBU-200
TAB 200MG
0
$0.00
0.00%
1
$2.49
0.00%
00904174760
IBU-200
TAB 200MG
1
$5.48
0.00%
1
$1.54
0.00%
00904174840
IBUPROFEN
TAB 400MG
24
$176.13
0.09%
0
$0.00
0.00%
00904174860
IBUPROFEN
TAB 400MG
4
$29.11
0.02%
8
$39.35
0.03%
00904337960
SULINDAC
TAB 200MG
10
$143.70
0.04%
5
$113.07
0.02%
Page 388 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
00904501960
00904518640
IBUPROFEN
00904518661
IBUPROFEN
00904518740
0
$0.00
0.00%
1
$16.85
0.00%
TAB 600MG
58
$349.18
0.23%
31
$140.88
0.11%
TAB 600MG
3
$4.63
0.01%
0
$0.00
0.00%
IBUPROFEN
TAB 800MG
38
$237.78
0.15%
50
$297.65
0.18%
00904518760
IBUPROFEN
TAB 800MG
9
$48.95
0.04%
4
$20.75
0.01%
00904522959
1
$5.91
0.00%
2
$15.85
0.01%
00904523051
ALL DAY RELI TAB 220MG
1
$7.60
0.00%
9
$68.40
0.03%
00904523059
ALL DAY RELI TAB 220MG
1
$6.94
0.00%
2
$13.15
0.01%
00904530920
CHLD IBUPROF SUS 100/5ML
56
$684.72
0.22%
12
$193.16
0.04%
00904546335
CHLD IBUPRFN DRO 40MG/ML
0
$0.00
0.00%
3
$22.80
0.01%
00904558460
INDOMETHACIN CAP 75MG CR
3
$104.47
0.01%
0
$0.00
0.00%
00904559040
NAPROXEN
TAB 375MG
3
$16.21
0.01%
0
$0.00
0.00%
00904559140
NAPROXEN
TAB 500MG
0
$0.00
0.00%
1
$10.45
0.00%
00904559160
NAPROXEN
TAB 500MG
0
$0.00
0.00%
1
$5.65
0.00%
00904791259
IBUPROFEN
TAB 200MG
9
$57.69
0.04%
6
$41.80
0.02%
00904791459
IBUPROFEN
TAB 200MG
30
$212.71
0.12%
17
$107.51
0.06%
00904791540
IBUPROFEN
TAB 200MG
2
$7.42
0.01%
2
$13.14
0.01%
00904791559
IBUPROFEN
TAB 200MG
1
$1.89
0.00%
20
$160.94
0.07%
10019002209
KETOROLAC
INJ 30MG/ML
1
$12.21
0.00%
1
$31.75
0.00%
10019002232
KETOROLAC
INJ 30MG/ML
9
$139.31
0.04%
6
$215.15
0.02%
11822008130
RA IBUPROFEN TAB 200MG
0
$0.00
0.00%
1
$2.89
0.00%
11822008650
IBUPROFEN
0
$0.00
0.00%
1
$4.91
0.00%
11822361590
RA IBUPROFEN SUS 100/5ML
0
$0.00
0.00%
1
$6.59
0.00%
15127033501
SB IBUPROFEN TAB 200MG
2
$9.37
0.01%
0
$0.00
0.00%
17236007801
NAPROXEN
TAB 500MG
1
$10.45
0.00%
1
$10.45
0.00%
24385060478
IBUPROFEN
TAB 200MG
2
$17.12
0.01%
0
$0.00
0.00%
24385064771
IBUPROFEN
TAB 200MG
0
$0.00
0.00%
1
$4.91
0.00%
TAB 200MG
Page 389 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
24385064778
IBUPROFEN
TAB 200MG
25866051324
ALEVE
37205026171
37205026178
$4.65
0.00%
0
$0.00
0.00%
0
$0.00
0.00%
1
$15.26
0.00%
7
$40.85
0.03%
9
$68.10
0.03%
10
$60.55
0.04%
11
$61.48
0.04%
37205026271
0
$0.00
0.00%
2
$8.22
0.01%
37205026278
0
$0.00
0.00%
3
$21.35
0.01%
37205028226
5
$78.52
0.02%
0
$0.00
0.00%
37205028326
0
$0.00
0.00%
2
$27.53
0.01%
37205034171
IBUPROFEN
TAB 200MG
0
$0.00
0.00%
2
$3.38
0.01%
37205034178
IBUPROFEN
TAB 200MG
13
$55.57
0.05%
1
$10.39
0.00%
37205035071
IBUPROFEN
TAB 200MG
1
$6.47
0.00%
2
$10.44
0.01%
37205035078
IBUPROFEN
TAB 200MG
11
$54.97
0.04%
9
$43.08
0.03%
37205035085
IBUPROFEN
TAB 200MG
12
$53.52
0.05%
12
$55.75
0.04%
37205035090
IBUPROFEN
TAB 200MG
0
$0.00
0.00%
1
$3.95
0.00%
37205040262
IBUPROFEN JR CHW 100MG
0
$0.00
0.00%
1
$9.75
0.00%
37205064326
12
$151.53
0.05%
2
$14.76
0.01%
37205064426
2
$18.15
0.01%
0
$0.00
0.00%
37205064605
IBU-DROPS
DRO 40MG/ML
3
$22.17
0.01%
0
$0.00
0.00%
49348022934
1
$17.13
0.00%
1
$15.43
0.00%
49348037469
CHLD IBUPRFN DRO 40MG/ML
0
$0.00
0.00%
1
$10.29
0.00%
49348049934
0
$0.00
0.00%
8
$56.00
0.03%
49348070609
IBUPROFEN
0
$0.00
0.00%
1
$19.59
0.00%
49614011678
MEDI-PROFEN TAB 200MG
0
$0.00
0.00%
1
$6.09
0.00%
49884016305
IBUPROFEN
TAB 600MG
5
$26.50
0.02%
0
$0.00
0.00%
49884021605
IBUPROFEN
TAB 800MG
1
$2.50
0.00%
0
$0.00
0.00%
49884046701
IBU
TAB 400MG
23
$141.53
0.09%
13
$75.71
0.05%
49884046705
IBU
TAB 400MG
22
$129.17
0.09%
7
$35.69
0.02%
TAB 220MG
TAB 200MG
1
Page 390 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
49884046805
IBU
TAB 600MG
215
49884046901
IBU
TAB 800MG
49884046905
IBU
TAB 800MG
49884059601
ETODOLAC
49884072301
OXAPROZIN
49884072305
OXAPROZIN
TAB 600MG
49884077701
IBUPROFEN
TAB 400MG
49884077705
IBUPROFEN
TAB 400MG
49884077801
IBUPROFEN
49884077805
49884077901
$1,169.80
0.84%
10
$82.44
0.04%
77
$485.85
0.30%
TAB 500MG
0
$0.00
0.00%
TAB 600MG
2
$85.30
0.01%
1
$43.90
0.00%
19
$113.69
0.07%
324
$1,687.17
1.27%
TAB 600MG
10
$47.77
IBUPROFEN
TAB 600MG
2,235
IBUPROFEN
TAB 800MG
14
49884077905
IBUPROFEN
TAB 800MG
50111040603
$230.37
0.14%
4
$22.70
0.01%
85
$516.69
0.30%
13
$304.35
0.05%
11
$184.85
0.04%
1
$6.50
0.00%
16
$103.04
0.06%
344
$1,817.62
1.22%
0.04%
37
$365.01
0.13%
$11,217.24
8.78%
1,802
$9,288.44
6.37%
$90.70
0.06%
124
$1,228.61
0.44%
4,671
$27,912.10
18.35%
3,656
$22,321.78
12.93%
3
$23.43
0.01%
0
$0.00
0.00%
50111060801
KETOROLAC
1
$9.65
0.00%
92
$678.01
0.33%
50428191238
0
$0.00
0.00%
2
$9.98
0.01%
50428196330
0
$0.00
0.00%
1
$4.99
0.00%
50428232565
IBUPROFEN IB TAB 200MG
1
$0.29
0.00%
0
$0.00
0.00%
50428291856
0
$0.00
0.00%
1
$1.39
0.00%
50580010015
CHLRNS MOTRN DRO BERRY
0
$0.00
0.00%
1
$87.84
0.00%
50580020724
CHILD MOTRIN CHW JR 100MG
0
$0.00
0.00%
1
$22.81
0.00%
50580048100
MOTRIN IB
TAB 200MG
1
$7.96
0.00%
0
$0.00
0.00%
50580048101
MOTRIN IB
TAB 200MG
0
$0.00
0.00%
1
$7.62
0.00%
50580060104
CHILD MOTRIN SUS 100/5ML
1
$8.50
0.00%
0
$0.00
0.00%
51079019020
1
$10.48
0.00%
0
$0.00
0.00%
51079066720
SULINDAC
TAB 200MG
0
$0.00
0.00%
8
$174.28
0.03%
51672401601
ETODOLAC
CAP 200MG
41
$908.45
0.16%
39
$875.50
0.14%
51672401701
ETODOLAC
CAP 300MG
40
$1,104.23
0.16%
31
$503.09
0.11%
TAB 10MG
41
Page 391 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
51672401801
ETODOLAC
TAB 400MG
141
$2,533.86
0.55%
177
$3,302.76
0.63%
51672403601
ETODOLAC
TAB 500MG
37
$1,600.73
0.15%
17
$472.95
0.06%
51672405101
0
$0.00
0.00%
6
$203.10
0.02%
51672405104
0
$0.00
0.00%
1
$17.35
0.00%
51672405201
0
$0.00
0.00%
6
$260.10
0.02%
51672405204
2
$120.50
0.01%
3
$155.55
0.01%
52544033810
6
$89.34
0.02%
0
$0.00
0.00%
52544033901
25
$324.34
0.10%
0
$0.00
0.00%
52544071201
PIROXICAM
CAP 10MG
3
$28.93
0.01%
2
$9.72
0.01%
52544071301
PIROXICAM
CAP 20MG
16
$61.34
0.06%
0
$0.00
0.00%
52555097201
PIROXICAM
CAP 10MG
3
$16.64
0.01%
1
$11.37
0.00%
52555097301
PIROXICAM
CAP 20MG
107
$439.44
0.42%
39
$140.87
0.14%
52555097305
PIROXICAM
CAP 20MG
49
$202.37
0.19%
63
$235.51
0.22%
52735057741
13
$89.05
0.05%
1
$17.70
0.00%
53265026910
105
$6,056.93
0.41%
157
$2,767.02
0.56%
53265026960
7
$361.84
0.03%
14
$250.42
0.05%
53265036310
0
$0.00
0.00%
8
$84.81
0.03%
53265036410
0
$0.00
0.00%
111
$2,033.47
0.39%
53265036450
0
$0.00
0.00%
63
$905.96
0.22%
53489047801
SULINDAC
TAB 150MG
192
$3,078.07
0.75%
381
$5,921.41
1.35%
53489047805
SULINDAC
TAB 150MG
1
$19.10
0.00%
0
$0.00
0.00%
53489047901
SULINDAC
TAB 200MG
323
$6,648.34
1.27%
449
$9,915.06
1.59%
53489047905
SULINDAC
TAB 200MG
0
$0.00
0.00%
5
$101.68
0.02%
53489050601
2
$162.70
0.01%
0
$0.00
0.00%
53746013105
IBUPROFEN
TAB 400MG
37
$210.87
0.15%
101
$593.77
0.36%
53746013201
IBUPROFEN
TAB 600MG
9
$48.69
0.04%
10
$59.68
0.04%
53746013205
IBUPROFEN
TAB 600MG
59
$326.84
0.23%
519
$2,757.59
1.83%
Page 392 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
53746013501
IBUPROFEN
TAB 200MG
53746013510
IBUPROFEN
TAB 200MG
53746013701
IBUPROFEN
TAB 800MG
53746013705
IBUPROFEN
TAB 800MG
53746018801
NAPROXEN
53746018805
53746018901
$57.41
0.04%
3
$17.40
0.01%
1
$0.69
0.00%
27
$164.67
0.11%
0
$0.00
0.00%
5
$27.00
0.02%
205
$1,240.28
0.81%
1,181
$7,249.26
4.18%
TAB 250MG
6
$41.40
0.02%
16
$97.80
0.06%
NAPROXEN
TAB 250MG
NAPROXEN
TAB 375MG
0
$0.00
0.00%
5
$17.83
0.02%
5
$57.05
0.02%
2
$8.30
0.01%
53746018905
NAPROXEN
TAB 375MG
2
$14.90
0.01%
8
$55.28
0.03%
53746019001
NAPROXEN
TAB 500MG
0
$0.00
0.00%
2
$21.80
0.01%
53746019005
54569200500
NAPROXEN
TAB 500MG
12
$122.78
0.05%
11
$137.43
0.04%
IBUPROFEN
TAB 200MG
1
$5.30
0.00%
1
$7.99
0.00%
54569517400
IBUPROFEN
SUS 100/5ML
0
$0.00
0.00%
1
$12.88
0.00%
55111010101
IBUPROFEN
TAB 400MG
39
$169.04
0.15%
38
$172.80
0.13%
55111010105
IBUPROFEN
TAB 400MG
1
$3.81
0.00%
10
$57.50
0.04%
55111010205
IBUPROFEN
TAB 600MG
255
$1,264.96
1.00%
296
$1,444.46
1.05%
55111010301
IBUPROFEN
TAB 800MG
2
$12.60
0.01%
3
$24.75
0.01%
55111010305
IBUPROFEN
TAB 800MG
392
$2,256.48
1.54%
627
$3,857.89
2.22%
55111017001
OXAPROZIN
TAB 600MG
81
$3,156.12
0.32%
161
$3,225.33
0.57%
55111036601
NAPROXEN
TAB 250MG
0
$0.00
0.00%
5
$40.55
0.02%
55111036801
NAPROXEN
TAB 500MG
0
$0.00
0.00%
4
$26.55
0.01%
55111036805
NAPROXEN
TAB 500MG
0
$0.00
0.00%
35
$377.73
0.12%
55370013907
NAPROXEN
TAB 250MG
52
$312.33
0.20%
31
$188.45
0.11%
55370013909
NAPROXEN
TAB 250MG
1
$15.25
0.00%
0
$0.00
0.00%
55370014007
NAPROXEN
TAB 375MG
134
$932.99
0.53%
13
$91.56
0.05%
55370014009
NAPROXEN
TAB 375MG
3
$21.55
0.01%
7
$60.25
0.02%
55370014107
NAPROXEN
TAB 500MG
129
$1,289.43
0.51%
2
$20.90
0.01%
55370014108
NAPROXEN
TAB 500MG
367
$3,643.13
1.44%
40
$453.10
0.14%
9
Page 393 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
55390048101
KETOROLAC
INJ 30MG/ML
2
57664016508
57664039108
OXAPROZIN
TAB 600MG
57664039113
OXAPROZIN
57896054001
$7.38
0.01%
0
$0.00
0.00%
10
$193.40
0.04%
45
$1,797.46
0.18%
32
$485.42
0.11%
91
$1,829.25
0.32%
TAB 600MG
0
$0.00
0.00%
1
$21.85
0.00%
IBUPROFEN
TAB 200MG
2
$11.24
0.01%
0
$0.00
0.00%
57896094101
IBUPROFEN
TAB 200MG
58177030104
KETOROLAC
TAB 10MG
0
$0.00
0.00%
2
$6.70
0.01%
94
$1,157.84
0.37%
109
$905.10
0.39%
58177030204
10
$374.50
0.04%
3
$88.95
0.01%
58177030304
197
$6,653.38
0.77%
114
$4,116.79
0.40%
59630040010
PONSTEL
59762372401
34
$1,506.49
0.13%
31
$1,333.47
0.11%
16
$382.00
0.06%
17
$232.90
0.06%
59762372403
1
$9.85
0.00%
0
$0.00
0.00%
59762500201
OXAPROZIN
TAB 600MG
26
$948.28
0.10%
5
$82.75
0.02%
59762500202
59762737801
OXAPROZIN
TAB 600MG
2
$82.80
0.01%
0
$0.00
0.00%
IBUPROFEN
TAB 400MG
0
$0.00
0.00%
1
$2.33
0.00%
59762737802
IBUPROFEN
TAB 400MG
76
$434.16
0.30%
81
$523.78
0.29%
59762737901
IBUPROFEN
TAB 600MG
2
$11.00
0.01%
0
$0.00
0.00%
59762737902
IBUPROFEN
TAB 600MG
143
$799.96
0.56%
199
$1,048.15
0.70%
59762738001
IBUPROFEN
TAB 800MG
8
$65.22
0.03%
4
$24.81
0.01%
59762738002
IBUPROFEN
TAB 800MG
417
$2,572.86
1.64%
268
$1,512.58
0.95%
59911360701
ETODOLAC
CAP 300MG
6
$138.90
0.02%
3
$46.05
0.01%
59930150801
OXAPROZIN
TAB 600MG
24
$1,001.01
0.09%
0
$0.00
0.00%
60505004001
ETODOLAC
CAP 300MG
0
$0.00
0.00%
9
$115.15
0.03%
60505004101
ETODOLAC
TAB 400MG
0
$0.00
0.00%
29
$541.90
0.10%
60505010201
ETODOLAC
TAB 500MG
0
$0.00
0.00%
42
$1,081.50
0.15%
60951078070
SULINDAC
TAB 150MG
7
$123.70
0.03%
9
$145.12
0.03%
60951078170
SULINDAC
TAB 200MG
7
$155.17
0.03%
0
$0.00
0.00%
CAP 250MG
Page 394 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
NSAIDS
62037052001
62037082675
62584031260
109
$8,806.62
0.43%
120
$4,165.61
0.42%
NAPROXEN SOD TAB 500MG CR
10
$623.15
0.04%
5
$375.68
0.02%
INDOMETHACIN CAP 75MG CR
0
$0.00
0.00%
4
$49.60
0.01%
63304068201
NALFON
1
$28.84
0.00%
0
$0.00
0.00%
63304069001
PIROXICAM
CAP 10MG
17
$86.28
0.07%
32
$180.17
0.11%
63304069101
PIROXICAM
CAP 20MG
287
$1,110.99
1.13%
446
$1,662.91
1.58%
63304069105
PIROXICAM
CAP 20MG
33
$131.49
0.13%
18
$58.50
0.06%
64899000950
IBUPROFEN M TAB 200MG
1
$7.93
0.00%
0
$0.00
0.00%
65162007850
NAPROXEN
0
$0.00
0.00%
13
$123.33
0.05%
65759074410
0
$0.00
0.00%
1
$6.36
0.00%
67253062010
NAPROXEN
TAB 250MG
18
$175.40
0.07%
102
$850.90
0.36%
67253062011
NAPROXEN
TAB 250MG
0
$0.00
0.00%
2
$8.76
0.01%
67253062110
NAPROXEN
TAB 375MG
17
$154.03
0.07%
142
$1,253.69
0.50%
67253062111
NAPROXEN
TAB 375MG
13
$120.12
0.05%
17
$144.53
0.06%
67253062210
NAPROXEN
TAB 500MG
163
$1,596.51
0.64%
281
$2,801.89
0.99%
67253062250
NAPROXEN
TAB 500MG
860
$8,439.06
3.38%
665
$6,803.24
2.35%
87701088535
2
$22.44
0.01%
0
$0.00
0.00%
3
$188.76
14.29%
3
$184.50
16.67%
1
$44.08
4.76%
0
$0.00
0.00%
CAP 300MG
TAB 500MG
OP. ADRENERGIC AGENTS
00023920815
PROPINE
SOL 0.1% OP
11980012215
EPIFRIN
24208054005
DIPIVEFRIN SOL 0.1% OP
5
$31.00
23.81%
0
$0.00
0.00%
24208054010
5
$50.25
23.81%
1
$9.55
5.56%
24208054015
1
$16.40
4.76%
1
$16.40
5.56%
60758008705
0
$0.00
0.00%
1
$5.20
5.56%
60758008710
0
$0.00
0.00%
1
$9.55
5.56%
61314023505
3
$17.50
14.29%
3
$23.10
16.67%
SOL 1% OP
Page 395 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
$
Market Share*
OP. ADRENERGIC AGENTS
61314023510
# of Scripts
3
$36.15
14.29%
8
$91.40
44.44%
3
$151.19
0.38%
0
$0.00
0.00%
42
$2,713.73
5.29%
31
$2,073.89
3.58%
0
$0.00
0.00%
2
$122.88
0.23%
OP. ANTIALLERGICS
00023642210
OPTICROM
SOL 4% OP
00023884205
ALOCRIL
SOL 2%
00037702560
OPTIVAR
DRO 0.05%
00065027105
PATANOL
SOL 0.1% OP
584
$38,184.54
73.55%
772
$51,544.77
89.25%
00065032505
EMADINE
SOL 0.05% OP
17
$944.95
2.14%
4
$210.94
0.46%
00065034510
ALOMIDE
SOL 0.1% OP
26
$1,639.85
3.27%
17
$1,118.26
1.97%
00093138943
CROMOLYN SOD SOL 4% OP
8
$267.28
1.01%
2
$41.70
0.23%
00451702506
OPTIVAR
DRO 0.05%
8
$394.39
1.01%
0
$0.00
0.00%
00451702530
OPTIVAR
DRO 0.05%
2
$58.15
0.25%
0
$0.00
0.00%
17478029111
0
$0.00
0.00%
1
$37.10
0.12%
24208030010
CROLOM
SOL 4% OP
1
$34.60
0.13%
0
$0.00
0.00%
58768010205
ZADITOR
SOL 0.025%OP
29
$1,390.33
3.65%
5
$165.88
0.58%
58768061005
LIVOSTIN
SUS 0.05% OP
27
$1,372.39
3.40%
6
$334.34
0.69%
58768061010
LIVOSTIN
SUS 0.05% OP
7
$454.97
0.88%
8
$559.60
0.92%
61314023710
20
$673.51
2.52%
1
$34.36
0.12%
65086071110
ALAMAST
20
$1,087.42
2.52%
16
$882.70
1.85%
DRO 0.1%
OP. ANTIBIOTICS
00023782410
POLYTRIM
00023921805
ZYMAR
SOL OP
1
$30.91
0.03%
3
$96.43
0.09%
DRO 0.3%
150
$6,389.89
4.46%
63
$2,826.15
1.99%
00049080108
TERRAMYCIN OIN POLYM OP
1
$10.25
0.03%
3
$39.96
0.09%
00065064435
TOBREX
31
$1,369.13
0.92%
23
$1,047.42
0.73%
00085015105
GARAMYCIN
00168002638
BACITRACIN OIN OP
0
$0.00
0.00%
1
$21.91
0.03%
55
$296.09
1.63%
94
$554.87
2.97%
OIN 0.3% OP
OIN 0.3% OP
Page 396 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. ANTIBIOTICS
00168002738
BAC/NEO/POLY OIN OP
00168007011
ERYTHROMYCIN OIN OP
0
$0.00
0.00%
12
$78.50
0.38%
00168007038
ERYTHROMYCIN OIN OP
604
$4,263.44
17.94%
990
$6,809.56
31.23%
00168007039
ERYTHROMYCIN OIN OP
1
$5.38
0.03%
0
$0.00
0.00%
00168007938
SULFACET SOD OIN 10% OP
36
$306.97
1.07%
33
$302.54
1.04%
00168022015
SOD SULFACET SOL 10% OP
9
$50.85
0.27%
11
$57.15
0.35%
00603713770
ERYTHROMYCIN OIN OP
1
$7.18
0.03%
0
$0.00
0.00%
00603728041
2
$11.30
0.06%
0
$0.00
0.00%
00603734537
TOBRAMYCIN SOL 0.3% OP
1
$6.75
0.03%
1
$6.71
0.03%
00677090621
OCUTRICIN SOL OP
1
$23.04
0.03%
2
$48.64
0.06%
00677091730
1
$5.65
0.03%
0
$0.00
0.00%
00904190705
GENTAMICIN SOL 0.3% OP
0
$0.00
0.00%
1
$5.00
0.03%
00904272835
13
$65.95
0.39%
9
$42.58
0.28%
00904297005
1
$4.25
0.03%
3
$12.25
0.09%
00904301610
NEOCIDIN
1
$25.54
0.03%
0
$0.00
0.00%
00904792638
ERYTHROMYCIN OIN OP
1
$7.66
0.03%
2
$11.33
0.06%
17478007035
ERYTHROMYCIN OIN OP
2
$7.53
0.06%
2
$11.70
0.06%
17478022112
SULFACET SOD SOL 10% OP
2
$10.53
0.06%
3
$14.45
0.09%
17478022735
AK-SULF
OIN 10% OP
1
$6.30
0.03%
0
$0.00
0.00%
17478023535
NEO/BAC/POLY OIN OP
2
$14.46
0.06%
2
$14.46
0.06%
17478023835
AK-POLY-BAC OIN OP
8
$77.80
0.24%
3
$31.05
0.09%
17478028310
GENTAK
SOL 0.3% OP
18
$86.62
0.53%
5
$17.85
0.16%
17478028435
GENTAK
OIN 0.3% OP
71
$1,373.37
2.11%
70
$1,311.92
2.21%
17478029010
AK-TOB
SOL 0.3% OP
7
$47.25
0.21%
1
$6.71
0.03%
17478070311
TRIMETHOPRIM SOL POLYMYXN
3
$44.63
0.09%
54
$412.58
1.70%
24208029005
102
$610.57
3.03%
65
$394.16
2.05%
24208031510
334
$4,973.58
9.92%
110
$1,580.07
3.47%
SOL OP
10
$84.45
0.30%
11
$101.26
Page 397 of 505
0.35%
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. ANTIBIOTICS
24208044405
CIPROFLOXACN SOL 0.3% OP
0
$0.00
0.00%
16
$728.94
0.50%
24208044410
0
$0.00
0.00%
1
$15.62
0.03%
24208044425
0
$0.00
0.00%
3
$69.11
0.09%
24208055555
BACIT/POLYMY OIN OP
43
$392.13
1.28%
50
$457.83
1.58%
24208058060
316
$1,412.53
9.39%
122
$532.64
3.85%
24208058064
12
$88.86
0.36%
22
$166.04
0.69%
24208067004
432
$2,166.86
12.83%
230
$1,096.82
7.26%
24208078055
NEO/BAC/POLY OIN OP
7
$106.92
0.21%
2
$34.14
0.06%
24208079062
NEO/POLY/GRA SOL OP
74
$1,863.68
2.20%
53
$1,175.97
1.67%
24208091055
ERYTHROMYCIN OIN OP
416
$3,125.46
12.36%
96
$755.34
3.03%
52238065015
OCUSULF-10 SOL 10% OP
2
$11.30
0.06%
0
$0.00
0.00%
58768036505
GENTACIDIN SOL 0.3% OP
1
$5.00
0.03%
0
$0.00
0.00%
60505055800
0
$0.00
0.00%
20
$142.22
0.63%
60505100001
60758018805
60758090810
0
$0.00
0.00%
37
$1,522.25
1.17%
16
$74.15
0.48%
51
$203.25
1.61%
6
$94.26
0.18%
0
$0.00
0.00%
61314004475
TRIFLURIDINE SOL 1% OP
5
$398.80
0.15%
8
$610.65
0.25%
61314062810
POLYMYXIN B/ SOL TRIMETHP
117
$1,748.21
3.48%
200
$2,993.30
6.31%
61314063305
239
$1,074.35
7.10%
265
$1,189.25
8.36%
61314064305
108
$634.85
3.21%
100
$601.67
3.15%
61314065605
0
$0.00
0.00%
103
$4,179.65
3.25%
61314065610
0
$0.00
0.00%
1
$77.49
0.03%
61314065625
61314070101
SULFACET SOD SOL 10% OP
61570003775
VIROPTIC
61570004635
61570004935
0
$0.00
0.00%
5
$153.59
0.16%
94
$455.44
2.79%
194
$921.73
6.12%
5
$377.44
0.15%
13
$1,173.28
0.41%
NEOSPORIN OIN OP
1
$30.47
0.03%
1
$35.25
0.03%
POLYSPORIN OIN OP
2
$61.10
0.06%
0
$0.00
0.00%
SOL 1% OP
Page 398 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. ANTIINFLAMMATORY / STEROIDS OPHTH.
00023010605
PRED-G
00023031304
SUS OP
2
$53.18
0.16%
0
$0.00
0.00%
BLEPHAMIDE OIN S.O.P.
14
$492.06
1.09%
3
$152.13
0.25%
00023031604
FML S.O.P. OIN 0.1% OP
23
$711.96
1.80%
34
$1,047.30
2.89%
00065009605
FLAREX
SUS 0.1% OP
16
$451.18
1.25%
11
$313.55
0.93%
00065062703
VEXOL
SUS 1% OP
3
$141.65
0.23%
4
$152.08
0.34%
00065062707
VEXOL
SUS 1% OP
13
$341.41
1.02%
8
$211.17
0.68%
00065064705
TOBRADEX
SUS OP
253
$13,295.48
19.78%
245
$13,215.50
20.82%
00065064710
TOBRADEX
SUS OP
55
$5,278.18
4.30%
37
$3,425.69
3.14%
00065064725
TOBRADEX
SUS OP
7
$205.31
0.55%
16
$500.42
1.36%
00065064835
TOBRADEX
OIN OP
127
$7,108.46
9.93%
119
$7,114.18
10.11%
00168002938
BAC/POLY/NEO OIN /HC OP1%
11
$104.60
0.86%
6
$43.88
0.51%
00998061505
MAXIDEX
3
$98.07
0.23%
0
$0.00
0.00%
00998063510
ECONOPRED
1
$36.85
0.08%
0
$0.00
0.00%
00998063705
ECONOPRED PL SUS 1% OP
1
$61.74
0.08%
0
$0.00
0.00%
00998063710
ECONOPRED PL SUS 1% OP
2
$92.30
0.16%
0
$0.00
0.00%
11980002205
BLEPHAMIDE SUS OP
25
$1,069.57
1.95%
28
$1,053.64
2.38%
11980002210
BLEPHAMIDE SUS OP
13
$712.52
1.02%
5
$290.55
0.42%
11980017405
PRED MILD SUS 0.12% OP
14
$364.23
1.09%
23
$514.55
1.95%
11980017410
PRED MILD SUS 0.12% OP
9
$308.11
0.70%
6
$201.07
0.51%
11980018001
PRED FORTE SUS 1% OP
1
$72.60
0.08%
0
$0.00
0.00%
11980018005
19
$634.80
1.49%
12
$328.75
1.02%
11980018010
56
$2,456.35
4.38%
53
$2,362.02
4.50%
11980018015
15
$938.47
1.17%
35
$2,149.86
2.97%
11980021105
FML LIQUIFLM SUS 0.1% OP
7
$194.40
0.55%
0
$0.00
0.00%
11980021110
1
$42.65
0.08%
0
$0.00
0.00%
11980021115
0
$0.00
0.00%
1
$60.46
0.08%
SUS 0.1% OP
SUS 0.125%OP
Page 399 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
FML FORTE
11980042205
FML-S
11980042210
FML-S
17478023235
SUS 0.25% OP
$
Market Share*
11980022815
# of Scripts
0
$0.00
0.00%
1
$45.70
0.08%
SUS LIQUIFLM
3
$76.92
0.23%
3
$75.42
0.25%
SUS LIQUIFLM
2
$67.84
0.16%
0
$0.00
0.00%
AK-SPORE HC OIN OP
1
$8.83
0.08%
0
$0.00
0.00%
24208028805
FLUOROMETHOL SUS 0.1% OP
3
$29.95
0.23%
4
$42.86
0.34%
24208028810
2
$37.38
0.16%
0
$0.00
0.00%
24208029905
LOTEMAX
SUS 0.5%
41
$1,179.34
3.21%
46
$1,357.48
3.91%
24208029910
LOTEMAX
SUS 0.5%
6
$263.52
0.47%
7
$337.82
0.59%
24208029915
LOTEMAX
SUS 0.5%
1
$67.92
0.08%
3
$174.33
0.25%
24208031705
SULF/PRED NA SOL OP
12
$196.02
0.94%
1
$1.00
0.08%
24208031710
SULF/PRED NA SOL OP
2
$31.03
0.16%
3
$44.85
0.25%
24208035305
ALREX
SUS 0.2%
10
$372.82
0.78%
38
$1,473.09
3.23%
24208035310
ALREX
SUS 0.2%
2
$123.56
0.16%
9
$534.08
0.76%
24208071502
PRED SOD PHO SOL 1% OP
8
$173.52
0.63%
4
$54.74
0.34%
24208071506
4
$121.06
0.31%
4
$114.98
0.34%
24208071510
0
$0.00
0.00%
1
$14.65
0.08%
24208072002
DEXAMETH PHO SOL 0.1% OP
14
$358.79
1.09%
12
$198.32
1.02%
24208078555
NEO/POLY/BAC OIN /HC OP1%
0
$0.00
0.00%
1
$14.46
0.08%
24208079535
NEO/POLY/DEX OIN 0.1% OP
0
$0.00
0.00%
2
$14.20
0.17%
24208083060
DEX/NEO/POLY SUS 0.1% OP
4
$36.24
0.31%
3
$25.50
0.25%
58768010710
EFLONE
3
$67.19
0.23%
0
$0.00
0.00%
58768035805
FLUOR-OP
1
$9.15
0.08%
0
$0.00
0.00%
58768088705
VASOCIDIN
1
$33.74
0.08%
0
$0.00
0.00%
60758011905
PREDNISOLONE SUS 1% OP
62
$619.13
4.85%
36
$394.18
3.06%
60758011910
66
$1,262.86
5.16%
27
$529.50
2.29%
60758011915
30
$738.58
2.35%
8
$185.31
0.68%
60758088005
5
$48.25
0.39%
5
$48.25
0.42%
SUS 0.1% OP
SUS 0.1% OP
SOL OP
Page 400 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
60758088010
2
$33.47
0.16%
4
$70.10
0.34%
61314032805
9
$94.85
0.70%
7
$69.05
0.59%
61314032810
1
$17.44
0.08%
5
$94.70
0.42%
61314063006
NEO/POLY/DEX SUS 0.1% OP
6
$56.32
0.47%
1
$7.81
0.08%
61314063136
NEO/POLY/DEX OIN 0.1% OP
4
$20.90
0.31%
12
$70.68
1.02%
61314063705
136
$1,461.19
10.63%
127
$1,435.54
10.79%
61314063710
71
$1,333.11
5.55%
57
$1,123.65
4.84%
61314063715
42
$1,113.59
3.28%
62
$1,639.57
5.27%
61314064175
NEO/POLY/HC SUS OP
17
$767.97
1.33%
26
$1,257.51
2.21%
61570003535
CORTISPORIN OIN OP 1%
2
$75.42
0.16%
8
$640.97
0.68%
61570003675
CORTISPORIN SUS OP 1%
15
$755.79
1.17%
4
$206.52
0.34%
0
$0.00
0.00%
2
$99.52
0.08%
1
$42.78
0.04%
0
$0.00
0.00%
OP. ARTIFICIAL TEARS AND LUBRICANTS
00006338060
LACRISERT
00023024001
LACRI-LUB NP OIN OP
00023031204
LACRI-LUBE OIN S.O.P.
68
$887.18
2.75%
53
$655.46
2.21%
00023031207
LACRI-LUBE OIN S.O.P.
25
$393.99
1.01%
12
$195.15
0.50%
00023040330
REFRESH PLUS SOL 0.5% OP
63
$731.51
2.55%
70
$674.18
2.92%
00023040350
43
$751.08
1.74%
35
$642.51
1.46%
00023050601
REFRESH
SOL OP
108
$1,249.48
4.37%
55
$552.11
2.29%
00023050650
REFRESH
SOL OP
47
$705.85
1.90%
32
$459.20
1.33%
00023066704
REFRESH-PM OIN OP
74
$1,011.48
2.99%
90
$1,062.41
3.75%
00023079815
REFRESH TEAR SOL 0.5% OP
76
$653.81
3.07%
102
$850.86
4.25%
00023079830
REFRESH TEAR SOL 0.5% OP
21
$214.54
0.85%
41
$430.22
1.71%
00023455430
CELLUVISC
151
$2,338.61
6.10%
147
$2,133.60
6.13%
00023548730
104
$1,085.46
4.20%
49
$677.65
2.04%
00023548750
3
$50.93
0.12%
31
$476.18
1.29%
MIS 5MG OP
SOL 1% OP
Page 401 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
REFRESH
SOL 1%
00023920530
REFRESH
SOL 1%
00023923520
REFRESH ENDU DRO 1-1%
00065041625
TEARS NATURA SOL FREE OP
00065041815
$
Market Share*
00023920515
# of Scripts
$343.24
1.41%
78
$759.95
3.25%
0
$0.00
0.00%
12
$117.48
0.50%
14
$283.22
0.57%
7
$101.85
0.29%
25
$320.50
1.01%
24
$283.51
1.00%
TEARS NATURA SOL II OP
34
$298.62
1.37%
27
$245.59
1.13%
00065041830
TEARS NATURA SOL II OP
16
$174.73
0.65%
8
$88.90
0.33%
00065041918
BION TEARS SOL OP
0
$0.00
0.00%
22
$333.40
0.92%
00065041928
BION TEARS SOL OP
54
$796.06
2.18%
23
$432.52
0.96%
00065042005
TEARS NATURA OIN PM
1
$7.70
0.04%
0
$0.00
0.00%
00065042615
TEARS NATURA SOL FORTE
2
$18.08
0.08%
3
$28.55
0.13%
00065042630
1
$5.49
0.04%
1
$5.49
0.04%
00065042915
SYSTANE
SOL
11
$100.84
0.44%
5
$61.56
0.21%
00065042930
SYSTANE
SOL
2
$24.88
0.08%
3
$41.76
0.13%
00074557405
MURINE
1
$4.14
0.04%
0
$0.00
0.00%
00168015038
PURALUBE
OIN OP
40
$258.01
1.62%
95
$584.64
3.96%
00168017715
PURALUBE
SOL TEARS OP
15
$88.99
0.61%
41
$265.29
1.71%
00182505631
EYE LUBRICAN OIN OP
2
$13.40
0.08%
11
$68.70
0.46%
00364242772
ARTIFIC TEAR SOL OP
408
$1,913.59
16.49%
6
$22.88
0.25%
00536197072
ARTIFI TEARS SOL OP
15
$77.28
0.61%
64
$368.62
2.67%
00536623772
NATURE'S
5
$26.37
0.20%
0
$0.00
0.00%
00536655091
ARTIFI TEARS OIN OP
0
$0.00
0.00%
2
$13.13
0.08%
00677098530
ARTIFICIAL SOL TEARS OP
58
$291.53
2.34%
150
$1,020.09
6.25%
00904501835
NATURAL
29
$169.99
1.17%
24
$133.41
1.00%
00904516838
LUBRIFRESH OIN P.M.
1
$5.99
0.04%
5
$40.60
0.21%
00998040815
ISOPTO TEARS SOL 0.5% OP
2
$79.30
0.08%
3
$53.88
0.13%
00998041315
8
$66.12
0.32%
4
$37.48
0.17%
00998041330
1
$9.82
0.04%
4
$41.24
0.17%
SOL OP
SOL TEARS
SOL BALANCE
35
Page 402 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
17478006012
AKWA TEARS SOL OP
19
$108.97
0.77%
324
$2,081.98
13.50%
17478006235
AKWA TEARS OIN OP
35
$230.44
1.41%
122
$808.96
5.08%
17478006335
TEARS RENEW OIN OP
4
$33.50
0.16%
2
$20.77
0.08%
24208028015
MUROCEL
7
$151.35
0.28%
1
$7.62
0.04%
24385000601
6
$37.49
0.24%
0
$0.00
0.00%
37205013479
DRY EYES
0
$0.00
0.00%
6
$32.94
0.25%
37205013705
ARTIFICIAL SOL TEARS
80
$415.31
3.23%
85
$438.13
3.54%
37205060305
TEARS PURE SOL
12
$73.40
0.49%
11
$72.66
0.46%
49348069929
SM ARTIFICIA SOL TEARS
9
$60.80
0.36%
4
$33.74
0.17%
50383002615
1
$2.04
0.04%
0
$0.00
0.00%
58768013015
HYPOTEARS
SOL OP
14
$180.32
0.57%
2
$21.72
0.08%
58768013030
HYPOTEARS
SOL OP
15
$187.83
0.61%
3
$42.78
0.13%
58768013136
HYPOTEARS
OIN OP
7
$77.73
0.28%
1
$9.63
0.04%
58768013230
HYPOTEARS PF SOL
0
$0.00
0.00%
2
$24.68
0.08%
58768072515
TEARISOL
SOL
2
$21.48
0.08%
0
$0.00
0.00%
58768078815
GENTEAL
SOL OPTH
402
$3,996.60
16.25%
196
$1,988.09
8.17%
58768078825
GENTEAL
SOL OPTH
122
$1,335.50
4.93%
179
$2,070.19
7.46%
58768079035
GENTEAL
GEL
4
$21.43
0.16%
63
$360.58
2.63%
58768079036
GENTEAL
GEL
140
$1,340.17
5.66%
20
$188.66
0.83%
58768079115
GENTEAL MILD DRO 0.2%
22
$199.57
0.89%
23
$206.40
0.96%
58768079125
GENTEAL MILD DRO 0.2%
1
$12.92
0.04%
14
$144.26
0.58%
58790000032
THERATEARS SOL OP
3
$68.02
0.12%
0
$0.00
0.00%
58790000115
THERATEARS SOL OP
5
$47.35
0.20%
1
$9.83
0.04%
19
$625.07
1.10%
1
$60.35
0.08%
1
$17.10
0.06%
0
$0.00
0.00%
SOL 1% OP
OIN OP
OP. BETA - BLOCKERS
00006355803
TIMOPTIC-XE SOL 0.5% OP
00006889535
TIMOPTIC
SOL 0.25% OP
Page 403 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. BETA - BLOCKERS
00006889635
TIMOPTIC
SOL 0.5% OP
2
$40.16
0.12%
4
$153.68
0.30%
00006889636
TIMOPTIC
SOL 0.5% OP
5
$190.80
0.29%
1
$37.30
0.08%
00006969060
TIMOPTIC OCU SOL 0.5% OP
2
$65.82
0.12%
0
$0.00
0.00%
00023438510
BETAGAN
SOL 0.5% OP
0
$0.00
0.00%
3
$6.00
0.23%
00023438515
BETAGAN
SOL 0.5% OP
2
$156.52
0.12%
0
$0.00
0.00%
00065024605
BETOPTIC-S SUS 0.25% OP
262
$9,729.32
15.16%
182
$7,066.04
13.86%
00065024610
130
$8,174.29
7.52%
105
$7,207.11
8.00%
00065024615
66
$6,359.77
3.82%
38
$3,966.98
2.89%
00065024620
1
$40.78
0.06%
0
$0.00
0.00%
00364303954
LEVOBUNOLOL SOL 0.5% OP
3
$31.55
0.17%
1
$11.35
0.08%
00364307753
TIMOLOL MAL SOL 0.25% OP
3
$19.80
0.17%
12
$79.20
0.91%
00904524805
1
$5.35
0.06%
4
$21.40
0.30%
00904524835
6
$49.60
0.35%
1
$9.35
0.08%
17478028812
1
$9.35
0.06%
2
$18.70
0.15%
24208032405
25
$96.05
1.45%
74
$376.90
5.64%
24208032410
45
$271.25
2.60%
24
$161.40
1.83%
24208032415
18
$135.80
1.04%
17
$136.45
1.29%
24208033005
12
$52.45
0.69%
3
$19.80
0.23%
24208033010
10
$76.00
0.58%
4
$29.40
0.30%
24208033015
1
$10.60
0.06%
1
$10.60
0.08%
24208036705
CARTEOLOL
SOL OPHTH 1%
7
$101.35
0.41%
6
$90.05
0.46%
24208036710
CARTEOLOL
SOL OPHTH 1%
6
$172.60
0.35%
0
$0.00
0.00%
24208036715
CARTEOLOL
SOL OPHTH 1%
1
$42.10
0.06%
1
$42.10
0.08%
24208050505
31
$221.85
1.79%
39
$311.15
2.97%
24208050510
22
$206.85
1.27%
14
$112.85
1.07%
24208050515
23
$308.05
1.33%
14
$179.40
1.07%
24208054510
2
$25.50
0.12%
1
$12.75
0.08%
Page 404 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. BETA - BLOCKERS
58768000102
OCUPRESS
SOL 1% OP
8
$435.47
0.46%
58768000104
OCUPRESS
SOL 1% OP
0
$0.00
60505055102
0
$0.00
60505055103
0
60505055104
60505055202
60505055301
0
$0.00
0.00%
0.00%
1
$74.94
0.08%
0.00%
22
$80.35
1.68%
$0.00
0.00%
27
$173.50
2.06%
0
$0.00
0.00%
7
$47.95
0.53%
0
$0.00
0.00%
5
$34.20
0.38%
0
$0.00
0.00%
1
$4.85
0.08%
60505055302
0
$0.00
0.00%
1
$8.85
0.08%
60505055303
1
$1.00
0.06%
2
$25.70
0.15%
60505055603
BETAXOLOL
0
$0.00
0.00%
1
$46.39
0.08%
60758006005
2
$9.70
0.12%
3
$14.55
0.23%
60758006010
4
$37.90
0.23%
4
$45.40
0.30%
60758006015
8
$102.80
0.46%
1
$12.85
0.08%
60758080110
4
$33.90
0.23%
3
$26.55
0.23%
60758080115
1
$6.85
0.06%
2
$13.70
0.15%
61314022405
TIMOLOL GEL SOL 0.25% OP
25
$488.14
1.45%
29
$564.80
2.21%
61314022505
520
$13,510.48
30.09%
391
$9,679.61
29.78%
61314022525
3
$87.42
0.17%
5
$126.39
0.38%
61314022605
34
$222.39
1.97%
11
$64.05
0.84%
61314022610
10
$74.50
0.58%
8
$63.80
0.61%
61314022615
1
$13.10
0.06%
0
$0.00
0.00%
61314022705
165
$775.05
9.55%
50
$243.20
3.81%
61314022710
62
$401.20
3.59%
43
$281.60
3.27%
61314022715
25
$180.90
1.45%
26
$189.49
1.98%
61314022905
8
$35.25
0.46%
13
$80.55
0.99%
61314022910
21
$230.85
1.22%
14
$141.05
1.07%
61314022915
4
$56.40
0.23%
11
$147.00
0.84%
SOL 0.5% OP
Page 405 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. BETA - BLOCKERS
61314023805
CARTEOLOL
SOL OPHTH 1%
39
$558.39
2.26%
16
$278.60
1.22%
61314023810
CARTEOLOL
SOL OPHTH 1%
14
$404.40
0.81%
10
$297.96
0.76%
61314023815
CARTEOLOL
SOL OPHTH 1%
1
$30.85
0.06%
0
$0.00
0.00%
61314024501
BETAXOLOL
SOL 0.5% OP
1
$23.39
0.06%
1
$20.40
0.08%
61314024503
BETAXOLOL
SOL 0.5% OP
1
$33.35
0.06%
1
$40.38
0.08%
65086052205
BETIMOL
SOL 0.25%
4
$74.64
0.23%
3
$53.21
0.23%
65086052210
BETIMOL
SOL 0.25%
11
$311.20
0.64%
8
$216.48
0.61%
65086052215
BETIMOL
SOL 0.25%
3
$136.05
0.17%
1
$46.83
0.08%
65086052505
BETIMOL
SOL 0.5%
15
$334.38
0.87%
17
$399.80
1.29%
65086052510
BETIMOL
SOL 0.5%
15
$548.85
0.87%
18
$621.80
1.37%
65086052515
BETIMOL
SOL 0.5%
11
$586.89
0.64%
5
$274.37
0.38%
OP. CARBONIC ANHYDRASE INHIBITORS/COMBO
00006351903
TRUSOPT
SOL 2% OP
16
$530.30
1.34%
13
$371.13
1.19%
00006351910
TRUSOPT
SOL 2% OP
32
$1,515.96
2.68%
39
$1,794.16
3.56%
00006351935
TRUSOPT
SOL
92
$2,736.49
7.70%
63
$2,160.24
5.75%
00006351936
TRUSOPT
SOL
194
$9,976.24
16.23%
151
$7,895.29
13.78%
00006362803
COSOPT
SOL 2-0.5%OP
57
$2,696.72
4.77%
30
$1,467.13
2.74%
00006362810
COSOPT
SOL 2-0.5%OP
39
$2,674.48
3.26%
76
$5,430.89
6.93%
00006362835
COSOPT
SOL 2-0.5%OP
272
$12,678.00
22.76%
276
$13,042.25
25.18%
00006362836
COSOPT
SOL 2-0.5%OP
283
$23,815.21
23.68%
255
$23,201.53
23.27%
00065027505
AZOPT
SUS 1% OP
98
$3,085.02
8.20%
97
$3,228.22
8.85%
00065027510
AZOPT
SUS 1% OP
90
$5,127.69
7.53%
72
$4,317.78
6.57%
00065027515
AZOPT
SUS 1% OP
22
$1,762.86
1.84%
24
$2,263.25
2.19%
1
$22.22
0.57%
0
$0.00
0.00%
OP. CYCLOPLEGICS
00065035905
CYCLOMYDRIL SOL OP
Page 406 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. CYCLOPLEGICS
00065039605
CYCLOGYL
SOL 1% OP
4
$89.52
2.27%
5
$121.30
3.40%
00065039615
CYCLOGYL
SOL 1% OP
2
$60.87
1.14%
2
$77.23
1.36%
00065039705
CYCLOGYL
SOL 2% OP
1
$27.54
0.57%
0
$0.00
0.00%
00168006538
ATROPINE SUL OIN 1% OP
2
$11.26
1.14%
1
$5.63
0.68%
00168017215
ATROPINE SUL SOL 1% OP
4
$23.00
2.27%
2
$11.50
1.36%
00998030305
ISO ATROPINE SOL 1% OP
1
$19.88
0.57%
0
$0.00
0.00%
00998031505
ISO HOMATROP SOL 5% OP
5
$115.65
2.84%
5
$114.50
3.40%
00998033105
ISO HYOSCINE SOL 0.25% OP
20
$370.62
11.36%
4
$79.08
2.72%
00998033115
ISO HYOSCINE SOL 0.25% OP
1
$28.36
0.57%
5
$88.72
3.40%
00998035515
MYDRIACYL
0
$0.00
0.00%
1
$41.07
0.68%
17478010012
AK-PENTOLATE SOL 1% OP
0
$0.00
0.00%
3
$37.74
2.04%
17478010020
AK-PENTOLATE SOL 1% OP
1
$8.70
0.57%
1
$8.70
0.68%
24208058559
TROPICAMIDE SOL 1% OP
1
$4.75
0.57%
1
$4.75
0.68%
24208058564
TROPICAMIDE SOL 1% OP
0
$0.00
0.00%
1
$13.85
0.68%
24208073501
CYCLOPENTOL SOL 1% OP
2
$24.10
1.14%
7
$49.12
4.76%
24208073506
3
$26.53
1.70%
6
$47.18
4.08%
24208075006
40
$201.10
22.73%
29
$160.52
19.73%
24208075060
26
$100.40
14.77%
26
$96.85
17.69%
24208082555
12
$65.40
6.82%
8
$45.04
5.44%
52238091316
0
$0.00
0.00%
1
$3.25
0.68%
58768046705
HOMATROPINE SOL 5% OP
26
$348.86
14.77%
8
$98.59
5.44%
59390018650
1
$5.06
0.57%
0
$0.00
0.00%
61314030301
19
$69.11
10.80%
14
$53.10
9.52%
61314030302
1
$5.75
0.57%
9
$41.05
6.12%
61314039603
3
$17.09
1.70%
8
$55.00
5.44%
SOL 1% OP
OP. MIOTICS - DIRECT ACTING
Page 407 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. MIOTICS - DIRECT ACTING
00065021535
PILOPINE HS GEL 4% OP
16
$649.21
8.47%
13
$529.42
8.50%
00364713272
PILOCARPINE SOL 2% OP
1
$6.35
0.53%
4
$25.40
2.61%
00603724741
1
$5.75
0.53%
0
$0.00
0.00%
00603725341
5
$38.50
2.65%
0
$0.00
0.00%
00998020315
ISOPTO CARP SOL 1% OP
3
$72.18
1.59%
0
$0.00
0.00%
00998022315
ISO CARBACHO SOL 1.5% OP
00998022515
ISO CARBACHO SOL 3% OP
24208067615
3
$94.78
1.59%
1
$31.50
0.65%
11
$494.95
5.82%
9
$402.76
5.88%
4
$15.50
2.12%
12
$49.00
7.84%
24208068115
16
$69.75
8.47%
10
$37.40
6.54%
24208068615
18
$115.39
9.52%
31
$200.62
20.26%
24208080615
PILOCARPINE SOL 0.5% OP
13
$72.00
6.88%
4
$19.15
2.61%
52238075215
PILOPTIC-2 SOL 2% OP
2
$12.70
1.06%
0
$0.00
0.00%
58768051815
PILOCAR
1
$9.55
0.53%
0
$0.00
0.00%
61314020315
12
$50.65
6.35%
8
$36.00
5.23%
61314020415
35
$174.75
18.52%
32
$172.35
20.92%
61314020615
48
$336.41
25.40%
29
$196.55
18.95%
SOL 4% OP
OP. MISC
00023074501
LENS PLUS
SOL REWET DR
5
$168.40
3.85%
0
$0.00
0.00%
00023082512
LENS PLUS
SOL SALINE
1
$7.61
0.77%
0
$0.00
0.00%
00023916332
RESTASIS
34
$3,094.09
26.15%
63
$5,221.87
38.41%
00024135801
NEO-SYNEPHRI SOL 2.5% OP
1
$30.70
0.77%
0
$0.00
0.00%
00182169233
GENEYES
SOL 0.05% OP
0
$0.00
0.00%
1
$5.00
0.61%
00182702464
SOD CHLORIDE SOL 5% OP
1
$13.01
0.77%
0
$0.00
0.00%
00536041772
0
$0.00
0.00%
1
$5.38
0.61%
00904531435
1
$10.12
0.77%
4
$37.98
2.44%
00904531538
SOD CHLORIDE OIN 5% OP
2
$15.24
1.54%
0
$0.00
0.00%
EMU 0.05%
Page 408 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. MISC
00904537720
EYE WASH
SOL
0
$0.00
0.00%
2
$7.50
1.22%
00998034205
MYDFRIN
SOL 2.5% OP
0
$0.00
0.00%
1
$21.73
0.61%
17478020012
AK-DILATE
SOL 2.5% OP
0
$0.00
0.00%
2
$18.34
1.22%
17478062235
23
$302.56
17.69%
31
$439.40
18.90%
17478062312
22
$281.80
16.92%
23
$294.36
14.02%
24208027615
MURO 128
SOL 2% OP
1
$12.76
0.77%
3
$47.04
1.83%
24208027715
MURO 128
SOL 5% OP
4
$45.17
3.08%
2
$44.08
1.22%
24208027730
MURO 128
SOL 5% OP
1
$19.98
0.77%
0
$0.00
0.00%
24208038555
MURO 128
OIN 5% OP
21
$311.18
16.15%
14
$212.00
8.54%
24208038556
MURO 128
OIN 5% OP
2
$82.42
1.54%
3
$77.58
1.83%
24208041105
BRIMONIDINE SOL 0.2% OP
1
$28.96
0.77%
1
$31.76
0.61%
24208041110
1
$48.79
0.77%
3
$183.10
1.83%
24208072506
NAPHAZOLINE SOL 0.1% OP
2
$9.06
1.54%
0
$0.00
0.00%
24208074002
PHENYLEPHRIN SOL 2.5% OP
1
$6.95
0.77%
0
$0.00
0.00%
24208074059
PHENYLEPHRIN SOL 2.5% OP
1
$6.15
0.77%
0
$0.00
0.00%
37205052505
1
$10.38
0.77%
0
$0.00
0.00%
37205052683
4
$41.52
3.08%
8
$89.93
4.88%
61314014305
0
$0.00
0.00%
1
$31.76
0.61%
61314014310
0
$0.00
0.00%
1
$60.11
0.61%
OP. NSAID'S
00023218105
ACULAR
SOL 0.5% OP
53
$3,167.41
34.42%
44
$2,581.57
26.99%
00023218110
ACULAR
SOL 0.5% OP
9
$973.04
5.84%
4
$376.66
2.45%
00023927705
ACULAR LS
SOL 0.4%
2
$110.92
1.30%
3
$166.33
1.84%
11980080103
OCUFEN
SOL 0.03% OP
0
$0.00
0.00%
1
$18.26
0.61%
24208031425
FLURBIPROFEN SOL 0.03% OP
2
$24.16
1.30%
2
$19.54
1.23%
58768010002
VOLTAREN
13
$438.47
8.44%
21
$950.26
12.88%
SOL 0.1% OP
Page 409 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. NSAID'S
58768010005
VOLTAREN
SOL 0.1% OP
60758091003
FLURBIPROFEN SOL 0.03% OP
74
$3,867.59
48.05%
81
$4,520.90
49.69%
1
$12.83
0.65%
7
$77.39
4.29%
INJ 100UNIT
22
$26,456.83
88.00%
29
$30,681.00
87.88%
SOL OP
3
$58.35
12.00%
4
$76.28
12.12%
OP. OF INTEREST
00023114501
BOTOX
00065008315
ENUCLENE
OP. PROSTAGLANDINS
00013830301
XALATAN
SOL 0.005%
283
$14,380.34
10.24%
311
$16,504.47
11.03%
00013830304
XALATAN
SOL 0.005%
1,633
$80,989.62
59.08%
1,568
$82,854.45
55.62%
00023918703
LUMIGAN
SOL 0.03%
249
$13,948.51
9.01%
193
$10,567.89
6.85%
00023918705
LUMIGAN
SOL 0.03%
202
$21,435.78
7.31%
127
$14,182.36
4.51%
00023918707
LUMIGAN
SOL 0.03%
0
$0.00
0.00%
1
$159.20
0.04%
00065026617
TRAVATAN
SOL 0.004%
7
$642.63
0.25%
15
$1,594.38
0.53%
00065026625
TRAVATAN
SOL 0.004%
363
$19,838.59
13.13%
563
$31,704.52
19.97%
00065026634
TRAVATAN
SOL 0.004%
0
$0.00
0.00%
33
$3,376.07
1.17%
58768096105
RESCULA
SOL 0.15%
27
$1,260.32
0.98%
8
$361.96
0.28%
OP. QUINOLONES
00065065435
CILOXAN
OIN 0.3% OP
24
$1,486.44
2.91%
51
$3,336.09
6.38%
00065065605
CILOXAN
SOL 0.3% OP
329
$14,449.35
39.83%
30
$1,392.87
3.75%
00065065610
CILOXAN
SOL 0.3% OP
2
$174.18
0.24%
8
$695.80
1.00%
00065065625
CILOXAN
SOL 0.3% OP
34
$824.71
4.12%
1
$24.49
0.13%
00065401303
VIGAMOX
DRO 0.5%
291
$13,158.39
35.23%
652
$31,057.51
81.50%
11980077905
OCUFLOX
SOL 0.3% OP
118
$4,888.58
14.29%
29
$1,346.29
3.63%
11980077910
OCUFLOX
SOL 0.3% OP
16
$1,158.97
1.94%
10
$821.50
1.25%
50383002405
OFLOXACIN
SOL 0.3%
0
$0.00
0.00%
1
$37.14
0.13%
Page 410 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OP. QUINOLONES
50383002410
OFLOXACIN
SOL 0.3%
0
$0.00
0.00%
60505056000
OFLOXACIN
SOL 0.3%
0
$0.00
0.00%
61314001205
OFLOXACIN
SOL 0.3%
0
$0.00
0.00%
65086013505
QUIXIN
12
$442.74
1.45%
SOL 0.5%
1
$75.82
0.13%
3
$90.00
0.38%
12
$456.98
1.50%
2
$77.04
0.25%
OP. SELECTIVE ALPHA ADRENERGIC AGONISTS
00023866505
ALPHAGAN
SOL 0.2% OP
1
$34.91
0.08%
1
$34.19
0.10%
00023866510
ALPHAGAN
SOL 0.2% OP
1
$66.41
0.08%
2
$124.94
0.19%
00023866515
ALPHAGAN
SOL 0.2% OP
1
$95.50
0.08%
0
$0.00
0.00%
00023917705
ALPHAGAN P SOL 0.15%
750
$28,111.17
56.82%
651
$26,165.33
62.90%
00023917710
469
$33,037.56
35.53%
316
$23,953.33
30.53%
00023917715
92
$9,514.61
6.97%
65
$7,793.51
6.28%
00065066505
IOPIDINE
6
$371.60
0.45%
0
$0.00
0.00%
SOL 0.5% OP
OSTEOPOROSIS
00002416502
EVISTA
TAB 60MG
406
$26,422.63
3.73%
244
$17,766.37
2.16%
00002416530
EVISTA
TAB 60MG
370
$24,924.26
3.40%
256
$17,758.11
2.27%
00002897101
FORTEO
SOL 750/3ML
24
$13,016.35
0.22%
50
$27,623.69
0.44%
00006003121
FOSAMAX
TAB 70MG
310
$18,465.50
2.85%
311
$18,894.06
2.75%
00006003144
FOSAMAX
TAB 70MG
4,441
$284,322.61
40.77%
4,641
$314,530.36
41.09%
00006007721
FOSAMAX
TAB 35MG
9
$585.42
0.08%
6
$404.82
0.05%
00006007744
FOSAMAX
TAB 35MG
286
$18,338.34
2.63%
334
$23,781.10
2.96%
00006092531
FOSAMAX
TAB 5MG
43
$2,910.36
0.39%
25
$1,744.09
0.22%
00006092558
FOSAMAX
TAB 5MG
15
$1,172.83
0.14%
13
$923.81
0.12%
00006093631
FOSAMAX
TAB 10MG
143
$9,112.75
1.31%
106
$6,729.27
0.94%
00006093658
FOSAMAX
TAB 10MG
155
$9,996.46
1.42%
102
$6,667.59
0.90%
00006383334
FOSAMAX
SOL
0
$0.00
0.00%
23
$1,316.16
0.20%
Page 411 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
OSTEOPOROSIS
00078031154
MIACALCIN SPR 200/ACT
0
$0.00
0.00%
1,048
$79,685.85
9.28%
00078031190
MIACALCIN SPR 200/ACT
1,228
$70,940.76
11.27%
23
$1,567.67
0.20%
00149040560
DIDRONEL
TAB 200MG
17
$2,032.32
0.16%
7
$259.06
0.06%
00149040660
DIDRONEL
TAB 400MG
27
$2,200.50
0.25%
18
$1,359.50
0.16%
00149047001
ACTONEL
TAB 30MG
363
$25,027.07
3.33%
297
$22,481.73
2.63%
00149047101
ACTONEL
TAB 5MG
00149047201
ACTONEL
TAB 35MG
152
$10,424.19
1.40%
105
$7,736.89
0.93%
2,905
$177,273.13
26.67%
3,687
$234,037.86
32.64%
Other Antihistamines
00054819004
DIPHENHYDRAM ELX 12.5/5ML
2
$9.98
0.05%
0
$0.00
0.00%
00085000902
CHLOR-TRIMET TAB 12MG CR
1
$19.53
0.02%
0
$0.00
0.00%
00085000903
8
$135.35
0.19%
0
$0.00
0.00%
00085000909
5
$79.11
0.12%
0
$0.00
0.00%
00085008001
CHLOR-TRIMET TAB 4MG
1
$8.37
0.02%
0
$0.00
0.00%
00085008002
CHLOR-TRIMET TAB 4MG
1
$6.53
0.02%
0
$0.00
0.00%
00085037409
10
$177.07
0.24%
0
$0.00
0.00%
00093030801
CLEMASTINE TAB 2.68MG
244
$3,723.40
5.79%
220
$3,476.65
5.79%
00093030912
CLEMASTINE SYP 0.67/5ML
39
$1,173.83
0.93%
51
$1,383.57
1.34%
00121048905
2
$9.98
0.05%
1
$7.46
0.03%
00172292960
CYPROHEPTAD TAB 4MG
173
$2,567.57
4.11%
148
$2,262.80
3.89%
00172292980
CYPROHEPTAD TAB 4MG
15
$158.33
0.36%
16
$167.46
0.42%
00182047101
CHLORPHENIR TAB 4MG
41
$130.23
0.97%
36
$107.48
0.95%
00182047110
CHLORPHENIR TAB 4MG
32
$71.07
0.76%
16
$39.37
0.42%
00182049210
DIPHENHYDRAM CAP 25MG
385
$1,380.92
9.14%
480
$1,643.82
12.63%
00182113289
CYPROHEPTAD TAB 4MG
4
$25.72
0.09%
0
$0.00
0.00%
00182200137
GENAHIST
ELX 12.5/5ML
10
$49.90
0.24%
0
$0.00
0.00%
00182209201
GENAHIST
CAP 25MG
0
$0.00
0.00%
14
$47.58
0.37%
Page 412 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00182616837
HYDRAMINE
ELX 12.5/5ML
00182616840
HYDRAMINE
ELX 12.5/5ML
00185064801
00185064810
00185064901
$4.97
0.02%
$0.00
0.00%
14
$86.76
0.33%
245
$1,337.77
5.81%
2
$8.23
0.05%
214
$1,163.02
5.63%
143
$627.12
3.39%
45
$166.67
1.18%
74
$348.37
1.76%
69
$296.26
1.82%
00185064910
83
00247082814
1
$404.35
1.97%
24
$128.64
0.63%
$29.18
0.02%
0
$0.00
0.00%
00472123216
HYDRAMINE
1
$1.59
0.02%
0
$0.00
0.00%
00536037097
ALLER-CHLOR SYP 2MG/5ML
6
$47.09
0.14%
0
$0.00
0.00%
00536077085
00536077097
DIPHENHIST ELX 12.5/5ML
36
$229.88
0.85%
63
$352.89
1.66%
DIPHENHIST ELX 12.5/5ML
12
$62.18
0.28%
8
$46.80
0.21%
00536359401
DIPHENHIST CAP 25MG
28
$144.30
0.66%
14
$74.59
0.37%
00555005902
618
$2,496.97
14.67%
330
$1,452.98
8.68%
00555005905
120
$513.19
2.85%
88
$380.61
2.32%
00573270020
ALAVERT
0
$0.00
0.00%
51
$764.84
1.34%
00591400901
DEXCHLOR
1
$30.10
0.02%
0
$0.00
0.00%
00603082358
Q-DRYL
ELX 12.5/5ML
1
$4.51
0.02%
4
$32.04
0.11%
00603082394
Q-DRYL
ELX 12.5/5ML
5
$17.41
0.12%
8
$59.56
0.21%
00603109654
1
$39.23
0.02%
2
$35.40
0.05%
00603278421
CHLORPHENIR CAP 8MG ER
33
$246.04
0.78%
36
$235.87
0.95%
00603278432
5
$39.80
0.12%
0
$0.00
0.00%
00603278521
CHLORPHENIR CAP 12MG TR
39
$217.85
0.93%
32
$211.27
0.84%
00603278532
9
$55.90
0.21%
1
$8.45
0.03%
00603333721
131
$771.22
3.11%
170
$994.28
4.47%
00603333732
17
$63.03
0.40%
1
$1.18
0.03%
00603333821
1
$0.91
0.02%
213
$863.96
5.61%
00603333832
168
$804.61
3.99%
141
$673.43
3.71%
SYP 12.5/5ML
SYP
TAB 6MG CR
1
0
Page 413 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00641037625
DIPHENHYDRAM INJ 50MG/ML
25
$294.16
0.59%
19
$310.69
0.50%
00677168701
CHLORPHENIR TAB 4MG
36
$96.75
0.85%
29
$68.15
0.76%
00677168710
CHLORPHENIR TAB 4MG
40
$61.24
0.95%
13
$26.79
0.34%
00677185801
DIPHENHYDRAM TAB 25MG
1
$0.59
0.02%
3
$5.80
0.08%
00781114801
CHLORPHENIR TAB 4MG
2
$3.04
0.05%
0
$0.00
0.00%
00781135801
382
$6,890.30
9.07%
287
$5,215.27
7.55%
00781135901
311
$4,755.01
7.38%
218
$3,359.80
5.74%
00904001224
ALLERGY
TAB 4MG
0
$0.00
0.00%
1
$2.90
0.03%
00904001259
ALLERGY
TAB 4MG
6
$28.32
0.14%
1
$4.38
0.03%
00904001280
ALLERGY
TAB 4MG
6
$16.56
0.14%
5
$10.19
0.13%
00904114560
CYPROHEPTAD TAB 4MG
0
$0.00
0.00%
4
$108.21
0.11%
00904122800
BANOPHEN
ELX 12.5/5ML
5
$24.95
0.12%
5
$22.86
0.13%
00904122820
BANOPHEN
ELX 12.5/5ML
0
$0.00
0.00%
2
$5.67
0.05%
00904203559
3
$15.27
0.07%
4
$22.88
0.11%
00904205560
1
$2.98
0.02%
0
$0.00
0.00%
00904205661
0
$0.00
0.00%
1
$4.15
0.03%
00904517416
BANOPHEN
4
$25.83
0.09%
2
$9.29
0.05%
00904530660
92
$322.14
2.18%
38
$162.12
1.00%
00904530661
5
$19.69
0.12%
0
$0.00
0.00%
00904530680
46
$161.72
1.09%
29
$90.39
0.76%
00904530760
12
$50.28
0.28%
38
$141.01
1.00%
00904530780
12
$42.13
0.28%
7
$20.55
0.18%
00904555124
BANOPHEN
0
$0.00
0.00%
1
$3.49
0.03%
10135013310
ALLERGY
TAB 4MG
2
$3.26
0.05%
2
$3.26
0.05%
10135013324
ALLERGY
TAB 4MG
4
$8.80
0.09%
2
$8.76
0.05%
10135014910
0
$0.00
0.00%
38
$92.54
1.00%
10135016613
0
$0.00
0.00%
1
$3.02
0.03%
LIQ 12.5/5
TAB 25MG
Page 414 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
10267083601
4
$22.00
0.09%
1
$3.39
0.03%
11822304090
RA ALLERGY CAP 25MG
4
$16.13
0.09%
12
$56.33
0.32%
11822319830
LORATADINE SYP
0
$0.00
0.00%
5
$49.76
0.13%
17236051601
19
$77.16
0.45%
6
$35.77
0.16%
17236051610
32
$125.51
0.76%
50
$211.45
1.32%
17236051801
3
$21.55
0.07%
29
$126.58
0.76%
17236051810
1
$0.90
0.02%
16
$92.22
0.42%
17236090510
0
$0.00
0.00%
3
$10.12
0.08%
17714001601
C.P.M.
TAB 4MG
1
$3.72
0.02%
0
$0.00
0.00%
17714002010
3
$5.68
0.07%
1
$1.28
0.03%
17714002101
1
$3.44
0.02%
0
$0.00
0.00%
17714002110
27
$82.89
0.64%
16
$42.48
0.42%
24385037926
DIPHEDRYL
ELX 12.5/5ML
1
$5.41
0.02%
3
$15.14
0.08%
24385047978
DIPHEDRYL
TAB 25MG
0
$0.00
0.00%
1
$2.90
0.03%
37205021562
ALLERGY
TAB 4MG
4
$15.01
0.09%
2
$2.72
0.05%
37205021578
ALLERGY
TAB 4MG
13
$44.61
0.31%
12
$35.43
0.32%
37205027062
COMP ALLERGY TAB 25MG
2
$10.25
0.05%
0
$0.00
0.00%
37205027078
COMP ALLERGY TAB 25MG
4
$8.14
0.09%
1
$2.19
0.03%
37205027762
COMP ALLERGY CAP 25MG
3
$11.59
0.07%
0
$0.00
0.00%
37205027778
COMP ALLERGY CAP 25MG
12
$44.10
0.28%
16
$62.37
0.42%
37205037826
ALLERGY RELF SYP CHILD
0
$0.00
0.00%
4
$74.45
0.11%
37205056526
COMP ALLERGY ELX 12.5/5ML
14
$55.51
0.33%
16
$92.97
0.42%
37205056534
COMP ALLERGY ELX 12.5/5ML
3
$15.66
0.07%
4
$22.85
0.11%
49348004534
VALU-DRYL
0
$0.00
0.00%
2
$9.98
0.05%
49348063634
SM LORATADIN SYP 5MG/5ML
0
$0.00
0.00%
27
$252.20
0.71%
49483004101
42
$247.58
1.00%
25
$144.18
0.66%
49483004301
3
$17.85
0.07%
2
$11.90
0.05%
ELX 12.5/5ML
Page 415 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
49884004301
CYPROHEPTAD TAB 4MG
49884004310
CYPROHEPTAD TAB 4MG
50111031401
CYPROHEPTAD TAB 4MG
50111031403
CYPROHEPTAD TAB 4MG
50428215046
$211.20
0.55%
$37.90
0.05%
2
$32.90
0.05%
166
$2,255.78
3.94%
0
$0.00
0.00%
150
$2,313.45
3.95%
14
$239.57
0.33%
10
$178.50
0.26%
CVS ALLERGY TAB 4MG
1
$1.19
0.02%
0
$0.00
0.00%
50428244958
CVS ALLERGY CAP 25MG
0
50428599035
CVS ALLERGY CAP 25MG
0
$0.00
0.00%
3
$21.78
0.08%
$0.00
0.00%
1
$1.09
0.03%
50428955724
CVS DAYHIST TAB 1.34MG
0
$0.00
0.00%
2
$13.74
0.05%
50844019016
1
$1.45
0.02%
3
$5.80
0.08%
50844029016
0
$0.00
0.00%
64
$257.42
1.68%
51079006620
1
$1.65
0.02%
0
$0.00
0.00%
51079016320
CHLORPHENIR TAB 4MG
4
$9.48
0.09%
0
$0.00
0.00%
51079096720
1
$6.67
0.02%
0
$0.00
0.00%
52735040101
ALLERGY
3
$7.68
0.07%
0
$0.00
0.00%
52735040241
CHILD ALLERG ELX 12.5/5ML
0
$0.00
0.00%
3
$16.62
0.08%
53746003701
CHLORPHENIR TAB 4MG
1
$1.36
0.02%
3
$4.75
0.08%
53807016001
0
$0.00
0.00%
1
$3.79
0.03%
53807020404
DIPHENHYDRAM LIQ 12.5/5ML
0
$0.00
0.00%
2
$5.53
0.05%
53807020408
DIPHENHYDRAM LIQ 12.5/5ML
0
$0.00
0.00%
1
$3.80
0.03%
54499029501
CHLOR-TABLET TAB 4MG
0
$0.00
0.00%
1
$2.98
0.03%
54838013580
SILADRYL SA ELX 12.5/5ML
0
$0.00
0.00%
4
$18.76
0.11%
59390006546
ALTARYL
SYP 12.5/5ML
1
$4.35
0.02%
0
$0.00
0.00%
59606027720
ALLERGY MED CAP 25MG
3
$12.93
0.07%
0
$0.00
0.00%
60432003304
DIPHEN AF
SYP 12.5/5ML
2
$9.98
0.05%
7
$34.87
0.18%
60432003316
DIPHEN AF
SYP 12.5/5ML
24
$128.04
0.57%
4
$15.21
0.11%
60432073204
2
$35.13
0.05%
0
$0.00
0.00%
60505035700
2
$43.32
0.05%
1
$21.97
0.03%
TAB 4MG
23
2
Page 416 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
61073002604
DIPHENHYDRAM LIQ 12.5MG/5
1
$4.17
0.02%
2
61646031101
1
$6.27
0.02%
61646031201
0
$0.00
0.00%
63323066401
DIPHENHYDRAM INJ 50MG/ML
1
$541.68
65162051611
0
66375010601
CHLORPHENIR TAB 4MG
66424002010
66424002101
$13.48
0.05%
0
$0.00
0.00%
7
$34.43
0.18%
0.02%
0
$0.00
0.00%
$0.00
0.00%
2
$8.86
0.05%
2
$10.80
0.05%
4
$8.28
0.11%
0
$0.00
0.00%
16
$66.37
0.42%
1
$7.47
0.02%
5
$20.14
0.13%
PARKINSONS - ANTICHOLINERGICS
00006327516
COGENTIN
INJ 1MG/ML
1
$3.80
0.02%
0
$0.00
0.00%
00006327538
COGENTIN
INJ 1MG/ML
0
$0.00
0.00%
1
$10.34
0.02%
00121065816
TRIHEXYPHEN ELX 0.4MG/ML
7
$137.55
0.17%
6
$105.76
0.14%
00143176301
TRIHEXYPHEN TAB 5MG
15
$291.39
0.36%
6
$61.99
0.14%
00143176310
TRIHEXYPHEN TAB 5MG
7
$69.53
0.17%
3
$143.52
0.07%
00143176401
TRIHEXYPHEN TAB 2MG
39
$426.42
0.93%
28
$311.21
0.66%
00143176410
TRIHEXYPHEN TAB 2MG
75
$769.13
1.79%
89
$796.33
2.08%
00182129989
BENZTROPINE TAB 0.5MG
2
$3.55
0.05%
4
$11.65
0.09%
00182170089
BENZTROPINE TAB 1MG
3
$8.64
0.07%
3
$4.32
0.07%
00182170189
BENZTROPINE TAB 2MG
6
$50.16
0.14%
3
$16.95
0.07%
00364040801
TRIHEXYPHEN TAB 2MG
39
$369.83
0.93%
27
$242.71
0.63%
00364040802
TRIHEXYPHEN TAB 2MG
2
$8.48
0.05%
0
$0.00
0.00%
00364040901
TRIHEXYPHEN TAB 5MG
4
$58.48
0.10%
3
$43.86
0.07%
00364040902
TRIHEXYPHEN TAB 5MG
4
$45.34
0.10%
20
$244.84
0.47%
00364040990
TRIHEXYPHEN TAB 5MG
6
$132.60
0.14%
0
$0.00
0.00%
00591533501
TRIHEXYPHEN TAB 2MG
250
$2,480.06
5.96%
232
$2,244.48
5.43%
00591533510
TRIHEXYPHEN TAB 2MG
315
$3,089.76
7.51%
285
$2,942.13
6.68%
Page 417 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00591533701
TRIHEXYPHEN TAB 5MG
214
$2,183.92
5.10%
213
$2,005.04
4.99%
00591533710
TRIHEXYPHEN TAB 5MG
20
$280.50
0.48%
15
$205.18
0.35%
00603624021
TRIHEXYPHEN TAB 2MG
24
$198.77
0.57%
4
$21.22
0.09%
00603624032
TRIHEXYPHEN TAB 2MG
0
$0.00
0.00%
7
$46.70
0.16%
00603624121
TRIHEXYPHEN TAB 5MG
5
$73.56
0.12%
5
$66.90
0.12%
00832108000
57
$278.05
1.36%
67
$287.68
1.57%
00832108100
BENZTROPINE TAB 1MG
108
$441.04
2.58%
143
$614.36
3.35%
00832108110
BENZTROPINE TAB 1MG
108
$538.01
2.58%
46
$220.94
1.08%
00832108200
BENZTROPINE TAB 2MG
29
$301.76
0.69%
51
$538.59
1.19%
00832108210
BENZTROPINE TAB 2MG
3
$16.95
0.07%
3
$16.95
0.07%
00904105560
30
$130.67
0.72%
6
$21.60
0.14%
00904105561
1
$2.70
0.02%
0
$0.00
0.00%
00904105660
BENZTROPINE TAB 1MG
7
$40.39
0.17%
10
$50.86
0.23%
00904105680
BENZTROPINE TAB 1MG
5
$30.85
0.12%
26
$121.60
0.61%
00904105760
BENZTROPINE TAB 2MG
6
$67.60
0.14%
12
$132.44
0.28%
00904105780
BENZTROPINE TAB 2MG
6
$92.10
0.14%
0
$0.00
0.00%
49884016401
410
$2,056.03
9.78%
453
$2,092.75
10.61%
49884016501
BENZTROPINE TAB 1MG
346
$1,585.15
8.25%
306
$1,401.75
7.17%
49884016510
BENZTROPINE TAB 1MG
446
$2,428.64
10.64%
371
$1,824.21
8.69%
49884016601
BENZTROPINE TAB 2MG
120
$1,151.66
2.86%
119
$1,108.44
2.79%
49884016610
BENZTROPINE TAB 2MG
145
$1,716.01
3.46%
309
$3,366.66
7.24%
49884069301
AKINETON
69
$1,903.41
1.65%
60
$1,802.55
1.41%
50111039301
240
$1,012.57
5.72%
277
$1,180.24
6.49%
50111039401
BENZTROPINE TAB 1MG
578
$2,354.53
13.78%
495
$2,035.11
11.60%
50111039403
BENZTROPINE TAB 1MG
91
$509.15
2.17%
129
$691.14
3.02%
50111039501
BENZTROPINE TAB 2MG
168
$1,846.68
4.01%
126
$1,342.93
2.95%
50111039503
BENZTROPINE TAB 2MG
78
$684.14
1.86%
46
$501.99
1.08%
TAB 2MG
Page 418 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
BENZTROPINE TAB 1MG
52544057501
TRIHEXYPHEN TAB 2MG
61570005901
KEMADRIN
63739003301
$
Market Share*
51079022120
# of Scripts
0
$0.00
0.00%
13
$51.99
0.30%
2
$17.00
0.05%
0
$0.00
0.00%
13
$464.32
0.31%
8
$192.38
0.19%
0
$0.00
0.00%
3
$22.20
0.07%
64980011101
3
$4.05
0.07%
3
$16.62
0.07%
64980011201
BENZTROPINE TAB 1MG
0
$0.00
0.00%
22
$95.92
0.52%
64980011210
BENZTROPINE TAB 1MG
86
$423.01
2.05%
124
$506.82
2.90%
64980011310
BENZTROPINE TAB 2MG
0
$0.00
0.00%
87
$701.16
2.04%
TAB 5MG
PARKINSONS - COMT INHIBITORS
00004592001
TASMAR
TAB 100MG
3
$794.94
2.68%
3
$877.20
2.46%
00078032705
COMTAN
TAB 200MG
109
$14,311.09
97.32%
119
$17,983.44
97.54%
PARKINSONS - SELECTED DOPAMIN AGONISTS
00007489020
REQUIP
TAB 0.25MG
52
$5,549.93
5.50%
57
$5,106.91
5.34%
00007489120
REQUIP
TAB 0.5MG
73
$7,071.46
7.72%
70
$6,608.50
6.55%
00007489214
REQUIP
TAB 1MG
0
$0.00
0.00%
1
$26.77
0.09%
00007489220
REQUIP
TAB 1MG
57
$7,795.47
6.03%
64
$6,404.27
5.99%
00007489320
REQUIP
TAB 2MG
36
$3,918.17
3.81%
27
$3,129.07
2.53%
00007489420
REQUIP
TAB 5MG
6
$1,297.59
0.63%
9
$1,118.44
0.84%
00007489520
REQUIP
TAB 3MG
8
$1,200.73
0.85%
13
$2,407.92
1.22%
00007489620
REQUIP
TAB 4MG
3
$433.38
0.32%
3
$575.41
0.28%
00009000202
MIRAPEX
TAB 0.125MG
188
$12,114.08
19.89%
26
$1,111.26
2.43%
00009000402
MIRAPEX
TAB 0.25MG
176
$11,222.80
18.62%
32
$1,798.33
3.00%
00009000602
MIRAPEX
TAB 1MG
33
$5,111.42
3.49%
5
$340.55
0.47%
00009000802
MIRAPEX
TAB 0.5MG
122
$16,555.24
12.91%
38
$3,710.64
3.56%
00009003702
MIRAPEX
TAB 1.5MG
17
$2,174.95
1.80%
3
$423.85
0.28%
Page 419 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
PARKINSONS - SELECTED DOPAMIN AGONISTS
00093715901
PERGOLIDE
TAB 0.25MG
57
00093716001
PERGOLIDE
TAB 0.05MG
00093716101
PERGOLIDE
TAB 1MG
00172452060
PERGOLIDE
00172452260
PERGOLIDE
00597008353
MIRAPEX
00597008490
MIRAPEX
00597008590
$9,056.86
6.03%
13
$706.91
1.22%
20
$1,996.34
2.12%
41
$12,252.80
4.34%
1
$29.75
0.09%
9
$425.65
0.84%
TAB 0.05MG
3
$315.19
0.32%
0
$0.00
0.00%
TAB 1MG
2
$361.62
0.21%
8
$558.55
0.75%
TAB 0.125MG
TAB 0.25MG
0
$0.00
0.00%
185
$12,775.31
17.32%
0
$0.00
0.00%
252
$21,192.98
23.60%
MIRAPEX
TAB 0.5MG
0
$0.00
0.00%
118
$18,115.11
11.05%
00597009090
MIRAPEX
TAB 1MG
0
$0.00
0.00%
43
$6,507.13
4.03%
00597009190
59075061530
MIRAPEX
TAB 1.5MG
0
$0.00
0.00%
21
$3,113.37
1.97%
PERMAX
TAB 0.05MG
9
$1,100.00
0.95%
2
$388.58
0.19%
59075062510
PERMAX
TAB 0.25MG
24
$3,474.18
2.54%
13
$2,412.66
1.22%
59075063010
PERMAX
TAB 1MG
7
$1,685.35
0.74%
0
$0.00
0.00%
65234002430
PERMAX
TAB 0.05MG
0
$0.00
0.00%
6
$1,037.08
0.56%
65234002510
PERMAX
TAB 0.25MG
0
$0.00
0.00%
26
$4,455.57
2.43%
65234002610
PERMAX
TAB 1MG
11
$2,220.47
1.16%
23
$9,613.40
2.15%
1
$43.23
0.07%
0
$0.00
0.00%
12
$380.60
0.89%
20
$548.38
1.59%
146
$1,798.93
11.58%
PLATELET AGGR. INHIBITORS / COMBO'S - MISC.
00039007810
TRENTAL
00093015401
TICLOPIDINE TAB 250MG
00093511601
PENTOXIFYLLI TAB 400MG ER
207
$2,596.24
15.29%
00093511605
9
$119.96
0.66%
0
$0.00
0.00%
00185011560
9
$324.07
0.66%
12
$288.02
0.95%
00228261196
35
$468.02
2.58%
25
$363.64
1.98%
00228261311
11
$273.49
0.81%
5
$101.74
0.40%
00228274711
5
$71.35
0.37%
12
$138.45
0.95%
00228274750
17
$210.76
1.26%
0
$0.00
0.00%
TAB 400MG CR
Page 420 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
PLATELET AGGR. INHIBITORS / COMBO'S - MISC.
00228276950
25
$321.11
1.85%
14
$198.79
1.11%
00228276996
5
$66.80
0.37%
19
$233.73
1.51%
00245002715
PENTOXIL
0
$0.00
0.00%
3
$45.15
0.24%
00378035701
47
$633.48
3.47%
56
$761.69
4.44%
00378035705
0
$0.00
0.00%
2
$24.45
0.16%
00597000160
AGGRENOX
423
$42,843.39
31.24%
410
$43,347.84
32.51%
00904544840
4
$50.20
0.30%
0
$0.00
0.00%
17236086201
PENTOXIFYLLI TAB 400MG CR
2
$17.30
0.15%
0
$0.00
0.00%
49884059902
7
$259.55
0.52%
9
$178.20
0.71%
50111060901
2
$30.10
0.15%
0
$0.00
0.00%
54092006301
AGRYLIN
CAP 0.5MG
8
$4,802.66
0.59%
16
$6,517.19
1.27%
54092006401
AGRYLIN
CAP 1MG
5
$3,962.97
0.37%
8
$6,083.33
0.63%
59148000216
PLETAL
TAB 100MG
294
$27,785.96
21.71%
317
$31,839.43
25.14%
59148000235
PLETAL
TAB 100MG
2
$200.88
0.15%
0
$0.00
0.00%
59148000316
PLETAL
TAB 50MG
63
$5,459.79
4.65%
27
$2,129.07
2.14%
60505002702
1
$105.25
0.07%
0
$0.00
0.00%
60505002704
69
$2,670.91
5.10%
47
$1,479.87
3.73%
60505002707
3
$54.75
0.22%
0
$0.00
0.00%
60505003306
35
$464.87
2.58%
54
$669.80
4.28%
60505003307
53
$669.70
3.91%
35
$482.09
2.78%
66993000860
CILOSTAZOL TAB 50MG
0
$0.00
0.00%
2
$187.80
0.16%
66993000960
CILOSTAZOL TAB 100MG
0
$0.00
0.00%
22
$1,978.11
1.74%
TAB 400MG CR
CAP 25-200MG
PLATELET AGGREGATION INHIBITORS
00555025202
DIPYRIDAMOLE TAB 25MG
11
$246.82
0.25%
9
$205.08
0.17%
00555025204
6
$186.90
0.13%
5
$101.20
0.10%
00555025205
6
$96.43
0.13%
27
$260.53
0.52%
Page 421 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
PLATELET AGGREGATION INHIBITORS
00555028502
14
$738.39
0.31%
16
$825.25
0.31%
00555028505
11
$147.09
0.25%
6
$54.59
0.11%
00555028602
9
$55.03
0.20%
5
$36.83
0.10%
00555028605
0
$0.00
0.00%
2
$11.32
0.04%
63653117101
PLAVIX
TAB 75MG
2,356
$249,465.10
52.84%
2,686
$302,243.46
51.28%
63653117103
PLAVIX
TAB 75MG
26
$2,937.36
0.58%
29
$3,306.09
0.55%
63653117105
PLAVIX
TAB 75MG
428
$44,819.84
9.60%
513
$54,185.57
9.79%
63653117106
PLAVIX
TAB 75MG
1,592
$173,542.38
35.70%
1,940
$237,016.06
37.04%
PPI/NSAID Combo
00300154530
PREVACID NAP KIT 375MG
0
$0.00
0.00%
34
$3,710.56
17.62%
00300154607
0
$0.00
0.00%
3
$347.88
1.55%
00300154630
0
$0.00
0.00%
156
$16,872.19
80.83%
00009006404
PROVERA
2
$23.89
0.15%
0
$0.00
0.00%
00032170801
PROMETRIUM CAP 100MG
138
$4,240.04
10.16%
97
$2,884.70
8.43%
00032171101
PROMETRIUM CAP 200MG
74
$2,604.78
5.45%
16
$620.51
1.39%
00046089401
AYGESTIN
0
$0.00
0.00%
1
$37.50
0.09%
00364668354
PROGESTERONE INJ 50MG/ML
1
$34.56
0.07%
0
$0.00
0.00%
00555021110
NORETHIN ACE TAB 5MG
119
$6,093.78
8.76%
99
$5,129.65
8.61%
00555077902
MEDROXYPR AC TAB 10MG
187
$702.39
13.77%
124
$1,086.88
10.78%
00555077904
38
$252.50
2.80%
28
$650.99
2.43%
00555087202
MEDROXYPR AC TAB 2.5MG
96
$539.93
7.07%
35
$230.75
3.04%
00555087204
28
$158.50
2.06%
24
$140.32
2.09%
00555087302
73
$370.81
5.38%
48
$231.57
4.17%
00555087304
2
$11.76
0.15%
5
$18.10
0.43%
PROGESTINS
TAB 2.5MG
TAB 5MG
Page 422 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
PROGESTINS
00574043000
PROGESTERONE POW MICRONIZ
1
$9.22
0.07%
3
00574043001
1
$32.41
0.07%
00574043010
0
$0.00
0.00%
00677080301
5
$35.45
00832008725
5
38779004309
51285054102
51285054202
$62.64
0.26%
0
$0.00
0.00%
1
$38.75
0.09%
0.37%
0
$0.00
0.00%
$22.75
0.37%
0
$0.00
0.00%
0
$0.00
0.00%
1
$18.70
0.09%
8
$49.26
0.59%
0
$0.00
0.00%
13
$34.25
0.96%
0
$0.00
0.00%
51285054204
2
$5.70
0.15%
0
$0.00
0.00%
59762374001
145
$884.88
10.68%
154
$879.10
13.39%
59762374005
23
$109.37
1.69%
11
$51.55
0.96%
59762374101
70
$373.29
5.15%
101
$492.16
8.78%
59762374104
8
$34.13
0.59%
1
$7.55
0.09%
59762374202
285
$1,230.77
20.99%
375
$4,217.46
32.61%
59762374208
31
$98.80
2.28%
26
$205.95
2.26%
59911589401
AYGESTIN
1
$41.65
0.07%
0
$0.00
0.00%
63323026110
PROGESTERONE INJ 50MG/ML
2
$196.80
0.15%
0
$0.00
0.00%
TAB 5MG
PSYCHOTHERAPEUTIC COMBINATION
00002323130
SYMBYAX
CAP 6-25MG
0
$0.00
0.00%
5
$149.40
3.91%
00002323230
SYMBYAX
CAP 12-25MG
0
$0.00
0.00%
2
$89.82
1.56%
00002323330
SYMBYAX
CAP 6-50MG
0
$0.00
0.00%
5
$173.64
3.91%
00002323430
SYMBYAX
CAP 12-50MG
0
$0.00
0.00%
2
$62.70
1.56%
00378004201
PERPHEN/AMIT TAB 4-10MG
6
$19.27
4.92%
3
$7.86
2.34%
00378007301
1
$22.73
0.82%
4
$121.04
3.13%
00378021101
CDP/AMITRIP TAB 5-12.5MG
12
$743.00
9.84%
11
$607.15
8.59%
00378027701
CDP/AMITRIP TAB 10-25MG
14
$665.81
11.48%
14
$1,402.80
10.94%
Page 423 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
PSYCHOTHERAPEUTIC COMBINATION
00378027705
CDP/AMITRIP TAB 10-25MG
4
$95.11
3.28%
0
$0.00
0.00%
00378033001
19
$87.38
15.57%
12
$59.05
9.38%
00378033005
0
$0.00
0.00%
1
$5.11
0.78%
00378044201
43
$281.51
35.25%
54
$376.48
42.19%
00378057401
12
$205.13
9.84%
14
$296.89
10.94%
00378057405
3
$77.37
2.46%
1
$25.79
0.78%
00781127305
3
$18.18
2.46%
0
$0.00
0.00%
52544070601
5
$43.04
4.10%
0
$0.00
0.00%
PULMONARY ANTI-HYPERTENSIVES
00173051700
FLOLAN
INJ 0.5MG
0
$0.00
0.00%
3
$2,826.96
8.57%
00173051900
FLOLAN
INJ 1.5MG
6
$12,924.27
23.08%
1
$39.52
2.86%
66215010106
TRACLEER
TAB 62.5MG
4
$11,351.34
15.38%
2
$132.16
5.71%
66215010206
TRACLEER
TAB 125MG
16
$45,385.36
61.54%
29
$87,135.92
82.86%
$9,189.84
63.74%
298
$7,713.49
60.45%
PURINE ANALOG
00054408425
AZATHIOPRINE TAB 50MG
348
00781105901
10
$365.20
1.83%
2
$28.70
0.41%
00781507501
79
$2,448.10
14.47%
112
$4,008.54
22.72%
60976059755
IMURAN
TAB 50MG
0
$0.00
0.00%
1
$255.47
0.20%
65483059010
IMURAN
TAB 50MG
9
$1,471.79
1.65%
5
$367.32
1.01%
65649024141
AZASAN
TAB 100MG
66591022141
66591024141
AZASAN
TAB 100MG
0
$0.00
0.00%
7
$1,089.48
1.42%
98
$3,456.86
17.95%
61
$1,752.76
12.37%
2
$220.49
0.37%
7
$674.65
1.42%
73
$100,406.39
16.01%
109
$149,784.59
17.36%
RHEUMATOID ARTHRITIS
00074379902
HUMIRA
KIT 40MG/0.8
Page 424 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
RHEUMATOID ARTHRITIS
00088216030
ARAVA
TAB 10MG
27
$8,223.25
5.92%
63
$24,373.54
10.03%
00088216130
ARAVA
TAB 20MG
140
$38,221.73
30.70%
180
$64,835.18
28.66%
55513017701
KINERET
INJ
1
$1,134.56
0.22%
0
$0.00
0.00%
55513017707
KINERET
INJ
7
$7,498.58
1.54%
2
$2,325.20
0.32%
58406042534
ENBREL
INJ 25MG
205
$235,953.17
44.96%
264
$317,467.58
42.04%
58406042541
ENBREL
INJ 25MG
3
$3,579.93
0.66%
3
$3,669.03
0.48%
58406043501
ENBREL
INJ 50MG/ML
0
$0.00
0.00%
2
$1,834.89
0.32%
58406043504
ENBREL
INJ 50MG/ML
0
$0.00
0.00%
5
$6,119.90
0.80%
RSV PROPHYLAXIS
60574411101
SYNAGIS
INJ 100MG
302
$354,805.92
66.37%
437
$539,467.63
67.23%
60574411201
SYNAGIS
INJ 50MG
153
$80,562.76
33.63%
213
$113,389.29
32.77%
SEDATIVE/HYPNOTICS - BARBITURATE
00024123105
MEBARAL
TAB 32MG
9
$320.38
0.41%
3
$68.76
0.16%
00024123205
MEBARAL
TAB 50MG
32
$1,909.67
1.45%
1
$28.87
0.05%
00024123305
MEBARAL
TAB 100MG
19
$1,041.65
0.86%
3
$150.90
0.16%
00037011360
BUTISOL SOD TAB 30MG
2
$32.40
0.09%
3
$105.57
0.16%
00037011460
BUTISOL SOD TAB 50MG
1
$43.29
0.05%
0
$0.00
0.00%
00074234931
LUMINAL
4
$361.08
0.18%
2
$479.12
0.11%
00121053105
PHENOBARB
ELX 20MG/5ML
1
$3.71
0.05%
0
$0.00
0.00%
00121053107
PHENOBARB
ELX 20MG/5ML
1
$6.05
0.05%
0
$0.00
0.00%
00121053204
CHLORAL HYDR SYP 500/5ML
1
$3.85
0.05%
0
$0.00
0.00%
00121053205
1
$11.11
0.05%
0
$0.00
0.00%
00143144510
PHENOBARB
TAB 15MG
66
$187.32
3.00%
53
$142.13
2.82%
00143145010
PHENOBARB
TAB 30MG
282
$685.18
12.80%
269
$604.17
14.33%
00143145510
PHENOBARB
TAB 60MG
123
$313.86
5.58%
180
$504.74
9.59%
INJ 130MG/ML
Page 425 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00143145801
PHENOBARBITA TAB 100MG
1
$4.58
0.05%
0
$0.00
0.00%
00143145810
PHENOBARBITA TAB 100MG
0
$0.00
0.00%
2
$3.54
0.11%
00182031440
PHENOBARB
ELX 20MG/5ML
2
$9.45
0.09%
0
$0.00
0.00%
00228202696
PHENOBARB
TAB 15MG
57
$190.96
2.59%
56
$169.63
2.98%
00228202896
PHENOBARB
TAB 30MG
184
$665.46
8.35%
190
$669.47
10.12%
00254501138
PHENOBARB
TAB 16.2MG
5
$16.31
0.23%
0
$0.00
0.00%
00254501238
PHENOBARB
TAB 32.4MG
3
$10.04
0.14%
3
$5.20
0.16%
00254501328
PHENOBARB
TAB 64.8MG
1
$0.42
0.05%
0
$0.00
0.00%
00254501338
PHENOBARB
TAB 64.8MG
16
$53.66
0.73%
7
$23.76
0.37%
00254501428
PHENOBARB
TAB 97.2MG
3
$7.56
0.14%
0
$0.00
0.00%
00254906858
2
$7.04
0.09%
0
$0.00
0.00%
00472101516
PHENOBARB
ELX 20MG/5ML
117
$618.69
5.31%
37
$246.91
1.97%
00603108858
17
$66.97
0.77%
36
$114.30
1.92%
00603150858
PHENOBARB
ELX 20MG/5ML
253
$1,404.85
11.48%
184
$1,045.80
9.80%
00603516521
PHENOBARB
TAB 16.2MG
11
$29.67
0.50%
6
$22.12
0.32%
00603516532
PHENOBARB
TAB 16.2MG
17
$48.47
0.77%
24
$52.83
1.28%
00603516621
PHENOBARB
TAB 32.4MG
12
$23.18
0.54%
1
$1.35
0.05%
00603516632
PHENOBARB
TAB 32.4MG
264
$565.45
11.98%
232
$482.14
12.36%
00603516721
PHENOBARB
TAB 64.8MG
99
$195.36
4.49%
100
$190.53
5.33%
00603516732
PHENOBARB
TAB 64.8MG
96
$302.63
4.36%
92
$249.99
4.90%
00603516821
PHENOBARB
TAB 97.2MG
45
$219.01
2.04%
62
$275.44
3.30%
00603516832
PHENOBARB
TAB 97.2MG
9
$42.21
0.41%
10
$39.82
0.53%
00641047625
PHENOBARB
INJ 65MG/ML
2
$12.62
0.09%
0
$0.00
0.00%
00677166610
PHENOBARB
TAB 30MG
1
$3.85
0.05%
0
$0.00
0.00%
00677169810
PHENOBARB
TAB 64.8MG
27
$70.30
1.23%
2
$2.54
0.11%
00677169910
PHENOBARB
TAB 97.2MG
6
$10.44
0.27%
3
$5.66
0.16%
00677173110
PHENOBARB
TAB 15MG
0
$0.00
0.00%
1
$3.46
0.05%
Page 426 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00677173210
PHENOBARB
TAB 30MG
16
$33.91
0.73%
9
$20.94
0.48%
00781109110
PHENOBARB
TAB 15MG
2
$2.38
0.09%
3
$3.57
0.16%
00781660516
1
$3.56
0.05%
0
$0.00
0.00%
00904130016
12
$41.77
0.54%
6
$18.82
0.32%
00904381580
PHENOBARB
4
$7.60
0.18%
0
$0.00
0.00%
00904382860
CHLORAL HYDR CAP 500MG
0
$0.00
0.00%
1
$3.57
0.05%
51660078610
PHENOBARB
TAB 60MG
5
$13.33
0.23%
2
$9.52
0.11%
51991008051
SOMNOTE
CAP 500MG
29
$1,350.73
1.32%
11
$647.35
0.59%
51991008052
SOMNOTE
CAP 500MG
9
$390.68
0.41%
14
$674.35
0.75%
60432053316
154
$729.00
6.99%
108
$527.34
5.75%
63304067901
SECONAL
1
$11.26
0.05%
3
$37.14
0.16%
63304074101
PHENOBARB
TAB 15MG
6
$14.01
0.27%
0
$0.00
0.00%
63304074201
PHENOBARB
TAB 30MG
6
$13.97
0.27%
0
$0.00
0.00%
63304074210
PHENOBARB
TAB 30MG
8
$29.91
0.36%
0
$0.00
0.00%
63304074301
PHENOBARB
TAB 60MG
11
$35.23
0.50%
0
$0.00
0.00%
63304074310
PHENOBARB
TAB 60MG
19
$59.97
0.86%
0
$0.00
0.00%
63304074401
PHENOBARB
TAB 100MG
28
$166.00
1.27%
0
$0.00
0.00%
64125090101
PHENOBARB
TAB 30MG
0
$0.00
0.00%
4
$13.47
0.21%
64125090110
PHENOBARB
TAB 30MG
47
$107.09
2.13%
50
$107.34
2.66%
64125090201
PHENOBARB
TAB 60MG
0
$0.00
0.00%
1
$1.48
0.05%
64125090210
PHENOBARB
TAB 60MG
31
$52.78
1.41%
29
$59.65
1.55%
64125090301
PHENOBARB
TAB 100MG
11
$45.47
0.50%
14
$57.35
0.75%
64125091501
PHENOBARB
TAB 15MG
0
$0.00
0.00%
2
$2.16
0.11%
64125091510
PHENOBARB
TAB 15MG
11
$35.28
0.50%
12
$30.36
0.64%
67386080102
MEBARAL
TAB 32MG
0
$0.00
0.00%
6
$328.15
0.32%
67386080202
MEBARAL
TAB 50MG
0
$0.00
0.00%
27
$1,996.97
1.44%
67386080302
MEBARAL
TAB 100MG
0
$0.00
0.00%
13
$910.05
0.69%
TAB 15MG
CAP 100MG
Page 427 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
SEDATIVE/HYPNOTICS - BENZODIAZEPINES
00009001011
HALCION
TAB 0.125MG
00037900201
DORAL
00054485806
TRIAZOLAM
00054485906
00054485929
1
$4.39
0.05%
0
$0.00
0.00%
21
$832.44
1.15%
7
$265.08
0.53%
TAB 0.125MG
2
$12.10
0.11%
0
$0.00
0.00%
TRIAZOLAM
TAB 0.25MG
0
$0.00
0.00%
3
$31.11
0.23%
TRIAZOLAM
TAB 0.25MG
0
$0.00
0.00%
3
$20.13
0.23%
00054885825
TRIAZOLAM
TAB 0.125MG
2
$27.18
0.11%
0
$0.00
0.00%
00074373513
PROSOM
TAB 1MG
3
$425.04
0.16%
3
$435.57
0.23%
00078014005
RESTORIL
CAP 7.5MG
11
$360.29
0.60%
0
$0.00
0.00%
00093012901
ESTAZOLAM
TAB 1MG
0
$0.00
0.00%
1
$6.78
0.08%
00093013001
ESTAZOLAM
TAB 2MG
0
$0.00
0.00%
2
$27.50
0.15%
00143336701
FLURAZEPAM CAP 15MG
20
$56.55
1.09%
5
$19.00
0.38%
00143337001
FLURAZEPAM CAP 30MG
14
$53.15
0.76%
14
$37.45
1.05%
00228207610
TEMAZEPAM
CAP 15MG
173
$444.52
9.44%
23
$64.74
1.73%
00228207650
TEMAZEPAM
CAP 15MG
24
$68.10
1.31%
19
$65.40
1.43%
00228207710
TEMAZEPAM
CAP 30MG
165
$609.92
9.00%
32
$134.87
2.41%
00228207750
TEMAZEPAM
CAP 30MG
31
$119.10
1.69%
17
$68.70
1.28%
00378401001
TEMAZEPAM
CAP 15MG
390
$1,044.18
21.28%
338
$740.16
25.41%
00378401005
TEMAZEPAM
CAP 15MG
115
$417.63
6.27%
73
$187.95
5.49%
00378441501
FLURAZEPAM CAP 15MG
45
$170.49
2.45%
30
$79.20
2.26%
00378443001
FLURAZEPAM CAP 30MG
84
$328.77
4.58%
49
$134.01
3.68%
00378505001
TEMAZEPAM
CAP 30MG
302
$1,209.37
16.48%
274
$970.79
20.60%
00378505005
TEMAZEPAM
CAP 30MG
89
$426.70
4.86%
54
$233.78
4.06%
00406991501
RESTORIL
40
$1,874.86
2.18%
38
$1,503.63
2.86%
00591074401
ESTAZOLAM
TAB 1MG
17
$193.07
0.93%
6
$45.68
0.45%
00591074501
ESTAZOLAM
TAB 2MG
11
$177.69
0.60%
9
$104.40
0.68%
00781144205
TRIAZOLAM
TAB 0.25MG
5
$27.43
0.27%
0
$0.00
0.00%
TAB 15MG
CAP 7.5MG
Page 428 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
TRIAZOLAM
TAB 0.25MG
00781220101
TEMAZEPAM
00781220105
TEMAZEPAM
00781220201
$
Market Share*
SEDATIVE/HYPNOTICS - BENZODIAZEPINES
00781144283
# of Scripts
1
$3.65
0.05%
0
$0.00
0.00%
CAP 15MG
4
$15.69
0.22%
99
$363.43
7.44%
CAP 15MG
13
$49.14
0.71%
0
$0.00
0.00%
TEMAZEPAM
CAP 30MG
3
$14.30
0.16%
28
$84.20
2.11%
00781220205
TEMAZEPAM
CAP 30MG
3
$6.60
0.16%
0
$0.00
0.00%
00781220901
TEMAZEPAM
CAP 7.5MG
8
$64.55
0.44%
0
$0.00
0.00%
49884045305
TRIAZOLAM
TAB 0.125MG
6
$59.62
0.33%
6
$40.11
0.45%
49884045312
TRIAZOLAM
TAB 0.125MG
5
$18.55
0.27%
0
$0.00
0.00%
49884045362
TRIAZOLAM
TAB 0.125MG
2
$17.30
0.11%
5
$27.45
0.38%
49884045405
TRIAZOLAM
TAB 0.25MG
28
$217.72
1.53%
16
$110.62
1.20%
49884045412
TRIAZOLAM
TAB 0.25MG
11
$93.35
0.60%
10
$36.65
0.75%
49884045462
TRIAZOLAM
TAB 0.25MG
45
$307.91
2.45%
50
$339.78
3.76%
52544074401
ESTAZOLAM
TAB 1MG
2
$19.48
0.11%
0
$0.00
0.00%
59762371704
TRIAZOLAM
TAB 0.125MG
26
$190.80
1.42%
16
$103.79
1.20%
59762371803
TRIAZOLAM
TAB 0.25MG
23
$186.27
1.25%
23
$142.51
1.73%
59762371804
TRIAZOLAM
TAB 0.25MG
88
$557.63
4.80%
76
$498.50
5.71%
63304020518
MIDAZOLAM
0
$0.00
0.00%
1
$5.22
0.08%
SYP 2MG/ML
SEDATIVE/HYPNOTICS - Non-Benzodiazepines
00008092581
SONATA
CAP 5MG
30
$1,166.68
0.60%
13
$357.90
0.47%
00008092681
SONATA
CAP 10MG
264
$16,065.56
5.29%
85
$4,825.53
3.10%
00024540131
AMBIEN
TAB 5MG
1,078
$40,436.40
21.60%
580
$17,395.89
21.14%
00024540134
AMBIEN
TAB 5MG
1
$21.69
0.02%
0
$0.00
0.00%
00024542131
AMBIEN
TAB 10MG
3,580
$175,503.12
71.74%
2,060
$84,339.89
75.10%
00024542134
AMBIEN
TAB 10MG
8
$544.48
0.16%
1
$12.50
0.04%
00024542150
AMBIEN
TAB 10MG
0
$0.00
0.00%
2
$57.59
0.07%
00025540131
AMBIEN
TAB 5MG
10
$223.24
0.20%
2
$57.31
0.07%
Page 429 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
SEDATIVE/HYPNOTICS - Non-Benzodiazepines
00025542131
AMBIEN
TAB 10MG
17
$701.86
0.34%
0
$0.00
0.00%
00025542134
AMBIEN
TAB 10MG
2
$48.34
0.04%
0
$0.00
0.00%
SOMATOSTATIC AGENTS
00078018001
SANDOSTATIN INJ 0.05MG/1
0
$0.00
0.00%
1
$587.55
3.85%
00078018003
SANDOSTATIN INJ 0.05MG/1
4
$2,085.96
12.50%
2
$936.77
7.69%
00078018101
SANDOSTATIN INJ 0.1MG/ML
3
$1,138.29
9.38%
0
$0.00
0.00%
00078018103
6
$3,015.85
18.75%
4
$3,959.80
15.38%
00078018325
3
$4,085.52
9.38%
3
$8,413.01
11.54%
00078018425
SANDOSTATIN INJ 1MG/ML
13
$88,538.63
40.63%
11
$93,333.72
42.31%
00078034161
SANDOSTATIN KIT LAR 20MG
0
$0.00
0.00%
3
$5,323.99
11.54%
00078034184
SANDOSTATIN KIT LAR 20MG
3
$5,095.26
9.38%
2
$3,552.66
7.69%
STIMULANTS
00002322730
STRATTERA
CAP 10MG
210
$19,376.90
0.79%
238
$19,287.25
0.79%
00002322830
STRATTERA
CAP 25MG
716
$59,253.96
2.68%
753
$60,032.79
2.49%
00002322930
STRATTERA
CAP 40MG
1,566
$159,450.55
5.86%
1,817
$185,592.41
6.01%
00002323830
STRATTERA
CAP 18MG
270
$23,283.28
1.01%
290
$20,891.30
0.96%
00002323930
STRATTERA
CAP 60MG
669
$52,708.05
2.50%
831
$63,425.58
2.75%
00007351220
DEXEDRINE
CAP 5MG CR
11
$792.25
0.04%
9
$862.07
0.03%
00007351320
DEXEDRINE
CAP 10MG
50
$2,634.06
0.19%
53
$3,177.11
0.18%
00007351420
DEXEDRINE
CAP 15MG CR
42
$3,116.61
0.16%
26
$2,233.31
0.09%
00007351920
DEXEDRINE
TAB 5MG
9
$410.84
0.03%
15
$820.80
0.05%
00074337704
DESOXYN
TAB 5MG
7
$1,852.34
0.03%
5
$1,093.54
0.02%
00074602513
CYLERT
TAB 18.75MG
15
$719.35
0.06%
0
$0.00
0.00%
00074605713
CYLERT
TAB 37.5MG
25
$2,829.14
0.09%
31
$2,733.50
0.10%
00074607313
CYLERT
TAB 75MG
15
$1,831.58
0.06%
15
$2,016.34
0.05%
Page 430 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
STIMULANTS
00074608813
CYLERT
00078037005
00078037105
CHW 37.5MG
7
$607.73
0.03%
8
$777.34
0.03%
RITALIN LA CAP 20MG
254
$18,399.82
0.95%
387
$31,313.18
1.28%
RITALIN LA CAP 30MG
169
$13,172.28
0.63%
274
$20,454.02
0.91%
00078037205
RITALIN LA CAP 40MG
110
$7,173.27
0.41%
159
$12,678.38
0.53%
00078038005
FOCALIN
TAB 2.5MG
26
$730.19
0.10%
29
$728.25
0.10%
00078038105
FOCALIN
TAB 5MG
43
$1,409.11
0.16%
55
$1,898.83
0.18%
00078038205
FOCALIN
TAB 10MG
22
$1,414.83
0.08%
33
$1,682.76
0.11%
00078042405
RITALIN LA CAP 10MG
0
$0.00
0.00%
49
$3,418.21
0.16%
00083000330
RITALIN
TAB 10MG
53
$2,821.72
0.20%
35
$1,871.90
0.12%
00083000730
RITALIN
TAB 5MG
42
$1,247.87
0.16%
21
$616.27
0.07%
00083001630
RITALIN SR TAB 20MG
44
$3,687.60
0.16%
32
$2,915.55
0.11%
00083003430
RITALIN
40
$2,966.15
0.15%
38
$2,970.29
0.13%
00093952401
PEMOLINE
TAB 37.5MG
3
$45.42
0.01%
0
$0.00
0.00%
00093957701
PEMOLINE
CHW 37.5MG
7
$469.07
0.03%
0
$0.00
0.00%
00185008401
AMPHETAMINE TAB 5MG
176
$10,038.08
0.66%
168
$5,000.74
0.56%
00185011101
AMPHETAMINE TAB 10MG
248
$1,335.26
0.93%
199
$1,064.66
0.66%
00185040101
170
$11,947.75
0.64%
202
$8,885.80
0.67%
00185040401
56
$2,938.85
0.21%
63
$2,377.64
0.21%
00364047901
METHYLPHENID TAB 10MG
1
$51.63
0.00%
2
$78.70
0.01%
00364047902
9
$251.84
0.03%
0
$0.00
0.00%
00364056101
1
$7.55
0.00%
0
$0.00
0.00%
00406112101
METHYLIN
TAB 5MG
584
$6,272.80
2.18%
508
$6,127.07
1.68%
00406112201
METHYLIN
TAB 10MG
824
$23,368.51
3.08%
1,044
$16,544.59
3.46%
00406112210
METHYLIN
TAB 10MG
4
$63.75
0.01%
3
$5.76
0.01%
00406112401
METHYLIN
TAB 20MG
373
$14,811.60
1.40%
605
$15,115.57
2.00%
00406112410
METHYLIN
TAB 20MG
6
$272.46
0.02%
1
$60.25
0.00%
00406142301
METHYLIN ER TAB 10MG
30
$1,015.26
0.11%
56
$1,864.84
0.19%
TAB 20MG
Page 431 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
STIMULANTS
00406145101
METHYLIN ER TAB 20MG
00406155401
PEMOLINE
00406895801
DEXTROAMPHET TAB 5MG
00406896001
82
$4,210.78
0.31%
75
$2,393.09
0.25%
0
$0.00
0.00%
1
$12.50
0.00%
0
$0.00
0.00%
6
$85.60
0.02%
DEXTROAMPHET CAP 5MG CR
1
$65.02
0.00%
3
$44.34
0.01%
00406896101
4
$301.91
0.01%
63
$1,751.56
0.21%
00406896201
6
$477.27
0.02%
22
$769.00
0.07%
00555077502
AMPHETAMINE TAB 7.5MG
22
$1,003.28
0.08%
24
$722.46
0.08%
00555077602
4
$181.17
0.01%
6
$238.78
0.02%
00555077702
43
$2,109.67
0.16%
123
$4,898.19
0.41%
00555095202
183
$3,179.92
0.68%
154
$2,240.34
0.51%
00555095302
202
$9,537.65
0.76%
179
$4,434.59
0.59%
00555095402
53
$1,944.22
0.20%
23
$467.01
0.08%
00555095502
179
$9,349.64
0.67%
123
$3,978.08
0.41%
00555095602
155
$8,685.75
0.58%
134
$5,343.66
0.44%
00555097102
AMPHETAMINE TAB 5MG
359
$19,743.75
1.34%
380
$10,712.55
1.26%
00555097202
471
$28,897.91
1.76%
494
$17,361.50
1.64%
00555097302
277
$18,179.31
1.04%
380
$14,590.74
1.26%
00555097402
99
$4,918.58
0.37%
128
$4,587.87
0.42%
00591311101
METHYLPHENID TAB 20MG ER
11
$519.07
0.04%
23
$765.45
0.08%
00591588201
220
$2,578.03
0.82%
31
$399.15
0.10%
00591588210
10
$116.50
0.04%
0
$0.00
0.00%
00591588301
211
$6,289.43
0.79%
136
$2,292.04
0.45%
00591588310
25
$761.90
0.09%
1
$24.85
0.00%
00591588401
131
$6,224.58
0.49%
44
$1,137.49
0.15%
00591588410
1
$21.01
0.00%
0
$0.00
0.00%
00603505521
PEMOLINE
TAB 18.75MG
2
$17.50
0.01%
3
$22.50
0.01%
00603505621
PEMOLINE
TAB 37.5MG
4
$268.00
0.01%
5
$566.07
0.02%
TAB 37.5MG
Page 432 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
STIMULANTS
00603505721
PEMOLINE
TAB 75MG
00781174101
PEMOLINE
TAB 37.5MG
00781174801
00781174810
00781174901
00781175101
PEMOLINE
00781175301
00781175310
00781175401
METHYLPHENID TAB 20MG SR
00781884001
00781884010
$1,489.31
0.05%
$91.98
0.01%
3
$99.35
0.01%
117
$1,505.30
0.44%
0
$0.00
0.00%
98
$1,197.56
0.32%
6
$104.55
0.02%
4
$111.40
0.01%
167
$5,420.23
0.62%
182
$3,021.77
0.60%
8
$551.20
0.03%
82
$3,602.84
0.31%
0
$0.00
0.00%
15
$357.00
0.05%
5
$174.94
0.02%
3
$50.73
0.01%
9
$482.55
0.03%
4
$233.40
0.01%
175
23
$2,292.20
0.65%
254
$3,143.36
0.84%
$206.19
0.09%
4
$46.90
0.01%
00781884101
397
$12,659.12
1.49%
458
$7,381.96
1.52%
00781884110
22
$778.28
0.08%
1
$15.35
0.00%
00781884201
179
$8,965.73
0.67%
342
$8,843.25
1.13%
00781884210
21
$1,443.68
0.08%
14
$526.80
0.05%
00781884301
METHYLPHENID TAB 20MG CR
503
$28,567.30
1.88%
438
$18,435.32
1.45%
17314585002
CONCERTA
TAB 18MG
2,215
$158,493.29
8.29%
2,284
$175,158.39
7.56%
17314585102
CONCERTA
TAB 36MG
2,925
$218,099.21
10.94%
2,890
$239,446.59
9.57%
17314585202
CONCERTA
TAB 54MG
3,038
$244,202.93
11.37%
3,727
$329,791.84
12.34%
17314585302
CONCERTA
TAB 27MG
966
$71,026.91
3.61%
1,264
$100,621.48
4.18%
52152016102
PEMOLINE
TAB 37.5MG
2
$118.78
0.01%
0
$0.00
0.00%
53014053007
32
$988.97
0.12%
23
$347.20
0.08%
53014053012
0
$0.00
0.00%
3
$102.95
0.01%
53014053107
2
$33.70
0.01%
40
$351.95
0.13%
53014053112
0
$0.00
0.00%
1
$24.36
0.00%
53014053207
17
$698.08
0.06%
19
$388.55
0.06%
53014057407
METADATE CD CAP 10MG
21
$1,206.94
0.08%
70
$4,904.31
0.23%
TAB 75MG
14
2
Page 433 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
STIMULANTS
53014057507
203
$13,462.69
0.76%
281
53014057530
44
$2,928.15
0.16%
53014057572
5
$383.46
0.02%
53014057607
10
$519.63
53014059307
METADATE
TAB 10MG ER
57
53014059407
METADATE
TAB 20MG ER
53265025310
53265025410
$21,830.34
0.93%
0
$0.00
0.00%
2
$362.31
0.01%
0.04%
117
$7,227.68
0.39%
$2,420.28
0.21%
17
$504.61
0.06%
39
$1,928.04
0.15%
42
$1,625.93
0.14%
12
$72.85
0.04%
187
$2,495.97
0.62%
4
$90.79
0.01%
36
$574.50
0.12%
53265025510
7
$288.48
0.03%
35
$788.82
0.12%
53265025511
0
$0.00
0.00%
1
$30.55
0.00%
53265026210
METHYLPHENID TAB 20MG CR
0
$0.00
0.00%
10
$458.50
0.03%
53489056401
AMPHETAMINE TAB 5MG
0
$0.00
0.00%
2
$84.70
0.01%
53489056701
0
$0.00
0.00%
1
$40.63
0.00%
53489056801
0
$0.00
0.00%
2
$133.20
0.01%
53489056901
0
$0.00
0.00%
7
$370.55
0.02%
53489057001
0
$0.00
0.00%
1
$24.95
0.00%
54092037101
ADDERALL
TAB 5MG
8
$489.63
0.03%
33
$2,755.62
0.11%
54092037201
ADDERALL
TAB 7.5MG
8
$424.78
0.03%
5
$413.44
0.02%
54092037301
ADDERALL
TAB 10MG
27
$2,967.46
0.10%
70
$6,627.67
0.23%
54092037401
ADDERALL
TAB 12.5MG
0
$0.00
0.00%
5
$268.00
0.02%
54092037501
ADDERALL
TAB 15MG
30
$2,314.39
0.11%
29
$1,814.25
0.10%
54092037601
ADDERALL
TAB 20MG
5
$381.30
0.02%
31
$3,796.39
0.10%
54092037701
ADDERALL
TAB 30MG
54092038101
ADDERALL XR CAP 5MG
54092038301
15
$1,049.98
0.06%
24
$1,921.62
0.08%
230
$18,015.94
0.86%
325
$27,242.23
1.08%
ADDERALL XR CAP 10MG
1,058
$83,966.43
3.96%
1,145
$96,443.52
3.79%
54092038501
485
$33,250.56
1.81%
690
$55,371.67
2.28%
54092038701
1,629
$143,955.41
6.09%
1,955
$190,607.76
6.47%
Page 434 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
STIMULANTS
54092038901
224
$18,542.31
0.84%
396
$35,461.75
1.31%
54092039101
1,325
$106,401.82
4.96%
1,586
$138,294.71
5.25%
54092044801
DEXTROSTAT TAB 5MG
55
$1,078.55
0.21%
22
$465.50
0.07%
54092045201
DEXTROSTAT TAB 10MG
40
$1,706.06
0.15%
49
$2,884.50
0.16%
58177031104
0
$0.00
0.00%
34
$634.40
0.11%
58177031204
9
$268.48
0.03%
23
$617.80
0.08%
58521003101
ADDERALL
TAB 5MG
48
$2,760.96
0.18%
0
$0.00
0.00%
58521003201
ADDERALL
TAB 10MG
79
$5,770.99
0.30%
0
$0.00
0.00%
58521003301
ADDERALL
TAB 20MG
27
$2,294.04
0.10%
0
$0.00
0.00%
58521003401
ADDERALL
TAB 30MG
18
$1,206.29
0.07%
2
$93.32
0.01%
58521007501
ADDERALL
TAB 7.5MG
19
$1,308.43
0.07%
0
$0.00
0.00%
58521012501
ADDERALL
TAB 12.5MG
11
$536.30
0.04%
0
$0.00
0.00%
58521015001
ADDERALL
TAB 15MG
18
$1,071.13
0.07%
2
$88.32
0.01%
58521045101
DEXTROSTAT TAB 5MG
24
$407.80
0.09%
3
$28.05
0.01%
58521045201
DEXTROSTAT TAB 10MG
33
$2,250.83
0.12%
0
$0.00
0.00%
59772884001
12
$226.76
0.04%
0
$0.00
0.00%
59772884201
6
$199.05
0.02%
0
$0.00
0.00%
59772884203
3
$77.67
0.01%
0
$0.00
0.00%
63304090801
AMPHETAMINE TAB 5MG
2
$81.28
0.01%
13
$488.45
0.04%
63304090901
1
$77.92
0.00%
6
$215.10
0.02%
63304091001
0
$0.00
0.00%
1
$45.95
0.00%
63459010001
PROVIGIL
TAB 100MG
41
$6,378.91
0.15%
21
$2,634.10
0.07%
63459010101
PROVIGIL
TAB 100MG
0
$0.00
0.00%
11
$613.58
0.04%
63459020001
PROVIGIL
TAB 200MG
249
$46,435.66
0.93%
85
$16,016.75
0.28%
63459020101
PROVIGIL
TAB 200MG
0
$0.00
0.00%
123
$26,599.04
0.41%
67386010201
DESOXYN
TAB 5MG
0
$0.00
0.00%
1
$574.60
0.00%
67767010101
AMPHETAMINE TAB 5MG
0
$0.00
0.00%
4
$143.81
0.01%
Page 435 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
STIMULANTS
67767010301
0
$0.00
0.00%
7
$154.17
0.02%
67767010601
0
$0.00
0.00%
5
$110.15
0.02%
67767010701
0
$0.00
0.00%
6
$191.16
0.02%
TETRACYCLINES
00003066345
SUMYCIN
TAB 250MG
3
$10.14
0.07%
0
$0.00
0.00%
00003081550
SUMYCIN
SYP 125/5ML
9
$585.80
0.21%
3
$131.07
0.07%
00005534323
MINOCIN
CAP 50MG
6
$695.56
0.14%
3
$192.69
0.07%
00005534418
MINOCIN
CAP 100MG
3
$630.93
0.07%
3
$616.47
0.07%
00005921823
DECLOMYCIN TAB 150MG
2
$834.41
0.05%
0
$0.00
0.00%
00005927029
DECLOMYCIN TAB 300MG
7
$3,765.19
0.16%
5
$6,527.54
0.12%
00069097065
VIBRAMYCIN SUS 25MG/5ML
2
$161.73
0.05%
0
$0.00
0.00%
00069097193
VIBRAMYCIN SYP 50MG/5ML
10
$845.17
0.23%
5
$464.95
0.12%
00093316501
MINOCYCLINE CAP 50MG
130
$1,882.10
2.98%
127
$1,773.22
3.03%
00093316753
273
$8,665.69
6.26%
275
$10,196.69
6.56%
00093730001
0
$0.00
0.00%
3
$312.57
0.07%
00115701701
31
$378.68
0.71%
11
$109.05
0.26%
00115701806
38
$1,288.60
0.87%
12
$392.25
0.29%
00115705401
1
$52.55
0.02%
0
$0.00
0.00%
00143211205
DOXYCYCL HYC TAB 100MG
0
$0.00
0.00%
33
$172.21
0.79%
00143211250
17
$79.65
0.39%
16
$66.14
0.38%
00143314150
DOXYCYCL HYC CAP 50MG
5
$28.30
0.11%
7
$53.92
0.17%
00143314205
139
$517.68
3.19%
153
$613.67
3.65%
00143314250
149
$591.59
3.42%
149
$634.86
3.56%
00172240760
TETRACYCLINE CAP 500MG
40
$283.99
0.92%
91
$704.18
2.17%
00172240780
47
$333.57
1.08%
33
$216.34
0.79%
00172241660
57
$244.62
1.31%
120
$496.17
2.86%
Page 436 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TETRACYCLINES
00172241680
00172298448
00172298548
00172298570
00172362648
46
$203.56
1.05%
4
$17.50
0.09%
123
$494.19
2.82%
37
$136.95
0.85%
211
$1,076.38
00172362670
25
00182011289
2
00185081053
DOXYCYC MONO CAP 100MG
00364203250
57
$257.95
1.36%
11
$71.98
0.26%
172
$692.01
4.11%
31
$103.19
0.74%
4.84%
104
$561.08
2.48%
$108.01
0.57%
2
$14.68
0.05%
$7.23
0.05%
0
$0.00
0.00%
3
$89.93
0.07%
2
$15.00
0.05%
2
$7.06
0.05%
0
$0.00
0.00%
00364203290
1
$3.53
0.02%
0
$0.00
0.00%
00364203305
6
$31.00
0.14%
3
$14.75
0.07%
00364249701
4
$37.50
0.09%
2
$17.26
0.05%
00364249850
2
$78.70
0.05%
1
$19.87
0.02%
00378010110
2
$7.28
0.05%
0
$0.00
0.00%
00378010201
1
$8.81
0.02%
0
$0.00
0.00%
00378010205
8
$70.29
0.18%
0
$0.00
0.00%
00378014589
1
$8.84
0.02%
0
$0.00
0.00%
00378014889
00430083819
DORYX
00555001002
2
$5.54
0.05%
0
$0.00
0.00%
17
$962.95
0.39%
8
$833.15
0.19%
329
$2,602.03
7.54%
255
$1,898.21
6.09%
00555001005
42
$277.92
0.96%
33
$190.91
0.79%
00555001102
82
$340.54
1.88%
32
$152.63
0.76%
00555001105
319
$1,523.04
7.31%
257
$1,178.12
6.13%
00591049805
622
$2,344.36
14.26%
6
$24.66
0.14%
00591049850
64
$266.38
1.47%
0
$0.00
0.00%
00591049905
4
$32.58
0.09%
2
$9.34
0.05%
00591049950
149
$811.76
3.42%
15
$94.12
0.36%
CAP 100MG EC
Page 437 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TETRACYCLINES
00591050050
32
$244.77
0.73%
10
$77.11
0.24%
00591544005
88
$431.66
2.02%
731
$2,791.22
17.45%
00591544050
44
$209.73
1.01%
123
$527.92
2.94%
00591553550
32
$139.78
0.73%
58
$332.23
1.38%
00591555305
91
$474.27
2.09%
110
$628.75
2.63%
00591555350
41
$230.37
0.94%
190
$923.78
4.53%
00591569401
81
$1,087.35
1.86%
71
$926.86
1.69%
00591569550
180
$5,449.43
4.13%
188
$6,565.12
4.49%
00603348019
1
$6.34
0.02%
0
$0.00
0.00%
00603348128
0
$0.00
0.00%
1
$8.15
0.02%
00603348219
0
$0.00
0.00%
6
$37.98
0.14%
00677056202
7
$25.13
0.16%
4
$14.96
0.10%
00677056205
24
$110.82
0.55%
2
$8.94
0.05%
00677059802
2
$17.93
0.05%
0
$0.00
0.00%
00677079902
0
$0.00
0.00%
2
$6.07
0.05%
00677079905
2
$11.99
0.05%
1
$4.45
0.02%
00904042751
2
$12.68
0.05%
0
$0.00
0.00%
00904042840
1
$2.45
0.02%
0
$0.00
0.00%
00904042851
24
$114.76
0.55%
30
$133.90
0.72%
00904043051
5
$32.26
0.11%
1
$5.15
0.02%
00904240760
0
$0.00
0.00%
3
$33.33
0.07%
00904240780
4
$26.13
0.09%
1
$9.78
0.02%
00904241680
2
$11.95
0.05%
1
$2.95
0.02%
49884072703
6
$202.03
0.14%
0
$0.00
0.00%
49884079701
SUMYCIN
TAB 250MG
2
$6.14
0.05%
1
$13.63
0.02%
49884079801
SUMYCIN
TAB 500MG
0
$0.00
0.00%
1
$15.18
0.02%
49884079933
SUMYCIN
SYP 125/5ML
6
$218.57
0.14%
6
$244.46
0.14%
Page 438 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TETRACYCLINES
52544031025
2
52544049805
52544049850
52544049905
$45.77
0.05%
0
$0.00
0.00%
14
$50.82
0.32%
0
$0.00
0.00%
26
$116.84
0.60%
2
$9.80
0.05%
25
$115.89
0.57%
6
$25.59
0.14%
52544049950
13
$89.90
0.30%
1
$2.65
0.02%
52544050050
13
$76.27
0.30%
0
$0.00
0.00%
53489011802
3
$13.93
0.07%
19
$94.38
0.45%
53489011805
0
$0.00
0.00%
1
$3.60
0.02%
53489011902
24
$104.38
0.55%
13
$47.63
0.31%
53489011905
10
$38.98
0.23%
5
$17.73
0.12%
53489012002
93
$413.45
2.13%
209
$1,034.30
4.99%
53489012005
12
$80.93
0.28%
9
$60.46
0.21%
53489055001
DOXYCYCLINE TAB 20MG
0
$0.00
0.00%
5
$209.76
0.12%
55515025904
MONODOX
CAP 100MG
1
$75.74
0.02%
1
$23.69
0.02%
59911586901
8
$84.40
0.18%
0
$0.00
0.00%
59911587001
2
$41.50
0.05%
0
$0.00
0.00%
62436072903
ADOXA
1
$47.02
0.02%
2
$101.69
0.05%
63304069401
81
$1,010.30
1.86%
118
$1,474.14
2.82%
63304069501
4
$347.80
0.09%
0
$0.00
0.00%
63304069605
0
$0.00
0.00%
2
$47.90
0.05%
63304069650
257
$7,554.29
5.89%
212
$8,450.05
5.06%
64682000802
PERIOSTAT
TAB
14
$422.39
0.32%
1
$68.65
0.02%
99207049250
DYNACIN
TAB 100MG
4
$351.49
0.09%
0
$0.00
0.00%
99207049710
DYNACIN
CAP 50MG
0
$0.00
0.00%
1
$8.05
0.02%
99207049850
DYNACIN
CAP 100MG
2
$60.70
0.05%
0
$0.00
0.00%
TAB 100MG
THYROID HORMONES
Page 439 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00048102003
SYNTHROID
TAB 25MCG
00048102005
SYNTHROID
TAB 25MCG
00048104003
SYNTHROID
TAB 50MCG
00048104005
SYNTHROID
TAB 50MCG
00048104013
SYNTHROID
00048105003
00048105005
$1,782.56
0.61%
$153.50
0.06%
4
$34.88
0.01%
163
$1,830.18
0.57%
0
$0.00
0.00%
10
$104.82
0.04%
103
$1,130.09
0.36%
9
$86.82
0.03%
TAB 50MCG
19
$191.16
0.07%
0
$0.00
0.00%
SYNTHROID
TAB 75MCG
222
SYNTHROID
TAB 75MCG
15
$2,625.83
0.77%
24
$299.19
0.09%
$171.34
0.05%
0
$0.00
0.00%
00048105013
SYNTHROID
TAB 75MCG
21
$231.99
0.07%
14
$93.52
0.05%
00048106003
SYNTHROID
TAB 88MCG
116
$1,466.29
0.40%
17
$224.60
0.06%
00048106004
SYNTHROID
TAB 88MCG
00048107003
SYNTHROID
TAB 100MCG
6
$65.88
0.02%
2
$21.48
0.01%
215
$2,673.63
0.75%
22
$291.82
0.08%
00048107005
SYNTHROID
TAB 100MCG
127
$1,451.71
0.44%
5
$54.86
0.02%
00048107013
SYNTHROID
TAB 100MCG
8
$95.29
0.03%
1
$12.41
0.00%
00048108003
00048108005
SYNTHROID
TAB 112MCG
70
$970.29
0.24%
4
$60.42
0.01%
SYNTHROID
TAB 112MCG
4
$53.30
0.01%
0
$0.00
0.00%
00048109003
SYNTHROID
TAB 150MCG
145
$2,121.58
0.51%
24
$362.90
0.09%
00048109005
SYNTHROID
TAB 150MCG
17
$267.84
0.06%
7
$97.38
0.03%
00048110003
SYNTHROID
TAB 175MCG
90
$1,541.37
0.31%
4
$64.88
0.01%
00048110004
SYNTHROID
TAB 175MCG
3
$46.41
0.01%
0
$0.00
0.00%
00048113003
SYNTHROID
TAB 125MCG
183
$2,595.17
0.64%
27
$400.17
0.10%
00048113005
SYNTHROID
TAB 125MCG
25
$328.50
0.09%
3
$37.38
0.01%
00048114003
SYNTHROID
TAB 200MCG
108
$1,950.12
0.38%
10
$177.50
0.04%
00048114005
SYNTHROID
TAB 200MCG
22
$336.08
0.08%
4
$60.80
0.01%
00048117003
SYNTHROID
TAB 300MCG
38
$936.09
0.13%
9
$213.88
0.03%
00074232701
SYNTHROID
INJ 200MCG
1
$1,612.00
0.00%
0
$0.00
0.00%
00074372713
SYNTHROID
TAB 137MCG
80
$1,304.44
0.28%
72
$1,209.28
0.26%
00074434113
SYNTHROID
TAB 25MCG
955
$11,064.84
3.33%
302
$3,448.64
1.09%
175
16
Page 440 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00074434119
SYNTHROID
TAB 25MCG
00074455211
SYNTHROID
TAB 50MCG
00074455213
SYNTHROID
TAB 50MCG
00074455219
SYNTHROID
TAB 50MCG
00074518211
SYNTHROID
00074518213
00074518219
$3,030.51
0.98%
$864.34
0.29%
18
$218.78
0.06%
1,600
$20,552.96
5.57%
0
$0.00
0.00%
555
$7,428.95
2.00%
540
$6,094.42
1.88%
164
$1,896.88
0.59%
TAB 75MCG
7
$97.27
0.02%
3
$47.02
0.01%
SYNTHROID
TAB 75MCG
1,384
SYNTHROID
TAB 75MCG
342
$19,077.06
4.82%
469
$6,639.70
1.69%
$4,148.09
1.19%
111
$1,390.15
0.40%
00074659413
SYNTHROID
TAB 88MCG
515
$7,298.41
1.79%
241
$3,509.47
0.87%
00074659419
SYNTHROID
TAB 88MCG
72
$927.20
0.25%
28
$389.88
0.10%
00074662411
SYNTHROID
TAB 100MCG
00074662413
SYNTHROID
TAB 100MCG
0
$0.00
0.00%
3
$48.61
0.01%
1,130
$15,781.26
3.94%
448
$6,521.36
1.61%
00074662419
SYNTHROID
TAB 100MCG
785
$9,865.70
2.73%
180
$2,225.24
0.65%
00074706813
SYNTHROID
TAB 125MCG
1,153
$19,135.99
4.02%
394
$6,813.12
1.42%
00074706819
00074706911
SYNTHROID
TAB 125MCG
197
$2,664.64
0.69%
53
$836.60
0.19%
SYNTHROID
TAB 150MCG
3
$52.22
0.01%
0
$0.00
0.00%
00074706913
SYNTHROID
TAB 150MCG
750
$12,543.95
2.61%
246
$4,159.28
0.88%
00074706919
SYNTHROID
TAB 150MCG
172
$2,539.89
0.60%
59
$878.64
0.21%
00074707013
SYNTHROID
TAB 175MCG
400
$7,663.28
1.39%
136
$2,731.36
0.49%
00074707019
SYNTHROID
TAB 175MCG
35
$592.39
0.12%
14
$252.97
0.05%
00074714811
SYNTHROID
TAB 200MCG
1
$21.13
0.00%
1
$21.66
0.00%
00074714813
SYNTHROID
TAB 200MCG
509
$10,327.24
1.77%
199
$4,405.07
0.72%
00074714819
SYNTHROID
TAB 200MCG
22
$374.94
0.08%
8
$139.08
0.03%
00074714913
SYNTHROID
TAB 300MCG
56
$1,503.95
0.20%
19
$521.42
0.07%
00074714919
SYNTHROID
TAB 300MCG
3
$72.48
0.01%
3
$56.86
0.01%
00074929613
SYNTHROID
TAB 112MCG
509
$8,209.68
1.77%
217
$3,606.02
0.78%
00074929619
SYNTHROID
TAB 112MCG
30
$345.89
0.10%
6
$76.81
0.02%
00254391128
LEVOTHYROXIN TAB 25MCG
2
$16.64
0.01%
0
$0.00
0.00%
280
81
Page 441 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00378180001
30
$256.25
0.10%
674
$5,298.95
2.42%
00378180301
27
$245.34
0.09%
1,225
$10,086.81
4.40%
00378180501
6
$74.83
0.02%
1,101
$10,391.06
3.96%
00378180701
11
$96.36
0.04%
269
$2,485.79
0.97%
00378180901
29
$273.02
0.10%
948
$8,755.59
3.41%
00378181101
6
$64.79
0.02%
239
$2,537.82
0.86%
00378181301
18
$207.49
0.06%
622
$7,432.11
2.24%
00378181501
6
$77.43
0.02%
460
$5,159.28
1.65%
00378181701
0
$0.00
0.00%
200
$2,582.04
0.72%
00378181901
0
$0.00
0.00%
199
$2,834.00
0.72%
00378182101
0
$0.00
0.00%
16
$311.05
0.06%
00456004001
THYROLAR-1/4 TAB 15MG
17
$407.79
0.06%
0
$0.00
0.00%
00456004501
THYROLAR-1/2 TAB 30MG
6
$109.34
0.02%
0
$0.00
0.00%
00456005001
THYROLAR-1 TAB 60MG
14
$311.20
0.05%
1
$53.74
0.00%
00456032001
LEVOTHROID TAB 25MCG
523
$4,393.54
1.82%
2
$9.93
0.01%
00456032100
197
$1,776.65
0.69%
0
$0.00
0.00%
00456032101
707
$5,917.77
2.46%
50
$369.86
0.18%
00456032163
7
$38.60
0.02%
0
$0.00
0.00%
00456032201
611
$5,658.33
2.13%
29
$297.62
0.10%
00456032300
50
$441.18
0.17%
0
$0.00
0.00%
00456032301
612
$5,922.72
2.13%
14
$154.61
0.05%
00456032401
338
$3,837.00
1.18%
27
$281.70
0.10%
00456032463
6
$43.77
0.02%
0
$0.00
0.00%
00456032501
293
$3,508.59
1.02%
17
$199.85
0.06%
00456032551
2
$14.94
0.01%
0
$0.00
0.00%
00456032563
2
$19.89
0.01%
0
$0.00
0.00%
00456032601
169
$2,001.58
0.59%
13
$142.41
0.05%
Page 442 of 505
Utilization Report
PDL Category
NDC
Q4 2003
Description
# of Scripts
$
Q4 2004
Market Share*
00456032763
00456032801
00456032901
00456033001
$
Market Share*
THYROID HORMONES
00456032701
# of Scripts
$1,929.57
0.51%
16
$204.25
0.06%
2
$22.23
0.01%
19
$334.86
0.07%
0
$0.00
0.00%
1
$15.67
0.00%
199
$1,862.93
0.69%
10
$99.68
0.04%
139
$1,451.60
0.48%
9
$83.60
0.03%
00456033101
00456045701
ARMOUR THYRO TAB 15MG
56
$647.02
0.20%
1
$9.35
0.00%
54
$290.15
0.19%
49
$232.87
0.18%
00456045801
63
$424.00
0.22%
84
$543.53
0.30%
00456045900
20
$115.23
0.07%
24
$169.03
0.09%
00456045901
103
$593.04
0.36%
104
$619.49
0.37%
00456045963
9
$93.69
0.03%
0
$0.00
0.00%
00456046001
72
$592.10
0.25%
54
$443.62
0.19%
00456046100
0
$0.00
0.00%
3
$21.28
0.01%
00456046101
46
$406.29
0.16%
31
$255.59
0.11%
00456046201
18
$202.74
0.06%
0
$0.00
0.00%
00456132001
9
$75.67
0.03%
164
$1,278.79
0.59%
00456132100
0
$0.00
0.00%
37
$350.30
0.13%
00456132101
21
$170.06
0.07%
440
$3,591.02
1.58%
00456132201
12
$116.82
0.04%
376
$3,363.97
1.35%
00456132300
0
$0.00
0.00%
18
$232.35
0.06%
00456132301
28
$235.66
0.10%
392
$3,619.51
1.41%
00456132401
6
$68.01
0.02%
218
$2,436.03
0.78%
00456132501
6
$62.08
0.02%
137
$1,562.67
0.49%
00456132601
1
$7.58
0.00%
67
$795.79
0.24%
00456132701
1
$11.51
0.00%
97
$1,231.95
0.35%
00456132801
1
$15.67
0.00%
15
$229.52
0.05%
00456132901
2
$15.96
0.01%
112
$1,068.12
0.40%
145
Page 443 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00456133001
00527134101
00527134110
4
$49.73
0.01%
114
$1,212.68
0.41%
199
$1,820.68
0.69%
324
$3,114.76
1.16%
92
$811.26
0.32%
50
$369.54
0.18%
00527134201
358
$3,520.13
1.25%
560
$5,540.60
2.01%
00527134210
87
$817.18
0.30%
138
$1,236.00
0.50%
00527134301
384
$3,991.99
1.34%
295
$2,975.46
1.06%
00527134310
18
$167.84
0.06%
40
$437.99
0.14%
00527134401
105
$1,050.02
0.37%
133
$1,466.22
0.48%
00527134410
0
$0.00
0.00%
1
$5.32
0.00%
00527134501
295
$3,119.41
1.03%
448
$4,840.27
1.61%
00527134510
28
$277.33
0.10%
109
$995.16
0.39%
00527134601
91
$1,125.65
0.32%
85
$1,036.76
0.31%
00527134610
0
$0.00
0.00%
1
$3.93
0.00%
00527134701
139
$1,670.57
0.48%
228
$2,771.13
0.82%
00527134901
110
$1,338.99
0.38%
132
$1,569.44
0.47%
00527134910
1
$12.78
0.00%
113
$1,355.87
0.41%
00527135001
45
$579.66
0.16%
61
$812.49
0.22%
00527135101
48
$660.87
0.17%
59
$803.05
0.21%
00527135110
0
$0.00
0.00%
8
$81.63
0.03%
00527135201
0
$0.00
0.00%
4
$89.92
0.01%
00527137001
UNITHROID
TAB 25MCG
1
$6.49
0.00%
12
$92.15
0.04%
00527137101
UNITHROID
TAB 50MCG
11
$91.52
0.04%
19
$175.38
0.07%
00527137201
UNITHROID
TAB 75MCG
1
$6.49
0.00%
8
$109.92
0.03%
00527137301
UNITHROID
TAB 88MCG
0
$0.00
0.00%
2
$19.30
0.01%
00527137401
UNITHROID
TAB 100MCG
3
$48.90
0.01%
8
$113.02
0.03%
00527137501
UNITHROID
TAB 112MCG
0
$0.00
0.00%
3
$42.53
0.01%
00527137601
UNITHROID
TAB 125MCG
4
$29.56
0.01%
3
$31.05
0.01%
Page 444 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00527137701
UNITHROID
TAB 150MCG
0
$0.00
0.00%
6
$59.20
0.02%
00527137801
UNITHROID
TAB 175MCG
0
$0.00
0.00%
4
$46.06
0.01%
00527137901
UNITHROID
TAB 200MCG
0
$0.00
0.00%
3
$42.00
0.01%
00603604632
THYROID
TAB 65MG
0
$0.00
0.00%
1
$2.42
0.00%
00603605021
THYROID
TAB 15MG
0
$0.00
0.00%
4
$17.44
0.01%
00603605121
THYROID
TAB 30MG
0
$0.00
0.00%
3
$17.92
0.01%
00603605221
THYROID
TAB 60MG
0
$0.00
0.00%
6
$28.98
0.02%
00603605232
THYROID
TAB 60MG
6
$30.08
0.02%
4
$38.62
0.01%
00603605321
THYROID
TAB 90MG
0
$0.00
0.00%
9
$61.74
0.03%
00603605521
THYROID
TAB 180MG
0
$0.00
0.00%
2
$46.78
0.01%
00677165710
THYROID
TAB 32.5MG
3
$3.99
0.01%
7
$9.38
0.03%
00677165810
THYROID
TAB 65MG
5
$11.80
0.02%
16
$43.72
0.06%
00677165910
THYROID
TAB 130MG
3
$4.89
0.01%
1
$1.63
0.00%
00689111205
LEVOXYL
TAB 200MCG
1
$21.30
0.00%
0
$0.00
0.00%
00781518001
0
$0.00
0.00%
682
$5,941.90
2.45%
00781518101
0
$0.00
0.00%
1,006
$9,825.99
3.62%
00781518201
0
$0.00
0.00%
702
$7,455.03
2.52%
00781518210
0
$0.00
0.00%
1
$9.39
0.00%
00781518301
0
$0.00
0.00%
268
$2,924.16
0.96%
00781518401
0
$0.00
0.00%
860
$9,521.50
3.09%
00781518501
0
$0.00
0.00%
232
$2,970.96
0.83%
00781518601
0
$0.00
0.00%
565
$7,402.75
2.03%
00781518701
0
$0.00
0.00%
422
$5,504.01
1.52%
00781518801
0
$0.00
0.00%
249
$3,652.73
0.90%
00781518901
0
$0.00
0.00%
248
$3,846.72
0.89%
00781519001
0
$0.00
0.00%
17
$348.38
0.06%
00781519101
0
$0.00
0.00%
111
$1,578.56
0.40%
Page 445 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
00904076160
THYROID
TAB 65MG
2
00904076260
THYROID
TAB 130MG
00904786560
THYROID
TAB 30MG
52544090201
UNITHROID
52544090301
$9.80
0.01%
13
$63.20
0.05%
0
$0.00
0.00%
1
$2.79
0.00%
8
$41.32
0.03%
0
$0.00
0.00%
TAB 25MCG
16
$141.65
0.06%
0
$0.00
0.00%
UNITHROID
TAB 50MCG
5
$45.85
0.02%
0
$0.00
0.00%
52544090401
UNITHROID
TAB 75MCG
15
$196.24
0.05%
0
$0.00
0.00%
52544090501
UNITHROID
TAB 88MCG
4
$38.56
0.01%
0
$0.00
0.00%
52544090701
UNITHROID
TAB 112MCG
8
$92.55
0.03%
0
$0.00
0.00%
52544090801
UNITHROID
TAB 125MCG
6
$58.26
0.02%
3
$36.19
0.01%
52544090901
UNITHROID
TAB 150MCG
11
$132.72
0.04%
0
$0.00
0.00%
52604341401
CYTOMEL
TAB 5MCG
60
$2,009.75
0.21%
72
$2,101.87
0.26%
52604341601
CYTOMEL
TAB 25MCG
102
$2,024.33
0.36%
119
$2,710.47
0.43%
52604341701
CYTOMEL
TAB 50MCG
12
$342.71
0.04%
9
$338.74
0.03%
52604502501
LEVOXYL
TAB 25MCG
758
$8,246.58
2.64%
573
$5,872.17
2.06%
52604502502
LEVOXYL
TAB 25MCG
237
$2,457.88
0.83%
208
$1,851.03
0.75%
52604505001
LEVOXYL
TAB 50MCG
1,342
$16,729.94
4.67%
889
$10,106.47
3.20%
52604505002
LEVOXYL
TAB 50MCG
407
$4,547.94
1.42%
378
$3,892.28
1.36%
52604507501
LEVOXYL
TAB 75MCG
854
$12,121.95
2.97%
775
$9,605.44
2.79%
52604507502
LEVOXYL
TAB 75MCG
384
$4,488.10
1.34%
246
$2,571.90
0.88%
52604508801
LEVOXYL
TAB 88MCG
382
$5,384.56
1.33%
326
$4,061.93
1.17%
52604508802
LEVOXYL
TAB 88MCG
10
$182.97
0.03%
23
$261.23
0.08%
52604510001
LEVOXYL
TAB 100MCG
818
$11,329.35
2.85%
618
$7,998.88
2.22%
52604510002
LEVOXYL
TAB 100MCG
454
$6,028.46
1.58%
344
$4,129.73
1.24%
52604511201
LEVOXYL
TAB 112MCG
337
$5,257.43
1.17%
282
$4,331.93
1.01%
52604511202
LEVOXYL
TAB 112MCG
12
$170.70
0.04%
5
$82.39
0.02%
52604512501
LEVOXYL
TAB 125MCG
630
$10,260.45
2.19%
467
$6,695.64
1.68%
52604512502
LEVOXYL
TAB 125MCG
117
$1,712.40
0.41%
108
$1,416.91
0.39%
Page 446 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
THYROID HORMONES
52604513701
LEVOXYL
TAB 137MCG
52604513702
LEVOXYL
TAB 137MCG
52604515001
LEVOXYL
TAB 150MCG
52604515002
LEVOXYL
TAB 150MCG
52604515005
LEVOXYL
52604517501
52604517502
235
$3,803.85
0.82%
2
$48.18
0.01%
522
$8,051.97
1.82%
74
$1,141.56
0.26%
TAB 150MCG
0
$0.00
LEVOXYL
TAB 175MCG
290
LEVOXYL
TAB 175MCG
22
52604520001
LEVOXYL
TAB 200MCG
52604520002
LEVOXYL
52604530001
LEVOXYL
55390088010
LEVOTHYROXIN INJ 200MCG
55390088110
198
$2,702.88
0.71%
5
$62.27
0.02%
455
$6,669.88
1.64%
37
$564.04
0.13%
0.00%
1
$12.49
0.00%
$5,638.37
1.01%
218
$3,727.30
0.78%
$299.16
0.08%
5
$71.50
0.02%
321
$6,413.11
1.12%
226
$3,998.66
0.81%
TAB 200MCG
22
$445.79
0.08%
15
$246.07
0.05%
TAB 300MCG
19
$506.11
0.07%
14
$254.68
0.05%
1
$27.49
0.00%
0
$0.00
0.00%
1
$117.54
0.00%
0
$0.00
0.00%
63323024710
0
$0.00
0.00%
1
$124.93
0.00%
64727329901
NATURE-THROI TAB 32.4MG
0
$0.00
0.00%
3
$17.26
0.01%
$30.25
0.01%
0
$0.00
0.00%
TOPICAL - ANTIFUNGALS
00003056660
MYCOLOG II CRE
1
00003056665
MYCOLOG II CRE
0
$0.00
0.00%
1
$54.55
0.01%
00003059320
MYCOSTATIN POW 100000
3
$87.17
0.03%
1
$29.28
0.01%
00003325105
ALOE VESTA OIN ANTIFUNG
1
$24.08
0.01%
0
$0.00
0.00%
00039000990
LOPROX
1
$9.17
0.01%
0
$0.00
0.00%
00062543401
MONISTAT
CRE DERM 2%
29
$1,084.40
0.33%
10
$317.15
0.12%
00062543402
MONISTAT
CRE DERM 2%
22
$485.48
0.25%
7
$137.98
0.08%
00062543403
MONISTAT
CRE DERM 2%
5
$295.15
0.06%
0
$0.00
0.00%
00062546001
SPECTAZOLE CRE 1%
96
$3,758.71
1.11%
129
$5,692.48
1.52%
00062546002
SPECTAZOLE CRE 1%
33
$695.62
0.38%
16
$434.12
0.19%
00062546003
SPECTAZOLE CRE 1%
39
$2,586.41
0.45%
51
$3,397.49
0.60%
CRE 1%
Page 447 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00066800801
PENLAC
SOL 8%
4
$348.50
0.05%
0
$0.00
0.00%
00066800802
PENLAC
SOL 8%
45
$5,074.30
0.52%
26
$2,795.40
0.31%
00067399842
LAMISIL AT CRE 1%
0
$0.00
0.00%
2
$21.14
0.02%
00067399885
LAMISIL AT CRE 1%
3
$50.19
0.03%
8
$113.44
0.09%
00072820015
EXELDERM
CRE 1%
2
$16.42
0.02%
0
$0.00
0.00%
00072820030
EXELDERM
CRE 1%
3
$62.74
0.03%
0
$0.00
0.00%
00078032882
LAMISIL
6
$370.50
0.07%
0
$0.00
0.00%
00085025406
TINACTIN
AER POWD 1%
3
$23.10
0.03%
3
$17.80
0.04%
00085070702
LOTRIMIN
LOT 1%
1
$30.37
0.01%
0
$0.00
0.00%
00085071505
TINACTIN
CRE 1%
0
$0.00
0.00%
2
$16.12
0.02%
00085071507
TINACTIN
CRE 1%
1
$8.40
0.01%
0
$0.00
0.00%
00085080901
LOTRISONE
LOT
39
$1,919.37
0.45%
2
$57.29
0.02%
00085092402
LOTRISONE
CRE
0
$0.00
0.00%
1
$9.73
0.01%
00093024831
CLOTRIMAZOLE SOL 1%
6
$53.75
0.07%
8
$81.60
0.09%
00093024843
CLOTRIMAZOLE SOL 1%
7
$32.75
0.08%
6
$22.00
0.07%
00093084015
KETOCONAZOLE CRE 2%
73
$1,213.68
0.84%
56
$887.45
0.66%
00093084030
KETOCONAZOLE CRE 2%
225
$5,730.45
2.60%
232
$5,370.96
2.74%
00093084092
KETOCONAZOLE CRE 2%
71
$2,849.10
0.82%
67
$2,657.27
0.79%
00168000715
NYSTATIN
OIN 100000
34
$162.46
0.39%
46
$236.35
0.54%
00168000730
NYSTATIN
OIN 100000
142
$934.90
1.64%
161
$1,025.79
1.90%
00168005415
NYSTATIN
CRE 100000
44
$168.40
0.51%
45
$198.69
0.53%
00168005430
NYSTATIN
CRE 100000
71
$358.55
0.82%
319
$1,737.75
3.77%
00168008115
NYSTAT/TRIAM CRE
3
$11.93
0.03%
7
$34.11
0.08%
00168008130
NYSTAT/TRIAM CRE
17
$85.72
0.20%
43
$247.33
0.51%
00168008160
NYSTAT/TRIAM CRE
5
$38.15
0.06%
18
$143.85
0.21%
00168008930
NYSTAT/TRIAM OIN
9
$56.94
0.10%
1
$6.28
0.01%
00168008960
NYSTAT/TRIAM OIN
1
$9.20
0.01%
6
$54.69
0.07%
SPR 1%
Page 448 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00168009915
KETOCONAZOLE CRE 2%
0
$0.00
0.00%
49
$829.41
0.58%
00168009930
KETOCONAZOLE CRE 2%
0
$0.00
0.00%
139
$3,389.94
1.64%
00168009960
KETOCONAZOLE CRE 2%
0
$0.00
0.00%
45
$2,174.62
0.53%
00168014231
MICONAZOLE CRE 2%
4
$20.05
0.05%
11
$49.68
0.13%
00168025815
CLOTRIM/BETA CRE DIPROP
137
$4,374.62
1.58%
188
$2,268.81
2.22%
00168025846
128
$5,870.09
1.48%
237
$5,565.60
2.80%
00168031215
ECONAZOLE
CRE 1%
8
$164.08
0.09%
6
$100.40
0.07%
00168031230
ECONAZOLE
CRE 1%
46
$1,302.13
0.53%
9
$221.40
0.11%
00168031285
ECONAZOLE
CRE 1%
23
$1,278.01
0.27%
1
$10.00
0.01%
00168031460
CICLOPIROX SUS 0.77%
0
$0.00
0.00%
1
$8.00
0.01%
00173042300
OXISTAT
CRE 1%
0
$0.00
0.00%
2
$67.37
0.02%
00173042301
OXISTAT
CRE 1%
8
$317.50
0.09%
1
$36.35
0.01%
00173042304
OXISTAT
CRE 1%
2
$102.96
0.02%
2
$76.77
0.02%
00173044801
OXISTAT
LOT 1%
2
$54.26
0.02%
0
$0.00
0.00%
00259412615
NAFTIN
CRE 1%
3
$96.99
0.03%
0
$0.00
0.00%
00259412630
NAFTIN
CRE 1%
2
$76.28
0.02%
0
$0.00
0.00%
00259412660
NAFTIN
CRE 1%
1
$58.39
0.01%
0
$0.00
0.00%
00259477040
NAFTIN
GEL 1%
1
$52.02
0.01%
0
$0.00
0.00%
00472015015
NYSTAT/TRIAM CRE
5
$23.88
0.06%
20
$88.71
0.24%
00472015030
NYSTAT/TRIAM CRE
193
$1,267.66
2.23%
149
$866.75
1.76%
00472015060
NYSTAT/TRIAM CRE
44
$388.21
0.51%
27
$218.40
0.32%
00472015515
NYSTAT/TRIAM OIN
7
$29.27
0.08%
0
$0.00
0.00%
00472015530
NYSTAT/TRIAM OIN
16
$135.54
0.18%
25
$168.92
0.30%
00472015560
NYSTAT/TRIAM OIN
1
$9.20
0.01%
8
$73.60
0.09%
00472016315
NYSTATIN
CRE 100000
14
$60.67
0.16%
7
$31.36
0.08%
00472016330
NYSTATIN
CRE 100000
325
$1,780.59
3.75%
267
$1,464.19
3.15%
00472016615
NYSTATIN
OIN 100000
22
$105.57
0.25%
15
$77.93
0.18%
Page 449 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
NYSTATIN
00472037915
00472037945
$
Market Share*
00472016630
# of Scripts
OIN 100000
120
$779.03
1.38%
104
$662.01
1.23%
0
$0.00
0.00%
0
$0.00
0.00%
26
$326.15
0.31%
59
$1,275.25
0.70%
00472073542
MICONAZOLE CRE 2%
2
$14.60
0.02%
0
$0.00
0.00%
00472073556
MICONAZOLE CRE 2%
1
$6.16
0.01%
1
$5.45
0.01%
00574200802
NYSTOP
POW 100000
1
$170.18
0.01%
00574200815
NYSTOP
POW 100000
913
$25,848.50
10.53%
13
$980.64
0.15%
553
$12,299.20
6.53%
00574200830
NYSTOP
POW 100000
36
$1,797.94
0.42%
39
$1,681.41
0.46%
00603780550
MICONAZOLE CRE 2%
0
$0.00
0.00%
1
$6.90
0.01%
00884039602
PEDI-DRI
184
00904257431
NYSTAT/TRIAM CRE
3
$10,809.02
2.12%
444
$27,175.71
5.25%
$13.62
0.03%
0
$0.00
0.00%
00904257436
NYSTAT/TRIAM CRE
1
$4.81
0.01%
0
$0.00
0.00%
00904270631
NYSTATIN
5
$32.63
0.06%
8
$42.87
0.09%
37205016010
CLOTRIMAZOLE CRE 1%
45802004811
NYSTATIN
OIN 100000
0
$0.00
0.00%
7
$62.56
0.08%
19
$108.12
0.22%
24
$135.79
0.28%
45802004835
NYSTATIN
OIN 100000
4
$24.66
0.05%
0
$0.00
0.00%
45802005911
NYSTATIN
CRE 100000
134
$599.09
1.55%
126
$697.36
1.49%
45802005935
NYSTATIN
45802046564
KETOCONAZOLE SHA 2%
CRE 100000
15
$65.63
0.17%
8
$39.02
0.09%
0
$0.00
0.00%
20
$358.10
0.24%
45802046611
ECONAZOLE
CRE 1%
0
$0.00
0.00%
4
$124.16
0.05%
49884098918
NYSTATIN
POW 100000
0
$0.00
0.00%
38
$1,151.51
0.45%
49884098960
NYSTATIN
POW 100000
0
$0.00
0.00%
5
$410.55
0.06%
50458022160
NIZORAL
CRE 2%
1
$47.48
0.01%
0
$0.00
0.00%
50458022304
NIZORAL
SHA 2%
490
$14,065.52
5.65%
420
$12,460.47
4.96%
51479042300
OXISTAT
CRE 1%
1
$137.05
0.01%
0
$0.00
0.00%
51479042304
OXISTAT
CRE 1%
2
$91.94
0.02%
1
$14.73
0.01%
51672126003
CLOTRIMAZOLE SOL 1%
7
$73.85
0.08%
4
$39.70
0.05%
POW 100000
CRE 100000
Page 450 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
51672126301
NYSTAT/TRIAM CRE
141
$620.72
1.63%
107
$491.71
1.26%
51672126302
NYSTAT/TRIAM CRE
423
$2,324.35
4.88%
341
$1,851.89
4.03%
51672126303
NYSTAT/TRIAM CRE
202
$1,573.60
2.33%
126
$1,057.88
1.49%
51672127201
NYSTAT/TRIAM OIN
43
$179.51
0.50%
34
$128.34
0.40%
51672127202
NYSTAT/TRIAM OIN
45
$235.11
0.52%
30
$153.85
0.35%
51672127203
NYSTAT/TRIAM OIN
21
$170.65
0.24%
11
$89.93
0.13%
51672127501
CLOTRIMAZOLE CRE 1%
288
$2,460.20
3.32%
271
$2,317.35
3.20%
51672127502
CLOTRIMAZOLE CRE 1%
609
$6,477.09
7.03%
534
$6,283.01
6.31%
51672127506
CLOTRIMAZOLE CRE 1%
350
$5,043.68
4.04%
501
$8,350.74
5.92%
51672127507
CLOTRIMAZOLE CRE 1%
191
$2,722.75
2.20%
110
$1,807.29
1.30%
51672128901
NYSTATIN
CRE 100000
259
$1,147.85
2.99%
233
$992.96
2.75%
51672128902
NYSTATIN
CRE 100000
783
$4,278.65
9.03%
599
$3,296.56
7.08%
51672129801
KETOCONAZOLE CRE 2%
71
$1,070.00
0.82%
38
$524.52
0.45%
51672129802
KETOCONAZOLE CRE 2%
190
$4,532.14
2.19%
113
$2,442.50
1.34%
51672129803
KETOCONAZOLE CRE 2%
77
$3,090.82
0.89%
80
$3,549.02
0.95%
51672130301
ECONAZOLE
CRE 1%
5
$121.42
0.06%
0
$0.00
0.00%
51672130302
ECONAZOLE
CRE 1%
13
$372.67
0.15%
0
$0.00
0.00%
51672130308
ECONAZOLE
CRE 1%
5
$281.05
0.06%
1
$55.71
0.01%
51672130803
CLOTRIM/BETA LOT DIPROP
0
$0.00
0.00%
7
$354.08
0.08%
51672200101
MICONAZOLE CRE 2%
0
$0.00
0.00%
1
$5.39
0.01%
51672200102
MICONAZOLE CRE 2%
0
$0.00
0.00%
10
$41.88
0.12%
51672200201
CLOTRIMAZOLE CRE 1%
0
$0.00
0.00%
1
$10.55
0.01%
51672200202
CLOTRIMAZOLE CRE 1%
3
$31.65
0.03%
8
$84.66
0.09%
51672404801
238
$6,993.93
2.75%
167
$1,970.40
1.97%
51672404806
365
$15,442.09
4.21%
308
$7,287.22
3.64%
58177080302
HYDROCORT/ CRE IODOQUIN
2
$67.20
0.02%
4
$173.41
0.05%
59366270601
HYDROCORT/ CRE IODOQUIN
0
$0.00
0.00%
5
$210.33
0.06%
Page 451 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
NYSTATIN
59930150301
59930150302
$
Market Share*
59366500001
# of Scripts
POW 100000
0
$0.00
0.00%
1
$22.55
0.01%
4
$105.89
0.05%
12
$514.39
0.14%
0
$0.00
0.00%
1
$24.50
0.01%
59930157001
CLOTRIMAZOLE CRE 1%
20
$145.45
0.23%
5
$55.85
0.06%
59930157002
CLOTRIMAZOLE CRE 1%
15
$144.78
0.17%
3
$28.61
0.04%
59930157003
CLOTRIMAZOLE CRE 1%
59930157009
CLOTRIMAZOLE CRE 1%
118
$1,591.24
1.36%
64
$885.74
0.76%
1
$24.95
0.01%
0
$0.00
0.00%
60258003230
HYDROC IODO CRE 1%
3
$145.79
0.03%
0
$0.00
0.00%
60267053104
VERSICLEAR LOT
1
$17.81
0.01%
0
$0.00
0.00%
62794015102
MENTAX
CRE 1%
6
$184.63
0.07%
3
$85.31
0.04%
62794015103
MENTAX
CRE 1%
24
$1,542.74
0.28%
6
$177.34
0.07%
67767011215
NYSTATIN
POW 100000
0
$0.00
0.00%
127
$3,767.53
1.50%
99207000915
LOPROX
CRE 0.77%
29
$869.35
0.33%
2
$51.54
0.02%
99207000930
LOPROX
CRE 0.77%
72
$3,473.13
0.83%
27
$1,192.13
0.32%
99207000990
LOPROX
CRE 0.77%
9
$839.59
0.10%
0
$0.00
0.00%
99207001010
LOPROX
SHA 1%
1
$44.35
0.01%
3
$67.40
0.04%
99207001301
LOPROX
GEL TOPICAL
0
$0.00
0.00%
2
$290.66
0.02%
99207001330
LOPROX
GEL TOPICAL
5
$238.29
0.06%
11
$527.64
0.13%
99207001345
LOPROX
GEL TOPICAL
19
$1,044.75
0.22%
26
$1,754.38
0.31%
99207001515
LOPROX
CRE 0.77%
0
$0.00
0.00%
25
$781.48
0.30%
99207001530
LOPROX
CRE 0.77%
5
$214.79
0.06%
95
$5,250.45
1.12%
99207001590
LOPROX
CRE 0.77%
1
$102.54
0.01%
14
$1,555.65
0.17%
99207002230
LOPROX
SUS 0.77%
3
$116.66
0.03%
1
$53.14
0.01%
99207002260
LOPROX
SUS 0.77%
20
$1,837.35
0.23%
20
$2,022.84
0.24%
2
$64.41
0.02%
1
$23.78
0.01%
TOPICAL - CORTICOSTEROIDS
00003024815
HALOG
OIN 0.1%
Page 452 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00003024820
HALOG
OIN 0.1%
0
00003024915
HALOG
SOL 0.1%
00003024920
HALOG
SOL 0.1%
00003050162
KENALOG
00003050649
KENALOG
00003148215
HALOG
CRE 0.1%
00003148220
HALOG
CRE 0.1%
00003148230
HALOG
00003148240
HALOG
00062035160
DERMATOP
00064041015
EMBELINE
00064220004
NUTRACORT
00064221002
NUTRACORT
00064221004
NUTRACORT
00064310015
CLODERM
CRE 0.1%
00064310045
CLODERM
00064310090
$178.30
0.06%
0
$0.00
0.00%
4
$225.12
0.05%
0.10%
2
$61.20
0.02%
$195.12
0.01%
0
$0.00
0.00%
2
$43.50
0.02%
0
$0.00
0.00%
4
$137.72
0.05%
5
$206.11
0.06%
CRE 0.1%
16
$2,056.71
0.20%
9
$512.35
0.11%
CRE 0.1%
0
$0.00
0.00%
2
$361.72
0.02%
CRE 0.1%
1
$43.64
0.01%
0
$0.00
0.00%
OIN 0.05%
0
$0.00
0.00%
1
$13.10
0.01%
LOT 1%
0
$0.00
0.00%
1
$11.45
0.01%
LOT 2.5%
3
$102.17
0.04%
1
$27.63
0.01%
LOT 2.5%
1
$81.26
0.01%
2
$78.88
0.02%
5
$159.30
0.06%
2
$46.36
0.02%
CRE 0.1%
13
$305.83
0.16%
0
$0.00
0.00%
CLODERM
CRE 0.1%
1
$69.36
0.01%
0
$0.00
0.00%
00066006960
PSORCON
CRE 0.05%
7
$819.08
0.09%
0
$0.00
0.00%
00066007160
PSORCON
OIN 0.05%
1
$125.28
0.01%
19
$2,993.50
0.23%
00066027231
PSORCON E
CRE 0.05%
4
$153.46
0.05%
0
$0.00
0.00%
00066027260
PSORCON E
CRE 0.05%
2
$184.85
0.02%
2
$181.48
0.02%
00066050715
DERMATOP
CRE 0.1%
13
$407.12
0.16%
3
$86.12
0.04%
00066050760
DERMATOP
CRE 0.1%
10
$489.16
0.12%
4
$179.94
0.05%
00066050815
DERMATOP
OIN 0.1%
3
$61.57
0.04%
2
$43.50
0.02%
00066050860
DERMATOP
OIN 0.1%
1
$49.68
0.01%
1
$48.61
0.01%
00066999701
HYTONE
1
$34.74
0.01%
0
$0.00
0.00%
00072140015
ULTRAVATE
46
$2,035.80
0.57%
27
$1,110.02
0.33%
$0.00
0.00%
5
1
$28.09
0.01%
5
$281.50
0.06%
AER SPRAY
8
$266.65
CRE 0.1%
1
OIN 2.5%
CRE 0.05%
Page 453 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ULTRAVATE
CRE 0.05%
00072145015
ULTRAVATE
OIN 0.05%
00072145050
ULTRAVATE
OIN 0.05%
00072780060
WESTCORT
OIN 0.2%
00072810015
WESTCORT
00072810060
WESTCORT
00085037001
ELOCON
OIN 0.1%
00085037002
ELOCON
OIN 0.1%
00085051701
DIPROLENE AF CRE 0.05%
00085051704
DIPROLENE AF CRE 0.05%
00085056701
ELOCON
CRE 0.1%
00085056702
ELOCON
CRE 0.1%
00085057502
DIPROLENE
00085057505
00085063401
$
Market Share*
00072140050
# of Scripts
$6,356.76
1.06%
87
$3,926.24
1.06%
131
$12,391.71
1.60%
0
$0.00
0.00%
0.01%
0
$0.00
0.00%
$73.35
0.02%
0
$0.00
0.00%
$248.22
0.06%
3
$83.42
0.04%
$152.67
0.05%
0
$0.00
0.00%
64
$3,325.79
0.79%
52
$3,425.31
0.64%
86
$6,885.19
1.06%
61
$5,301.23
0.75%
182
$6,329.89
2.25%
201
$7,818.96
2.46%
198
$9,033.46
2.45%
191
$9,137.97
2.34%
OIN 0.05%
4
$227.24
0.05%
13
$731.40
0.16%
DIPROLENE
OIN 0.05%
22
$2,162.65
0.27%
25
$2,243.55
0.31%
DIPROLENE
GEL 0.05%
1
$36.88
0.01%
0
$0.00
0.00%
00085063403
DIPROLENE
GEL 0.05%
6
$502.60
0.07%
0
$0.00
0.00%
00085085401
ELOCON
LOT 0.1%
14
$739.29
0.17%
12
$339.50
0.15%
00085085402
ELOCON
LOT 0.1%
29
$1,750.54
0.36%
30
$1,612.01
0.37%
00085096201
DIPROLENE
LOT 0.05%
3
$132.01
0.04%
7
$423.38
0.09%
00085096202
DIPROLENE
LOT 0.05%
13
$1,110.25
0.16%
13
$1,180.91
0.16%
00093026230
FLUOCINONIDE CRE 0.05%
5
$57.56
0.06%
8
$93.96
0.10%
00093026292
0
$0.00
0.00%
8
$65.45
0.10%
00093026330
FLUOCINONIDE CRE -E 0.05%
1
$6.22
0.01%
1
$6.22
0.01%
00093026392
3
$43.15
0.04%
2
$50.86
0.02%
00093026415
FLUOCINONIDE OIN 0.05%
1
$18.17
0.01%
4
$82.92
0.05%
00093026430
5
$187.91
0.06%
3
$81.84
0.04%
00093026492
8
$338.70
0.10%
24
$1,483.68
0.29%
95
$6,654.94
1.18%
57
$2,576.47
0.71%
114
$10,654.83
1.41%
1
$41.39
0.01%
CRE 0.2%
1
$18.60
CRE 0.2%
2
5
4
87
Page 454 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00093026592
FLUOCINONIDE GEL 0.05%
3
$92.98
0.04%
5
$153.89
0.06%
00093026639
FLUOCINONIDE SOL 0.05%
43
$782.09
0.53%
39
$630.95
0.48%
00093030239
BETAMETH DIP LOT 0.05%
5
$52.35
0.06%
6
$69.47
0.07%
00093067139
BETA-VAL
LOT 0.1%
11
$91.82
0.14%
9
$105.19
0.11%
00093067315
BETA-VAL
CRE 0.1%
3
$12.24
0.04%
3
$12.24
0.04%
00093067395
BETA-VAL
CRE 0.1%
4
$27.46
0.05%
14
$95.09
0.17%
00093965015
CLOBETASOL CRE 0.05%
1
$41.05
0.01%
1
$10.90
0.01%
00145062202
SARNOL-HC
2
$38.56
0.02%
0
$0.00
0.00%
00145253804
LACTICARE-HC LOT 2.5%
5
$496.70
0.06%
0
$0.00
0.00%
00168000215
TRIAMCINOLON CRE 0.5%
211
$1,640.40
2.61%
283
$2,132.44
3.46%
00168000315
76
$258.06
0.94%
94
$276.31
1.15%
00168000380
25
$118.56
0.31%
51
$260.80
0.62%
00168000415
532
$1,621.97
6.58%
602
$1,822.89
7.36%
00168000416
58
$886.54
0.72%
107
$1,439.07
1.31%
00168000480
285
$1,580.68
3.53%
273
$1,479.72
3.34%
00168000580
TRIAMCINOLON OIN 0.025%
7
$25.64
0.09%
9
$46.68
0.11%
00168000615
97
$285.57
1.20%
114
$369.99
1.39%
00168000680
73
$482.70
0.90%
94
$577.26
1.15%
00168001431
HYDROCORT
CRE 0.5%
0
$0.00
0.00%
2
$8.43
0.02%
00168001516
HYDROCORT
CRE 1%
20
$359.74
0.25%
34
$166.33
0.42%
00168001531
HYDROCORT
CRE 1%
116
$461.03
1.43%
125
$489.78
1.53%
00168002016
HYDROCORT
OIN 1%
22
$605.44
0.27%
20
$516.56
0.24%
00168002031
HYDROCORT
OIN 1%
2
$9.88
0.02%
24
$100.24
0.29%
00168003315
BETAMETH VAL OIN 0.1%
17
$82.40
0.21%
17
$72.02
0.21%
00168003346
80
$568.95
0.99%
59
$511.55
0.72%
00168004015
BETAMETH VAL CRE 0.1%
14
$79.64
0.17%
24
$125.00
0.29%
00168004046
17
$108.56
0.21%
21
$173.45
0.26%
LOT 1%
Page 455 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
BETAMETH VAL LOT 0.1%
00168005515
BETAMETH DIP CRE 0.05%
00168005546
00168005615
BETAMETH DIP OIN 0.05%
00168005646
$
Market Share*
00168004160
# of Scripts
$238.74
0.36%
29
$267.64
0.35%
7
$47.60
0.09%
13
$118.38
0.16%
17
$199.06
0.21%
22
$252.18
0.27%
3
$45.94
0.04%
7
$90.52
0.09%
7
$133.98
0.09%
11
$222.86
0.13%
00168005760
23
$234.26
0.28%
21
$202.33
0.26%
00168005815
FLUOCIN ACET CRE 0.01%
4
$9.68
0.05%
20
$80.23
0.24%
00168005860
7
$26.09
0.09%
2
$9.24
0.02%
00168005960
FLUOCIN ACET SOL 0.01%
35
$343.85
0.43%
32
$283.00
0.39%
00168006015
17
$79.19
0.21%
3
$19.19
0.04%
00168006060
16
$133.64
0.20%
22
$198.98
0.27%
00168006415
FLUOCIN ACET OIN 0.025%
10
$42.86
0.12%
4
$16.09
0.05%
00168006460
FLUOCIN ACET OIN 0.025%
26
$367.25
0.32%
24
$291.30
0.29%
00168008016
HYDROCORT
CRE 2.5%
3
$106.56
0.04%
2
$171.82
0.02%
00168008031
HYDROCORT
CRE 2.5%
252
$2,163.86
3.12%
268
$2,255.76
3.28%
00168013460
43
$873.74
0.53%
36
$613.70
0.44%
00168013515
4
$43.15
0.05%
8
$76.35
0.10%
00168013560
1
$20.34
0.01%
0
$0.00
0.00%
00168013915
4
$20.34
0.05%
3
$15.78
0.04%
00168013930
5
$36.10
0.06%
12
$98.93
0.15%
00168013960
6
$107.62
0.07%
19
$130.46
0.23%
00168014015
3
$77.61
0.04%
3
$54.83
0.04%
00168014030
11
$298.78
0.14%
16
$446.13
0.20%
00168014060
23
$1,001.77
0.28%
22
$963.28
0.27%
00168014630
HYDROCORT
67
$811.19
0.83%
91
$1,027.28
1.11%
00168015115
DESOXIMETAS OIN 0.25%
1
$30.16
0.01%
0
$0.00
0.00%
00168015160
1
$33.11
0.01%
0
$0.00
0.00%
OIN 2.5%
29
Page 456 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
HYDROCORT
00168016215
00168016230
CRE 1%
$
Market Share*
00168015431
# of Scripts
0
$0.00
0.00%
1
$6.86
0.01%
CLOBETASOL OIN 0.05%
3
$31.80
0.04%
1
$13.10
0.01%
2
$49.85
0.02%
2
$45.70
0.02%
00168016246
0
$0.00
0.00%
6
$193.10
0.07%
00168016260
1
$39.85
0.01%
5
$211.75
0.06%
00168016315
2
$24.30
0.02%
3
$40.20
0.04%
00168016330
11
$295.65
0.14%
3
$65.35
0.04%
00168016346
2
$94.65
0.02%
2
$62.25
0.02%
00168016360
0
$0.00
0.00%
13
$461.70
0.16%
00168018131
HYDROCORT
1
$4.99
0.01%
1
$6.53
0.01%
00168024215
DIFLORASONE CRE 0.05%
0
$0.00
0.00%
1
$16.40
0.01%
00168024230
3
$200.55
0.04%
1
$40.45
0.01%
00168024260
4
$307.48
0.05%
2
$121.05
0.02%
00168024330
DIFLORASONE OIN 0.05%
1
$45.14
0.01%
3
$12.50
0.04%
00168024360
7
$552.55
0.09%
2
$106.71
0.02%
00168026615
BETA DIPROP GEL 0.05%
1
$32.60
0.01%
0
$0.00
0.00%
00168026650
BETA DIPROP GEL 0.05%
0
$0.00
0.00%
1
$57.93
0.01%
00168026815
AUG BETAMET OIN 0.05%
14
$195.75
0.17%
3
$28.45
0.04%
00168026850
23
$294.97
0.28%
12
$74.35
0.15%
00168026950
CLOBETASOL SOL 0.05%
34
$1,309.90
0.42%
56
$2,169.77
0.68%
00168027960
AMCINONIDE OIN 0.1%
0
$0.00
0.00%
3
$127.82
0.04%
00168028802
HYDROCRTSONE LOT 2.5%
2
$84.60
0.02%
1
$43.55
0.01%
00168029330
CLOBETASOL GEL 0.05%
1
$28.75
0.01%
1
$31.25
0.01%
00168029360
1
$5.62
0.01%
1
$12.70
0.01%
00168030115
CLOBETASOL E CRE 0.05%
1
$41.35
0.01%
0
$0.00
0.00%
00168030130
0
$0.00
0.00%
4
$128.14
0.05%
00168030160
2
$253.65
0.02%
1
$50.74
0.01%
OIN 1%
Page 457 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00168030960
DESONIDE
OIN 0.05%
2
$50.62
0.02%
1
$27.81
0.01%
00168031002
DESONIDE
LOT 0.05%
22
$720.95
0.27%
22
$594.69
0.27%
00168031004
DESONIDE
LOT 0.05%
18
$658.23
0.22%
19
$777.58
0.23%
00168033230
FLUTICASONE CRE 0.05%
0
$0.00
0.00%
3
$74.24
0.04%
00168033660
TRIAMCINOLON LOT 0.025%
1
$33.74
0.01%
1
$36.27
0.01%
00168033760
0
$0.00
0.00%
15
$530.96
0.18%
00173040100
ACLOVATE
CRE 0.05%
15
$386.82
0.19%
2
$31.44
0.02%
00173040101
ACLOVATE
CRE 0.05%
11
$416.89
0.14%
0
$0.00
0.00%
00173040200
ACLOVATE
OIN 0.05%
13
$298.30
0.16%
1
$25.20
0.01%
00173040201
ACLOVATE
OIN 0.05%
4
$153.90
0.05%
1
$41.07
0.01%
00173040206
ACLOVATE
OIN 0.05%
2
$97.24
0.02%
0
$0.00
0.00%
00173043000
CUTIVATE
CRE 0.05%
19
$575.32
0.24%
16
$464.63
0.20%
00173043001
CUTIVATE
CRE 0.05%
52
$1,845.87
0.64%
33
$1,366.07
0.40%
00173043002
CUTIVATE
CRE 0.05%
18
$923.30
0.22%
17
$955.56
0.21%
00173043100
CUTIVATE
OIN 0.005%
3
$105.29
0.04%
3
$108.43
0.04%
00173043101
CUTIVATE
OIN 0.005%
9
$422.53
0.11%
9
$399.23
0.11%
00173043102
CUTIVATE
OIN 0.005%
5
$254.25
0.06%
3
$171.14
0.04%
00182121753
1
$4.43
0.01%
3
$36.21
0.04%
00182121851
2
$18.36
0.02%
0
$0.00
0.00%
00182139545
27
$631.25
0.33%
17
$409.38
0.21%
00182177768
1
$11.07
0.01%
0
$0.00
0.00%
00182506651
DESONIDE
CRE 0.05%
0
$0.00
0.00%
2
$11.22
0.02%
00182506652
DESONIDE
CRE 0.05%
00182506851
00299384704
CLOBEX
00299384802
CLOBEX
00299550004
CAPEX
1
$10.36
0.01%
0
$0.00
0.00%
31
$304.06
0.38%
20
$182.49
0.24%
SHA 0.05%
0
$0.00
0.00%
1
$113.85
0.01%
LOT 0.05%
3
$331.82
0.04%
1
$9.21
0.01%
67
$2,244.93
0.83%
59
$3,251.72
0.72%
SHA 0.01%
Page 458 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00299576502
DESOWEN
LOT 0.05%
4
$207.76
0.05%
0
$0.00
0.00%
00299576504
DESOWEN
LOT 0.05%
12
$677.09
0.15%
4
$240.58
0.05%
00299577515
DESOWEN
OIN 0.05%
1
$21.89
0.01%
0
$0.00
0.00%
00364244656
HYDROCORT
2
$17.20
0.02%
0
$0.00
0.00%
00364721160
1
$6.26
0.01%
2
$7.52
0.02%
00364721260
2
$13.67
0.02%
1
$6.74
0.01%
00364721372
2
$15.54
0.02%
4
$36.06
0.05%
00364734358
FLUOCIN ACET SOL 0.01%
0
$0.00
0.00%
1
$10.25
0.01%
00364734658
4
$49.56
0.05%
2
$25.32
0.02%
00414005405
2
$19.62
0.02%
0
$0.00
0.00%
00414005436
0
$0.00
0.00%
2
$10.16
0.02%
00414005505
43
$846.21
0.53%
49
$828.93
0.60%
00414005536
14
$75.58
0.17%
24
$142.85
0.29%
00414006305
0
$0.00
0.00%
3
$54.64
0.04%
00414006336
13
$71.38
0.16%
6
$32.56
0.07%
00414006405
27
$208.50
0.33%
7
$56.91
0.09%
00414006436
64
$342.39
0.79%
78
$449.97
0.95%
00462039530
APEXICON E CRE 0.05%
0
$0.00
0.00%
1
$46.40
0.01%
00462039560
APEXICON E CRE 0.05%
0
$0.00
0.00%
1
$83.56
0.01%
00469510215
ARISTOCORT A CRE 0.1%
1
$49.81
0.01%
0
$0.00
0.00%
00469510260
ARISTOCORT A CRE 0.1%
1
$33.04
0.01%
1
$29.86
0.01%
00469705415
CYCLOCORT
CRE 0.1%
0
$0.00
0.00%
1
$50.39
0.01%
00469705430
CYCLOCORT
CRE 0.1%
0
$0.00
0.00%
1
$29.43
0.01%
00469705460
CYCLOCORT
CRE 0.1%
2
$91.36
0.02%
4
$181.10
0.05%
00469711515
CYCLOCORT
OIN 0.1%
0
$0.00
0.00%
1
$66.86
0.01%
00469711530
CYCLOCORT
OIN 0.1%
0
$0.00
0.00%
1
$29.43
0.01%
00469711560
CYCLOCORT
OIN 0.1%
3
$144.54
0.04%
3
$138.95
0.04%
CRE 2.5%
Page 459 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
CYCLOCORT
00472030115
00472030116
LOT 0.1%
$
Market Share*
00469740460
# of Scripts
3
$125.55
0.04%
1
$40.91
0.01%
183
$599.64
2.26%
130
$417.56
1.59%
28
$379.00
0.35%
22
$396.54
0.27%
00472030180
376
$2,287.63
4.65%
312
$1,847.15
3.81%
00472030615
58
$171.04
0.72%
60
$206.94
0.73%
00472030680
00472032126
HYDROCORT
CRE 1%
00472033720
HYDROCORT
00472033730
HYDROCORT
00472037015
00472037045
00472037115
90
$590.44
1.11%
73
$484.33
0.89%
107
$496.32
1.32%
131
$576.12
1.60%
CRE 2.5%
22
$149.95
0.27%
21
$230.14
0.26%
CRE 2.5%
110
$1,141.86
1.36%
131
$1,161.51
1.60%
16
$66.41
0.20%
29
$134.56
0.35%
48
$394.52
0.59%
59
$446.96
0.72%
12
$49.86
0.15%
8
$52.38
0.10%
00472037145
11
$79.13
0.14%
23
$165.54
0.28%
00472037202
BETAMETH VAL LOT 0.1%
4
$29.66
0.05%
0
$0.00
0.00%
00472038015
3
$20.40
0.04%
3
$24.80
0.04%
00472038045
29
$387.30
0.36%
28
$368.60
0.34%
00472038115
13
$145.86
0.16%
30
$344.37
0.37%
00472038145
43
$539.45
0.53%
44
$574.67
0.54%
00472038215
4
$29.30
0.05%
0
$0.00
0.00%
00472038245
22
$320.06
0.27%
4
$38.80
0.05%
00472040015
5
$91.30
0.06%
4
$137.35
0.05%
00472040030
10
$230.13
0.12%
1
$20.95
0.01%
00472040045
26
$1,195.40
0.32%
25
$830.00
0.31%
00472040115
3
$61.05
0.04%
1
$10.60
0.01%
00472040130
9
$252.52
0.11%
2
$37.91
0.02%
00472040145
2
$62.70
0.02%
0
$0.00
0.00%
00472040250
6
$227.10
0.07%
4
$158.90
0.05%
Page 460 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
HYDROCORT
00472138202
00472390115
OIN 1%
$
Market Share*
00472132626
# of Scripts
2
$9.88
0.02%
3
$12.35
0.04%
1
$9.47
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
1
$8.72
0.01%
00472390130
4
$32.38
0.05%
0
$0.00
0.00%
00472390160
3
$45.48
0.04%
2
$17.17
0.02%
00496080215
LOCOID
CRE 0.1%
26
$813.17
0.32%
43
$1,477.32
0.53%
00496080245
LOCOID
CRE 0.1%
28
$1,307.19
0.35%
20
$930.50
0.24%
00496080315
LOCOID
OIN 0.1%
23
$631.50
0.28%
27
$858.34
0.33%
00496080345
LOCOID
OIN 0.1%
4
$180.30
0.05%
5
$237.00
0.06%
00496080420
LOCOID
SOL 0.1%
0
$0.00
0.00%
3
$46.36
0.04%
00496080460
LOCOID
SOL 0.1%
3
$194.49
0.04%
1
$31.10
0.01%
00496082115
LOCOID LIPO CRE 0.1%
4
$259.70
0.05%
8
$361.16
0.10%
00496082145
LOCOID LIPO CRE 0.1%
2
$114.08
0.02%
8
$455.93
0.10%
00501420307
ANUSOL HC-1 OIN 1%
2
$21.69
0.02%
0
$0.00
0.00%
00536518020
0
$0.00
0.00%
1
$4.05
0.01%
00591244630
HYDROCORT
8
$55.29
0.10%
0
$0.00
0.00%
00591721230
14
$61.48
0.17%
3
$18.20
0.04%
00591721284
5
$29.65
0.06%
0
$0.00
0.00%
00591721386
5
$37.27
0.06%
1
$3.68
0.01%
00591734660
1
$16.13
0.01%
1
$12.12
0.01%
00591736086
4
$9.44
0.05%
2
$8.96
0.02%
00603053450
HYDROCORT AC CRE 1%
1
$5.00
0.01%
1
$2.86
0.01%
00603778552
HYDROCORT
0
$0.00
0.00%
1
$27.63
0.01%
00603785190
1
$6.93
0.01%
0
$0.00
0.00%
00677074744
6
$78.81
0.07%
3
$29.42
0.04%
00677075140
1
$6.18
0.01%
0
$0.00
0.00%
00781706819
MOMETASONE OIN 0.1%
0
$0.00
0.00%
4
$154.89
0.05%
CRE 2.5%
LOT 2.5%
Page 461 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00781706827
MOMETASONE OIN 0.1%
0
$0.00
0.00%
2
$42.08
0.02%
00781706903
0
$0.00
0.00%
2
$43.25
0.02%
00781706927
0
$0.00
0.00%
2
$45.52
0.02%
00904076436
DESOXIMETAS CRE 0.25%
1
$5.19
0.01%
0
$0.00
0.00%
00904077645
0
$0.00
0.00%
1
$6.24
0.01%
00904274111
7
$48.51
0.09%
2
$13.86
0.02%
00904772436
DESONIDE
0
$0.00
0.00%
1
$6.86
0.01%
28105014904
DERMA-SMOOTH OIL /FS
144
$5,427.99
1.78%
139
$5,099.50
1.70%
28105015004
DERMA-SMOOTH OIL /FS
18
$568.10
0.22%
29
$1,088.45
0.35%
37205016210
HYDROCORT
0
$0.00
0.00%
3
$9.02
0.04%
38245012871
1
$1.00
0.01%
0
$0.00
0.00%
38245012872
7
$228.20
0.09%
0
$0.00
0.00%
38779000904
HYDROCORT
POW MICRONIZ
0
$0.00
0.00%
1
$17.50
0.01%
45802000403
HYDROCORT
CRE 2.5%
33
$273.22
0.41%
37
$295.64
0.45%
45802001402
HYDROCORT
OIN 2.5%
12
$105.01
0.15%
22
$173.41
0.27%
45802001405
HYDROCORT
OIN 2.5%
2
$55.06
0.02%
0
$0.00
0.00%
45802002146
3
$35.91
0.04%
2
$23.94
0.02%
45802004935
27
$221.31
0.33%
41
$427.58
0.50%
45802005435
17
$56.40
0.21%
13
$33.81
0.16%
45802005505
2
$22.23
0.02%
0
$0.00
0.00%
45802005535
14
$34.53
0.17%
4
$9.66
0.05%
45802006335
4
$11.14
0.05%
4
$11.14
0.05%
45802006435
26
$99.68
0.32%
37
$118.78
0.45%
45802006535
60
$405.82
0.74%
35
$249.89
0.43%
45802006737
1
$5.87
0.01%
0
$0.00
0.00%
45802011937
MOMETASONE OIN 0.1%
31
$918.99
0.38%
35
$1,312.71
0.43%
45802011942
MOMETASONE OIN 0.1%
44
$1,682.13
0.54%
58
$2,399.12
0.71%
CRE 0.05%
CRE 1%
Page 462 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
45802022111
FLUTICASONE OIN 0.005%
0
$0.00
0.00%
1
$11.88
0.01%
45802022211
0
$0.00
0.00%
7
$117.39
0.09%
45802022235
0
$0.00
0.00%
2
$34.57
0.02%
45802022237
0
$0.00
0.00%
1
$22.40
0.01%
45802028306
HYDROCORT
0
$0.00
0.00%
1
$8.55
0.01%
45802037632
AUG BETAMET CRE 0.05%
0
$0.00
0.00%
3
$208.90
0.04%
45802037635
0
$0.00
0.00%
2
$76.01
0.02%
45802042235
DESONIDE
CRE 0.05%
8
$106.50
0.10%
5
$43.31
0.06%
45802042237
DESONIDE
CRE 0.05%
13
$256.89
0.16%
18
$304.18
0.22%
45802042335
DESONIDE
OIN 0.05%
5
$84.02
0.06%
7
$89.34
0.09%
45802042337
DESONIDE
OIN 0.05%
3
$78.19
0.04%
9
$272.25
0.11%
45802042435
TRIDESILON CRE 0.05%
1
$50.88
0.01%
0
$0.00
0.00%
45802045535
HC VALERATE CRE 0.2%
42
$783.31
0.52%
57
$1,060.00
0.70%
45802045537
2
$70.77
0.02%
2
$65.62
0.02%
45802045542
54
$1,494.20
0.67%
27
$772.19
0.33%
45802049535
0
$0.00
0.00%
8
$258.84
0.10%
45802049537
1
$29.49
0.01%
12
$592.03
0.15%
46287000316
HYDROCORT/AB OIN 1%
0
$0.00
0.00%
2
$7.40
0.02%
49158010108
HYDROCORT
4
$9.90
0.05%
0
$0.00
0.00%
49158014008
7
$29.18
0.09%
12
$40.85
0.15%
49158016008
3
$10.72
0.04%
7
$21.01
0.09%
49158016016
1
$23.64
0.01%
0
$0.00
0.00%
49158020008
HYDROCORT
4
$30.24
0.05%
0
$0.00
0.00%
49158021224
2
$28.16
0.02%
0
$0.00
0.00%
51479040100
ACLOVATE
CRE 0.05%
2
$56.42
0.02%
1
$14.22
0.01%
51479040101
ACLOVATE
CRE 0.05%
1
$31.87
0.01%
0
$0.00
0.00%
51479040106
ACLOVATE
CRE 0.05%
1
$36.96
0.01%
1
$38.63
0.01%
LOT 1%
CRE 1%
CRE 2.5%
Page 463 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
ACLOVATE
51479040201
ACLOVATE
51479043000
CUTIVATE
51479043001
CUTIVATE
51479043002
$
Market Share*
51479040200
# of Scripts
OIN 0.05%
1
$44.39
0.01%
0
OIN 0.05%
1
$29.37
0.01%
CRE 0.05%
3
$52.95
0.04%
CRE 0.05%
5
$152.85
CUTIVATE
CRE 0.05%
1
51479043101
CUTIVATE
OIN 0.005%
51479043102
CUTIVATE
OIN 0.005%
51672125301
$0.00
0.00%
0
$0.00
0.00%
1
$19.76
0.01%
0.06%
4
$109.60
0.05%
$44.18
0.01%
1
$43.24
0.01%
1
$29.24
0.01%
0
$0.00
0.00%
0
$0.00
0.00%
1
$43.24
0.01%
43
$227.31
0.53%
47
$272.05
0.57%
51672125302
114
$903.94
1.41%
106
$925.94
1.30%
51672125303
141
$2,188.59
1.74%
121
$962.17
1.48%
51672125304
1
$21.47
0.01%
1
$21.47
0.01%
51672125401
3
$16.33
0.04%
3
$10.59
0.04%
51672125402
0
$0.00
0.00%
7
$56.40
0.09%
51672125403
12
$70.59
0.15%
2
$31.14
0.02%
51672125801
29
$542.10
0.36%
37
$485.68
0.45%
51672125802
47
$1,055.11
0.58%
57
$1,378.74
0.70%
51672125803
37
$1,409.34
0.46%
37
$1,558.00
0.45%
51672125806
53
$1,695.31
0.66%
32
$966.90
0.39%
51672125901
21
$430.79
0.26%
34
$670.23
0.42%
51672125902
32
$799.26
0.40%
34
$823.47
0.42%
51672125903
43
$1,731.40
0.53%
53
$2,269.05
0.65%
51672125906
30
$900.98
0.37%
38
$1,200.11
0.46%
51672126101
DESOXIMETAS GEL 0.05%
0
$0.00
0.00%
2
$34.58
0.02%
51672126103
DESOXIMETAS GEL 0.05%
1
$55.04
0.01%
2
$112.58
0.02%
51672126201
3
$70.05
0.04%
13
$578.48
0.16%
51672126203
29
$1,715.74
0.36%
15
$900.77
0.18%
51672126401
15
$390.71
0.19%
15
$440.69
0.18%
Page 464 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
51672126402
33
$939.53
0.41%
17
$480.84
0.21%
51672126403
64
$2,891.92
0.79%
43
$2,599.07
0.53%
51672126901
67
$344.73
0.83%
36
$184.93
0.44%
51672126906
138
$1,074.61
1.71%
79
$613.33
0.97%
51672127001
33
$626.75
0.41%
42
$664.45
0.51%
51672127003
113
$4,543.01
1.40%
62
$2,459.75
0.76%
51672127101
13
$376.21
0.16%
11
$212.76
0.13%
51672127103
7
$318.86
0.09%
10
$397.93
0.12%
51672127302
0
$0.00
0.00%
4
$53.07
0.05%
51672127304
13
$219.49
0.16%
9
$179.04
0.11%
51672127401
48
$330.92
0.59%
60
$416.58
0.73%
51672127406
97
$1,217.26
1.20%
105
$1,218.12
1.28%
51672127901
2
$29.05
0.02%
1
$8.30
0.01%
51672127902
2
$31.50
0.02%
7
$79.50
0.09%
51672127903
1
$33.14
0.01%
0
$0.00
0.00%
51672128001
DESONIDE
CRE 0.05%
19
$233.75
0.24%
25
$181.52
0.31%
51672128003
DESONIDE
CRE 0.05%
24
$488.52
0.30%
21
$290.06
0.26%
51672128101
DESONIDE
OIN 0.05%
10
$136.08
0.12%
15
$172.32
0.18%
51672128103
DESONIDE
OIN 0.05%
13
$334.66
0.16%
10
$264.40
0.12%
51672129001
69
$1,463.48
0.85%
68
$1,418.55
0.83%
51672129003
35
$1,208.01
0.43%
37
$1,329.11
0.45%
51672129006
80
$2,316.51
0.99%
91
$2,654.13
1.11%
51672129201
HC VALERATE OIN 0.2%
28
$594.03
0.35%
30
$885.96
0.37%
51672129203
8
$246.48
0.10%
9
$314.46
0.11%
51672129206
15
$519.32
0.19%
11
$328.14
0.13%
51672129302
4
$137.90
0.05%
4
$172.40
0.05%
51672129303
42
$1,762.52
0.52%
20
$1,094.67
0.24%
Page 465 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
51672129401
2
$60.00
0.02%
0
$0.00
0.00%
51672129402
1
$28.75
0.01%
4
$101.25
0.05%
51672129403
1
$59.15
0.01%
1
$56.65
0.01%
51672129501
1
$35.18
0.01%
0
$0.00
0.00%
51672129502
1
$47.09
0.01%
0
$0.00
0.00%
51672129503
2
$80.16
0.02%
3
$175.72
0.04%
51672129603
2
$145.17
0.02%
0
$0.00
0.00%
51672129702
3
$88.55
0.04%
5
$165.60
0.06%
51672129703
0
$0.00
0.00%
3
$152.22
0.04%
51672131001
0
$0.00
0.00%
8
$260.10
0.10%
51672131003
0
$0.00
0.00%
3
$154.77
0.04%
51672131601
ALCLOMETASON OIN 0.05%
0
$0.00
0.00%
3
$20.47
0.04%
51672201302
HYDROCORT
0
$0.00
0.00%
4
$7.78
0.05%
51672405402
AMCINONIDE CRE 0.1%
2
$76.26
0.02%
0
$0.00
0.00%
51672405403
AMCINONIDE CRE 0.1%
0
$0.00
0.00%
1
$17.03
0.01%
51672406102
HYDROCORT
SOL BUTYRATE
0
$0.00
0.00%
2
$37.40
0.02%
51672406104
HYDROCORT
SOL BUTYRATE
0
$0.00
0.00%
1
$37.71
0.01%
51672520203
TOPICORT
0
$0.00
0.00%
1
$81.75
0.01%
55515001424
CORDRAN 24X3 TAP 4MCG/CM
1
$20.02
0.01%
2
$46.76
0.02%
55515001480
CORDRAN 80X3 TAP 4MCG/CM
9
$324.51
0.11%
4
$232.40
0.05%
55515005260
CORDRAN
LOT 0.05%
1
$39.31
0.01%
1
$41.77
0.01%
55515042045
CORMAX
CRE 0.05%
2
$41.90
0.02%
4
$124.00
0.05%
55515043025
CORMAX
SOL 0.05%
1
$37.85
0.01%
0
$0.00
0.00%
55515043050
CORMAX
SOL 0.05%
6
$237.64
0.07%
0
$0.00
0.00%
59366270704
HYDROCORT
LOT 1%
16
$208.42
0.20%
25
$323.90
0.31%
59366270802
HYDROCORT
LOT 2.5%
23
$1,163.30
0.28%
33
$2,151.77
0.40%
59366270804
HYDROCORT
LOT 2.5%
4
$389.45
0.05%
4
$286.01
0.05%
CRE 1%
GEL 0.05%
Page 466 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
59366279101
0
$0.00
0.00%
1
$17.30
0.01%
59366279103
1
$28.75
0.01%
1
$28.75
0.01%
59366279106
0
$0.00
0.00%
1
$7.50
0.01%
59366285502
DESONIDE
LOT 0.05%
4
$127.59
0.05%
5
$147.58
0.06%
59366285504
DESONIDE
LOT 0.05%
3
$140.11
0.04%
4
$190.00
0.05%
59772780002
12
$329.57
0.15%
7
$111.34
0.09%
59772780004
5
$149.10
0.06%
3
$91.46
0.04%
59772780007
13
$453.92
0.16%
12
$535.05
0.15%
59772810004
47
$1,388.88
0.58%
54
$1,627.63
0.66%
59772810005
26
$1,093.59
0.32%
42
$1,627.90
0.51%
59772810007
80
$1,671.16
0.99%
71
$1,569.83
0.87%
59930157501
10
$71.55
0.12%
4
$41.00
0.05%
59930157503
7
$104.85
0.09%
3
$32.12
0.04%
60432013325
0
$0.00
0.00%
3
$58.05
0.04%
60432013350
2
$60.98
0.02%
0
$0.00
0.00%
60432056060
14
$498.42
0.17%
10
$336.19
0.12%
60432056160
44
$1,955.01
0.54%
44
$1,797.66
0.54%
61570007001
PROCTOCORT CRE 1%
1
$43.84
0.01%
0
$0.00
0.00%
63032002100
LUXIQ
AER 0.12%
9
$753.72
0.11%
3
$261.20
0.04%
63032002150
LUXIQ
AER 0.12%
2
$106.04
0.02%
4
$238.14
0.05%
63032003100
OLUX
AER 0.05%
9
$429.26
0.11%
4
$606.98
0.05%
63032003150
OLUX
AER 0.05%
2
$161.00
0.02%
2
$343.19
0.02%
63304040501
PROCTO-KIT CRE 1%
0
$0.00
0.00%
8
$37.58
0.10%
64980030230
PROCTO-PAK CRE 1%
1
$36.95
0.01%
0
$0.00
0.00%
65880029301
TEXACORT
SOL 2.5%
0
$0.00
0.00%
1
$19.22
0.01%
99207001115
TOPICORT
CRE 0.25%
1
$30.66
0.01%
0
$0.00
0.00%
99207001160
TOPICORT
CRE 0.25%
1
$72.43
0.01%
0
$0.00
0.00%
Page 467 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TOPICAL - ACNE PREPARATIONS
00004015549
ACCUTANE
CAP 10MG
3
$677.91
0.08%
16
$6,890.24
0.44%
00004015649
ACCUTANE
CAP 40MG
5
$2,118.70
0.13%
34
$18,537.13
0.93%
00004016949
ACCUTANE
CAP 20MG
11
$6,344.92
0.28%
21
$11,275.41
0.58%
00009311601
CLEOCIN-T
SOL 1%
26
$676.64
0.65%
55
$1,698.13
1.51%
00009311602
CLEOCIN-T
SOL 1%
121
$5,317.23
3.03%
158
$7,501.82
4.33%
00009311614
CLEOCIN-T
PAD 1%
29
$1,591.81
0.73%
97
$5,299.40
2.66%
00009332901
CLEOCIN-T
LOT 1%
42
$2,323.22
1.05%
117
$6,974.99
3.21%
00009333101
CLEOCIN-T
GEL 1%
83
$5,709.06
2.08%
177
$12,434.00
4.85%
00009333102
CLEOCIN-T
GEL 1%
55
$2,513.83
1.38%
94
$4,307.95
2.58%
00023869430
AZELEX
CRE 20%
64
$2,922.25
1.60%
55
$2,672.23
1.51%
00023869450
AZELEX
CRE 20%
14
$1,008.30
0.35%
15
$1,104.51
0.41%
00062007507
RETIN-A
LIQ 0.05%
4
$284.34
0.10%
2
$140.89
0.05%
00062016501
RETIN-A
CRE 0.025%
17
$725.93
0.43%
33
$1,527.38
0.90%
00062016502
RETIN-A
CRE 0.025%
17
$1,266.19
0.43%
53
$4,253.93
1.45%
00062017512
RETIN-A
CRE 0.05%
19
$875.23
0.48%
23
$1,298.20
0.63%
00062017513
RETIN-A
CRE 0.05%
12
$1,033.87
0.30%
34
$3,009.27
0.93%
00062019002
RETIN-A MICR GEL 0.1%
40
$1,797.76
1.00%
6
$252.98
0.16%
00062019003
46
$3,244.05
1.15%
15
$611.56
0.41%
00062020402
8
$388.34
0.20%
4
$138.49
0.11%
00062020403
12
$838.91
0.30%
4
$145.67
0.11%
00062027501
RETIN-A
CRE 0.1%
12
$1,207.39
0.30%
22
$2,272.07
0.60%
00062027523
RETIN-A
CRE 0.1%
7
$436.69
0.18%
11
$610.26
0.30%
00062047542
RETIN-A
GEL 0.025%
14
$551.08
0.35%
19
$1,004.28
0.52%
00062047545
RETIN-A
GEL 0.025%
4
$257.81
0.10%
25
$1,945.50
0.68%
00062057544
RETIN-A
GEL 0.01%
7
$309.24
0.18%
18
$748.32
0.49%
00062057546
RETIN-A
GEL 0.01%
23
$1,791.33
0.58%
32
$2,521.51
0.88%
Page 468 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
AKNE-MYCIN OIN 2%
00066002825
00066043015
$
Market Share*
00064300025
# of Scripts
13
$524.36
0.33%
16
$713.82
0.44%
SULFACET-R LOT
1
$45.20
0.03%
5
$241.88
0.14%
BENZAGEL-5 GEL 5%
1
$25.53
0.03%
0
$0.00
0.00%
00066043115
BENZAGEL-10 GEL 10%
3
$87.77
0.08%
0
$0.00
0.00%
00066049425
BENZACLIN
GEL 1-5%
154
$8,713.19
3.85%
33
$1,258.06
0.90%
00066049450
BENZACLIN
GEL 1-5%
69
$6,099.88
1.73%
24
$1,360.56
0.66%
00066051046
BENZAMYCIN GEL
37
$3,896.52
0.93%
4
$316.48
0.11%
00066057760
BENZAMYCIN GEL PAK
17
$935.76
0.43%
7
$142.27
0.19%
00066750002
KLARON
LOT 10%
2
$116.52
0.05%
0
$0.00
0.00%
00066750004
KLARON
LOT 10%
7
$554.98
0.18%
2
$123.82
0.05%
00066902825
SULFACET-R LOT TINT-FRE
1
$46.11
0.03%
0
$0.00
0.00%
00066985030
NORITATE
CRE 1%
18
$824.27
0.45%
0
$0.00
0.00%
00066985060
NORITATE
CRE 1%
0
$0.00
0.00%
2
$171.24
0.05%
00072200004
DESQUAM-X
BAR 10%
1
$5.87
0.03%
0
$0.00
0.00%
00072610345
DESQUAM-E
GEL 5%
2
$41.69
0.05%
0
$0.00
0.00%
00072620345
DESQUAM-E
GEL 10%
1
$15.33
0.03%
0
$0.00
0.00%
00072672101
DESQUAM-X
GEL 10%
1
$12.44
0.03%
0
$0.00
0.00%
00072700005
DESQUAM-X
LIQ WASH 10%
2
$36.10
0.05%
0
$0.00
0.00%
00072830360
T-STAT
1
$25.39
0.03%
0
$0.00
0.00%
00074269802
ERYDERM
0
$0.00
0.00%
1
$7.47
0.03%
00145231005
BREVOXYL
1
$17.50
0.03%
0
$0.00
0.00%
00145237105
DUAC
26
$1,842.86
0.65%
26
$1,050.39
0.71%
00145237406
BREVOXYL
GEL 4%
1
$69.44
0.03%
1
$20.00
0.03%
00145237408
BREVOXYL
GEL 4%
2
$66.10
0.05%
0
$0.00
0.00%
00145238408
BREVOXYL
GEL 8%
3
$202.37
0.08%
0
$0.00
0.00%
00145247280
CLINDETS
1
$31.25
0.03%
0
$0.00
0.00%
00145247406
BREVOXYL-4 LIQ CREM WSH
5
$152.82
0.13%
5
$162.43
0.14%
PAD 2%
SOL 2%
LOT 4%
GEL 1-5%
PAD 1%
Page 469 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00145248406
BREVOXYL-8 LIQ CREM WSH
0
$0.00
0.00%
4
00168020130
CLINDAMYCIN SOL 1%
3
$24.18
0.08%
00168020160
CLINDAMYCIN SOL 1%
7
$79.39
0.18%
00168020230
CLINDAMYCIN GEL 1%
63
$1,439.83
00168020260
CLINDAMYCIN GEL 1%
84
00168020360
CLINDAMYCIN LOT 1%
00168021560
ERYTHROMYCIN SOL 2%
00168021630
$134.35
0.11%
0
$0.00
0.00%
7
$60.43
0.19%
1.58%
18
$198.38
0.49%
$2,910.72
2.10%
19
$315.07
0.52%
44
$1,850.61
1.10%
4
$113.33
0.11%
22
$151.94
0.55%
107
$703.51
2.93%
ERYTHROMYCIN GEL 2%
31
$503.37
0.78%
38
$627.80
1.04%
00168021660
ERYTHROMYCIN GEL 2%
29
$695.70
0.73%
57
$1,370.93
1.56%
00168032346
METRONIDAZOL CRE 0.75%
0
$0.00
0.00%
33
$1,933.93
0.90%
00172362149
ERYTHROMYCIN PAD 2%
1
$21.88
0.03%
0
$0.00
0.00%
00173044002
EMGEL
GEL 2%
2
$46.70
0.05%
0
$0.00
0.00%
00245016812
CLENIA
EMU FOAMING
0
$0.00
0.00%
1
$52.54
0.03%
00299359060
BENZAC W
GEL 2.5%
1
$21.67
0.03%
0
$0.00
0.00%
00299362060
BENZAC AC
GEL 2.5%
0
$0.00
0.00%
1
$14.20
0.03%
00299362560
BENZAC AC
GEL 5%
1
$22.54
0.03%
0
$0.00
0.00%
00299363060
BENZAC AC
GEL 10%
1
$18.81
0.03%
0
$0.00
0.00%
00299363508
BENZAC AC
LIQ WASH2.5%
1
$29.28
0.03%
0
$0.00
0.00%
00299364008
BENZAC AC
LIQ WASH 5%
2
$65.35
0.05%
0
$0.00
0.00%
00299364508
BENZAC AC
LIQ WASH 10%
3
$109.21
0.08%
1
$27.03
0.03%
00299367208
BENZAC W
LIQ 10% WASH
4
$130.28
0.10%
0
$0.00
0.00%
00299383528
METROGEL
GEL 0.75%
6
$322.17
0.15%
4
$149.72
0.11%
00299383545
METROGEL
GEL 0.75%
290
$17,513.00
7.26%
280
$17,723.64
7.67%
00299383645
METROCREAM CRE 0.75%
95
$6,534.08
2.38%
51
$3,764.37
1.40%
00299383802
METROLOTION LOT 0.75%
29
$2,050.55
0.73%
35
$2,714.81
0.96%
00299383906
ROSANIL
13
$425.18
0.33%
0
$0.00
0.00%
00299450042
CLINDAGEL
3
$130.78
0.08%
1
$52.97
0.03%
EMU CLEANSER
GEL 1%
Page 470 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
CLINDAGEL
00299450077
CLINDAGEL
00299590516
DIFFERIN
00299590530
DIFFERIN
00299591015
$
Market Share*
00299450075
# of Scripts
GEL 1%
1
GEL 1%
PAD 0.1%
$86.49
0.03%
0
$0.00
0.00%
1
$83.99
0.03%
4
$290.94
0.10%
0
$0.00
0.00%
4
$272.66
0.11%
SOL 0.1%
5
$425.98
0.13%
1
$32.17
0.03%
DIFFERIN
GEL 0.1%
19
$1,115.69
0.48%
1
$110.93
0.03%
00299591045
DIFFERIN
GEL 0.1%
00299591515
DIFFERIN
CRE 0.1%
322
$25,544.15
8.06%
303
$26,137.98
8.30%
7
$277.30
0.18%
1
$75.07
0.03%
00299591545
DIFFERIN
CRE 0.1%
106
$8,344.73
2.65%
142
$12,036.49
3.89%
00472011720
TRETINOIN CRE 0.025%
9
$190.75
0.23%
7
$80.34
0.19%
00472011745
14
$730.50
0.35%
2
$60.48
0.05%
00472098792
CLINDAMYCIN SOL 1%
3
$38.31
0.08%
0
$0.00
0.00%
00472124492
ERYTHROMYCIN SOL 2%
7
$38.89
0.18%
0
$0.00
0.00%
00536408956
BENZOYL PER GEL 5%
0
$0.00
0.00%
1
$8.67
0.03%
00536409256
BENZOYL PER GEL 10%
0
$0.00
0.00%
4
$37.10
0.11%
00555093586
CLARAVIS
CAP 20 MG
0
$0.00
0.00%
2
$20.00
0.05%
00555093686
CLARAVIS
CAP 40MG
0
$0.00
0.00%
1
$383.46
0.03%
00603770982
BENZOYL PER GEL 5%
4
$31.24
0.10%
4
$69.52
0.11%
00603771082
BENZOYL PER GEL 10%
0
$0.00
0.00%
1
$16.78
0.03%
00603771482
BENZOYL PER GEL 5%
15
$115.26
0.38%
11
$195.89
0.30%
00603771487
BENZOYL PER GEL 5%
0
$0.00
0.00%
1
$22.72
0.03%
00603771582
BENZOYL PER GEL 10%
1
$1.00
0.03%
5
$72.01
0.14%
00603771587
BENZOYL PER GEL 10%
0
$0.00
0.00%
2
$33.98
0.05%
00603773752
ERYTHROMYCIN SOL 2%
2
$14.94
0.05%
0
$0.00
0.00%
00781704519
2
$112.00
0.05%
0
$0.00
0.00%
00781704719
TRETINOIN CRE 0.05%
4
$244.90
0.10%
0
$0.00
0.00%
00781704722
TRETINOIN CRE 0.05%
1
$29.35
0.03%
0
$0.00
0.00%
00781704919
TRETINOIN CRE 0.1%
1
$72.20
0.03%
0
$0.00
0.00%
Page 471 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
00781704922
TRETINOIN CRE 0.1%
1
$33.95
0.03%
00781705449
ERYTHROMYCIN GEL /BENZOYL
0
$0.00
0.00%
00781705459
0
$0.00
0.00%
00781706119
TRETINOIN GEL 0.025%
1
$56.00
0.03%
00781706127
1
$20.90
24208042160
ERYTHROMYCIN SOL 2%
30
45802003846
ERYTHROMYCIN SOL 2%
13
45802008302
45802008386
45802026337
45802026393
$0.00
0.00%
5
$265.55
0.14%
39
$3,160.44
1.07%
0
$0.00
0.00%
0.03%
0
$0.00
0.00%
$209.29
0.75%
6
$44.82
0.16%
$84.40
0.33%
5
$39.16
0.14%
49
$3,030.59
1.23%
49
$3,067.06
1.34%
146
$13,923.06
3.65%
105
$11,299.02
2.88%
CLINDAMYCIN PAD 1%
19
$469.20
0.48%
1
$31.25
0.03%
CLINDAMYCIN PAD 1%
1
$35.44
0.03%
2
$18.47
0.05%
50419082001
FINEVIN
2
$74.56
0.05%
0
$0.00
0.00%
50419082501
FINACEA
5
$169.24
0.13%
8
$256.67
0.22%
59366246203
ERYTHROMYCIN GEL 2%
55
$880.99
1.38%
57
$943.83
1.56%
59366246205
ERYTHROMYCIN GEL 2%
34
$860.51
0.85%
28
$718.44
0.77%
59366272405
SOD SUL/SULF SUS 10-5%
0
$0.00
0.00%
2
$62.31
0.05%
59366273103
SOD SUL/SULF LOT 10%-5%
40
$1,638.41
1.00%
47
$2,097.66
1.29%
59366273608
BENZOYL PER LIQ WASH 2.5
18
$342.40
0.45%
17
$280.95
0.47%
59366273904
BENZOYL PER LIQ WASH 5%
9
$170.24
0.23%
6
$114.42
0.16%
59366273905
29
$442.13
0.73%
13
$195.60
0.36%
59366273908
90
$2,302.94
2.25%
94
$2,714.72
2.58%
59366274003
7
$192.45
0.18%
7
$246.09
0.19%
59366274105
13
$224.23
0.33%
24
$467.85
0.66%
59366274108
82
$2,503.59
2.05%
58
$1,865.73
1.59%
59366274201
BENZOYL PER GEL 2.5%
37
$762.53
0.93%
50
$995.10
1.37%
59366274301
BENZOYL PER GEL 5%
140
$1,328.37
3.50%
123
$2,642.97
3.37%
59366274303
BENZOYL PER GEL 5%
37
$470.05
0.93%
30
$802.17
0.82%
CRE 20%
GEL 15%
0
Page 472 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
59366274401
BENZOYL PER GEL 10%
55
$1,041.51
1.38%
89
$1,793.76
2.44%
59366274403
BENZOYL PER GEL 10%
12
$269.80
0.30%
14
$369.55
0.38%
59366274501
BENZOYL PER GEL 5%
11
$118.75
0.28%
8
$172.15
0.22%
59366274601
BENZOYL PER GEL 10%
8
$161.07
0.20%
7
$140.05
0.19%
59366276205
9
$322.90
0.23%
11
$395.30
0.30%
59366276207
59366285206
CLINDAMYCIN PAD 1%
59366287605
METRONIDAZOL CRE 0.75%
59366287806
ERYTHROMYCIN PAD 2%
59762372801
59762372802
0
$0.00
0.00%
2
$148.54
0.05%
14
$372.75
0.35%
0
$0.00
0.00%
0
$0.00
0.00%
25
$1,483.55
0.68%
151
$3,649.02
3.78%
169
$4,062.43
4.63%
CLINDAMYCIN SOL 1%
18
$147.00
0.45%
7
$46.70
0.19%
CLINDAMYCIN SOL 1%
52
$605.21
1.30%
11
$97.92
0.30%
59762372803
CLINDAMYCIN PAD 1%
2
$62.50
0.05%
0
$0.00
0.00%
59762374301
CLINDAMYCIN GEL 1%
15
$266.32
0.38%
3
$30.00
0.08%
59762374302
CLINDAMYCIN GEL 1%
10
$418.50
0.25%
1
$42.35
0.03%
59762374401
CLINDAMYCIN LOT 10MG/ML
0
$0.00
0.00%
1
$7.50
0.03%
60267011930
5
$54.66
0.13%
2
$43.27
0.05%
60432067160
ERYTHROMYCIN SOL 2%
137
$926.68
3.43%
53
$363.38
1.45%
60432069330
CLINDAMYCIN SOL 1%
1
$12.77
0.03%
0
$0.00
0.00%
60432069360
CLINDAMYCIN SOL 1%
33
$375.65
0.83%
1
$4.85
0.03%
62436053004
BENZASHAVE 5 CRE 5%
0
$0.00
0.00%
1
$9.67
0.03%
62794061188
AMNESTEEM
CAP 10MG
0
$0.00
0.00%
1
$130.62
0.03%
62794061193
AMNESTEEM
CAP 10MG
1
$382.65
0.03%
0
$0.00
0.00%
62794061293
AMNESTEEM
CAP 20MG
6
$1,517.46
0.15%
2
$306.04
0.05%
62794061488
AMNESTEEM
CAP 40MG
3
$770.38
0.08%
2
$795.73
0.05%
62794061493
AMNESTEEM
CAP 40MG
17
$4,876.85
0.43%
7
$3,254.69
0.19%
63304044731
SOTRET
CAP 30MG
0
$0.00
0.00%
1
$24.66
0.03%
63304058631
SOTRET
CAP 40MG
0
$0.00
0.00%
1
$93.11
0.03%
Page 473 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
AVAR
GEL GREEN
65880020008
AVAR
EMU CLEANSER
66530024120
TRETINOIN CRE 0.1%
66530024145
TRETINOIN CRE 0.1%
66530024220
$
Market Share*
65880000245
# of Scripts
$46.87
0.03%
0
$0.00
0.00%
1
$37.24
0.03%
10
$304.06
0.25%
0
$0.00
0.00%
4
$101.39
0.11%
9
$576.03
0.23%
6
$158.96
0.16%
TRETINOIN CRE 0.05%
12
$394.20
0.30%
1
$61.85
0.03%
66530024245
TRETINOIN CRE 0.05%
66530024320
25
$1,359.65
0.63%
6
$114.68
0.16%
24
$516.86
0.60%
3
$28.75
0.08%
66530024345
42
$2,157.75
1.05%
2
$19.09
0.05%
66530024415
5
$99.50
0.13%
1
$5.54
0.03%
66530024445
14
$721.50
0.35%
2
$59.73
0.05%
66530024515
TRETINOIN GEL 0.01%
5
$208.71
0.13%
2
$42.81
0.05%
66530024545
TRETINOIN GEL 0.01%
20
$1,129.08
0.50%
1
$24.10
0.03%
99207005101
TRIAZ
5
$413.20
0.13%
0
$0.00
0.00%
99207010612
TRIAZ CLEANS LOT 10%
1
$25.79
0.03%
0
$0.00
0.00%
99207011609
TRIAZ CLEANS LOT 6%
7
$316.51
0.18%
2
$85.00
0.05%
99207011612
TRIAZ CLEANS LOT 6%
20
$532.97
0.50%
1
$6.90
0.03%
99207020609
TRIAZ CLEANS LOT 3%
3
$143.26
0.08%
0
$0.00
0.00%
99207020612
TRIAZ CLEANS LOT 3%
4
$139.43
0.10%
0
$0.00
0.00%
99207020701
TRIAZ
1
$35.22
0.03%
0
$0.00
0.00%
99207020809
TRIAZ CLEANS LOT 9%
7
$225.14
0.18%
0
$0.00
0.00%
99207020812
TRIAZ CLEANS LOT 9%
1
$30.19
0.03%
0
$0.00
0.00%
99207020901
TRIAZ
GEL 3%
4
$130.41
0.10%
2
$47.24
0.05%
99207022230
TRIAZ
PAD 6%
7
$513.05
0.18%
1
$20.04
0.03%
99207074106
PLEXION
EMU 10-5%
8
$268.87
0.20%
1
$48.00
0.03%
99207074112
PLEXION
EMU 10-5%
2
$146.58
0.05%
0
$0.00
0.00%
99207074330
PLEXION TS SUS 10-5%
10
$544.70
0.25%
0
$0.00
0.00%
99207074404
PLEXION SCT CRE 10-5%
1
$46.14
0.03%
0
$0.00
0.00%
GEL 6%
GEL 9%
1
Page 474 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TOPICAL - ANTIBIOTIC
00029152544
BACTROBAN
OIN 2%
601
$27,094.61
36.80%
68
$3,504.24
4.28%
00029152722
BACTROBAN
CRE 2%
381
$12,980.63
23.33%
328
$11,315.89
20.63%
00029152725
BACTROBAN
CRE 2%
438
$22,672.63
26.82%
425
$22,143.12
26.73%
00062161001
CENTANY
OIN 2%
9
$231.16
0.55%
4
$63.60
0.25%
00062161003
CENTANY
OIN 2%
3
$149.92
0.18%
5
$144.75
0.31%
00093101042
MUPIROCIN OIN 2%
51
$1,954.47
3.12%
360
$7,887.02
22.64%
00168001131
BACITR ZINC OIN 500/GM
5
$24.26
0.31%
0
$0.00
0.00%
00168001231
BAC/NEO/POLY OIN
3
$20.22
0.18%
2
$12.37
0.13%
00168001235
BAC/NEO/POLY OIN
0
$0.00
0.00%
1
$6.97
0.06%
00168007115
GENTAMICIN CRE 0.1%
26
$101.10
1.59%
27
$119.03
1.70%
00168007815
GENTAMICIN OIN 0.1%
26
$156.95
1.59%
20
$132.13
1.26%
00182020833
BACITRACIN OIN 500/GM
2
$8.11
0.12%
3
$21.31
0.19%
00182020834
0
$0.00
0.00%
7
$43.43
0.44%
00182512234
TRIPLE ANTIB OIN
1
$5.84
0.06%
1
$8.54
0.06%
00295122395
0
$0.00
0.00%
2
$8.02
0.13%
00472017934
TRIPLE ANTIB OIN
1
$2.99
0.06%
0
$0.00
0.00%
00472017956
TRIPLE ANTIB OIN
7
$60.14
0.43%
4
$39.92
0.25%
00536110095
TRIPLE ANTIB OIN
1
$7.66
0.06%
0
$0.00
0.00%
00603044150
2
$12.96
0.12%
0
$0.00
0.00%
00677075237
TRIPLE ANTIB OIN
1
$5.25
0.06%
0
$0.00
0.00%
00713028031
1
$1.08
0.06%
2
$8.29
0.13%
00904788031
0
$0.00
0.00%
1
$0.48
0.06%
00904788036
0
$0.00
0.00%
1
$2.05
0.06%
24385006003
0
$0.00
0.00%
4
$26.10
0.25%
24385006103
TRIPLE ANTIB OIN
1
$7.65
0.06%
0
$0.00
0.00%
37205027310
TRIPLE ANTIB OIN
18
$83.91
1.10%
11
$63.48
0.69%
Page 475 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TOPICAL - ANTIBIOTIC
37205027510
45802004611
GENTAMICIN OIN 0.1%
45802004635
GENTAMICIN OIN 0.1%
45802005611
$92.13
1.10%
19
$124.47
1.19%
1
$5.98
0.06%
7
$37.05
0.43%
1
$5.49
0.06%
7
$28.00
0.44%
GENTAMICIN CRE 0.1%
0
$0.00
0.00%
4
$22.48
0.25%
45802005635
GENTAMICIN CRE 0.1%
9
$35.65
0.55%
9
$31.35
0.57%
45802006001
45802006003
1
$1.72
0.06%
0
$0.00
0.00%
1
$5.49
0.06%
6
$43.06
0.38%
45802006070
1
$3.84
0.06%
0
$0.00
0.00%
45802011222
MUPIROCIN OIN 2%
2
$78.50
0.12%
256
$5,595.88
16.10%
49348002972
SM TRIPLE
1
$6.54
0.06%
0
$0.00
0.00%
50428219634
1
$3.99
0.06%
1
$1.49
0.06%
51672201602
TRPL ANTIBIO OIN
1
$6.18
0.06%
0
$0.00
0.00%
52735080226
TRIPLE ANTIB OIN
0
$0.00
0.00%
3
$15.45
0.19%
55045142206
61570003150
CORTISPORIN OIN 1%
68115098730
OIN ANTIBIOT
18
1
$5.29
0.06%
1
$5.52
0.06%
11
$526.21
0.67%
6
$212.07
0.38%
0
$0.00
0.00%
1
$7.80
0.06%
TOPICAL - ANTIPRURITICS
00064360045
PRUDOXIN
CRE 5%
4
$179.74
8.00%
1
$42.47
2.56%
62436052330
ZONALON
CRE 5%
40
$2,104.51
80.00%
30
$1,640.25
76.92%
62436052345
ZONALON
CRE 5%
6
$327.56
12.00%
8
$557.51
20.51%
TOPICAL - ANTISEBORRHEICS
00064410050
OVACE
AER 10%
1
$37.30
0.51%
0
$0.00
0.00%
00064420060
OVACE
GEL 10%
0
$0.00
0.00%
1
$72.41
0.47%
00072685004
CAPITROL
SHA 2%
6
$98.77
3.08%
13
$279.58
6.16%
00145098605
ZNP
0
$0.00
0.00%
1
$6.63
0.47%
BAR
Page 476 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TOPICAL - ANTISEBORRHEICS
00182608837
SELENIUM SUL SHA 2.5%
8
$78.49
4.10%
35
$325.13
16.59%
00472153304
12
$110.60
6.15%
2
$22.20
0.95%
00677055241
3
$23.96
1.54%
1
$8.82
0.47%
00904153320
8
$107.80
4.10%
3
$34.70
1.42%
45802004064
SELENIUM SUL LOT 2.5%
84
$921.63
43.08%
123
$1,381.81
58.29%
60432052804
73
$723.40
37.44%
32
$347.44
15.17%
TOPICAL - ANTISEPTICS / DISINFECTANTS
00024153502
PHISOHEX
LIQ 3%
44
$797.72
40.00%
41
$786.66
37.61%
00024153506
PHISOHEX
LIQ 3%
43
$1,393.51
39.09%
39
$1,274.48
35.78%
00024153508
PHISOHEX
LIQ 3%
1
$8.02
0.91%
0
$0.00
0.00%
00024153548
PHISOHEX
LIQ 3%
0
$0.00
0.00%
2
$143.36
1.83%
00034210080
BETADINE
SOL 10%
0
$0.00
0.00%
1
$12.93
0.92%
00034340489
BETASEPT
LIQ 4%
0
$0.00
0.00%
1
$5.49
0.92%
00310057508
HIBICLENS
LIQ 4%
0
$0.00
0.00%
3
$42.39
2.75%
00884398603
LAZERFORMALY SOL 10%
5
$117.28
4.55%
8
$334.00
7.34%
00884478902
FORMALYDE-10 AER 10% SPRA
2
$52.92
1.82%
0
$0.00
0.00%
08213010040
IODOSORB
12
$520.98
10.91%
11
$599.65
10.09%
45802005207
POVIDONE-IOD SOL 10%
3
$12.48
2.73%
3
$12.48
2.75%
GEL
TOPICAL - ANTIVIRALS
00067315510
DENAVIR
CRE 1%
0
$0.00
0.00%
74
$1,949.25
10.68%
00067602415
DENAVIR
CRE 1%
182
$4,578.98
26.26%
221
$5,868.16
31.89%
00078036964
DENAVIR
CRE 1%
148
$3,968.50
21.36%
43
$1,079.31
6.20%
00135031552
DENAVIR
CRE 1%
9
$205.93
1.30%
1
$58.72
0.14%
00173099341
ZOVIRAX
OIN 5%
57
$1,602.39
8.23%
5
$482.46
0.72%
00173099394
ZOVIRAX
OIN 5%
93
$7,564.34
13.42%
19
$1,425.30
2.74%
Page 477 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TOPICAL - ANTIVIRALS
64455099394
ZOVIRAX
OIN 5%
176
$13,737.83
25.40%
251
$19,712.12
36.22%
64455099442
ZOVIRAX
CRE 5%
19
$621.07
2.74%
38
$1,338.93
5.48%
64455099445
ZOVIRAX
CRE 5%
9
$766.02
1.30%
41
$4,797.13
5.92%
TOPICAL - ANTNEOPLASTICS
00023081230
FLUOROPLEX CRE 1%
7
$483.91
20.59%
3
$248.95
6.38%
00066715030
CARAC
CRE 0.5%
3
$265.39
8.82%
1
$96.83
2.13%
00187320210
EFUDEX
SOL 2%
1
$64.86
2.94%
0
$0.00
0.00%
00187320426
EFUDEX
CRE 5%
21
$1,947.26
61.76%
17
$1,743.46
36.17%
00187320447
EFUDEX
CRE 5%
0
$0.00
0.00%
21
$2,870.22
44.68%
62436000350
SOLARAZE
2
$187.62
5.88%
5
$511.31
10.64%
GEL 3% W/W
TOPICAL - ASTRINGENTS / PROTECTANTS
00003324908
ALOE VESTA OIN PROTECTV
0
$0.00
0.00%
1
$7.21
0.65%
00064030004
PROSHIELD
0
$0.00
0.00%
9
$103.35
5.81%
00096070735
DRYSOL
SOL 20%
29
$232.82
25.66%
32
$264.61
20.65%
00096070737
DRYSOL
SOL 20%
15
$127.57
13.27%
14
$112.08
9.03%
00096070760
DRYSOL
SOL 20%
10
$108.80
8.85%
15
$150.90
9.68%
00096070935
XERAC-AC
SOL 6.25%
2
$17.62
1.77%
4
$27.11
2.58%
00096070960
XERAC-AC
SOL 6.25%
5
$46.81
4.42%
2
$16.78
1.29%
00182507945
MOISTURIN
CRE DRY SKIN
1
$13.53
0.88%
0
$0.00
0.00%
00904775127
DRY SKIN
1
$9.91
0.88%
1
$9.91
0.65%
53303001030
CARRASYN
2
$38.48
1.77%
0
$0.00
0.00%
59366271003
ALUMINUM CL SOL 20%
30
$239.98
26.55%
50
$468.04
32.26%
59366271004
ALUMINUM CL SOL 20%
6
$39.26
5.31%
11
$93.91
7.10%
59366271006
ALUMINUM CL SOL 20%
12
$116.77
10.62%
16
$174.39
10.32%
CRE PLUS
CRE
GEL DRESSING
Page 478 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TOPICAL - BURN PRODUCTS
00591081046
SILVER SULFA CRE 1%
7
$144.27
1.83%
7
$122.15
1.76%
00591081055
SILVER SULFA CRE 1%
95
$1,208.57
24.80%
43
$354.09
10.80%
00591081083
SILVER SULFA CRE 1%
8
$48.78
2.09%
5
$26.96
1.26%
00904510850
THERMAZENE CRE 1%
0
$0.00
0.00%
1
$6.20
0.25%
08880950502
THERMAZENE CRE 1%
0
$0.00
0.00%
4
$16.04
1.01%
08880950505
THERMAZENE CRE 1%
0
$0.00
0.00%
5
$32.50
1.26%
08880950540
THERMAZENE CRE 1%
0
$0.00
0.00%
2
$31.64
0.50%
08880950550
THERMAZENE CRE 1%
2
$8.36
0.52%
13
$55.59
3.27%
49884060036
SSD
CRE 1%
82
$594.57
21.41%
100
$701.47
25.13%
49884060040
SSD
CRE 1%
44
$1,049.80
11.49%
38
$876.81
9.55%
49884060057
SSD
CRE 1%
25
$165.46
6.53%
47
$340.82
11.81%
49884060058
SSD
CRE 1%
46
$352.16
12.01%
35
$260.43
8.79%
49884060085
SSD
CRE 1%
62
$809.28
16.19%
90
$1,076.26
22.61%
49884060136
SSD AF
CRE 1%
5
$40.45
1.31%
5
$41.68
1.26%
49884060140
SSD AF
CRE 1%
3
$83.53
0.78%
0
$0.00
0.00%
52544081055
SILVER SULFA CRE 1%
0
$0.00
0.00%
1
$5.82
0.25%
52544081085
SILVER SULFA CRE 1%
2
$25.54
0.52%
0
$0.00
0.00%
61570013120
SILVADENE
CRE 1%
2
$13.00
0.52%
0
$0.00
0.00%
61570013140
SILVADENE
CRE 1%
0
$0.00
0.00%
1
$9.13
0.25%
61570013150
SILVADENE
CRE 1%
0
$0.00
0.00%
1
$9.99
0.25%
TOPICAL - DEPIGMENTING AGENTS
00187039631
SOLAQUIN FOR CRE 4%
0
$0.00
0.00%
1
$47.16
33.33%
00187042046
GLYQUIN
CRE 4% W/SUN
1
$53.38
12.50%
1
$55.25
33.33%
00299595030
TRI-LUMA
CRE
4
$325.28
50.00%
1
$79.47
33.33%
59366278503
HYDROQUINONE CRE 4%
2
$78.65
25.00%
0
$0.00
0.00%
59366278703
HYDROQUINONE CRE 4%/SUNS
1
$71.49
12.50%
0
$0.00
0.00%
Page 479 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TOPICAL - EMOLLIENTS
00062018503
RENOVA
CRE 0.05%
0
$0.00
0.00%
4
$434.30
0.79%
00062018505
RENOVA
CRE 0.05%
3
$210.31
0.56%
4
$321.63
0.79%
00062018702
RENOVA
CRE 0.02%
0
$0.00
0.00%
1
$87.84
0.20%
00066060303
VANAMIDE
CRE 40%
13
$534.65
2.43%
1
$3.68
0.20%
00066060307
VANAMIDE
CRE 40%
4
$309.62
0.75%
6
$349.75
1.19%
00072571208
LAC-HYDRIN LOT 12%
81
$3,237.65
15.14%
88
$3,549.72
17.43%
00072571214
LAC-HYDRIN LOT 12%
77
$4,533.80
14.39%
110
$6,431.62
21.78%
00072573028
LAC-HYDRIN CRE 12%
148
$5,110.80
27.66%
194
$6,820.68
38.42%
00072573038
LAC-HYDRIN CRE 12%
32
$1,625.46
5.98%
60
$2,994.31
11.88%
00072576004
LAC-HYDRIN LOT FIVE
0
$0.00
0.00%
2
$11.78
0.40%
00245002322
AMLACTIN
LOT 12%
1
$10.28
0.19%
0
$0.00
0.00%
00245002414
AMLACTIN
CRE 12%
4
$35.25
0.75%
1
$17.82
0.20%
00259030320
MEDERMA
GEL
1
$36.87
0.19%
0
$0.00
0.00%
00299391816
CETAPHIL
LOT MOISTURE
1
$8.97
0.19%
0
$0.00
0.00%
00299392116
CETAPHIL
LOT CLEANSER
1
$8.96
0.19%
0
$0.00
0.00%
00299392804
CETAPHIL
LOT SPF 15
0
$0.00
0.00%
1
$18.55
0.20%
00574202108
LACLOTION LOT 12%
32
$1,139.29
5.98%
5
$149.02
0.99%
00574202116
LACLOTION LOT 12%
24
$1,242.52
4.49%
0
$0.00
0.00%
00884044904
UREACIN-20 CRE 20%
5
$57.71
0.93%
2
$58.23
0.40%
00884499004
LACTINOL-E CRE
3
$77.00
0.56%
2
$73.00
0.40%
00884529212
LACTINOL
LOT 10%
0
$0.00
0.00%
1
$56.05
0.20%
10337065219
CARMOL 40
CRE 40%
13
$543.54
2.43%
4
$241.13
0.79%
10337065249
CARMOL 40
CRE 40%
9
$600.86
1.68%
1
$100.52
0.20%
10337065252
CARMOL 40
CRE 40%
4
$110.78
0.75%
2
$90.36
0.40%
10337065651
CARMOL 40
LOT
2
$147.73
0.37%
0
$0.00
0.00%
10337065715
CARMOL 40
GEL 40%
0
$0.00
0.00%
2
$284.22
0.40%
Page 480 of 505
Utilization Report
PDL Category
NDC
Q4 2003
# of Scripts
Description
$
Q4 2004
Market Share*
# of Scripts
$
Market Share*
TOPICAL - EMOLLIENTS
45802041954
AMMONIUM LAC LOT 12%
0
45802049326
AMMONIUM LAC CRE 12%
14
45802049383
61
50383066308
UREA
LOT 40%
1
50383066403
UREA
CRE 40%
0
50383066430
UREA
CRE 40%
51672130104
59366222603
UREA
60258004512
LACTIC ACID LOT 10%
CRE 40%
$0.00
0.00%
1
$5.11
0.20%
$571.56
2.62%
$1,617.81
11.40%
1
$44.43
0.20%
6
$163.48
1.19%
$69.55
0.19%
0
$0.00
0.00%
$0.00
0.00%
2
$96.96
0.40%
0
$0.00
0.00%
1
$23.09
0.20%
1
$34.67
0.19%
1
$2.07
0.20%
0
$0.00
0.00%
1
$42.70
0.20%
0
$0.00
0.00%
1
$35.09
0.20%
TOPICAL - ENZYMES / KERATOLYTICS / UREA
00064341007
PANAFIL
OIN
0
$0.00
0.00%
3
$705.97
0.39%
00064341030
PANAFIL
OIN
89
$6,693.94
24.12%
92
$6,932.04
11.93%
00064351033
PANAFIL
LIQ SPRAY
00064390060
XENADERM
00064401013
SALEX
00074231650
SANTYL
00574060115
PODOCON
00603127054
GRANUL-DERM AER
50484022030
GLADASE-C
50484052715
SANTYL
50484052730
SANTYL
53706100101
TBC
AER
58980076511
ZIOX
OIN
60258003130
0
$0.00
0.00%
28
$1,994.77
3.63%
259
$12,255.73
70.19%
614
$30,041.95
79.64%
0
$0.00
0.00%
1
$37.50
0.13%
OIN 250/GM
0
$0.00
0.00%
2
$58.60
0.26%
SOL 25%
1
$47.59
0.27%
2
$110.66
0.26%
1
$15.44
0.27%
3
$48.88
0.39%
0
$0.00
0.00%
4
$227.64
0.52%
OIN 250/GM
1
$29.09
0.27%
0
$0.00
0.00%
OIN 250/GM
7
$354.40
1.90%
1
$53.83
0.13%
2
$34.31
0.54%
5
$90.50
0.65%
5
$364.55
1.36%
4
$190.14
0.52%
PAPA-UREA-CH OIN
0
$0.00
0.00%
2
$115.94
0.26%
62794000250
GRANULEX
AER
0
$0.00
0.00%
1
$16.10
0.13%
62794000251
GRANUL

Supplemental Rebate Utilization Report

Transcription

Similar documents

Utilization Report

Colorado Health OP Formulary

mhccr Formulary